Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6507536727630133,-2.3732790149642855,0.0,0.0,0.0,63/87,19.39%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6407794088060491,-2.3676444551340583,0.0,0.0,0.0,67/91,19.83%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;SSR1;RPL10A;RPL3;RPL12;TRAM1;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10;SSR2;ARL6IP1
prerank,protein targeting to ER (GO:0045047),-0.6168175047999314,-2.3016379852899664,0.0,0.0,0.0,67/99,19.73%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;ZFAND2A;RPS17;RPL32;RPL39;RPL14;SPCS3;RPS2;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;SEC61G;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10;SPCS1
prerank,cytoplasmic translation (GO:0002181),-0.6215715420371893,-2.254795733835886,0.0,0.00023076524679560003,0.001,64/91,19.39%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;EIF3M;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;EIF3I;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;RPS10
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.627857174025289,-2.076899777259238,0.0,0.00793832448976864,0.038,16/46,9.25%,ATP1A2;CDH2;SHANK3;GRM7;GRM3;NRXN1;DGKI;GRM5;GRM1;MEF2C;GRIK1;OPHN1;CACNG4;GRM8;CACNG7;SYT1
prerank,organic anion transport (GO:0015711),0.7390054326143385,2.0341629449567917,0.0,0.01761069871788871,0.017,9/76,2.41%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;LRRC8D;SLCO2A1;SLCO4A1;ABCG2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5355575910327548,-2.0339880651195457,0.0,0.013384384314144801,0.074,66/110,19.39%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;SMG7;CTIF;RPL10A;RPL3;RPL12;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;MAGOH;RPS10
prerank,bicarbonate transport (GO:0015701),0.8637130388768693,2.0046893769538743,0.0,0.020200507352872345,0.032,3/25,0.03%,SLC4A10;SLC26A7;SLC4A4
prerank,response to glucocorticoid (GO:0051384),0.8474889520981708,1.9696126889782097,0.0,0.04281816943172942,0.099,7/26,7.16%,SLIT3;SLIT2;ADAM9;ANXA1;FAM107A;ISL1;IL10
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6248770291460283,-1.956665901450405,0.0,0.044175061529443435,0.247,19/41,18.02%,IL34;TGFA;GRM5;NEDD9;ACE;DOCK3;EPHA4;GPRC5B;ADRA2A;LRP8;NTRK2;GAS6;HBEGF;CSF1R;AGT;NOX4;FCGR1A;RELN;ERBB3
prerank,regulation of intracellular pH (GO:0051453),0.7971608804500694,1.945853543586671,0.0014044943820224719,0.05878865601412849,0.166,10/34,8.86%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC4A8;SLC9A1
prerank,regulation of BMP signaling pathway (GO:0030510),0.7074720713730469,1.9430006456953053,0.0,0.05013869517328316,0.173,22/73,9.06%,BMPER;BMP4;CRIM1;FSTL1;HTRA3;SMAD9;FOXD1;VWC2;CCN1;SMAD6;SULF1;SKIL;BMPR1A;ZNF423;SFRP4;NOG;SKI;BAMBI;GDF5;NBL1;CHRD;UBE2D3
prerank,ion homeostasis (GO:0050801),0.8065199490861106,1.9410022997882725,0.0,0.045062670248715235,0.189,5/30,1.93%,SLC4A10;SLC4A4;FHL1;CAMK2D;WNK1
prerank,cation transport (GO:0006812),0.6526103280328595,1.924843827096419,0.0,0.06230339630446343,0.284,18/166,3.29%,SLC47A1;SLC4A4;PIEZO2;SLC23A1;SLC9B2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC5A6;KCNMB3;KCNMB2;ATP1B1;KCNJ15;KCNS3;ANO6;TRPM6;FGF13
prerank,positive regulation of blood coagulation (GO:0030194),0.8739599421154044,1.9011995605807763,0.0,0.09504597690389938,0.44,5/17,2.98%,F3;ST3GAL4;THBS1;ANO6;THBD
prerank,regulation of cellular pH (GO:0030641),0.8011501937884734,1.8994431433786052,0.0,0.08805349358944357,0.453,11/29,8.86%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC4A8;ATP1A4;SLC9A1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6959561079885076,1.899171759867156,0.0,0.07935173657589856,0.453,21/79,9.33%,SLIT2;BMPER;THBS1;CRIM1;HTRA3;SMAD9;VWC2;NEDD4;SMAD6;SULF1;SKIL;BMPR1A;FGF2;ATP2B4;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3;NIBAN2
prerank,response to ketone (GO:1901654),0.8274595877180457,1.893991757898538,0.0,0.08249717688166049,0.488,4/24,1.84%,SLIT3;SLIT2;THBS1;TGFB3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8211996044784434,-1.893260691608756,0.0,0.10880581386412543,0.546,6/10,13.42%,LYN;RAPGEF2;CXCL12;GAS6;AXL;CCL19
prerank,cellular component maintenance (GO:0043954),-0.7812144324921874,-1.878762500922962,0.0026041666666666665,0.12010049066562117,0.629,4/12,7.80%,IGF1R;ITGA3;INSR;CLDN1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7982823253528258,-1.8787261820316348,0.0,0.10809044159905905,0.629,7/12,14.45%,IL34;LYN;CSF1;BST2;PTK2;MAPK3;CSF1R
prerank,chloride transport (GO:0006821),0.6900131257260724,1.8729900933929164,0.0012391573729863693,0.12016712066324062,0.629,11/74,4.00%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;SLC12A8;ANO6;GLRB;ANO9;SLC26A6;GABRA3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.9262434430917604,1.8554327661533039,0.0,0.16407433782865546,0.751,3/11,1.53%,EGFR;BMP4;DDX5
prerank,cellular response to drug (GO:0035690),-0.6513470087253764,-1.8517074096364607,0.008823529411764706,0.14760584331398563,0.76,11/25,13.77%,PDE4B;PPM1E;ACER2;TFRC;RAP2A;MEF2C;AIM2;GAS6;KCNQ1;CERS1;PPM1F
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.7171599212961667,1.8401954760381747,0.0,0.20696270720140644,0.856,15/51,9.06%,BMPER;CRIM1;FSTL1;HTRA3;SMAD9;VWC2;SMAD6;SKIL;BMPR1A;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6812802640646048,-1.839570606410484,0.0,0.1573049765656674,0.813,5/19,2.83%,TJP1;PRKCH;CLDN5;OCLN;F11R
prerank,ion transport (GO:0006811),0.6503223382617133,1.831703494835806,0.0,0.2298368836593476,0.894,11/111,3.83%,SLC26A7;PIEZO2;SLC9A2;SLC26A2;SLC12A7;SLC12A2;SLC24A3;WNK1;ANO6;GLRB;SLC26A6
prerank,endodermal cell differentiation (GO:0035987),0.7571982627755052,1.825089646316528,0.0029717682020802376,0.2454491133805739,0.915,10/31,6.67%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;ITGAV;COL11A1;SETD2
prerank,acute inflammatory response (GO:0002526),0.7855459021979472,1.8249517842940663,0.0074850299401197605,0.23125467693559748,0.915,5/23,6.55%,F3;LBP;ANO6;VNN1;PLSCR1
prerank,inorganic anion transport (GO:0015698),0.6985316370773865,1.8201559047406726,0.0013333333333333333,0.2371113683585016,0.929,6/53,3.83%,SLC4A10;SLC26A7;CLIC4;ANO6;ANO9;SLC26A6
prerank,cellular response to copper ion (GO:0071280),-0.7274102646236376,-1.8193124841882673,0.002717391304347826,0.18865946484181825,0.879,11/16,19.05%,SNCA;MT2A;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;MT3
prerank,endoderm formation (GO:0001706),0.7328823867554333,1.8099102098803892,0.0042796005706134095,0.2696672317606117,0.952,12/35,9.32%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;ITGAV;COL11A1;SETD2;DUSP5;MMP14
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.7874171574751979,1.8097466566912475,0.0015060240963855422,0.2569608127630762,0.952,4/23,3.15%,SLC12A7;SLC12A2;SLC12A8;ATP6V0A4
prerank,monosaccharide transmembrane transport (GO:0015749),0.8371923354838944,1.8055340869135466,0.0049261083743842365,0.2621872932369146,0.956,2/16,0.16%,SLC23A1;SLC23A2
prerank,neuron cell-cell adhesion (GO:0007158),-0.7293498749945895,-1.8025269655116762,0.0025188916876574307,0.21830392346863764,0.922,6/14,7.64%,NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,organic cation transport (GO:0015695),0.8032824608349117,1.796490208489436,0.0031847133757961785,0.2889755562344466,0.971,1/19,0.02%,SLC47A1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8007412299203833,1.7940008627190904,0.006230529595015576,0.287401198257923,0.975,6/20,7.02%,SMOC2;THBS1;SULF1;FGF2;NOG;LRIT3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5033547682811569,-1.785319133971312,0.0,0.2514418129084858,0.956,38/69,28.21%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX6C;COX8A;CYCS;AFG1L;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;CYC1;UQCRC1;NDUFA2;NDUFA6;UQCRB;SDHC;NDUFA10;NDUFS6;NDUFV3;COA6
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7099559022801443,1.7839919648348332,0.0013605442176870747,0.32424404109995103,0.985,7/40,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6
prerank,aerobic electron transport chain (GO:0019646),-0.5031539406022197,-1.7771017411118573,0.0,0.26041858100883464,0.968,37/68,27.98%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX6C;COX8A;CYCS;AFG1L;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;CYC1;UQCRC1;NDUFA2;NDUFA6;UQCRB;SDHC;NDUFA10;NDUFS6;NDUFV3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8042044996026196,1.767989802144049,0.0031446540880503146,0.39704874144661095,0.996,8/18,15.39%,EGFR;BMP4;DDX5;ESR1;NCOR1;ZC3H12A;NCOR2;MAP2K2
prerank,response to copper ion (GO:0046688),-0.6720297599027989,-1.7678833280900377,0.0,0.2726287774495783,0.982,14/20,24.84%,SNCA;MT2A;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;ATP5F1D;MT3;AQP1;IL1A
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7589471629860373,-1.7658519561606758,0.002531645569620253,0.2642518481639393,0.985,5/10,13.41%,PDE4B;CALM1;CACNA2D1;NOS1AP;CALM3
prerank,collagen fibril organization (GO:0030199),0.6444759007557682,1.7619949379040547,0.0,0.41927009639896584,0.996,22/88,6.23%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;COL6A1;COL5A2;CYP1B1;PLOD2;BMP1;DDR2;COL3A1;COL23A1;LOXL1;COL6A3;TGFBR1;P3H2;P4HA1;COL11A1;P4HA2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6882229256705014,1.761822766586507,0.0028011204481792717,0.40466239515810953,0.997,4/45,1.53%,SLC38A2;EGFR;BMP4;DDX5
prerank,regulation of phagocytosis (GO:0050764),-0.5358286152444095,-1.7587952897830246,0.004329004329004329,0.2701653763011225,0.989,27/53,23.30%,CAMK1D;MERTK;TGM2;IL15RA;DYSF;CD47;SYT7;SIRPA;GATA2;SYT11;GAS6;SPHK1;DOCK2;CALR;CYBA;SCARB1;HCK;LYAR;RACK1;SNX3;PRTN3;TREM2;SYK;AHSG;RAB27A;PLA2G5;PYCARD
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.6138626978773526,-1.7570878322351924,0.008955223880597015,0.2615954837674922,0.99,12/26,16.57%,LYN;PICALM;MBP;GRIN2B;EPHA4;AIM2;GRIN1;ROCK2;APH1B;PSME2;TTBK1;VSIR
prerank,cGMP-mediated signaling (GO:0019934),-0.7301880054423069,-1.7562630489383546,0.007246376811594203,0.25138027550934033,0.99,6/13,7.70%,IRAG1;APOE;GUCY1B1;KCNC2;PDE2A;HTR2C
prerank,carbohydrate transport (GO:0008643),0.8633544893132551,1.7562429917255897,0.00667779632721202,0.4231007364238977,0.999,3/11,3.83%,SLC23A1;SLC23A2;SLC26A6
prerank,positive regulation of phosphatase activity (GO:0010922),-0.6396014622559553,-1.7555257164502185,0.012084592145015106,0.24196785059458645,0.99,9/21,9.40%,ITGA1;PDGFRB;CALM1;MEF2C;BMP2;CD300A;HSP90AB1;PPP1R15B;PLEK
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.8401835852712026,1.7550133823180936,0.00667779632721202,0.4157625200355106,0.999,8/15,10.34%,BMP4;SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.7012963932477326,1.7540876216115788,0.004297994269340974,0.40742869445562535,0.999,7/39,2.75%,STK39;FHL1;PTPN3;NEDD4;ANK2;FXYD5;WWP2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6251187052154352,1.75007389711948,0.0011890606420927466,0.41704273244639684,0.999,28/104,11.05%,BMPER;CRIM1;CCN3;HTRA3;SMAD9;VWC2;CD109;SMAD6;SKIL;BMPR1A;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;NOG;SKI;BAMBI;IL17RD;TGFB1I1;NBL1;IGSF1;CHRD;UBE2D3;ACVR1;LDLRAD4;BCL9L;SMAD2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7521317966960591,-1.7495731612305043,0.007556675062972292,0.24738034456488325,0.992,5/11,5.95%,PLCB1;IGF1;IGF1R;PIK3R1;GHR
prerank,sulfate transport (GO:0008272),0.8302252964220976,1.7430958824581246,0.009819967266775777,0.4438284548203203,0.999,3/14,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6670141180042122,-1.7400428262543608,0.004962779156327543,0.26284161610018847,0.994,12/17,21.55%,COX4I1;COX7C;COX5B;COX6B1;COX6C;COX8A;CYCS;AFG1L;NDUFA4;COX6A1;COX4I2;COX10
prerank,positive regulation of heart contraction (GO:0045823),-0.6584098640984961,-1.7387012392736205,0.0028169014084507044,0.25587250564696135,0.994,8/19,14.09%,ATP1A2;RYR2;KCNQ1;EDN1;ADM;ATP2A2;GSK3A;CHGA
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7612155159089705,-1.735775615090215,0.00702576112412178,0.25412579024044696,0.996,3/10,11.66%,ATP1A2;ADRA2A;BIN1
prerank,positive regulation of chemotaxis (GO:0050921),0.6836870399836267,1.7323975726532135,0.0013717421124828531,0.4935704383981537,1.0,7/43,3.98%,SMOC2;F3;THBS1;MET;NTRK3;FGF2;NRP1
prerank,embryonic skeletal system development (GO:0048706),0.7072512286656102,1.7323152985544286,0.007331378299120235,0.47951068585144047,1.0,11/35,6.72%,KIAA1217;SIX1;PCSK5;WNT9A;WNT11;HOXA3;SULF1;NOG;XYLT1;HOXB3;HOXC4
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6950312686241339,-1.7249384080739674,0.015873015873015872,0.27582429794768903,1.0,7/15,21.27%,ATP1A2;ADRA2A;SLC30A1;TMBIM6;STC1;TRIM27;INPP5K
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.658317038811528,-1.7224500727887944,0.00546448087431694,0.2732590186698184,1.0,4/18,7.60%,IGF1;IGFBP2;RPS3;IL18
prerank,sprouting angiogenesis (GO:0002040),0.6664811313201574,1.7212548289058085,0.004,0.5362235775999828,1.0,11/51,3.98%,RSPO3;SLIT2;BMPER;THBS1;BMP4;PGF;PTK2B;SEMA3E;PARVA;FGF2;NRP1
prerank,mesonephric tubule development (GO:0072164),0.8192620032724933,1.721143769907296,0.00684931506849315,0.521875215600702,1.0,5/15,2.04%,SLIT2;BMP4;SIX1;PKD1;WNT11
prerank,regulation of cellular senescence (GO:2000772),-0.5831284109692533,-1.7201695860034967,0.0,0.26982027546017956,1.0,10/28,14.14%,SLC30A10;B2M;AKT3;CDK6;NUAK1;YPEL3;ABI3;YBX1;RBL1;VASH1
prerank,response to interferon-alpha (GO:0035455),-0.6610541000407861,-1.7194263794287399,0.015,0.26285700044997484,1.0,7/16,10.81%,IFNAR1;IFITM1;BST2;IFNAR2;IFITM3;GAS6;AXL
prerank,ureteric bud development (GO:0001657),0.7892287371459678,1.718154489624396,0.0067226890756302525,0.5283769573990394,1.0,5/17,2.20%,SLIT2;BMP4;SIX1;WNT11;GPC3
prerank,chemical homeostasis (GO:0048878),0.6500807701373071,1.7179456697885438,0.006510416666666667,0.5158898800887399,1.0,8/61,8.09%,SLC4A10;SLC4A4;WNK1;PNPLA3;RBP1;SLC4A2;ACOX3;SLC4A8
prerank,positive regulation of hemostasis (GO:1900048),0.8698739660422572,1.7170945071876935,0.008403361344537815,0.495145512922521,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),0.8698739660422572,1.7170945071876935,0.008403361344537815,0.495145512922521,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8569297003078895,1.7168649980081712,0.0073937153419593345,0.48428158152908607,1.0,2/11,0.41%,SLIT2;CCN3
prerank,extracellular matrix organization (GO:0030198),0.56734306362983,1.7155190073558797,0.0,0.481211109224102,1.0,53/276,6.52%,COL25A1;COL8A1;ADAMTSL3;COL12A1;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;TLL1;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;CYP1B1;MMP28;PLOD2;BMP1;DDR2;FN1;DSPP;CD44;SMOC1;GSN;COL3A1;COL23A1;ITGB1;CAPN2;FGF2;ADAMTSL5;LOXL1;COL6A3;HTRA1;TGFBR1;ITGB5;P3H2;ITGA10;P4HA1;ITGA5;ADAM12;MMP16;ITGAV;TIMP2;COL11A1;P4HA2;ADAMTS5;FLRT2
prerank,renal water homeostasis (GO:0003091),-0.6149230216801942,-1.7149978022066192,0.0058997050147492625,0.26509716028660996,1.0,9/23,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;AQP4;ADCY2
prerank,negative regulation of leukocyte migration (GO:0002686),0.8565448206940586,1.7139976067240623,0.005136986301369863,0.47915073433664657,1.0,2/10,1.20%,SLIT2;BMP5
prerank,ceramide transport (GO:0035627),-0.7312454304043727,-1.71124820976921,0.009685230024213076,0.26699539054250926,1.0,6/12,21.19%,PLTP;CERT1;ABCB4;PSAP;ABCA2;SGPP1
prerank,digestive tract development (GO:0048565),0.6996387307616916,1.7101492182494293,0.005943536404160475,0.4918517472131191,1.0,15/32,12.18%,PCSK5;RARB;PKD1;COBL;SMO;GLI3;STRA6;CLMP;GATA4;AGR2;EPHB3;GLI2;CCDC40;MEGF8;NIPBL
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5645187304030219,-1.7044825947553146,0.0034602076124567475,0.27630292216326513,1.0,15/35,7.70%,KSR1;IRAG1;APOE;PDE7B;ADCY1;RAPGEF3;RAPGEF2;GUCY1B1;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A;HTR2C
prerank,epiboly involved in wound healing (GO:0090505),0.7837215279740712,1.7032637181050378,0.012965964343598054,0.5233485289574928,1.0,5/16,9.06%,TMEFF2;CCN1;CD44;MRTFA;RHOA
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.696515493584153,1.7032099291301583,0.0043541364296081275,0.5121740676994156,1.0,10/35,6.36%,NR3C2;NEDD4;DDX5;RBFOX2;ESR2;PMEPA1;DDX17;ESR1;UBR5;TADA3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8292038707134466,1.7026921584609034,0.009950248756218905,0.5042963537738345,1.0,1/13,0.01%,SLC4A10
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5506763492702734,-1.7001174039879272,0.017921146953405017,0.2798503722316524,1.0,17/37,9.82%,PLCB1;GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRIN2A;GRM1;APP;GRIN2B;GRIK1;GRIA3;GRM8;GRIN1;CPEB4;GRIA2
prerank,xenobiotic transport (GO:0042908),0.776674273972014,1.6961721674406647,0.013975155279503106,0.5326804727388839,1.0,2/16,2.41%,SLC47A1;ABCG2
prerank,response to glucagon (GO:0033762),-0.6386631501751672,-1.694757947908671,0.021052631578947368,0.28723020604010063,1.0,9/19,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6557048746799905,-1.6944753123104725,0.020356234096692113,0.2801746501928357,1.0,9/17,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2
prerank,aorta development (GO:0035904),-0.6903063588499841,-1.6931161458146415,0.01937046004842615,0.2763445014870121,1.0,7/14,9.85%,ROBO1;PDGFRB;ADAMTS9;ROBO2;TBX1;PDE2A;EFEMP2
prerank,sulfur compound transport (GO:0072348),0.7251518963959717,1.6921721523194861,0.01228878648233487,0.5455511169449199,1.0,5/27,3.83%,SLC26A7;SLC5A6;LRRC8D;ABCG2;SLC26A6
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.7285917943340418,1.6921441741971357,0.011834319526627219,0.5348887162349799,1.0,5/27,5.94%,EGFR;BMP4;DDX5;EIF4G1;STAT3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7763032140029438,1.691516703993596,0.0140625,0.5283818982104257,1.0,6/17,8.59%,BMP4;SOX9;FGF2;TMEM100;SFRP4;ATOH8
prerank,regulation of fibrinolysis (GO:0051917),0.8316106041138949,1.6881943008412097,0.014634146341463415,0.5381223911398302,1.0,2/13,2.98%,THBS1;THBD
prerank,transepithelial transport (GO:0070633),0.7981474817328132,1.6874464025517657,0.015050167224080268,0.5323278352738059,1.0,6/15,3.83%,SLC23A1;SLC23A2;SLC12A2;CXADR;ABCG2;SLC26A6
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.664200847769731,-1.685780160280568,0.018276762402088774,0.288845215752261,1.0,6/16,6.28%,APOE;NOS3;GUCY1B1;NDNF;KCNC2;GUCY1A1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8366949612769058,1.681638840463439,0.018456375838926176,0.5586888657528029,1.0,6/11,6.70%,BMP4;ZFPM2;BMPR1A;ISL1;GATA4;JAG1
prerank,vesicle transport along actin filament (GO:0030050),-0.6290358022625664,-1.6799643499674664,0.010869565217391304,0.29772267071198494,1.0,7/19,17.23%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,regulation of acrosome reaction (GO:0060046),-0.7514422012890902,-1.6797910286630104,0.014669926650366748,0.2907642109624561,1.0,2/10,8.26%,PLCB1;GLRA1
prerank,organic acid transport (GO:0015849),0.5940173325318052,1.6780177902530786,0.004866180048661801,0.5709068329817377,1.0,9/94,2.41%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;SLC16A1;ABCG2
prerank,circulatory system development (GO:0072359),0.586716443901699,1.677610163153004,0.005701254275940707,0.5631168904109772,1.0,31/118,9.97%,MICAL2;PLCE1;NXN;ZFPM2;PCSK5;NTRK3;PKD1;SOX9;CACNA1C;FN1;AKAP13;CXADR;HDAC9;PDLIM7;COL3A1;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;PDLIM5;ID2;CDKN1B;FOXC1;GLI2;TNNI3;NF1;ACVR1
prerank,nucleotide biosynthetic process (GO:0009165),0.742172211436524,1.676538724863544,0.023696682464454975,0.5598166693571992,1.0,4/18,8.13%,ME1;NMNAT2;PRPS2;NMNAT1
prerank,positive regulation of potassium ion transport (GO:0043268),0.6780461975655716,1.675836403395282,0.004424778761061947,0.5542011871372909,1.0,6/38,2.72%,KCNJ2;FHL1;KCNMB3;KCNMB2;ANK2;KCNJ15
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5832147685506447,-1.6754352472952583,0.008241758241758242,0.29477164646778453,1.0,8/25,10.06%,ERRFI1;PPARA;SLC6A9;CBLB;CNRIP1;SOCS5;ZFYVE28;ACE2
prerank,positive regulation of phagocytosis (GO:0050766),-0.5193014385082985,-1.6736179669347868,0.011811023622047244,0.2927641764346846,1.0,23/47,23.30%,CAMK1D;MERTK;IL15RA;CD47;SIRPA;GATA2;GAS6;C4B;DOCK2;CALR;CYBA;MYO18A;C2;RAB31;LYAR;C3;CCL2;TREM2;PTPRJ;AHSG;RAB27A;PLA2G5;PYCARD
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.736765803763052,-1.673484501061507,0.02444987775061125,0.2862777052340579,1.0,2/10,1.97%,LYN;KIT
prerank,carboxylic acid transport (GO:0046942),0.6353866941443203,1.672787454136204,0.009358288770053475,0.5629805021838322,1.0,8/55,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC6A7;SLC38A6
prerank,positive regulation of wound healing (GO:0090303),0.6827316330589317,1.6716960679949344,0.017341040462427744,0.5601410769651602,1.0,8/36,3.69%,SMOC2;ST3GAL4;THBS1;ANXA1;PLPP3;ITGB1;PRKCE;FOXC2
prerank,ureteric bud morphogenesis (GO:0060675),0.7765704418184423,1.6694984049530162,0.01889763779527559,0.5643744942059745,1.0,5/16,6.04%,BMP4;SIX1;WNT11;FGF2;GDNF
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6756015918866276,1.6693705901801892,0.015558698727015558,0.5561238103664212,1.0,11/39,6.04%,SLIT2;BMP4;SIX1;MET;PKD1;LRP6;SEMA3E;FGF2;NRP1;TGFBR2;GDNF
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.8183835741040333,1.6675322385330609,0.025996533795493933,0.5575076937721912,1.0,7/12,10.34%,SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.6320386154857441,-1.6668397524661376,0.016574585635359115,0.2975403177547269,1.0,7/18,14.30%,CAMK1D;PRKD1;RPS6KA5;ADCY1;LRP8;CD200;EPHA5
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7359009018621528,1.6667834772455363,0.015313935681470138,0.553150751824567,1.0,7/21,4.10%,BMP4;CCN3;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.729302079832435,-1.666638337055884,0.010075566750629723,0.291379584953911,1.0,7/11,17.94%,MERTK;CXCL12;GAS6;AXL;CCL19;SELENOS;IRF7
prerank,heart development (GO:0007507),0.5694345345440132,1.666590368841698,0.003303964757709251,0.5456447891442134,1.0,38/150,10.34%,MICAL2;BMP4;PLCE1;ZFPM2;SGCD;PCSK5;NTRK3;PKD1;SOX9;BMP5;CACNA1C;CSRP3;FN1;AKAP13;GPC3;CXADR;HDAC9;PDLIM7;COL3A1;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;GATA4;PDLIM5;FLRT2;ID2;CDKN1B;FOXC1;GLI2;TNNI3;NF1;ACVR1;VEGFA
prerank,central nervous system neuron development (GO:0021954),-0.6502196762292697,-1.6651870783544638,0.007936507936507936,0.28970068417287637,1.0,6/15,8.24%,RAPGEF2;MAP2;LHX6;NTRK2;MAPT;HSP90AB1
prerank,protein hydroxylation (GO:0018126),0.7618914795181552,1.6650617346633014,0.020100502512562814,0.5460101393040951,1.0,7/15,14.54%,EGLN3;PLOD2;P3H2;P3H1;P3H4;JMJD4;P3H3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.766225939155767,1.662281112768513,0.027243589743589744,0.5543736633273922,1.0,5/16,6.04%,BMP4;SIX1;FOXD1;FGF2;GDNF
prerank,negative regulation of cartilage development (GO:0061037),0.8004724941811976,1.6602637946850938,0.03166666666666667,0.5577076724595051,1.0,7/13,7.23%,WNT9A;SOX9;WNT11;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,regulation of cell junction assembly (GO:1901888),-0.5710285357628104,-1.6602257911880494,0.0029411764705882353,0.2975595109957563,1.0,9/27,11.32%,TJP1;PRKCH;CLDN5;OCLN;RAPGEF2;F11R;MEF2C;RAPGEF1;ROCK2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.788607411810897,1.6558438348653506,0.011570247933884297,0.5749225035829756,1.0,3/14,1.93%,STK39;PTK2B;WNK1
prerank,ventricular septum morphogenesis (GO:0060412),0.7031417614663444,1.65394471103804,0.01661631419939577,0.5781340807672608,1.0,9/27,5.48%,SLIT3;SLIT2;BMP4;ZFPM2;HES1;BMPR1A;TGFBR1;TGFBR2;NOG
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6631564857023217,1.6532713435798654,0.012482662968099861,0.5739599553971054,1.0,13/43,8.59%,BMP4;KLF5;NFIB;SOX9;DDX5;FOXO3;KLF4;FGF2;NFATC4;STAT3;IL10;TEAD1;ATOH8
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.7485372089244167,-1.6528689631791116,0.004640371229698376,0.3124946050357084,1.0,3/10,2.60%,ERRFI1;ENG;ENPP1
prerank,axon extension (GO:0048675),0.7257708845483187,1.6474135114344282,0.018461538461538463,0.5993248816124627,1.0,5/23,3.98%,SLIT3;SLIT2;ULK2;ALCAM;NRP1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7484412733772056,1.6449615015816912,0.0322061191626409,0.6057455966734873,1.0,5/17,7.02%,SLIT2;FSTL1;SULF1;SFRP4;LRIT3
prerank,heterochromatin organization (GO:0070828),-0.6481013927068817,-1.644022254057654,0.023622047244094488,0.3323019553856641,1.0,3/14,9.50%,MECOM;PRDM16;HP1BP3
prerank,peptide biosynthetic process (GO:0043043),-0.4208323248052431,-1.6418669562468224,0.0,0.331729657573611,1.0,72/153,19.67%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;GGT5;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;MRPS11;MRPL51;RPL10A;RPL3;RPL12;GGT1;PCSK1;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;RPS10;GGT7
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6422298302096825,1.6411325702236854,0.015427769985974754,0.619832199627948,1.0,8/44,2.86%,KCNJ2;KCNMB3;KCNMB2;ANK2;ATP1B1;WNK1;KCNJ15;ANO6
prerank,cartilage development (GO:0051216),0.6312113807626762,1.64112601183614,0.01455026455026455,0.611623019550455,1.0,11/49,4.23%,BMP4;CCN3;NFIB;PKD1;SOX9;ITGB8;ZBTB16;CD44;SULF1;FGF2;SLC39A14
prerank,histone H4 deacetylation (GO:0070933),0.8328518861877883,1.638589580690541,0.031135531135531136,0.6185144548929072,1.0,3/10,5.36%,HDAC4;HDAC9;HDAC8
prerank,regulation of T cell migration (GO:2000404),-0.6209832099725902,-1.6374210614946159,0.013404825737265416,0.3385642907104701,1.0,5/18,4.62%,APOD;LRCH1;CXCL12;RIPOR2;APP
prerank,regulation of T cell chemotaxis (GO:0010819),0.8101485052061932,1.6373635054700577,0.01340033500837521,0.6178677993260177,1.0,2/11,1.93%,STK39;WNK1
prerank,cellular response to zinc ion (GO:0071294),-0.6549088748161442,-1.6343060058624954,0.020356234096692113,0.34108878593672726,1.0,12/15,19.43%,GLRA1;MT2A;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;MT3;HVCN1
prerank,regulation of multicellular organism growth (GO:0040014),-0.6618642701002365,-1.631336215597033,0.015915119363395226,0.3435354334372234,1.0,6/15,11.54%,IGF1;PTCH1;APP;GHR;MFSD2A;PPIB
prerank,amino acid transmembrane transport (GO:0003333),0.6407269826272812,1.6298068127848029,0.014360313315926894,0.6545176879449408,1.0,4/45,1.31%,SLC47A1;SLC38A2;SLC38A1;LRRC8D
prerank,negative regulation of endocytosis (GO:0045806),-0.5729787131707824,-1.6284970086298163,0.008426966292134831,0.34548121503599055,1.0,7/24,8.24%,PRKD1;MCTP1;PICALM;NR1H3;SYT11;RAC1;CD300A
prerank,skeletal system development (GO:0001501),0.5525937769509809,1.6258034439258935,0.0,0.6703604913297891,1.0,31/148,6.24%,KIAA1217;TNFRSF11B;CDH11;TLL1;EXT1;PCSK5;PKD1;SOX9;BMP5;ITGB8;BMP1;AKAP13;WNT11;DSPP;ZBTB16;CD44;SULF1;ALPL;FGFR1;BMP6;PAPSS2;HHIP;CMKLR1;TGFBR1;NPR3;PHEX;NOG;MMP16;SLC10A7;XYLT1;PTHLH
prerank,secretion (GO:0046903),-0.673671414425794,-1.6244470573525631,0.02763819095477387,0.3499911604854868,1.0,6/14,9.99%,RIMS1;SLC22A6;NPR1;SLC22A4;FBLN5;SLC22A2
prerank,detection of mechanical stimulus (GO:0050982),0.7367583003388685,1.6221420070163455,0.027993779160186624,0.6845123203125244,1.0,5/19,7.62%,PIEZO2;PKD1;CSRP3;PKD2L2;JUP
prerank,vitamin transport (GO:0051180),0.6709631986065662,1.6221324346722084,0.022796352583586626,0.6761127076397274,1.0,3/29,2.41%,SLC23A1;SLC5A6;ABCG2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7815007264428301,1.620908942414764,0.023923444976076555,0.6754599916422926,1.0,6/14,15.05%,THBS1;CMKLR1;IL10;IRAK3;PIBF1;TLR8
prerank,extracellular structure organization (GO:0043062),0.5426480838734696,1.6187689726473957,0.001076426264800861,0.6799651779947392,1.0,39/204,6.39%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;SMOC1;COL3A1;COL23A1;ITGB1;FGF2;ADAMTSL5;LOXL1;COL6A3;TGFBR1;ITGB5;ITGA10;ITGA5;ADAM12;MMP16;ITGAV;COL11A1;ADAMTS5
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6694587666377672,-1.6184383538134393,0.021739130434782608,0.36151024233722145,1.0,5/15,12.71%,PLTP;APOE;ABCA5;ABCG1;SCARB1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.540652404464023,-1.6179190513383486,0.006472491909385114,0.35672258641498095,1.0,5/30,7.60%,IGF1;IGFBP2;RPS3;PRKAR1A;IL18
prerank,B cell receptor signaling pathway (GO:0050853),-0.5362400454328767,-1.6173653570803437,0.012903225806451613,0.35238648927918453,1.0,9/32,11.67%,BCL2;RFTN1;TEC;PRKCB;MEF2C;VAV3;CD38;BMX;BLNK
prerank,glycine transport (GO:0015816),-0.7029015822578957,-1.6159815979654977,0.036613272311212815,0.35074753002783443,1.0,6/10,19.57%,SLC6A9;SLC38A5;SLC6A17;SLC6A5;SLC36A2;SLC25A38
prerank,mesenchyme development (GO:0060485),0.7470534514080958,1.6157649701310708,0.03559870550161812,0.6906033035735645,1.0,5/15,6.17%,BMP4;WNT11;TGFBR1;ISL1;GATA4
prerank,negative regulation of T cell differentiation (GO:0045581),0.8158103399603085,1.6154527810717996,0.02689075630252101,0.6842335350300525,1.0,3/10,7.56%,BMP4;GLI3;IRF1
prerank,neutral amino acid transport (GO:0015804),0.6779840834133107,1.6139238227484975,0.0206794682422452,0.6856970071927599,1.0,4/28,3.56%,SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6677953575280426,-1.6125456458551048,0.017948717948717947,0.3552707896167195,1.0,8/15,13.90%,IL31RA;NR1H3;GRN;LRFN5;CD300A;CD84;CD200;HAVCR2
prerank,response to zinc ion (GO:0010043),-0.5751120065195535,-1.6123841740978757,0.03003003003003003,0.34996117132077653,1.0,16/25,21.70%,PAM;CRIP1;GLRA1;MT2A;SLC30A4;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;MT3;HVCN1;KHK
prerank,base conversion or substitution editing (GO:0016553),-0.7033438084327673,-1.610863467113501,0.016241299303944315,0.34869373194837083,1.0,5/11,21.08%,APOBEC1;ADARB2;ADARB1;ADAR;METTL3
prerank,regulation of smooth muscle contraction (GO:0006940),0.7180679033852793,1.610606798386353,0.044233807266982623,0.699355495940822,1.0,3/20,2.69%,KCNB2;PLCE1;ADRB2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.8148885376053812,1.6102599592479578,0.018998272884283247,0.6937979614546839,1.0,2/10,1.93%,STK39;WNK1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6785223821465451,1.6101935343174487,0.01834862385321101,0.6862934684759777,1.0,7/26,3.09%,STK39;FHL1;NEDD4;ANK2;ATP1B1;WWP2;ITGB1
prerank,cellular response to amyloid-beta (GO:1904646),-0.5257724927975238,-1.6066054122982794,0.0189873417721519,0.3556861670609515,1.0,14/35,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;CACNA2D1;ITGA4;GRIN1;LGMN;CACNB1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.770078316619967,1.605536344840829,0.03852889667250438,0.7069486957869326,1.0,4/12,3.85%,ANK2;PTK2B;UBASH3B;DIAPH1
prerank,external encapsulating structure organization (GO:0045229),0.5370208185202358,1.6054483337457477,0.0010660980810234541,0.6996695310917105,1.0,38/205,6.39%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;SMOC1;COL3A1;COL23A1;ITGB1;FGF2;ADAMTSL5;LOXL1;COL6A3;ITGB5;ITGA10;ITGA5;ADAM12;MMP16;ITGAV;COL11A1;ADAMTS5
prerank,cellular response to peptide (GO:1901653),-0.4723320331472185,-1.6038217024663048,0.011904761904761904,0.3577005553611048,1.0,17/56,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;NOD1;CASP4;APP;GJA1;EPHA4;VIM;CACNA2D1;ITGA4;GRIN1;RPL23;LGMN;CACNB1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.675564824463651,1.6019680205035232,0.031117397454031116,0.7139652005148144,1.0,2/27,0.29%,SLC47A1;SLC38A1
prerank,response to alcohol (GO:0097305),0.6733772511908555,1.6002844600786998,0.038461538461538464,0.7161684145274744,1.0,5/27,4.97%,SLIT3;SLIT2;ADH7;TGFBR1;TGFBR2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6390959642978308,1.5980775759161177,0.02200825309491059,0.7222480362166912,1.0,10/39,5.27%,STK39;PTPN3;NEDD4;FXYD5;CAMK2D;SLMAP;WNK1;FGF13;PRKCE;DMD
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.7731953306406221,1.598020172743826,0.04340567612687813,0.7149943679462818,1.0,2/12,2.63%,BDH2;GCLC
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.6075761018132237,-1.5977132950240134,0.013927576601671309,0.37007645116882076,1.0,7/19,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,vasculature development (GO:0001944),-0.6253117236411077,-1.5973029968904402,0.02756892230576441,0.3657279517396934,1.0,11/16,18.38%,ERRFI1;PDGFRB;NOTCH4;ACVR2B;PDGFRA;SOX18;FLT4;ACVRL1;APLNR;FOXF1;CDH5
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.7844529069067342,1.5963082272502527,0.025210084033613446,0.7176143910153402,1.0,2/12,1.48%,BMP4;NEDD4
prerank,alcohol catabolic process (GO:0046164),-0.6960747858051068,-1.595154317125794,0.02926829268292683,0.36702007012744986,1.0,2/10,1.88%,APOE;CYP27A1
prerank,sodium ion transport (GO:0006814),0.5759485906394597,1.5942266304783674,0.013349514563106795,0.7233202022218826,1.0,11/85,4.49%,SLC4A4;SLC23A1;SLC9B2;SLC12A2;SLC5A6;SLC24A3;ATP1B1;SLC6A7;ANO6;FGF13;NALCN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.613842834317094,1.5930822535449116,0.006675567423230975,0.7228525872901465,1.0,16/56,10.06%,BMPER;BMP4;BMP5;TGFB3;SMAD6;BMP6;BMPR1A;INHBA;TGFBR1;PMEPA1;NOG;GDF6;GDF5;GDF10;ACVR1;LDLRAD4
prerank,cellular response to estradiol stimulus (GO:0071392),0.7292097509272698,1.59185407675885,0.04468412942989214,0.723158281873612,1.0,4/18,7.53%,EGFR;ESR1;MYOG;LCOR
prerank,response to amyloid-beta (GO:1904645),-0.49485419903413974,-1.5904740981352552,0.01818181818181818,0.37525144014220985,1.0,15/44,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;CACNA1B;CACNA2D1;ITGA4;GRIN1;LGMN;CACNB1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.705020273423799,1.5904496727493835,0.04285714285714286,0.7243901936740024,1.0,8/23,7.87%,BMP4;SIX1;SOX9;SMO;FGF2;NOG;GDNF;SIX4
prerank,regulation of response to stress (GO:0080134),0.8022379519582997,1.5893789451570421,0.0273972602739726,0.7233617575875477,1.0,3/10,7.16%,SLC38A2;EIF4G1;IL10
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6549120718708452,1.5878992586817806,0.03561253561253561,0.7253089155921225,1.0,12/32,18.56%,FZR1;FOXN3;ATM;CLSPN;UIMC1;CHEK1;MRNIP;TRIM39;NBN;TICRR;CDKN1A;TOPBP1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5505205341476257,1.587529168173329,0.004694835680751174,0.7205702510811746,1.0,37/128,11.64%,BMP4;SMAD9;BMP5;DDX5;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMP6;BMPR1A;INHBA;ID1;TGFBR1;ITGB5;LTBP2;PDCD4;TMEM100;TGFBR2;GCNT2;SKI;BAMBI;TGFB1I1;GDF6;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;JUN;SMAD2;MEGF8;INHBB;RNF111;RGMB
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7611759430626346,1.587212941391383,0.03864734299516908,0.7154944002288824,1.0,3/14,3.29%,THBS1;SULF1;FGF2
prerank,pharyngeal system development (GO:0060037),0.754981022500267,1.5861762503693597,0.0288135593220339,0.714550400751713,1.0,8/15,7.87%,BMP4;BMP5;HES1;BMPR1A;TGFBR1;NOG;ISL1;SIX4
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.6115284138219389,1.5859114439243513,0.014905149051490514,0.7092459700628955,1.0,8/54,2.75%,STK39;KCNJ2;FHL1;KCNMB3;KCNMB2;NEDD4;KCNJ15;WWP2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5514464255426498,-1.5846685196145438,0.015015015015015015,0.38806019008966763,1.0,5/26,13.41%,ATP1A2;CALM1;ADRA2A;CASQ2;CALM3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.6800072104639234,-1.5838737837853432,0.03225806451612903,0.38477137921421795,1.0,8/12,20.55%,MAP2;SNCA;ARHGEF7;STMN1;TUBB4A;STMN2;CDH5;DYRK1A
prerank,gland development (GO:0048732),0.6063017226211606,1.5831122010657372,0.022929936305732482,0.7189696031818865,1.0,20/59,12.00%,SIX1;MET;SOX9;IGSF3;COBL;EZR;TGFB3;ANXA1;WNT11;HES1;TGFBR1;STRA6;EPHB3;GLI2;RIPK3;NF1;DKK3;FOXE1;PRKCSH;NKX2-1
prerank,inorganic anion transmembrane transport (GO:0098661),0.5897058159983012,1.5826512406477504,0.02207792207792208,0.7151516748411475,1.0,9/63,4.00%,SLC26A2;SLC12A7;SLC12A2;SLC5A6;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,regulation of viral life cycle (GO:1903900),-0.5683211072770681,-1.5819533308654818,0.03089887640449438,0.3850984436807025,1.0,8/21,14.71%,HS3ST5;TRIM14;PPIA;TRIM62;NECTIN2;AXL;TYRO3;TRIM21
prerank,cellular response to chemokine (GO:1990869),0.617610370913854,1.5816261950643107,0.023578363384188627,0.7146351210970988,1.0,10/46,12.53%,STK39;SLC12A2;PTK2B;WNK1;CXCL2;FOXC1;RHOA;CCL3;CCL1;ZC3H12A
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6798805013686847,1.580628167671025,0.053929121725731895,0.7134875701950185,1.0,3/24,2.86%,SLIT2;CCN3;ANO6
prerank,purine nucleotide metabolic process (GO:0006163),0.6758205996997563,1.5804540684757467,0.05120481927710843,0.7080676797701201,1.0,4/24,2.82%,NT5E;NT5C1A;FHIT;PRPS2
prerank,activation of protein kinase A activity (GO:0034199),-0.6243495092046318,-1.5795421333693307,0.034210526315789476,0.3871599826655736,1.0,7/16,6.79%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A
prerank,negative regulation of cell growth (GO:0030308),0.556781387471579,1.5792988594478825,0.0035087719298245615,0.708654886380504,1.0,12/121,4.05%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ULK2;ESR2;INHBA;FGF13;IP6K2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6916333923836073,-1.578925472719279,0.03349282296650718,0.3838163452730764,1.0,3/10,4.97%,SLC1A3;SLC1A1;SLC1A2
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7625712292290147,1.5788531447832719,0.04326123128119801,0.7048496520685016,1.0,4/13,5.80%,BMP4;NR3C2;ESR2;ESR1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7712891383809795,1.5784008216853225,0.05,0.7015110063582511,1.0,7/12,18.47%,FOXP1;PIAS2;NCOR1;SMARCA4;NCOR2;ZBTB7A;HEYL
prerank,melanocyte differentiation (GO:0030318),-0.6962459248544944,-1.5780460806171352,0.039627039627039624,0.3812865566919517,1.0,6/11,8.34%,LRMDA;KIT;ENPP1;MITF;MEF2C;SLC24A5
prerank,response to hexose (GO:0009746),0.6824310510260551,1.575463620043914,0.03927492447129909,0.7123460071160724,1.0,2/25,0.74%,THBS1;TCF7L2
prerank,regulation of membrane depolarization (GO:0003254),0.7306452165804358,1.575440437164992,0.03257328990228013,0.7063390488806743,1.0,3/18,1.74%,FHL1;PTPN3;CAMK2D
prerank,response to progesterone (GO:0032570),0.7220197483282622,1.5750456834108937,0.04833836858006042,0.7026040151127908,1.0,2/18,1.84%,THBS1;TGFB3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6260120905470987,1.5749629722517462,0.03274215552523874,0.6970272413281208,1.0,15/43,18.56%,FZR1;FOXN3;RAD17;ATM;CLSPN;NABP1;UIMC1;CHEK1;MRNIP;TRIM39;CHFR;NBN;TICRR;CDKN1A;TOPBP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.6086750687301793,-1.5747243140364047,0.02406417112299465,0.3857041103641232,1.0,7/17,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7499814619743773,1.574402465598957,0.03588907014681892,0.6942602294360161,1.0,6/13,4.10%,BMP4;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,regulation of sensory perception of pain (GO:0051930),0.783781995462171,1.5739933104481325,0.04013961605584642,0.6908918822500341,1.0,6/11,12.58%,CCN3;MGLL;TMEM100;ACP3;CCL3;SCN11A
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5696699996917992,1.5730558257113174,0.014423076923076924,0.6906270511301151,1.0,23/86,11.43%,THBS1;BMP4;BMP5;FOXD1;CCN1;TGFB3;SULF1;GIPC1;BMP6;BMPR1A;INHBA;ZNF423;NUP93;TGFBR1;CREBBP;TGFB1I1;GDF6;GDF5;GDF10;ACVR1;SMAD2;INHBB;RNF111
prerank,regulation of ion transmembrane transport (GO:0034765),0.6318788846839478,1.572533311713895,0.03111111111111111,0.6878107175723912,1.0,6/33,2.86%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;ANO6
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7293499624822982,1.5723623114910985,0.046511627906976744,0.683263106114853,1.0,4/16,6.63%,DPYSL3;NT5E;NT5C1A;UPP2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5687601577762983,1.5722786495208658,0.011876484560570071,0.6783126526092297,1.0,16/92,5.01%,SMOC2;FOXP1;THBS1;BMP4;DOCK5;SOX9;PTK2B;ADAM9;ANXA3;MAPRE2;FGF2;PRKCE;ABL1;FOXC2;NRP1;BCAS3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7545537995673424,1.5715939949199014,0.045307443365695796,0.6766486253732601,1.0,6/14,7.23%,WNT9A;SOX9;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,entry into host (GO:0044409),0.7571364161645131,1.5715746216349895,0.051580698835274545,0.6713688359496146,1.0,3/13,5.85%,CDH1;MET;ITGAV
prerank,sensory perception of sound (GO:0007605),-0.43249328726592207,-1.5708936094109953,0.005494505494505495,0.39230091955252006,1.0,19/88,9.29%,COL4A3;CEMIP;CACNA1D;DCDC2;GRM7;KIT;ADGRV1;USP53;RIPOR2;PCDH15;TBX1;EPS8L2;ALDH7A1;CLIC5;EYA1;KCNQ1;CCDC50;GRAP;NDUFB9
prerank,negative regulation of growth (GO:0045926),0.5496634503498935,1.5699136981042434,0.004602991944764097,0.6746798161429963,1.0,11/121,4.05%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ESR2;INHBA;NOTCH2;IP6K2
prerank,regulation of endothelial cell migration (GO:0010594),0.5699823722843411,1.5677386711453758,0.007453416149068323,0.6808364106812445,1.0,14/85,5.01%,SLIT2;SMOC2;BMPER;FOXP1;THBS1;BMP4;RHOJ;PTK2B;ANXA3;FGF2;ABL1;FOXC2;NRP1;BCAS3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6876164132850203,-1.5672247646025605,0.036585365853658534,0.39774338303538775,1.0,5/11,16.62%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,anterior/posterior pattern specification (GO:0009952),0.5941937990014686,1.5636585625412427,0.035422343324250684,0.6980517997041469,1.0,18/53,11.05%,PCSK5;HOXA5;HOXA3;HES1;HOXB6;HOXA6;TGFBR1;HOXC6;BHLHE40;SKI;HOXB3;GATA4;DDIT3;HOXB5;HOXC4;HOXB4;LRP5;SMAD2
prerank,regulation of cholesterol storage (GO:0010885),-0.6298197488631007,-1.5635888373762412,0.038560411311053984,0.4034604902052509,1.0,10/15,20.32%,PPARA;NR1H3;ABCA1;PPARD;ABCG1;SCARB1;MSR1;LPL;NR1H2;TREM2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.7387231348749671,1.5629140506509207,0.049403747870528106,0.6963397771324459,1.0,3/13,3.22%,BMP4;SOX9;PRICKLE1
prerank,peptide cross-linking (GO:0018149),0.6908460888485577,1.5629016695694191,0.035168195718654434,0.6911111922535258,1.0,7/25,8.16%,THBS1;FN1;ANXA1;DSP;COL3A1;TGM3;SPRR1A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5210549404384002,-1.561143997427146,0.020833333333333332,0.40520040474048685,1.0,14/32,26.77%,CEMIP;CALM1;AKAP6;SNCA;JPH2;PLCG1;CALM3;TRPC1;APLNR;CX3CL1;GPER1;F2R;HAP1;CASQ1
prerank,regulation of mononuclear cell migration (GO:0071675),0.6771606684950414,1.5608281196239846,0.06327160493827161,0.6969410473889596,1.0,4/23,3.93%,SLIT2;THBS1;BMP5;CMKLR1
prerank,response to estradiol (GO:0032355),0.6540805838265231,1.5607608459245879,0.03343023255813953,0.6920825451472807,1.0,8/31,8.46%,EGFR;ANXA1;ESR1;STAT3;MYOG;LCOR;SOCS2;STRN3
prerank,nucleotide metabolic process (GO:0009117),0.6734677069317113,1.5605415881376905,0.044709388971684055,0.6881778658775317,1.0,6/23,10.51%,ME1;FHIT;NMNAT2;CTPS2;NMNAT1;NUDT5
prerank,lymphocyte mediated immunity (GO:0002449),0.7746287070616992,1.5602249634977292,0.03614457831325301,0.6846456474978069,1.0,5/12,8.83%,CD55;GNL1;JAG1;KLRC2;CD46
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7150967842087748,1.5583035260098155,0.05374592833876222,0.6895746344854953,1.0,2/15,2.18%,CD55;GLI3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7678012447186264,1.5580685077151901,0.05026929982046679,0.6856225353572878,1.0,3/12,1.20%,SLIT2;CCN3;BMP5
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6216753216736086,1.5577799827134864,0.026912181303116147,0.6822231546799497,1.0,7/42,11.36%,STK39;PTK2B;WNK1;CXCL2;FOXC1;CCL3;CCL1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6853817329079368,-1.5571260794927742,0.03597122302158273,0.41170827680803,1.0,4/11,5.14%,MECOM;WNT5A;ETV6;CD34
prerank,response to hydrogen peroxide (GO:0042542),0.6287071529645185,1.5569823621536274,0.02203856749311295,0.6815183897401825,1.0,9/45,9.09%,MAP3K5;CYP1B1;ADAM9;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3
prerank,regulation of interleukin-1 production (GO:0032652),0.7280993653867597,1.5567202648528509,0.06965174129353234,0.6780858951711435,1.0,4/15,8.03%,FOXP1;ANXA1;IL10;TLR4
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5282181267732816,-1.555041374486951,0.02147239263803681,0.4133375934085535,1.0,14/30,7.80%,TJP1;GJB6;PECAM1;CLDN5;LAMA2;ESAM;OCLN;MBP;F11R;SLC1A1;ACTB;GJA1;JAM3;CLDN1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7364048158136518,1.5550205185930002,0.058333333333333334,0.6821666149169658,1.0,3/14,8.13%,ME1;NMNAT2;NMNAT1
prerank,BMP signaling pathway (GO:0030509),0.5801238395538655,1.555019169443889,0.014492753623188406,0.6773845103778462,1.0,19/62,11.64%,BMP4;SMAD9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;NOG;GDF6;GDF5;CHRD;USP15;ACVR1;SMAD2;MEGF8;RGMB
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6845416994501126,-1.5544065127828715,0.046875,0.4102330677547342,1.0,5/10,15.05%,APOD;LRCH1;RIPOR2;CD200;AKT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6099033316299209,-1.5542449379629062,0.03735632183908046,0.4058799251591431,1.0,7/17,13.41%,ITGA1;PDGFRB;CALM1;CD300A;HSP90AB1;PPP1R15B;CALM3
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7141821765178157,1.5536024875911076,0.04304635761589404,0.6797034259989075,1.0,6/16,6.36%,DDX5;RBFOX2;ESR2;DDX17;ESR1;TADA3
prerank,negative regulation of myotube differentiation (GO:0010832),0.7630967163639507,1.552057401398381,0.046875,0.6830332518254337,1.0,2/12,1.24%,CCN3;HDAC4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5949487534832817,1.5520427086432314,0.015789473684210527,0.6783798320723752,1.0,24/59,20.11%,STK39;CIT;CAMK2D;WNK1;PRKCD;HIPK1;GSK3B;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;CHEK1;PRKDC;CDC42BPG;DYRK2;PRKCA;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1;DYRK3;MAPK8
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5926071828759301,-1.5517435562565225,0.030303030303030304,0.40878415146649155,1.0,7/19,11.66%,IGF1;APOE;PICALM;RTN1;NTRK2;RTN4;BIN1
prerank,sodium ion import across plasma membrane (GO:0098719),0.7158576591957798,1.5511355370119044,0.0467741935483871,0.6786930557865468,1.0,5/17,8.86%,SLC9A2;SLC12A2;TRPM4;SLC9C1;SLC9A1
prerank,aortic valve morphogenesis (GO:0003180),0.647007203491558,1.54984991165789,0.0436046511627907,0.6806580860603109,1.0,5/30,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.6709547385142789,-1.5487501784446032,0.03731343283582089,0.41334671006027884,1.0,5/12,18.55%,SERINC3;SERINC5;GGT1;CBS;SEPHS2
prerank,positive regulation of organelle organization (GO:0010638),0.6312006605189713,1.548130402563396,0.045779685264663805,0.6844864222261745,1.0,9/32,10.91%,SORBS3;ANXA1;ANXA2;ATL3;ADRB2;GSK3B;RAB3GAP2;C2CD5;SMCR8
prerank,transition metal ion transport (GO:0000041),-0.5060284502990449,-1.5473283845606887,0.016722408026755852,0.4126511943397041,1.0,14/35,13.73%,CP;SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP2C1;ATOX1;TRPC4;TRPC6;SLC30A1;SLC31A1;TTYH1;TRPC1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5600665908673592,-1.5463548552191988,0.03225806451612903,0.41050750178246265,1.0,12/23,18.49%,ACSL1;ELOVL7;FAR2;ELOVL6;HSD17B12;ACSL5;ACOT7;DGAT1;HACD2;ACSBG1;ACSL4;HACD1
prerank,import into cell (GO:0098657),0.6237563369658151,1.5460777533384977,0.02861035422343324,0.6902448356541616,1.0,5/41,1.31%,SLC47A1;SLC12A7;SLC38A1;SLC5A6;LRRC8D
prerank,negative chemotaxis (GO:0050919),0.6440424921581702,1.5453546357508146,0.0377906976744186,0.689628055636162,1.0,7/33,2.43%,SLIT3;SLIT2;NTN1;SEMA3E;UNC5C;SEMA3D;SEMA3C
prerank,positive regulation of DNA replication (GO:0045740),0.7285399814881584,1.5452018306366917,0.05,0.6857676057032162,1.0,4/16,9.08%,EGFR;BCAR3;STN1;GLI2
prerank,embryonic digestive tract development (GO:0048566),0.7088014663131579,1.5451927755433983,0.05619834710743802,0.6813104990053789,1.0,7/18,12.18%,PCSK5;RARB;GLI3;STRA6;ID2;GLI2;NIPBL
prerank,peptidyl-threonine modification (GO:0018210),0.582254320445375,1.54423409118109,0.02193548387096774,0.6819152331303966,1.0,24/66,18.53%,STK39;CIT;CAMK2D;WNK1;PRKCD;HIPK1;GSK3B;GALNT13;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;GALNT11;CHEK1;PRKDC;CDC42BPG;DYRK2;PRKCA;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1
prerank,histone deacetylation (GO:0016575),0.6002228807291132,1.543941201816566,0.040927694406548434,0.6790343705413584,1.0,16/43,19.06%,HDAC4;HDAC9;RCOR3;HDAC8;TBL1X;PER1;MIER1;MTA1;HDAC10;REST;BAZ2A;PRDM5;SIRT6;RBM14;PER2;BRMS1L
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.6500488777624764,1.543501160263455,0.045714285714285714,0.6770327858902636,1.0,11/30,18.47%,FOXP1;DDX5;KDM1A;PIAS2;NCOR1;SMARCA4;EP300;NCOR2;ZBTB7A;RNF14;HEYL
prerank,hippo signaling (GO:0035329),-0.5327756216979885,-1.5433748884188123,0.02601156069364162,0.41472710580929245,1.0,7/26,13.13%,TJP1;AMOTL1;TEAD2;TEAD4;AMOTL2;YWHAB;CASP3
prerank,regulation of protein import into nucleus (GO:0042306),0.6323223644120154,1.5401362627989295,0.02538787023977433,0.6895000261221044,1.0,8/36,7.62%,BMP4;CDH1;PRKCD;ZIC1;MDFIC;UBR5;MAVS;JUP
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6762549299917475,1.5398845246824144,0.05963302752293578,0.6863223821056247,1.0,11/26,16.02%,FOXP1;CRY2;ISL1;PIAS2;STRN3;KANK2;NCOR1;PER1;SMARCA4;NCOR2;ZBTB7A
prerank,regulation of cell death (GO:0010941),0.5513392245960831,1.5387185337312708,0.013095238095238096,0.6874138894553397,1.0,19/94,8.47%,BMP4;CCN3;ACER3;CCN1;CCN5;WNT11;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;WNT16;LRP1;CLU;RIPK2;AGR2;SRSF6;CELF1;CDKN1B
prerank,postsynaptic membrane organization (GO:0001941),-0.5885793111124522,-1.5384272530592238,0.03636363636363636,0.4261119175099877,1.0,5/17,13.65%,SHANK3;APOE;NRXN1;GPHN;MUSK
prerank,ganglioside biosynthetic process (GO:0001574),-0.6190259318410316,-1.5381991982863437,0.03178484107579462,0.42213630190489343,1.0,4/15,5.35%,ST6GALNAC3;ST3GAL1;ST8SIA4;ST8SIA6
prerank,cellular response to BMP stimulus (GO:0071773),0.5672700716145359,1.5372571754476518,0.020887728459530026,0.6902507824520909,1.0,18/66,11.64%,BMP4;SMAD9;SOX9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;GDF6;GDF5;USP15;ACVR1;SMAD2;MEGF8;RGMB
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7175614224478847,1.5370463469990487,0.0473186119873817,0.6869855875589338,1.0,3/15,1.54%,F3;NTRK3;PGF
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7559533305217535,1.534814156469745,0.07375643224699828,0.6939207251107579,1.0,1/12,0.33%,FZR1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.758345582185856,1.534169479414779,0.059726962457337884,0.6928729259910659,1.0,3/11,3.10%,RSPO3;MLLT3;PLEKHA4
prerank,regulation of interleukin-13 production (GO:0032656),-0.6360659793127347,-1.5340701815654605,0.061224489795918366,0.43001455417168677,1.0,4/13,7.60%,LEF1;TNFRSF21;PRKCZ;IL18
prerank,cellular response to osmotic stress (GO:0071470),0.6848754391025527,1.5340407244858854,0.05045871559633028,0.6892005094777062,1.0,3/21,2.92%,STK39;LRRC8D;YBX3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5819941462741803,1.5333171665247878,0.02190721649484536,0.6884911507007591,1.0,23/61,19.56%,SMOC2;EGFR;EYA2;FGF2;EYA4;EYA3;WRN;APLF;STPG4;USP7;UIMC1;ATRX;RNF168;ERCC8;DHX9;PML;NBN;SIRT6;RAD51;DHX36;USP9X;PARP3;UBE2N
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5640161866028504,-1.5327830824268307,0.04712041884816754,0.4292133257682163,1.0,12/20,28.25%,PLCB1;CHRM2;CHRM3;GRK2;LYPD1;CHRNA7;CDK5R1;LY6G6D;RGS8;RGS10;AGRN;CHRM1
prerank,aorta morphogenesis (GO:0035909),-0.5840967028623101,-1.5321624942178973,0.053763440860215055,0.42663283304352995,1.0,9/17,9.85%,ENG;MYLK;PDGFRB;ADAMTS9;TBX1;RBPJ;HEY2;PROX1;EFEMP2
prerank,keratinocyte differentiation (GO:0030216),0.6541501073549143,1.5317237080042574,0.05135520684736091,0.6921726603386078,1.0,10/29,8.16%,CLIC4;ADAM9;ANXA1;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;SPRR1A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5635959687668297,1.5316162563909672,0.020481927710843374,0.6885895527743715,1.0,19/76,13.94%,EGFR;NR3C2;CCN3;RASSF2;TCIM;EZR;NFAT5;PDCD4;TRIM44;DLG1;IFI35;TLR4;RHOA;LIMS1;ZC3H12A;TRIP6;PPM1A;EP300;TRADD
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.6252068629989267,1.531593236765662,0.04107648725212465,0.6846089341316617,1.0,10/38,7.62%,KCNJ2;ANK2;CACNA1C;CAMK2D;DSP;DSG2;CACNA1G;TRPM4;ISL1;JUP
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6691655847932881,1.5307262352556785,0.052552552552552555,0.6849920515310999,1.0,4/25,3.98%,EGFR;THBS1;FZD7;NRP1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6899654578072559,1.5305184633437228,0.05238095238095238,0.6817111894226506,1.0,7/19,9.97%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;MDM4;ACVR1
prerank,negative regulation of heart contraction (GO:0045822),-0.6500834780686584,-1.5298971364894725,0.0340632603406326,0.4288305671303767,1.0,2/11,5.79%,ATP1A2;PDE4D
prerank,translation (GO:0006412),-0.36848061816270367,-1.5298075703748397,0.0,0.424559471946684,1.0,77/208,19.70%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;EEF1B2;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;LARS2;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;FASTKD2;RPL8;RPL24;RPL29;IARS1;MRPS11;MRPL51;RPL10A;RPL3;RPL12;EEF2;EEF1G;PPA1;RPS27A;RPS12;RPL27;RPS28;DARS2;RPL5;GSPT2;RPS10;MRPL2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7452590954777383,1.5296800163424553,0.04923599320882852,0.681631539060316,1.0,4/15,3.29%,SMOC2;THBS1;MET;FGF2
prerank,ventricular septum development (GO:0003281),0.6215532680078015,1.5293252294622213,0.04341736694677871,0.6793416386396018,1.0,10/37,6.17%,SLIT3;SLIT2;ZFPM2;HES1;BMPR1A;TGFBR1;STRA6;TGFBR2;NOG;GATA4
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5701907407969498,1.5282902883603593,0.02600780234070221,0.6804631846257814,1.0,8/68,6.65%,SLC23A1;SLC23A2;AOX1;SLC5A6;VNN1;RFK;PNPO;MMACHC
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6541453582073489,1.528073757756268,0.0571870170015456,0.677643638832816,1.0,6/25,3.53%,BMP4;FOXD1;CCN1;SULF1;BMPR1A;ZNF423
prerank,membrane repolarization during action potential (GO:0086011),0.7317227115712709,1.5280116507448394,0.05432937181663837,0.6740289535656028,1.0,2/13,1.55%,KCNJ2;ATP1B1
prerank,aortic valve development (GO:0003176),0.6240458504762646,1.5257423487580393,0.05135520684736091,0.680791135276715,1.0,5/34,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,epidermal cell differentiation (GO:0009913),0.6225646561507524,1.5249031314678352,0.038408779149519894,0.680972522782799,1.0,11/41,8.16%,CLIC4;ADAM9;ANXA1;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;PITX2;SPRR1A
prerank,thymus development (GO:0048538),0.7397633603326653,1.5247396039634176,0.06473594548551959,0.677903626153411,1.0,6/13,10.53%,SIX1;HES1;TGFBR1;EPHB3;RIPK3;FOXE1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5601391091155261,-1.5240613317817733,0.03724928366762178,0.43757898401754014,1.0,8/23,10.71%,IGF1;EFNB2;PIEZO1;AKAP6;MEF2C;EDN1;PROX1;MYOCD
prerank,potassium ion transmembrane transport (GO:0071805),0.5268775219796922,1.5236469810638902,0.010501750291715286,0.6793213544429206,1.0,13/135,3.00%,SLC9A2;KCNB2;KCNK5;SLC12A7;KCNJ2;SLC12A2;SLC24A3;ATP1B1;KCNQ5;SLC12A8;KCNJ15;KCNS3;KCNB1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6674730537308097,1.523445474500634,0.05112781954887218,0.6765158882763841,1.0,4/25,3.08%,SLIT2;PRKCD;LIMK2;ARHGAP44
prerank,stem cell development (GO:0048864),-0.5955970607553278,-1.523201918404812,0.028132992327365727,0.43581801124721203,1.0,7/16,24.39%,CDH2;TAPT1;NRG1;NOLC1;SHH;SNAI2;WNT7A
prerank,regulation of muscle cell differentiation (GO:0051147),0.6401604294864147,1.5231233063703642,0.04505813953488372,0.6743286172467388,1.0,8/31,7.45%,CDON;BOC;HDAC9;CTNNA1;ABL1;MEF2A;MYOG;ID2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6540106307997445,1.5226651852828146,0.04956268221574344,0.6727435716917487,1.0,13/25,12.24%,ANK2;CACNA1C;CAMK2D;CXADR;DSP;DSG2;FGF13;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.6502568837602373,1.5221992674356655,0.05972434915773354,0.6713239332846368,1.0,15/27,22.93%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;MTA1;ATOH7;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4
prerank,Rac protein signal transduction (GO:0016601),-0.5767647987051943,-1.5195050396423735,0.040106951871657755,0.44257948638496547,1.0,7/18,12.41%,EPS8;ELMO1;CDH13;RHOH;RAC1;HACD3;HACE1
prerank,neuron remodeling (GO:0016322),-0.6694384698533588,-1.5190519805353988,0.0472972972972973,0.43935838220211176,1.0,7/10,23.39%,APP;EPHA8;ADGRB3;C1QA;C3;CX3CL1;RND1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.560807885233908,1.518694591433718,0.03940886699507389,0.6840095011824645,1.0,12/74,6.67%,THBS1;BMP4;EYA2;TCF7L2;BMP5;GSK3B;EYA4;TGFBR1;ITGAV;GDNF;BIRC6;EYA3
prerank,response to chemokine (GO:1990868),0.7233344743434779,1.517546345538734,0.0727580372250423,0.6857531764498078,1.0,3/13,1.93%,STK39;SLC12A2;WNK1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.6759126677591543,-1.5171497481501337,0.05176470588235294,0.4409462335770326,1.0,5/10,17.36%,SNCA;KLF15;NOC2L;SET;CTBP1
prerank,histone H3 deacetylation (GO:0070932),0.7038954616643889,1.5166248530148276,0.06844741235392321,0.6864364781334892,1.0,6/15,18.45%,HDAC4;HDAC9;HDAC8;PER1;SIRT6;PER2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6897562505496836,1.5158769345424603,0.07119741100323625,0.6862268850185023,1.0,3/19,4.55%,SLC26A2;PAPSS2;SULT1A1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6710454713644656,1.515602136996294,0.0794392523364486,0.6838701308665126,1.0,7/19,14.18%,PLCE1;PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,L-serine metabolic process (GO:0006563),-0.6777981742749464,-1.5145102058273083,0.06097560975609756,0.4443761819779193,1.0,2/10,2.78%,SERINC3;SERINC5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6108500424338097,-1.5138812207595627,0.03513513513513514,0.44209191515524127,1.0,5/15,7.51%,GRM7;GRM3;GRM5;GRM1;GRM8
prerank,positive regulation of nuclear division (GO:0051785),-0.5388389677488471,-1.5136856481532879,0.04843304843304843,0.4383464278257548,1.0,6/25,9.16%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,epithelial tube morphogenesis (GO:0060562),0.6328857141390977,1.5136847444072252,0.0463768115942029,0.689462160944026,1.0,5/32,2.38%,SLIT2;BMP4;MET;PKD1;HES1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6401677572411753,-1.5132958534811396,0.0430622009569378,0.43524100662933213,1.0,7/12,19.91%,APOE;PICALM;ROCK2;RANBP9;ABCA2;TMED10;CHRNA7
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7328667081572731,1.5119872511708412,0.061872909698996656,0.6939371683401863,1.0,4/13,5.30%,BMP4;NFIB;SOX9;NFATC4
prerank,negative regulation of coagulation (GO:0050819),-0.6130616528864485,-1.5117241335933451,0.05200945626477541,0.435640830664989,1.0,6/14,8.69%,VTN;APOE;HS3ST5;CD34;TFPI;EDN1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7453236050190477,1.510217121733841,0.0763765541740675,0.6989321021806779,1.0,4/10,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,chordate embryonic development (GO:0043009),0.5798378234126681,1.5093461417088807,0.04539385847797063,0.6994923971808152,1.0,18/55,10.34%,KIAA1217;PCSK5;MBNL1;PKD1;BMP5;FUT8;TGFB3;WNT11;SULF1;FGFR1;TGFBR1;NOG;ISL1;XYLT1;SIX4;GRHL2;DACT1;VEGFA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5404174170404683,-1.50893958182604,0.022922636103151862,0.43937702989882244,1.0,4/23,3.51%,ENG;TGFBR3;NREP;ITGA3
prerank,regulation of RNA splicing (GO:0043484),0.5615696638278996,1.5086749620292963,0.0375,0.6992051679683315,1.0,12/69,8.00%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK1;CLK2;SON;HNRNPH1;CELF1;MBNL2;RBM39;FUS
prerank,regulation of integrin activation (GO:0033623),-0.59194940618549,-1.5082125640070736,0.07547169811320754,0.437712069426615,1.0,5/15,12.01%,RASIP1;PIEZO1;JAM3;PLEK;FBLIM1
prerank,cellular response to reactive oxygen species (GO:0034614),0.5790593159785622,1.5073621727108537,0.030104712041884817,0.7021306676880398,1.0,11/59,10.17%,EGFR;MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3;CHUK;JUN
prerank,lung epithelium development (GO:0060428),0.745575845899791,1.5073053823109257,0.07944732297063903,0.69874638915344,1.0,4/10,8.58%,BMP4;PKD1;STRA6;GRHL2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5759648059696866,-1.5070438651800484,0.04918032786885246,0.4370266431259044,1.0,7/18,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,inorganic cation import across plasma membrane (GO:0098659),0.5523474469460882,1.5067215550211384,0.02654867256637168,0.6979095995973437,1.0,15/75,8.86%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15;SLC39A14;TRPM4;ATP2B4;SLC9C1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,neurotransmitter secretion (GO:0007269),-0.47705646713629174,-1.5066536405878865,0.045283018867924525,0.4341774019526758,1.0,22/44,27.01%,NRXN1;RIMS1;LIN7A;RIMS2;HSPA8;SYN2;SNCA;SNAP25;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;PPFIA3;SNAPIN;UNC13A
prerank,photoperiodism (GO:0009648),0.640136602888461,1.5065701419751716,0.0680786686838124,0.6950147871259447,1.0,15/28,22.93%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;MTA1;ATOH7;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4
prerank,actin filament-based transport (GO:0099515),-0.5459382949220186,-1.5065130327857703,0.06077348066298342,0.4306415163746691,1.0,7/21,17.23%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.593792063220786,1.5061251165005423,0.05907172995780591,0.6935586401906526,1.0,9/43,7.45%,FOXP1;THBS1;BMP4;IGFBP5;BMPR1A;FGF2;NR4A3;IL10;ID2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.6438170971661779,-1.504929331042898,0.06038647342995169,0.43147695838690103,1.0,2/12,7.60%,IL1R1;IL18
prerank,cellular response to purine-containing compound (GO:0071415),-0.6582699416162611,-1.5038931604391532,0.05938242280285035,0.43062443375250364,1.0,5/10,16.82%,SLC8A1;RYR2;P2RY1;CASQ2;RYR3
prerank,cAMP-mediated signaling (GO:0019933),-0.5457230300745157,-1.5025545440199184,0.04153354632587859,0.43057936013603093,1.0,11/24,7.31%,KSR1;PDE7B;ADCY1;RAPGEF3;RAPGEF2;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5986544635501366,1.5020105961026236,0.03523035230352303,0.7092727220407907,1.0,9/45,4.91%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.657641369274508,-1.5012945542605234,0.060674157303370786,0.4306160475467931,1.0,4/10,12.71%,SEMA6A;DCN;DAB2IP;CADM4
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6691939871139094,1.5007027729873263,0.07253086419753087,0.7119396951683754,1.0,5/20,5.19%,THBS1;GSN;ANO6;PDCD4;SFRP4
prerank,rRNA metabolic process (GO:0016072),-0.38279432131347474,-1.5002044785888429,0.0,0.42982535533580457,1.0,69/160,23.14%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;MAPT;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;NIFK;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;DIS3L;NOC4L;RRP9
prerank,positive regulation of nervous system development (GO:0051962),-0.46565042912760773,-1.5001721764896123,0.03460207612456748,0.4261915811422601,1.0,15/42,24.39%,IL1RAPL1;TGM2;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2;MME;CLSTN3;GPER1;SYNDIG1;BDNF;CX3CR1;WNT7A
prerank,response to prostaglandin E (GO:0034695),-0.677196988354106,-1.49980700255615,0.06205250596658711,0.4235903201949594,1.0,3/10,13.42%,TGFBR3;GNG2;CCL19
prerank,negative regulation of potassium ion transport (GO:0043267),0.7145893342434462,1.4996005064878222,0.07337883959044368,0.7135026381725311,1.0,2/13,1.67%,STK39;PTK2B
prerank,dopaminergic neuron differentiation (GO:0071542),0.6627740690812721,1.4992171829558907,0.05555555555555555,0.7118082590942482,1.0,6/19,13.81%,LRP6;NR4A2;PITX3;PHOX2A;VEGFA;CDNF
prerank,neuron maturation (GO:0042551),-0.5597048397319747,-1.4988818833114486,0.03580562659846547,0.4224646752014636,1.0,11/18,29.10%,APP;EPHA8;ADGRB3;C1QA;ACTL6B;C3;CX3CL1;RND1;SRRM4;B4GALT5;B4GALT6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6895237427318897,1.4981423916335768,0.09313725490196079,0.7136486931228764,1.0,2/16,2.14%,ST3GAL4;NFAT5
prerank,negative regulation of insulin secretion (GO:0046676),0.7047694907406776,1.4973178142782941,0.06763285024154589,0.7139757949343748,1.0,4/17,3.88%,CCN3;KCNB1;IRS1;KLF7
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.43943816069671715,-1.4968497542158865,0.008438818565400843,0.4244529178035373,1.0,14/57,15.34%,ADCY5;GRM7;ADCY1;LPAR1;ADCY7;CHRM2;ADRA2A;PDE2A;GRM8;CHRM3;ADCY2;GPR37;ADCY4;PSAP
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.588935936604091,1.496584201601443,0.045081967213114756,0.7141321140125166,1.0,17/46,18.05%,CDH1;TCF7L2;NEDD4;PRKCD;ZIC1;GSK3B;UBR5;MAVS;JUP;EMD;ZC3H12A;BAG3;DHX9;XPO4;HCLS1;EFCAB7;KHDRBS1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5677124907842569,1.4961363880628094,0.02849740932642487,0.7125940575041018,1.0,18/57,18.56%,FZR1;FOXN3;CHEK2;RAD17;ATM;WAC;CLSPN;UIMC1;CHEK1;PRKDC;MRNIP;CCND1;ATF2;TRIM39;NBN;TICRR;CDKN1A;TOPBP1
prerank,metal ion homeostasis (GO:0055065),0.5982860156373578,1.4956751244231208,0.04252400548696845,0.7113424863332232,1.0,7/40,7.66%,SLC12A7;SLC12A2;CNNM2;SLC12A8;CNNM4;CLDN16;FAM20A
prerank,skeletal system morphogenesis (GO:0048705),0.5990679218270011,1.4955867159333032,0.05755395683453238,0.7082913927082197,1.0,13/42,11.10%,SIX1;LRP6;HOXA3;FGFR1;HHIP;TGFBR1;SFRP4;SKI;HOXB3;HOXC4;HOXB4;LRP5;MEGF8
prerank,regulation of cell killing (GO:0031341),0.6893042060991048,1.494969476201943,0.07450331125827815,0.7078046607434695,1.0,5/16,8.99%,CFH;CD55;FZD7;IL10;CR1L
prerank,regulation of DNA repair (GO:0006282),0.5975723096692717,1.4940546092827325,0.04827586206896552,0.7087401659642294,1.0,13/44,15.50%,EGFR;EYA2;EYA4;UBR5;EYA3;TRIP12;USP1;RAD52;UIMC1;RNF168;ERCC8;DHX9;PML
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.36929813531047373,-1.4934676034683347,0.0,0.4304310304980464,1.0,75/168,19.39%,RPS14;RPL38;CNOT6L;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;DCP2;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;NBDY;POLR2G;RPL24;CNOT9;RPL29;SMG7;CTIF;RPL10A;PAN2;RPL3;RPL12;RPS27A;RPS12;AGO1;RPL27;EXOSC9;RPS28;RPL5;GSPT2;MAGOH;CNOT2;RPS10
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5466224175685951,1.4933773077011931,0.021791767554479417,0.7086357711262934,1.0,14/84,5.01%,SMOC2;FOXP1;THBS1;BMP4;MET;PTK2B;ANXA3;PLPP3;FGFR1;FGF2;ABL1;FOXC2;NRP1;BCAS3
prerank,positive regulation of cellular senescence (GO:2000774),-0.6752741634020685,-1.4924371482308947,0.0625,0.4298717903118038,1.0,3/10,10.01%,B2M;YPEL3;ABI3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6972059512764882,1.491730591996634,0.08361774744027303,0.7125975061915917,1.0,2/17,1.11%,EGFR;PKD1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5235175116390978,1.4893177581677195,0.01995305164319249,0.7208903360575483,1.0,15/113,4.29%,F3;EGFR;BMP4;TCF7L2;SOX9;BMP5;PGF;NRAS;BMP6;FGF2;NOTCH2;FZD7;NRP1;TGFBR1;NR4A3
prerank,positive regulation of protein sumoylation (GO:0033235),0.7447686213454102,1.4893127286212775,0.08650519031141868,0.7175253283474939,1.0,3/10,8.88%,HDAC4;SAE1;PIAS3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6254779853184316,1.488686944343515,0.050505050505050504,0.7168493486358625,1.0,8/33,9.09%,MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3
prerank,negative regulation of complement activation (GO:0045916),0.7495613902986071,1.488213979649717,0.10085470085470086,0.7157508329801282,1.0,4/10,9.25%,CD55;CD46;CR1L;SERPING1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6514104887066557,1.4880447623651842,0.08709677419354839,0.7132620737259927,1.0,4/20,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,histone modification (GO:0016570),0.5226187049716569,1.4872092872304197,0.018561484918793503,0.7141331670656346,1.0,39/109,21.01%,EYA2;HDAC4;CCNA2;PRKCD;HDAC9;EYA4;RCOR3;KAT6B;UBE2B;CREBBP;TBL1X;EYA3;TRRAP;EHMT1;SGF29;CPA4;PRMT8;CTCFL;MIER1;MTA1;KAT2A;EP300;PRMT6;HDAC10;BAZ2A;PRDM5;NSD1;BRD8;RBM14;CARM1;EHMT2;USP22;BRMS1L;PHF20;UBE2N;USP21;USP36;MIER2;HUWE1
prerank,motor neuron axon guidance (GO:0008045),0.7037753296797306,1.486536137525186,0.06825938566552901,0.7140363763484603,1.0,4/15,6.83%,SLIT2;NTN1;TMEFF1;NTN5
prerank,cardiac muscle cell contraction (GO:0086003),0.6848478996804568,1.4861821249263445,0.07704654895666131,0.7124788241433881,1.0,5/19,3.27%,KCNJ2;CACNA1C;CAMK2D;GSN;CACNA1G
prerank,nucleoside catabolic process (GO:0009164),0.7430068886686654,1.4850597886482317,0.08629441624365482,0.714693008396029,1.0,4/11,7.59%,NT5E;NT5C1A;UPP2;DERA
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5423376671632729,-1.4844010681813091,0.049132947976878616,0.44912969885356113,1.0,11/24,17.11%,RAPGEF2;PEX5L;PRKAR2B;PRKAR1B;PDE4D;PRKAR1A;PDE2A;RNF157;MGRN1;APLNR;PDE3B
prerank,positive regulation of cytokinesis (GO:0032467),0.6262050699064863,1.4836156221602959,0.05102040816326531,0.7179418279818975,1.0,9/32,13.96%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3
prerank,negative regulation of peptidase activity (GO:0010466),-0.4553212945502285,-1.4835617152754097,0.026119402985074626,0.4476620651008499,1.0,9/47,7.55%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;CST3;SPOCK1;SERPIND1;GAPDH
prerank,sensory perception (GO:0007600),-0.46017592751493125,-1.4834112351703204,0.04602510460251046,0.44446875340876413,1.0,17/45,20.59%,RETREG1;ADGRV1;PCDH15;ADORA2A;TTC8;P2RX7;TRPV2;WHRN;MME;PENK;KCNA2;NTSR2;SCN9A;TRPA1;CCL2;CHRNA7;KCNK4
prerank,skin development (GO:0043588),0.5638339065756561,1.483171225800851,0.04456094364351245,0.7167050415419304,1.0,16/65,8.16%,CLIC4;MET;PKD1;COL5A2;ADAM9;ANXA1;DSP;COL3A1;BCR;WNT16;PIP5K1A;JAG1;TGM3;ASPRV1;PDGFA;SPRR1A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7104609933226882,1.4823228535834532,0.07742998352553541,0.7174722225218876,1.0,4/15,6.02%,PIEZO2;TMEM120A;TMC1;COL11A1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5588020913505652,-1.4819012243437786,0.0639386189258312,0.4452107753378153,1.0,10/18,28.25%,PLCB1;CHRM2;CHRM3;GRK2;CDK5R1;GNA15;RGS8;RGS10;AGRN;CHRM1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7403194127224856,1.4818905599600094,0.07046979865771812,0.7160034683822701,1.0,5/11,11.45%,MAP3K5;CYP1B1;PRKCD;DIABLO;ARL6IP5
prerank,response to purine-containing compound (GO:0014074),-0.5684578626328446,-1.4817724674722432,0.049738219895287955,0.4420289987667592,1.0,8/17,17.79%,TRPC3;ABCC9;RYR2;P2RY1;P2RX7;STAT1;VGF;NDUFS4
prerank,cellular zinc ion homeostasis (GO:0006882),-0.516266114974603,-1.4814282392472862,0.044444444444444446,0.439493321046814,1.0,15/26,19.05%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SLC39A7;MT3
prerank,regulation of B cell proliferation (GO:0030888),-0.4557042552170671,-1.479992423129583,0.04819277108433735,0.43999721149958565,1.0,14/44,15.03%,LYN;BCL2;TFRC;AHR;TNFRSF21;MEF2C;VAV3;CD81;CD38;CD300A;MIF;CD74;CD40;TYROBP
prerank,positive regulation of synapse assembly (GO:0051965),-0.49453959353673715,-1.479822752385334,0.06606606606606606,0.4371087327442735,1.0,7/27,12.17%,IL1RAPL1;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2
prerank,muscle cell migration (GO:0014812),0.7483022971933259,1.4794867094759214,0.08876811594202899,0.7240828697159843,1.0,2/10,0.70%,CCN3;SIX1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4881880349682476,-1.4791828793776804,0.03870967741935484,0.43557117844397814,1.0,22/34,25.71%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SYN1;SYT13;SYT10;RAB15;SYT9;SYT6;SYT15;RAB3A;SYT2;RIMS4;SYT4;RAB27A;SYT5;SYT17;DOC2A;SNAPIN
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6728527335727046,1.4782501277268847,0.07197549770290965,0.7267415565652836,1.0,4/18,5.64%,ANXA1;FAM107A;KLF9;ISL1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.559083626064539,1.4780218291505653,0.05459387483355526,0.7246581190748128,1.0,11/55,17.12%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;USP47;PSMD11;PSMD1;CUL1;PSMC1;PSMD7
prerank,spinal cord development (GO:0021510),0.7303869948089388,1.4776133165607652,0.06655574043261231,0.7232199636529034,1.0,4/12,9.78%,VIT;PKD1;GLI2;NF1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.70778116872367,1.4771990330087486,0.0770440251572327,0.722056742166258,1.0,6/14,11.77%,THBS1;MEOX2;KLF4;RHOA;STARD13;ITGB1BP1
prerank,regulation of synapse maturation (GO:0090128),-0.6418511622587975,-1.4766998953627413,0.06235011990407674,0.43929247469388977,1.0,5/10,17.88%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;RELN
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6393983477349137,1.4761030960287045,0.06896551724137931,0.7238717815455039,1.0,6/24,7.12%,CDON;BOC;CTNNA1;ABL1;MEF2A;MYOG
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6931713182605002,1.4760587183226836,0.07855973813420622,0.7209623633253921,1.0,3/18,3.62%,CCN3;KCNB1;IRS1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7287020189657609,1.474864970634502,0.08843537414965986,0.7235657414906173,1.0,4/11,6.23%,EGLN3;P3H2;P4HA1;P4HA2
prerank,regulation of interleukin-12 production (GO:0032655),0.5729812590265142,1.474452460868956,0.04660452729693742,0.7223409770251608,1.0,10/47,11.40%,FOXP1;THBS1;CMKLR1;ISL1;RIPK2;IL10;TLR4;PLCG2;IRAK3;MAST2
prerank,endothelial cell proliferation (GO:0001935),0.6786584588342672,1.4692758521703424,0.08466453674121406,0.7437974669906074,1.0,2/17,0.28%,BMPER;BMP4
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6066890511447813,1.4688938161367269,0.08357348703170028,0.7424529517544741,1.0,13/31,16.69%,SIX1;HOXA3;TGFBR1;TGFBR2;NOG;HOXB3;HOXC4;HOXB4;MEGF8;HOXD3;TWIST1;TFAP2A;DYNC2I1
prerank,negative regulation of nuclear division (GO:0051784),0.7251696192630827,1.4688710382506462,0.08103448275862069,0.7393947547939885,1.0,1/11,0.28%,BMP4
prerank,negative regulation of histone acetylation (GO:0035067),-0.6360410377389274,-1.468332757308267,0.085995085995086,0.46039065312975513,1.0,5/11,19.91%,SNCA;NOC2L;SET;CTBP1;SPI1
prerank,zinc ion homeostasis (GO:0055069),-0.4978506760588053,-1.467936534770697,0.06645569620253164,0.4580186976550024,1.0,15/28,19.05%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SLC39A7;MT3
prerank,positive regulation of dendrite extension (GO:1903861),-0.5664397674757609,-1.4678231183768196,0.06852791878172589,0.4549519619288181,1.0,10/17,27.01%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17;UNC13A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.722776619796295,1.46713522765624,0.09169550173010381,0.7441208638451459,1.0,2/11,1.55%,KCNJ2;ATP1B1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5787862200259379,1.4670894881284966,0.06285714285714286,0.7412467575278621,1.0,5/41,2.72%,KCNJ2;KCNMB3;KCNMB2;ANK2;KCNJ15
prerank,negative regulation of cell death (GO:0060548),0.5338781866884363,1.4670797128690802,0.0343980343980344,0.7381843163293603,1.0,16/88,6.62%,BMP4;CCN3;CCN1;CCN5;WNT11;GSK3B;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;WNT16;GATA4;CLU;AGR2;SRSF6
prerank,vasculogenesis (GO:0001570),-0.4923320918361126,-1.4653327952530248,0.028169014084507043,0.45849464856668914,1.0,12/32,9.87%,ENG;TGFBR3;PDGFRB;KDR;RASIP1;NOTCH1;SOX17;SPRED1;HEY2;ADM;SOX18;RAMP2
prerank,regulation of ossification (GO:0030278),0.5962815420617142,1.4651418060947763,0.08875739644970414,0.7440304390921733,1.0,8/36,4.55%,BMP4;SOX9;LRP6;DDR2;SMAD6;ZBTB16;SGMS2;TXLNG
prerank,catecholamine biosynthetic process (GO:0042423),-0.6322300246133419,-1.4645617555472032,0.06880733944954129,0.45743101685400767,1.0,3/11,8.39%,MOXD1;SNCA;DDC
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6534412732211868,1.463707073485119,0.08497723823975721,0.7476143509656408,1.0,1/21,0.11%,SLIT2
prerank,potassium ion import across plasma membrane (GO:1990573),0.5770664937072602,1.4635890896938186,0.07132667617689016,0.7451029266487957,1.0,6/41,2.72%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.7092600532751523,1.4620100319764644,0.08919382504288165,0.7493137019957834,1.0,3/12,8.98%,TMEFF2;IL10;AP2A1
prerank,potassium ion homeostasis (GO:0055075),0.635442498272575,1.4618928503399882,0.08841463414634146,0.7468880735655015,1.0,5/23,2.62%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,regulation of neuron projection development (GO:0010975),-0.36623021215961926,-1.461564411839223,0.0,0.4625478819785325,1.0,60/163,15.05%,CAMK1D;EFNB2;LYN;IL1RAPL1;CDH2;SHANK3;APOE;PRKD1;ITGA6;PTK7;LRRC4C;CTNNA2;CSMD3;PPFIA2;PAK1;RAPGEF2;WNT5A;TENM3;SERPINI1;LPAR1;DCC;FUT9;SPOCK1;ROR2;TOX;CHN1;ATP1B2;NDNF;RIT2;EPHA4;DAB2IP;LRRC7;CCDC88A;DENND5A;SETX;NTRK2;MAG;PLK5;CRMP1;PAK3;CFL1;RAPGEF1;ABI3;TWF2;PTPRO;MFSD2A;BRSK2;MDK;CAMK2B;FES;KNDC1;RTN4RL1;NDRG4;CAMSAP2;GSK3A;KIF1A;MYLIP;TRPV4;FKBP4;AKT1
prerank,potassium ion transport (GO:0006813),0.5091497387696224,1.4612234535327187,0.02677532013969732,0.7469261798832555,1.0,11/120,3.00%,SLC9A2;KCNB2;KCNK5;KCNJ2;SLC24A3;KCNMB3;KCNMB2;KCNQ5;KCNJ15;KCNS3;KCNB1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6973039900500455,1.460468437367871,0.07333333333333333,0.7471029417349373,1.0,3/14,4.43%,THBS1;ANO6;PDCD4
prerank,sodium ion transmembrane transport (GO:0035725),0.5281621473652335,1.459776160451782,0.03506650544135429,0.747282466338646,1.0,16/84,8.86%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;SLC6A7;ANO6;NALCN;TRPM4;SLC6A19;SLC9C1;SLC4A8;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5477157090327224,-1.4593637122593293,0.04843304843304843,0.4651424713671312,1.0,5/19,6.40%,VCAM1;GRM5;KDR;RYR2;PTGFR
prerank,regulation of fibroblast migration (GO:0010762),0.6481505364806915,1.4591311538966132,0.10452418096723869,0.7473644696171562,1.0,9/20,12.07%,THBS1;DDR2;ITGB1;FGF2;PRKCE;DMTN;HAS1;ITGB1BP1;CORO1C
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6262810992824108,-1.4590309603927751,0.07932692307692307,0.4626195727415448,1.0,9/11,32.86%,UQCRH;UQCR10;CYCS;UQCR11;CYC1;UQCRC1;UQCRB;UQCRC2;UQCRQ
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.613651429798315,1.457124616072094,0.08273894436519258,0.753811127024393,1.0,1/29,0.01%,SLC4A10
prerank,odontogenesis (GO:0042476),0.5979285042916151,1.456695412353019,0.06956521739130435,0.7525901019386122,1.0,9/35,9.82%,BMP4;LRP6;EDA;TGFB3;INHBA;PITX2;FOXC1;GLI2;AQP6
prerank,mesenchymal to epithelial transition (GO:0060231),0.7454443395053624,1.4561716807233929,0.11352253756260434,0.7521216994500041,1.0,2/10,3.31%,BMP4;FZD7
prerank,basement membrane organization (GO:0071711),-0.603158096149131,-1.4556579479067233,0.07901234567901234,0.46882926868270663,1.0,7/14,14.92%,NID1;NID2;COL4A1;LAMB1;CTSS;RAMP2;LAMB2
prerank,endothelial cell migration (GO:0043542),0.5871799700459552,1.455506270246284,0.06881405563689605,0.7520845384066045,1.0,11/37,10.34%,CCN3;FSTL1;CYP1B1;GIPC1;ABL1;ID1;NRP1;RHOA;STARD13;S100A2;VEGFA
prerank,rRNA processing (GO:0006364),-0.366505184033752,-1.4553654580239992,0.010526315789473684,0.4664403924591916,1.0,68/172,23.14%,NSA2;RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;TSR3;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5488478893561175,-1.455318358673944,0.05115089514066496,0.4632791091232569,1.0,4/17,10.82%,KCNAB1;ANK3;AKAP6;NOS1AP
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5052428697906446,-1.4546272552070914,0.04815864022662889,0.46192424687943867,1.0,15/28,23.31%,PRKAG2;MITF;CD47;PRKAA2;SIRPA;RAC1;FGFR4;NOS1AP;NR1H4;MED1;SIRT5;C3;PDK4;MFSD12;CX3CR1
prerank,atrioventricular valve development (GO:0003171),0.7014580762176692,1.4545072327601907,0.09540034071550256,0.7538328988969121,1.0,5/14,9.97%,SLIT3;BMPR1A;TGFBR2;MDM4;ACVR1
prerank,regulation of histone acetylation (GO:0035065),-0.48745376329904927,-1.454305966111432,0.035483870967741936,0.45962027015939205,1.0,12/33,19.91%,RPS6KA5;RAPGEF3;PPARGC1A;SNCA;MYOCD;NOC2L;SET;ARRB1;MAPK3;CTBP1;RUVBL2;SPI1
prerank,sulfation (GO:0051923),0.7097724420041747,1.454204221647875,0.10829103214890017,0.752365918314915,1.0,3/11,4.55%,UST;CHST5;SULT1A1
prerank,endothelial tube morphogenesis (GO:0061154),0.7227853154773856,1.4541912541090656,0.07966101694915254,0.7494804628519697,1.0,3/10,9.13%,BMP4;RHOA;STARD13
prerank,cellular response to organic substance (GO:0071310),0.5067444466088099,1.4536587218970212,0.020761245674740483,0.749000983269212,1.0,25/116,12.45%,SLIT3;SLIT2;DPYSL3;RAMP1;CYP1B1;PID1;NFAT5;IGFBP5;SHC1;KLF4;BMPR1A;TGFBR1;PTPN2;TGFBR2;STAT3;SOCS2;RHOA;ACVR1;IL18BP;EMD;CCL3;ERBB2;ARL6IP5;PTPN9;CPNE3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.624668998595287,-1.4534599684810836,0.07142857142857142,0.4587995062567087,1.0,2/10,3.15%,KCNAB1;ANK3
prerank,positive regulation of macrophage activation (GO:0043032),0.661311737739525,1.4534300198368397,0.09936908517350158,0.7471628143156986,1.0,5/17,10.91%,THBS1;LBP;TLR4;IL33;CCL3
prerank,regulation of cell growth (GO:0001558),0.48597248759980216,1.4534210497655975,0.01284796573875803,0.7442909256583663,1.0,19/204,5.38%,SLIT3;SLIT2;EGFR;CCN3;PLCE1;FHL1;NDRG3;OSGIN2;CAMK2D;WNT11;ESR2;INHBA;FAM107A;IP6K2;TGFBR1;AGTR1;EIF4G1;SGK3;KLHL22
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4985533709218883,-1.453350168110218,0.05654761904761905,0.4559984500036343,1.0,18/27,24.10%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SDF4;SYT13;PPP3CB;SYT10;SYT9;SYT6;SYT15;SYT2;DOC2B;SYT4;SYT5;SYT17
prerank,androgen receptor signaling pathway (GO:0030521),0.7253600322903898,1.4521178074223153,0.1,0.7472687831391928,1.0,9/11,25.52%,DDX5;PMEPA1;DDX17;PLPP1;ZMIZ1;RNF14;TMF1;ARID1A;AR
prerank,amino sugar metabolic process (GO:0006040),-0.6538405163304214,-1.4520851798312622,0.07434052757793765,0.45636888725471075,1.0,3/10,3.26%,ST6GAL1;ST3GAL1;CSGALNACT1
prerank,regulation of dendrite extension (GO:1903859),-0.556420155477886,-1.4517439539552726,0.0712401055408971,0.4542956912592299,1.0,10/18,27.01%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17;UNC13A
prerank,"wound healing, spreading of cells (GO:0044319)",0.6186850393436908,1.4511699772639606,0.07951070336391437,0.7487654725464684,1.0,6/24,9.06%,TMEFF2;CCN1;CD44;ITGA5;MRTFA;RHOA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6946181759193343,1.4509688474289881,0.09852216748768473,0.7467142647264537,1.0,4/15,3.29%,SMOC2;MET;FGFR1;FGF2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7364506281237275,1.4504001423590027,0.1,0.746343309539154,1.0,3/10,6.63%,NT5E;NT5C1A;UPP2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.657400330564548,1.4498729147483105,0.0978441127694859,0.745829437023249,1.0,3/17,4.70%,EZR;UBASH3A;PTPN2
prerank,ganglion development (GO:0061548),0.7127777371592325,1.448257004003634,0.10998307952622674,0.7504716070835757,1.0,2/11,3.98%,UNC5C;NRP1
prerank,negative regulation of protein processing (GO:0010955),0.723192366804158,1.4479473272388712,0.08196721311475409,0.7491681144927375,1.0,5/12,15.60%,THBS1;GAS1;SNX12;ACP4;SERPINE2
prerank,metanephros development (GO:0001656),0.6259198645550506,1.4473425563731959,0.08623298033282904,0.7491245407511985,1.0,8/26,9.78%,BMP4;SIX1;PKD1;FOXD1;GDNF;GDF6;SIX4;NF1
prerank,chondrocyte differentiation (GO:0002062),0.5886944143310475,1.4465146765339225,0.08464849354375897,0.7500628987749905,1.0,6/32,4.23%,BMP4;CCN3;NFIB;SOX9;SULF1;SLC39A14
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.521636401904439,-1.446034188343144,0.05956112852664577,0.4668644231882743,1.0,8/22,11.35%,SLC16A2;TOX;NES;TAFA1;GATA2;KDM2B;PROX1;MDK
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6463826657587637,1.445476584409987,0.09190031152647975,0.7521074853014039,1.0,3/18,2.85%,SLIT2;PTK2B;MTUS1
prerank,positive regulation of transporter activity (GO:0032411),0.6952867058136276,1.44545447859962,0.0875,0.7494001200751603,1.0,1/13,0.13%,STK39
prerank,modulation by symbiont of host process (GO:0044003),-0.6325988180259906,-1.4430655717563654,0.08816705336426914,0.4722195398227723,1.0,5/10,19.06%,B2M;UBC;MRC1;RPS27A;ENO1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6450207236729822,1.4411968328683227,0.09175738724727839,0.76538245209923,1.0,4/21,8.14%,LRP6;GSK3B;FZD1;CSNK1A1
prerank,positive regulation of vasoconstriction (GO:0045907),0.6955576159091517,1.4405062467642207,0.11016949152542373,0.7658991113121121,1.0,2/13,4.96%,ADRA1B;TRPM4
prerank,response to UV (GO:0009411),0.5149713843829503,1.440148755149619,0.038461538461538464,0.7647057446947926,1.0,31/95,20.11%,EGFR;SCARA3;NEDD4;PRKCD;UBE4B;UBE2B;CREBBP;KDM1A;ERCC5;WRN;USP1;UVSSA;USP47;EP300;EIF2AK4;ERCC8;CCND1;ZBTB1;ERCC3;XPA;YY1;USP28;EIF2S1;ATR;MAP3K4;DHX36;INO80;CIRBP;REV1;FMR1;MAPK8
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6042978276201075,1.439904015372813,0.0836940836940837,0.7630316183986067,1.0,13/32,11.77%,THBS1;RHOJ;ANXA1;HDAC9;MEOX2;KLF4;FGF2;FOXC2;MAP3K3;RHOA;STARD13;VEGFA;ITGB1BP1
prerank,skeletal muscle organ development (GO:0060538),0.6115352655700799,1.4395398473839944,0.08701657458563536,0.7618801122443241,1.0,7/26,7.87%,SIX1;CSRP3;DISP1;LARGE1;STRA6;MYOG;SIX4
prerank,organic substance transport (GO:0071702),0.500782418164652,1.439271089028443,0.04055619930475087,0.7603376792761698,1.0,7/120,2.41%,SLC47A1;SLC23A1;ABCD3;RAMP1;SLCO2A1;DISP1;ABCG2
prerank,integrin-mediated signaling pathway (GO:0007229),0.524315844822633,1.4379990106457679,0.05806451612903226,0.7634718322473276,1.0,15/73,6.31%,ITGBL1;ITGB8;PTK2B;FN1;ADAM9;PLPP3;COL3A1;ITGB1;ABL1;NRP1;ITGB5;ITGA10;ITGA5;ITGAV;PTPRA
prerank,activation of phospholipase C activity (GO:0007202),0.6043317025566309,1.4368294494621552,0.08199121522693997,0.7659887284129717,1.0,2/29,0.91%,EGFR;EDNRA
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5360612157936324,1.4365737147428135,0.06753246753246753,0.764317739192465,1.0,16/65,19.38%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;NABP1;USP47;CHEK1;PSMD11;PSMD1;CHFR;CUL1;PSMC1;PSMD7;ZFYVE19;PSMD14
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5591399653214014,1.436530808583725,0.07387862796833773,0.7617416205286056,1.0,13/53,14.40%,EGFR;EYA2;DDX5;PRKCD;EYA4;SPRED2;EYA3;BCLAF1;ATM;UIMC1;RNF168;ERCC8;DHX9
prerank,lipid catabolic process (GO:0016042),-0.5565560312867295,-1.4354566264038264,0.06983240223463687,0.49164306592802465,1.0,9/18,32.52%,PLA1A;LIPE;LPL;PLAAT3;MT3;HSD11B1;PPT1;HSD17B14;SIRT2
prerank,cellular response to ketone (GO:1901655),-0.4688956534149389,-1.4352506190403895,0.059375,0.48901584903848655,1.0,8/35,11.32%,ADCY5;ADCY1;GNG2;AHR;PTGFR;SPP1;ADCY2;ROCK2
prerank,signal release from synapse (GO:0099643),-0.4600795591712006,-1.4340529156109334,0.07142857142857142,0.48945158018388085,1.0,21/43,27.01%,NRXN1;RIMS1;LIN7A;HSPA8;SYN2;SNCA;SNAP25;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;PPFIA3;SNAPIN;UNC13A
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6322280469720849,-1.433751417351046,0.09382151029748284,0.48712445732671206,1.0,3/10,2.96%,BCL2;DCN;KDR
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5066250500079289,-1.4328926773397705,0.07941176470588235,0.4865246030312294,1.0,11/27,20.32%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1;ABCB4;SCP2;NR1H2;GPS2;TREM2
prerank,protein localization to cilium (GO:0061512),0.594013114223492,1.4328018462635492,0.06983240223463687,0.7763839317752581,1.0,8/32,10.05%,BBS9;ZNF423;INVS;ARL3;RABEP1;TULP2;WDR35;EHD1
prerank,blood vessel morphogenesis (GO:0048514),-0.4244787561312369,-1.4325691163623069,0.016666666666666666,0.4842993312750326,1.0,19/54,9.87%,FLT1;EFNB2;ENG;LAMA1;TGFBR3;CDH2;CCBE1;KDR;RASIP1;SLC1A1;TBX1;COL4A1;SOX17;RBPJ;HEY2;PROX1;ADM;SOX18;RAMP2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6176969836751746,1.4315870912977458,0.09185185185185185,0.779080795489098,1.0,12/27,12.24%,ANK2;CACNA1C;CAMK2D;DSP;DSG2;FGF13;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,positive regulation of angiogenesis (GO:0045766),0.4987146481840307,1.4307794430957559,0.05190311418685121,0.7800577078319216,1.0,18/108,6.17%,SMOC2;BMPER;F3;THBS1;ITGB8;PGF;CYP1B1;ANXA3;PTGIS;KLF4;HIPK1;ITGB1;FGF2;FOXC2;ITGA5;ADAM12;ISL1;GATA4
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6089214659605848,1.4304252854642545,0.0888208269525268,0.7788167700302303,1.0,6/25,5.58%,STK39;ANK2;ATP1B1;WNK1;DMD;COA8
prerank,negative regulation of actin filament polymerization (GO:0030837),0.632559701843249,1.4303431639098776,0.10725075528700906,0.7764902858884171,1.0,3/22,2.48%,SLIT2;PRKCD;GSN
prerank,mesonephros development (GO:0001823),0.7057814637140138,1.429791749349098,0.10696095076400679,0.776204722210316,1.0,2/11,2.37%,BMP4;ZBTB16
prerank,ERBB signaling pathway (GO:0038127),0.5370694281324008,1.4292314960411827,0.04779874213836478,0.7760479293302778,1.0,9/64,4.91%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.43768113086470406,-1.4292032689630998,0.04779411764705882,0.49075683860574604,1.0,15/49,15.46%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18;IL6ST;CSF1R;CD40;TNFRSF1A;FLT3
prerank,actin filament depolymerization (GO:0030042),0.7219743583185199,1.4291567924122157,0.10296684118673648,0.7736579551531598,1.0,2/11,2.48%,MICAL2;GSN
prerank,regulation of cholesterol efflux (GO:0010874),-0.4909493804935866,-1.4291131265659696,0.04229607250755287,0.48784357388404526,1.0,6/30,7.26%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1
prerank,hexose transmembrane transport (GO:0008645),-0.5323199333824928,-1.4290723964472591,0.06775067750677506,0.4849553431715837,1.0,5/21,10.87%,SLC2A1;PPARD;SLC2A12;SLC5A3;SLC50A1
prerank,primary neural tube formation (GO:0014020),0.5975645493804203,1.4283632256305057,0.09037037037037036,0.7743743635987315,1.0,6/30,8.58%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2
prerank,myoblast differentiation (GO:0045445),0.6676234799432662,1.4280745581677023,0.12084063047285463,0.7730175518026237,1.0,10/14,15.45%,TCF7L2;MBNL1;DDX5;DDX17;PLEKHM3;JAG1;MAPK12;RB1;REST;HINFP
prerank,atrial septum development (GO:0003283),0.6857563377579478,1.4279121353192257,0.10684474123539232,0.771091409054948,1.0,5/13,8.35%,ANK2;NOTCH2;ISL1;GATA4;MDM4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6827576349786304,1.4277207481747913,0.1076158940397351,0.7692710611364789,1.0,4/14,6.11%,SLIT2;IGFBP5;BMPR1A;LRP1
prerank,gastrulation (GO:0007369),0.6535418520341963,1.4275902826138476,0.11726384364820847,0.7671545329280768,1.0,5/15,11.10%,GPC3;NR4A3;LRP5;SMAD2;MEGF8
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5612363926941463,1.4275024415704942,0.0743801652892562,0.7648933511394258,1.0,6/46,4.29%,FOXP1;THBS1;BMP4;TCF7L2;IGFBP5;NR4A3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.37827234270148097,-1.4268117212963407,0.018633540372670808,0.4884954126792659,1.0,29/107,10.31%,ATP1A2;CDH2;GRM7;LRRC4C;GRM3;MCTP1;NRG3;DGKI;GRM5;GRID2;RIMS1;GRIK2;RIMS2;GRM1;APP;MCTP2;MEF2C;GRIK1;OPHN1;DLGAP1;LRP8;CACNA1B;GRM8;EIF4EBP2;ABR;SYT1;TMEM108;CAMK2A;SYN1
prerank,response to nitric oxide (GO:0071731),-0.6069627410353692,-1.4263617890630387,0.08018867924528301,0.48668247216740623,1.0,9/13,25.16%,FOXO1;GUCY1B1;KCNC2;EGLN1;CCL19;MT3;MMP3;AQP1;TXN
prerank,eye development (GO:0001654),0.5577997945255837,1.4263232651630007,0.07397622192866579,0.7677743155723318,1.0,16/54,13.40%,PBX3;COL5A2;CACNA1C;PBX1;SMOC1;HIPK1;STRA6;EFEMP1;TSKU;SKI;PITX2;FOXC1;SCO2;ATF6;NIPBL;PAX6
prerank,positive regulation of DNA repair (GO:0045739),0.5650273760971125,1.4262294313191275,0.07534246575342465,0.7656071297849518,1.0,11/46,14.40%,EGFR;EYA2;EYA4;EYA3;DDX11;SPIDR;UIMC1;RNF168;HDAC10;ERCC8;DHX9
prerank,anion transport (GO:0006820),0.6015863075691564,1.4261078947907708,0.07982583454281568,0.7635175824899589,1.0,3/33,2.41%,SLC26A7;LRRC8D;ABCG2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6685996794534502,1.4259298445246416,0.10543657331136738,0.7617106789678533,1.0,4/16,14.53%,SOX9;NCOR1;ERLIN1;WDTC1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6251011433453393,-1.425173658706851,0.09738717339667459,0.48724514936375674,1.0,5/10,19.56%,APOE;DBI;ABCB4;TRIAP1;TMEM30A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.642648755404934,1.4250234372557185,0.10476190476190476,0.7633052491863108,1.0,7/17,10.13%,CD55;STAT3;GNL1;JAG1;TLR4;CD46;IL18BP
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6949634144907532,1.4248409614155493,0.12542372881355932,0.7615007482394086,1.0,3/12,8.03%,FOXP1;KLF4;TLR4
prerank,protein K11-linked ubiquitination (GO:0070979),0.5949196515851753,1.4236510004256595,0.1099554234769688,0.7640349842583318,1.0,5/27,9.06%,FZR1;ANAPC5;UBE2B;CDC16;UBE2D3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6357022250317068,-1.4224848165604156,0.09655172413793103,0.4919122248564367,1.0,6/11,10.71%,EFNB2;SOX6;MEF2C;FRS2;BMP2;MYOCD
prerank,linoleic acid metabolic process (GO:0043651),-0.5473705259888574,-1.422390165400439,0.06593406593406594,0.48917729584144365,1.0,4/17,10.64%,ACSL1;FADS2;PNPLA8;ALOX12
prerank,outflow tract septum morphogenesis (GO:0003148),0.6186761128565132,1.4222978375740187,0.08620689655172414,0.7674816151627714,1.0,9/24,5.64%,BMP4;ZFPM2;SMAD6;SEMA3C;PARVA;BMPR1A;NRP1;TGFBR2;ISL1
prerank,regulation of neutrophil migration (GO:1902622),-0.6145216447774798,-1.422205486158581,0.11961722488038277,0.4867720158588788,1.0,7/10,31.18%,JAM3;RHOH;RAC1;RHOG;BST1;RAC2;OLFM4
prerank,regulation of MAPK cascade (GO:0043408),-0.35874465833883906,-1.4220707231387877,0.0,0.4842010938607341,1.0,33/157,7.98%,FLT1;IGF1;IGF1R;KSR1;PHLPP1;LYN;TEK;TGFBR3;KIT;EPHA7;TNIK;JCAD;PAK1;KDR;EPHB1;LPAR1;PELI2;INSR;ROR2;TBX1;NRK;RIT2;LBH;MAP4K4;DAB2IP;EPHA8;PAK5;SPRED1;FAS;BMP2;ADRA2A;NTRK2;ZDHHC17
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6551939263105941,1.4220027567297582,0.13179571663920922,0.7661717307416483,1.0,2/15,1.55%,KCNJ2;ATP1B1
prerank,transport across blood-brain barrier (GO:0150104),0.5114282157870651,1.420869282181472,0.061274509803921566,0.7685560550738165,1.0,10/83,2.41%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,negative regulation of transmembrane transport (GO:0034763),0.717760706315974,1.4207350463183457,0.11224489795918367,0.7665629100975112,1.0,1/10,0.27%,THBS1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6880946455155623,1.420705757602074,0.12086092715231789,0.7642024302461413,1.0,3/13,9.08%,BMP4;VNN1;GLI2
prerank,tube closure (GO:0060606),0.5921002947455916,1.42068760656417,0.09523809523809523,0.7617761294693037,1.0,6/31,8.58%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2
prerank,vascular transport (GO:0010232),0.5147806732120749,1.42060614283601,0.05693069306930693,0.7596119622875647,1.0,10/81,2.41%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6413563691934947,1.4185509087479409,0.11092985318107668,0.7660620308403213,1.0,2/20,1.11%,EGFR;PKD1
prerank,establishment of endothelial barrier (GO:0061028),-0.49657902344425653,-1.416937327572315,0.07384615384615385,0.49593800643677166,1.0,11/29,9.84%,TJP1;PECAM1;RAPGEF3;PPP1R16B;RAPGEF2;F11R;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6114770504962851,1.4161723319405108,0.09009009009009009,0.7737476550528386,1.0,9/27,11.39%,PTPN3;FXYD5;CAMK2D;SLMAP;ATP2B4;SNTA1;DLG1;COMMD1;RANGRF
prerank,positive regulation of T cell migration (GO:2000406),0.6385486281244953,1.415845009180668,0.10501567398119123,0.7726953043337171,1.0,2/20,1.93%,STK39;WNK1
prerank,visual perception (GO:0007601),0.5219522760116924,1.4151045656835768,0.0558858501783591,0.7735383661543144,1.0,13/84,13.63%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;PAX6;CRYBB3
prerank,glucose transmembrane transport (GO:1904659),-0.5480313987178912,-1.4150995747646349,0.0807799442896936,0.4982826063487184,1.0,4/18,6.19%,SLC2A1;SORT1;PPARD;SLC5A3
prerank,positive regulation of protein catabolic process (GO:0045732),0.5076493407815383,1.4145891725651063,0.052763819095477386,0.7731973287768062,1.0,20/84,12.34%,WWP1;FZR1;NEDD4;EZR;ADAM9;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;RDX;NSF;PLK3;CDKN1B;DACT1;ASB11;SH3D19;TNFRSF1B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5454631135624993,1.4121010505891538,0.08047493403693931,0.7817085003153798,1.0,13/50,13.94%,EGFR;NR3C2;TCIM;NFAT5;PDCD4;TRIM44;IFI35;TLR4;RHOA;LIMS1;TRIP6;EP300;TRADD
prerank,regulation of interleukin-8 production (GO:0032677),0.5281296960375591,1.4119070103825815,0.0654911838790932,0.7800602582149114,1.0,11/69,8.03%,F3;LBP;ANXA1;ANXA4;KLF4;CD2;STAT3;MAVS;DDIT3;IL10;TLR4
prerank,response to fatty acid (GO:0070542),0.6470686125464536,1.4116410406450344,0.1339712918660287,0.7786921501062792,1.0,7/17,12.84%,SOX9;PID1;FOXO3;IRS1;SCD;PPP5C;PDK3
prerank,cell differentiation in spinal cord (GO:0021515),-0.6390266604635302,-1.411551047532916,0.11138014527845036,0.5061214397412421,1.0,4/10,8.02%,SOX13;SOX6;MDGA2;ZC4H2
prerank,cAMP biosynthetic process (GO:0006171),-0.6227083759778066,-1.4113955553727888,0.11013215859030837,0.5035514875900506,1.0,5/10,15.24%,ADCY5;ADCY1;ADCY7;ADCY2;ADCY4
prerank,protein deacetylation (GO:0006476),0.5612120802570685,1.4113562669425155,0.0735930735930736,0.7774179351179671,1.0,15/41,23.60%,HDAC4;HDAC9;RCOR3;TBL1X;MIER1;MTA1;HDAC10;BAZ2A;PRDM5;SIRT6;RBM14;BRMS1L;MIER2;FLNA;BRMS1
prerank,positive regulation of cell cycle (GO:0045787),0.5364299817563356,1.4112559769333288,0.06028833551769332,0.7753674639814472,1.0,15/62,15.08%,SMOC2;EGFR;PKD1;LRP6;USP2;CDC25B;CDKN1B;RARA;CCNYL1;CHEK1;PKN2;HCFC1;CCND1;TGM1;PRKCA
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6034644013174911,1.4111346132279083,0.07941176470588235,0.7734178446547729,1.0,6/28,7.62%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP
prerank,regulation of peptide hormone secretion (GO:0090276),-0.405510367314718,-1.4111068797644135,0.014925373134328358,0.5014866188960195,1.0,13/67,7.70%,ITPR1;RAPGEF4;CHD7;SLC2A1;CACNA1D;RAPGEF3;CACNA1E;KCNC2;DPP4;SYT7;ADRA2A;SNAP25;HTR2C
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7003039474452752,1.4107578912368333,0.11815068493150685,0.7724546713307675,1.0,3/11,8.83%,THBS1;BMPR1A;CD46
prerank,regulation of T cell mediated immunity (GO:0002709),0.7218453603258502,1.4107176922130835,0.10469314079422383,0.7702382233912763,1.0,4/10,15.15%,TRPM4;RIPK3;TNFRSF1B;ZBTB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6473089231109446,1.410558594592043,0.10606060606060606,0.7684873897179474,1.0,7/17,10.24%,BMP4;BMPR1A;NOTCH2;NOG;JAG1;ACVR1;GALNT11
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6421216113419295,-1.4098706094641076,0.09158415841584158,0.5018285456420876,1.0,3/10,10.07%,TGFA;ADRA2A;HBEGF
prerank,regulation of protein catabolic process (GO:0042176),0.4977024934843018,1.409775783238345,0.05143540669856459,0.7695495715594476,1.0,24/99,15.12%,EGFR;WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;NSF;CHEK2;MDM4;CDKN1B;DACT1;IRAK3;ASB11;SNX12;ZDHHC2;SMURF1;AZIN1;SEC22B;HMGCR
prerank,negative regulation of cell aging (GO:0090344),-0.5612486050894723,-1.4091231649346752,0.0855614973262032,0.5009393285699817,1.0,6/16,14.00%,SLC30A10;AKT3;CDK6;YBX1;MIF;RBL1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5597910097877437,-1.4082245132876214,0.0773067331670823,0.5006704014270148,1.0,6/17,11.66%,IGF1;APOE;RTN1;NTRK2;RTN4;BIN1
prerank,calcineurin-mediated signaling (GO:0097720),0.7017647161347504,1.4078852716590398,0.14359861591695502,0.7730035235342263,1.0,6/10,14.18%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7017647161347504,1.4078852716590398,0.14359861591695502,0.7730035235342263,1.0,6/10,14.18%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,osteoclast differentiation (GO:0030316),0.6318220467746172,1.4072171207247475,0.0945945945945946,0.7736276354423113,1.0,3/22,3.34%,FOXP1;ANXA2;GAB2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6946963592321507,1.4068418859573946,0.12966252220248667,0.7729387145686125,1.0,1/11,0.13%,STK39
prerank,dendritic spine organization (GO:0097061),-0.4809645994920901,-1.4066649746813769,0.06267806267806268,0.5022875921509624,1.0,6/26,3.90%,IGF1R;DOCK10;SHANK3;EPHB1;ITGA3;INSR
prerank,regulation of cell communication (GO:0010646),0.5719823763289705,1.4057053114658302,0.10818713450292397,0.7754473126043108,1.0,6/35,2.23%,GRK5;ANK2;CAMK2D;MGLL;ANXA1;CXADR
prerank,positive regulation of leukocyte activation (GO:0002696),0.6447406332443852,1.405581757613052,0.12618296529968454,0.773651638546733,1.0,5/18,9.65%,THBS1;LBP;CD2;TLR4;IL33
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.5147132002995427,-1.4053947020792077,0.07027027027027027,0.5030367700262087,1.0,9/22,22.78%,APOD;ADRA2A;PPP2R5A;ASXL3;PDE3B;CCDC3;GPER1;APOC1;ALK
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.45860997992429064,-1.4042882469048112,0.05723905723905724,0.5033394197733543,1.0,15/34,15.60%,GRID2;GABRG3;GRIN2A;GRIN2B;GABRA2;MEF2C;GRIN1;GLRA1;GABRA1;GABRG1;GSK3A;GABRA4;AKT1;ARRB2;GABRA5
prerank,Wnt signaling pathway (GO:0016055),0.5038329966830216,1.403803839689808,0.06028368794326241,0.7787719872329937,1.0,22/92,10.96%,TCF7L1;NXN;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;STRN;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;GPC4;CSNK1G3;USP34;RARG;PLCG2;LRP5;BCL9L
prerank,positive regulation of locomotion (GO:0040017),0.5779916205655107,1.4036560290003772,0.10309278350515463,0.7770618786503987,1.0,2/27,0.80%,THBS1;NTN1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5912489145822346,-1.4025411389474909,0.12643678160919541,0.5056196200688673,1.0,4/12,5.71%,SEMA6A;DCN;ADAMTS12;DAB2IP
prerank,positive regulation of cell communication (GO:0010647),-0.4866854159096011,-1.4006165743417673,0.06493506493506493,0.5086169174680856,1.0,7/28,9.25%,WLS;RIMS1;ANK3;GRIK2;RIMS2;EDN1;SYT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6464865540573651,1.4004187349769228,0.1116751269035533,0.7885818633815002,1.0,5/17,9.48%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5219897732965775,-1.4003906948586113,0.09510869565217392,0.5064425387342193,1.0,5/21,7.26%,PLTP;APOE;PTCH1;NR1H3;EEPD1
prerank,regulation of autophagosome maturation (GO:1901096),0.6666976116309008,1.4003632252661373,0.11234177215189874,0.7864250344007713,1.0,7/13,21.03%,ADRB2;CLEC16A;TMEM39A;SMCR8;TBC1D25;CLN3;RUBCN
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4804166365539412,-1.3996110154074082,0.055900621118012424,0.5060465121387977,1.0,14/32,11.40%,GRIA4;SLC6A9;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;GRIA3;GRIN1;ACTN2;GRIA2;CAMK2A;GRIA1;CAMK2B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6041181352521051,1.399472135671316,0.10398860398860399,0.7877653463402651,1.0,7/26,11.11%,EGFR;SOX9;GAREM1;FOXC1;IQGAP1;SYAP1;ERBB2
prerank,cardiac muscle tissue development (GO:0048738),0.5482036920838727,1.3984356736554948,0.08531468531468532,0.7900777277036599,1.0,8/50,3.31%,BMP4;SGCD;BMP5;CSRP3;AKAP13;BMPR1A;CACNA1G;NOTCH2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6869890291789085,1.3974374848306432,0.10596026490066225,0.7920547036881233,1.0,4/13,7.16%,MET;NFE2L2;NR4A3;IL10
prerank,regulation of amyloid-beta formation (GO:1902003),-0.45511531764192525,-1.397172566270632,0.07232704402515723,0.5100520565822662,1.0,18/34,20.67%,IGF1;APOE;PICALM;RTN1;EPHA4;ABCG1;LRRTM3;NTRK2;RTN4;ROCK2;BIN1;CASP3;GSK3A;ABCA2;GSAP;TMED10;CHRNA7;GGA3
prerank,metal ion export (GO:0070839),0.58163166660513,1.396992006983449,0.09927007299270073,0.7916890841869079,1.0,8/31,8.86%,SLC4A4;KCNK5;ATP1B1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,actin polymerization or depolymerization (GO:0008154),0.5399756606696539,1.3965292766635073,0.0912751677852349,0.7913133387070173,1.0,7/50,3.85%,MICAL2;VILL;COBL;ABI1;GSN;FAM107A;DIAPH1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5386985768559386,1.3962737516715498,0.09946949602122016,0.7901276280663324,1.0,16/50,14.91%,SMO;GLI3;GPC3;ZIC1;HHIP;VCP;GLIS2;CREBBP;GAS1;RORA;KIF7;MEGF8;EVC;ARMC9;HERC4;TTC23
prerank,regulation of endopeptidase activity (GO:0052548),-0.41974806910912227,-1.3959219584580347,0.05263157894736842,0.5107755450549256,1.0,15/59,16.57%,VTN;TIMP3;SPOCK2;PICALM;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH;APH1B;PSMB8;PSME2;AGT;AKT1;VSIR
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5358572907470964,-1.3958940221415213,0.07435897435897436,0.5080898904501124,1.0,6/18,9.82%,UNC13C;CDH8;GRID2;GRIK2;GRIK1;GRIA2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5549948111507134,-1.395862372847421,0.12433862433862433,0.5054382594679845,1.0,4/14,6.18%,ZEB1;OSR1;NOTCH4;SPRED1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6841938985693868,1.3956978989650042,0.12833333333333333,0.790379037183023,1.0,3/13,6.35%,CYFIP2;PERP;RIPK2
prerank,negative regulation of phosphorylation (GO:0042326),0.5045119112297084,1.3954894032826177,0.07553956834532374,0.7890171924014904,1.0,9/85,3.19%,SLIT2;BMP4;NTRK3;HDAC4;LRP6;PID1;PLPP3;NIBAN1;INHBA
prerank,regulation of blood coagulation (GO:0030193),0.599815275008935,1.3952219901681466,0.10735294117647058,0.7879002910773614,1.0,3/27,2.98%,ST3GAL4;THBS1;THBD
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.44371280259365153,-1.3951958762452994,0.05387205387205387,0.5046860760887171,1.0,16/38,19.58%,IL34;GRM5;NEDD9;ACE;APP;EPHA4;GPRC5B;LRP8;GAS6;CSF1R;AGT;NOX4;FCGR1A;RELN;ERBB3;HYAL2
prerank,response to laminar fluid shear stress (GO:0034616),0.7173908814364935,1.3949464573622081,0.12100840336134454,0.78674751511666,1.0,3/10,3.18%,SMAD6;KLF4;NFE2L2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.616502708957588,1.3947803891230313,0.11703703703703704,0.7851182312821465,1.0,4/21,6.54%,RASSF2;NCK2;DMD;DMTN
prerank,supramolecular fiber organization (GO:0097435),0.4550596377207466,1.3944071003633474,0.007231404958677686,0.7843386021317412,1.0,50/333,9.35%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;SNCAIP;COL6A1;COL5A2;CYP1B1;PLOD2;BMP1;DDR2;CLIP4;DSP;GSN;COL3A1;SHROOM3;COL23A1;MAP7D3;RHOBTB1;FGF13;LOXL1;COL6A3;TGFBR1;LTBP2;LTBP3;TMOD3;FAT1;P3H2;CLIP1;HDGFL3;NLRP5;P4HA1;TLE6;COL11A1;PCM1;P4HA2;DLG1;TNXB;P3H1;ARHGAP17;PLK3;SHROOM4;P3H4;OPTC;RHOA;RIPK3;RND3
prerank,positive regulation of catabolic process (GO:0009896),0.5167586659608695,1.3943370454785993,0.07470511140235911,0.7823654245759951,1.0,13/65,9.55%,WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;NSF;CDKN1B;DACT1
prerank,regulation of microtubule-based movement (GO:0060632),-0.5915797087404777,-1.393450662690098,0.11491442542787286,0.5068394604433244,1.0,6/11,28.08%,MAP2;LAMP1;NEFH;HAP1;CFAP298;DYNLT2B
prerank,kidney development (GO:0001822),0.5256139082135822,1.393359572475525,0.07483870967741936,0.784436568545222,1.0,17/65,10.34%,BMP4;SIX1;PCSK5;PKD1;ZBTB16;SULF1;TGFBR1;STRA6;AGTR1;ARL3;GDNF;GDF6;FOXC1;KANK2;GLI2;NF1;VEGFA
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4188398520454138,-1.3929630394260615,0.04938271604938271,0.5056606646167076,1.0,18/57,15.46%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18;NF2;INPP5F;IL6ST;CSF1R;CD40;TNFRSF1A;SH2B3;FLT3
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.576448375936558,-1.3925809915195186,0.12039312039312039,0.5041720040625733,1.0,5/13,16.62%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6108567264893127,-1.3920087899735045,0.11241217798594848,0.5031896934074584,1.0,3/11,2.83%,TJP1;RAPGEF2;F11R
prerank,regulation of lipid storage (GO:0010883),0.607798504442858,1.3917778259479967,0.11746522411128284,0.7885825488441408,1.0,8/22,12.53%,FTO;PTPN2;ITGAV;IKBKE;NFKB1;HILPDA;ITGB3;ZC3H12A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4591152729864472,-1.3910768202806556,0.08125,0.5031842247353105,1.0,9/35,10.40%,VTN;SGIP1;B2M;PICALM;TNK2;HIP1R;RAC1;SNAP91;HIP1
prerank,limb morphogenesis (GO:0035108),0.6395824980978457,1.390730459323078,0.12866449511400652,0.7906894138012449,1.0,5/20,5.66%,PCSK5;MBNL1;LRP6;GLI3;SKI
prerank,positive regulation of cell junction assembly (GO:1901890),-0.41760235385370537,-1.3898608061721456,0.020833333333333332,0.5041836033739202,1.0,17/56,16.00%,TEK;IL1RAPL1;CLDN5;CNTNAP2;NRXN1;GRID2;KDR;EPHB1;MAP4K4;RAC1;SRPX2;LRRC4B;ACE2;CUX2;PPM1F;AGT;CLSTN3
prerank,protein localization to centrosome (GO:0071539),0.6466004698622961,1.3880944976573197,0.14241960183767227,0.7995726203324717,1.0,10/17,20.28%,GOLGB1;PCM1;CEP131;PIBF1;STIL;NUDCD3;HOOK3;C2CD3;CSNK1D;CCDC14
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4850059264824774,1.3880209496003013,0.05798816568047337,0.7976255421993939,1.0,21/108,9.55%,RSPO3;TCF7L1;NXN;TRABD2B;CTNND2;GPC3;SULF1;GRB10;FZD7;MDFIC;FOXL1;MDFI;SFRP4;TSKU;SKI;ESR1;LRP1;RSPO4;NLK;DISC1;DACT1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6167377468670321,-1.3880021176499517,0.0995260663507109,0.506923093743263,1.0,6/11,9.52%,KDR;NDNF;CD34;GATA2;MCAM;PRCP
prerank,potassium ion export across plasma membrane (GO:0097623),0.6628384112358432,1.3879022065021924,0.14023372287145242,0.79588434755415,1.0,1/13,0.19%,KCNK5
prerank,defense response to symbiont (GO:0140546),-0.37149945759634573,-1.3875770411787869,0.040229885057471264,0.5054662933625521,1.0,23/92,12.65%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;TLR7;RNASEL;STAT1;TLR3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4535612141437608,-1.3873389229066224,0.06367041198501873,0.5035368689771315,1.0,3/33,3.43%,IL34;LEF1;CSF1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.358823382465194,-1.3862940288596037,0.01282051282051282,0.5039489135480975,1.0,33/124,14.45%,PTPRM;LYN;FRYL;APOE;CNTNAP2;RAPGEF2;MAP2;GPM6A;CNTN4;PLP1;RASGRF1;APP;ATP1B2;SH3GL2;EPHA8;LAMB1;GPM6B;OPHN1;STMN4;STMN3;MICALL1;RAC1;MAPT;PLEK;TMEM108;UHMK1;BICDL1;ATXN10;STMN1;BLOC1S6;WDPCP;PRMT1;CSF1R
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6178227961684553,1.3857578517223685,0.12420382165605096,0.8025081218724799,1.0,4/21,3.93%,THBS1;PTK2B;MTUS1;CMKLR1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5729849295799961,-1.3857025820935798,0.09852216748768473,0.5030541812481059,1.0,5/13,14.00%,SLC30A10;AKT3;CDK6;YBX1;RBL1
prerank,regulation of B cell differentiation (GO:0045577),0.6465819556201439,1.385643426713908,0.12300319488817892,0.8007541568001977,1.0,4/17,9.32%,PPP2R3C;INHBA;ID2;MMP14
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6440885932458145,1.3855054965609217,0.12752721617418353,0.7990305854971881,1.0,3/15,5.64%,ANXA1;FAM107A;ISL1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.6514840212843063,1.3852304971642648,0.11745513866231648,0.7979966404121686,1.0,7/16,17.68%,DDX5;DDX17;SRSF6;DHX9;HNRNPM;CDK13;SCNM1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6307426927142036,1.3849783954719732,0.12093023255813953,0.7968026398588693,1.0,5/17,5.01%,NTRK3;BAIAP2L1;ABL1;NRP1;BCAS3
prerank,regulation of myotube differentiation (GO:0010830),0.5985532028012566,1.384931515065405,0.1191553544494721,0.7947970359080363,1.0,7/24,14.50%,CCN3;HDAC4;HDAC9;MYOG;MMP14;ATP11A;CEACAM5
prerank,negative regulation of hemostasis (GO:1900047),-0.5890388205995883,-1.384893890139901,0.12441314553990611,0.5028071702604575,1.0,5/12,8.69%,VTN;APOE;CD34;TFPI;EDN1
prerank,establishment of epithelial cell polarity (GO:0090162),0.6240652299495044,1.3845847675716045,0.10526315789473684,0.7940758384590434,1.0,7/19,10.59%,CYTH3;EZR;GOLPH3;RHOA;PARD3;SYNE4;MYO9A
prerank,negative regulation of cellular component movement (GO:0051271),-0.549667198452127,-1.3845360972746998,0.10393258426966293,0.5013844634498492,1.0,4/15,2.97%,FRMD5;TGFBR3;SPOCK3;FBLN1
prerank,negative regulation of cell motility (GO:2000146),0.4943115215600025,1.384462622706447,0.06929510155316607,0.7924381585952153,1.0,19/108,6.70%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;FOXO3;SULF1;IGFBP5;SRGAP2;SRGAP3;CCDC125;VCL;NOG;ZMYND8;SLURP1;JAG1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5791297618985134,1.384030486094245,0.11959654178674352,0.7920987261400445,1.0,10/33,12.63%,KLF5;FOXO3;KLF4;FGF2;STAT3;IL10;TEAD1;ATOH8;JUN;SMARCA4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6199628137639434,1.3839593527305525,0.109375,0.7901800278725745,1.0,5/22,7.16%,WNK1;CD44;KLF4;GCNT2;IL10
prerank,pancreas development (GO:0031016),0.6867658190329188,1.3833642292339616,0.13050570962479607,0.790607050420004,1.0,5/12,12.96%,TCF7L2;MET;ISL1;CCDC40;SELENOT
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5470064069642635,1.3821218438198242,0.1008174386920981,0.7936201019692989,1.0,5/44,3.74%,THBS1;NGF;CD44;KLF4;CAST
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.33660240906379646,-1.381982964933574,0.0,0.5063081820794184,1.0,58/224,11.06%,SLC1A3;UNC13C;DTNA;PDE7B;GRM7;NOVA1;GRM3;NRXN1;CACNA1E;MBP;GRM5;GRIA4;SLC6A1;GABRG3;GRIK2;PRKAR2B;GRIN2A;KCND2;GRM1;SLC1A1;PLP1;CALM1;APBA1;GRIN2B;SLC1A2;RIT2;KCNQ3;PRKAR1B;GABRA2;GABRB1;GRIK1;APBA2;GABRB2;PRKACB;DLGAP1;PRKAR1A;CHRM2;GRIA3;CACNB4;SYN2;CACNA1B;SNCA;SNAP25;GABRB3;HTR2C;GRIN1;CHRM3;GLRA1;GABRA1;RPS6KA1;SYT1;GRIA2;CACNB1;SYN1;HTR2A;GRIA1;SDCBP;GLRA3
prerank,AMP metabolic process (GO:0046033),0.6764845398836481,1.3818010856698515,0.13050570962479607,0.7928286474186931,1.0,7/13,20.35%,NT5E;NT5C1A;AMPD3;XDH;AK4;AK3;AK9
prerank,positive regulation of embryonic development (GO:0040019),-0.5206622492768814,-1.381537616065425,0.08241758241758242,0.5049878374802899,1.0,9/19,18.30%,PLCB1;WNT4;TENM4;OSR1;CFL1;NR2C2;RBM19;RACK1;LHX1
prerank,regulation of DNA replication (GO:0006275),0.5429402888397177,1.3812531041017713,0.10144927536231885,0.7929128405652853,1.0,13/49,18.67%,EGFR;CCNA2;BCAR3;STN1;RAD17;GLI2;WAPL;GTPBP4;DHX9;ANKRD17;EHMT2;ATR;EGF
prerank,aminoglycan biosynthetic process (GO:0006023),0.5410964057245404,1.3810295782772406,0.08618331053351573,0.7915955296243912,1.0,11/49,8.43%,GPC6;EXT1;GPC3;HS3ST1;B3GNT2;HS6ST2;HEXA;GCNT2;XYLT1;GPC4;HAS1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6176060039916907,-1.3807554597136242,0.12135922330097088,0.5044711079305715,1.0,5/10,15.48%,LYN;FAS;MAPK3;RNF13;GREM1
prerank,regulation of stem cell proliferation (GO:0072091),-0.5415733828182241,-1.3805681477305014,0.10863509749303621,0.5024543797224396,1.0,3/17,4.99%,FBLN1;ACE;GJA1
prerank,purine nucleotide catabolic process (GO:0006195),0.6625580851713906,1.38024773483259,0.13976705490848584,0.7927721783152409,1.0,2/13,1.29%,NT5E;NT5C1A
prerank,retina homeostasis (GO:0001895),-0.4962398237494497,-1.3801689192934086,0.11206896551724138,0.5011180454385472,1.0,10/23,24.76%,B2M;ACTB;POTEF;ATP1B2;WHRN;ACTG1;HSPB1;CDH3;JCHAIN;TULP1
prerank,regulation of axon regeneration (GO:0048679),-0.5882987720382553,-1.3800589460252206,0.12441314553990611,0.49902027788037406,1.0,5/12,12.50%,EPHA4;GRN;INPP5F;CERS2;RTN4RL1
prerank,regulation of mRNA metabolic process (GO:1903311),0.6799774317297042,1.3799848994444208,0.15100671140939598,0.7917016847051112,1.0,4/11,17.05%,SLTM;DHX9;CDK11B;SRPK1
prerank,regulation of glycogen metabolic process (GO:0070873),0.6660695819954409,1.37973722077746,0.14991181657848324,0.7905724234737846,1.0,2/12,3.16%,PPP1R3B;PPP1R3C
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6392139564140217,1.3791053909570399,0.1308562197092084,0.7910423486418768,1.0,3/17,3.88%,SOX9;DSPP;KLF7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6194041592795304,-1.376858076723831,0.14814814814814814,0.5055372021111921,1.0,6/10,14.99%,SHANK3;APP;SYP;NETO1;CAMK2B;SYNGR1
prerank,embryonic organ morphogenesis (GO:0048562),0.5498071223478167,1.376835666517402,0.11527777777777778,0.7982809382994515,1.0,14/42,12.18%,SIX1;MFAP5;HOXA3;HES1;EFEMP1;HOXB3;HOXC4;ID2;RARG;HOXB4;ACVR1;FOXE1;MEGF8;NIPBL
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5216035753309647,-1.3760409858044942,0.10886075949367088,0.5051908323617454,1.0,9/18,27.40%,APOE;TMCC2;ABCG1;NSG1;APH1B;ADAM19;NCSTN;ACHE;PSENEN
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.45441175689929914,-1.3760046195024511,0.08280254777070063,0.5028640995268582,1.0,15/32,26.77%,CEMIP;TRPC3;AKAP6;SNCA;GRIN1;P2RX7;PLCG1;TRPC1;APLNR;CX3CL1;GPER1;F2R;P2RX3;RAMP3;CASQ1
prerank,action potential (GO:0001508),0.5521773858315796,1.375949967269784,0.09724047306176084,0.7996298710856405,1.0,6/44,5.27%,KCNJ2;KCNMB3;KCNMB2;KCNB1;CACNA1G;DMD
prerank,regulation of protein localization to membrane (GO:1905475),0.5912062977606991,1.375816106305478,0.12298682284040996,0.7979943325360297,1.0,6/28,9.32%,GPC6;GPC3;GSN;GPC4;STX8;MMP14
prerank,protein import into peroxisome membrane (GO:0045046),0.5933327459453728,1.3749136464517875,0.1282051282051282,0.7995445567640383,1.0,8/22,23.92%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;SLC25A17;PEX2;PEX26
prerank,response to cholesterol (GO:0070723),0.6215798521143973,1.374783086622223,0.12439418416801293,0.7979925550802373,1.0,8/17,12.83%,LRP6;SMO;TGFBR1;TGFBR2;GRAMD1C;CCL3;SMAD2;GRAMD1A
prerank,signal peptide processing (GO:0006465),0.6818759077159094,1.3743930939330211,0.141156462585034,0.7975839163390236,1.0,1/11,0.88%,PCSK5
prerank,fatty acid beta-oxidation (GO:0006635),0.5273670454186579,1.3742647297932402,0.10419485791610285,0.7960343574933569,1.0,9/51,8.44%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;DECR1;ACOX3;ACOT8;ACADM
prerank,response to estrogen (GO:0043627),0.5659863382692496,1.3739387323284573,0.13131313131313133,0.7952164994665939,1.0,14/31,25.61%,SERPINB9;BCAS3;KRT19;ESR1;SLC34A2;RARA;KMT2D;EP300;CYP27B1;TRIM25;GATA3;SRA1;AR;CITED2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.49179261954453035,1.3719034038381204,0.06868451688009314,0.8015341559715523,1.0,20/101,13.81%,THBS1;CYFIP2;SAMD4A;PERP;EZR;NIBAN1;KLF4;INHBA;AGTR1;EIF4G1;RDX;LARP4B;FBXW11;DACT1;ERBB2;EIF3E;EIF6;MTOR;PRKDC;TBC1D10A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5396938730018521,1.3715973192421986,0.09806629834254144,0.8006652375915404,1.0,12/45,11.38%,BMP4;BMP5;TGFB3;BMP6;BMPR1A;INHBA;TGFBR1;GDF6;GDF5;GDF10;ACVR1;INHBB
prerank,muscle tissue development (GO:0060537),0.650922278127965,1.3715256039819697,0.15265866209262435,0.7989009049687152,1.0,6/13,9.78%,BMP4;SMO;CSRP3;STRA6;CSRP2;NF1
prerank,purine-containing compound catabolic process (GO:0072523),0.664702598536814,1.3713956919496308,0.14429530201342283,0.797384451741694,1.0,2/13,1.29%,NT5E;NT5C1A
prerank,organelle disassembly (GO:1903008),0.5642743684717445,1.3707608088814647,0.12756598240469208,0.7979315356726078,1.0,17/33,19.42%,ULK2;VCP;STX5;GBF1;PLK3;KIF9;KLC1;MRRF;EIF2D;RB1CC1;MTIF3;DDRGK1;GFM2;UBA5;MTIF2;ATG2A;DYRK3
prerank,B cell homeostasis (GO:0001782),-0.6172379054232886,-1.3703136515704504,0.10666666666666667,0.5163267503757553,1.0,4/10,5.56%,DOCK10;LYN;DOCK11;MEF2C
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5853313686072539,1.3702479565773946,0.12913385826771653,0.7980144605449415,1.0,11/25,12.24%,CXADR;DSP;PARVA;ITGB1;DSG2;ITGA5;CD2;ITGAV;JUP;ITGB3;DSC2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.4533524704737168,-1.3698660145792094,0.08278145695364239,0.515142754832456,1.0,11/32,14.71%,ITGA1;PDGFRB;PPP1R16B;CALM1;PPIA;CD300A;HSP90AB1;PPP1R15B;PPP2R5A;CALM3;SMPD1
prerank,positive regulation of protein import (GO:1904591),0.57763149163593,1.369240880772687,0.10174418604651163,0.8000800081077909,1.0,9/30,13.86%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP;ARHGEF5;ZC3H12A;BAG3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6433160669112669,1.3691870795073824,0.13043478260869565,0.7982568497479815,1.0,4/15,5.23%,BMPER;KLF4;FGF2;ITGA5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6046289301207717,1.3683705900732004,0.13292117465224113,0.7993956290793204,1.0,3/22,8.47%,BMP4;INHBA;CDKN1B
prerank,response to UV-A (GO:0070141),0.6608066982280585,1.3681206224411548,0.13477537437603992,0.798352565179558,1.0,1/14,0.24%,EGFR
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5633857528178764,1.3678666476828458,0.11350574712643678,0.7973601357952647,1.0,6/33,5.23%,BMPER;THBS1;RHOJ;KLF4;FGF2;ITGA5
prerank,regulation of lamellipodium assembly (GO:0010591),0.5641967569546982,1.3671517235951356,0.12112676056338029,0.7982666763634478,1.0,2/34,0.43%,SLIT2;PLCE1
prerank,T cell migration (GO:0072678),0.6681167035389065,1.3666230861353834,0.1386481802426343,0.7982863228361933,1.0,1/13,0.48%,SLC12A2
prerank,negative regulation of macrophage activation (GO:0043031),-0.5456760890967639,-1.3663424294150963,0.1421188630490956,0.5225050151046992,1.0,6/16,11.73%,IL31RA;NR1H3;SYT11;GRN;LRFN5;CD200
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5583994810034891,-1.3663166622528031,0.11479591836734694,0.520123095970981,1.0,7/15,19.67%,GGT5;ABHD12;ALDH4A1;SARDH;GGT1;GOT2;GGT7
prerank,axon development (GO:0061564),-0.37744421360153557,-1.3662400768883871,0.028708133971291867,0.5179195525828311,1.0,28/78,18.01%,NREP;GRM7;CTNNA2;ANK3;DCC;CNTN4;PLP1;ACTB;BAIAP2;APP;ZDHHC17;MAPT;PLPPR4;PAK3;RTN4;BRSK2;DSCAML1;RTN4RL1;ADGRB1;LMTK2;CAMSAP2;NRCAM;APBB1;SLITRK5;NEFH;RAB3A;S100A6;SPTBN4
prerank,regulation of telomere maintenance (GO:0032204),0.5826869120658781,1.3659886669213555,0.13190184049079753,0.7987445509426565,1.0,12/26,18.25%,SMG6;HDAC8;USP7;ATRX;SMG1;XRCC5;PML;NBN;YLPM1;SIRT6;ERCC1;DHX36
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.41812346108633835,-1.3653127766454802,0.07829181494661921,0.5179709282513949,1.0,8/47,7.55%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5817577880388551,-1.365267873840054,0.10831234256926953,0.5156905603507628,1.0,2/11,3.43%,IL34;CSF1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5448954750897285,1.364376855933463,0.13280212483399734,0.8033072377898549,1.0,10/46,13.07%,PIEZO2;SOX9;CRADD;IRF1;TLR4;SLC9A1;NFKB1;MYD88;MAP2K4;CHEK1
prerank,activation of protein kinase B activity (GO:0032148),-0.4684463740426312,-1.3640188423019972,0.09696969696969697,0.5166662938533636,1.0,10/29,7.99%,IGF1;OSBPL8;WNT5A;INSR;PPIA;FGF1;CCDC88A;ADRA2A;IL18;GAS6
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5291498184353857,-1.363610725431833,0.12219451371571072,0.5154295985155697,1.0,7/17,4.99%,ATP1A2;GJC1;GJD3;SLC8A1;RYR2;ATP1B2;GJA1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5398243210612518,-1.3635239165111654,0.12928759894459102,0.5133489356147699,1.0,11/16,40.22%,TNFRSF21;TYROBP;JAK3;VSIR;DLL1;TRIB2;FCGR2B;IL23A;FOXP3;IL12B;CD274
prerank,nucleotide catabolic process (GO:0009166),0.637298383912957,1.363413987166618,0.15780998389694043,0.8052385504237134,1.0,7/16,17.86%,NT5E;NT5C1A;VCP;DERA;NUDT15;XDH;DNPH1
prerank,integrated stress response signaling (GO:0140467),0.6371359692987837,1.3629340503491703,0.13848631239935588,0.8051433117629172,1.0,8/14,22.64%,NFE2L2;DDIT3;OMA1;EIF2AK4;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,pyroptosis (GO:0070269),-0.552619477367522,-1.3629035258386795,0.12266666666666666,0.5127498411539422,1.0,6/15,20.32%,CASP4;AIM2;GSDMD;CASP1;ZBP1;TREM2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5338905365310732,1.3623602180899324,0.11005434782608696,0.8055926755156365,1.0,7/49,8.03%,F3;LBP;CD2;STAT3;MAVS;DDIT3;TLR4
prerank,regulation of protein sumoylation (GO:0033233),0.631428694278447,1.3617851066987128,0.14497528830313014,0.8058284157739506,1.0,5/17,19.07%,HDAC4;SAE1;PIAS3;ZMIZ1;PIAS1
prerank,cell-cell junction maintenance (GO:0045217),-0.5924179962576602,-1.3615040453284666,0.1,0.5141323826653171,1.0,5/11,23.89%,TJP1;CSF1R;MYADM;PRTN3;F2R
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6373109446680758,1.361405082189577,0.1478405315614618,0.8053784290249357,1.0,2/16,1.84%,BMP4;TGFB3
prerank,sensory perception of light stimulus (GO:0050953),0.4983949388353625,1.3612125866993834,0.07801418439716312,0.804216715518151,1.0,13/87,13.63%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;PAX6;CRYBB3
prerank,urogenital system development (GO:0001655),0.6736401196947065,1.361184495648977,0.16415410385259632,0.8023227151179299,1.0,3/11,6.81%,SOX9;ANXA1;EPHB3
prerank,neuromuscular junction development (GO:0007528),-0.4930522520023892,-1.3604122440984743,0.10315186246418338,0.5147631283497507,1.0,9/24,10.16%,UNC13C;PDZRN3;PPFIBP2;ANK3;PPFIBP1;CACNB4;ZC4H2;GPHN;CACNB1
prerank,regulation of cartilage development (GO:0061035),0.6103716757099001,1.35990615891052,0.14533965244865718,0.8055583613177475,1.0,5/18,2.37%,BMP4;SOX9;BMP1;WNT11;ZBTB16
prerank,dicarboxylic acid transport (GO:0006835),0.5795883408751692,1.3597039358011715,0.14032496307237813,0.8043687927857678,1.0,3/28,3.83%,SLC26A7;GIPC1;SLC26A6
prerank,cGMP biosynthetic process (GO:0006182),0.6820620137171687,1.3583581399943536,0.15619694397283532,0.807696407377417,1.0,1/10,0.24%,GUCY2C
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6668747652581508,1.3581368619510952,0.13636363636363635,0.8066638497902341,1.0,4/13,11.74%,GLI3;TGFBR2;ZBTB7B;CBFB
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6218564704887901,1.357998172295989,0.15097402597402598,0.8052629472422891,1.0,2/17,1.84%,BMP4;TGFB3
prerank,neural tube closure (GO:0001843),0.5574594568532791,1.3579736019439441,0.13352685050798258,0.8033688447143272,1.0,15/34,24.19%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2;STIL;BCL10;FUZ;SCRIB;DVL1;TGFB2;CELSR1;PHACTR4;MTHFR
prerank,regulation of protein phosphorylation (GO:0001932),0.45031163177645234,1.3578843892192969,0.0306553911205074,0.8017182143308944,1.0,21/256,3.61%,SLIT2;BMPER;EGFR;BMP4;PLCE1;SLCO3A1;CARD14;NTRK3;SOX9;LRP6;PGF;CCN1;EFNA5;PID1;FN1;PLPP3;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5135284469958822,-1.3571255984182313,0.12777777777777777,0.521325719071696,1.0,9/18,18.49%,ACSL1;ELOVL7;ELOVL6;HSD17B12;ACSL5;HACD2;ACSBG1;ACSL4;HACD1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5084789734235893,1.356961284995824,0.09431524547803617,0.8034475045544963,1.0,12/66,9.55%,EGFR;FHL1;PKD1;ANXA1;KLF4;FAM107A;EIF4G1;DLG1;RDX;ID2;KANK2;DACT1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48766816942019614,1.3562872562858632,0.08588235294117647,0.804112152575745,1.0,15/93,10.34%,EGFR;RASSF2;NTRK3;NGF;CD44;DOCK7;EIF4G1;NCK2;ATP2B4;DMD;RIPK2;DMTN;BCAR3;AKAP9;VEGFA
prerank,canonical Wnt signaling pathway (GO:0060070),0.5027355658342719,1.3555281509428003,0.09912170639899624,0.8052233007891115,1.0,16/68,10.96%,TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;RARG;LRP5;BCL9L
prerank,cellular response to organonitrogen compound (GO:0071417),0.4895093115998633,1.3549003228923833,0.07023809523809524,0.8058072994856815,1.0,15/99,8.66%,SLIT2;CDH1;SOX9;EZR;IGFBP5;CTNNA1;CAPN2;SLC26A6;DIAPH1;RAP1A;GOLPH3;DMTN;RRAGB;JUP;P2RX4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.46843789990597207,1.3538661047269727,0.07191011235955057,0.8080529810199956,1.0,22/122,13.69%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;SORBS1;KLF4;FGF2;IRS1;TLR4;BCAR3;STN1;LARP4B;GLI2;NFKB1;IL33;ERBB2;EIF3E;EIF6;MTOR;PRKDC;DYRK2
prerank,neuron projection development (GO:0031175),-0.33670018704922433,-1.3529368005878617,0.0,0.5305655211437923,1.0,40/168,9.53%,PTPRM;DOCK10;LYN;FRYL;SHANK3;APOE;GRM7;CNTNAP2;ADGRV1;TNIK;PAK1;RAPGEF2;MAP2;EPB41L3;EPHB1;GPM6A;CNTN4;PLP1;BMP7;RASGRF1;APP;NRK;EPHA4;MAP4K4;SH3GL2;SGK1;DAB2IP;EPHA8;LAMB1;GPM6B;OPHN1;STMN4;MYO16;STMN3;MICALL1;NYAP2;MAPT;PAK3;TMEM108;UHMK1
prerank,early endosome to Golgi transport (GO:0034498),0.6929986097432714,1.352877346439391,0.15304347826086956,0.8103479865248356,1.0,8/11,23.16%,RAB6A;SNX2;STX5;EHD3;TRAPPC10;RBSN;SNX8;SURF4
prerank,reverse cholesterol transport (GO:0043691),-0.5697859771022071,-1.3525598181701353,0.125,0.5291611941342249,1.0,5/13,12.71%,APOE;ABCA5;ABCA1;ABCG1;SCARB1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5689388006882796,-1.3524147481266482,0.12254901960784313,0.5272893583180743,1.0,4/13,8.52%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.43334084026896436,1.3521907649214946,0.004020100502512563,0.8111555890130916,1.0,126/572,14.22%,FOXP2;FOXP1;BMP4;KLF12;ZFHX3;ZFPM2;TCF7L2;RARB;NFIB;SOX9;HDAC4;PRDM6;NEDD4;DDX5;EZR;FOXP4;CUX1;GLI3;FOXO3;HDAC9;ZBTB16;HES1;SKIL;WWP2;USP2;ESR2;KLF4;BMP6;ZNF148;CRY2;NR2F1;FOXC2;ID1;MEF2A;KLF7;JDP2;GLIS1;NR4A3;NR4A2;TCF25;MDFI;SMYD2;KLF10;ZBTB7B;NFATC4;HDAC8;BHLHE40;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;ESR1;STAT3;KDM1A;DDIT3;TBL1X;NFIL3;PHF21A;DLG1;SOX14;ID2;LCOR;NFIX;PLK3;MDM4;RXRA;ZNF8;FOXC1;KANK2;ZMYM5;PHF12;UBE2D3;GLI2;PER3;NFKB1;DACT1;IL33;GATA1;RARG;RARA;CBX5;JUN;MTDH;VEGFA;FOXE1;ZNF25;NCOR1;ZBTB32;TCERG1;PER1;MIER1;SMAD2;OTUD7B;MXD1;EED;GTF2IRD1;RB1;BPTF;DCAF1;CBFB;MTA1;ID4;NKX2-1;NIPBL;NCOA5;NR6A1;SMARCA4;CTR9;ATRX;NFATC3;MXD4;TCF3;PPM1A;PAX6;EP300;CHD3;HCFC1;NCOR2;BAG3;VPS72;RNF2;HDAC10;REST
prerank,lipid phosphorylation (GO:0046834),-0.6024841975182181,-1.3519807861732909,0.14558472553699284,0.5261937747817831,1.0,6/10,19.64%,DGKB;DGKI;DGKD;DGKG;DGKE;DGKZ
prerank,NAD biosynthetic process (GO:0009435),0.6069273143500391,1.351852185333606,0.1424,0.8106912292854312,1.0,5/20,8.31%,PTGIS;NMNAT2;QPRT;NMNAT1;NNMT
prerank,protein localization to cell surface (GO:0034394),0.5742048858525232,1.351761029187701,0.14135338345864662,0.809120962784762,1.0,9/26,14.72%,ANK2;PTPRU;WNT11;VCL;RIC3;USP4;SMURF1;PIGU;GGA2
prerank,engulfment of apoptotic cell (GO:0043652),0.6282144118265566,1.3517076018819254,0.15912897822445563,0.8073818472859339,1.0,2/15,3.26%,THBS1;RHOBTB1
prerank,carboxylic acid metabolic process (GO:0019752),0.5718496042005273,1.3513122686065004,0.1326676176890157,0.8070240232333022,1.0,5/33,5.77%,SLC23A1;SLC23A2;PTGIS;CYP2S1;PON3
prerank,regulation of cardiac conduction (GO:1903779),-0.40800684280360816,-1.3508001616972376,0.08536585365853659,0.5269864967219274,1.0,13/54,10.07%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;RYR2;ATP1B2;DMPK;ATP2B1;FXYD6;ACE2;ATP2A2
prerank,negative regulation of chemotaxis (GO:0050922),0.558822338494145,1.3504151523514785,0.1447562776957164,0.8086977237721594,1.0,6/31,4.70%,SLIT2;THBS1;SEMA3E;SEMA3D;SEMA3C;PTPN2
prerank,protein targeting to peroxisome (GO:0006625),0.5663300352066699,1.3501838249626406,0.1263001485884101,0.8077317154384244,1.0,12/29,23.92%,ABCD3;PXMP2;ACBD5;LONP2;HACL1;PEX13;ZFAND6;ABCD1;SLC25A17;PEX2;PEX7;PEX26
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.48635343434020484,1.3496102986696041,0.08322981366459627,0.8081014947656819,1.0,24/87,11.05%,SMAD9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;TGFBR1;ITGB5;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;JUN;SMAD2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7064891823251951,1.3490904323266844,0.156140350877193,0.8081872201690918,1.0,3/10,5.02%,CD55;TGFBR2;ZBTB7B
prerank,regulation of plasminogen activation (GO:0010755),0.6581937127032599,1.3488086910133015,0.16610738255033558,0.8073076375543451,1.0,1/12,0.27%,THBS1
prerank,pulmonary valve development (GO:0003177),0.6157448235807707,1.3477288489979162,0.14308943089430895,0.809772079767048,1.0,5/18,4.15%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6
prerank,inorganic cation transmembrane transport (GO:0098662),0.44466425809624494,1.3467349092887464,0.029535864978902954,0.8116959942763577,1.0,36/268,8.86%,SLC4A4;SLC9A2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC24A3;PKD1;ATP1B1;CACNA1C;ATP2C2;SLC6A7;KCNQ5;KCNS3;ANO6;TRPM6;KCNB1;ATP6V0A4;CACNA1G;SLC39A11;SCARA5;SLC39A14;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7;SLC9A8;SLC6A19;SLC9C1;SLC4A8;P2RX4;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of bone mineralization (GO:0030500),0.5022654467831555,1.346166588492063,0.1194225721784777,0.812022946709432,1.0,12/55,4.96%,BMP4;CCN1;PTK2B;TGFB3;DDR2;ANO6;SGMS2;BMP6;BMPR1A;NELL1;TXLNG;TRPM4
prerank,nucleosome assembly (GO:0006334),0.5556854764617377,1.3459690316742412,0.14563106796116504,0.8108781813017892,1.0,15/31,27.52%,SOX9;CHAF1B;KAT6B;UBN1;CABIN1;HIRA;ATRX;NAP1L2;SMARCA5;CHAF1A;IPO4;RBBP4;NASP;HAT1;NAA60
prerank,negative regulation of vascular permeability (GO:0043116),0.6646351386526074,1.3459185617016711,0.15316901408450703,0.8091917589553911,1.0,1/12,0.11%,SLIT2
prerank,fatty acid oxidation (GO:0019395),0.5078978629202332,1.3456922337950492,0.10144927536231885,0.8082303764936758,1.0,9/57,8.76%,ABCD3;EHHADH;BDH2;ADH7;AUH;ECHDC1;DECR1;ACADM;PECR
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5229394263638776,1.34568599593114,0.11363636363636363,0.8063700439614393,1.0,2/48,0.11%,SLIT3;SLIT2
prerank,protein localization to organelle (GO:0033365),0.4584059159857228,1.3453050435660259,0.07166853303471445,0.8060686239417091,1.0,30/133,16.80%,BMP4;SIX1;BBS9;ANK2;CSRP3;CNTLN;ZNF423;LMNA;RAB6A;STX5;GAK;ARL3;TOR1AIP1;GBF1;SIX4;TULP2;WDR35;EHD1;EMD;CNEP1R1;TRAM2;COG3;DDRGK1;FAM83H;DHX9;DCP1A;ZBTB7A;XPA;RPA1;TOR1B
prerank,cellular response to hormone stimulus (GO:0032870),0.4955986593320067,1.3452786502161738,0.10266159695817491,0.8043082350714174,1.0,14/69,9.89%,SLIT3;SLIT2;RAMP1;NR4A3;SERPINB9;BCAS3;KLF9;STAT3;RDX;SOCS2;ATP1A3;ATP1A1;GATA1;RARA
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5748780402255342,1.3449665858568745,0.14619883040935672,0.8036493191716004,1.0,4/26,6.52%,SMOC2;HES1;USP2;CDC25B
prerank,Golgi to endosome transport (GO:0006895),0.6188513767561088,1.3442672770047075,0.14790996784565916,0.8045162949663629,1.0,6/16,11.14%,VPS13A;VPS13C;DOP1B;GBF1;AP2A1;KIF16B
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5278909143498667,1.3442649256520158,0.11050477489768076,0.802676357952224,1.0,4/48,4.22%,SLC26A2;GUCY2C;PAPSS2;ADCY9
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5272165082322102,1.3440339123302718,0.1298342541436464,0.8017667378513372,1.0,22/45,22.07%,BMP4;PTPN3;GAS1;IL10;CDKN1B;FOXC1;BTG3;NABP1;ANGEL2;CHEK1;BCL6;CHFR;PRCC;MAD2L1;HECA;ZWILCH;TRIM35;ZW10;SCRIB;TOM1L1;WEE1;FZD3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5610151145226918,-1.3438887749214112,0.1328125,0.54350478687396,1.0,7/13,18.49%,ELOVL7;ELOVL6;HACD3;ELOVL4;TECRL;HACD2;HACD1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4949831419376039,1.3429813472602876,0.10152284263959391,0.8040022386125624,1.0,13/67,10.17%,DOCK5;VIT;PTK2B;FN1;GSK3B;ABL1;NRP1;DMTN;AGR2;JUP;S100A10;LIMS1;LIMS2
prerank,neuron differentiation (GO:0030182),0.45516390895623565,1.3428266718275184,0.0684326710816777,0.8028146605024749,1.0,25/165,9.21%,VSX1;PBX3;MET;WNT9A;LRP6;PBX1;WNK1;WNT11;INHBA;FZD7;TGFBR1;ACSL3;NR4A2;ITM2C;WNT16;THOC2;PITX3;PHOX2A;LHX2;ID2;FZD1;PITX2;ATOH8;GLI2;CTF1
prerank,epithelial cell differentiation (GO:0030855),0.4952685109633804,1.3427809717084846,0.0922882427307206,0.8011605458671514,1.0,9/88,4.84%,BMP4;SIX1;FSTL1;BDH2;ANXA1;ANXA4;FZD7;EHF;CASP6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.6031391130464048,1.3424182967357055,0.15981012658227847,0.8008559416819346,1.0,2/19,1.84%,BMP4;TGFB3
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5996142039484764,1.342396207026926,0.1498371335504886,0.7991174598957665,1.0,5/20,9.48%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,pulmonary valve morphogenesis (GO:0003184),0.627334020017066,1.3412555082613171,0.13741721854304637,0.8017367855625038,1.0,6/17,6.70%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6;JAG1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5828209595771392,1.3411914088584227,0.13893129770992366,0.8001351160407045,1.0,7/26,9.70%,EYA2;FGFR1;INHBA;EYA4;GDNF;EYA3;GATA1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.6054071329598688,1.3409577994594526,0.14354066985645933,0.7992686074573951,1.0,3/18,3.31%,CCN3;HDAC4;FZD7
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5116121298071012,-1.3407162343458352,0.13008130081300814,0.5499992383365245,1.0,7/18,12.58%,FLT1;COL4A3;AKT3;MEF2C;ITGA4;MDK;PLCG1
prerank,muscle cell differentiation (GO:0042692),-0.4524396886776396,-1.3405395515404996,0.11326860841423948,0.5481096008802693,1.0,13/32,10.98%,WNT5B;MRTFB;SGCZ;SPEG;TBX18;TBX1;TMEM204;MEF2C;HEY2;GATA6;MEGF10;MYOCD;NINJ1
prerank,in utero embryonic development (GO:0001701),0.5731672085711166,1.3395456911874106,0.1476407914764079,0.8028406768449265,1.0,5/25,4.10%,MBNL1;PKD1;FUT8;TGFB3;TGFBR1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5794374278326764,1.3391684406158233,0.14961832061068703,0.802617697805502,1.0,6/21,5.99%,EXT1;HS3ST4;SULF1;HS6ST2;GLCE;XYLT1
prerank,cytosolic transport (GO:0016482),0.4688188406567138,1.3388286933630127,0.08422301304863583,0.8021778712345414,1.0,50/108,25.05%,VPS13A;VPS13C;ERC1;EEA1;RAB6A;SNX2;STX5;BECN1;GAK;EHD3;ANKRD27;DOP1B;VPS54;GBF1;RGP1;RNF126;AP2A1;STX8;SNX32;KIF16B;VTI1A;WDR81;TBC1D10A;TBC1D5;MON2;HOOK3;TMEM87A;BET1L;TMEM87B;TBC1D17;SNF8;RBSN;WASHC1;AP4M1;VPS52;CLN3;RAB5A;VPS51;EMP2;HOOK2;VPS53;UBE2O;CORO7;PHETA2;TBC1D23;SYS1;ARL1;VPS29;SPAG9;RAB7A
prerank,chemical synaptic transmission (GO:0007268),-0.31766950585543097,-1.3387048464018383,0.0,0.5508835963374583,1.0,65/284,11.06%,SLC1A3;UNC13C;DTNA;APOE;PDE7B;GRM7;NOVA1;GRM3;NRXN1;CDH8;CACNA1E;MBP;GRM5;GRIA4;GRID2;SLC6A1;GABRG3;RIMS1;LIN7A;GRIK2;PRKAR2B;GRIN2A;KCND2;GRM1;SLC1A1;HSPA8;PLP1;CALM1;APBA1;GRIN2B;SLC1A2;RIT2;KCNQ3;PRKAR1B;GABRA2;GABRB1;GRIK1;APBA2;GABRB2;PRKACB;DLGAP1;PRKAR1A;CHRM2;GRIA3;CACNB4;SYN2;CACNA1B;SNCA;SNAP25;GABRB3;HTR2C;GRIN1;CHRM3;GLRA1;GABRA1;RPS6KA1;SYT1;GRIA2;CACNB1;SYN1;HTR2A;GRIA1;SDCBP;NSG1;GLRA3
prerank,regulation of osteoblast differentiation (GO:0045667),0.4874610284008298,1.338381990350139,0.10401002506265664,0.8021169178246144,1.0,16/82,6.21%,BMP4;CRIM1;SOX9;DDX5;CCN1;DDR2;SMAD6;SMOC1;TWIST2;BMP6;BMPR1A;NELL1;TRPM4;NOG;SKI;BAMBI
prerank,T-helper cell differentiation (GO:0042093),0.6401613108170491,1.3382794074959015,0.17263843648208468,0.8007157648156884,1.0,1/14,0.25%,FOXP1
prerank,cardiac conduction system development (GO:0003161),0.5690171371266777,1.338042982568641,0.13476263399693722,0.7998503111410655,1.0,5/24,6.17%,BMP4;BMPR1A;CACNA1G;NOTCH2;GATA4
prerank,regulation of muscle contraction (GO:0006937),0.5821915023329438,1.3377021723779603,0.1443932411674347,0.7994182246355026,1.0,3/26,3.94%,KCNB2;PLCE1;PPP1R12B
prerank,embryonic limb morphogenesis (GO:0030326),0.5463799872689772,1.3375476239673496,0.12640449438202248,0.7982615284797077,1.0,14/34,15.72%,MBNL1;LRP6;CACNA1C;GLI3;AFF3;NOG;CREBBP;SKI;RARG;MEGF8;NIPBL;ECE1;TWIST1;TFAP2A
prerank,negative regulation of protein catabolic process (GO:0042177),0.5368817838391049,1.337353269900224,0.13986013986013987,0.7972380003277435,1.0,14/40,16.63%,EGFR;PTPN3;NELL1;TIMP2;IL10;RGP1;MDM4;IRAK3;TIMP1;SNX12;SNRNP70;AZIN1;HMGCR;MAD2L1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5811585502637773,1.3373230326641383,0.14508580343213728,0.7955732402789154,1.0,12/25,24.66%,RNF185;VCP;ZYG11B;YME1L1;CLPP;OMA1;CUL3;UFD1;UBE2W;UGGT2;FBXL17;POMT2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6634116162712622,1.337067094154062,0.16808149405772496,0.7948014554909687,1.0,6/12,7.62%,CACNA1C;DSP;DSG2;TRPM4;DLG1;JUP
prerank,negative regulation of telomere maintenance (GO:0032205),0.6214643891441556,1.3370102323841004,0.15435139573070608,0.7932538413715663,1.0,7/15,21.85%,SMG6;TNKS2;ATM;SLX4;NBN;ERCC1;RAD50
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6630887993145946,1.3356004149724292,0.1857638888888889,0.7968291473044657,1.0,4/10,17.52%,SMYD2;SETD2;EHMT1;KMT5A
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5504471090896291,1.3348870692326558,0.14484679665738162,0.7978578397943861,1.0,10/33,18.46%,PKD1;TCIM;ATP2B4;ID2;CDKN1B;PLCG2;DDRGK1;TRIM39;CDKN1A;INO80
prerank,protein localization to Golgi apparatus (GO:0034067),0.5789012583081083,1.3346106966365698,0.1297709923664122,0.7971397124771978,1.0,8/27,10.96%,VPS13A;VPS13C;RAB6A;GAK;GOLPH3;GBF1;VPS13D;ZDHHC15
prerank,smoothened signaling pathway (GO:0007224),0.5588460658243375,1.333354467773592,0.1422475106685633,0.8002463641949258,1.0,8/32,14.43%,SMO;GLI3;HIPK1;GLI2;TMEM231;EVC2;DYRK2;STIL
prerank,acidic amino acid transport (GO:0015800),-0.5086921750535836,-1.3331260897378128,0.13793103448275862,0.5644398575285827,1.0,6/17,4.99%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;SLC1A2;GJA1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4317107168732847,-1.3330197542209659,0.10638297872340426,0.5624056091131978,1.0,18/38,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,respiratory tube development (GO:0030323),0.5606832380450163,1.3329799120273982,0.140625,0.7999149234021946,1.0,8/28,12.00%,BMP4;PCSK5;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,embryonic organ development (GO:0048568),0.5069468661432697,1.3326666344328508,0.1141732283464567,0.7993562070451306,1.0,13/61,9.08%,PBX3;PCSK5;RARB;COBL;PBX1;GLI3;BMPR1A;STRA6;TGFBR2;GDNF;TEAD1;PDGFA;GLI2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6753697037565861,1.332162559179097,0.17398945518453426,0.7995225894102133,1.0,2/10,1.38%,BMP5;LRP6
prerank,negative regulation of cell differentiation (GO:0045596),0.4511080805745008,1.3320914175404275,0.06392199349945829,0.7980517634638578,1.0,32/181,9.09%,EGFR;BMP4;CRIM1;ZFPM2;WNT9A;SOX9;BMP5;COL5A2;PTK2B;SMAD6;ZBTB16;HES1;TWIST2;TGFBR1;SPRED2;EFEMP1;PDCD4;TRPM4;TSKU;NOG;SKI;TRIO;ITGAV;BAMBI;PTHLH;IL17RD;JAG1;GDF5;ID2;RORA;CHRD;GDF10
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6049827166903818,1.3319617169305646,0.1629032258064516,0.7967944483414034,1.0,4/19,8.03%,LBP;PRKCE;PIK3AP1;TLR4
prerank,epithelial cell-cell adhesion (GO:0090136),0.6571051881333504,1.331741323185351,0.16934046345811052,0.7959360024927729,1.0,5/11,7.62%,CCN3;DSP;ITGB5;VCL;JUP
prerank,retinol metabolic process (GO:0042572),0.6256646605289595,1.3317235887439833,0.15993537964458804,0.7942915355350962,1.0,2/14,2.10%,CYP1B1;ADH7
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6203652677989465,1.3301097311589454,0.1568627450980392,0.7969321582107421,1.0,7/16,12.07%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6203652677989465,1.3301097311589454,0.1568627450980392,0.7969321582107421,1.0,7/16,12.07%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.47671519690561187,1.3297591516523026,0.09113300492610837,0.7966339524907871,1.0,18/87,17.71%,FBXL7;FHL1;KLF4;FAM107A;PSMB2;DLG1;KANK2;AURKA;DACT1;PSMC6;RB1;USP47;PSMD11;PSMD1;CUL1;PSMC1;PSMD7;CDKN1A
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4665415232497653,1.3289621837549663,0.08630609896432681,0.7979117926402571,1.0,28/136,12.53%,TCF7L2;PKD1;HDAC4;CYP1B1;PTGIS;HES1;ANXA4;WWP2;KLF4;TAX1BP1;ID1;CMKLR1;MDFI;SFRP4;BHLHE40;GLIS2;ESR1;KDM1A;DDIT3;ID2;CHUK;COMMD1;ERBIN;IRAK3;USP7;RB1;CHP1;ZC3H12A
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4583887314267662,-1.3289357921315248,0.12121212121212122,0.571524649858696,1.0,9/29,14.78%,BCL2;TFRC;MEF2C;VAV3;CD81;CD38;MIF;CD74;CD40
prerank,positive regulation of RNA splicing (GO:0033120),0.5577964989037414,1.3288065788791936,0.16516516516516516,0.7967436527873127,1.0,1/29,0.04%,SLC38A2
prerank,positive regulation of cartilage development (GO:0061036),0.6060369880148881,1.3283376405294665,0.15629984051036683,0.7968463375350322,1.0,6/17,7.23%,BMP4;SOX9;BMP1;ZBTB16;GDF6;GDF5
prerank,positive regulation of synaptic transmission (GO:0050806),-0.368852375838702,-1.3283043720882568,0.04888888888888889,0.5709387520464281,1.0,15/72,10.09%,SHANK3;ADCY1;NRXN1;SLC24A2;RIMS1;GRIK2;GRIN2A;RIMS2;APP;GRIN2B;CACNG4;PRKCZ;CACNG7;SYT1;LGMN
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.647501376228748,1.3282605292743104,0.16666666666666666,0.7954864945185808,1.0,2/12,4.38%,SOAT1;ACSL3
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3613163715716245,-1.3280914145426737,0.03954802259887006,0.5690983888009051,1.0,25/91,13.82%,CP;SLC30A10;SLC39A10;FTH1;TFRC;APP;SLC40A1;SLC39A8;FTL;ATOX1;SLC30A1;SLC31A1;MT2A;ABCB7;SLC22A17;BOLA2;ATP6AP1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.49758416647708664,1.3273966998806,0.11518987341772152,0.7972379666274336,1.0,7/63,6.64%,THBS1;BMP4;TCF7L2;FGFR1;TGFBR1;ITGAV;BIRC6
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4678971981865574,-1.3271266091985428,0.10746268656716418,0.5693222061703567,1.0,8/26,10.07%,ERRFI1;TGFA;CBLB;APP;SOCS5;ADRA2A;ZFYVE28;HBEGF
prerank,negative regulation of cell migration (GO:0030336),0.4603530400980319,1.326805916281255,0.0860091743119266,0.797863456384248,1.0,34/137,12.07%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;ARHGDIB;FOXO3;PHLDB2;SULF1;COL3A1;IGFBP5;BMPR1A;FGF2;SRGAP2;SRGAP3;VCL;NOG;ZMYND8;LRP1;SLURP1;JAG1;RAP2C;HAS1;CHRD;NF1;LDLRAD4;TIMP1;DUSP10;ITGB1BP1;NKX2-1;CORO1C
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5967800600595159,1.32653780932648,0.17683881064162754,0.7972049926455281,1.0,3/20,2.37%,HOXA5;PTK2B;ZBTB16
prerank,artery morphogenesis (GO:0048844),0.5462813826046429,1.3264774595364994,0.15851851851851853,0.7958015986470799,1.0,11/30,10.34%,BMP4;HES1;BMPR1A;NRP1;TGFBR1;STRA6;NOG;LRP1;JAG1;NF1;VEGFA
prerank,response to sterol (GO:0036314),0.651730287027829,1.3260515491637905,0.16694772344013492,0.7957752030992136,1.0,5/11,11.05%,TGFBR1;TGFBR2;RORA;CCL3;SMAD2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6700532456464583,1.3260119429363566,0.16551724137931034,0.7942317213074684,1.0,6/10,22.64%,NFE2L2;DDIT3;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.6653375996328231,1.3255884995757783,0.16478190630048464,0.79422162141274,1.0,8/11,27.10%,UBN1;CABIN1;HIRA;ATRX;IPO4;RBBP4;NASP;HAT1
prerank,regulation of cell morphogenesis (GO:0022604),0.5568515681707342,1.3254219678824046,0.1582089552238806,0.7932121766916265,1.0,9/30,12.99%,FMNL2;EFNA5;CD44;MOV10;MYO9A;BCL9L;ZMYM4;SH3D19;ZRANB1
prerank,sodium-independent organic anion transport (GO:0043252),0.6588374898738361,1.3251950967837844,0.18600682593856654,0.7923870724665331,1.0,3/10,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,renal system development (GO:0072001),0.5113305264696029,1.3250124567609765,0.12450331125827814,0.7914754835790068,1.0,12/52,10.34%,BMP4;SIX1;PCSK5;PKD1;SULF1;TGFBR1;STRA6;AGTR1;ARL3;FOXC1;GLI2;VEGFA
prerank,embryonic eye morphogenesis (GO:0048048),0.669327547684016,1.324305101636275,0.1866913123844732,0.7924878500789344,1.0,4/11,9.77%,LRP6;MFAP5;EFEMP1;RARG
prerank,negative regulation of lipid storage (GO:0010888),-0.49448958475917687,-1.3241763943782627,0.13164556962025317,0.5754005380604239,1.0,6/19,7.19%,OSBPL8;PPARA;NR1H3;ABCA1;PPARD;ABCG1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6151955826163599,1.323718712790378,0.18381112984822934,0.7930569553349885,1.0,3/15,8.69%,BMP4;SFRP4;FOXC1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.6708338983905336,1.3231406159871681,0.18181818181818182,0.7936088333329521,1.0,5/10,10.84%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4201291236866188,-1.3230071370768628,0.07749077490774908,0.5762063380741282,1.0,14/41,14.66%,ITPR1;SLC24A2;GRIN2A;SLC8A1;RYR2;GRIN2B;CACNA2D1;HTR2C;GRIN1;HTR2A;TRPV2;ERO1A;CCL19;TRPV4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4623505675501102,-1.3224771664811366,0.11144578313253012,0.5753939124475957,1.0,11/27,14.87%,PRKCH;PPARA;CSF1;ABCA5;NR1H3;ABCA1;ABCG1;IL18;MSR1;LPL;AGT
prerank,base-excision repair (GO:0006284),0.5149498140983766,1.322474519116215,0.14102564102564102,0.7942752032038127,1.0,19/48,25.16%,MPG;APEX2;SMUG1;ERCC5;WRN;APEX1;USP47;PRMT6;POLB;XPA;RPA1;NEIL3;RFC1;TDG;HUWE1;POLD3;MBD4;RFC5;POLQ
prerank,protein localization to nucleus (GO:0034504),0.4721360388997837,1.3222043703327355,0.10144927536231885,0.7935745639865065,1.0,30/102,20.35%,BMP4;SIX1;PRICKLE1;NUP93;LMNA;STAT3;IPO7;TOR1AIP1;E2F3;SIX4;TNPO2;WRN;CNEP1R1;MORC3;TBRG1;SEC13;NUP153;PML;NUP214;ZBTB7A;XPA;TOR1B;NUP188;NUP88;ABCA7;NUTF2;RAN;TNPO3;DVL1;HEATR3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6460156044019344,1.322057519569523,0.1646655231560892,0.7925342955424408,1.0,3/12,7.16%,CD44;GCNT2;IL10
prerank,glycosaminoglycan metabolic process (GO:0030203),0.5129476985889054,1.3217847225130528,0.12362637362637363,0.7918738130692484,1.0,14/54,11.67%,GPC6;EXT1;GPC3;HS3ST1;HS6ST2;HEXA;GCNT2;XYLT1;NAGLU;GPC4;HAS1;B3GALT6;SGSH;GLB1
prerank,calcium-mediated signaling (GO:0019722),0.4782683839609697,1.3212560796406894,0.11870503597122302,0.7921929839448354,1.0,23/93,14.55%,EGFR;PLCE1;ANK2;ATP1B1;PPP3CA;CACNA1C;AGTR1;TRPM4;DMTN;NUDT4;P2RX4;SLC9A1;TNNI3;PLCG2;MCU;CCL3;PPP3CC;SAMD14;RCAN1;TNFSF11;HTR2B;BCAP31;CXCR4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.532456489230191,-1.3209682759947061,0.1580188679245283,0.5773114503610622,1.0,4/13,10.09%,SHANK3;ADCY1;APP;LGMN
prerank,regulation of filopodium assembly (GO:0051489),0.5366211216814922,1.3209566399279993,0.15064562410329985,0.7916472402538046,1.0,10/38,6.54%,DPYSL3;ARAP1;TGFB3;PRKCD;PALM;ARHGAP44;NRP1;BCAS3;RHOQ;DMTN
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4803295453556894,1.3203441551807977,0.11901983663943991,0.7923807857750494,1.0,26/95,13.42%,THBS1;HTRA3;CD109;SMAD6;SKIL;GIPC1;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;CREBBP;SKI;BAMBI;IL17RD;TGFB1I1;LTBP4;DKK3;LDLRAD4;BCL9L;SMAD2;RNF111;NKX2-1;PPM1A;SMURF1;EP300
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6460975781190599,1.320317262140929,0.19611021069692058,0.7908783769196204,1.0,3/12,8.03%,SOX9;MUC6;TLR4
prerank,regulation of intracellular protein transport (GO:0033157),0.5558230030700824,1.3196944560587027,0.1376281112737921,0.7915958948362557,1.0,6/32,10.52%,BMP4;NDEL1;BCAS3;PCM1;PLK3;CEP131
prerank,activin receptor signaling pathway (GO:0032924),0.6252259327627203,1.319491890172006,0.17045454545454544,0.7907305857630313,1.0,6/15,11.38%,INHBA;TGFBR1;GDF6;ACVR1;SMAD2;INHBB
prerank,negative regulation of wound healing (GO:0061045),0.5620741941971765,1.3192743710829067,0.15935672514619884,0.7899602792000923,1.0,5/28,3.29%,SLC12A2;CD109;PHLDB2;THBD;FGF2
prerank,nitrogen compound transport (GO:0071705),0.4505750257962855,1.3187463581931855,0.07562076749435666,0.7904428113794979,1.0,7/141,2.41%,SLC38A2;SLC23A1;SLC38A1;SLC12A2;RAMP1;LRRC8D;ABCG2
prerank,"phagocytosis, engulfment (GO:0006911)",0.5310889546358628,1.3185288542308773,0.14550641940085593,0.7897424606926334,1.0,4/36,3.26%,THBS1;GULP1;GSN;RHOBTB1
prerank,neuron projection regeneration (GO:0031102),-0.5982034226052011,-1.3183699314417299,0.1688888888888889,0.5821806674984996,1.0,3/10,18.93%,NREP;RTN4RL1;OMG
prerank,endocrine system development (GO:0035270),0.5934392751712655,1.318127688251733,0.16901408450704225,0.7898078913548654,1.0,9/21,12.00%,SIX1;WNT11;TGFBR1;STRA6;GLI2;NF1;DKK3;FOXE1;NKX2-1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5633189497554806,-1.3180323096002458,0.16428571428571428,0.5807838953673493,1.0,5/12,7.19%,PPARA;ABCA5;NR1H3;ABCA1;ABCG1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5620398218552294,-1.3175558831700347,0.14761904761904762,0.579913065197343,1.0,4/11,8.73%,NEDD4L;PICALM;GPM6B;ACTN2
prerank,positive regulation of cell division (GO:0051781),0.5345156589624631,1.3172124665671434,0.14225352112676057,0.7916374329570174,1.0,10/38,14.31%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3;HTR2B
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6619473894738477,1.3170439873459148,0.1826086956521739,0.7906279013336321,1.0,4/12,4.29%,DOCK5;IGFBP5;DOCK7;NR4A3
prerank,visual system development (GO:0150063),0.5414744251938185,1.316891471142491,0.13067400275103164,0.7895915447329389,1.0,7/37,11.06%,PBX3;PBX1;SMOC1;HIPK1;FOXC1;SCO2;ATF6
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.43687765747238266,-1.3164919539490854,0.08626198083067092,0.5805036358493464,1.0,14/33,19.06%,IGF1;IGF1R;PIK3R1;PIK3C2A;MYO16;NYAP2;EDN1;HTR2A;PIK3R5;TYRO3;AKT1;ERBB3;PIK3CG;TPTE
prerank,regulation of epidermal cell differentiation (GO:0045604),0.5891511110024217,1.316312620697944,0.1671875,0.7901593327011889,1.0,3/21,5.19%,BMP4;KLF7;SFRP4
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6190764312927679,1.315703053608349,0.15397631133671744,0.7907535383619674,1.0,6/15,15.72%,SIX1;TGFBR1;TGFBR2;NIPBL;TWIST1;TFAP2A
prerank,mitochondrial RNA metabolic process (GO:0000959),0.6177640140043681,1.3156487484787505,0.17957166392092258,0.7893654989769053,1.0,3/14,6.55%,FOXO3;EARS2;FASTKD1
prerank,DNA double-strand break processing (GO:0000729),0.5961813940742561,1.3155692721839047,0.1747269890795632,0.7881236304522677,1.0,11/18,24.83%,RNF138;ATM;RAD52;SLX4;RBBP8;BARD1;NBN;UBE2N;EXD2;RAD50;KAT5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5728778428570834,1.3154963110542153,0.17784711388455537,0.7868052330452913,1.0,10/22,23.34%,NEDD4;RNF115;RNF126;VPS37A;MVB12B;VPS37B;TSG101;SNF8;TOM1L1;UBAP1
prerank,endocardial cushion development (GO:0003197),0.5869002443462937,1.314813150256926,0.1921875,0.7877852559802218,1.0,8/21,9.97%,BMP4;SOX9;BMPR1A;NOG;ISL1;GATA4;MDM4;ACVR1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5679821085196377,1.3146837516287653,0.17113095238095238,0.7867382502400929,1.0,17/27,28.31%,KAT6B;CREBBP;TRRAP;ATAT1;SGF29;CPA4;KAT2A;EP300;KAT2B;BRD8;PHF20;PHF20L1;KAT5;NAA50;KAT6A;MORF4L2;TAF6L
prerank,mesenchymal cell development (GO:0014031),-0.4991277453615681,-1.313503431799064,0.12777777777777777,0.5869016875088358,1.0,4/18,7.41%,CDH2;NOTCH1;TAPT1;HEY2
prerank,cation transmembrane transport (GO:0098655),-0.41101685986906783,-1.3132243028423118,0.09157509157509157,0.585370149434319,1.0,6/44,5.81%,ATP1A2;TRPM3;SLC6A9;ABCC9;SLC7A5;SLC38A5
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4971500555313411,-1.3132039897974643,0.13866666666666666,0.5830879483508372,1.0,8/19,22.96%,IGF1;IL18;SPHK1;CD200;NUPR1;PTGS2;TREM2;MMP3
prerank,response to interferon-gamma (GO:0034341),-0.380343746977458,-1.3129132732749993,0.06756756756756757,0.5816507553087555,1.0,24/67,19.66%,WNT5A;CD47;GBP7;GBP4;SIRPA;IFITM1;BST2;SNCA;GAPDH;IFITM3;AQP4;RPL13A;STAT1;CCL19;CD74;TRIM21;CD40;GBP3;SP100;GCH1;CASP1;GBP5;CX3CL1;CCL2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.46087496818014645,-1.3127557956456501,0.12209302325581395,0.5797339913658295,1.0,14/25,28.65%,TNFSF10;PDCD5;BMF;BIK;GPER1;DNM1L;PLAUR;PMAIP1;PYCARD;MFF;MLLT11;PINK1;HRK;BCL2L11
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5563910401046925,1.31271330758811,0.15597667638483964,0.7923984874971527,1.0,5/28,9.33%,EGFR;TCIM;WWP2;MMP14;NIBAN2
prerank,regulation of protein localization to nucleus (GO:1900180),0.5279190947736581,1.3109154048447946,0.16939890710382513,0.7977963556206076,1.0,4/43,3.24%,BMP4;CTNNA1;LIMK2;GSK3B
prerank,positive regulation of vasculature development (GO:1904018),0.46652343404420377,1.3106859404411049,0.11203814064362336,0.7970382962533952,1.0,14/94,6.17%,SMOC2;F3;THBS1;ITGB8;PGF;CYP1B1;ANXA3;PTGIS;HIPK1;ITGB1;FGF2;ADAM12;ISL1;GATA4
prerank,regulation of microtubule-based process (GO:0032886),0.5227569623254622,1.310244469512233,0.15121255349500715,0.7970274364914488,1.0,9/36,11.11%,EFNA5;PHLDB2;GSK3B;FAM107A;DIAPH1;MARK2;MEMO1;AURKA;ERBB2
prerank,histone deubiquitination (GO:0016578),0.603852192257627,1.3101916610631141,0.17563291139240506,0.7956634939999138,1.0,11/18,24.66%,TRRAP;USP49;USP15;USP7;KAT2A;UIMC1;USP22;USP21;USP36;BRCC3;USP3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5715848703655215,1.3094723671484982,0.18630573248407642,0.7967874374744929,1.0,3/22,4.70%,EZR;UBASH3A;PTPN2
prerank,dendrite self-avoidance (GO:0070593),-0.5151336037955029,-1.3094630151846165,0.14805194805194805,0.5866365163918299,1.0,7/16,13.34%,BSG;CNTN4;ROBO4;PALLD;CNTN2;DSCAML1;NEXN
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5552650631594813,1.3092479925207412,0.1846590909090909,0.7960951752806025,1.0,6/27,10.00%,SMOC2;FGF2;SMG6;PDGFA;NIBAN2;ATM
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6259715626704108,1.3086048023234527,0.19617224880382775,0.797008367918975,1.0,3/14,6.63%,NT5E;NT5C1A;UPP2
prerank,autonomic nervous system development (GO:0048483),0.6197987346960123,1.3081393194304956,0.19138755980861244,0.7972606353167812,1.0,5/17,9.78%,FN1;NRP1;GDNF;PHOX2A;NF1
prerank,ncRNA processing (GO:0034470),-0.3212568903369371,-1.308041616808721,0.029411764705882353,0.5885136493160107,1.0,75/200,23.22%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;LIN28B;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;AGO4;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;TARBP2;RPL10A;DDX10;RPL3;LYAR;RPL12;ADAR;PIH1D1;AGO1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;METTL3;NOLC1;POP7;EMG1;SMAD3;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9;SARS1
prerank,positive regulation of ossification (GO:0045778),0.5212944006060504,1.307986507688977,0.14509246088193456,0.7963109789122692,1.0,8/39,3.97%,BMP4;CCN1;TGFB3;ZBTB16;ANO6;BMP6;BMPR1A;NELL1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.37243306095649553,-1.3077240417571914,0.06637168141592921,0.5869828732128081,1.0,15/66,7.12%,ROBO1;FLT1;IL34;SASH1;PDGFD;PDGFRB;KIT;PAK1;TPD52L1;DAB2IP;FGF1;PIK3R6;RPS3;ADRA2A;TNFRSF11A
prerank,carnitine shuttle (GO:0006853),-0.5659696302832457,-1.3073405030938805,0.13225058004640372,0.5858384625973465,1.0,3/11,5.41%,PRKAG2;ACACB;PRKAA2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6210808987395973,1.3070489394637408,0.19561815336463223,0.7982087892173008,1.0,1/14,0.57%,CARD14
prerank,defense response to virus (GO:0051607),-0.3459765045902884,-1.3068007279057208,0.039735099337748346,0.585235145261676,1.0,24/100,12.65%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;ZDHHC1;IFNAR2;IFITM3;OAS2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;TLR7;RNASEL;STAT1;TLR3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6272432678559867,1.3067277259713783,0.2015873015873016,0.7978710172922123,1.0,4/14,8.85%,PKD1;MDFI;IL10;G3BP2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5026802360655861,-1.306517171021793,0.13920454545454544,0.5837964116160751,1.0,10/20,30.70%,RPS6KA5;PRKAA2;PPARGC1A;ARRB1;MAPK3;RUVBL2;RPS6KA4;NOS1;DIP2A;SOX4
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4604006423752543,-1.3053999720000573,0.11834319526627218,0.5847932563114833,1.0,6/23,8.16%,CEMIP;PRKAG2;BMP7;CALM1;APP;SPHK1
prerank,regulation of interleukin-4 production (GO:0032673),-0.48072991439077783,-1.3053870508514307,0.12885154061624648,0.5825480823177299,1.0,4/21,7.50%,LEF1;SLC7A5;PRKCQ;PRKCZ
prerank,regulation of chromatin organization (GO:1902275),0.6274172963636969,1.305155992994337,0.17905405405405406,0.8021190889428129,1.0,5/14,17.39%,MLLT3;TLK1;SETD5;TLK2;ALKBH4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4961899205415713,1.30515407602314,0.13434727503168567,0.8005932162466437,1.0,19/65,13.35%,HTRA3;CD109;SMAD6;SKIL;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;SKI;BAMBI;IL17RD;TGFB1I1;LDLRAD4;BCL9L;SMAD2;NKX2-1;PPM1A;SMURF1
prerank,regulation of cell cycle (GO:0051726),0.42623241303841586,1.3044026963000073,0.0529595015576324,0.801741731431755,1.0,66/271,19.24%,THBS1;BMP4;TCF7L2;PLAGL1;GRK5;PKD1;SOX9;LRP6;INHBA;NOTCH2;NEK7;TTC28;ABL1;TGFBR1;PDCD4;SON;TXLNG;GADD45G;STAT3;GBF1;MYOG;BIRC7;ID2;IRF1;CDKN1B;CDC14A;IQGAP1;RARA;PIM2;ATM;JUN;MAPK12;FBXL6;TBRG1;RB1;CDKN3;NR4A1;CHEK1;EP300;HCFC1;TMEM8B;BAP1;CCND1;TGM1;CDK11B;PUM1;ADAM10;PML;KAT2B;PRCC;ANKRD17;UHRF2;BARD1;NBN;SMIM22;WDR12;CDKN1A;GAS2L1;CDK10;WHAMM;PER2;CSNK2A2;CSNK2A1;BIRC3;NEK6;FBXL8
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.4971411208537312,-1.303861158625673,0.14893617021276595,0.5846789466842528,1.0,7/17,6.08%,MAML3;MAML2;NOTCH3;NOTCH1;PLXND1;RBPJ;NOTCH4
prerank,cellular response to type I interferon (GO:0071357),-0.41679401444760583,-1.3024033036045257,0.12056737588652482,0.5843895573219641,1.0,23/41,26.04%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;IFIT3;RNASEL;STAT1;PSMB8;SP100;IFIT1;ADAR;IRF7;OASL;XAF1;RSAD2;JAK1;IFITM2;IRF8
prerank,type I interferon signaling pathway (GO:0060337),-0.41679401444760583,-1.3024033036045257,0.12056737588652482,0.5843895573219641,1.0,23/41,26.04%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;IFIT3;RNASEL;STAT1;PSMB8;SP100;IFIT1;ADAR;IRF7;OASL;XAF1;RSAD2;JAK1;IFITM2;IRF8
prerank,detection of calcium ion (GO:0005513),0.6316656512714268,1.3021638030985576,0.18282988871224165,0.8087161516152994,1.0,3/13,6.34%,KCNMB3;KCNMB2;CASR
prerank,microglial cell activation (GO:0001774),-0.4797851205635426,-1.3013247235020677,0.12698412698412698,0.5849458614576104,1.0,9/21,23.31%,APP;SNCA;MAPT;GRN;C1QA;TYROBP;CX3CL1;TREM2;CX3CR1
prerank,macromolecule catabolic process (GO:0009057),0.5508631343168143,1.3010564168368899,0.17194570135746606,0.8111673040016467,1.0,8/26,13.51%,NEDD4;BECN1;IDE;LRSAM1;KIF16B;MTOR;SMURF1;SH3GLB1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5391543454220588,1.3007967944616714,0.1636904761904762,0.8106247897553689,1.0,7/31,11.32%,FHL1;KLF4;FAM107A;DLG1;KANK2;DACT1;RB1
prerank,cellular response to interleukin-2 (GO:0071352),0.6330958314746464,1.300774795732632,0.21025641025641026,0.8076749862968962,1.0,2/11,2.97%,PTK2B;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6330958314746464,1.300774795732632,0.21025641025641026,0.8076749862968962,1.0,2/11,2.97%,PTK2B;SHC1
prerank,positive regulation of binding (GO:0051099),0.47114632628920033,1.300371704327373,0.11936662606577345,0.8075724324712501,1.0,20/84,12.29%,BMP4;TCF7L2;MET;PKD1;NGF;HES1;GSK3B;SKI;LRP1;BAMBI;RIPK2;IDE;FOXC1;DACT1;RARA;MARK3;DDX11;TIAM1;ADD1;USP33
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.46660352672374694,-1.2999714833838432,0.147239263803681,0.5864385448187075,1.0,14/23,34.83%,ELOVL6;ALOX12;ACOT7;LTA4H;ACSBG1;GPX4;PTGS2;GSTM1;CYP2E1;ASAH2;GSTM2;CYP1A1;LTC4S;GSTP1
prerank,regulation of heart contraction (GO:0008016),-0.36058165794606056,-1.299623001808111,0.06358381502890173,0.5851926943285756,1.0,23/90,13.73%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;CALM1;RYR2;ATP1B2;DMPK;PDE4D;ATP2B1;DES;FXYD6;KCNQ1;ACE2;ATP2A2;KCNJ12;CELF2;CASQ2;GSK3A;CALM3;TRPC1
prerank,regulation of response to biotic stimulus (GO:0002831),0.5556695960049917,1.2994250950778066,0.1563845050215208,0.8095712639390718,1.0,2/28,1.39%,FOXP1;CD55
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.514995649804282,-1.2990698829038345,0.15,0.5845309825700111,1.0,4/17,5.41%,PPARA;PRKAG2;PPARD;PRKAA2
prerank,lung development (GO:0030324),0.5311027813016622,1.2983645972955076,0.15664335664335666,0.8119583551853184,1.0,9/33,12.00%,BMP4;PKD1;WNT11;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5213314306799444,-1.2976402642886322,0.16666666666666666,0.5864005182632733,1.0,2/15,1.94%,OSBPL8;PPARA
prerank,regulation of nervous system process (GO:0031644),-0.48454722132627726,-1.297614351121637,0.14285714285714285,0.5842872334146932,1.0,11/18,20.57%,NOS3;APP;DLGAP1;HTR2C;TMEM108;ROCK2;NPTXR;DLGAP2;CHRNA7;DLGAP3;BEGAIN
prerank,chloride transmembrane transport (GO:1902476),0.5057841719366638,1.2969157428894103,0.15172413793103448,0.8157093633407033,1.0,7/48,4.00%,SLC12A7;SLC12A2;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,regulation of leukocyte activation (GO:0002694),-0.5299625205621848,-1.2963569707841676,0.17150395778364116,0.5852964395367687,1.0,6/14,13.57%,LYN;MFHAS1;CD200;MIF;MYO18A;CD74
prerank,connective tissue development (GO:0061448),0.5327412905573249,1.2963096253375421,0.15647226173541964,0.8163849894672888,1.0,6/35,2.53%,PKD1;SOX9;ITGB8;ZBTB16;CD44;SULF1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5949838655755719,1.2958277799539561,0.19391025641025642,0.8165893294643147,1.0,3/16,4.28%,THBS1;FGF2;AGTR1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4181870837850775,-1.295616073665552,0.10457516339869281,0.5850422302924764,1.0,9/34,6.10%,FLT1;TEK;PIK3R1;PDGFRB;PRKD1;KIT;DAB2IP;EPHA8;PTK2
prerank,cAMP metabolic process (GO:0046058),-0.535862921680472,-1.295480699241755,0.14754098360655737,0.5832446316121921,1.0,6/13,15.24%,ADCY5;ADCY1;ADCY7;PDE4D;ADCY2;ADCY4
prerank,regulation of axon guidance (GO:1902667),0.6602512344107186,1.2944102888887616,0.18890814558058924,0.8203339195578088,1.0,3/10,10.34%,NRP1;MYCBP2;VEGFA
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.612685756056054,1.292417352708112,0.180623973727422,0.8261306961686607,1.0,3/15,5.19%,RSPO3;GPC3;SFRP4
prerank,regulation of calcium ion import (GO:0090279),-0.48006696442239255,-1.2923871548654828,0.14613180515759314,0.5897746604856818,1.0,8/21,21.23%,PDGFRB;CXCL12;SLC30A1;PLPP4;STC1;CCL2;SPHK2;TRIM27
prerank,endocardial cushion morphogenesis (GO:0003203),0.6102989143865659,1.2920342572153225,0.19283276450511946,0.8260242600699468,1.0,8/18,9.97%,BMP4;SOX9;BMPR1A;TGFBR2;NOG;ISL1;MDM4;ACVR1
prerank,protein kinase B signaling (GO:0043491),-0.46538016784581643,-1.2916346646279797,0.14285714285714285,0.5897952475307074,1.0,10/23,21.77%,IGF1;KDR;SETX;GAS6;THEM4;TYRO3;AKT1;MT3;CCL2;EPHA2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5320735589527308,1.2913400346612705,0.18373071528751753,0.8270460527819529,1.0,16/38,22.23%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;SREBF1;CSNK2A2;RNF31;USP36;HUWE1;PARL;ATP5IF1
prerank,extracellular matrix disassembly (GO:0022617),0.5004085858612313,1.291071749000304,0.16176470588235295,0.8264815203918732,1.0,12/53,11.25%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,positive regulation of gene expression (GO:0010628),0.41639058665474554,1.2906346641278945,0.030518819938962362,0.8265276484927769,1.0,81/442,13.52%,SLC38A2;F3;EGFR;THBS1;BMP4;SLC24A3;SAMD4A;NTRK3;SOX9;FOXD1;HOXA5;NGF;ITGB8;ANK2;DDX5;EZR;SMO;PID1;FN1;WNT11;GSN;KRAS;NIBAN1;KLF4;BMP6;NFE2L2;INHBA;GSK3B;FGF2;POLR1G;TGFBR1;SERPINB9;ZBTB7B;SFRP4;NOG;WNT16;STAT3;UBR5;CLU;TADA3;PLSCR1;AGR2;IL10;PKP1;CELF1;MOV10;RDX;ID2;TNRC6C;TLR4;LARP4B;CD46;POLR1A;IL33;CTCFL;PLCG2;HILPDA;ATM;LIMS1;U2AF2;VEGFA;CCL3;ERBB2;EIF3E;TAF1D;TAF1C;RBMS3;FGF22;MYD88;NKX2-1;KAT2A;EIF6;ZC3H12A;DDRGK1;MTOR;PIK3R3;PRKDC;PAX6;EP300;POLR1F;HCFC1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4146248707914965,-1.290308816044141,0.125,0.5913101634484237,1.0,11/39,7.28%,ROBO1;EPN2;MAML3;MAML2;NOS3;ROBO2;TSPAN5;NOTCH1;RBPJ;NOTCH4;JAG2
prerank,embryonic appendage morphogenesis (GO:0035113),0.633628489246847,1.2894701688507504,0.19430485762144054,0.8293995452508948,1.0,3/12,5.66%,MBNL1;LRP6;SKI
prerank,positive regulation of bone mineralization (GO:0030501),0.5193960021040703,1.2894215275444108,0.1643059490084986,0.8280449795971343,1.0,7/35,3.97%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,positive regulation of mRNA processing (GO:0050685),0.5732999454618347,1.2890008833643944,0.20030581039755352,0.8280974772470526,1.0,15/21,30.20%,CELF3;RBMX;THRAP3;DHX36;CIRBP;DAZAP1;SNW1;TRA2B;NUP98;RBM3;PAF1;CELF4;NCBP2;RBMXL1;PRDX6
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46485763991933626,1.28879856158618,0.11916461916461916,0.8273051360381394,1.0,17/95,6.43%,ST3GAL4;GPC6;EXT1;UST;DSE;GPC3;HS3ST1;B3GNT2;HS6ST2;CHST13;GLCE;HEXA;CHST5;GCNT2;SLC10A7;XYLT1;B4GALT1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.439584489878501,1.2886314626704944,0.1078107810781078,0.8263965931956792,1.0,40/153,13.69%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;TGFBR1;MKNK2;TGFBR2;SGK3;VRK3;MARK2;IKBKE;CSNK1A1;CSNK1G3;NLK;CHUK;AURKA;MARK3;ATM;TOP1;CAB39;MAPK12;CLSPN;MORC3;MAST2;PDK3;MTOR;CSNK1G1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;DYRK2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6161428331694798,1.2884155457367432,0.2082616179001721,0.8257177915192739,1.0,1/12,0.20%,F3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6302828898421099,1.2883155932899513,0.19614711033274956,0.8245536324406295,1.0,6/12,10.65%,NFIB;PAFAH1B1;TSKU;MYCBP2;GLI2;EPHB6
prerank,protein modification by small protein removal (GO:0070646),0.427512781839556,1.287657189478208,0.060669456066945605,0.8255012673911755,1.0,96/252,24.95%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;PSMB2;TRRAP;MDM4;USP34;USP49;RHOA;USP15;IL33;USP25;RAD23B;USP1;PSMC6;USP10;USP32;DESI1;DESI2;CLSPN;COPS7B;USP7;SMAD2;OTUD7B;USP47;COPS5;FOXK2;USP4;USP33;KAT2A;ZC3H12A;UIMC1;IFIH1;ZRANB1;JOSD1;EP300;HCFC1;PSMD11;BAP1;SENP5;POLB;TNIP1;PSMD1;OTUD3;OTUD5;KAT2B;IKBKG;VCPIP1;YY1;PSMC1;PSMD7;USP28;BARD1;INO80;WDR48;USP22;USP9X;BIRC3;UFD1;USP40;TRAF3;PSMD14;RNF123;SENP3;PSMD3;SENP1;USP21;USP36;SMAD4;GATA3;HGS;USP48;RHOT1;ASXL2;BRCC3;STAMBP;CDC20;SMAD7;TOMM20;ADRM1;MCRS1;USP3;COPS3;PSMD12;MAP3K7
prerank,peptidyl-serine modification (GO:0018209),0.43921191460529196,1.286156671558748,0.0978021978021978,0.8295738826458989,1.0,42/166,13.69%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;GALNT13;TGFBR1;MKNK2;TGFBR2;SGK3;VRK3;POGLUT3;MARK2;IKBKE;CSNK1A1;CSNK1G3;CHUK;AURKA;MARK3;ATM;TOP1;MBOAT4;CAB39;MAPK12;CLSPN;MORC3;MAST2;PDK3;MTOR;CSNK1G1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;DYRK2
prerank,cellular component disassembly (GO:0022411),0.49824892894030326,1.2860243329739849,0.17173051519154559,0.8286076336436244,1.0,12/53,11.25%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,regulation of hippo signaling (GO:0035330),0.5829283283981594,1.2855080605493718,0.2022653721682848,0.8289949392113641,1.0,2/17,1.73%,MOB3B;CIT
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5249300127455887,-1.2847730307218093,0.16272965879265092,0.604662216811706,1.0,5/15,6.24%,PPARA;LPGAT1;NR1H3;PPARD;PPARGC1A
prerank,amino acid import (GO:0043090),0.5563306069679261,1.2838543130393816,0.1917808219178082,0.8333901528296309,1.0,1/21,0.02%,SLC47A1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.43436987869189947,-1.2836188722991293,0.12312312312312312,0.60576296857021,1.0,6/29,9.22%,ENG;TGFBR3;NOTCH1;BMP2;S1PR1;PROX1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.41402008083907044,1.2836154208019797,0.038657171922685654,0.832807930143543,1.0,90/417,14.22%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HDAC9;ZBTB16;HES1;TWIST2;GCLC;WWP2;SHC1;KLF4;ZNF148;PRICKLE1;CRY2;RCOR3;ZNF423;MDFIC;ID1;L3MBTL3;BTAF1;PDCD4;FOXK1;PHC2;KAT6B;ARID4A;SAMD7;KLF10;TLE2;BHLHE40;GLIS2;SCMH1;SPINDOC;KDM1A;MBD1;DDIT3;NFIL3;DMBX1;SOX14;ID2;IRF1;MBTD1;SIX4;EHMT1;CDKN1B;ATOH8;ATP8B1;CIPC;PHF12;NIBAN2;FBXW11;BCLAF1;RARA;CBX5;DKK3;LIMS1;JUN;ELF3;FOXE1;NCOR1;PER1;SMAD2;EED;RB1;USP47;FOXK2;ID4;NKX2-1;NIPBL;SMARCA4;UIMC1;HNF4A;XRCC5;ERN2;NCOR2;SP3;BAP1;GCFC2;PRMT6;HDAC10;REST
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5865021069115084,1.2834945570832914,0.21153846153846154,0.8317237849966652,1.0,3/20,6.43%,ST3GAL4;FUT8;B4GALT1
prerank,regulation of RNA metabolic process (GO:0051252),0.48472781460350306,1.2834328304612366,0.15979381443298968,0.8304207464372684,1.0,13/59,12.56%,AHNAK2;MBNL1;AHNAK;CLK1;CLK2;SON;HNRNPH1;CELF1;MBNL2;FUS;PCBP4;TNFRSF1B;SNRNP70
prerank,regulation of gene expression (GO:0010468),0.41341098152648154,1.283112901096009,0.003,0.830087872809266,1.0,193/903,16.24%,SLC38A2;BNC2;F3;FOXP1;BMP4;CDH1;VSX1;TCF7L1;ZFHX3;AHNAK2;SLC24A3;SIX1;PRRX2;MBNL1;NTRK3;SOX9;FOXD1;HDAC4;HOXA5;PRDM6;NGF;FOXN3;ITGB8;ANK2;ATP1B1;EZR;SMO;AHNAK;PID1;FN1;WNT11;NFIA;AFF3;GSN;KRAS;WWP2;YBX3;USP13;COQ7;CLK1;ESR2;KLF4;JMJD1C;BMP6;NFE2L2;BMPR1A;INHBA;ZNF148;GSK3B;FGF2;NOTCH2;FZD7;ZNF423;ERC1;ABL1;NELL1;TGFBR1;EFEMP1;SERPINB9;CLK2;SON;ZFP64;KAT6B;ZBTB7B;ATP2B4;SFRP4;TSKU;GCNT2;BHLHE40;NOG;CREBBP;WNT16;ZC3H7A;HMG20A;ESR1;STAT3;UBR5;GDNF;C1D;GATA4;DDIT3;CLU;PTHLH;TADA3;NFIL3;TRIM44;PLSCR1;TOB2;AGR2;TRRAP;AFF4;HNRNPH1;IL10;PITX3;PKP1;CELF1;SOX14;MOV10;RDX;ID2;MBNL2;TNRC6C;REL;CRABP2;CHEK2;FUS;TLR4;IGSF1;NLK;ATOH8;FOXC1;NFYA;RORA;CD46;SERTAD3;PHF12;NFKB1;AURKA;TOB1;IL33;CTCFL;PCBP4;PLCG2;ATF7;ATM;LIMS1;VEGFA;BRCA2;TRIM26;SMCR8;CCL3;GON4L;PER1;MEGF8;GTF2IRD1;RB1;NFKB2;FOXK2;RBMS3;MTA1;FGF22;MYD88;SNX12;NKX2-1;TCF19;ZC3H12A;DDRGK1;SNRNP70;CTR9;ATRX;KMT2D;MTOR;PIK3R3;TCF3;PAX6;EP300;CHD3;PUM2;HCFC1;ANXA7;TDRD7;SP3;GPBP1;GCFC2;HDAC10;REST;ZNF507;GPBP1L1;CNOT7;CDK11B;CREB3L1;ATF2;TRIM39;HOXD3;BAZ2A;PCGF1;PUM1;TWIST1;MAP2K2;ADAM10;HINFP;CLK4;PML;TFAP2A;ZNF462;WWTR1;ZNF219;AGO2;CPNE1;BCL6;CREBL2;CALCOCO1;XDH
prerank,positive regulation of glucose import (GO:0046326),-0.4767192970153283,-1.2826831965872227,0.1553672316384181,0.6061400371592428,1.0,5/21,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.33681603928807013,-1.2814156540804233,0.019867549668874173,0.6076040617252814,1.0,24/121,7.99%,IGF1;IL34;VTN;LYN;IL31RA;PECAM1;ENPP2;KIT;GRM5;NEDD9;TEC;PARP14;ACE;IL6R;ERBB4;EPHA4;TNK2;GHR;GPRC5B;LRP8;CD81;ARL2BP;IL18;GAS6
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4420713345331001,1.2812549932837352,0.10643015521064302,0.8352928289045822,1.0,17/150,5.80%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;FGFR1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;STRN;TGFBR1;CD80;GCNT2;ESR1
prerank,regulation of platelet activation (GO:0010543),-0.4755954744978623,-1.2805416357525525,0.15,0.6079385913207711,1.0,7/21,9.40%,LYN;APOE;NOS3;TEC;PRKCQ;PDGFRA;PLEK
prerank,positive regulation of phosphorylation (GO:0042327),0.42209004148000756,1.2804914567258612,0.0863157894736842,0.8367860972633966,1.0,22/240,3.98%,SLC4A4;EGFR;THBS1;BMP4;SLCO3A1;CARD14;MET;NTRK3;SOX9;PGF;CCN1;EFNA5;LMO4;DDR2;KRAS;FGFR1;NIBAN1;LIMK2;FGF2;FZD7;ABL1;NRP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6289248905340905,1.2803900008207223,0.2179054054054054,0.8356381608607728,1.0,5/12,11.37%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,cellular response to heat (GO:0034605),0.5303961572293134,1.2802636557649103,0.19476744186046513,0.8346102227714824,1.0,4/35,8.52%,THBS1;TCIM;VCP;CLPB
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.49419126313824124,1.280234189315872,0.14191852825229961,0.8332498057532877,1.0,14/55,16.24%,THBS1;CYP1B1;PID1;COQ7;AGTR1;TGFBR2;ARF4;AATF;EIF6;ZC3H12A;PDK3;TFAP2A;ACOD1;XDH
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5249862041349861,1.2798842778647823,0.17474302496328928,0.8331648149079314,1.0,8/33,11.32%,FHL1;KLF4;FAM107A;DLG1;PLK3;KANK2;DACT1;RB1
prerank,myelination in peripheral nervous system (GO:0022011),0.6286027081459697,1.2792406974876764,0.2231686541737649,0.8339403435061575,1.0,5/13,9.90%,SKI;ARHGEF10;PARD3;NF1;ADGRG6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5723064447935041,1.2778778641123338,0.21656050955414013,0.8373952099761052,1.0,1/21,0.33%,FZR1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6278106826893481,1.2769882887648674,0.22129783693843594,0.8391837167528977,1.0,3/11,8.01%,LRP6;NR4A2;FZD1
prerank,regulation of protein binding (GO:0043393),0.44866656148468625,1.2768571100368549,0.12748538011695906,0.8382059019658806,1.0,25/114,12.54%,BMP4;TCF7L2;PKD1;HDAC4;PRKCD;GSK3B;LRPAP1;KDM1A;LRP1;BAMBI;RIPK2;IDE;SLPI;MARK2;PRMT8;DISC1;AURKA;DACT1;MARK3;DDX11;TIAM1;ITGB1BP1;ADD1;USP33;CARD16
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4073654985171037,-1.2768159268294932,0.11702127659574468,0.6161051616275762,1.0,18/36,27.94%,WNT5A;CSF1;PARP14;CASP4;HIF1A;GAS6;EDN1;NLRC5;AXL;CD74;CASP1;ZBP1;IL7;C1QTNF4;TSLP;LAPTM5;CD300LF;TRIM6
prerank,positive regulation of ERAD pathway (GO:1904294),0.6117973633978486,1.2763654226471053,0.20757825370675453,0.8385491400450378,1.0,3/13,4.79%,USP13;NFE2L2;RNF185
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5188420637139023,-1.275930310693132,0.16533333333333333,0.616433313825938,1.0,9/16,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME;ATP5MC3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5422915034201703,1.2758889278704726,0.19681620839363242,0.8388385633145206,1.0,11/31,10.84%,CRIM1;SOX9;SMAD6;TWIST2;TRPM4;NOG;SKI;BAMBI;CHRD;GDF10;LRP5
prerank,positive regulation of integrin activation (GO:0033625),-0.5559172207563137,-1.2758608363118145,0.18407960199004975,0.6144826846416874,1.0,3/11,9.40%,RASIP1;PIEZO1;PLEK
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.41319192109489367,1.2752248059997584,0.05333333333333334,0.8397934428506652,1.0,45/348,8.03%,SLC38A2;F3;BMP4;SLC24A3;NTRK3;SOX9;FOXD1;HOXA5;NGF;ITGB8;ANK2;EZR;SMO;PID1;FN1;ANXA2;WNT11;GSN;KRAS;KLF4;BMP6;NFE2L2;INHBA;GSK3B;FGF2;TGFBR1;SERPINB9;ZBTB7B;SFRP4;NOG;WNT16;STAT3;UBR5;CLU;TADA3;PLSCR1;AGR2;PKP1;CELF1;MOV10;RDX;ID2;TNRC6C;NSF;TLR4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4687896625656137,1.2743553994738281,0.16559691912708602,0.8414627235249653,1.0,15/69,15.29%,THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5176185659585226,-1.2738050716629925,0.18138424821002386,0.6181235348210087,1.0,5/14,10.06%,NOS3;ACE;ENPEP;EDN1;ACE2
prerank,response to glucose (GO:0009749),0.49640209806844915,1.2731406513036803,0.16847826086956522,0.84454291247459,1.0,5/46,4.23%,THBS1;TCF7L2;KCNB1;UNC13B;SLC39A14
prerank,clathrin coat assembly (GO:0048268),-0.5140323647239586,-1.2731093331569763,0.1628498727735369,0.617919204377188,1.0,7/15,15.26%,SGIP1;PICALM;PIK3C2A;HIP1R;HIP1;NSG1;EPS15
prerank,regulation of establishment of cell polarity (GO:2000114),0.5852647840228594,1.272695216046325,0.214170692431562,0.8446901827802552,1.0,4/16,5.51%,PTK2B;GSN;BCAS3;SHTN1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5055037066086501,-1.2725175097019295,0.16216216216216217,0.6173750403320766,1.0,1/14,0.56%,AUTS2
prerank,cGMP metabolic process (GO:0046068),0.6245196507224849,1.2722665311383121,0.2255892255892256,0.8448045691227551,1.0,1/12,0.24%,GUCY2C
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5119691859924816,1.2720650198563275,0.18270571827057183,0.8440190829814844,1.0,7/34,10.17%,DOCK5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5440836587755216,1.2716479218243513,0.17897727272727273,0.8440464140953824,1.0,13/29,15.73%,TCF7L1;TCF7L2;TLE2;CREBBP;TRRAP;BCL9L;SMARCA4;KMT2D;EP300;TLE3;PYGO1;TLE4;PYGO2
prerank,regulation of protein kinase activity (GO:0045859),0.45128768029757926,1.2716413646805063,0.14994096812278632,0.842611907343753,1.0,19/106,14.12%,PLCE1;RASSF2;LRP6;CCN1;PTK2B;DDR2;UBASH3B;RAP1A;RAP2C;IQGAP1;NF1;SMCR8;RB1;CEP85;ITGB1BP1;CHP1;PAK2;XRCC5;MRNIP
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5974400149404527,1.2714846037405094,0.20458265139116202,0.8416967367442846,1.0,12/16,30.20%,CELF3;RBMX;THRAP3;CIRBP;DAZAP1;SNW1;TRA2B;NUP98;RBM3;CELF4;RBMXL1;PRDX6
prerank,actin nucleation (GO:0045010),-0.4600349719711779,-1.2713607680741872,0.16023738872403562,0.6185285928637603,1.0,10/21,25.07%,IQGAP2;LMOD1;SPIRE1;ARPC4;ARPC3;ARPC5;ARPC5L;TRIM27;ARPC1A;SPIRE2
prerank,muscle organ development (GO:0007517),0.4855515096328011,1.2708454052076616,0.16937669376693767,0.8425605852521765,1.0,13/54,11.29%,FHL1;MKX;SGCD;MRAS;LARGE1;COL6A3;MEF2A;DMD;COPRS;CTF1;EMD;MAPK12;EVC
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5398805081234211,1.26979123267674,0.2006079027355623,0.8449593309546295,1.0,3/26,6.41%,ST3GAL4;LARGE1;GOLPH3
prerank,actin filament bundle organization (GO:0061572),0.5192641084370929,1.2695295655229115,0.1936813186813187,0.8443842280531032,1.0,8/33,6.54%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3733198133673826,-1.2694486833043104,0.1072961373390558,0.6217170772130073,1.0,20/57,13.10%,GRIA4;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;DLGAP1;GRIA3;CACNG4;GRIN1;CACNG7;ACTN2;GRIA2;CAMK2A;GRIA1;NETO1;CAMK2B;NPTXR;DLGAP2;GSG1L
prerank,positive regulation of histone acetylation (GO:0035066),-0.4672821848804421,-1.269361869879784,0.17559523809523808,0.6197534387634585,1.0,11/23,28.85%,RPS6KA5;PPARGC1A;ARRB1;MAPK3;PIH1D1;RUVBL2;SPHK2;MUC1;RPS6KA4;NOS1;WBP2
prerank,protein localization to chromatin (GO:0071168),0.5732370438637071,1.269122906901335,0.20376175548589343,0.8444301653763145,1.0,8/18,18.84%,ESR1;SGF29;WAPL;NIPBL;MRNIP;MCM9;LEMD2;TASOR
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4972529096193409,-1.268714067467426,0.17783505154639176,0.6194316137110895,1.0,6/16,7.89%,RANBP3L;PLCB1;IGFBP3;RIPOR2;MEF2C;BTG1
prerank,respiratory electron transport chain (GO:0022904),-0.5133712032934169,-1.2685435984705355,0.19363395225464192,0.6177769310720853,1.0,3/14,6.24%,GPD2;SDHA;PPARGC1A
prerank,regulation of myeloid cell differentiation (GO:0045637),0.47828115232497825,1.2678260639144523,0.15167095115681234,0.8476474651464588,1.0,16/62,14.17%,THBS1;HOXA5;PTK2B;ZBTB16;NR4A3;CREBBP;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;CTR9;KMT2D;EP300;PRMT6
prerank,regulation of actin nucleation (GO:0051125),0.626317529217052,1.2672740674040128,0.21227197346600332,0.8483276160850386,1.0,5/12,18.07%,GSN;WASHC5;ARFIP1;ARFIP2;WHAMM
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6339644945182479,1.2672559064595112,0.22338568935427575,0.8469283084082392,1.0,4/11,17.02%,DDIT3;ATF6;CREB3L1;CREB3L3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4379921437923345,1.267099926971143,0.11670480549199085,0.8460200100658885,1.0,34/144,13.99%,CDH1;TCF7L2;ABLIM3;PRKCD;KCNB1;NPEPPS;ZIC1;GSK3B;BCAS3;HPS4;UBR5;MAVS;PCM1;JUP;PLK3;SEC16A;SAE1;UBE2D3;HSPA1L;C2CD5;EMD;CEP131;ERBB2;MIEF1;ITGB1BP1;TMEM30B;PPP3CC;CHP1;ZC3H12A;ZDHHC2;ARIH2;SH3GLB1;BAG3;BAP1
prerank,DNA replication (GO:0006260),0.4473914350710089,1.2669044498015352,0.1492361927144536,0.8452818803564988,1.0,45/105,26.27%,REV3L;EXO1;MCM7;RAD17;WRN;MCMBP;MCM2;ATM;TOP1;CLSPN;IGHMBP2;TBRG1;CDC45;BAZ1A;CHEK1;POLG2;POLB;RNASEH2A;POLE2;MCM9;KIN;RBBP8;RPA1;RMI2;TOP3A;RECQL5;BARD1;NBN;TICRR;ATR;TOPBP1;RFC1;REV1;HELB;POLA1;RAD9B;RAD50;TOP1MT;CDK2;RFC5;BRIP1;KAT5;ORC3;FAM111A;CDK2AP1
prerank,positive regulation of neuron migration (GO:2001224),-0.5509374781958064,-1.2661375609959227,0.21271393643031786,0.6224423044395416,1.0,4/11,11.35%,SEMA6A;RAPGEF2;DAB2IP;MDK
prerank,estrogen metabolic process (GO:0008210),0.588283075451619,1.2660461319432974,0.2035541195476575,0.8468656678371841,1.0,2/15,4.55%,CYP1B1;SULT1A1
prerank,nuclear migration (GO:0007097),0.6157111797735482,1.266016150089599,0.19516129032258064,0.8455431593934689,1.0,8/13,17.94%,DOCK7;PAFAH1B1;CLMN;PCM1;FBXW11;SYNE2;HOOK3;TMEM201
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5510779118975846,-1.2659123100475878,0.21768707482993196,0.6209091853471441,1.0,2/11,1.40%,LYN;MFHAS1
prerank,positive regulation of protein metabolic process (GO:0051247),0.44474040705945284,1.265826632079514,0.14404761904761904,0.8448848201373266,1.0,19/110,8.47%,WWP1;FZR1;NEDD4;GPC3;WWP2;KLF4;INHBA;GSK3B;AGTR1;EIF4G1;VCP;STX5;CD80;ISL1;CLU;IDE;ASB9;NSF;CDKN1B
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.602968009669613,1.2656957995481202,0.20853858784893267,0.8440033485927305,1.0,9/14,26.38%,SEC24B;SEC23A;SEC31A;SEC13;SEC24D;RAB1A;SEC24A;MIA3;TBC1D20
prerank,mitochondrion localization (GO:0051646),0.5867970606627676,1.2655078635304295,0.2171875,0.8433236585579738,1.0,4/19,7.72%,MARK1;MEF2A;TLE6;MARK2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.43288411809876753,1.265212021823131,0.13595505617977527,0.8429892396165047,1.0,15/142,5.80%,SLC35G1;PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;ATP2B4;PTGER1;ESR1
prerank,regulation of signal transduction (GO:0009966),0.4248113570220613,1.2651060054349386,0.10687022900763359,0.8419433109799782,1.0,40/190,12.58%,RSPO3;PLCE1;TCF7L1;GRK5;CD55;MGLL;SULF1;IGFBP5;UBASH3B;ZIC1;ELF1;MDFIC;HHIP;FOXL1;PTPN2;NCK2;CD80;CREBBP;ESR1;GDNF;CLU;PLSCR1;GAS1;LRIT3;GDF5;SOCS2;FRMPD1;RORA;CD46;SIK2;ACVR1;IGFBP6;GALNT11;SRMS;TIMP1;CBFB;ITGB1BP1;USP33;CSK;CASTOR2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.522607856705192,1.2649733221066168,0.1986206896551724,0.8410379682900823,1.0,8/33,9.13%,THBS1;MEOX2;KLF4;FGF2;ATP2B4;JUP;RHOA;STARD13
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4669294180490543,1.264582775355333,0.17575757575757575,0.8410711027749961,1.0,9/77,6.64%,THBS1;BMP4;TCF7L2;TGFBR1;NR4A2;ITGAV;GATA4;CLU;BIRC6
prerank,substrate-dependent cell migration (GO:0006929),0.5915166510799962,1.2642586044538637,0.2304,0.8408706547302622,1.0,3/14,5.51%,NTN1;NRP1;SHTN1
prerank,ATP transport (GO:0015867),-0.5588828450569272,-1.2641980582237036,0.20422535211267606,0.6235561473515903,1.0,2/10,5.11%,ABCC6;CD47
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.45269066457079626,-1.2637978290550267,0.17302052785923755,0.6225936095287434,1.0,9/26,12.17%,SHANK3;NRXN1;RIMS1;RIMS2;APP;PRKCZ;GRIN1;TMEM108;CUX2
prerank,cell junction maintenance (GO:0034331),-0.5110737637468812,-1.2637693075148317,0.19294117647058823,0.6205701340868616,1.0,6/14,23.89%,CLDN1;CSF1R;MYADM;CHCHD10;PRTN3;F2R
prerank,response to calcium ion (GO:0051592),0.45401275178714606,1.263704901590611,0.13736903376018628,0.8413269596998734,1.0,18/102,12.45%,THBS1;CLIC4;KCNMB3;KCNMB2;NEDD4;PPP3CA;CAMK2D;ADAM9;MEF2A;CASR;DMTN;SYT8;IQGAP1;PLCG2;CARF;SEC31A;ADD1;CPNE3
prerank,positive regulation of filopodium assembly (GO:0051491),0.5484566001277277,1.2634125810446883,0.18973561430793157,0.8409457680220203,1.0,7/24,6.03%,DPYSL3;ARAP1;TGFB3;PALM;NRP1;BCAS3;RHOQ
prerank,positive regulation of glycolytic process (GO:0045821),0.5511180665097445,1.2634081120977405,0.21518987341772153,0.8381737409880169,1.0,1/20,0.03%,SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5511180665097445,1.2634081120977405,0.21518987341772153,0.8381737409880169,1.0,1/20,0.03%,SLC4A4
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4916427553506274,-1.263340294340991,0.18518518518518517,0.6196743083477618,1.0,9/16,21.02%,AUTS2;ARHGAP24;RASGRF1;STMN3;CADM4;GABARAP;PIK3CG;ARF6;KBTBD7
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5120826814989577,1.2631279072980832,0.17475728155339806,0.8378494012537253,1.0,3/38,3.24%,THBS1;BMP5;GSK3B
prerank,DNA geometric change (GO:0032392),0.5514556625541871,1.2624204345794734,0.21076923076923076,0.8390021106050717,1.0,10/24,21.85%,ANXA1;WRN;DDX11;DHX9;MCM9;RECQL5;NBN;DHX36;DDX1;RAD50
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4594476658725961,1.2620299643119537,0.15671641791044777,0.8389492760507083,1.0,15/85,9.82%,PLCE1;ARHGEF28;NGF;AKAP13;ARHGDIB;SHC1;ARHGAP44;NOTCH2;BCR;SHOC2;RDX;ARHGAP17;KANK2;STARD13;ERBIN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5039080196276282,-1.2619150886644264,0.1793478260869565,0.621453928069832,1.0,2/15,4.83%,IGF1;BCL2L1
prerank,negative regulation of protein polymerization (GO:0032272),0.5369649651747177,1.2613433598896049,0.2018348623853211,0.839973498116738,1.0,2/27,2.06%,SLIT2;PRKCD
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4018919628527599,1.261022352742387,0.0,0.8397710072154992,1.0,366/1646,17.26%,BNC2;FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;WWP1;CDH1;VSX1;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;ZFPM2;TCF7L2;SLTM;PLAGL1;MAP3K5;PRRX2;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;MLLT3;LRP6;FOXN3;DDX5;TCIM;RBFOX2;CAMK2D;TGFB3;PBX1;KLF3;FOXP4;CUX1;WNT11;NFIA;NFAT5;SMAD6;GLI3;FOXO3;HDAC9;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;ANXA4;GCLC;PURG;HOXB6;WWP2;TCF20;USP13;ESR2;SHC1;KLF4;JMJD1C;NFE2L2;INHBA;ZNF148;PRICKLE1;ZIC1;FGF2;FZD7;ELF1;CRY2;RCOR3;PRRX1;ZNF423;MDFIC;ERC1;ABL1;NR2F1;FOXC2;ID1;MEF2A;KLF7;L3MBTL3;JDP2;HOXA6;TGFBR1;GLIS1;BTAF1;EFEMP1;EHF;NR4A3;FOXL1;NR4A2;PDCD4;SP140;FOXK1;PHC2;HDGFL3;KAT6B;ARID4A;SAMD7;DDX17;KLF10;ZBTB7B;HOXC6;ATP2B4;CD80;FOXO6;NFATC4;TLE2;BHLHE40;ARID4B;BRD3;KLF9;GLIS2;CREBBP;ISL1;CCNL2;HMG20A;ESR1;MNAT1;SCMH1;STAT3;ATF1;SPINDOC;HOXB3;KDM1A;E2F5;MBD1;GATA4;DDIT3;BAMBI;HOXB5;TBL1X;TASP1;TADA3;NFIL3;HIF3A;E2F3;TRIM44;TGFB1I1;HOXC4;TRRAP;ELP3;DMRT3;GDF6;MYOG;DMBX1;NOBOX;IL10;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;ID2;LCOR;IRF1;NFIX;MBTD1;REL;SRCAP;SIX4;TEAD1;CRABP2;EHMT1;CHEK2;FUS;FZD1;PITX2;IGSF1;MLXIP;MDM4;HIVEP3;PIAS2;CAMTA2;CDKN1B;NLK;RXRA;ZNF8;GRHL2;ATOH8;ATP8B1;FOXC1;CIPC;NFYA;RORA;PIAS3;SERTAD3;PHF12;GLI2;CHUK;EGR2;NFKB1;NIBAN2;BAZ2B;MED13;FBXW11;TOX4;BCLAF1;GATA1;CTCFL;CCNL1;HOXB4;MED27;ATF7;RARA;CBX5;ACVR1;PIM2;DKK3;LIMS1;JUN;LBX1;MTDH;NFE2L1;NRF1;VEGFA;WAC;CARF;ELF3;FOXE1;ZNF25;BRCA2;PRDM15;NCOR1;ZBTB32;MYNN;LRP5;GON4L;PER1;SMAD2;ATF6;ERBB2;MXD1;EED;GTF2IRD1;RB1;NFKB2;BPTF;RNF111;USP47;SP110;FOXK2;RGMB;CBFB;BRD9;ATOH7;HTATIP2;ID4;NKX2-1;AATF;KDM3B;ELOA;NIPBL;BCL11B;KAT2A;NR4A1;HIRA;CDC45;NR6A1;SMARCA4;UIMC1;BAZ1A;CTR9;ATRX;KMT2D;NFATC3;MXD4;TCF3;PPM1A;SETD5;HNF4A;HNF1A;RFX2;XRCC5;PAX6;EP300;ERN2;CHD3;HCFC1;CC2D1B;NCOR2;SP3;E2F2;BAP1;GPBP1;GCFC2;EBF4;ZXDC;PRMT6;NFATC1;HDAC10;REST;ZNF691;ETV3;DHX9;FOXD2;MED14;GPBP1L1;STAT5A;ELP4;CNOT7;CDK11B;URI1;CREB3L1;ATF2;RFX7;CDK16;ZBTB1;HOXD3;KDM2A;BAZ2A;PCGF1;TWIST1;ZNF585B;ZNF585A;MAP2K2;HINFP;PML;EPC1;TFAP2A;THRAP3;WWTR1;BRWD1;ZNF219;ZBTB7A;TRIM16;HSF2;BCL6;ZFP1;CREBL2;CALCOCO1;RBBP8;JMJD6;POU6F1;ZMIZ1;SMARCAL1;PRDM5;MED24;RRM2;NAA15;NSD1;HR;RNF14;YY1;RET;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;SBNO2;POU3F4;HOXA2;BCL10;SREBF1;PITHD1
prerank,L-amino acid transport (GO:0015807),0.5251145430664196,1.2609352203697926,0.1793400286944046,0.8387033602284143,1.0,1/28,0.04%,SLC38A2
prerank,peptidyl-lysine modification (GO:0018205),0.44756947528512897,1.260920222159518,0.13727810650887573,0.8373674960959774,1.0,31/99,20.88%,HDAC4;PLOD2;HDAC9;LOXL1;NUP93;TRPM4;P3H4;PIAS2;SAE1;PIAS3;EGR2;RANBP2;IFIH1;NUP153;EP300;HDAC10;SENP5;P3H3;LOXL4;ETFBKMT;NUP214;KAT2B;LIPT2;NUP188;LOX;NUP88;PIAS1;NDUFAB1;SENP3;SENP1;NUP98
prerank,cell projection assembly (GO:0030031),0.5513457926095592,1.2608733697326284,0.1963470319634703,0.8361682502248764,1.0,6/22,10.18%,RHOJ;GSN;PARVA;RHOQ;PDGFA;NCKAP1
prerank,metal ion transport (GO:0030001),-0.336341766330523,-1.2604614423126301,0.0784313725490196,0.6236504608450572,1.0,27/86,15.94%,ITPR1;CACNA1D;CACNA1E;TRPC3;CALCRL;SLC8A1;RYR2;SLC39A8;ATP2C1;TPT1;SLC41A1;CACNA1B;CACNA2D1;CACNG7;TRPC4;MMGT1;SLC30A1;RAMP2;CAMK2A;NDFIP2;TRPC1;SLC3A2;GRIN3A;SELENOK;TRPV4;CCR5;ATP2A3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.502401114685202,-1.2602319632655354,0.17473118279569894,0.6222515185641303,1.0,9/17,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME;ATP5MC3
prerank,striated muscle tissue development (GO:0014706),0.5347830301640704,1.2591654993342587,0.20223152022315202,0.8408025319147161,1.0,4/29,1.77%,SIX1;SGCD;BMP5;CSRP3
prerank,sphingosine metabolic process (GO:0006670),0.5722727176933703,1.2589355607191985,0.21474358974358973,0.8402708050382398,1.0,2/17,2.22%,ACER3;PLPP3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6063783131167816,1.258827607052804,0.22203389830508474,0.8392616533943675,1.0,5/14,12.36%,ATP1B1;WNK1;DMD;SLC9A1;CHP1
prerank,regulation of vasculature development (GO:1901342),0.5384137320957162,1.2583641521553075,0.1997126436781609,0.8395426868271435,1.0,6/26,11.90%,BMPER;FGF2;NF1;PROK2;ERBB2;HTATIP2
prerank,amino acid transport (GO:0006865),0.4836251993493385,1.2582908884773676,0.180349932705249,0.8384337286367634,1.0,5/49,7.03%,SLC38A2;SLC38A1;SLC38A6;SLC7A2;SLC6A19
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3584817503559459,-1.2573381549351796,0.08181818181818182,0.6283421236293735,1.0,13/72,4.05%,FLT1;IGF1;IGF1R;LYN;TEK;PDGFD;PIK3R1;PDGFRB;KIT;DCN;KDR;INSR;ROR2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3972057070391931,-1.2569636045574832,0.15384615384615385,0.6272260945303555,1.0,18/40,28.65%,IGF1;BCL2L1;TNFSF10;PDCD5;BMF;AKT1;BIK;TRIAP1;GPER1;DNM1L;PLAUR;PMAIP1;PYCARD;MFF;MLLT11;PINK1;HRK;BCL2L11
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6393697959927158,1.2568888355952137,0.2545757071547421,0.8406753504372992,1.0,3/10,7.16%,WNK1;KLF4;IL10
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6393697959927158,1.2568888355952137,0.2545757071547421,0.8406753504372992,1.0,3/10,7.16%,WNK1;KLF4;IL10
prerank,positive regulation of protein modification process (GO:0031401),0.4212606749343509,1.256871385328317,0.11231101511879049,0.839394214942059,1.0,17/203,3.61%,EGFR;BMP4;SLCO3A1;CARD14;TRABD2B;NTRK3;SOX9;RAMP1;PGF;CCN1;EFNA5;PRKCD;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.48313102587573475,1.2564464369738266,0.1723684210526316,0.8395975801746073,1.0,14/49,17.26%,THBS1;NR4A3;RAB7B;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;KMT2D;EP300;PRMT6;KAT2B;PITHD1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.43547761847702304,-1.2560211505698702,0.1476923076923077,0.6278900033342927,1.0,5/28,8.96%,ARHGAP28;ESAM;CXCL12;PAK3;COTL1
prerank,regulation of protein transport (GO:0051223),0.5247794188768837,1.255857666559523,0.21706586826347304,0.8403441085561678,1.0,9/27,14.14%,DISP1;WWP2;NDEL1;P3H1;DNAJC1;GAPVD1;SNX12;CHP1;ARFIP1
prerank,regulation of DNA metabolic process (GO:0051052),0.49456670304689365,1.255655128566884,0.18281036834924966,0.8397025639948255,1.0,17/44,21.49%,SMG6;HDAC8;KPNA1;PDGFA;GRHL2;USP1;SMG1;XRCC5;WDR18;NBN;YLPM1;TICRR;UBE2N;HELB;WDR70;TOM1L1;MPV17
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5275148497297455,-1.2556364049486892,0.19451371571072318,0.6269723648303026,1.0,5/12,9.25%,UNC13C;RIMS1;RIMS2;SYT7;SYT1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5897786335534654,1.2554919834572564,0.2048780487804878,0.8389782762440273,1.0,1/15,0.24%,EGFR
prerank,fatty acid transport (GO:0015908),-0.478473676813355,-1.2552144715926665,0.18932038834951456,0.6260760153756323,1.0,7/17,18.23%,ACSL1;APOE;PPARD;FABP5;MFSD2A;GOT2;SLC27A1
prerank,ceramide biosynthetic process (GO:0046513),-0.403806260385868,-1.2551362061344904,0.15658362989323843,0.6241805195793567,1.0,9/40,12.05%,ST6GALNAC3;CERS4;ST8SIA4;SGMS1;DEGS2;ST8SIA6;SPTSSA;CERS1;CERS2
prerank,actin filament bundle assembly (GO:0051017),0.5124470552091023,1.2548566696911045,0.20391061452513967,0.8399562868784709,1.0,8/33,6.54%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,sodium ion export across plasma membrane (GO:0036376),0.603976937508283,1.2546956629370065,0.23220338983050848,0.8391560094481212,1.0,6/13,8.86%,SLC4A4;ATP1B1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,protein localization to microtubule organizing center (GO:1905508),0.6047718844358625,1.2546309194511271,0.2432,0.8380091197271453,1.0,11/15,29.62%,PCM1;CEP131;PIBF1;STIL;HOOK3;C2CD3;CSNK1D;CCDC14;CEP192;BBS4;CEP83
prerank,regulation of mitotic cell cycle (GO:0007346),0.42440694470091056,1.2542382506601097,0.11386696730552424,0.8380455523755367,1.0,51/171,22.25%,SMOC2;FZR1;PTPN3;USP2;NEK7;TTC28;ANAPC5;CCDC8;CDC25B;PSMB2;CDC16;GAS1;GBF1;IL10;ANAPC16;CDKN1B;FOXC1;IQGAP1;PIM2;BTG3;PSMC6;RB1;ANGEL2;PKN2;PSMD11;TMEM8B;UBE2S;PSMD1;CDK11B;PRKCA;ERCC3;CUL1;MAD2L1;CDK13;PSMC1;PSMD7;HECA;CDK10;USP22;NEK6;PSMD14;TRIM35;SCRIB;PSMD3;PDXP;FOXA1;CUL7;ANAPC11;ANAPC10;THAP1;PRMT5
prerank,regulation of cytokinesis (GO:0032465),0.4618808597019751,1.2540414983390549,0.16180048661800486,0.8373016272866102,1.0,19/78,13.96%,CIT;KIF13A;GIPC1;PRKCE;RAB11FIP3;BECN1;CDC25B;BIRC6;SETD2;PLK3;KLHL13;CDC14A;RHOA;AURKA;DRD3;ENTR1;PKN2;SH3GLB1;CUL3
prerank,gliogenesis (GO:0042063),0.592803896744369,1.2533378487471514,0.25370675453047775,0.8384046372034872,1.0,3/15,2.62%,NFIB;ANXA1;CD9
prerank,protein deubiquitination (GO:0016579),0.41742870053270653,1.2532941598211373,0.09619450317124736,0.8372086706733665,1.0,98/242,27.03%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;PSMB2;TRRAP;MDM4;USP34;USP49;RHOA;USP15;IL33;USP25;RAD23B;USP1;PSMC6;USP10;USP32;DESI2;CLSPN;USP7;SMAD2;OTUD7B;USP47;COPS5;FOXK2;USP4;USP33;KAT2A;ZC3H12A;UIMC1;IFIH1;ZRANB1;JOSD1;EP300;HCFC1;PSMD11;BAP1;POLB;TNIP1;PSMD1;OTUD3;OTUD5;KAT2B;IKBKG;VCPIP1;YY1;PSMC1;PSMD7;USP28;BARD1;INO80;WDR48;USP22;USP9X;BIRC3;UFD1;USP40;TRAF3;PSMD14;RNF123;PSMD3;USP21;USP36;SMAD4;GATA3;HGS;USP48;RHOT1;ASXL2;BRCC3;STAMBP;CDC20;SMAD7;TOMM20;ADRM1;MCRS1;USP3;PSMD12;MAP3K7;TRAF6;AR;MBD5;OGT;USP30;PSMD4;ASXL1;PSME3
prerank,negative regulation of signal transduction (GO:0009968),0.4133383777456334,1.2528889384910102,0.09947089947089947,0.8373577776693518,1.0,46/249,11.32%,EGFR;THBS1;NXN;TRABD2B;NTN1;BMP5;NEDD4;TCIM;PID1;PRKCD;GLI3;GPC3;SULF1;GRB10;IGFBP5;WWP2;UBASH3B;PALM;FGF2;LRPAP1;IRS1;HHIP;NR4A2;MDFI;PTPN2;VCP;SFRP4;TSKU;NOG;GLIS2;LRP1;GATA4;IL10;NLK;KANK2;MMP14;NIBAN2;DACT1;KIF7;IRAK3;ACVR1;DKK3;SRMS;MEGF8;ERBB2;RB1
prerank,cell-cell junction assembly (GO:0007043),-0.364758139357129,-1.2528734574091,0.09836065573770492,0.6285409772524249,1.0,16/63,6.57%,TJP1;GJB6;TLN2;CDH2;CLDN5;CDH8;EPB41L3;CDH10;GJB2;GJC1;GJD3;ARVCF;ACTB;GJA1;JAM3;TLN1
prerank,cellular response to fatty acid (GO:0071398),0.6119041013825801,1.2522638033415934,0.24875621890547264,0.8383685896064901,1.0,4/12,12.84%,PID1;IRS1;ZC3H12A;PDK3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.39941989336923817,1.2511269352876693,0.007,0.8410160108280315,1.0,170/807,14.22%,FOXP2;FOXP1;BMP4;KLF12;WWP1;ZFHX3;ZFPM2;TCF7L2;RARB;SOX9;FOXD1;HDAC4;PRDM6;FOXN3;DDX5;EZR;RBFOX2;FOXP4;CUX1;WNT11;GLI3;FOXO3;HDAC9;ZBTB16;HES1;TWIST2;SKIL;GCLC;WWP2;USP2;ESR2;SHC1;KLF4;BMP6;ZNF148;PRICKLE1;CRY2;RCOR3;ZNF423;MDFIC;NR2F1;FOXC2;ID1;MEF2A;KLF7;L3MBTL3;JDP2;GLIS1;BTAF1;NR4A3;NR4A2;PDCD4;TCF25;MDFI;FOXK1;PHC2;KAT6B;ARID4A;SAMD7;SMYD2;KLF10;ZBTB7B;TLE2;HDAC8;BHLHE40;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;ESR1;SCMH1;STAT3;SPINDOC;KDM1A;MBD1;DDIT3;TBL1X;NFIL3;PHF21A;DLG1;DMBX1;SOX14;ID2;LCOR;IRF1;NFIX;MBTD1;SIX4;EHMT1;PLK3;MDM4;CDKN1B;RXRA;ZNF8;ATOH8;ATP8B1;FOXC1;CIPC;KANK2;ZMYM5;PHF12;UBE2D3;GLI2;PER3;NFKB1;NIBAN2;FBXW11;BCLAF1;DACT1;IL33;GATA1;RARG;RARA;CBX5;DKK3;LIMS1;JUN;MTDH;VEGFA;ELF3;FOXE1;ZNF25;NCOR1;ZBTB32;TCERG1;PER1;MIER1;SMAD2;OTUD7B;MXD1;EED;GTF2IRD1;RB1;BPTF;USP47;FOXK2;DCAF1;CBFB;MTA1;ID4;NKX2-1;NIPBL;NCOA5;NR6A1;SMARCA4;UIMC1;CTR9;MXD4;TCF3;PPM1A;HNF4A;XRCC5;PAX6;EP300;ERN2;CHD3;HCFC1;NCOR2;SP3;VPS72;PRDX5;RNF2;BAP1;GCFC2;PRMT6;HDAC10;REST
prerank,cellular protein metabolic process (GO:0044267),-0.3015370867908681,-1.250909018127049,0.0,0.6318955765098289,1.0,103/396,13.32%,CP;IGF1;LTBP1;IGFBP2;IGFBP7;CDH2;SPARCL1;APOE;ST3GAL1;ST3GAL6;ST8SIA4;MSRA;IGFBP3;PAPPA;RPS14;CTSH;CST3;ITIH2;CSF1;IGFBP4;EEF1A1;RPL38;TNC;RPLP1;APP;RPS9;RPL21;LGALS1;RPS13;PLAT;RPL41;VWA1;RPL37A;RPLP2;RPS21;NOTUM;RPL27A;DAB2IP;RPS29;LAMB1;RPS19;RPL34;RPS3;RPS8;RPN2;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;SERPIND1;RPS27;RPL30;RPL37;RPS11;QSOX1;RPS24;RPL19;ADORA2A;RPL18;GATA6;SPP1;RPL18A;GAS6;CHRM3;F5;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;PDIA6;RPL26;RPL35A;MRPL3;RPS18;LGMN;RPL11;RPL13A;RPL7;CSF2RA;RPL36;RPS17;RPL32;APH1B;RPL39;RPL14;SPCS3;MSRB1;HSP90B1;MMP2;ERO1A;FAM20C;RPS2;MFGE8;RPL8;LTA4H;RPL24
prerank,peroxisomal membrane transport (GO:0015919),0.5276938810939902,1.2508472740116572,0.21407185628742514,0.8406453471210253,1.0,9/27,23.92%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;SLC25A17;PEX2;PEX7;PEX26
prerank,superoxide metabolic process (GO:0006801),0.5239553153512164,1.2507505564219032,0.22998544395924309,0.8397048694274306,1.0,1/29,0.12%,SH3PXD2A
prerank,regulation of tissue remodeling (GO:0034103),-0.47816831998449943,-1.2502646665827224,0.1712707182320442,0.6315180374718,1.0,6/18,11.35%,LEPR;CST3;SYT7;IL18;FLT4;MDK
prerank,T cell differentiation in thymus (GO:0033077),0.5885797477474304,1.25006409775526,0.23519736842105263,0.8407528691643474,1.0,2/14,9.09%,GLI3;RIPK3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4663787852332153,1.2500402502368222,0.18250950570342206,0.8395224498877466,1.0,9/75,4.28%,F3;BMP4;PGF;NRAS;FGFR1;FGF2;NRP1;TGFBR1;AGTR1
prerank,amino acid import across plasma membrane (GO:0089718),0.5412682890420469,1.249865939596649,0.2303120356612184,0.8387943649981822,1.0,1/24,0.02%,SLC47A1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5831422805997145,1.249829460902255,0.2483221476510067,0.8375968003663126,1.0,5/15,17.09%,TCF7L2;GSK3B;EMD;BAG3;XPO4
prerank,myeloid cell development (GO:0061515),0.5679166327273951,1.2490269751452454,0.23604465709728867,0.8390850486915226,1.0,4/18,9.70%,FOXP1;ANXA2;DMTN;GATA1
prerank,macrophage activation (GO:0042116),0.505870310957702,1.248612582489042,0.19444444444444445,0.8391901157329466,1.0,6/34,9.84%,FOXP1;LBP;CLU;IFI35;TLR4;PLCG2
prerank,endothelial cell development (GO:0001885),-0.44876953241974643,-1.2486032758113486,0.16863905325443787,0.634211828073222,1.0,12/25,9.84%,COL22A1;PECAM1;COL18A1;RAPGEF3;PPP1R16B;RAPGEF2;COL15A1;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,early endosome to late endosome transport (GO:0045022),0.5519454868411106,1.2481728093971465,0.2318181818181818,0.8394352376130224,1.0,12/20,25.05%,EEA1;BECN1;ANKRD27;STX8;KIF16B;WDR81;HOOK3;SNF8;RAB5A;EMP2;HOOK2;RAB7A
prerank,negative regulation of locomotion (GO:0040013),-0.5272241044942998,-1.2479353302967238,0.21921182266009853,0.6341458854466946,1.0,3/12,2.97%,FRMD5;SPOCK3;FBLN1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4664925582201728,1.2479041049371438,0.15920398009950248,0.8390561096945671,1.0,11/73,10.34%,EGFR;NTRK3;NGF;CD44;DOCK7;EIF4G1;ATP2B4;RIPK2;BCAR3;AKAP9;VEGFA
prerank,regulation of cellular protein catabolic process (GO:1903362),0.575119590859624,1.2476326877334813,0.20733652312599682,0.8386733334616319,1.0,5/18,9.55%,EZR;NELL1;RDX;RGP1;DACT1
prerank,ether lipid metabolic process (GO:0046485),0.5911700242840496,1.2474501251663068,0.23113964686998395,0.8380042552972253,1.0,5/14,10.50%,NCEH1;PAFAH1B1;AGPS;PEDS1;GNPAT
prerank,regulation of dopamine secretion (GO:0014059),-0.43970730482123455,-1.2473066014913183,0.15339233038348082,0.6339493531486093,1.0,15/25,24.10%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,phosphatidylserine metabolic process (GO:0006658),-0.41788651205614646,-1.2467137533141266,0.1504424778761062,0.6334750887984374,1.0,6/32,8.25%,OSBPL8;PLA1A;SERINC5;OSBPL10;ABHD12;SERINC1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4304592586000564,1.2466704877274593,0.12040133779264214,0.8394716357606735,1.0,33/150,13.31%,SLIT2;RASSF2;NTRK3;LRP6;PID1;PRKCD;SMAD6;PLPP3;UBASH3B;NIBAN1;SPRED2;EIF4G1;NCK2;PMEPA1;DMD;NOG;DNAJC3;DMTN;KLHL31;IBTK;PARD3;PPEF2;NF1;LDLRAD4;SMCR8;RB1;CEP85;ITGB1BP1;CORO1C;CHP1;ZC3H12A;PAK2;PRKDC
prerank,endochondral bone morphogenesis (GO:0060350),0.6040050262658901,1.2465401752880447,0.24027072758037224,0.8386080555756217,1.0,1/11,0.28%,BMP4
prerank,regulation of actin filament polymerization (GO:0030833),0.46787659161670875,1.2462601062679555,0.18306351183063513,0.8381963606543699,1.0,15/69,13.07%,SLIT2;BAIAP2L1;CDC42EP5;PTK2B;PRKCD;PRKCE;NCK2;WASHC5;KANK4;NCKAP1;CTTN;FCHSD2;ARHGAP40;FCHSD1;SSH3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4940624910752071,-1.2434066508416408,0.193717277486911,0.6407877538905001,1.0,4/16,6.14%,CXCL12;BCL2L1;TPT1;RPS3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4291870137950294,-1.2432458757982647,0.16666666666666666,0.6390973469434029,1.0,9/25,15.10%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GLRA1;GSK3A;AKT1;ARRB2
prerank,positive chemotaxis (GO:0050918),0.5703787293549888,1.243024561576089,0.22778675282714056,0.8481068605611058,1.0,3/17,10.34%,MET;NRP1;VEGFA
prerank,superoxide anion generation (GO:0042554),-0.5257878572111175,-1.2429084783967206,0.20698254364089774,0.6379880057460114,1.0,5/13,17.91%,ALOX12;CYBA;NCF2;NOX4;TAFA4
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6085923351760218,1.2428942383405803,0.23578595317725753,0.8472578870953844,1.0,2/13,4.59%,PKD1;MDFI
prerank,synaptic membrane adhesion (GO:0099560),0.5860893236976533,1.242882078723088,0.23116438356164384,0.8459882412919812,1.0,3/14,8.24%,GPC6;PTPRF;GPC4
prerank,monoacylglycerol metabolic process (GO:0046462),0.5958579162589397,1.2426843883023344,0.24573378839590443,0.84540886883786,1.0,4/13,11.79%,MGLL;MOGAT3;ABHD6;DGAT2L6
prerank,glucose import (GO:0046323),-0.5267073009887973,-1.2425591369863858,0.17994858611825193,0.637011713135425,1.0,2/13,1.89%,SLC2A1;SORT1
prerank,O-glycan processing (GO:0016266),0.47964632873228646,1.2423758680223098,0.1662303664921466,0.8451977307830969,1.0,6/54,6.76%,ST3GAL4;B3GNT2;GXYLT2;GALNT15;GALNT13;MUC6
prerank,regulation of inclusion body assembly (GO:0090083),0.6152157428932548,1.2422508614845487,0.2539130434782609,0.8443267184099764,1.0,1/11,1.14%,SNCAIP
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.39537770896566304,1.2420701652891382,0.001,0.8436750396825707,1.0,381/1668,17.15%,FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;ZFPM2;TCF7L2;SLTM;MET;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;PKD1;SOX9;BMP5;ZIC4;FOXD1;HDAC4;HOXA5;PRDM6;LRP6;DDX5;CCN1;PPP3CA;EZR;CAMK2D;CSRP3;TGFB3;PBX1;KLF3;FOXP4;PID1;CUX1;NFIA;NFAT5;SMAD6;GLI3;FOXO3;HDAC9;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;ANXA4;SKIL;PURG;HOXB6;WWP2;TCF20;USP2;ESR2;KLF4;JMJD1C;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;ZNF148;ZIC1;FGF2;ELF1;CRY2;RCOR3;PRRX1;ABL1;NR2F1;FOXC2;ID1;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;TCF25;SP140;MDFI;ZFP64;FOXK1;MLLT10;HDGFL3;KAT6B;ARID4A;NCK2;DDX17;SMYD2;KLF10;BCAS3;ZBTB7B;HOXC6;ATP2B4;FOXO6;NFATC4;HDAC8;BHLHE40;ARID4B;BRD3;KLF9;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;CCNL2;MRTFA;ESR1;MNAT1;MED15;CDK12;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;HOXB5;TBL1X;RIPK2;TADA3;NFIL3;HIF3A;E2F3;PHF21A;MYSM1;PLSCR1;JAG1;DLG1;HOXC4;ELP3;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;MOV10;ID2;LCOR;TNRC6C;IRF1;JUP;NFIX;REL;SRCAP;SIX4;TEAD1;FUS;PLK3;TLR4;GABPB1;GABPB2;PITX2;MLXIP;MDM4;HIVEP3;PIAS2;CAMTA2;RXRA;THAP3;ZNF8;GRHL2;ATOH8;FOXC1;KANK2;ZMYM5;NFYA;RORA;PAXBP1;SLC9A1;PIAS3;PHF12;UBE2D3;GLI2;CHUK;PER3;EGR2;NFKB1;BAZ2B;SSBP3;MED13;TOX4;BCLAF1;DACT1;LPIN2;IL33;GATA1;CTCFL;CCNL1;RARG;HOXB4;MED27;ATF7;RARA;RBMX;CBX5;ACVR1;ATM;PPP1R12A;JUN;LBX1;MTDH;NFE2L1;NRF1;VEGFA;SLC30A9;APEX1;ARF4;CARF;ELF3;FOXE1;ZNF25;PRDM15;NCOR1;ZBTB32;MYNN;TCERG1;LRP5;BCL9L;PER1;MIER1;SMAD2;ATF6;ERBB2;OTUD7B;MXD1;EED;GTF2IRD1;KANSL3;ZBED4;RB1;NFKB2;BPTF;RNF111;COPS5;SP110;FOXK2;DCAF1;CBFB;ITGB1BP1;MTA1;BRD9;ATOH7;HTATIP2;ID4;NKX2-1;AATF;KDM3B;ELOA;NIPBL;BCL11B;KAT2A;NR4A1;HIRA;NCOA5;NR6A1;ZC3H12A;DDRGK1;SMARCA4;BAZ1A;CTR9;ATRX;KMT2D;NFATC3;MXD4;PPRC1;TCF3;PPM1A;HNF4A;HNF1A;PRKDC;RFX2;PAX6;EP300;CHD3;HCFC1;CC2D1B;TNFSF11;NCOR2;SP3;E2F2;VPS72;RNF2;CRTC1;EBF4;ZXDC;NFATC1;HDAC10;REST;ZNF691;TNIP1;ETV3;DHX9;FOXD2;CCND1;ZNF507;DNMT3A;MED14;STAT5A;ELP4;URI1;CREB3L1;ATF2;RFX7;ZBTB1;HOXD3;KDM2A;PCGF1;TWIST1;ZNF585B;ZNF585A;SQSTM1;GALR1;HINFP;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;BRWD1;ZNF219;KAT2B;ZBTB7A;AGO2;HSF2;BCL6;ZFP1;CALCOCO1;RBBP8;IKBKG;JMJD6;POU6F1;ZMIZ1;SMARCAL1;PRDM5;MED24;NSD1;HR;RNF14;YY1;CDK13;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;SBNO2;BRD8;POU3F4;HOXA2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4550914542707627,1.2414635442382562,0.1952141057934509,0.844443425923368,1.0,18/78,14.52%,FZR1;NFE2L2;PRICKLE1;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;PLK3;CSNK1A1;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;BCAP31
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42309286116631145,1.2413605300819477,0.14735658042744657,0.8434829339988617,1.0,27/140,9.40%,SLIT2;PLCE1;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;AKAP13;ARHGDIB;VAV2;ARHGAP44;ARHGAP31;BCR;SRGAP2;SRGAP3;TIAM2;ARAP2;TRIO;ITGAV;RHOQ;ARHGEF6;OCRL;ARHGAP17;RHOA;STARD13;ARHGAP5;GNA13
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4791306812031778,1.241025580508056,0.20662251655629138,0.8433156860830994,1.0,4/50,2.97%,THBS1;NGF;CD44;KLF4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3979073881750892,1.240946056455795,0.023023023023023025,0.8423205213776209,1.0,203/834,17.11%,MICAL2;EGFR;BMP4;KLF5;ZFHX3;SIX1;ZFPM2;TCF7L2;MET;PLAGL1;RARB;NFIB;SMAD9;PKD1;SOX9;BMP5;HDAC4;HOXA5;LRP6;CCN1;PPP3CA;CSRP3;TGFB3;PBX1;PID1;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;TCF20;KLF4;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;FGF2;ELF1;ABL1;NR2F1;FOXC2;MEF2A;KLF7;GLIS1;EHF;NR4A3;NR4A2;ZFP64;MLLT10;KAT6B;NCK2;DDX17;KLF10;BCAS3;HDAC8;GLIS2;CREBBP;ISL1;SKI;MRTFA;ESR1;CDK12;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;TBL1X;RIPK2;E2F3;MYSM1;PLSCR1;JAG1;HOXC4;MYOG;IL10;PHOX2A;IRF1;JUP;NFIX;REL;TEAD1;TLR4;GABPB1;GABPB2;PITX2;MLXIP;CAMTA2;RXRA;THAP3;GRHL2;ATOH8;FOXC1;RORA;PAXBP1;SLC9A1;GLI2;CHUK;EGR2;NFKB1;SSBP3;MED13;BCLAF1;LPIN2;IL33;GATA1;CTCFL;RARG;HOXB4;RARA;RBMX;ACVR1;ATM;PPP1R12A;JUN;NRF1;VEGFA;SLC30A9;APEX1;ARF4;ELF3;PRDM15;TCERG1;LRP5;BCL9L;PER1;SMAD2;ATF6;KANSL3;ZBED4;NFKB2;BPTF;RNF111;COPS5;FOXK2;ITGB1BP1;HTATIP2;NKX2-1;AATF;BCL11B;KAT2A;NR4A1;ZC3H12A;DDRGK1;SMARCA4;ATRX;KMT2D;NFATC3;PPRC1;TCF3;HNF4A;HNF1A;PRKDC;PAX6;EP300;HCFC1;TNFSF11;SP3;E2F2;CRTC1;NFATC1;REST;TNIP1;DHX9;FOXD2;ZNF507;MED14;ATF2;HOXD3;TWIST1;SQSTM1;GALR1;HINFP;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;KAT2B;AGO2;HSF2;CALCOCO1;IKBKG;JMJD6;ZMIZ1;MED24;YY1;CDK13;ZNF76;CREB3L3;SBNO2;BRD8
prerank,regulation of ruffle assembly (GO:1900027),-0.44951619791768704,-1.2407917725438,0.18980169971671387,0.639920792601419,1.0,6/23,13.71%,EPS8;ARHGAP24;EVL;EPS8L2;ABI3;PLEKHM1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5518545805348614,1.2405760311073386,0.2182890855457227,0.8410413337149575,1.0,4/23,6.69%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5518545805348614,1.2405760311073386,0.2182890855457227,0.8410413337149575,1.0,4/23,6.69%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5540337124237359,1.2389643842658808,0.24006359300476948,0.8452634636089184,1.0,4/18,6.04%,ABL1;RFK;AGTR1;GDNF
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5229317420448691,1.2388356700894418,0.2227204783258595,0.8444401128013697,1.0,13/30,21.01%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;CSNK2A2;RNF31;USP36;HUWE1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4002228425184653,1.2388040568174332,0.04853387259858443,0.8432572928075086,1.0,99/497,14.22%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SAMD4A;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HDAC9;ZBTB16;HES1;TWIST2;GCLC;IGFBP5;WWP2;SHC1;KLF4;ZNF148;PRICKLE1;GSK3B;CRY2;RCOR3;ZNF423;MDFIC;ID1;L3MBTL3;BTAF1;PDCD4;FOXK1;PHC2;PAIP2;KAT6B;ARID4A;SAMD7;KLF10;TLE2;BHLHE40;GLIS2;SCMH1;SPINDOC;KDM1A;MBD1;DDIT3;NFIL3;SYNCRIP;DMBX1;SOX14;ID2;IRF1;MBTD1;SIX4;EHMT1;CDKN1B;ATOH8;ATP8B1;CIPC;RAD17;PHF12;NIBAN2;TOB1;FBXW11;BCLAF1;RARA;CBX5;DKK3;LIMS1;JUN;ELF3;FOXE1;NCOR1;PER1;SMAD2;EED;RB1;USP47;FOXK2;WAPL;ID4;NKX2-1;NIPBL;SMARCA4;UIMC1;GTPBP4;HNF4A;XRCC5;ERN2;NCOR2;SP3;BAP1;GCFC2;PRMT6;HDAC10;REST
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5224006775698958,1.2387516743275686,0.2345132743362832,0.8421637080466661,1.0,8/31,20.58%,FZR1;DCUN1D5;UBE2S;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;RAB1A
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5100548121741709,-1.2373945208757235,0.2289156626506024,0.6472608469238254,1.0,6/12,24.22%,ASS1;ACLY;IDH2;ACO1;GLUD1;IDH3A
prerank,macrophage differentiation (GO:0030225),0.5924745468805825,1.2371190377157293,0.23548387096774193,0.8464987842123264,1.0,1/13,0.28%,BMP4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4991032108137345,1.2366490183740548,0.20567375886524822,0.8467765667849878,1.0,6/40,5.80%,EGFR;EDNRA;NTRK3;FGFR1;FGF2;ESR1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.48378936161081026,1.2365647079558635,0.1955617198335645,0.8458408048873375,1.0,10/52,6.71%,EGFR;EPB41L2;SORBS1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;AGR2;DLG1
prerank,protein localization to mitochondrion (GO:0070585),-0.52597024720221,-1.2356314479867394,0.23132530120481928,0.6501455246796441,1.0,8/11,40.71%,HK2;AKT1;COX18;RALA;PINK1;HK1;LRRK2;ISG15
prerank,carbohydrate biosynthetic process (GO:0016051),0.5605224630445925,1.2353882695718044,0.2352,0.8487046780165739,1.0,2/21,1.56%,ST3GAL4;FUT8
prerank,epithelial cell migration (GO:0010631),0.5009472420003344,1.2353340768492194,0.21128798842257598,0.8476420469985302,1.0,10/37,9.87%,FSTL1;FAT2;CYP1B1;GIPC1;ABL1;NRP1;KANK2;RHOA;STARD13;S100A2
prerank,peptidyl-proline modification (GO:0018208),0.5374553007697153,1.2353215621382285,0.22141823444283648,0.8464281982705558,1.0,3/25,6.59%,FKBP5;P3H2;NKTR
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5718679099710243,1.2348560015094756,0.22170542635658916,0.8467009359416852,1.0,5/17,11.11%,ANXA1;ANXA4;KLF4;IL10;OTUD7B
prerank,negative regulation of histone modification (GO:0031057),-0.5047211650896983,-1.234699383018437,0.21140142517814728,0.6508476978150112,1.0,7/14,19.98%,JARID2;SNCA;NOC2L;SET;CTBP1;AASS;SPHK2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5230422815521609,1.2346093364802102,0.23865300146412885,0.8462724988031426,1.0,2/29,3.19%,THBS1;INHBA
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3555212710306702,-1.2345233688748973,0.12135922330097088,0.6492810983841003,1.0,12/66,6.26%,ROBO1;MCC;PTPRM;MTSS1;NR2F2;TGFBR3;APOE;B2M;CDK6;DAB2IP;AQP11;SPARC
prerank,substantia nigra development (GO:0021762),-0.4005877391593661,-1.2333631069204989,0.1522491349480969,0.6506429727876192,1.0,12/37,14.73%,MBP;GNB4;MAOB;PLP1;ACTB;CALM1;ATP5PF;BASP1;COX6B1;DYNLL1;CALM3;TTBK1
prerank,nerve growth factor signaling pathway (GO:0038180),0.6321173370335111,1.2331217655293552,0.2674616695059625,0.8502226475269893,1.0,3/10,4.43%,NGF;RAP1A;KIDINS220
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42304216192452054,1.2330176702208238,0.1590909090909091,0.8493191091474329,1.0,19/140,10.21%,PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;GPR4;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;PTGER1;ESR1;LPAR4;P2RX2;P2RX4;DRD3;PROK2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.47645340111229784,1.232944120614649,0.20435967302452315,0.8483385575388107,1.0,14/52,12.78%,EGFR;SORBS1;ITGB1;PRKCE;ACSL3;ATP2B4;LRP1;PLS1;AGR2;DLG1;CNST;RANGRF;PTPN9;ZDHHC2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.44518850413753497,1.2326432906696032,0.17385943279901356,0.8480678401088624,1.0,30/80,24.33%,PLPP3;ERGIC1;RAB6A;ERGIC2;GOLPH3;GBF1;ARF3;KIF1C;NSF;KLC1;ARF4;COPA;ARCN1;COG3;ATP9B;SEC22B;ARFGAP1;ARFGAP3;COPG1;KIF3B;BNIP1;ZW10;RAB1A;NBAS;PITPNB;TMED3;KIF2C;SURF4;ATP9A;STX18
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5618552776751333,-1.2325661228576343,0.23556581986143188,0.6508583286795901,1.0,7/10,15.60%,GABRG3;GABRA2;GABRB2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5036424691591461,1.232118913583083,0.20953757225433525,0.8485878510868411,1.0,9/35,5.01%,NTRK3;BAIAP2L1;PTK2B;SEMA3E;ARHGDIB;NOTCH2;ABL1;NRP1;BCAS3
prerank,mesenchymal cell differentiation (GO:0048762),-0.3677602929429314,-1.2317506988536993,0.13157894736842105,0.6510437733590047,1.0,15/51,7.41%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;BMP7;NOTCH1;LOXL3;RBPJ;MEF2C;HIF1A;NOTCH4;BMP2;HEY2
prerank,ameboidal-type cell migration (GO:0001667),0.4716756718607752,1.2314911327661413,0.20772303595206393,0.8494877454838807,1.0,9/51,6.04%,CCN3;FAT2;SEMA3E;GPC3;SEMA3D;SEMA3C;SRGAP2;PDXDC1;GDNF
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5247999028856776,1.2305132868791349,0.23964497041420119,0.8514529083404135,1.0,4/27,5.27%,ANK2;CAMK2D;AHNAK;DMD
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.33647907231678176,-1.2305037023408205,0.1111111111111111,0.6523334673398633,1.0,26/75,18.01%,DCDC2;CTNNA2;MAP2;ANK3;DCC;CNTN4;ACTB;BAIAP2;APP;MEF2C;OPHN1;ZDHHC17;PLPPR4;PAK3;MFSD2A;BRSK2;DSCAML1;ADGRB1;LMTK2;NRCAM;APBB1;SLITRK5;NEFH;RAB3A;S100A6;SPTBN4
prerank,protein localization to plasma membrane (GO:0072659),0.42995967099831794,1.2302859514956426,0.15028901734104047,0.8509905815281201,1.0,26/129,10.05%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;NECTIN3;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;SEC16A;S100A10;C2CD5;FCHO2;EHD1
prerank,positive regulation of programmed cell death (GO:0043068),0.4029453599305593,1.2301369671535853,0.10864978902953587,0.8502592375293367,1.0,39/272,12.21%,SLIT2;BMP4;RASSF2;MAP3K5;HOXA5;NGF;CYP1B1;TGFB3;AKAP13;PAWR;FOXO3;VAV2;ANO6;CRADD;ITGB1;UNC13B;ABL1;IP6K2;TIAM2;SFRP4;GADD45G;TRIO;CLU;ARHGEF6;CALHM2;GNA13;BCLAF1;RARG;NF1;ATM;JUN;DIABLO;ATF6;ARHGEF5;ARL6IP5;TIAM1;UBE2Z;HTATIP2;SOS2
prerank,sulfur compound biosynthetic process (GO:0044272),0.44000362632653434,1.2299113453705162,0.16805721096543505,0.8497090086924401,1.0,12/104,6.43%,SLC26A2;ST3GAL4;UST;DSE;GCLC;B3GNT2;CHST13;PAPSS2;GLCE;CHST5;SLC10A7;B4GALT1
prerank,T cell proliferation (GO:0042098),-0.5084254258906469,-1.2294559217324041,0.23918575063613232,0.6531977171574065,1.0,5/13,19.01%,CADM1;CTPS1;PPP3CB;DOCK8;PIK3CG
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6390543021099659,1.229421663443575,0.2593984962406015,0.8500509194003125,1.0,4/10,9.89%,RARB;RXRA;RARG;RARA
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4769630492845777,-1.229237852797991,0.18271604938271604,0.651788653016765,1.0,7/16,16.62%,APOE;HIF1A;NOS1AP;NUS1;SCARB1;AKT1;GCH1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.48937265787253414,1.2290603692679012,0.21751025991792067,0.8500213190605292,1.0,10/44,12.85%,BAIAP2L1;CDC42EP5;PTK2B;GSN;PRKCE;NCK2;NCKAP1;CTTN;FCHSD2;FCHSD1
prerank,regulation of vasoconstriction (GO:0019229),0.5250045473606791,1.228473036480908,0.24283559577677225,0.8508012145983262,1.0,4/27,4.96%,KCNMB2;ADRA1B;AGTR1;TRPM4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4700202194710543,-1.228424595329951,0.2005813953488372,0.6520762512572135,1.0,3/21,3.39%,OSBPL8;PLA1A;OSBPL10
prerank,protein localization to cell periphery (GO:1990778),0.425111751874595,1.2282594787426357,0.16132723112128147,0.8503046689284084,1.0,27/133,10.05%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;ARL3;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;RABEP1;SEC16A;S100A10;C2CD5;FCHO2;EHD1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4896462813865813,-1.2282550425119143,0.18882978723404256,0.6505413017684304,1.0,5/14,14.66%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5314982133304408,-1.228066806080107,0.23114355231143552,0.647113303641475,1.0,2/12,5.49%,IGF1;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5314982133304408,-1.228066806080107,0.23114355231143552,0.647113303641475,1.0,2/12,5.49%,IGF1;AKAP6
prerank,dendritic cell differentiation (GO:0097028),-0.43986860879666106,-1.2273818542800925,0.1813186813186813,0.6470685407187513,1.0,9/22,26.04%,LYN;GAS6;AXL;CCL19;FLT3;PRTN3;TREM2;BATF;IRF8
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5479100989289428,1.2269277401978191,0.2391653290529695,0.85370030246846,1.0,7/19,9.82%,CLIC4;DLG2;DLG1;MARK2;PATJ;PARD3;ERBIN
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.44965895724102556,1.226922264819006,0.20998719590268886,0.8524732880782763,1.0,15/73,15.29%,THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6060371878850983,1.2265029138807715,0.26833631484794274,0.8526520802602814,1.0,2/11,7.43%,EZR;RDX
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.507881731222264,1.226364476528238,0.22028985507246376,0.8518963747632677,1.0,7/32,6.70%,THBS1;SEMA3E;PHLDB2;FAM107A;BCAS3;DMTN;JAG1
prerank,glutathione biosynthetic process (GO:0006750),0.6022080005542351,1.226214290809045,0.2622673434856176,0.8511772843680402,1.0,1/11,2.63%,GCLC
prerank,response to lipid (GO:0033993),0.4290069682733728,1.226077980347762,0.18845700824499412,0.8503720737664704,1.0,19/105,9.96%,FOXP1;SOX9;LBP;ANXA1;SMAD6;FOXO3;ALPL;ESR1;STAT3;SLPI;SOCS2;TLR4;STRN3;RXRA;SCD;RARG;ERBIN;RARA;IRAK3
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4738644467060311,-1.2259871531714912,0.19518716577540107,0.6490314270688925,1.0,4/18,4.27%,SLC2A1;OCLN;PRKAG2;PRKCB
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4263486201526611,-1.225704261477256,0.2022792022792023,0.6479444617233816,1.0,6/27,10.55%,GPCPD1;ENPP2;ENPP6;ABHD12;INPP5F;PNPLA8
prerank,response to X-ray (GO:0010165),0.580583965815782,1.2254739670904298,0.25,0.8511768055008576,1.0,4/14,13.35%,ANXA1;ATM;NIPBL;XRCC5
prerank,stabilization of membrane potential (GO:0030322),0.5562778782295388,1.2253218143950935,0.23557692307692307,0.8504797408925308,1.0,1/16,0.19%,KCNK5
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.47124844579784114,1.2251633248189946,0.20295698924731181,0.8498204008418366,1.0,11/47,13.70%,DOCK5;EFNA5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2;ITGB1BP1;CORO1C;TRIOBP
prerank,skeletal muscle tissue development (GO:0007519),0.5048596702365296,1.2245192388014519,0.22594142259414227,0.8508483719488615,1.0,6/32,9.27%,SIX1;CSRP3;SKI;MYOG;SIX4;EGR2
prerank,keratan sulfate catabolic process (GO:0042340),-0.5350406764488613,-1.2244113883289405,0.23284313725490197,0.649658061014794,1.0,7/11,16.83%,FMOD;OGN;LUM;OMD;HEXB;PRELP;GALNS
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4893648356152259,1.2239039643882463,0.20170454545454544,0.8517576353601476,1.0,7/40,3.97%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,regulation of transport (GO:0051049),-0.3948500604984408,-1.223630997588129,0.1518987341772152,0.6498762660653882,1.0,6/36,7.40%,LEPR;EPB41;ICA1;ACTB;MYO6;SNCA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.405124012755694,-1.2234904319316824,0.18900343642611683,0.6483377080775573,1.0,9/34,11.32%,MFHAS1;NEDD4L;PICALM;RIPOR2;GPM6B;ANKRD13A;MAPT;ACTN2;ROCK2
prerank,negative regulation of cell projection organization (GO:0031345),-0.38595760464964113,-1.2232338067581034,0.16044776119402984,0.6471780532032141,1.0,16/48,14.77%,EFNB2;APOE;RAPGEF2;LPAR1;DCC;SPOCK1;GRIN2B;EPHA4;DENND5A;MAG;CRMP1;PTPRO;RTN4RL1;MYLIP;TRPV4;FKBP4
prerank,t-circle formation (GO:0090656),0.5989857332892778,1.2231176739306011,0.26837606837606837,0.8507399449109605,1.0,6/10,17.93%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5989857332892778,1.2231176739306011,0.26837606837606837,0.8507399449109605,1.0,6/10,17.93%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5989857332892778,1.2231176739306011,0.26837606837606837,0.8507399449109605,1.0,6/10,17.93%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,positive regulation of dendrite development (GO:1900006),0.6348224218561762,1.2230571929337937,0.2685025817555938,0.8497435131151942,1.0,2/10,1.25%,BMP5;COBL
prerank,regulation of endothelial cell proliferation (GO:0001936),0.447355484819785,1.2230065450466283,0.19112207151664612,0.8487145503104604,1.0,9/88,4.10%,F3;THBS1;BMP4;PGF;NRAS;SULF1;FGF2;NRP1;TGFBR1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4787119213669496,-1.222620007820771,0.20604395604395603,0.6470439044175328,1.0,5/16,14.71%,HS3ST5;TRIM14;TRIM62;NECTIN2;TRIM21
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5419680719900766,-1.2225883887638926,0.22149122807017543,0.6452114613591952,1.0,2/10,1.28%,ACSL1;SLC2A1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5973223880945809,1.2222556085651386,0.2606473594548552,0.8500605399680089,1.0,5/13,16.07%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,positive regulation of calcium ion transport (GO:0051928),-0.39042677111225826,-1.2220413323818533,0.21019108280254778,0.6447961079404964,1.0,10/36,10.70%,MYLK;PDGFRB;CACNA1D;TRPC3;CXCL12;ATP2B1;GRIN1;TRPC6;CAMK2A;P2RX7
prerank,regulation of protein kinase B signaling (GO:0051896),0.41355338132495806,1.2220186577301662,0.1499460625674218,0.8497099682095071,1.0,21/193,6.18%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;NTRK3;FGFR1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;PHLPP2;STRN;TGFBR1;CD80;GCNT2;ESR1;GATA4;DDIT3
prerank,relaxation of muscle (GO:0090075),0.5936237458589501,1.2219282713009367,0.2441077441077441,0.8487719967887752,1.0,6/13,8.78%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4;ATP1A1
prerank,calcium ion transmembrane transport (GO:0070588),0.44268415959655855,1.2213570834301155,0.19148936170212766,0.8495920341950952,1.0,21/86,13.76%,SLC35G1;SLC24A3;PKD1;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7;P2RX4;MCUB;MCU;MCOLN3;SLC8B1;PMPCB;YME1L1;GRIN2C
prerank,central nervous system neuron differentiation (GO:0021953),-0.40351960718437113,-1.2212147658570183,0.18275862068965518,0.645230457735362,1.0,11/33,9.22%,MAP2;GRID2;SPOCK1;TOX;MDGA2;OPHN1;NTRK2;ZC4H2;MAPT;FAIM2;PROX1
prerank,central nervous system development (GO:0007417),0.40129485203826487,1.220819335190691,0.13844515441959532,0.8502049114907206,1.0,28/250,8.61%,SLC23A1;WWP1;PBX3;DCLK1;VIT;ZFHX3;NFIB;PKD1;SOX9;ZIC4;ADGRL2;PDGFC;SMO;PBX1;ZBTB16;GSN;ZIC1;ECRG4;NR4A2;TGFBR2;GLIS2;STAT3;ELP3;DMBX1;SNTG2;SHROOM4;GRHL2;PAFAH1B2
prerank,regulation of cytoskeleton organization (GO:0051493),0.42827179492293405,1.2197811796568694,0.1721698113207547,0.8524729530208133,1.0,24/108,9.47%,CLIC4;SORBS3;EZR;EFNA5;PRKCD;PHLDB2;ARHGAP44;GSK3B;CAPN2;RHOBTB1;ABL1;FAM107A;DIAPH1;RHOQ;LRP1;DMTN;ARHGAP17;MARK2;PDGFA;CAPN6;RHOA;IQGAP1;RND3;MLST8
prerank,T cell differentiation (GO:0030217),-0.3846685971415611,-1.2194597622891759,0.1696113074204947,0.6482722089191624,1.0,8/40,9.17%,LEPR;CHD7;SOX13;KIT;RHOH;JAG2;TCF7;LFNG
prerank,epithelial to mesenchymal transition (GO:0001837),-0.381932117345399,-1.2190555737454625,0.13793103448275862,0.6473994533629984,1.0,17/47,11.32%,LEF1;WNT4;ENG;TGFBR3;TBX3;WNT5A;BMP7;NOTCH1;LOXL3;RBPJ;HIF1A;NOTCH4;BMP2;HEY2;FOXF2;OLFM1;ROCK2
prerank,relaxation of cardiac muscle (GO:0055119),0.5874507445190152,1.218938441910851,0.2533557046979866,0.854130560194549,1.0,4/13,2.48%,KCNJ2;ATP1B1;CAMK2D;GSN
prerank,protein depolymerization (GO:0051261),0.5304545961636055,1.2186871959488632,0.24924012158054712,0.8537597385469846,1.0,2/27,2.48%,MICAL2;GSN
prerank,ribosome biogenesis (GO:0042254),-0.31014991405197406,-1.2186045714831313,0.03488372093023256,0.646665937808205,1.0,68/187,23.14%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;NOC2L;RPL32;RPL39;RPL14;NPM1;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9
prerank,negative regulation of ion transport (GO:0043271),0.5304739990201915,1.2184351470254855,0.2363919129082426,0.853378318943891,1.0,3/24,1.93%,NEDD4;PTK2B;WNK1
prerank,cell differentiation in hindbrain (GO:0021533),-0.5422860819067494,-1.2183106822707117,0.24278846153846154,0.6456263119826766,1.0,7/11,18.52%,GRID2;OPHN1;FAIM2;PROX1;KNDC1;LHX1;ATP7A
prerank,contractile actin filament bundle assembly (GO:0030038),0.5737297447874433,1.2180840047730617,0.2572347266881029,0.8521631107644049,1.0,5/15,9.06%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,stress fiber assembly (GO:0043149),0.5737297447874433,1.2180840047730617,0.2572347266881029,0.8521631107644049,1.0,5/15,9.06%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5261995558988384,1.2180435940806746,0.24208860759493672,0.8510929771411475,1.0,1/23,0.03%,SLC4A4
prerank,vesicle transport along microtubule (GO:0047496),0.5385144758687068,1.2178775217431055,0.25299401197604793,0.8504468574736983,1.0,6/23,9.48%,KIF13A;NDEL1;PAFAH1B1;KIF1C;DYNC1I1;FBXW11
prerank,cognition (GO:0050890),0.4878574710494013,1.2176706484424897,0.22297297297297297,0.849961468377064,1.0,10/42,13.20%,ST3GAL4;SOBP;FAM107A;STRA6;MGAT3;DOP1B;SHROOM4;NF1;NIPBL;SETD5
prerank,response to nutrient levels (GO:0031667),0.5569998876101994,1.2176441409779866,0.25972006220839816,0.8488772305636219,1.0,3/17,4.82%,KCNB1;FAM107A;EIF4G1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5527007166456493,1.217474251027917,0.24251968503937008,0.8482541779156828,1.0,4/21,11.57%,NT5E;NT5C1A;NUDT4;AMPD3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.46637009612978836,-1.2171967780992081,0.2231404958677686,0.6469296938924743,1.0,8/19,5.71%,ROBO1;SEMA6A;CCBE1;DCN;JCAD;TSPAN12;CD63;DAB2IP
prerank,morphogenesis of an epithelium (GO:0002009),0.5198777070522113,1.21696100577445,0.25617283950617287,0.848839994549961,1.0,4/25,8.15%,SOX9;LRP6;VCL;RIPK4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.418164389747086,1.2167403757378912,0.16647662485746864,0.8484069409502641,1.0,34/152,13.71%,RSPO3;EGFR;WNK1;GPC3;SULF1;PLEKHA4;VCP;TRPM4;TMEM198;SFRP4;UBE2B;SKI;UBR5;BAMBI;TBL1X;PSMB2;RSPO4;JUP;CSNK1G3;USP34;DISC1;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;RNF146;USP47;SMARCA4;CSNK1G1;ZRANB1;PPM1A;CSNK1E;PSMD11
prerank,cell junction assembly (GO:0034329),-0.3220106375673978,-1.2167400611071886,0.08904109589041095,0.6464140230757857,1.0,22/100,6.57%,TJP1;ADGRL3;DNM3;TLN2;CDH2;SHANK3;SPOCK2;ITGA6;CLDN5;NRXN1;CDH8;CDH10;GPM6A;GJC1;VASP;ARVCF;ACTB;PLXND1;KIRREL3;OPHN1;TLN1;OBSL1
prerank,regulation of cellular response to stress (GO:0080135),0.43134524526092405,1.2166464014997607,0.18683901292596944,0.8475475174307744,1.0,32/115,20.88%,SLC38A2;CAMK2D;GSK3B;ABL1;NUP93;EIF4G1;CREBBP;HSPA1L;MLST8;RANBP2;ATM;HSPB8;CHORDC1;SEC13;NUP153;MTOR;SMG1;EP300;BAG3;MAPKAPK2;NUP214;RPA1;NUP188;ABCD1;NUP88;ATR;AIFM2;NEK6;DYRK3;CLN3;MCL1;NUP98
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5924061931049314,1.216188974524648,0.26455906821963393,0.8479026306873805,1.0,5/13,11.37%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49343101363435965,-1.2159050899205632,0.2620192307692308,0.6469357807839087,1.0,4/14,11.73%,IGF1;SYT11;GRN;CD200
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5893483720146472,1.2158972600025562,0.2440273037542662,0.8476829987346433,1.0,5/12,13.78%,ESR1;STAT3;NCOR1;ZC3H12A;NCOR2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5915134069568005,1.2157616322518812,0.2608695652173913,0.8469910200241594,1.0,3/14,6.76%,EHHADH;ACOX3;ACOT8
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.41546114739014467,1.2157360159065451,0.15986769570011025,0.8459114061270098,1.0,30/166,13.69%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;SORBS1;KLF4;GIPC1;FGF2;IRS1;PTPN2;LDLR;CLU;TLR4;BCAR3;STN1;LARP4B;NNMT;STARD4;P2RX4;GLI2;CNEP1R1;ELOVL5;ERBB2;EIF3E;CHP1;EIF6;MTOR;PRKDC;DYRK2
prerank,negative regulation of cellular process (GO:0048523),0.3937753366112634,1.215608993408606,0.06720977596741344,0.845195269343553,1.0,58/521,7.56%,SLIT3;SLIT2;ZBTB7C;BMP4;CCN3;FHL1;NDRG3;WNT9A;OSGIN2;TES;BMP5;NGF;CYP1B1;CCN1;CCN5;PTK2B;ABI1;PTPRU;TGFB3;WNT11;ARHGDIB;SMAD6;VPS13C;CD9;ESR2;KLF4;INHBA;FGF2;LRPAP1;LMNA;SRGAP2;STRN;IP6K2;PDCD4;P3H2;PTPN2;NCK2;SMYD2;KLF10;SFRP4;BECN1;CLMN;WNT16;FRK;SKI;CLU;PTHLH;PLSCR1;AGR2;SLURP1;SRSF6;TGFB1I1;IFI35;MYOG;IL10;CELF1;P3H1;IRF1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5506237828416524,1.2153413778704896,0.2582236842105263,0.8450104454700584,1.0,2/17,2.27%,PCSK5;HDAC9
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5469271546128355,1.2152352221744889,0.23113207547169812,0.8430032872489305,1.0,5/21,9.70%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5469271546128355,1.2152352221744889,0.23113207547169812,0.8430032872489305,1.0,5/21,9.70%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,monocarboxylic acid transport (GO:0015718),0.4679767760392152,1.214706162678663,0.205761316872428,0.8435832203501412,1.0,10/51,8.62%,SLCO3A1;SLC5A6;SLC16A9;SLCO2A1;SLC16A1;ABCG2;SLC26A6;SLC10A2;RXRA;ATP8B1
prerank,gene expression (GO:0010467),-0.29015618750358335,-1.2145452469628335,0.0,0.6487505366820121,1.0,103/348,19.39%,RBPMS;RBMS1;NOVA1;ATXN1;TSPAN5;RPS14;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;APOBEC1;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;ADARB2;RPS4X;RPL13;ANGPT2;RPL9;RPS16;ELAVL4;RPS15;SETX;RPS27;RPL30;DTX1;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;RPL7;RNASEL;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;CELF2;NUP160;HHEX;FASTKD2;RPL8;POLR2G;RPL24;NUP210;HNRNPH3;RPL29;MRPS11;SMG7;MRPL51;ADARB1;NOX4;RPL10A;RPL3;DDX20;RPL12;TFIP11;ADAR;PABPN1;RPS27A;POLR2K;NUP62;BCL3;RPS12;RPL27;RPS28;NUP205;DDX54;RPL5;RBM15B;PWP1;GSPT2;MAGOH;RPS10
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5675345340731831,1.2145424186427656,0.26533996683250416,0.8429728043153452,1.0,7/16,26.01%,SMG6;TNKS2;ATM;SLX4;DHX36;NAF1;HNRNPA2B1
prerank,cellular response to estrogen stimulus (GO:0071391),0.5669393436098055,1.214392651248482,0.26178861788617885,0.8423739466656073,1.0,3/14,9.89%,SERPINB9;BCAS3;RARA
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.49699916537292166,1.21413198600397,0.20874471086036672,0.8421577825415882,1.0,8/39,7.43%,CDH1;FXYD5;WNK1;KLF4;BMP6;JAG1;IL10;RDX
prerank,sensory organ development (GO:0007423),0.47186814931617926,1.2138837076087612,0.2233632862644416,0.8419323406816102,1.0,11/51,14.14%,PBX3;PBX1;SMOC1;HIPK1;STRA6;SIX4;FOXC1;SCO2;ATF6;PAX6;ECE1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5873532980322238,1.213574131155995,0.272,0.8418370018671312,1.0,2/12,2.77%,FUT8;GMDS
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4352937977475203,1.2134760245753295,0.1857318573185732,0.8410306907458793,1.0,33/95,22.64%,REV3L;RNF138;ERCC5;MCM7;WRN;MCM2;BRCA2;NABP1;SMC5;SPIDR;NIPBL;RAD52;CDC45;SLX4;KDM4D;MCM9;NSMCE1;RBBP8;YY1;RPA1;RECQL5;NBN;RAD51;FANCM;INO80;PSMD14;SWSAP1;UBE2N;EXD2;RAD51C;SMC6;RAD50;ZFYVE26
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4265885728940362,-1.2133540848258846,0.19883040935672514,0.6501936101028578,1.0,6/28,15.03%,SH3KBP1;CD47;SIRPA;PRKCQ;TNIP2;TYROBP
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5994859132915495,1.2133454782040456,0.2751798561151079,0.8403486858072018,1.0,4/10,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,DNA repair (GO:0006281),0.3981029509623503,1.2131549280882932,0.11522198731501057,0.8397988931704169,1.0,109/284,26.06%,MPG;ABL1;HERC2;APEX2;FTO;VCP;UBE2B;SMUG1;MNAT1;EXO1;SETD2;EYA3;TRRAP;CHEK2;ERCC5;CHD1L;RAD17;WRN;APLF;COMMD1;ATM;RAD23B;USP1;SLC30A9;APEX1;BRCA2;IGHMBP2;NABP1;USP47;SMC1A;MTA1;PPP5C;RAD52;UIMC1;SLX4;CHEK1;RNF168;PRKDC;XRCC5;CSNK1E;MLH3;BAP1;PRMT6;ERCC8;POLB;RNASEH2A;POLE2;FANCL;EID3;ZBTB1;HINFP;ERCC3;NSMCE1;RBBP8;SMARCAL1;XPA;VCPIP1;RPA1;RMI2;RECQL5;BARD1;NBN;TICRR;RAD51;ERCC1;ATR;FANCM;NEIL3;SMARCA5;TNKS1BP1;INO80;WDR48;TOPBP1;PARP3;UBE2N;MAPK8;ASCC1;PARP4;EXD2;RAD51C;FAAP24;TDG;POLA1;KMT5B;RNF8;HUWE1;DDX1;POLD3;ALKBH5;NUDT1;RAD9B;RAD50;MBD4;BRCC3;PARP2;RFC5;UBE2V1;BRIP1;ERCC2;USP3;ASCC2;KAT5;POLK;POLQ;PWWP3A;MDC1;XPC;RAD51AP1;FAM111A
prerank,cell-matrix adhesion (GO:0007160),0.43106658479648846,1.212888069065879,0.1900121802679659,0.8395851617373862,1.0,16/95,6.03%,MSLN;ITGBL1;PKD1;ITGB8;FN1;ADAM9;CD44;COL3A1;SORBS1;ITGB1;BCR;ITGB5;ITGA10;VCL;ITGAV;PIP5K1A
prerank,inner ear morphogenesis (GO:0042472),0.5329120643774823,1.2124225613931692,0.24920127795527156,0.8400332646587483,1.0,3/22,3.23%,SIX1;SOX9;ZIC1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.610383922823452,1.2121560516903758,0.2787456445993031,0.8398100205939114,1.0,3/10,7.86%,ANXA2;NELL1;RGP1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5015328411537135,-1.2118423560705678,0.22135416666666666,0.6526014881345746,1.0,3/14,11.38%,MOXD1;SLC22A2;ALDH9A1
prerank,fat cell differentiation (GO:0045444),0.4700596366874693,1.211700277520216,0.22509702457956016,0.8401492578750893,1.0,14/57,13.42%,TCF7L2;BBS9;PID1;SMAD6;TMEM120A;KLF4;NR4A3;NR4A2;GDF6;EGR2;ERAP1;INHBB;NR4A1;EP300
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5680753098539522,1.211644145950681,0.26622296173044924,0.8392121720938742,1.0,3/15,3.61%,EGFR;PTK2B;ABL1
prerank,positive regulation of protein binding (GO:0032092),0.4631693342506751,1.2115731360029514,0.21846553966189858,0.8382970689971133,1.0,14/56,12.29%,BMP4;TCF7L2;PKD1;GSK3B;ABL1;LRP1;BAMBI;RIPK2;IDE;DACT1;MARK3;TIAM1;ADD1;USP33
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5307254031886759,1.2113597885864786,0.25426356589147286,0.8378468354933463,1.0,8/24,7.23%,WNT9A;SOX9;ZBTB16;TGFBR1;EFEMP1;PTHLH;GDF6;GDF5
prerank,somite development (GO:0061053),0.6005309167670868,1.2113241593203377,0.25773195876288657,0.8368444828582057,1.0,2/11,2.30%,SMO;MEOX2
prerank,amide transport (GO:0042886),0.517931409514292,1.2112036304531606,0.25736434108527134,0.8360885570053823,1.0,3/26,2.41%,SLC5A6;DISP1;ABCG2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5932196681462366,1.2111232637938258,0.2599337748344371,0.8341131340740809,1.0,6/12,13.69%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5932196681462366,1.2111232637938258,0.2599337748344371,0.8341131340740809,1.0,6/12,13.69%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,proteolysis (GO:0006508),0.40074343528007106,1.2101800589020657,0.14690451206715635,0.8360660939372573,1.0,50/252,15.41%,F3;TRABD2B;CAPN5;HTRA3;PCSK5;BMP1;NPEPPS;CPQ;CAPN2;HTRA1;DDI2;CASP6;PHEX;HTRA4;MMP16;SPPL2A;TBL1X;TASP1;XPNPEP1;IDE;CPA5;CNDP1;ASPRV1;XPNPEP3;CAPN6;CPA4;CPA3;NLN;BACE2;MMP14;USP25;FBXL6;DESI1;DESI2;PGPEP1;LONP2;CAPN10;ERAP1;ADAMTS3;CAPN12;YME1L1;CLPP;TMPRSS2;PITRM1;ECE1;PCSK7;LAP3;DPP3;CPB1;ADAM10
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4535741518076742,-1.2099837268494946,0.23544973544973544,0.6560000383311422,1.0,7/18,11.35%,IL34;DAAM2;TNFRSF21;NOTCH1;TENM4;OPALIN;MDK
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.41771928116611634,-1.2098692099453296,0.20440251572327045,0.6544842336597251,1.0,9/26,12.59%,SLC30A10;PPARA;SLC5A3;SNCA;GRIN1;SLC25A33;ABCB7;CYBA;ADGRB1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.5196920158581669,1.2095694022369436,0.23742138364779874,0.8368773745859774,1.0,6/24,14.02%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;EIF2AK4
prerank,extracellular matrix assembly (GO:0085029),-0.44243509961095556,-1.2091581356613443,0.21008403361344538,0.654392874540237,1.0,9/23,9.87%,FBLN5;MYH11;LAMB1;GPM6B;MFAP4;QSOX1;GAS6;EFEMP2;RAMP2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3501110911618217,-1.2088728785560992,0.16666666666666666,0.6534127713661645,1.0,13/61,8.12%,ROBO1;IGF1;AUTS2;LYN;ARHGEF3;F11R;LPAR1;NOTCH1;RASGRF1;MAP4K4;NET1;ADGRG1;RAC1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5478220327248863,1.2085685877028582,0.25075528700906347,0.8389274074182365,1.0,2/20,6.59%,FKBP5;NKTR
prerank,non-motile cilium assembly (GO:1905515),0.5089629578960865,1.2081166761755113,0.25608011444921314,0.8394084999901386,1.0,20/30,32.42%,PCM1;ARL13A;TOGARAM1;DISC1;RPGRIP1;PIBF1;CEP89;C2CD3;GORAB;FUZ;CSNK1D;BBS4;IFT88;CEP290;TMEM80;RPGRIP1L;IFT122;DCTN1;TMEM17;TMEM107
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.479161260172101,1.2079868969062177,0.24050632911392406,0.8387138142020907,1.0,10/43,11.37%,PID1;PRKCD;GRB10;SORBS1;IRS1;PTPN2;ZBTB7B;C1QTNF12;SIK2;ERFE
prerank,peptidyl-lysine acetylation (GO:0018394),0.6047138907562442,1.2079307076083328,0.2805071315372425,0.8377619853436346,1.0,6/10,25.87%,CREBBP;KAT2A;EP300;KAT2B;KAT5;ESCO1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4824656020350419,-1.2074372719994508,0.216,0.65541737965451,1.0,4/16,5.65%,APOD;PPARA;ADCY7;SIRPA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.44454921563803645,1.207214840490896,0.21525215252152521,0.8390295747852924,1.0,23/76,21.01%,HDAC4;TANK;PRICKLE1;FAM107A;RIPK2;BIRC7;MYCBP2;SAE1;PIAS3;DCUN1D5;COMMD1;ZC3H12A;FBXO4;CUL3;TNIP1;BCL10;WDR48;BIRC3;DCUN1D4;PIAS1;DCUN1D2;DCUN1D1;HUWE1
prerank,autophagy of peroxisome (GO:0030242),0.5889530187513379,1.206932014717767,0.2981878088962109,0.8388069005108181,1.0,5/12,17.63%,ACBD5;RB1CC1;ATM;SQSTM1;NBR1
prerank,regulation of angiogenesis (GO:0045765),0.404968352888887,1.2068087220961,0.15081967213114755,0.8381166684021266,1.0,22/192,6.17%,SMOC2;BMPER;F3;THBS1;HOXA5;RHOJ;ITGB8;PGF;CYP1B1;ANXA3;SEMA3E;PTGIS;SULF1;KLF4;HIPK1;ITGB1;FGF2;ISM1;ATP2B4;ADAM12;ISL1;GATA4
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.41029183552211357,1.2066126072518166,0.16478555304740405,0.8376804182713381,1.0,15/151,6.17%,BMPER;EGFR;TNFAIP8L3;NTRK3;PDGFC;PTK2B;CD44;SHC1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A;GCNT2;GATA4
prerank,negative regulation of phagocytosis (GO:0050765),-0.4731711073045557,-1.2065060417440978,0.24155844155844156,0.6560067741260018,1.0,8/17,19.72%,DYSF;CD47;SIRPA;SYT11;CD300A;RACK1;SNX3;PRTN3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4944613953458055,1.206185737194273,0.23222060957910015,0.8379450054015405,1.0,5/32,8.17%,SLC4A4;PID1;VCP;PFKFB2;PFKFB1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4094380723380956,-1.205834067006712,0.20833333333333334,0.6560926696576714,1.0,9/29,9.13%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2;CD81;PDGFRA
prerank,DNA duplex unwinding (GO:0032508),0.4657273496496228,1.2054977854781335,0.2190082644628099,0.8390069126016035,1.0,23/50,28.47%,ANXA1;CHD1L;MCM7;WRN;MCM2;RAD23B;DDX11;DHX9;MCM9;ERCC3;XPA;RPA1;RECQL5;NBN;RAD51;DDX1;RAD50;CUL4A;ERCC2;XPC;GTF2H3;MCM6;RECQL
prerank,mitochondrion disassembly (GO:0061726),0.49422193667160463,1.205359235568204,0.24684431977559607,0.8383594101082592,1.0,16/34,26.30%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG5;ATG7;USP30
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5791039851261162,1.2052034452555378,0.2673434856175973,0.8377773309229309,1.0,2/14,4.97%,CD55;TGFBR2
prerank,negative regulation of protein modification process (GO:0031400),0.44295562654676823,1.203916731500297,0.21313506815365552,0.8408448490492748,1.0,13/79,8.59%,SLIT2;NTRK3;LRP6;PID1;PLPP3;NIBAN1;GSK3B;ATP2B4;DMD;SNTA1;KLHL31;P3H1;IBTK
prerank,calcium ion import into cytosol (GO:1902656),-0.4769056174145619,-1.2036287427506271,0.20911528150134048,0.660412853921447,1.0,5/15,14.66%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,regulation of sodium ion transport (GO:0002028),0.4975380052980371,1.202869948117405,0.25,0.8429874440188819,1.0,10/34,11.39%,NEDD4;SLMAP;WNK1;ATP2B4;SNTA1;DLG1;P2RX4;ATP1A1;PER1;RANGRF
prerank,regulation of cell cycle phase transition (GO:1901987),0.42884974906663137,1.202663785350961,0.22195121951219512,0.8425461236513146,1.0,32/91,27.17%,FZR1;TCIM;ANAPC5;ATP2B4;PSMB2;CDC16;ANAPC16;CDKN1B;PSMC6;PSMD11;UBE2S;PSMD1;TRIM39;ERCC3;CUL1;MAD2L1;PSMC1;PSMD7;CDKN1A;PSMD14;PSMD3;ANAPC11;ANAPC10;CCNB1;CDC20;ERCC2;BUB3;PSMD12;XPC;PSMD4;PSME3;TAF1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5422517714107998,1.2024533499806118,0.2527646129541864,0.8420668356542803,1.0,4/20,12.51%,PLOD2;GCLC;PLSCR1;FPGS
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38540799812613225,-1.202391513909628,0.18211920529801323,0.6620270321821106,1.0,5/35,1.24%,FLT1;PTPRM;NR2F2;COL4A3;APOE
prerank,positive regulation of lipid transport (GO:0032370),-0.5044024889382813,-1.202377543174694,0.255,0.6602212887989442,1.0,4/12,11.76%,APOE;SPP1;DBI;ABCB4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5533876630292538,1.2023596745109448,0.2523809523809524,0.8412520180246007,1.0,5/17,4.96%,KCNJ2;ANK2;CACNA1C;CACNA1G;TRPM4
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4427088973033715,1.201961259920874,0.2202970297029703,0.8414254621183451,1.0,10/76,5.01%,NTRK3;BAIAP2L1;CDC42EP5;SORBS3;PTK2B;PRKCE;ABL1;NRP1;NCK2;BCAS3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5846284623894582,1.2019325567122972,0.27104377104377103,0.8404268282094051,1.0,5/12,18.56%,CHEK2;RAD17;CLSPN;TICRR;TOPBP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.42277348371234325,1.201923026761465,0.19905771495877503,0.8393677135562683,1.0,23/114,19.38%,TNFRSF11B;CARD14;EDA;PTK2B;FOXO3;PSMB2;TNFRSF13B;CHUK;LIMS1;PSMC6;CDIP1;TRAF5;TNFRSF1B;TNFSF11;PSMD11;TRADD;PSMD1;PSMC1;PSMD7;TNFRSF4;BIRC3;TRAF3;PSMD14
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.583251482224849,1.2017980750412125,0.2611683848797251,0.8386946174505422,1.0,5/12,18.73%,ESR1;NCOR1;ZC3H12A;NCOR2;PPARG
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45197281133320394,-1.201357334923532,0.21978021978021978,0.6613910465617983,1.0,1/19,0.18%,IGF1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.39015652352971386,1.2011463838982772,0.12268041237113401,0.8397243700557168,1.0,100/341,22.89%,FBXL7;WWP1;FZR1;NEDD4;FBXO10;UBE4B;WWP2;NFE2L2;RNF144A;RNF115;ANAPC5;RNF185;UBR4;VCP;UBE2B;KLHL22;ARIH1;DDIT3;TBL1X;RNF19A;PSMB2;BIRC6;TGFB1I1;CDC16;RNF114;TRIP12;CBLC;ANAPC16;RNF126;UBE2D3;AURKA;FBXW11;UBE4A;FEM1B;RAD23B;PSMC6;PPP2R5C;OTUD7B;RNF146;RNF111;SPSB2;MTA1;VPS37A;WDR81;MVB12B;USP33;COP1;RNF122;ZRANB1;RNF168;ARIH2;ANKIB1;SMURF1;PSMD11;CUL3;NPLOC4;ERCC8;UBE2S;PSMD1;SPOP;NTAN1;SQSTM1;PML;UBE2K;APPBP2;CHFR;BFAR;MAD2L1;RNF14;UBE3C;VPS37B;OS9;PSMC1;PSMD7;TSG101;FBXL19;USP9X;UFD1;TRIM25;PSMD14;UBE2W;FBXL4;CNOT4;PSMD3;TRPC4AP;MIB1;RNF8;HUWE1;RNF130;TOM1L1;RBCK1;CUL4A;RMND5A;ANAPC11;KCTD17;ANAPC10;FBXL17;HERPUD1;ANKRD9;FBXO11
prerank,cellular potassium ion homeostasis (GO:0030007),0.5713324628882962,1.2006917602165406,0.28311258278145696,0.8400911475751066,1.0,6/13,8.78%,KCNJ2;SLC12A2;ATP1B1;ATP1A3;ATP1A4;ATP1A1
prerank,cellular response to alcohol (GO:0097306),0.47711662333483085,1.2006680255218127,0.24753867791842477,0.8391073424050298,1.0,8/42,7.62%,CDH1;LRP6;SMO;CTNNA1;KLF9;GOLPH3;GRAMD1C;JUP
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.591923478225784,1.200511469091095,0.25538971807628524,0.8385433720501915,1.0,5/11,10.84%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,regulation of smooth muscle cell migration (GO:0014910),0.540603394273518,1.2004503841177177,0.2543720190779014,0.8376999005281511,1.0,6/20,7.96%,SLIT2;IGFBP5;BMPR1A;NRP1;LRP1;PDGFA
prerank,regulation of B cell apoptotic process (GO:0002902),0.5912963489572517,1.2003976506512828,0.2962962962962963,0.8368120511141395,1.0,1/12,0.25%,FOXP1
prerank,polyamine metabolic process (GO:0006595),0.5875346749608584,1.2002653215601602,0.2690972222222222,0.8361708499236699,1.0,6/13,24.27%,SMOX;SRM;HDAC10;SAT1;ODC1;OAZ2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5183785749674981,1.2002244613654092,0.28173374613003094,0.8352500925617974,1.0,5/24,3.62%,PPP1R3B;SORBS1;PPP1R3C;GSK3B;IRS1
prerank,actin crosslink formation (GO:0051764),0.5857183705815624,1.199688240656055,0.2940251572327044,0.835841859819204,1.0,4/12,9.23%,DPYSL3;BAIAP2L1;GAS2L2;GAS2
prerank,regulation of catecholamine secretion (GO:0050433),-0.405440119947388,-1.1993923196714518,0.2032258064516129,0.664835311735057,1.0,17/29,24.10%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;GRK2;CHGA;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.461112374464754,-1.198899608863832,0.24331550802139038,0.6643452508243705,1.0,7/18,17.12%,MSRA;ASPA;ASPG;ASS1;SMS;ASNS;GOT2
prerank,response to ATP (GO:0033198),-0.4707250310906868,-1.1988285546844755,0.23834196891191708,0.6627046811785227,1.0,6/18,16.82%,TRPC3;ABCC9;P2RY1;P2RX7;HSP90B1;RYR3
prerank,mesoderm development (GO:0007498),-0.4561174254178215,-1.198144028377783,0.21680216802168023,0.6627224804531914,1.0,8/18,16.61%,TIE1;TBX3;TBX1;BMX;IKZF1;HCK;GDF11;BTK
prerank,positive regulation of apoptotic process (GO:0043065),0.39117768685065446,1.1980092447607606,0.12920168067226892,0.8399579597335426,1.0,44/293,12.86%,SLIT2;BMP4;RASSF2;MAP3K5;HOXA5;NGF;CYP1B1;TGFB3;AKAP13;PAWR;FOXO3;PTGIS;VAV2;ANO6;CRADD;ITGB1;UNC13B;ABL1;IP6K2;TGFBR1;TIAM2;SFRP4;GADD45G;TRIO;DDIT3;CLU;ARHGEF6;CALHM2;GNA13;BCLAF1;RARG;NF1;ATM;JUN;DIABLO;CCL3;ATF6;ARHGEF5;ARL6IP5;TIAM1;UBE2Z;SOS2;ZC3H12A;RNF122
prerank,organelle transport along microtubule (GO:0072384),0.5038566226266376,1.197207530052014,0.24411764705882352,0.8413614376284357,1.0,15/31,26.19%,ARHGAP21;NDEL1;RAB6A;PAFAH1B1;DYNC1I1;FBXW11;COPG1;TMEM201;CLN3;RAB1A;CDC42;RHOT1;TRAK1;BICD1;MAP1S
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.390478105969557,1.1968234940182974,0.140641158221303,0.8415037155138441,1.0,80/314,23.09%,FBXL7;WWP1;FZR1;NEDD4;UBE4B;WWP2;NFE2L2;ECRG4;ANAPC5;RNF185;VCP;UBE2B;KLHL22;DDIT3;TBL1X;PSMB2;FBXL20;CDC16;ANAPC16;ANKZF1;RNF126;UBE2D3;AURKA;FBXW11;UBE4A;FEM1B;RAD23B;PSMC6;FBXL6;PPP2R5C;FBXO17;RB1;SPSB2;MTA1;COP1;UBXN4;RNF122;FBXO4;ERLIN1;SMURF1;PSMD11;CUL3;NPLOC4;ERCC8;UBE2S;PSMD1;SPOP;AMN1;PML;UBE2K;APPBP2;BFAR;CUL1;MAD2L1;OS9;PSMC1;PSMD7;FBXL19;UFD1;TRIM25;FBXL8;PSMD14;UBE2W;FBXL4;ECPAS;PSMD3;HUWE1;RBCK1;CUL4A;RMND5A;ANAPC11;KCTD17;ANAPC10;FBXL17;FAF2;HERPUD1;ANKRD9;FBXO27;CDK2;CCNB1
prerank,glycolipid biosynthetic process (GO:0009247),0.4882691574543362,1.1963420792485013,0.26901408450704223,0.8420054368434883,1.0,11/38,20.01%,ST3GAL4;LARGE1;PGAP2;PIGB;A4GALT;DPM1;PIGU;ST3GAL2;ST6GALNAC5;PIGL;PIGN
prerank,bile acid and bile salt transport (GO:0015721),-0.430058088060069,-1.196262710110836,0.2072072072072072,0.6660727598626484,1.0,3/24,1.62%,SLCO2B1;NCOA1;SLCO1C1
prerank,positive regulation of lipid localization (GO:1905954),0.5851353364718804,1.1961981514034508,0.28865979381443296,0.8413922983450032,1.0,5/11,12.53%,LRP1;IKBKE;NFKB1;HILPDA;ZC3H12A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3186105497548441,-1.195909971513429,0.10273972602739725,0.6652334985642162,1.0,25/110,11.28%,ADGRL4;ADGRL3;ADCY5;ADCY1;LGR4;RAPGEF2;LPAR1;GNG2;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;ADGRB3;ADRA2A;ADGRG1;ADORA2A;S1PR1;PTH1R;ADM;RAMP2;TBXA2R;LPAR2;S1PR3;ADCY2
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5512351471437207,1.1954735957975093,0.29439252336448596,0.8426264476719035,1.0,4/17,8.09%,KCNB1;CACNA1G;CLTRN;SLC4A8
prerank,regulation of lipase activity (GO:0060191),0.5666519726548332,1.1952122762604678,0.29692832764505117,0.8423843303143498,1.0,2/13,9.06%,PCSK5;RHOA
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5044585101730337,1.1952089743670922,0.2578241430700447,0.8413337565816074,1.0,5/30,5.73%,KCNJ2;ANK2;CACNA1C;CACNA1G;SNTA1
prerank,triglyceride homeostasis (GO:0070328),-0.4309377611358863,-1.1952021285181045,0.2310126582278481,0.6654444215889251,1.0,9/26,18.16%,APOE;NR1H3;C1QTNF3;IL18;PNPLA8;SCARB1;NR1H4;LPL;XBP1
prerank,aminoglycan catabolic process (GO:0006026),0.5037816286279942,1.194836848551991,0.24849397590361447,0.841468442047881,1.0,9/28,16.86%,GPC6;GPC3;NAGLU;GPC4;SGSH;GLB1;IDUA;SDC4;HPSE
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5863644677644926,1.1942350500113488,0.2874564459930314,0.8422855551303818,1.0,5/11,24.66%,RNF185;VCP;UFD1;UGGT2;POMT2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.487529058198959,-1.1941321712238828,0.24056603773584906,0.6666995086881747,1.0,4/14,6.10%,LYN;PIK3R1;GHR;PTK2
prerank,negative regulation of protein metabolic process (GO:0051248),0.4657512422264901,1.1937524644511288,0.23537414965986395,0.8427478970164853,1.0,13/48,16.63%,EGFR;LDLR;ITGAV;CLU;MDM4;NFKB1;IRAK3;ITGB3;INHBB;SNX12;AZIN1;HMGCR;MAD2L1
prerank,regulation of defense response to virus by host (GO:0050691),0.4955215805212181,1.1934646620012768,0.2474074074074074,0.8426363156279345,1.0,8/30,14.40%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;IFNLR1;EIF2AK4;DHX9
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5358786871074716,-1.1931573286579005,0.23529411764705882,0.667529839938246,1.0,5/11,12.02%,PARP14;PARP16;PARP8;TIPARP;PARP11
prerank,negative regulation of cellular catabolic process (GO:0031330),0.44714175238691756,1.193131913904934,0.23107569721115537,0.8426162283331659,1.0,13/63,7.86%,MET;PTPN3;EIF4G3;DAPL1;NELL1;FOXK1;TAB3;EIF4G1;KLHL22;TIMP2;STAT3;IL10;RGP1
prerank,negative regulation of programmed cell death (GO:0043069),0.38866173720001473,1.1926136266984713,0.12359550561797752,0.8432182661459328,1.0,76/355,16.63%,EGFR;THBS1;BMP4;CARD14;MET;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;ANXA1;WNT11;SMAD6;CD44;ANXA4;GCLC;SHC1;TAX1BP1;GSK3B;NOTCH2;ERC1;SERPINB9;SON;DNAJC3;GDNF;RIPK2;GOLPH3;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;KANK2;RIPK3;NFKB1;NIBAN2;NTSR1;GATA1;PIM2;PROK2;MTDH;VEGFA;ARF4;KRT18;USP47;COPS5;UBE2Z;HTATIP2;MYD88;AATF;DDRGK1;YME1L1;PAK2;PRKDC;BAG3;FATE1;PRDX5;HTR2B;STIL;CEACAM5;PIDD1;SQSTM1;ADAM10;ZFAND6;TFAP2A;DPEP1;CLEC5A;TMBIM4;BFAR;CASP2;NAA15;MAD2L1
prerank,positive regulation of axonogenesis (GO:0050772),0.4689915764355018,1.1922845265570627,0.2386206896551724,0.8432039979745536,1.0,5/43,5.51%,SLIT2;NTN1;NGF;TIAM2;SHTN1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.49417692753476616,1.192198677123734,0.2703488372093023,0.8424264535442704,1.0,8/32,17.17%,DDX5;FHIT;HIPK1;CDIP1;EP300;DYRK2;PML;USP28
prerank,sphingoid biosynthetic process (GO:0046520),0.590402231913811,1.1921647450462614,0.2778761061946903,0.840421389947174,1.0,1/11,0.61%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.590402231913811,1.1921647450462614,0.2778761061946903,0.840421389947174,1.0,1/11,0.61%,ACER3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.40812144272087036,-1.1921003972436577,0.22044728434504793,0.6687527225201694,1.0,11/29,20.68%,ACSL1;ELOVL7;ELOVL6;HSD17B12;ACSL5;HACD2;ACLY;ACSBG1;ACSL4;HACD1;GCDH
prerank,regulation of protein polymerization (GO:0032271),-0.3810831478630215,-1.1920771319640064,0.19377162629757785,0.667006838971205,1.0,6/35,8.96%,ARHGAP28;ESAM;MAP2;MAPT;PAK3;COTL1
prerank,cytosolic calcium ion transport (GO:0060401),0.5067976008996979,1.1919152676832772,0.2603550295857988,0.8401390943395224,1.0,2/28,1.62%,SLC35G1;CACNA1C
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.43131078691727487,-1.1916137697845701,0.2417910447761194,0.6664771815982571,1.0,7/24,10.60%,TEK;KDR;NDNF;GATA2;GAS6;RAMP2;TNIP2
prerank,protein stabilization (GO:0050821),0.40715587427930794,1.1912414649856573,0.19344262295081968,0.8411905114447592,1.0,38/168,15.16%,RASSF2;ANK2;ATP1B1;PRKCD;PLPP3;PARVA;USP2;USP13;TELO2;HPS4;UBE2B;COA8;CLU;TBL1X;TRIM44;P3H1;CHEK2;MDM4;SEC16A;NLK;PER3;IFT46;AAK1;PIM2;USP7;MORC3;TBRG1;WDR81;USP33;CHP1;COG3;GTPBP4;EP300;HCFC1;BAG3;GOLGA7;OTUD3;TRIM39
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5122335397588789,1.1902557156720686,0.26146788990825687,0.8433242558110146,1.0,6/23,7.26%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;CACNG6
prerank,apoptotic cell clearance (GO:0043277),0.5005032408925666,1.1901862955743765,0.24890190336749635,0.8425098451304371,1.0,7/30,10.86%,THBS1;ANXA1;RHOBTB1;ITGAV;LRP1;RARA;ITGB3
prerank,modification-dependent protein catabolic process (GO:0019941),0.3995866271816791,1.189716323993087,0.18162162162162163,0.842904533855086,1.0,54/193,21.16%,FBXL7;FZR1;NEDD4;FBXO10;UBE4B;RNF144A;ANAPC5;RNF185;UBR4;UBE2B;ARIH1;RNF19A;BIRC6;CDC16;RNF114;TRIP12;CBLC;ANAPC16;RNF126;AURKA;UBE4A;RNF146;RNF111;SPSB2;WDR81;USP33;RNF168;ARIH2;ANKIB1;SMURF1;PSMD11;CUL3;NPLOC4;UBE2S;NTAN1;SQSTM1;UBE2K;CHFR;BFAR;MAD2L1;RNF14;UBE3C;OS9;PCYOX1L;UFD1;TRIM25;PSMD14;FBXL4;CNOT4;PSMD3;TRPC4AP;MIB1;RNF8;RNF130
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5396467715225742,-1.1897005665242348,0.2535211267605634,0.6701299692145934,1.0,2/10,1.27%,ST6GAL1;ST3GAL1
prerank,positive regulation of metabolic process (GO:0009893),-0.3144842005061505,-1.1896154671700945,0.10909090909090909,0.6685539244106273,1.0,15/103,7.60%,CAMK1D;LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;INSR;PRDM16;GJA1;ACACB;PPARGC1A;ELOVL6;IL18
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5198625520550774,1.189397529200258,0.26461538461538464,0.8428522563068003,1.0,8/23,13.45%,GLI3;GPC3;HHIP;VCP;GLIS2;KIF7;MEGF8;HERC4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.39379573071226787,1.1891279618868091,0.1337448559670782,0.8425921534246233,1.0,76/327,17.73%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;NFIA;USP13;ESR2;JMJD1C;FZD7;ZNF423;ERC1;ABL1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;HMG20A;ESR1;STAT3;GATA4;DDIT3;NFIL3;TRRAP;PITX3;SOX14;CRABP2;CHEK2;FUS;IGSF1;NLK;FOXC1;NFYA;RORA;SERTAD3;PHF12;ATF7;BRCA2;GON4L;GTF2IRD1;RB1;NFKB2;FOXK2;CTR9;ATRX;KMT2D;TCF3;EP300;CHD3;HCFC1;SP3;GPBP1;GCFC2;HDAC10;REST;GPBP1L1;CDK11B;ATF2;BAZ2A;PCGF1;HINFP;PML;WWTR1;ZNF219;CREBL2;ZMIZ1;NSD1;RNF14;POU6F2;SBNO2;HCLS1;UTP4;CARM1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5232249127506255,-1.188740903609872,0.25245098039215685,0.6693269469630386,1.0,3/10,5.33%,CST3;NOTCH1;DPP4
prerank,response to organophosphorus (GO:0046683),-0.4688465122438874,-1.1885443134672662,0.26273458445040215,0.6680983559370901,1.0,6/16,17.79%,TRPC3;ABCC9;P2RX7;STAT1;VGF;NDUFS4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5178748574712371,-1.1885148046019631,0.270935960591133,0.6664402906772267,1.0,5/11,22.55%,NOVA1;NOVA2;PCBP1;PCBP3;IGF2BP1
prerank,mitochondrion morphogenesis (GO:0070584),0.6130067241450253,1.1884561417509416,0.2823529411764706,0.8436199061780575,1.0,1/11,1.88%,PID1
prerank,regulation of myoblast differentiation (GO:0045661),0.49885210545273745,1.1881645917939774,0.26906474820143883,0.8434849863050086,1.0,3/32,1.12%,BMP4;BOC;SOX9
prerank,cell projection organization (GO:0030030),0.4886931003962427,1.1878639880687563,0.2762039660056657,0.8433849303492481,1.0,7/30,10.18%,RHOJ;GSN;PARVA;ITGB1;RHOQ;PDGFA;NCKAP1
prerank,regulation of phosphorylation (GO:0042325),0.4183047647825993,1.1875199635244924,0.23317865429234338,0.8433975271380784,1.0,26/120,17.93%,EGFR;THBS1;BMP4;FN1;INHBA;FZD7;NUP93;NRP1;MCM7;CDKN1B;RAD17;RANBP2;CORO1C;EIF6;SEC13;NUP153;EP300;KDM4D;PML;NUP214;ZBTB7A;NUP188;BCL10;BARD1;CDKN1A;NUP88
prerank,cellular response to metal ion (GO:0071248),0.41218697277765104,1.187317299633522,0.21348314606741572,0.8429737803125694,1.0,17/123,10.41%,EGFR;CDH1;SLC12A2;CLIC4;CAMK2D;BMP6;MEF2A;DLG2;DMTN;SYT8;CDKN1B;P2RX4;CHUK;IQGAP1;PLCG2;JUN;CARF
prerank,7-methylguanosine mRNA capping (GO:0006370),0.49321593883211334,1.1870287422371364,0.2591508052708638,0.8418392497247491,1.0,2/31,5.82%,RNMT;MNAT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.49321593883211334,1.1870287422371364,0.2591508052708638,0.8418392497247491,1.0,2/31,5.82%,RNMT;MNAT1
prerank,ERBB2 signaling pathway (GO:0038128),0.4923472638731382,1.1868201986096991,0.25285714285714284,0.841492696860248,1.0,7/31,15.08%,EGFR;SHC1;ERBIN;ERBB2;CPNE3;GAB1;PRKCA
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.46794384693733115,1.1867221279931144,0.24702774108322326,0.8407623306368855,1.0,7/47,9.84%,THBS1;PID1;PRKCD;AGTR1;TGFBR2;TLR4;PLCG2
prerank,regulation of chromatin binding (GO:0035561),0.5927042136356946,1.1861386504045188,0.27882960413080893,0.8416161666204148,1.0,4/10,14.85%,BTAF1;DDX11;WAPL;KDM4D
prerank,acylglycerol biosynthetic process (GO:0046463),0.5208566486966237,1.1860687930616132,0.28484848484848485,0.8407835895650951,1.0,7/23,13.91%,PLCE1;PNPLA3;MOGAT3;PLA2G15;LPIN2;DGAT2L6;MOGAT1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.43068289477994703,-1.185930732205769,0.23249299719887956,0.6719033798936521,1.0,4/23,8.52%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.5114135335783443,-1.1857177548453943,0.2607594936708861,0.6707746098116263,1.0,4/12,9.63%,NKD1;PROM1;RORB;SDK2
prerank,glial cell differentiation (GO:0010001),0.5074009650334765,1.185484727875415,0.2705382436260623,0.8415998983354289,1.0,5/28,9.90%,NFIB;SOX9;STAT3;EGR2;ADGRG6
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3920158028864778,-1.1853395472920942,0.18439716312056736,0.6700649522138209,1.0,8/33,9.25%,DNAJC6;DNM3;PICALM;OPHN1;SNCA;DNM1;SNAP91;SYT1
prerank,positive regulation of cell development (GO:0010720),0.494713495507603,1.1852262103681097,0.24,0.8413403930162077,1.0,3/31,9.33%,BMP4;MYOG;NIBAN2
prerank,regulation of cellular protein localization (GO:1903827),0.47155339783358685,1.18457411620176,0.24456521739130435,0.8423672762600288,1.0,11/45,13.47%,GPC6;GPC3;NDEL1;VCP;KDM1A;SETD2;GBF1;GPC4;CCDC66;SPIDR;CSNK1E
prerank,regulation of DNA recombination (GO:0000018),0.49692451139471944,1.1845588615050382,0.26551226551226553,0.8413903879570991,1.0,9/32,17.86%,KDM1A;SETD2;KPNA1;IL10;SPIDR;CHEK1;PPP4R2;SIRT6;RAD51
prerank,membrane assembly (GO:0071709),-0.38711051819767,-1.1839680095863576,0.20727272727272728,0.671976348264255,1.0,6/34,3.38%,IL1RAPL1;NRXN1;PICALM;RFTN1;ANK3;UGCG
prerank,negative regulation of neuron projection development (GO:0010977),-0.36294558946563976,-1.1836646710125074,0.20481927710843373,0.6710965871421086,1.0,23/56,19.05%,EFNB2;APOE;LPAR1;DCC;SPOCK1;EPHA4;DENND5A;ARHGDIA;MAG;CRMP1;RTN4;LINGO1;PTPRO;EFNB3;RTN4RL1;NGEF;MYLIP;TRPV4;FKBP4;STMN2;BCL11A;OMG;MT3
prerank,neuronal action potential (GO:0019228),0.5273315720310472,1.1835520297765687,0.2750759878419453,0.8435739926343339,1.0,3/22,3.27%,KCNMB3;KCNMB2;CACNA1G
prerank,SNARE complex assembly (GO:0035493),0.5835301792388576,1.1835066209595304,0.28520499108734404,0.8427124151257548,1.0,2/10,7.18%,STXBP6;CLTRN
prerank,sarcomere organization (GO:0045214),0.4993590743400812,1.1832514524102289,0.25487256371814093,0.8424795030214907,1.0,4/27,7.90%,CSRP3;KRT19;SIX4;CSRP2
prerank,regulation of membrane repolarization (GO:0060306),0.5698167697390226,1.1827946063382284,0.2988313856427379,0.8428416194177126,1.0,1/13,0.28%,KCNJ2
prerank,protein insertion into membrane (GO:0051205),0.4784154953358343,1.1826561371918503,0.25884016973125884,0.8422809257837874,1.0,4/32,11.05%,EGFR;STX5;EMD;TRAM2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4148038112747462,-1.1823608506082353,0.24096385542168675,0.6729570133150774,1.0,7/27,6.10%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2
prerank,homeostasis of number of cells (GO:0048872),0.5753500785391883,1.1821172088313887,0.28689883913764513,0.8429501816898253,1.0,1/12,0.41%,CCN3
prerank,DNA metabolic process (GO:0006259),0.38914480290803494,1.181979115758538,0.1706806282722513,0.842368216889222,1.0,91/270,25.95%,TCF7L2;NT5E;MPG;VCP;UBE2B;SMUG1;MNAT1;EXO1;TRRAP;STN1;ERCC5;CHD1L;MCM7;RAD17;WRN;MCM2;ATM;TOP1;APEX1;IGHMBP2;USP7;NABP1;SMC1A;RAD52;CDC45;SLX4;CHEK1;PRKDC;XRCC5;CSNK1E;PRIM2;POLB;NUDT15;RNASEH2A;POLE2;FANCL;EID3;ZBTB1;HINFP;ERCC3;DFFB;DDX21;RBBP8;SMARCAL1;XPA;UHRF2;RPA1;RMI2;TOP3A;RECQL5;BARD1;NBN;TICRR;PRIM1;RAD51;ERCC1;ATR;NEIL3;INO80;TOPBP1;RFC1;PARP3;UBE2N;HELB;RAN;PARP4;EXD2;RAD51C;TDG;POLA1;KMT5B;POLD3;NUDT1;RAD9B;RAD50;TOP1MT;MBD4;NOC3L;DNASE2;CDK2;PARP2;RFC5;USP3;KAT5;POLK;POLQ;PWWP3A;ORC3;XPC;SRPK2;RAD51AP1
prerank,protein deacylation (GO:0035601),0.5085393354271341,1.181928667586199,0.27769110764430577,0.8415255532985737,1.0,6/23,17.32%,HDAC4;ABHD17B;LYPLA2;HDAC10;LYPLAL1;SIRT6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5900891522985069,1.181851503412736,0.27918781725888325,0.8407497409074307,1.0,9/11,39.45%,RESF1;SIRT6;TASOR;ATF7IP;MPHOSPH8;TPR;TRIM28;SETDB1;PPHLN1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4225818947768163,1.181829455656903,0.23558282208588957,0.8398039696077916,1.0,27/88,27.03%,FBXL7;PSMB2;FBXL20;FBXW11;PSMC6;FBXL6;FBXO17;FBXO4;PSMD11;PSMD1;AMN1;CUL1;PSMC1;PSMD7;FBXL8;PSMD14;FBXL4;PSMD3;CUL4A;FBXL17;FBXO27;PSMD12;FBXW5;CCNF;FBXO48;PSMD4;PSME3
prerank,recombinational repair (GO:0000725),0.4333147673219344,1.1815746429970455,0.22952853598014888,0.8395705678577677,1.0,28/77,22.64%,REV3L;RNF138;ERCC5;WRN;BRCA2;NABP1;SMC5;SPIDR;RAD52;SLX4;KDM4D;MCM9;NSMCE1;RBBP8;YY1;RPA1;RECQL5;NBN;RAD51;INO80;PSMD14;SWSAP1;UBE2N;EXD2;RAD51C;SMC6;RAD50;ZFYVE26
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.48998866570749533,-1.1807837487467523,0.24338624338624337,0.6755060740888529,1.0,6/13,18.11%,NOTCH1;RYR2;RBPJ;HEY2;GSK3A;FOXF1
prerank,neurogenesis (GO:0022008),0.46023183758675384,1.1802223915280314,0.2569444444444444,0.8428044672631345,1.0,8/43,9.87%,SIX1;CIT;ANXA1;THOC2;NTN5;DAGLB;SIX4;BTBD3
prerank,regulation of JNK cascade (GO:0046328),-0.31850891946311066,-1.1801993175367127,0.11538461538461539,0.6753061708475231,1.0,17/101,5.71%,PLCB1;IGF1R;MECOM;PHLPP1;TNFRSF19;TGFBR3;MFHAS1;CCN2;EPHB1;RAP2A;MTURN;SH3RF1;TPD52L1;APP;MAP4K4;SIRPA;DAB2IP
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.41033881582481385,-1.1800034026735409,0.22658610271903323,0.6741556887701358,1.0,11/26,19.60%,SHANK3;SYNPO2;SYNPO;FHOD1;RAC1;PLEK;ROCK2;ALMS1;LIMK1;ACTG1;CX3CL1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.31447655047455286,-1.1794793490746882,0.16875,0.673867741347061,1.0,17/102,6.79%,TBC1D4;ADCY5;PIK3R1;SLC30A10;ADCY1;FOXO1;CPEB2;ENPP1;PRKAR2B;INSR;ADCY7;PRKAR1B;INSIG2;LPIN3;PRKACB;MYO5A;PRKAR1A
prerank,protein methylation (GO:0006479),0.4765876575759279,1.1792329526862166,0.256011315417256,0.8448507846283114,1.0,18/40,25.98%,RAB6A;EHMT1;PRMT8;ETF1;CTCFL;GSPT1;PCMT1;PRMT6;METTL22;ETFBKMT;NSD1;CARM1;EHMT2;EEF1AKMT1;PRMT5;METTL21A;PRMT2;METTL21C
prerank,apoptotic mitochondrial changes (GO:0008637),-0.38732679788162094,-1.179227137032275,0.22327044025157233,0.6728735904872648,1.0,8/32,12.64%,BCL2;BCL2L1;ERBB4;IFIT2;CAMK2A;HK2;BOK;THEM4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5886298785519282,1.1791395003133744,0.2902097902097902,0.8441375918583714,1.0,2/10,8.03%,DDIT3;TLR4
prerank,oxoacid metabolic process (GO:0043436),-0.405101568856422,-1.1789224927992956,0.24169184290030213,0.6720379748343394,1.0,7/27,17.19%,DDO;ENPP1;TPST1;SULT4A1;MIF;AGXT;PPA1
prerank,regulation of striated muscle contraction (GO:0006942),-0.41782552738532186,-1.1784132736449995,0.2197452229299363,0.6717976641280685,1.0,3/27,4.69%,ATP1A2;CALM1;RYR2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.38954125802210005,1.1783963974442966,0.1473899692937564,0.8454187397652169,1.0,83/366,17.89%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;CCNA2;NFIA;FOXO3;USP13;ESR2;JMJD1C;FZD7;ZNF423;ERC1;ABL1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;HMG20A;ESR1;STAT3;GATA4;DDIT3;NFIL3;TRRAP;PITX3;SOX14;CRABP2;CHEK2;PDGFA;FUS;IGSF1;NLK;FOXC1;NFYA;RORA;SERTAD3;PHF12;GATA1;ATF7;BRCA2;ATXN2;GON4L;GTF2IRD1;RB1;NFKB2;FOXK2;CTR9;ATRX;KMT2D;TCF3;EP300;CHD3;HCFC1;SP3;GPBP1;GCFC2;HDAC10;REST;GPBP1L1;CDK11B;ATF2;BAZ2A;PCGF1;HINFP;PML;WWTR1;ZNF219;CREBL2;ANKRD17;NSD1;RNF14;POU6F2;SBNO2;HCLS1;UTP4;CARM1;EHMT2;PUM3
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4822795183359977,-1.1782176070635897,0.25984251968503935,0.6706096790772452,1.0,4/14,13.57%,CD81;PRKCZ;IL18;CD74
prerank,B cell proliferation (GO:0042100),-0.46180199927996113,-1.1778950074190127,0.27851458885941643,0.669804914303168,1.0,5/17,16.85%,BCL2;MEF2C;CTPS1;CD40;CD180
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5718926566352163,1.1778626563950993,0.2988313856427379,0.8460181641970547,1.0,2/12,1.65%,UST;DSE
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4255403699141366,1.1776314290419878,0.2453066332916145,0.8457172893161742,1.0,35/80,25.05%,SGSM2;ERC1;RAB6A;SNX2;RAB7B;STX5;EHD3;VPS54;GBF1;RGP1;RNF126;SNX32;VTI1A;SNX12;TBC1D10A;TBC1D5;TRAPPC10;TMEM87A;BET1L;TMEM87B;TBC1D17;RBSN;SNX8;WASHC1;VPS52;VPS51;VPS53;SURF4;UBE2O;PHETA2;TBC1D23;ARL1;VPS29;SPAG9;RAB7A
prerank,mammary gland epithelium development (GO:0061180),-0.46598980882799973,-1.1770406342701798,0.2794871794871795,0.670523185405589,1.0,7/14,25.40%,WNT4;ERBB4;CSF1R;AKT1;EPHA2;WNT3;WNT2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4560787593352588,1.1770082022846688,0.24770642201834864,0.8467601315676276,1.0,6/48,5.27%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;DMD
prerank,negative regulation of cell junction assembly (GO:1901889),0.500316742485287,1.1770034376744294,0.28043143297380585,0.8457631366283462,1.0,5/25,6.54%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN
prerank,blood vessel diameter maintenance (GO:0097746),0.48108707104484993,1.1768007888553988,0.27510917030567683,0.8453713631645224,1.0,4/34,4.28%,KCNMB2;EDNRA;GCLC;AGTR1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.46816730642720983,1.176522700305282,0.26359832635983266,0.8452078570624026,1.0,15/40,15.79%,TCF7L2;TGFB3;TGFBR1;TGFBR2;GCNT2;BAMBI;TGFB1I1;JAG1;FOXC1;BCL9L;SMAD2;TIAM1;MTOR;TWIST1;WWTR1
prerank,ceramide catabolic process (GO:0046514),0.5583546109057422,1.176352588743294,0.30434782608695654,0.8447170232943918,1.0,2/14,3.83%,ACER3;HEXA
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4458450602494874,1.1754659561220062,0.24775353016688062,0.8464414077813492,1.0,7/66,7.62%,CDH1;PRKCD;LIMK2;ZIC1;UBR5;MAVS;JUP
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.4307256792749466,-1.1753929461115242,0.26506024096385544,0.6735151788369804,1.0,7/23,9.37%,PDE4B;TGM2;GNG2;RYR2;SNCA;KCNQ1;APLP1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5112666005409385,-1.1753053031249658,0.27488151658767773,0.6720907026572912,1.0,3/11,13.01%,FOXO1;FAS;ATP6AP1
prerank,heart morphogenesis (GO:0003007),-0.3610744975702639,-1.1752819314987752,0.2134387351778656,0.6704994409959957,1.0,14/50,7.41%,ENG;CHD7;TGFBR3;NOS3;TBX3;INSR;NOTCH1;TBX1;RYR2;SOX17;EPHB4;PTK2;BMP2;HEY2
prerank,negative regulation of protein secretion (GO:0050709),0.4841724724976512,1.1750883444285376,0.2556497175141243,0.8466310959486073,1.0,9/38,15.12%,CCN3;KCNB1;IRS1;RAB11FIP3;DRD3;INHBB;REST;SERGEF;HMGCR
prerank,regulation of osteoblast proliferation (GO:0033688),0.5382682197738137,1.1749447790087857,0.2995090016366612,0.8461011827377275,1.0,4/17,9.06%,CCN1;NELL1;NPR3;RHOA
prerank,Golgi localization (GO:0051645),0.5851017686637883,1.174887702129574,0.31118314424635335,0.8452891063017244,1.0,4/11,16.28%,ARHGAP21;ARCN1;COPG1;HOOK3
prerank,sensory perception of pain (GO:0019233),-0.4304997462103093,-1.174563099294058,0.23652694610778444,0.6708339940757948,1.0,8/21,20.59%,RETREG1;P2RX7;MME;KCNA2;SCN9A;TRPA1;CCL2;KCNK4
prerank,positive regulation of ion transport (GO:0043270),0.4522440040351598,1.1740582905084238,0.2658569500674764,0.8468472908516734,1.0,8/48,8.66%,FHL1;ANK2;ANO6;STIM2;GDNF;DLG1;CRACR2A;P2RX4
prerank,positive regulation of chemokine production (GO:0032722),-0.36845747839616444,-1.1734111627311585,0.19921875,0.672216856263115,1.0,11/44,14.82%,MBP;WNT5A;IL6R;APP;HIF1A;IL18;TLR7;TLR3;CD74;CSF1R;LPL
prerank,atrial septum morphogenesis (GO:0060413),0.5905337118009151,1.1733633150182636,0.295,0.8480300953750717,1.0,4/10,9.97%,NOTCH2;ISL1;GATA4;ACVR1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5467291623830582,1.1733296986730541,0.30578512396694213,0.847132186684588,1.0,4/15,9.08%,LRP6;EDA;FOXC1;GLI2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4726371888687483,1.172864253895411,0.27170868347338933,0.8476261281411647,1.0,10/39,12.07%,THBS1;EFNA5;SEMA3E;FZD7;GCNT2;DMTN;JAG1;RHOA;ITGB1BP1;CORO1C
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5343613267821915,1.172243546576722,0.29516129032258065,0.8485706858251417,1.0,6/18,6.79%,RHOJ;ANXA1;HDAC9;FGF2;FOXC2;MAP3K3
prerank,"phototransduction, visible light (GO:0007603)",0.5549276972014213,1.1721602099905422,0.3047945205479452,0.8478499739882838,1.0,2/14,4.42%,RP1;PDE6A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.37556426226393214,-1.1711902940554637,0.2098360655737705,0.6767072890022634,1.0,8/39,5.76%,TJP1;APOE;RAPGEF2;TIE1;HSPA8;NOTCH1;DAB2IP;GFAP
prerank,thyroid hormone generation (GO:0006590),0.5997832998947222,1.1710866749255382,0.3163444639718805,0.8501042300809859,1.0,3/10,10.53%,CPQ;IYD;FOXE1
prerank,regulation of epithelial cell migration (GO:0010632),0.4512018245727846,1.1701611178031532,0.25421530479896237,0.8520373593820082,1.0,5/51,3.42%,BMPER;DOCK5;SOX9;RHOJ;PRKCE
prerank,myotube differentiation (GO:0014902),-0.4587783473913576,-1.170010056906229,0.28346456692913385,0.6782615395070518,1.0,5/17,8.51%,IGF1;SORT1;MEF2C;ADGRB3;ADAMTS15
prerank,protein K63-linked ubiquitination (GO:0070534),0.4666463570339848,1.1699082442106234,0.2647887323943662,0.851816768543238,1.0,15/41,20.94%,NEDD4;TRAF3IP2;WWP2;RNF115;UBE2B;RNF126;TRAF5;RNF168;ARIH2;UBE2S;RNF135;BFAR;TRAF3;UBE2N;RNF8
prerank,positive regulation of vacuole organization (GO:0044090),0.5909152864874962,1.1696416625509791,0.30715532286212915,0.8516932815016668,1.0,4/10,13.51%,ANXA2;RAB3GAP2;LRSAM1;SH3GLB1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39256224862591216,1.1695830462600116,0.19474835886214442,0.8509152432826391,1.0,54/173,21.04%,CD55;ANK2;ATL3;SPTAN1;ERGIC1;GOLGB1;SEC24B;TMED5;ATL2;ERGIC2;STX5;TRAPPC3L;LMAN2L;GBF1;NSF;COG5;SEC16A;DYNC1I1;ARF4;SEC23A;COPA;CAPZA1;RANGRF;VTI1A;CNIH2;SEC31A;ARCN1;COG3;GOPC;SEC13;DCTN6;CUL3;SEC24D;BCAP31;SEC22B;ARFGAP1;ARFGAP3;COPG1;SAR1B;TRIP11;DYNC1LI2;NRBP2;BET1L;WHAMM;BCAP29;USO1;DCTN5;TRAPPC3;BET1;ZW10;CAPZA2;RAB1A;TMED3;SEC24A
prerank,response to cadmium ion (GO:0046686),0.5011852598803528,1.1688579016064011,0.2831858407079646,0.852189179244001,1.0,1/26,0.24%,EGFR
prerank,embryonic heart tube morphogenesis (GO:0003143),0.45949466306650266,1.1685824783808578,0.2714486638537271,0.8520981753425946,1.0,8/43,11.10%,MICAL2;SMO;HES1;TGFBR2;GATA4;ACVR1;CCDC40;MEGF8
prerank,protein polyglutamylation (GO:0018095),-0.5034506555739298,-1.1682066748010846,0.2593516209476309,0.6813862131363045,1.0,5/11,15.92%,TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4202967047724873,1.1681859167351494,0.23757575757575758,0.852303017354744,1.0,19/86,10.86%,EGFR;PTK2B;EFNA5;PRKCD;CD44;BMP6;ABL1;NRP1;ITGA5;CD80;RIPK2;DMTN;RAP2C;PDGFA;GATA1;PLCG2;ACVR1;VEGFA;ITGB3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5324068794958915,1.16693760274552,0.29096477794793263,0.8550869900952918,1.0,11/20,27.58%,MCUB;MCU;SLC8B1;PMPCB;YME1L1;SPG7;PARL;MICU3;MICU1;MICU2;STOML2
prerank,protein-containing complex assembly (GO:0065003),0.3877125970861621,1.1668096311843754,0.16367476240760295,0.8544941702725793,1.0,62/259,16.43%,FBXL7;TCF7L1;TCF7L2;REPS2;SOX9;PTK2B;FN1;HES1;ANO6;GSK3B;SEC24B;STX5;DMD;TLE2;CREBBP;MNAT1;DMTN;TRRAP;TEAD1;NSF;CSNK1A1;MDM4;SEC16A;SHANK1;SLC9A1;SAMM50;PARD3;ANKRD28;MCU;PPP6R3;SEC23A;MATN1;BCL9L;CAPZA1;TIAM1;ITGB1BP1;CNIH2;BIN2;SEC31A;ZC3H12A;SMARCA4;SEC13;SLC7A9;KMT2D;EP300;TLE3;TRADD;CUL3;MAGI1;DHX9;SEC24D;PYGO1;TLE4;SEC22B;ADAM10;PML;SAR1B;PYGO2;TRAPPC10;SEC23IP;IKBKG;CUL1
prerank,response to iron ion (GO:0010039),-0.4932036141989948,-1.1663625450529618,0.26108374384236455,0.6847878730504602,1.0,4/12,7.40%,B2M;BCL2;HIF1A;SNCA
prerank,protein neddylation (GO:0045116),0.5646085479115672,1.1660970899320107,0.3091216216216216,0.8557506169575634,1.0,6/13,21.43%,UBE2F;DCUN1D5;DCUN1D4;DCUN1D2;DCUN1D1;UBE2M
prerank,autophagy of nucleus (GO:0044804),0.5438519649969682,1.1653386276956734,0.31211180124223603,0.8572075187162297,1.0,9/16,26.19%,ULK2;WIPI2;ATG3;RB1CC1;ATG2A;WDR45B;ULK1;ATG5;ATG7
prerank,positive regulation of T cell proliferation (GO:0042102),-0.34151063390599223,-1.1648562073932063,0.1821705426356589,0.6871243196956474,1.0,10/55,15.05%,IGF1;IGFBP2;VCAM1;TFRC;RPS3;IL18;IL6ST;CCL19;ICOSLG;JAK3
prerank,androgen metabolic process (GO:0008209),-0.4369470561682681,-1.1648351606206961,0.2587601078167116,0.6854728191490307,1.0,14/18,44.57%,SPP1;MED1;HSD17B7;SRD5A1;SHH;HSD17B10;HSD17B11;HSD17B4;SRD5A2;HSD3B2;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,anion transmembrane transport (GO:0098656),0.42686451485708493,1.164733845662341,0.25155666251556663,0.858058861969325,1.0,4/67,1.31%,SLC23A1;SLC23A2;SLC5A6;LRRC8D
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3724926316611133,1.1647151082627498,0.057,0.8571252140625445,1.0,255/1082,17.26%,EGFR;BMP4;CDH1;KLF5;ZFHX3;SIX1;ZFPM2;TCF7L2;MET;PLAGL1;MAP3K5;RARB;NFIB;PKD1;SOX9;BMP5;HDAC4;HOXA5;MLLT3;LRP6;CCN1;PPP3CA;CSRP3;TGFB3;PBX1;PID1;WNT11;NFIA;NFAT5;GLI3;FOXO3;MEOX2;ZBTB16;HES1;GRHL1;TCF20;ESR2;SHC1;KLF4;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;ZIC1;FGF2;FZD7;ELOF1;ELF1;ZNF423;MDFIC;ABL1;NR2F1;FOXC2;MEF2A;KLF7;TGFBR1;GLIS1;EHF;NR4A3;NR4A2;ZFP64;FOXK1;MLLT10;KAT6B;NCK2;DDX17;KLF10;BCAS3;CD80;HDAC8;GLIS2;CREBBP;ISL1;SKI;MRTFA;ESR1;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;BAMBI;TBL1X;TASP1;RIPK2;TADA3;NFIL3;E2F3;TRIM44;MYSM1;PLSCR1;TGFB1I1;JAG1;HOXC4;GDF6;MYOG;IL10;PITX3;PHOX2A;LHX2;ID2;SCAF8;IRF1;JUP;NFIX;REL;SIX4;TEAD1;CHEK2;FZD1;TLR4;GABPB1;GABPB2;PITX2;MLXIP;HIVEP3;CAMTA2;RXRA;THAP3;GRHL2;ATOH8;FOXC1;NFYA;RORA;WDR43;PAXBP1;SLC9A1;SERTAD3;GLI2;CHUK;EGR2;NFKB1;NIBAN2;SSBP3;MED13;FBXW11;BCLAF1;LPIN2;IL33;GATA1;CTCFL;RARG;HOXB4;RARA;RBMX;ACVR1;PIM2;ATM;PPP1R12A;JUN;NRF1;VEGFA;SLC30A9;APEX1;WAC;ARF4;ELF3;FOXE1;BRCA2;PRDM15;TCERG1;LRP5;BCL9L;PER1;SMAD2;ATF6;ERBB2;KANSL3;ZBED4;NFKB2;BPTF;RNF111;COPS5;FOXK2;RGMB;ITGB1BP1;HTATIP2;NKX2-1;AATF;BCL11B;KAT2A;NR4A1;ZC3H12A;DDRGK1;SMARCA4;ATRX;KMT2D;NFATC3;MTOR;PPRC1;TCF3;CHEK1;PPM1A;HNF4A;HNF1A;PRKDC;PAX6;EP300;HCFC1;TNFSF11;SP3;E2F2;CRTC1;ZXDC;NFATC1;REST;TNIP1;DHX9;FOXD2;ZNF507;MED14;ATF2;HOXD3;TWIST1;MAP2K2;SQSTM1;GALR1;HINFP;PML;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;KAT2B;TRIM16;AGO2;HSF2;CREBL2;CALCOCO1;IKBKG;JMJD6;ZMIZ1;MED24;NAA15;NSD1;RNF14;YY1;RET;ZNF76;CREB3L3;SBNO2;BRD8;BCL10;SREBF1;PITHD1
prerank,regulation of glucose import (GO:0046324),-0.39964708132648863,-1.1645938369438127,0.2367601246105919,0.6843941568994697,1.0,7/30,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;ENPP1;PRKAG2;INSR
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.44631812693914946,-1.1644404302278688,0.2810810810810811,0.6831194282201045,1.0,6/18,7.93%,SHANK3;NRXN1;RIMS1;RIMS2;PRKCZ;GRIN1
prerank,positive regulation of calcium ion import (GO:0090280),-0.49047176344372134,-1.1643271486582174,0.28860759493670884,0.6818080523490577,1.0,5/12,19.98%,PDGFRB;CXCL12;STC1;CCL2;SPHK2
prerank,cellular metal ion homeostasis (GO:0006875),0.41286583630234575,1.1637566227286074,0.23684210526315788,0.8591655874061885,1.0,21/102,11.42%,KCNJ2;SLC12A2;SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;CLDN16;ATP1A3;ATP1A4;ATP1A1;SLC9A1;TNNI3;DRD3;CCL3;CCL1;SLC8B1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3220204910835994,-1.1633940287112707,0.18848167539267016,0.6827904635870828,1.0,28/82,13.07%,EFNB2;LYN;EPHA7;PAK1;EPHB1;ACTB;CHN1;GRIN2B;EPHA4;EPHB4;EPHA8;PTK2;VAV3;EPHA6;GRIN1;RAC1;DNM1;PAK3;ARPC4;SDCBP;ROCK2;EFNB3;ARHGEF7;APH1B;MMP2;ARPC3;ARPC5;NGEF
prerank,phospholipid biosynthetic process (GO:0008654),0.4753839726165198,1.1632579101221954,0.27155172413793105,0.8597390702346704,1.0,13/36,20.33%,DHDDS;SGMS2;PIP5K1A;MBOAT1;GNPAT;MVD;CPNE3;AGK;HDHD5;CPNE1;FDPS;LPCAT1;CLN3
prerank,positive regulation of neuron projection development (GO:0010976),-0.3254810753815252,-1.1632330194595264,0.13368983957219252,0.681562629784015,1.0,28/85,11.43%,CAMK1D;LYN;APOE;PRKD1;ITGA6;PTK7;RAPGEF2;WNT5A;TENM3;SERPINI1;FUT9;ROR2;BMP7;TOX;ATP1B2;NDNF;RIT2;DAB2IP;LRRC7;SETX;LRP8;NTRK2;PLK5;RAPGEF1;TWF2;MDK;CAMK2B;FES
prerank,cellular response to misfolded protein (GO:0071218),0.5239030765612593,1.1631574429157998,0.3017656500802568,0.8590398215614578,1.0,8/20,24.66%,RNF185;VCP;RNF126;CUL3;UFD1;UBE2W;UGGT2;POMT2
prerank,histone H3-K4 trimethylation (GO:0080182),0.5681575001058617,1.1629113574512002,0.3169491525423729,0.8588173709145569,1.0,6/11,28.10%,CTR9;KMT2D;WDR82;OGT;KMT2A;SETD1B
prerank,double-strand break repair (GO:0006302),0.3941902538881067,1.162880316683908,0.21283783783783783,0.857930920000826,1.0,60/158,25.95%,REV3L;HERC2;RNF138;VCP;EYA3;CHEK2;ERCC5;WRN;APLF;ATM;BRCA2;NABP1;SMC5;MTA1;PPP5C;SPIDR;RAD52;UIMC1;SLX4;RNF168;PRKDC;XRCC5;BAP1;POLB;KDM4D;MCM9;KDM2A;NSMCE1;RBBP8;SMARCAL1;YY1;RPA1;RECQL5;BARD1;NBN;RAD51;ERCC1;SMARCA5;TNKS1BP1;INO80;PSMD14;PARP3;SWSAP1;UBE2N;MAPK8;EXD2;RAD51C;SMC6;POLA1;RNF8;DDX1;RAD50;ZFYVE26;BRCC3;PARP2;BRIP1;KAT5;POLQ;MDC1;RAD51AP1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42596625459791115,1.1628544576105013,0.24812967581047382,0.8570299038393508,1.0,17/78,12.78%,EGFR;PID1;SORBS1;ITGB1;PRKCE;MRAP;ATP2B4;RHOQ;LRP1;PLS1;AGR2;DLG1;STX8;MMP14;RANGRF;PTPN9;ZDHHC2
prerank,camera-type eye development (GO:0043010),0.5168016435179035,1.162816063352164,0.3223787167449139,0.8561664645189531,1.0,9/25,10.34%,CYP1B1;CACNA1C;STRA6;EFEMP1;TSKU;SKI;PITX2;NF1;VEGFA
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.4209177143371008,-1.162735969491523,0.2755681818181818,0.6813086261121825,1.0,5/22,8.16%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5733193098552756,1.1625741302454702,0.305,0.855940031789235,1.0,2/12,6.15%,DPYSL3;CTPS2
prerank,response to interleukin-4 (GO:0070670),-0.5314246170055724,-1.1625071645505305,0.3020304568527919,0.6802691273794672,1.0,4/10,18.16%,LEF1;TCF7;JAK3;XBP1
prerank,nucleosome organization (GO:0034728),0.4451397102934892,1.1622986335660241,0.26957637997432604,0.8558097936606945,1.0,18/55,24.12%,SOX9;CHAF1B;KAT6B;SETD2;SRCAP;BPTF;SMARCA4;ATRX;VPS72;NAP1L2;SMARCA5;INO80;SMARCC1;CHAF1A;RNF8;PAF1;DMAP1;ARID1A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4891059381181248,1.1622265792265378,0.30640243902439024,0.8550450836164463,1.0,5/28,4.70%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3917914197787168,1.1620637924695187,0.22087912087912087,0.8545838159206747,1.0,26/175,14.58%,TNFRSF11B;CARD14;EDA;PTK2B;PID1;TANK;FOXO3;YBX3;NFE2L2;PSMB2;TNFRSF13B;CHUK;ERBIN;LIMS1;PSMC6;CDIP1;CCL3;CCL1;TRAF5;TNFRSF1B;ZC3H12A;TNFSF11;PSMD11;TRADD;DHX9;PSMD1
prerank,negative regulation of response to stimulus (GO:0048585),0.44378077134925714,1.162015443381384,0.25620915032679736,0.8537363024510708,1.0,9/60,6.79%,SLIT2;VPS13C;COL3A1;UBASH3B;KLF4;HHIP;KLF7;CLU;MAP3K3
prerank,regulation of cellular component movement (GO:0051270),0.4516191528612477,1.1619164766471246,0.27807486631016043,0.8530741454919804,1.0,11/49,11.11%,EGFR;ARAP1;CD9;ABL1;DIAPH1;TGFBR1;MEMO1;MYCBP2;RHOA;VEGFA;ERBB2
prerank,wound healing (GO:0042060),0.44054320667074304,1.1617468658538812,0.24650571791613723,0.8526108087757345,1.0,16/62,11.25%,AHNAK2;PPP3CA;DSP;COL3A1;FGF2;FZD7;TGFBR1;SYTL4;TSKU;NOG;GATA4;PDGFA;NF1;ITGB3;ERBB2;PLEC
prerank,mitochondrial transcription (GO:0006390),0.5726676770003095,1.1616458192867873,0.3133561643835616,0.8519490798581904,1.0,1/10,2.23%,FOXO3
prerank,positive regulation of immune system process (GO:0002684),0.547336678873681,1.161397738041393,0.3113673805601318,0.8517552479910134,1.0,5/16,25.50%,ANXA1;VEGFA;TGFB2;IL15;MIA3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.46797246734163744,1.1610146640579806,0.28345323741007195,0.8520335797573887,1.0,7/37,7.72%,EFNA5;MAPRE2;PHLDB2;GSK3B;FAM107A;GAS2L2;MARK2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.48421719339978375,1.1607760216654817,0.282089552238806,0.8517968291498476,1.0,9/29,15.97%,RAB6A;TRAPPC3L;NSF;COG5;COPA;VTI1A;COG3;COPG1;TRAPPC10
prerank,intestinal absorption (GO:0050892),-0.4910638611529975,-1.16074492384759,0.30548302872062666,0.683446394835769,1.0,4/13,8.64%,F11R;UGCG;ADRA2A;KCNQ1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.38375016628850117,-1.160686300046151,0.2367601246105919,0.6819329906535886,1.0,6/34,9.16%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,positive regulation of protein polymerization (GO:0032273),0.43780994191664513,1.1606672864062992,0.25440806045340053,0.8511763746920824,1.0,14/65,12.85%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;TOGARAM1;AKAP9;NCKAP1;CTTN;SLAIN2;FCHSD2;FCHSD1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4072610381341617,1.1603868445552543,0.24530516431924881,0.8510496146110071,1.0,21/112,15.29%,FOXP1;THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;IL10;TLR4;IL33;PLCG2;RARA;IRAK3;CCL3;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TWIST1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.38816904796988216,-1.1600835502292295,0.22740524781341107,0.6818846775217525,1.0,7/30,8.12%,ROBO1;ARHGEF3;F11R;LPAR1;NET1;ADGRG1;RAC1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5492549138015661,1.1599812901321949,0.30491803278688523,0.8512983560736306,1.0,4/14,16.62%,PAICS;RFK;PFAS;GMPS
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.44441864313859036,1.159298165232089,0.2897196261682243,0.8523915727549887,1.0,11/48,13.70%,DOCK5;CUX1;ABL1;NRP1;FBXW8;DMTN;S100A10;LIMS1;LIMS2;PRKDC;TRIOBP
prerank,positive regulation of protein acetylation (GO:1901985),-0.48215538069190494,-1.159052838509473,0.28717948717948716,0.6829898689476759,1.0,2/12,5.41%,RAPGEF3;PRKAA2
prerank,regulation of chromosome segregation (GO:0051983),0.5546947267876868,1.1590471379361162,0.3234323432343234,0.8522103935979277,1.0,9/16,22.97%,SMC5;PUM2;PUM1;IHO1;RMI2;CSNK2A2;CSNK2A1;SMC6;KIF2C
prerank,positive regulation of vascular permeability (GO:0043117),-0.48800434981512597,-1.158783873569447,0.2857142857142857,0.6821023204900681,1.0,3/12,7.31%,TJP1;OCLN;PDE2A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4786626112405708,-1.1587506508509546,0.2784503631961259,0.6805603086953428,1.0,5/12,27.45%,PCGF5;RBM15B;CDYL;METTL3;SMCHD1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34779923675796603,-1.1584254026622782,0.20149253731343283,0.6797377154326091,1.0,17/51,9.82%,LIMCH1;PPM1E;RAPGEF3;PAK1;CCN2;LPAR1;EVL;CD47;ARHGEF15;SYNPO2;CCDC88A;SYNPO;FHOD1;RAC1;RGCC;PLEK;NF2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4342697123770837,1.1582285265871415,0.27735368956743,0.8537600309260286,1.0,26/63,23.65%,PLAGL1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;WAC;PRKDC;EP300;CCND1;CNOT7;PIDD1;PML;CASP2;CDKN1A;CARM1;TNKS1BP1;CNOT4;E2F1;CNOT11;CDK2;CCNB1;CNOT3
prerank,inositol lipid-mediated signaling (GO:0048017),0.4548375696373048,1.1582098004507617,0.26649076517150394,0.8528584949477662,1.0,10/50,4.52%,PLCE1;TNFAIP8L3;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.37924105136900804,-1.1581756072911737,0.2280130293159609,0.6788006326050717,1.0,11/34,11.56%,FLT1;SEMA6A;PRKD1;KDR;NOTCH1;DAB2IP;ERN1;SPHK1;RAMP2;FLT4;NUS1
prerank,protein monoubiquitination (GO:0006513),0.47064799405290464,1.1579928215631832,0.30482758620689654,0.8525128588385925,1.0,15/36,26.57%,UBE2B;KLHL22;RNF126;UBE2D3;WAC;CTR9;CUL3;FANCL;TRIM25;UBE2W;HUWE1;PAF1;UBE2O;UBE2R2;RNF20
prerank,microtubule polymerization (GO:0046785),0.4920034996706104,1.1576745448091113,0.2972181551976574,0.8524897679723558,1.0,9/28,16.89%,MAP7D3;FGF13;NDEL1;HDGFL3;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,regulation of dendritic spine development (GO:0060998),-0.44645986337357807,-1.1574484564527883,0.24242424242424243,0.6792241468811082,1.0,7/19,14.15%,SHANK3;APOE;PPFIA2;MEF2C;CAMK2B;KIF1A;GRIN3A
prerank,regulation of keratinocyte migration (GO:0051547),0.569244524605726,1.1574149335061799,0.32100840336134456,0.8523314573936362,1.0,2/12,2.33%,ADAM9;MAPRE2
prerank,regulation of feeding behavior (GO:0060259),-0.5098922254407077,-1.1573845932121256,0.291358024691358,0.6777689862693693,1.0,2/11,1.20%,LEPR;SGIP1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.45673143154929846,1.1573065223573225,0.28669410150891633,0.8516942263999223,1.0,13/42,19.70%,KDM1A;SETD2;FUS;SPIDR;CHEK1;PPP4R2;MRNIP;SHLD1;RMI2;SIRT6;RAD51;WDR48;HELB
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4098618415265919,-1.1572799922985,0.26912181303116145,0.6764382492768081,1.0,11/22,17.56%,LYN;PICALM;EPHA4;ABCG1;LRRTM3;ROCK2;CASP3;GSK3A;RANBP9;ABCA2;GSAP
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.44410903504692933,1.1571199649743895,0.2797385620915033,0.8513491192062014,1.0,14/60,18.09%,SMOC2;KLF4;FGF2;NEK7;GRHL2;TNKS2;ATM;CHTF18;FBXO4;XRCC5;POLG2;CHTF8;ATR;MAP3K4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3674533960236243,-1.1569980142360594,0.2336448598130841,0.6756393763616194,1.0,12/40,15.48%,VTN;SGIP1;B2M;INSR;CD63;DGKD;HIP1;ARRB1;CCL19;NTF3;ARRB2;GREM1
prerank,protein localization to chromosome (GO:0034502),0.47849765018280754,1.1569590925721482,0.30428571428571427,0.8508711122279691,1.0,12/34,19.48%,ESR1;TNKS2;RB1;WAPL;ATRX;XRCC5;MRNIP;MCM9;RPA1;LEMD2;ATR;PARP3
prerank,striated muscle contraction (GO:0006941),-0.352850650214074,-1.156551444093291,0.21011673151750973,0.6752407802222163,1.0,11/53,14.28%,ATP1A2;DTNA;SLC8A1;RYR2;RCSD1;KCNQ1;STAC;ARHGEF11;CASQ2;GRK2;MYH14
prerank,protein O-linked glycosylation (GO:0006493),0.41968760363203705,1.1565406055631189,0.24879807692307693,0.8512113959900609,1.0,8/96,3.90%,ST3GAL4;TMTC1;PLOD2;B3GNT2;GXYLT2;LARGE1;GALNT15;GALNT13
prerank,fatty acid catabolic process (GO:0009062),0.4286910470594955,1.1565063589600457,0.2655440414507772,0.8503931276037671,1.0,13/67,11.31%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;PLA2G15;DECR1;ACOT8;ACADM;PECR;ACBD5;LPIN2;HACL1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3720630467206774,1.1564347488162956,0.13751263902932254,0.8496513243630189,1.0,115/476,16.80%,EGFR;BMP4;CDH1;ZFHX3;SIX1;MAP3K5;NFIB;SOX9;HDAC4;MLLT3;LRP6;TGFB3;WNT11;GLI3;FOXO3;ZBTB16;HES1;ESR2;SHC1;KLF4;INHBA;ZIC1;FGF2;FZD7;ELF1;ZNF423;MDFIC;FOXC2;TGFBR1;EHF;FOXK1;KAT6B;CD80;GLIS2;CREBBP;ESR1;STAT3;GATA4;DDIT3;BAMBI;TBL1X;TASP1;TADA3;NFIL3;TRIM44;TGFB1I1;GDF6;IL10;PITX3;LHX2;ID2;IRF1;SIX4;TEAD1;CHEK2;FZD1;HIVEP3;RXRA;ATOH8;FOXC1;NFYA;RORA;SERTAD3;GLI2;CHUK;EGR2;NFKB1;NIBAN2;MED13;FBXW11;GATA1;CTCFL;RARA;ACVR1;PIM2;JUN;WAC;FOXE1;BRCA2;LRP5;SMAD2;RNF111;FOXK2;RGMB;NKX2-1;KAT2A;SMARCA4;TCF3;PPM1A;HNF4A;HNF1A;PAX6;EP300;HCFC1;SP3;ZXDC;NFATC1;REST;MED14;MAP2K2;HINFP;PML;EPC1;TFAP2A;THRAP3;TRIM16;CREBL2;CALCOCO1;JMJD6;ZMIZ1;MED24;NAA15;NSD1;RNF14;RET
prerank,calcium ion transport (GO:0006816),0.40543165601209114,1.1562698571007248,0.24627720504009165,0.8492312334701617,1.0,19/113,7.26%,SLC24A3;PKD1;RAMP1;ANK2;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;ATP2B4;STIM2;ITGAV;TRPM7;CASR;CRACR2A;CACNG6;CACNA1F
prerank,regulation of focal adhesion assembly (GO:0051893),0.43914237502536413,1.1557608350360253,0.268,0.8497643423251522,1.0,17/54,12.07%,THBS1;EFNA5;PHLDB2;ABL1;FAM107A;NRP1;BCAS3;VCL;PTPRA;DMTN;SLC9A1;S100A10;RHOA;LIMS1;VEGFA;ITGB1BP1;CORO1C
prerank,smooth muscle tissue development (GO:0048745),0.5762568098291361,1.1556756445335132,0.33562822719449226,0.8491023855666343,1.0,3/10,4.15%,BMP4;SMO;STRA6
prerank,diterpenoid metabolic process (GO:0016101),0.43972327383811693,1.1555719551071355,0.2767379679144385,0.8484773355858104,1.0,9/55,8.76%,GPC6;ADH7;GPC3;STRA6;RBP1;RLBP1;LRP1;GPC4;PECR
prerank,sulfur compound catabolic process (GO:0044273),-0.3688826330820312,-1.154980179952877,0.22697368421052633,0.6779418177758139,1.0,13/38,16.83%,FMOD;OGN;DCN;GGT5;LUM;OMD;CSPG5;NCAN;IDS;HEXB;PRELP;GGT1;GALNS
prerank,response to ionizing radiation (GO:0010212),0.42376843296123184,1.1540126193862645,0.2562189054726368,0.8521983748210314,1.0,21/70,18.56%,TANK;ANXA1;CLK2;EYA3;ATM;NABP1;MTA1;SPIDR;COP1;UIMC1;RNF168;MRNIP;KDM4D;USP28;TICRR;CDKN1A;RAD51;BRAT1;TNKS1BP1;INO80;TOPBP1
prerank,cardiac muscle cell action potential (GO:0086001),0.4850219055273909,1.1539893790277407,0.3020527859237537,0.8513362696410719,1.0,6/30,5.27%,KCNJ2;ANK2;ATP1B1;CACNA1C;CACNA1G;DMD
prerank,positive regulation of chromosome organization (GO:2001252),0.5529365953930743,1.1535401332827482,0.31864406779661014,0.8517399106886573,1.0,7/15,21.85%,DDX11;ATRX;PML;NBN;SIRT6;DHX36;RAD50
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.34024282996380995,-1.1532464910697993,0.23628691983122363,0.6796074172133395,1.0,22/56,28.23%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA2;NDUFA6;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.34024282996380995,-1.1532464910697993,0.23628691983122363,0.6796074172133395,1.0,22/56,28.23%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA2;NDUFA6;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,regulation of neuron death (GO:1901214),-0.3208753243006748,-1.1532346223893044,0.16666666666666666,0.6780548413426885,1.0,17/82,9.24%,EFNB2;PICALM;WNT5A;GRID2;EPHB1;DCC;CSF1;TRIM2;GRIN2B;CD34;MEF2C;PPARGC1A;SNCA;CTSZ;MAPT;FAIM2;C1QA
prerank,negative regulation of ossification (GO:0030279),0.5046783242811216,1.153203761796621,0.30877742946708464,0.8518102584058458,1.0,4/23,4.96%,SOX9;PTK2B;SMAD6;TRPM4
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5436317935458514,1.1531501716089074,0.3273905996758509,0.8510389770874804,1.0,2/14,3.93%,THBS1;CMKLR1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4739895713458867,1.1531372930770205,0.28613138686131384,0.850144440267687,1.0,8/30,15.66%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3
prerank,regulation of viral entry into host cell (GO:0046596),-0.3806927257575745,-1.1531076798668871,0.23839009287925697,0.6768007375045155,1.0,13/30,21.23%,LY6E;HS3ST5;TRIM14;LGALS1;IFITM1;TRIM62;IFITM3;NECTIN2;CD74;TRIM21;SNX3;P4HB;TRIM27
prerank,cellular response to cadmium ion (GO:0071276),0.5019849446081117,1.1530359250650375,0.31390134529147984,0.8495411954023381,1.0,1/24,0.24%,EGFR
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.47648279797983406,1.1526520786239445,0.29178885630498536,0.8497927173319428,1.0,5/35,9.28%,PCDHB16;CDH11;PCDHB13;PCDHB9;PCDHB3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.41572506648672225,1.152574745570167,0.2527881040892193,0.8490892813210278,1.0,25/84,24.77%,FZR1;ECRG4;ANAPC5;PSMB2;CDC16;ANAPC16;AURKA;PSMC6;RB1;PSMD11;CUL3;UBE2S;PSMD1;MAD2L1;PSMC1;PSMD7;PSMD14;PSMD3;ANAPC11;ANAPC10;CDK2;CCNB1;CDC20;BUB3;PSMD12
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5525165644855249,1.1523618704483125,0.28595317725752506,0.8487809416354529,1.0,2/12,6.40%,PRPS2;ADA
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.36696018611106324,-1.1523244291916919,0.23778501628664495,0.6773494172262888,1.0,15/39,18.62%,RPS14;RPS19;RPS5;RPS16;RPS15;RPS27;RPS24;RPS7;RPS25;SNU13;RPS17;NPM1;MRPS11;RPS28;TSR3
prerank,smooth muscle contraction (GO:0006939),-0.46308684278392953,-1.1508355245650073,0.2846153846153846,0.679760870630143,1.0,8/14,11.32%,MYLK;SLC8A1;PIK3C2A;MYH11;SMTN;ACTA2;BDKRB2;ROCK2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.49235931356315255,1.150513339445973,0.315625,0.8533139854610373,1.0,5/27,4.70%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,fatty acid elongation (GO:0030497),-0.4825007826655182,-1.1504015620699737,0.27918781725888325,0.6792856849522501,1.0,6/13,18.49%,ELOVL7;ELOVL6;HACD3;ELOVL4;HACD2;HACD1
prerank,regulation of apoptotic process (GO:0042981),0.3701159524518365,1.1502885731553754,0.10542168674698796,0.8530637805959426,1.0,115/676,14.50%,SLIT2;EGFR;THBS1;BMP4;RASSF2;CARD14;FSTL1;MAP3K5;GRK5;PERP;SOX9;HOXA5;NGF;ARHGAP10;EGLN3;CYP1B1;TCIM;PTK2B;NDRG1;TGFB3;ANXA1;AKAP13;WNT11;PAWR;SMAD6;FOXO3;FBXO10;CD44;ANXA4;GCLC;VAV2;ANO6;SHC1;TAX1BP1;CRADD;ITGB1;GSK3B;NOTCH2;UNC13B;ERC1;ABL1;IP6K2;SERPINB9;TIAM2;SON;CASP6;VCP;SFRP4;DNAJC3;GADD45G;CREBBP;TRIO;GDNF;CLU;RIPK2;GOLPH3;BIRC6;ARHGEF6;GAS1;IL10;BIRC7;CALHM2;SOCS2;SIX4;PLK3;ERCC5;RIPK3;WRN;NFKB1;NIBAN2;GNA13;RBM25;BCLAF1;NTSR1;GATA1;RARG;NF1;PIM2;ATM;JUN;PROK2;MTDH;VEGFA;APEX1;ARF4;DIABLO;ATF6;KRT18;ARHGEF5;ARL6IP5;USP47;COPS5;TIAM1;DDX42;UBE2Z;HTATIP2;MYD88;AATF;SOS2;DDRGK1;RNF122;YME1L1;PAK2;PRKDC;OMA1;PLSCR3;BAG3;FATE1;TRADD;PRDX5;REST;TMEM219;HTR2B;STIL;CEACAM5
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5845275010624145,1.149829656100289,0.34440559440559443,0.8534622769232052,1.0,2/10,2.33%,ADAM9;MAPRE2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.48798541155608577,1.1490527662528687,0.3219584569732938,0.8548147581377852,1.0,2/26,1.54%,ACER3;CYP1B1
prerank,phospholipid metabolic process (GO:0006644),0.42078374710941646,1.1488720112673778,0.27728983688833125,0.85445126065219,1.0,13/71,14.88%,TNFAIP8L3;PLPPR2;PLPP3;PNPLA3;PLA2G4F;PIP5K1A;PLA2G15;MBOAT1;GNPAT;LCAT;PLPP1;PLA2G2C;PLCD1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.4868164974056716,-1.1483651167444657,0.3132530120481928,0.6816572507982874,1.0,3/11,13.41%,CALM1;CASQ2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.4868164974056716,-1.1483651167444657,0.3132530120481928,0.6816572507982874,1.0,3/11,13.41%,CALM1;CASQ2;CALM3
prerank,regulation of protein export from nucleus (GO:0046825),0.4989879521350212,1.1482878550265163,0.31738437001594894,0.8553210983336254,1.0,6/23,17.18%,TCF7L2;GSK3B;EMD;BAG3;XPO4;BARD1
prerank,protein localization to synapse (GO:0035418),0.5582379962590939,1.1481039742949797,0.33217993079584773,0.8549612069424369,1.0,5/12,10.96%,BSN;NPHS1;SHANK1;PCLO;ZDHHC15
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.49845751800066707,-1.1479476699339264,0.29772727272727273,0.68120633493438,1.0,3/11,5.56%,LYN;RAPGEF2;MEF2C
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5592783263059194,1.1473232149865742,0.34121621621621623,0.85631854346342,1.0,5/15,16.07%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,positive regulation of B cell activation (GO:0050871),-0.34666231784165186,-1.146946006922708,0.24369747899159663,0.6822537641221331,1.0,17/50,21.55%,BCL2;TFRC;SH3KBP1;MEF2C;VAV3;CD81;CD38;TNIP2;RIF1;MIF;CD74;CD40;BTK;XBP1;SHLD3;SYK;IL7
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.42656798864742407,-1.1468878402713905,0.2832369942196532,0.6808657642448331,1.0,4/22,4.85%,APOE;PPARA;ZBTB20;PPARD
prerank,response to molecule of bacterial origin (GO:0002237),0.42410179237094753,1.1468527997513949,0.28846153846153844,0.8568005296668861,1.0,9/69,9.96%,FOXP1;LBP;SMAD6;SLPI;IL10;TLR4;CXCL2;ERBIN;IRAK3
prerank,cortical cytoskeleton organization (GO:0030865),0.45584093468245523,1.1467367499980137,0.29411764705882354,0.8562164650057642,1.0,9/41,10.18%,FMNL2;EZR;PPP2R3C;RHOBTB1;RHOQ;DLG1;RHOA;RND3;NCKAP1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3901565370967656,1.1463835551018058,0.23793859649122806,0.8562974560738703,1.0,35/170,16.77%,FOXP1;CDH1;PRDM6;ATP1B1;AFF3;YBX3;COQ7;NELL1;ZFP64;TSKU;LDLR;HMG20A;GDNF;C1D;PTHLH;TRIM44;TOB2;AFF4;IL10;TOB1;PCBP4;TRIM26;MEGF8;KIF16B;MKLN1;TCF19;ZC3H12A;REST;ZNF507;TRIM39;HINFP;ZNF462;GNB3;PRDM5;SCARB2
prerank,inhibitory synapse assembly (GO:1904862),-0.4921575894669874,-1.1462672661430515,0.29280397022332505,0.6809378945126967,1.0,5/11,8.53%,WNT5A;GABRA2;GABRB2;GABRB3;GABRA1
prerank,microvillus organization (GO:0032528),0.5572677154873409,1.1461075483240046,0.3193717277486911,0.8562141769589233,1.0,5/13,7.79%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,regulation of epithelial cell proliferation (GO:0050678),0.41759772785912175,1.1458553318498303,0.26498800959232616,0.8560407544192793,1.0,16/85,12.33%,EGFR;BMP4;TCF7L2;SOX9;BMP5;BMP6;FGF2;NR4A3;SRSF6;GDF5;SIX4;LIMS1;VEGFA;ERBB2;DUSP10;NR4A1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5563904987567815,1.1458294767580937,0.3393739703459638,0.8551882281572086,1.0,8/14,30.11%,TNKS2;BRCA2;ATRX;XRCC5;ATR;ACD;TPP1;PINX1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.434740240410205,1.145451763663151,0.2853333333333333,0.8553745694694088,1.0,37/58,35.22%,HERC2;ATM;SMC5;UIMC1;RNF168;PRKDC;XRCC5;ERCC8;POLB;KDM2A;ZBTB7A;SMARCAL1;BARD1;NBN;ERCC1;PSMD14;UBE2N;POLA1;RNF8;RAD50;BRCC3;KAT5;POLQ;MDC1;XRCC4;POLM;IFFO1;PIAS4;BABAM2;PAXIP1;LIG4;NSMCE2;SUMO1;MRE11;BRCA1;ERCC4;ABRAXAS1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5622344506814044,1.1451575823889337,0.33568904593639576,0.8553137566084212,1.0,4/11,13.42%,CLK2;C1QTNF12;ERFE;EP300
prerank,chromatin assembly or disassembly (GO:0006333),0.5737299892949184,1.145152145017311,0.32482993197278914,0.8544158969536618,1.0,2/11,5.36%,CHAF1B;HDAC8
prerank,zymogen activation (GO:0031638),0.46714403435846713,1.1451063429544217,0.28888888888888886,0.8536353089889718,1.0,7/39,13.81%,CYFIP2;PERP;PRSS12;RIPK2;MMP14;OMA1;TBC1D10A
prerank,monocyte differentiation (GO:0030224),0.5739478955938352,1.1450252050176692,0.35495495495495494,0.8529472417720432,1.0,1/10,0.28%,BMP4
prerank,UV protection (GO:0009650),0.5917338456715749,1.1449924830791784,0.32869565217391306,0.8521134462592306,1.0,2/10,8.17%,SCARA3;ERCC5
prerank,regulation of transferase activity (GO:0051338),0.5174795367903923,1.144729031965487,0.32248062015503876,0.8519746257695553,1.0,9/17,23.69%,SMG6;SPTSSB;FEM1B;ATM;PPP1R3F;PARP4;EMP2;LDB2;LDB1
prerank,erythrocyte differentiation (GO:0030218),-0.3643239984304311,-1.1444721971214677,0.2550607287449393,0.68426029564804,1.0,14/44,16.12%,LYN;TGFBR3;MFHAS1;KIT;RPS14;RPS19;ALAS1;TAL1;CASP3;IKZF1;MED1;JAK3;SH2B3;LYAR
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4413993170513449,1.1444165248271572,0.3129161118508655,0.8519354969129702,1.0,4/51,3.93%,THBS1;PGF;ANO6;CMKLR1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5316759154073304,1.144334128297999,0.32591414944356123,0.8512974030107994,1.0,4/17,10.78%,HDAC4;PID1;PFKFB1;NCOR1
prerank,dorsal/ventral pattern formation (GO:0009953),0.5069099320243275,1.1439960024033826,0.30077519379844964,0.8513527517861944,1.0,6/20,9.97%,BMPR1A;MDFI;NOG;NBL1;GLI2;ACVR1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3807954389459147,-1.1438811205886648,0.24126984126984127,0.684293094000187,1.0,15/34,22.47%,LYN;MFHAS1;LGR4;DAB2IP;CD300A;GRAMD4;TLR3;TYRO3;LRRC14;SARM1;TNFAIP3;GPS2;TREM2;SMPDL3B;CACTIN
prerank,positive regulation of protein phosphorylation (GO:0001934),0.37351124052090634,1.1438567847392351,0.20717948717948717,0.8508762602578388,1.0,50/348,10.42%,EGFR;BMP4;SLCO3A1;RASSF2;CARD14;NTRK3;SOX9;BMP5;NGF;PGF;CCN1;PDGFC;PTK2B;EFNA5;TGFB3;DDR2;CD44;KRAS;NIBAN1;LIMK2;BMP6;BMPR1A;INHBA;FGF2;DOCK7;ABL1;NRP1;TGFBR1;RAP1A;EIF4G1;ATP2B4;ITGA5;CD80;MAVS;RIPK2;GDF6;GDF5;FAM20A;RAP2C;PDGFA;BCAR3;GDF10;IQGAP1;GATA1;PLCG2;ACVR1;RB1CC1;AKAP9;VEGFA;CAB39
prerank,negative regulation of catabolic process (GO:0009895),0.4475937567665149,1.1438363158465081,0.2875,0.8500433758000869,1.0,10/47,16.63%,EGFR;HDAC4;PFKFB1;MDM4;IRAK3;NCOR1;SNX12;AZIN1;HMGCR;MAD2L1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4102787048898191,1.1437725772762322,0.27909738717339666,0.8493243089046074,1.0,41/96,28.59%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4598650616783122,1.143719214190394,0.28330995792426367,0.8485903048078367,1.0,4/36,5.13%,SLIT2;THBS1;FGF2;ATP2B4
prerank,positive regulation of transport (GO:0051050),-0.31090703864101044,-1.1435837404297975,0.15736040609137056,0.6835443721110301,1.0,36/85,23.30%,CAMK1D;APOE;MERTK;NEDD4L;IL15RA;ACTB;NR1H3;CD47;SIRPA;SGK1;GATA2;SNCA;HIP1R;GAS6;DOCK2;CALR;BOK;CYBA;GSK3A;CCL19;SMPD1;LYAR;CHCHD10;DOC2B;CDH3;DLL1;TREM2;SGK2;INPP5K;SPAG5;AHSG;MLC1;CD151;RAB27A;PLA2G5;PYCARD
prerank,ether lipid biosynthetic process (GO:0008611),0.5898004357240417,1.1432406157903727,0.3402777777777778,0.8490691720601202,1.0,5/10,22.95%,AGPS;PEDS1;GNPAT;PLA2G4A;PEX7
prerank,iron ion transport (GO:0006826),-0.348276216955432,-1.1427550443809311,0.1893939393939394,0.6842044039856426,1.0,15/47,20.54%,CP;FTH1;TFRC;SLC40A1;ABCB7;LMTK2;ATP6AP1;TTYH1;STEAP3;ATP6V1D;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.44659271802135314,1.1427470090607386,0.3092369477911647,0.8495875439987602,1.0,7/48,3.69%,THBS1;RHOJ;ANXA1;HDAC9;FGFR1;FGF2;FOXC2
prerank,synaptic vesicle cycle (GO:0099504),-0.4027788211471119,-1.142734549542972,0.2564102564102564,0.6827290948297546,1.0,16/30,26.34%,RIMS1;SYT7;SNCA;SNAP25;PIP5K1C;SYT10;RAB3A;PLD2;SLC32A1;CPLX1;SYNDIG1;OTOF;WNT7A;SNAPIN;SLC17A8;SLC18A2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3692807320096306,1.1425916801688167,0.18949536560247168,0.8491793816333286,1.0,114/336,21.90%,FOXP1;TANK;ABL1;HERC2;VCP;UBE2B;MNAT1;SUSD6;UBR5;DDIT3;GNL1;EXO1;TRRAP;TRIP12;IKBKE;CHEK2;PLK3;CHD1L;MCM7;RAD17;CEP63;WRN;DCUN1D5;APLF;CBX5;ATM;BOD1L1;USP10;APEX1;WAC;MAPK12;IGHMBP2;NABP1;SMC5;DDX11;USP47;SMC1A;ALKBH8;AATF;SPIDR;NIPBL;RAD52;MACROD2;TNFRSF1B;ZC3H12A;SLX4;CHEK1;RNF168;PRKDC;XRCC5;CSNK1E;DYRK2;MRNIP;ERCC8;POLB;CCND1;POLE2;FANCL;MAPKAPK2;ATF2;EID3;ZBTB1;MCM9;PIDD1;KIN;HINFP;PML;ERCC3;TLK2;BCL6;RBBP8;IKBKG;SMARCAL1;XPA;VCPIP1;CASP2;YY1;RPA1;RMI2;RECQL5;USP28;BARD1;NBN;TICRR;CDKN1A;NCOA6;RAD51;ERCC1;ATR;ALKBH7;BRAT1;INO80;WDR48;TOPBP1;MOAP1;PARP3;HELB;FMR1;PARP4;RAD51C;SMC6;POLA1;WDR76;MCL1;KMT5B;E2F1;RNF8;NRDE2;NUDT1;CBX1;IRF3;RAD9B;RAD50;CUL4A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3735666909868367,1.142264505783519,0.21816283924843424,0.8492638161867029,1.0,72/259,18.08%,NTN1;PKD1;BBS9;ABLIM3;FXYD5;EZR;EXOC4;GSN;PARVA;ANO6;ITGB1;EMP1;SRGAP2;PMP22;NRP1;PDE6D;RAP1A;PTPDC1;DZIP1;VCL;RAB11FIP3;SHTN1;ABLIM2;ARL3;PIP5K1A;PCM1;EHD3;GOLPH3;DMTN;ARHGEF6;GBF1;ATAT1;CEP164;RAPGEF6;OCRL;RAP2C;EXOC5;FGD6;CFAP70;CDC14A;TMEM231;IFT46;DISC1;WDR35;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;EHD2;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;ARFIP2;SSTR3;MKS1;NUDCD3;IFT52;CEP89;KIF3B;DYNC2I1;FAM161A;HYLS1;S1PR2;TEKT2;LZTFL1;WHAMM;RILPL1
prerank,activation of protein kinase activity (GO:0032147),-0.3091235157994628,-1.1413119947004626,0.19078947368421054,0.6850230132366679,1.0,25/106,8.87%,IGF1;ADCY5;OSBPL8;ADCY1;TNIK;PAK1;WNT5A;PRKAR2B;INSR;ADCY7;CARD10;NRK;PRKAR1B;MAP4K4;PPIA;FGF1;GHR;PAK5;CCDC88A;PRKACB;PRKAR1A;ADRA2A;IL18;GAS6;PAK3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5189669236882462,1.1410716413964592,0.3158756137479542,0.8519024046001803,1.0,5/18,19.46%,NUP93;THOC2;DDX19B;ZC3H11A;NXF1
prerank,negative regulation of viral transcription (GO:0032897),-0.47034102217087675,-1.1410135543602042,0.3125,0.6843330487389806,1.0,5/13,21.23%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27
prerank,respiratory system development (GO:0060541),0.46877261292401745,1.140346908027618,0.30013831258644535,0.853126582193251,1.0,8/32,12.00%,BMP4;DISP1;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.35218829930827067,-1.1392705100524778,0.24904214559386972,0.6873672540445227,1.0,10/47,6.50%,IGF1R;PHLPP1;TGFBR3;FOXO1;EPHB1;RAP2A;MAP4K4;PPIA;DAB2IP;FAS
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4080771128759635,-1.1388189430773021,0.2921686746987952,0.6870821932520684,1.0,5/26,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,protein import (GO:0017038),0.41415216071499045,1.1386294793332714,0.2883895131086142,0.8572990965704247,1.0,22/84,20.35%,ABCD3;PRICKLE1;NUP93;PXMP2;STAT3;IPO7;CLU;E2F3;TNPO2;ACBD5;SAMM50;SEC13;NUP153;PEX13;NUP214;NUP188;ABCD1;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,RNA export from nucleus (GO:0006405),0.40596494195377913,1.1385108358760947,0.2825322391559203,0.8567271950856932,1.0,42/100,28.59%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;RAN;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.41190782910332013,-1.1383814182570398,0.2976878612716763,0.6867266057641329,1.0,5/20,7.60%,IL1R1;B2M;CD81;PRKCZ;IL18
prerank,positive regulation of protein processing (GO:0010954),-0.4230480960972208,-1.1381187386628788,0.29896907216494845,0.6858936677306882,1.0,4/19,5.59%,CCBE1;CLEC3B;NKD2;MYH9
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33876996955545263,-1.1379998975279277,0.244,0.6847274571600347,1.0,15/57,12.29%,RPL38;RPS19;RPS16;RPS15;RPS24;RPS7;RPS25;RPL26;RPL35A;RPL11;RPL7;RPS17;NOC2L;RPL14;NPM1
prerank,cilium organization (GO:0044782),0.37820972491829524,1.1377069884943618,0.24653148345784417,0.8582457329310192,1.0,65/209,22.67%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PARVA;PDE6D;PTPDC1;DZIP1;RAB11FIP3;ARL3;PCM1;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;TMEM231;IFT46;DISC1;WDR35;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;EHD2;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;MKS1;FAM161B;NUDCD3;IFT52;CEP89;KIF3B;DYNC2I1;FAM161A;TTC17;HYLS1;TEKT2;LZTFL1;RILPL1;IQCB1;FUZ;POC1B;IFT80;DYNC2H1;RAB1A;OFD1;CLUAP1;TSGA10IP;TRAF3IP1;TRAPPC14;FLNA;PLK4;BBS2
prerank,peripheral nervous system development (GO:0007422),0.4976192319413514,1.1376962957709131,0.3215926493108729,0.8573786804893931,1.0,6/23,9.90%,NGF;PMP22;GDNF;EGR2;NF1;ADGRG6
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.45261500743970484,-1.1375662649605516,0.31155778894472363,0.6843305187556832,1.0,4/14,6.13%,KIT;SEMA7A;WNT5A;GPRC5B
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5564486297090332,1.1373801567244408,0.32332155477031804,0.8556067423500101,1.0,4/12,13.96%,ANAPC5;CDC16;RB1;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5564486297090332,1.1373801567244408,0.32332155477031804,0.8556067423500101,1.0,4/12,13.96%,ANAPC5;CDC16;RB1;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5564486297090332,1.1373801567244408,0.32332155477031804,0.8556067423500101,1.0,4/12,13.96%,ANAPC5;CDC16;RB1;CUL3
prerank,chromatin organization (GO:0006325),0.39347381334027404,1.1373731506440077,0.24436936936936937,0.8547244380621082,1.0,38/132,21.13%,TCF7L1;SOX9;HDAC4;HDAC8;HMG20A;ESR1;MYSM1;SETD2;EHMT1;CHD1L;BAZ2B;TOP1;NUDT5;DDX11;RB1;BPTF;KAT2A;SMARCA4;BAZ1A;ATRX;SETD5;PBRM1;HCFC1;HDAC10;KDM4D;ZBTB1;BAZ2A;BRWD1;KAT2B;ZBTB7A;EZH1;SMARCA5;INO80;SMARCC1;SATB2;CHD1;FOXA1;HMGN2
prerank,Golgi inheritance (GO:0048313),0.5538023936754799,1.136892199669536,0.3460207612456747,0.8552342068647854,1.0,4/11,16.51%,STX5;GBF1;PLK3;VCPIP1
prerank,regulation of histone deacetylation (GO:0031063),0.5536214995468286,1.13667242796893,0.32656514382402707,0.8549692083194222,1.0,4/13,14.17%,CAMK2D;ZBTB7B;NIPBL;PRMT6
prerank,secretory granule organization (GO:0033363),-0.5055950575909363,-1.136082425837955,0.3009478672985782,0.6867675403336087,1.0,2/10,4.77%,SRGN;ABCA1
prerank,autophagy of mitochondrion (GO:0000422),0.46148437195332453,1.1359937956471158,0.2983425414364641,0.8561082704756099,1.0,16/38,26.30%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG5;ATG7;USP30
prerank,cell junction organization (GO:0034330),-0.32850626130461824,-1.1359653213263436,0.2532188841201717,0.6855746391768325,1.0,18/71,10.39%,TJP1;OCLN;PPFIA2;PPFIBP2;GRM5;SLC6A1;VASP;PPFIBP1;ACTB;APP;OPHN1;SNCA;CLDN1;MAPT;PAK3;C1QA;SDK2;FLNC
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.44160651669607265,-1.1359001582247004,0.3136729222520107,0.684271587419276,1.0,4/17,13.90%,SLC7A5;PRKCQ;PRKCZ;HAVCR2
prerank,body fluid secretion (GO:0007589),-0.4533368793191762,-1.1358735132269484,0.3020304568527919,0.682830830570746,1.0,4/15,9.99%,NPR1;SLC22A4;ERBB4;SLC22A2
prerank,regulation of cell migration (GO:0030334),0.36704178774467566,1.135547549965392,0.20102564102564102,0.8565697836401484,1.0,49/382,8.11%,SLIT2;F3;EGFR;THBS1;CDH1;TMEFF2;CLIC4;DPYSL3;NTRK3;CYP1B1;CCN1;PPP3CA;PDGFC;PTK2B;SMO;PHACTR1;LMO4;PTPRU;ADAM9;ANXA1;SEMA3E;WNT11;FOXO3;SEMA3D;SEMA3C;TWIST2;SULF1;IGFBP5;ITGB1;FGF2;LMNA;SRGAP2;SRGAP3;FAM107A;TGFBR1;SGK3;VCL;GCNT2;NOG;ZMYND8;STAT3;MGAT3;SLURP1;JAG1;ELP3;RDX;RAP2C;PDGFA;ARSB
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5005107556610573,-1.135466297673781,0.315668202764977,0.6823698116490854,1.0,3/11,5.72%,LYN;ANK3;PRKCQ
prerank,barbed-end actin filament capping (GO:0051016),0.5153971906978599,1.1354307788918985,0.33072100313479624,0.8551537366622038,1.0,6/18,13.70%,VILL;ADD3;GSN;CAPZA1;ADD1;TRIOBP
prerank,actin filament capping (GO:0051693),0.5153971906978599,1.1354307788918985,0.33072100313479624,0.8551537366622038,1.0,6/18,13.70%,VILL;ADD3;GSN;CAPZA1;ADD1;TRIOBP
prerank,eye morphogenesis (GO:0048592),0.5114198715388028,1.1351467996845004,0.32131147540983607,0.8550759093297633,1.0,9/19,12.18%,COL5A2;MFAP5;EFEMP1;SKI;STAT3;RARG;NF1;VEGFA;NIPBL
prerank,negative regulation of cation channel activity (GO:2001258),-0.39367861229188583,-1.1347794742780002,0.28823529411764703,0.6826126496389062,1.0,5/26,13.41%,KCNAB1;SLC6A9;CALM1;CASQ2;CALM3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4082021454808624,1.1346015168825547,0.30392156862745096,0.8557392608393253,1.0,20/87,9.47%,EZR;PTK2B;EFNA5;SEMA3E;PRKCD;ARHGDIB;ARHGAP44;RHOBTB1;NOTCH2;ABL1;FAM107A;RHOQ;LRP1;DMTN;ARHGAP17;PDGFA;RHOA;IQGAP1;RND3;MLST8
prerank,excitatory postsynaptic potential (GO:0060079),-0.4252856413507127,-1.133850057020458,0.2612137203166227,0.683596893909766,1.0,8/19,15.10%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GSK3A;AKT1;ARRB2
prerank,positive regulation of signal transduction (GO:0009967),0.3723594391905904,1.1337588213785783,0.2356687898089172,0.8573761011183959,1.0,43/238,11.77%,RSPO3;SMOC2;F3;CCN3;NTRK3;PTK2B;SMO;PTGIS;SULF1;GRB10;SORBS1;CRADD;BMP6;IRS1;NRP1;TGFBR1;SLC39A14;ZBTB7B;ITGA5;CD80;CREBBP;SKI;ITGAV;STAT3;TRIM44;DMTN;JAG1;RSPO4;SHANK1;AAK1;DISC1;DRD3;DACT1;KIF7;C1QTNF12;LIMS1;LIMS2;ELF3;ITGB3;EVC;ERFE;ADAMTS3;ITGB1BP1
prerank,regulation of macrophage migration (GO:1905521),0.5695397371165956,1.1336691233212364,0.3226890756302521,0.8567365208428795,1.0,2/10,2.85%,PTK2B;MTUS1
prerank,positive regulation of cell migration (GO:0030335),0.3733097214621643,1.133565541890927,0.24064171122994651,0.8561795095488436,1.0,48/253,13.01%,F3;EGFR;THBS1;DOCK5;NTRK3;SOX9;CCN1;PPP3CA;PDGFC;PTK2B;SMO;DDR2;FN1;ADAM9;SEMA3E;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;PRKCE;FAM107A;NRP1;TGFBR1;GCNT2;SHTN1;STAT3;DMTN;ELP3;RDX;PDGFA;RAB25;MMP14;ELP5;PLCG2;ACVR1;ATM;VEGFA;CCL3;SYNE2;TIAM1;NIPBL;CPNE3;DDRGK1;TRIP6;MTOR;FAM83H;PIK3R3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.43234926951036695,1.133260855918696,0.300132802124834,0.8561939386125607,1.0,11/56,14.51%,EGFR;ANXA1;ANAPC5;EIF4G1;CDC25B;CDC16;RDX;RB1;LSM11;CUL3;CCND1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3761876622427997,1.133251480175517,0.22938689217758984,0.8553367113219625,1.0,57/234,16.38%,SLCO3A1;CARD14;HDAC4;LRP6;EDA;SMO;DDR2;ANXA3;PLPP3;ESR2;ERC1;RAB7B;TAB3;ESR1;STAT3;MAVS;KDM1A;DDIT3;CLU;RIPK2;IL10;JUP;IKBKE;FZD1;TLR4;RIPK4;ROR1;RIPK3;CHUK;NFKB1;PLCG2;IRAK3;MTDH;VEGFA;TRIM41;TRIM26;ARHGEF5;NFKB2;COPS5;MYD88;TRAF5;DDRGK1;CARD16;SMARCA4;PPRC1;TCF3;EP300;TNFSF11;TRADD;CRTC1;DHX9;ATF2;PIDD1;IL18RAP;ZBTB7A;TAF12;IKBKG
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3988282858145021,1.1330351349074668,0.25741399762752076,0.855096194203726,1.0,25/112,10.17%,SMAD9;SOX9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;TGFBR1;ITGB5;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;LIMS1;JUN
prerank,positive regulation of axon extension (GO:0045773),0.5051311319962307,1.1329821262879411,0.32701421800947866,0.8543770701789525,1.0,6/22,11.97%,NTN1;NRP1;SHTN1;VEGFA;MEGF8;ZFYVE27
prerank,negative regulation of mRNA processing (GO:0050686),0.5413999174860313,1.1326416478091765,0.3392568659127625,0.854518792559596,1.0,7/15,21.94%,SRSF6;PCBP4;RBMX;U2AF2;BARD1;SFSWAP;SRSF12
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5036234094278975,-1.132531076650703,0.29,0.6855940372976471,1.0,7/10,20.38%,PDE4D;PDE2A;RNF157;MGRN1;APLNR;PDE3B;PDE11A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4854815972826878,1.1323532466598134,0.3284457478005865,0.8544944764750247,1.0,9/27,17.95%,DDX5;CD44;SPRED2;SMYD2;KDM1A;ATM;TWIST1;KMT5A;ATR
prerank,dermatan sulfate metabolic process (GO:0030205),0.5428882589364497,1.1308997378193353,0.3404255319148936,0.8579027680568306,1.0,2/13,1.65%,UST;DSE
prerank,DNA replication checkpoint signaling (GO:0000076),0.5329107661034341,1.130832030499776,0.3248,0.857234610509066,1.0,6/16,21.73%,RAD17;CLSPN;CDC45;TICRR;TOPBP1;RAD9B
prerank,hyaluronan metabolic process (GO:0030212),0.49769160114985195,1.13080161713157,0.3187311178247734,0.8564608374666614,1.0,7/23,12.36%,CD44;FGF2;HEXA;SPAM1;HAS1;SLC9A1;CHP1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4961871064572982,-1.1306610470321352,0.330188679245283,0.6889591346539115,1.0,5/11,19.74%,EFNB2;MEF2C;MYOCD;GREM1;GPER1
prerank,peroxisome organization (GO:0007031),0.4841879651646617,1.1306478455358526,0.3288888888888889,0.8560611120257794,1.0,4/25,11.20%,ABCD3;TMEM135;ACOT8;LONP2
prerank,regulation of complement activation (GO:0030449),0.4572043636505799,1.1305894729768433,0.3171428571428571,0.8553482541206582,1.0,6/40,9.25%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5530036753269447,1.130049973424067,0.3511326860841424,0.8560476484584986,1.0,3/13,7.18%,KCNB1;CACNA1G;CLTRN
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.47079729116389935,1.1300322100565237,0.328928046989721,0.855236039485402,1.0,6/31,5.64%,ZFPM2;DSP;BMPR1A;TGFBR1;NOG;ISL1
prerank,positive regulation of endocytosis (GO:0045807),-0.35404425175471893,-1.1299465285679908,0.25263157894736843,0.6892873191564367,1.0,5/45,1.85%,VTN;SGIP1;APOE;B2M;NEDD4L
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4968777512864432,1.1299150723321947,0.3402555910543131,0.8547443410932335,1.0,4/23,7.16%,CYP1B1;PTK2B;HES1;IL10
prerank,synapse assembly (GO:0007416),-0.33037869291180827,-1.129729168999603,0.21782178217821782,0.688416497013943,1.0,18/67,9.63%,ADGRL3;DNM3;CDH2;SHANK3;SPOCK2;NRXN1;WNT5A;GRID2;GPM6A;PLXND1;KIRREL3;GABRA2;GABRB2;OBSL1;GABRB3;LRRTM3;GABRA1;SDK2
prerank,bone morphogenesis (GO:0060349),0.5416182106276752,1.1295397185336697,0.3191126279863481,0.8549747879884326,1.0,5/14,15.72%,LRP6;SFRP4;SKI;LRP5;TFAP2A
prerank,negative regulation of inflammatory response (GO:0050728),-0.27831625366163937,-1.1293853280493258,0.11764705882352941,0.6878590924161493,1.0,59/182,20.32%,IGF1;LYN;ADCY5;TEK;APOE;MFHAS1;ADCY1;PPARA;PRKAR2B;GNG2;CALCRL;ADCY7;NR1H3;PPARD;GGT5;PRKAR1B;MYH9;SIRPA;RPS19;C1QTNF3;ENPP3;PRKACB;PRKAR1A;ADORA2A;GRN;LRFN5;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;MDK;CD200;PLCG1;TYRO3;NR1H4;HCK;GPR176;ADCY4;TNFRSF1A;FCGR1A;PLK2;METRNL;GGT1;AOAH;RHBDF2;SELENOS;VIPR2;CDH5;LHCGR;TNFAIP3;GPS2;TSHR;OTULIN;GPER1;RXFP1;FNDC4;TREM2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.44277044659558296,1.1292272912643997,0.3169761273209549,0.855023874753807,1.0,10/49,13.42%,SMAD6;GSK3B;PMEPA1;ISL1;CLU;ANKRD27;DACT1;LDLRAD4;PPM1A;EP300
prerank,heart trabecula morphogenesis (GO:0061384),-0.43306294720941174,-1.1289437298130671,0.27692307692307694,0.6875596055791755,1.0,8/18,8.17%,ENG;TEK;TGFBR3;RBP4;BMP7;NOTCH1;RBPJ;S1PR1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3910258974706151,-1.128358666939264,0.2774390243902439,0.6875282390996824,1.0,4/27,11.35%,CSF1;IL6R;JAM3;MDK
prerank,sodium ion homeostasis (GO:0055078),-0.4113590412489214,-1.128171375398164,0.2864721485411141,0.6865601392100343,1.0,5/21,4.71%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,acute-phase response (GO:0006953),0.5511946703790251,1.1280518601771634,0.32663316582914576,0.8575660124145119,1.0,2/12,6.55%,LBP;PLSCR1
prerank,cellular component assembly (GO:0022607),0.37270807856015303,1.1279363238047289,0.23004201680672268,0.8569973276074476,1.0,47/253,12.29%,REPS2;DPYSL3;BAIAP2L1;SOX9;RHOJ;EZR;PTK2B;PAWR;CALD1;CHAF1B;RP1;HES1;GSN;PARVA;BSN;FAM107A;CREBBP;MNAT1;RHOQ;PLS1;DMTN;KRT14;PKP1;TEAD1;PDGFA;TOGARAM1;FZD1;P3H4;MDM4;HAS1;SHANK1;GRHL2;RHOA;PARD3;PCLO;LIMS1;SPAG17;LIMS2;NCKAP1;MYO9A;CCDC40;MATN1;CAPZA1;ZFYVE27;ADD1;RTN3;LIMA1
prerank,fibrinolysis (GO:0042730),-0.47265323176416596,-1.1275887113153735,0.2936893203883495,0.686702266345068,1.0,8/13,40.76%,PLAT;HRG;PLAUR;PLG;CPB2;SERPINE1;GP1BA;F2
prerank,axonal transport of mitochondrion (GO:0019896),-0.48508516162006465,-1.1270848897760952,0.30845771144278605,0.6865040236821174,1.0,5/11,25.77%,HIF1A;MAPT;TRAK2;NEFL;HAP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4824050025697992,-1.1270117483956688,0.314214463840399,0.6852483363317939,1.0,5/11,21.52%,PTPRT;NF2;SH2B3;BCL3;LEPROT
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5160951356074758,1.126901570629292,0.3328025477707006,0.8591496173036962,1.0,5/17,16.83%,DHDDS;ALG13;MVD;ALG14;ALG12
prerank,establishment of skin barrier (GO:0061436),0.5314021112266324,1.1264888277573268,0.33996683250414594,0.8586340491347558,1.0,1/15,0.77%,MET
prerank,regulation of water loss via skin (GO:0033561),0.5314021112266324,1.1264888277573268,0.33996683250414594,0.8586340491347558,1.0,1/15,0.77%,MET
prerank,artery development (GO:0060840),-0.4094391446056234,-1.126158431523737,0.2978723404255319,0.6860024983174083,1.0,7/23,9.85%,ROBO1;ENG;ROBO2;TBX1;PDE2A;ACVR2B;EFEMP2
prerank,negative regulation of immune system process (GO:0002683),0.527249372057378,1.1259343146227854,0.3464696223316913,0.8593335236907069,1.0,2/16,2.65%,SOX9;COL3A1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5240181658228795,1.1249090808381703,0.3390894819466248,0.8614570270426147,1.0,5/16,9.50%,TELO2;KLHL22;CLEC16A;RRAGB;SIK3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.501523051169372,1.1248662860172876,0.3512269938650307,0.8607115547536667,1.0,4/22,4.43%,NTRK3;NGF;RAP1A;KIDINS220
prerank,regulation of interferon-alpha production (GO:0032647),0.5017353607862367,1.1246879231998042,0.327893175074184,0.8603969591323476,1.0,11/23,18.38%,MAVS;RIPK2;SETD2;IL10;TLR4;CHUK;IFIH1;DHX9;TLR8;DHX36;PTPRS
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3705104039038454,-1.1245144765646715,0.26479750778816197,0.6890289241234949,1.0,10/33,10.27%,LRRC4C;NRG3;GRID2;GRIK2;GRIK1;LRP8;CACNA1B;EIF4EBP2;ABR;FABP5
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.38334339659690214,1.12444946701401,0.2790960451977401,0.8602464531326564,1.0,23/159,9.28%,CDH1;PCDHB16;GPC6;HMCN1;CDH11;PKD1;FAT2;MPZL2;CXADR;NECTIN3;ITGB1;DSG2;ALCAM;PTPRF;TGFBR2;CLDN11;PCDHB13;CLDN16;EMB;GPC4;PCDHB9;PVR;PCDHB3
prerank,regulation of transmembrane transport (GO:0034762),0.4605790982250909,1.1244161486536097,0.3224368499257058,0.8594773994993036,1.0,4/31,2.75%,KCNJ2;NEDD4;KCNJ15;WWP2
prerank,protein polyubiquitination (GO:0000209),0.3698617495752962,1.124315565347889,0.24382716049382716,0.858914579594841,1.0,59/297,17.18%,FBXL7;WWP1;FZR1;NEDD4;TRAF3IP2;FBXO10;UBE4B;WWP2;NPEPPS;RNF144A;RNF115;FBXO40;ANAPC5;FBXW8;UBE2B;ARIH1;MKRN3;UBR5;RNF19A;PSMB2;FBXL20;CDC16;RNF114;TRIP12;RNF126;UBE2D3;LRSAM1;FBXW11;UBE4A;TNKS2;PSMC6;FBXO17;RNF146;CBFB;TRAF5;FBXO4;HERC6;RNF168;ARIH2;ANKIB1;SMURF1;HECTD2;PSMD11;CUL3;ERCC8;UBE2S;PSMD1;RNF135;SPOP;UBE2K;CHFR;MKRN1;BFAR;CUL1;RNF14;UBE3C;PSMC1;PSMD7;BARD1
prerank,positive regulation of histone methylation (GO:0031062),-0.4006755373304679,-1.123907304353271,0.2917933130699088,0.6892363969039657,1.0,2/24,2.94%,AUTS2;JARID2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.48682178348379496,1.12385921006241,0.34609720176730485,0.8593649370525553,1.0,4/26,7.43%,EGFR;ANXA1;EIF4G1;RDX
prerank,extracellular transport (GO:0006858),0.5354153225682778,1.1231373368177626,0.346218487394958,0.8606190741753182,1.0,5/12,17.26%,WWP2;SPAG17;CCDC40;DNAAF4;TSG101
prerank,regulation of double-strand break repair (GO:2000779),0.45196944392011124,1.1230296228003163,0.3347222222222222,0.8600951302236909,1.0,13/39,17.86%,UBR5;KDM1A;SETD2;TRIP12;DDX11;SPIDR;CHEK1;PPP4R2;MRNIP;TWIST1;PML;SIRT6;RAD51
prerank,positive regulation of cell population proliferation (GO:0008284),0.36614042882594255,1.12283151239537,0.19716885743174925,0.8598061179289123,1.0,43/423,6.79%,EGFR;FOXP1;THBS1;BMP4;ACER3;ZFPM2;TCF7L2;GRK5;NTRK3;SOX9;BMP5;HDAC4;PGF;CCN1;PDGFC;PTK2B;TGFB3;PID1;DDR2;FN1;HES1;KRAS;FGFR1;SHC1;BMP6;BMPR1A;FGF2;GAB2;IRS1;GAREM1;TGFBR1;CLCF1;NR4A3;TRPM4;TGFBR2;GCNT2;ITGAV;GDNF;KDM1A;BAMBI;PTHLH;CDC25B;MAP3K3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5039958786163126,1.122772423857807,0.34321372854914195,0.8591382574474811,1.0,7/20,8.86%,KCNJ2;SLC12A2;ATP1B1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of cell population proliferation (GO:0042127),0.3614965374851814,1.1225499095961813,0.1653306613226453,0.8589364999324107,1.0,104/691,10.61%,ZBTB7C;EGFR;THBS1;BMP4;ACER3;SIX1;TCF7L2;WNT9A;GRK5;NTRK3;SOX9;TES;BMP5;HDAC4;NGF;EGLN3;PGF;CYP1B1;PDGFC;RBFOX2;PTK2B;ABI1;PTPRU;TGFB3;FN1;SMAD6;HES1;KRAS;FGFR1;SHC1;KLF4;BMP6;BMPR1A;INHBA;FGF2;GAB2;ECRG4;IRS1;LMNA;STRN;GAREM1;TGFBR1;CLCF1;AGTR1;NR4A3;P3H2;PTPN2;NPR3;NCK2;TRPM4;TGFBR2;SMYD2;SGK3;KLF10;SFRP4;GCNT2;CLMN;FRK;SKI;ITGAV;STAT3;GDNF;CLU;BAMBI;PTHLH;CDC25B;SLURP1;BIRC6;TGFB1I1;JAG1;IFI35;MYOG;IL10;BIRC7;CELF1;ID2;P3H1;IRF1;JUP;SIX4;PDGFA;MDM4;CDKN1B;KANK2;RNF126;RHOA;CTF1;RAB25;NIBAN2;TOB1;RARG;RARA;HILPDA;PIM2;LIMS1;BTG3;IGFBP6;JUN;PROK2;ELN;VEGFA;CEP131;PPP2R5C;MVD
prerank,neuromuscular synaptic transmission (GO:0007274),0.521372874374389,1.1225277653614165,0.3333333333333333,0.8581532112290711,1.0,6/18,15.53%,ERC1;ERC2;KIF1B;FCHSD2;FCHSD1;CHRNB1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.3682732306880238,-1.1224495330176196,0.2756183745583039,0.6915844976050974,1.0,7/33,16.65%,IGF1;TFRC;BCL2L1;MAPT;VAT1;AKT1;TMEM14A
prerank,positive regulation of proteolysis (GO:0045862),0.4289661456629034,1.1222825034904884,0.3170731707317073,0.8580126200041303,1.0,13/55,15.35%,CYFIP2;PERP;TANK;ADAM9;TNP2;FBXW11;MAPK12;SH3D19;TNFRSF1B;ZC3H12A;TBC1D10A;TNIP1;IST1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.41403472595895485,-1.1220770329051786,0.3035230352303523,0.6911011908739758,1.0,7/19,17.81%,TAPT1;ARL2BP;TAF3;HK2;AKT1;CHCHD10;BCL3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5210309468746552,1.1218209607126994,0.34235668789808915,0.8584520547106488,1.0,5/17,4.29%,DOCK5;IGFBP5;DOCK7;NRP1;NR4A3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.381706348041332,1.1215115951053385,0.2876404494382023,0.8584390075246984,1.0,25/145,17.12%,FBXL7;FHL1;SFI1;PAFAH1B1;PCM1;CDC25B;PSMB2;CEP164;CEP63;AURKA;AKAP9;PSMC6;CEP131;USP47;CSNK1E;PSMD11;CCND1;PSMD1;SDCCAG8;CEP43;HAUS2;CUL1;CEP57;PSMC1;PSMD7
prerank,positive regulation of protein maturation (GO:1903319),-0.48066703451231996,-1.1212434985174211,0.3356643356643357,0.6919261289642596,1.0,2/11,5.28%,CCBE1;NKD2
prerank,tyrosine metabolic process (GO:0006570),0.5580547637352928,1.121182712880775,0.347008547008547,0.8584989530566107,1.0,1/11,4.52%,IYD
prerank,regulation of immune effector process (GO:0002697),0.45221282108462524,1.1209315031943534,0.3290414878397711,0.8583606298891328,1.0,6/41,9.25%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.544189690312593,1.120808781350996,0.34655172413793106,0.8578605202534126,1.0,2/10,9.79%,MLLT3;HOXB4
prerank,positive regulation of response to wounding (GO:1903036),-0.4021498034906477,-1.120716696541192,0.27927927927927926,0.6918728316918359,1.0,9/24,11.35%,VTN;MYLK;OCLN;PTK2;ADRA2A;CLDN1;GRN;HBEGF;MDK
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5391948676612782,1.120440461632635,0.34991423670668953,0.858056114199373,1.0,4/13,13.59%,SAE1;DESI1;DESI2;UBA5
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5224501967390526,1.1200979920346177,0.34846029173419774,0.8582185651231794,1.0,2/18,1.74%,STK39;CAMK2D
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.49192318355170717,1.119836274871349,0.3333333333333333,0.8581403774354004,1.0,7/22,12.34%,PTPN3;ADAM9;TIMP2;IL10;TIMP1;SH3D19;TNFRSF1B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5589165723132643,1.1195040323696603,0.3577512776831346,0.8582523654259434,1.0,2/10,8.01%,LRP6;FZD1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.417269549959489,1.1194383407690875,0.29449423815621,0.8575864246993196,1.0,12/64,9.78%,THBS1;PTK2B;EFNA5;SEMA3E;GSK3B;VCL;PTPRA;JAG1;JUP;SLC9A1;RHOA;NF1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5386379807703616,1.1189275876572127,0.350253807106599,0.858231993342612,1.0,5/13,26.07%,SMUG1;UPP2;TDG;MBD4;NT5C
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5570635808366236,1.1184693800896182,0.3402061855670103,0.8586929431471578,1.0,2/10,7.03%,LBP;IFI35
prerank,negative regulation of neurogenesis (GO:0050768),-0.37453165261155097,-1.1182810649032362,0.29449838187702265,0.6967433912394452,1.0,8/34,11.55%,B2M;RAPGEF2;NOTCH1;ARHGDIA;MAG;RTN4;LINGO1;EFNB3
prerank,negative regulation of autophagy (GO:0010507),0.4289679981348025,1.1182118114350896,0.3168724279835391,0.8586044974297864,1.0,22/54,21.03%,MET;EIF4G3;DAPL1;FOXK1;TAB3;EIF4G1;KLHL22;STAT3;IL10;SMCR8;FOXK2;SNRNP70;MTOR;SMG1;HTR2B;TLK2;NRBP2;WASHC1;EIF4G2;MCL1;USP36;RUBCN
prerank,heart looping (GO:0001947),0.4439202664298766,1.117908992122711,0.31285714285714283,0.8586605836279223,1.0,4/39,6.17%,MICAL2;SMO;TGFBR2;GATA4
prerank,positive regulation of secretion by cell (GO:1903532),0.4127457199451579,1.117856695743728,0.2864450127877238,0.8579761792668841,1.0,9/70,6.41%,SLC12A2;EZR;TGFB3;ADAM9;KCNB1;BMP6;UNC13B;SYTL4;GOLPH3
prerank,cellular response to sterol (GO:0036315),0.5450222304385254,1.1176554225407414,0.35678391959798994,0.8576776552170953,1.0,5/13,12.83%,LRP6;SMO;GRAMD1C;RORA;GRAMD1A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.5435012576648457,1.117439563158214,0.3644067796610169,0.8574760096176284,1.0,2/13,1.62%,ANK2;CACNA1C
prerank,protein maturation (GO:0051604),0.3970969475322602,1.1174177300508292,0.3143203883495146,0.8567248985789438,1.0,21/95,16.60%,F3;PCSK5;DDI2;NAA40;PHEX;MMP16;TASP1;ASPRV1;XPNPEP3;MMP14;CCS;LONP2;ADAMTS3;PITRM1;NFU1;ECE1;PCSK7;ADAM10;LIPT2;CASP2;NAA15
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5231151045801308,1.1165576791068466,0.3652037617554859,0.8583617227453844,1.0,3/15,9.96%,TGFB3;IL10;IRAK3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.38433827200042603,-1.1162123738987844,0.2834890965732087,0.7006725188454804,1.0,10/27,13.69%,DCN;CSGALNACT1;CHSY3;PXYLP1;CHST3;CHSY1;UGDH;CSPG5;XYLT2;NCAN
prerank,ncRNA 3'-end processing (GO:0043628),0.5255229892736526,1.1161642185923448,0.3549432739059968,0.858660275174207,1.0,11/14,37.57%,INTS8;INTS5;INTS6;SSB;PTCD1;INTS2;ERI1;INTS7;ELAC2;TOE1;TRNT1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.43797573837181103,1.1159957750974348,0.3256484149855908,0.8583100362167515,1.0,6/43,3.97%,BMP4;CCN1;DDR2;BMP6;BMPR1A;NELL1
prerank,regulation of mast cell activation (GO:0033003),-0.49442973216857666,-1.1157496774749742,0.31422018348623854,0.7004881465287579,1.0,8/10,31.95%,LYN;NECTIN2;CD84;CRLF2;TSLP;CD300LF;CD226;MILR1
prerank,regulation of RNA export from nucleus (GO:0046831),0.5460093755981907,1.115568094066115,0.38860103626943004,0.8586756397196624,1.0,6/11,23.48%,SETD2;NUP153;DHX9;KHDRBS1;NRDE2;AKAP8L
prerank,regulation of mast cell degranulation (GO:0043304),-0.45120739696190065,-1.1154721198955069,0.32754342431761785,0.6998085375916063,1.0,7/14,23.69%,LYN;CD300A;CD84;FES;SPHK2;SYK;STXBP2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3666649662946918,1.1150935710256036,0.25390218522372526,0.8591473489415591,1.0,48/291,12.91%,SLIT2;EGFR;WNT9A;SOX9;EZR;PTK2B;LBP;PID1;ADAM9;WNT11;PRKCD;IGFBP5;CAPN2;FZD7;IRS1;SLC26A6;IP6K2;NR4A3;RAP1A;PDCD4;VCP;ATP2B4;CD80;ESR1;DMTN;RRAGB;MYOG;IL10;LCOR;TLR4;CXCL2;P2RX4;RORA;RHOA;CHUK;NFKB1;SHPK;ATM;AKAP9;JUN;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;PDK3;CTR9;MTOR
prerank,gonad development (GO:0008406),-0.35030696302865016,-1.115081997275759,0.25704225352112675,0.6994642740574444,1.0,8/41,8.84%,NR2F2;WNT4;KIT;WNT5A;SALL1;MAMLD1;GATA6;BASP1
prerank,liver development (GO:0001889),0.4626757734713522,1.1143163692093394,0.33382137628111275,0.8604899680689122,1.0,7/32,11.01%,MET;COBL;ANXA1;AURKA;NF1;CCDC40;PRKCSH
prerank,regulation of chromosome organization (GO:0033044),0.49111921044191686,1.1141108543960223,0.36187399030694667,0.8602680489804336,1.0,8/22,17.31%,SMG6;HDAC8;RB1;WAPL;SMG1;XRCC5;RMI2;YLPM1
prerank,cytoplasmic microtubule organization (GO:0031122),0.43180261105595863,1.1138294195612681,0.31216931216931215,0.8601952671464342,1.0,14/54,16.89%,EZR;CLIP4;LIMK2;CLIP1;PCM1;DLG1;PLK3;RHOA;SLAIN2;CHP1;TUBGCP6;TUBGCP5;HOOK3;TUBGCP4
prerank,response to acidic pH (GO:0010447),0.538094597724195,1.11333132792935,0.3723228995057661,0.8607881469535837,1.0,6/13,22.56%,GPR4;SLC9A1;CHP1;GPR65;RAB11B;PKD2L1
prerank,cellular response to alkaloid (GO:0071312),-0.4232845636090723,-1.1129378539996468,0.32717678100263853,0.7035975160273847,1.0,7/17,16.82%,TGM2;SLC8A1;RYR2;BLM;CASQ2;CASP3;RYR3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.44940953844739956,1.1127619207498018,0.3245492371705964,0.8615804448935351,1.0,14/40,20.77%,PRKCD;ABL1;SMYD2;BCLAF1;FEM1B;USP1;SMG1;NSMCE1;KMT5A;FXR2;UBE2N;FMR1;WDR76;MCL1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4105431815727148,-1.1126344365395593,0.3128834355828221,0.7029328287524959,1.0,8/21,13.69%,DCN;CSGALNACT1;CHSY3;CHST3;CHSY1;UGDH;CSPG5;NCAN
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.43604305372069785,-1.1121216915204124,0.32732732732732733,0.7028197752221452,1.0,4/18,12.64%,BCL2;BCL2L1;CAMK2A;THEM4
prerank,polyol biosynthetic process (GO:0046173),0.5269943968959012,1.1118437828231083,0.36633663366336633,0.8633470221838827,1.0,3/16,4.05%,ACER3;FGF2;IP6K2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4059771979810064,1.1114890362607772,0.3299874529485571,0.863433691319622,1.0,5/80,2.97%,THBS1;MAP3K5;NGF;CD44;KLF4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4058319040390059,1.1114609785402607,0.3333333333333333,0.8626812551308709,1.0,10/80,6.03%,PLCE1;DPYSL3;CDC42EP5;ARAP1;TGFB3;PALM;NDEL1;NRP1;BCAS3;RHOQ
prerank,regulation of cation transmembrane transport (GO:1904062),-0.37985233775003524,-1.1108876482482284,0.3010033444816054,0.7045874251955844,1.0,10/29,11.53%,KCNIP4;CACNA1D;KCNIP3;FGF12;KCNAB1;DPP10;CD63;KCNIP1;KCNN2;DPP6
prerank,positive regulation of cell adhesion (GO:0045785),0.40952907629692265,1.1107884297170345,0.3006369426751592,0.8637583703338125,1.0,12/74,11.11%,VIT;ZFHX3;PPP3CA;ADAM9;FOXC2;ITGAV;AGR2;CHRD;ATM;LIMS1;VEGFA;ERBB2
prerank,histone H3-K9 demethylation (GO:0033169),0.5443614250043621,1.1101873515923886,0.3602811950790861,0.8646378022733744,1.0,5/11,16.68%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.27491564539222757,-1.1101203369817338,0.15384615384615385,0.7051864383942756,1.0,34/163,16.93%,PIK3R1;PDE4B;BCL2;PAK1;FYB1;RFTN1;INPP5D;TEC;TNFRSF21;PRKCB;MEF2C;PRKCQ;PDE4D;VAV3;CD38;PAG1;BMX;MOG;PAK3;BTRC;THEMIS;PSMB4;BLNK;PSMB3;PLCG1;PSMB8;PSME2;ICOSLG;PSMB10;MALT1;BTN3A3;LCP2;BTK;CD276
prerank,diol biosynthetic process (GO:0034312),0.5293642086905677,1.1100890510271952,0.3688811188811189,0.8640808023417369,1.0,1/15,0.61%,ACER3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4924924615366142,1.1099196595658065,0.32983508245877063,0.8636852424831345,1.0,1/23,0.11%,SLIT2
prerank,histone methylation (GO:0016571),0.48107735789769474,1.1098016394911554,0.3586309523809524,0.8631720229018537,1.0,12/26,25.84%,SMYD2;CREBBP;EHMT1;PRMT8;CTCFL;PRMT6;NSD1;CARM1;EHMT2;PRMT5;PRMT2;SETD6
prerank,small GTPase mediated signal transduction (GO:0007264),0.3921940141329175,1.1096122871769676,0.3074245939675174,0.8629023654721439,1.0,22/103,12.36%,PLCE1;NTN1;CCNA2;NRAS;KRAS;MRAS;SHC1;FGF2;ARHGAP31;BCR;TIAM2;SHOC2;SHTN1;ARL3;RAPGEF6;G3BP2;NF1;JUN;RB1;TIAM1;RIT1;CHP1
prerank,microvillus assembly (GO:0030033),0.5336966181764199,1.1088267603471302,0.37221269296740994,0.8643395688370845,1.0,5/14,7.79%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,cellular response to superoxide (GO:0071451),-0.49750012751842415,-1.1087456281917383,0.3448275862068966,0.7074365832869842,1.0,4/10,19.05%,NOS3;SOD3;ATP7A;MT3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.43662045078566675,-1.1085600484332878,0.32151898734177214,0.7064939254080119,1.0,10/17,34.55%,ADRA2A;MFSD2A;AKT1;PDE3B;APOC1;ALK;GPLD1;PLIN5;CIDEA;TNF
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4401442856825394,-1.1084213042200226,0.32085561497326204,0.7054159901414764,1.0,5/16,7.05%,IGF1;IGFBP2;IGFBP3;IGFBP4;BMP2
prerank,exit from mitosis (GO:0010458),-0.4744735789150355,-1.108171552739732,0.33578431372549017,0.704627610038731,1.0,2/12,4.67%,EPS8;CLASP2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.46406387585546416,1.1078009845161536,0.36428571428571427,0.8664130368549386,1.0,10/33,17.97%,EGFR;ANXA1;EIF4G1;RDX;PLCG2;DDRGK1;LSM11;CCND1;ANKRD17;ADAMTS1
prerank,regulation of telomere capping (GO:1904353),0.4831342051732377,1.1077224757865587,0.3551829268292683,0.8658040052472177,1.0,7/23,18.09%,NEK7;SMG6;TNKS2;ATM;USP7;NBN;MAP3K4
prerank,phospholipid dephosphorylation (GO:0046839),0.450657606724631,1.1077038346131283,0.339568345323741,0.8650257950822583,1.0,7/37,14.01%,PLPPR2;PLPP3;MTMR12;OCRL;PIP4P2;SYNJ1;PLPP1
prerank,icosanoid metabolic process (GO:0006690),0.45417276657899985,1.1075717380661967,0.33381712626995647,0.8645696437706168,1.0,6/40,7.69%,CYP1B1;MGLL;PTGIS;CYP2S1;PON3;DAGLB
prerank,acylglycerol homeostasis (GO:0055090),-0.4136062940747126,-1.1075444045545415,0.3087818696883853,0.7047879572356458,1.0,6/20,14.82%,APOE;NR1H3;IL18;PNPLA8;SCARB1;LPL
prerank,ganglioside metabolic process (GO:0001573),-0.4054854165816019,-1.107315433154708,0.3185378590078329,0.7039946975543083,1.0,12/20,28.16%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ABCA2;GM2A;ST3GAL5;NEU2;ST6GALNAC4;ST6GALNAC6;B4GALNT1;CLN6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.35798850884044675,-1.1066204582825463,0.30303030303030304,0.7043943660127383,1.0,11/35,13.41%,ITGA1;PDGFRB;NUAK1;CALM1;PPP4R4;CD300A;HSP90AB1;PPP1R15B;TIPRL;HSP90B1;CALM3
prerank,chromatin assembly (GO:0031497),0.44770938202088245,1.1065235692853503,0.34316353887399464,0.8667446991514368,1.0,3/38,4.82%,SOX9;CHAF1B;KAT6B
prerank,response to metal ion (GO:0010038),0.4172682128327441,1.1062393979333434,0.32997481108312343,0.8667568576960404,1.0,5/67,1.97%,THBS1;NEDD4;PPP3CA;NDRG1;ADAM9
prerank,myotube cell development (GO:0014904),0.5556589768427364,1.106160488074626,0.373134328358209,0.8661267205400354,1.0,2/10,5.66%,SIX1;SKI
prerank,mRNA transport (GO:0051028),0.3973038527503578,1.1061052209685296,0.3182897862232779,0.8654593419564434,1.0,42/101,28.59%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;FMR1;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,negative regulation of type I interferon production (GO:0032480),0.44109658226840004,1.1058824259365962,0.32968536251709984,0.8652786981827241,1.0,17/40,21.89%,TAX1BP1;MAVS;IL10;REL;IKBKE;IFIH1;NPLOC4;RNF135;OTUD5;ACOD1;YY1;PTPRS;UFD1;TRIM25;GPATCH3;IRF3;TRAF3IP1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.45025115512255576,1.1053314936980305,0.33618233618233617,0.8660674237249887,1.0,5/35,3.98%,MET;SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,regulation of monocyte differentiation (GO:0045655),0.5249879195240305,1.1050599513634238,0.3602584814216478,0.8659887621571463,1.0,1/14,0.25%,FOXP1
prerank,chromosome organization (GO:0051276),0.397942796794259,1.104878107467389,0.324736225087925,0.8657030650199606,1.0,15/99,16.48%,TCF7L1;TCF7L2;ABL1;HDAC8;HMG20A;EHMT1;RAD23B;COPS7B;COPS5;SMARCA4;HDAC10;BRWD1;ZBTB7A;CENPT;XPA
prerank,membrane depolarization (GO:0051899),-0.37746028703785295,-1.1047137711453523,0.3108108108108108,0.70790217070638,1.0,11/32,16.15%,SCN7A;CACNA1E;SCN1A;CACNB4;CACNG4;CACNA1B;P2RX7;SCN3A;CACNA1I;SCN2A;SCN9A
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4800850657882408,1.1040456516073394,0.36160714285714285,0.8672248890916108,1.0,5/24,4.75%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4986342451160092,1.1039434867112217,0.330188679245283,0.8666670864393672,1.0,7/19,19.81%,HIPK1;CDIP1;EP300;DYRK2;PML;USP28;SNW1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.49334936445647026,1.1036898022650985,0.3595505617977528,0.8665538858003217,1.0,6/19,17.40%,PRKCD;IRS1;DAGLB;TWIST1;ABCD1;ANGPTL3
prerank,calcium ion transport into cytosol (GO:0060402),-0.4083595320871207,-1.1035940232018218,0.3416666666666667,0.7094122998593816,1.0,8/21,10.81%,GRIN2A;SLC8A1;RYR2;GRIN2B;CACNA2D1;GRIN1;JPH1;JPH2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4414569627646311,-1.10313367569373,0.34673366834170855,0.7091814544294339,1.0,6/13,13.41%,ANK3;SLC8A1;CALM1;PDE4D;CASQ2;CALM3
prerank,mismatch repair (GO:0006298),0.4666476637824787,1.1025728934666137,0.3430321592649311,0.8688864217394271,1.0,10/27,21.21%,ABL1;EXO1;SETD2;MLH3;RNASEH2A;MCM9;RPA1;ERCC1;TDG;POLD3
prerank,positive regulation of telomere maintenance (GO:0032206),0.4717643530712455,1.10217615774714,0.336322869955157,0.869173982920215,1.0,13/31,22.04%,NEK7;TNKS2;ATM;SLX4;ATRX;PML;NBN;SIRT6;ERCC1;MAP3K4;DHX36;RAD50;NAF1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4070551559490355,-1.102121250293926,0.31547619047619047,0.7103352008016354,1.0,6/22,9.85%,AEBP1;APOE;MAP2;HSPA8;MAPT;EFEMP2
prerank,cell cycle G1/S phase transition (GO:0044843),0.41791808216336396,1.1019848335903344,0.3169469598965071,0.86888299385866,1.0,21/61,23.07%,CCNA2;INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;PIM2;GSPT1;RB1;CDKN3;CUL3;CCND1;HINFP;CUL1;CDKN1A;KHDRBS1;PPP6C;E2F1;CUL4A;CDK2
prerank,actin filament network formation (GO:0051639),0.5516481168065988,1.1016595872746657,0.36486486486486486,0.868981755678712,1.0,2/11,6.13%,COBL;PLS1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4623644327123579,1.1010562858098263,0.3451202263083451,0.8698550815836978,1.0,10/33,17.73%,DDX5;ESR1;KDM1A;CBFB;DDRGK1;EP300;UBA5;DNAAF4;RNF14;CARM1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5014800691415889,1.1009553119750992,0.3426470588235294,0.869310160047546,1.0,10/19,21.58%,MAVS;RIPK2;SETD2;TLR4;CHUK;IFIH1;DHX9;TLR8;DHX36;IRF3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5454747423116827,1.1007657322854438,0.36772046589018303,0.8690172179425704,1.0,5/13,19.88%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,response to organic cyclic compound (GO:0014070),0.4243756404894799,1.1007574444954211,0.3418918918918919,0.8682262994326335,1.0,11/52,11.45%,CYP1B1;ANXA1;IGFBP5;ALPL;ESR1;STAT3;SOCS2;STRN3;DRD3;CCL3;ARL6IP5
prerank,Golgi organization (GO:0007030),0.3900044317871018,1.100704664746677,0.32046783625730996,0.8675174460433165,1.0,39/112,22.25%,ARHGAP21;ATL3;GOLGB1;RAB43;TMED5;ATL2;BCAS3;STX5;FBXW8;RAB30;GAK;LMAN2L;GOLPH3;GBF1;PLK3;CSNK1A1;SEC16A;ATP8B1;PLEKHM2;VTI1A;COG3;NPLOC4;SEC22B;SEC23IP;TRIP11;VCPIP1;GORASP2;ARFGEF1;BET1;ZW10;CSNK1D;DYNC2H1;RAB1A;HUWE1;TMED3;VPS51;CUL7;CDC42;PRMT5
prerank,lipid oxidation (GO:0034440),-0.45809754713765505,-1.100267482786098,0.3088235294117647,0.7138510605594836,1.0,3/12,22.07%,PPARGC1A;ALOX12;PLA2G7
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4982811791016063,1.100039546517705,0.3633440514469453,0.8685713779529045,1.0,11/21,23.65%,SAMD4A;PAN3;TUT7;CNOT7;TUT4;TNKS1BP1;PNLDC1;CNOT4;CNOT11;SAMD4B;CNOT3
prerank,bicellular tight junction assembly (GO:0070830),-0.32983624191479416,-1.0993423525530877,0.2690909090909091,0.7148729646122155,1.0,6/46,2.83%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.37212868623172235,-1.0991419773117868,0.3033033033033033,0.7139895123524933,1.0,7/28,10.91%,SHANK3;APOE;ADCY1;APP;EPHA4;LGMN;NSG1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5204338786463447,1.0990275505315115,0.3681592039800995,0.8705323148540984,1.0,5/14,10.59%,EZR;PATJ;RHOA;SYNE4;MYO9A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.44748578390617433,1.098873192092783,0.3353028064992615,0.8701960325624767,1.0,8/33,13.31%,HOXA5;FOXO3;INHBA;RAB7B;STAT3;GATA1;BRD1;PRKDC
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4724434308343584,1.0987359095238336,0.3518796992481203,0.8697752603554785,1.0,3/24,3.09%,NT5E;EZR;ITGB1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4673859849919231,-1.0987022970452271,0.36538461538461536,0.7138160906784264,1.0,2/12,9.40%,PLEKHH2;PLEK
prerank,cellular response to unfolded protein (GO:0034620),-0.37918501026791857,-1.0986784180047822,0.3265895953757225,0.7124657218388631,1.0,9/26,20.70%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ABCB10;HSPA9
prerank,protein modification by small protein conjugation (GO:0032446),0.3601682334624943,1.097997869521876,0.26859504132231404,0.8709429804799402,1.0,113/361,22.89%,FBXL7;WWP1;NEDD4;FBXO10;WWP2;NFE2L2;NUP93;RNF144A;HERC2;RNF138;VCP;TRPM4;FBXW8;UBE2B;ARIH1;MKRN3;ATG3;HIF3A;TRIM44;BIRC6;CDC16;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;PIAS2;SAE1;TRIM47;UBE2F;PIAS3;KLHL13;UBE2D3;EGR2;DCUN1D5;FBXW11;RANBP2;COMMD1;UVSSA;WAC;TRIM41;TRIM7;TRIM26;USP7;TRIM55;ASB11;RNF111;SPSB2;UBE2Z;DDRGK1;IFIH1;NUP153;CTR9;FBXO4;PEX13;RNF168;ARIH2;PRKDC;SMURF1;UBA5;CUL3;UBE2S;RNF135;CCDC22;ASB1;TRIM39;UBE2K;NUP214;CHFR;MKRN1;CUL1;VCPIP1;UHRF2;RNF14;NUP188;OS9;BCL10;BARD1;MKRN2;NUP88;DTX3;USP9X;FBXO25;DCUN1D4;PIAS1;GAN;DCUN1D2;RTF1;TSPAN17;TRIM35;UBE2N;MOCS3;UBE2W;DCUN1D1;CNOT4;TRPC4AP;KLHL18;MIB1;NFX1;NUP98;RNF8;DET1;HUWE1;UBE2M;CUL7;CUL4A;ANAPC11;FBXL17;PEX2;PAF1;AAAS;ANKRD9;FBXO11
prerank,negative regulation of multicellular organismal process (GO:0051241),0.367737426538831,1.09748745147965,0.3096280087527352,0.8715978031697222,1.0,26/199,7.16%,EGFR;BMP4;NFIB;SOX9;BMP5;WNT11;ARHGDIB;SMAD6;HDAC9;GSK3B;DOCK7;ZNF423;LRPAP1;FOXC2;ID1;KLF7;SPRED2;NPR3;ATP2B4;RAB11FIP3;DDIT3;IL17RD;ADAMTS5;SRSF6;ABHD6;IL10
prerank,natural killer cell mediated immunity (GO:0002228),0.5225633882818174,1.0973020920164975,0.36908517350157727,0.8713003631304382,1.0,4/15,15.80%,RAET1E;KLRC2;PLEKHM2;LYST
prerank,heart process (GO:0003015),0.5269460139101932,1.0968995749675912,0.36666666666666664,0.8715999756475266,1.0,1/14,0.75%,SGCD
prerank,cellular response to growth factor stimulus (GO:0071363),0.3748135115795604,1.0968386605673028,0.3191489361702128,0.8709439791577416,1.0,32/151,12.45%,EGFR;BMP4;NTRK3;SMAD9;SOX9;ANXA1;CD44;SHC1;KLF4;BMP6;BMPR1A;NRP1;GAREM1;TGFBR1;RAP1A;KIDINS220;TMEM100;TGFBR2;GAS1;HAS1;FOXC1;IQGAP1;ACVR1;LIMS1;EHD1;SYAP1;VEGFA;EMD;ERBB2;ITGB1BP1;NR4A1;CPNE3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4936643394497091,1.0966019693410487,0.35,0.8707749402698566,1.0,3/18,13.31%,ABL1;CD2;PRKDC
prerank,hyaluronan catabolic process (GO:0030214),0.5053072076452897,1.0964850539918842,0.37597503900156004,0.870316963643682,1.0,6/18,12.36%,CD44;FGF2;HEXA;SPAM1;SLC9A1;CHP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.473605780228052,1.09637882969747,0.36470588235294116,0.8698022312677509,1.0,12/25,28.35%,CDK12;WDR43;TCERG1;NELFE;RNF168;CDK13;RECQL5;RNF8;LDB1;EAF2;HEXIM1;EAF1
prerank,retinoid metabolic process (GO:0001523),0.40539571392079005,1.0958833616838615,0.32957393483709274,0.8703234163655336,1.0,9/71,6.11%,GPC6;CYP1B1;ADH7;GPC3;STRA6;RBP1;CYP2S1;RLBP1;LRP1
prerank,negative regulation of cell cycle process (GO:0010948),0.41402099322768526,1.0955739852375332,0.31065468549422337,0.8703999438043016,1.0,21/61,23.45%,BMP4;EHMT1;CBX5;EED;WAPL;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;ZFYVE19;E2F1;TOM1L1;NANOS2;E2F6;MGA;YAF2
prerank,neuron migration (GO:0001764),-0.3354755230868345,-1.095545480648924,0.30303030303030304,0.7190773039198626,1.0,14/48,8.12%,AUTS2;ADGRL3;DCDC2;RAPGEF2;ASTN2;GPM6A;SPOCK1;SH3RF1;NDNF;MEF2C;DCX;ASTN1;NTRK2;RAC1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3270951262691121,-1.0950502476062027,0.2713178294573643,0.7189240432126924,1.0,26/57,28.65%,DCN;KDR;PPARGC1A;TNFSF10;PDCD5;HIP1R;SPIRE1;BOK;GSK3A;BMF;BIK;CHCHD10;CAMKK2;GPER1;TREM2;DNM1L;PLAUR;PMAIP1;RALA;PYCARD;MFF;MLLT11;PINK1;HRK;FBXO7;BCL2L11
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.44953015362260007,1.0948936424698352,0.3492753623188406,0.8714720417950806,1.0,11/37,18.00%,ENTPD6;SIDT2;PABPC4;NUDT5;ENTPD2;EXOSC7;ENTPD7;NUDT15;RNASEH2A;DFFB;RNASE6
prerank,negative regulation of dephosphorylation (GO:0035305),-0.42736989999245734,-1.0946228379432712,0.3277777777777778,0.7186148126367189,1.0,8/18,24.61%,MFHAS1;PPP1R16B;YWHAB;INPP5K;PPP1R35;SH3RF2;ENSA;SH2D4A
prerank,adipose tissue development (GO:0060612),-0.4691703014172264,-1.0943903761473588,0.3411764705882353,0.717772587042872,1.0,5/11,25.47%,ARID5B;XBP1;DYRK1B;RORC;SH3PXD2B
prerank,cell part morphogenesis (GO:0032990),0.5387335387601357,1.0940658485188315,0.391304347826087,0.8729850339347215,1.0,1/13,1.88%,PID1
prerank,epithelial structure maintenance (GO:0010669),0.5438653020111974,1.0935891254611427,0.40640809443507586,0.8735682551014353,1.0,2/11,6.76%,CXADR;MUC6
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.37345716021087033,-1.093494829356997,0.33762057877813506,0.7187181344599781,1.0,5/32,5.41%,APOE;PPARA;PRKAG2;ZBTB20;PRKAA2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.42079666775702884,1.0928870686267154,0.3508541392904074,0.8747079858117425,1.0,22/54,23.65%,PLAGL1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;EP300;CNOT7;PIDD1;PML;CASP2;CDKN1A;CARM1;TNKS1BP1;CNOT4;E2F1;CNOT11;CCNB1;CNOT3
prerank,miRNA metabolic process (GO:0010586),0.4938930213554057,1.0928595914389643,0.3722397476340694,0.8739826723534772,1.0,8/20,19.88%,DDX17;DGCR8;TUT7;DIS3L2;AGO2;TUT4;DROSHA;RAN
prerank,organophosphate biosynthetic process (GO:0090407),0.4402012261181034,1.0927175316202393,0.34951456310679613,0.8735731871994751,1.0,14/37,21.52%,FGF2;IP6K2;PNPO;PIP5K1A;NFS1;MBOAT1;GNPAT;PPIP5K2;MOCOS;IP6K1;IP6K3;MOCS3;LPCAT1;PPIP5K1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4101720824453581,1.0925830784897343,0.3541114058355438,0.8731311300320707,1.0,8/59,3.27%,CDH1;HMCN1;PKD1;FAT2;MPZL2;NECTIN3;ITGB1;DSG2
prerank,mRNA export from nucleus (GO:0006406),0.3900975737932406,1.0923895564841786,0.3432657926102503,0.872867770569195,1.0,41/102,28.59%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,bile acid biosynthetic process (GO:0006699),-0.38303030470681243,-1.0922250596565386,0.3220338983050847,0.7205432165180858,1.0,7/24,20.37%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5297508943405526,1.0922067907473887,0.38358458961474035,0.8725782834569741,1.0,3/13,3.29%,ZFPM2;BMPR1A;FGF2
prerank,transition metal ion homeostasis (GO:0055076),-0.3770545679673626,-1.0921563126841092,0.32608695652173914,0.7193625619757259,1.0,5/28,7.01%,CP;B2M;PICALM;SLC40A1;FTL
prerank,cellular response to interleukin-4 (GO:0071353),-0.5025078828943706,-1.0917912677998864,0.3842364532019704,0.7189148721753708,1.0,4/10,18.16%,LEF1;TCF7;JAK3;XBP1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5531473763915452,1.0913477197165709,0.4064748201438849,0.8741133499005238,1.0,6/11,21.52%,FGF2;IP6K2;PPIP5K2;IP6K1;IP6K3;PPIP5K1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5076570108347565,1.0912307987358814,0.3790322580645161,0.8736287795344793,1.0,2/15,1.65%,UST;DSE
prerank,B cell differentiation (GO:0030183),0.4278169329755244,1.0911588195063808,0.3474240422721268,0.8730389444967831,1.0,9/46,13.05%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2794564919437558,-1.0908188428650585,0.1962025316455696,0.7200631422468368,1.0,35/117,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;CD81;ADORA2A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;PLCG1;HCK;GPR176;ADCY4;FCGR1A;PLK2;GGT1;RHBDF2;VIPR2;LHCGR;TSHR;RXFP1;TREM2;SYK;CD163
prerank,regulation of pseudopodium assembly (GO:0031272),0.5502265611032873,1.0905032188486625,0.3685121107266436,0.8732295469339447,1.0,1/10,1.20%,CDC42EP5
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5502265611032873,1.0905032188486625,0.3685121107266436,0.8732295469339447,1.0,1/10,1.20%,CDC42EP5
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.40850359082270266,1.0904895730629822,0.34886649874055414,0.8724573794730597,1.0,16/76,12.53%,CYP1B1;PTGIS;ANXA4;KLF4;TAX1BP1;CMKLR1;DDIT3;IL10;G3BP2;CHUK;COMMD1;ERBIN;IRAK3;USP7;CHP1;ZC3H12A
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5181834937761891,1.0903846444485217,0.3671497584541063,0.8711484127215934,1.0,4/12,12.07%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5181834937761891,1.0903846444485217,0.3671497584541063,0.8711484127215934,1.0,4/12,12.07%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,eye photoreceptor cell development (GO:0042462),0.5061643540803007,1.0902784171585531,0.38924050632911394,0.8706441762922944,1.0,3/15,10.38%,RP1;VEGFA;RPGRIP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.40239273420429367,1.0900143721472424,0.3469387755102041,0.870589128987504,1.0,20/73,18.84%,HDAC4;POLR1G;POLR1A;CTCFL;EED;TAF1D;TAF1C;MTA1;KAT2A;EP300;POLR1F;DNMT3A;SUZ12;SF3B1;EPC1;KAT2B;DDX21;SMARCA5;RBBP7;TASOR
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.395204485397546,-1.089905665680959,0.3213213213213213,0.7210830314851151,1.0,6/22,14.56%,SASH1;MFHAS1;BMP2;SPHK1;PRMT1;RELL1
prerank,negative regulation of cell cycle (GO:0045786),0.40214881092333454,1.0896981117161673,0.34575835475578404,0.8707101287131463,1.0,13/73,12.93%,BMP4;PTPN3;INHBA;PDCD4;IPO7;GAS1;IL10;CDKN1B;FOXC1;BTG3;RB1;NR4A1;ANGEL2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.40057126331435644,1.089519675768715,0.34444444444444444,0.8704135313307809,1.0,5/80,2.89%,THBS1;SAMD4A;SLC2A13;PRKCD;NIBAN1
prerank,regulation of humoral immune response (GO:0002920),0.43568844545384483,1.0893246644956733,0.37011173184357543,0.870146586552077,1.0,6/44,9.25%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.40106039260191995,-1.0889097383943127,0.34195402298850575,0.7222728180773353,1.0,6/21,5.79%,ATP1A2;SLC8A1;CALM1;RYR2;AKAP6;PDE4D
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4920520281424734,1.0880133997004604,0.3763440860215054,0.8729193971692446,1.0,5/19,5.48%,ZFPM2;BMPR1A;FGF2;TGFBR1;NOG
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3946674236632593,1.0879576356767309,0.3527950310559006,0.872306609961675,1.0,10/72,4.54%,ARHGEF28;MET;AKAP13;ARHGDIB;GPR4;COL3A1;ABL1;BCR;NRP1;CCDC125
prerank,catecholamine metabolic process (GO:0006584),0.525986449972571,1.0878677187818597,0.3698854337152209,0.8717679887611818,1.0,2/14,9.48%,SNCAIP;DRD3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.44818224669284534,-1.0872915817168103,0.36904761904761907,0.7251574270816464,1.0,3/13,11.71%,ENPP1;TPST1;SULT4A1
prerank,positive regulation of cell motility (GO:2000147),0.3600537955875949,1.087153273422794,0.31346578366445915,0.8729428428662072,1.0,19/205,4.10%,F3;EGFR;THBS1;NTN1;NTRK3;CCN1;PPP3CA;PDGFC;PTK2B;SMO;ADAM9;SEMA3E;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;FAM107A;TGFBR1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4034887777886907,1.0869237275965211,0.3436724565756824,0.8727823390708673,1.0,20/74,15.83%,BMP5;TGFB3;PHLDB2;TGFBR1;SPRED2;TGFBR2;GCNT2;BAMBI;IL17RD;TGFB1I1;FOXC1;LDLRAD4;BCL9L;SMAD2;TIAM1;NKX2-1;MTOR;TWIST1;WWTR1;PHLDB1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5184498724630315,1.0864768632570425,0.38562091503267976,0.8731657743718438,1.0,2/14,1.55%,ANK2;ATP1B1
prerank,determination of heart left/right asymmetry (GO:0061371),0.4268456640461305,1.0863318431665507,0.3590844062947067,0.8727711095757226,1.0,4/42,6.17%,MICAL2;SMO;TGFBR2;GATA4
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5391197378709913,1.0862818642016607,0.3733108108108108,0.8721328600673114,1.0,2/10,2.58%,PID1;GRB10
prerank,protein polymerization (GO:0051258),0.414657363481509,1.0858031953587215,0.35209424083769636,0.872655582860374,1.0,13/55,15.55%,COBL;GSN;MAP7D3;FGF13;FAM107A;DIAPH1;HDGFL3;WASHC5;MSRB2;PSTPIP1;UBE2S;RNF135;UBE2K
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4390968515327893,-1.0857848870239466,0.36633663366336633,0.7276755789206618,1.0,6/15,14.87%,PRKCH;CSF1;IL18;MSR1;LPL;AGT
prerank,organophosphate ester transport (GO:0015748),0.4728049376840033,1.085604530941474,0.37598736176935227,0.8724355595272739,1.0,4/24,5.59%,TNFAIP8L3;PITPNC1;PITPNA;LDLR
prerank,positive regulation of cell differentiation (GO:0045597),0.36089036808119357,1.0853104419492594,0.3351177730192719,0.8724939752959784,1.0,46/237,11.05%,BMP4;CDON;BOC;SOX9;HOXA5;VWC2;NGF;CCN1;TGFB3;DDR2;ZBTB16;CTNNA1;FGFR1;BMP6;BMPR1A;ABL1;MEF2A;CMKLR1;NELL1;TGFBR1;AGTR1;RAP1A;TMEM100;TRPM4;TGFBR2;GCNT2;ISL1;GDNF;BAMBI;TGFB1I1;GDF6;MYOG;GDF5;ID2;NBL1;FOXC1;RHOA;NFKB1;HOXB4;ACVR1;CDS1;SYAP1;MAPK12;LRP5;BCL9L;SMAD2
prerank,tRNA wobble base modification (GO:0002097),0.5150667336905318,1.0850789739679114,0.38016528925619836,0.8723228036882937,1.0,9/14,30.53%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3;GTPBP3;DPH3;URM1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4986470273613128,1.0850163705336446,0.38564273789649417,0.8717017391308141,1.0,6/17,22.30%,MPG;SMUG1;ERCC5;NEIL3;TDG;MBD4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5448617563981131,1.0849163011083685,0.36833333333333335,0.8712023506504463,1.0,2/10,5.21%,FN1;TSKU
prerank,protein localization to cell-cell junction (GO:0150105),-0.4300279298971861,-1.0848640316431053,0.344559585492228,0.7286515130904591,1.0,4/15,4.28%,TJP1;F11R;CGNL1;ACTB
prerank,sterol metabolic process (GO:0016125),-0.321656346263952,-1.084544862276043,0.2956521739130435,0.7280905870689447,1.0,11/60,7.19%,CYP7B1;APOE;CYP27A1;CYP26B1;PRKAG2;ABCA5;LIPA;ABCA1;PPARD;INSIG2;ABCG1
prerank,regulation of cellular metabolic process (GO:0031323),0.4263733987974804,1.084526796153948,0.35907859078590787,0.8714886741043301,1.0,10/45,13.78%,CYP1B1;PID1;COQ7;CNDP1;ARF4;KIF16B;MKLN1;EIF6;PDK3;NCOR2
prerank,arachidonic acid metabolic process (GO:0019369),0.44637322841067034,1.0844540569321761,0.3649025069637883,0.8709200109675581,1.0,6/35,7.69%,CYP1B1;MGLL;PTGIS;CYP2S1;PTGES2;DAGLB
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5021296947642108,1.0844374939923727,0.3696,0.8701905002609867,1.0,4/15,9.97%,SKI;IGSF1;DACT1;ACVR1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36243366929839577,1.084326383132677,0.3347826086956522,0.8697644739352085,1.0,19/214,5.28%,BMPER;EGFR;TNFAIP8L3;NTRK3;CCN1;PDGFC;EZR;PTK2B;FN1;CD44;SHC1;FGF2;NOTCH2;NRP1;GAREM1;SPRED2;RAP1A;PTPN2;GCNT2
prerank,protein localization to membrane (GO:0072657),0.3642178382197,1.083750692131681,0.3279044516829533,0.8705560939240602,1.0,37/187,13.57%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;DLG2;GAK;ARL3;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;RABEP1;SEC16A;FRMPD1;S100A10;C2CD5;FCHO2;EHD1;EHD2;ZDHHC15;ITGB1BP1;ZFYVE27;ZDHHC2;SMURF1;SH3GLB1;PRAM1
prerank,protein-containing complex disassembly (GO:0032984),0.41699859991025334,1.0837005932307022,0.34395750332005315,0.8699063428072472,1.0,7/54,9.24%,LRP6;GSK3B;WIPI2;VCP;FZD1;CSNK1A1;LIX1L
prerank,central nervous system myelination (GO:0022010),-0.46835524564014636,-1.083411527651863,0.33710407239819007,0.7297720164664055,1.0,8/11,29.10%,PLP1;TENM4;CNTNAP1;MYRF;ABCA2;SOX10;B4GALT5;B4GALT6
prerank,mitochondrial fission (GO:0000266),-0.42998540872267826,-1.083376153020457,0.35475578406169667,0.7284616596408391,1.0,6/16,23.73%,DNM3;DNM1;MTFP1;MTFR2;DNM1L;MFF
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.43654181795597413,-1.0825956012897018,0.356234096692112,0.7292676927239834,1.0,4/16,8.43%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST8SIA1
prerank,membrane lipid catabolic process (GO:0046466),0.5293391734645341,1.0825049756149843,0.3844765342960289,0.8724401710399654,1.0,2/10,3.98%,CYP1B1;PDXDC1
prerank,carbohydrate derivative transport (GO:1901264),-0.409137863534879,-1.0823622536044932,0.34293193717277487,0.7284839669282684,1.0,7/18,12.71%,PLTP;SLC29A1;ABCG1;NPC2;MFSD2A;SLC15A2;SCARB1
prerank,protein deneddylation (GO:0000338),0.5538573164728879,1.082233588082962,0.41830065359477125,0.8723829089271432,1.0,4/10,27.48%,COPS7B;COPS5;COPS3;COPS2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.411412363208239,1.0821553324425723,0.35262449528936746,0.8718142268177004,1.0,23/62,28.59%,MLLT3;ELOF1;MNAT1;CDK12;SETD2;AFF4;ELOA;CTR9;NELFE;ELP4;ERCC3;CDK13;CCNT1;RTF1;PAF1;EAF2;ADRM1;ERCC2;GTF2F2;GTF2H3;CCNT2;EAF1;NCBP2
prerank,negative regulation of nervous system development (GO:0051961),-0.43144379706248026,-1.081838675753832,0.34285714285714286,0.7284536598961627,1.0,3/17,4.40%,B2M;ROBO2;NOTCH1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3962555449265715,1.0815849830972548,0.3371647509578544,0.8726106270240916,1.0,20/76,16.44%,EGFR;CCN3;TCIM;WWP2;CREBBP;STAT3;JAG1;CD46;AAK1;MMP14;NIBAN2;GALNT11;ELF3;ITGB1BP1;EP300;SYNJ2BP;NEPRO;KAT2B;ZBTB7A;ZMIZ1
prerank,negative regulation of apoptotic process (GO:0043066),0.35022633653818813,1.081578688473797,0.28888888888888886,0.8718526483642458,1.0,88/444,16.63%,EGFR;THBS1;BMP4;CARD14;SIX1;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;TGFB3;ANXA1;WNT11;PRKCD;SMAD6;CD44;ANXA4;GCLC;SHC1;KLF4;TAX1BP1;ITGB1;GSK3B;NOTCH2;ERC1;CLCF1;SERPINB9;NR4A2;SON;ITGA5;NFATC4;DNAJC3;ISL1;GDNF;GATA4;RIPK2;GOLPH3;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;NFKB1;NIBAN2;NTSR1;GATA1;PIM2;PROK2;MTDH;VEGFA;ARF4;KRT18;RB1;USP47;COPS5;UBE2Z;HTATIP2;MYD88;AATF;ZC3H12A;DDRGK1;CARD16;YME1L1;PAK2;PRKDC;BAG3;FATE1;PRDX5;HTR2B;STIL;CEACAM5;PRKCA;PIDD1;SQSTM1;ADAM10;ZFAND6;TFAP2A;DPEP1;CLEC5A;TMBIM4;BFAR;CASP2;NAA15;MAD2L1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.39412824762361515,1.0814709632869879,0.34892541087231355,0.8713786204405821,1.0,9/78,13.05%,EGFR;PKD1;CCNA2;MNAT1;IPO7;CDKN1B;CCNYL1;CDKN3;GTPBP4
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5150114279325073,1.081190016200892,0.3915171288743883,0.8713738889247395,1.0,9/16,27.52%,NAA40;CREBBP;EP300;KAT2B;NAA15;NAA35;NAA50;NAA80;NAA60
prerank,phospholipid catabolic process (GO:0009395),-0.388667724133782,-1.081075616523741,0.3433734939759036,0.7289966452371724,1.0,4/24,7.65%,GPCPD1;ENPP2;ENPP6;ABHD12
prerank,tight junction assembly (GO:0120192),-0.32224324479962,-1.0809959783679735,0.28846153846153844,0.727847627343698,1.0,6/49,2.83%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,glycerol metabolic process (GO:0006071),-0.4887232085505839,-1.0799458753173379,0.38734177215189874,0.7292899929679756,1.0,2/10,6.98%,GK;COQ2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4208121725558824,-1.0795823985596846,0.34688346883468835,0.7287968584765374,1.0,7/15,24.17%,IQGAP2;ARPC4;ARPC3;ARPC5;ARPC5L;TRIM27;ARPC1A
prerank,inflammatory response (GO:0006954),0.36065242289401384,1.0793323521104086,0.3289902280130293,0.875644754355204,1.0,32/195,15.00%,THBS1;PTGDR;HDAC4;TRAF3IP2;MGLL;ANXA1;HDAC9;CD44;VNN1;CMKLR1;AGTR1;NFATC4;PTGER1;STAT3;RIPK2;REL;TLR4;CXCL2;CHUK;NFKB1;PROK2;ELF3;CCL3;CDO1;CCL1;NFATC3;ABCF1;FOLR2;PRDX5;TLR1;CXCR4;MAPKAPK2
prerank,sympathetic nervous system development (GO:0048485),0.5184373018380743,1.0786162255781009,0.40425531914893614,0.876783831443977,1.0,5/15,22.07%,NRP1;GDNF;NF1;GATA3;FZD3
prerank,transcription by RNA polymerase I (GO:0006360),0.4336066256539759,1.0779484624586766,0.36312056737588655,0.8778331231790335,1.0,14/34,27.33%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3;UBTF;ERCC2;RRN3;POLR1H;TAF1;GTF2H3
prerank,negative regulation of cell population proliferation (GO:0008285),0.3523056493404011,1.0779471031775627,0.30546955624355004,0.877063587459537,1.0,59/351,11.85%,ZBTB7C;BMP4;CCN3;WNT9A;SOX9;TES;BMP5;NGF;CYP1B1;PTK2B;ABI1;PTPRU;TGFB3;SMAD6;HES1;IGFBP5;KLF4;INHBA;LMNA;STRN;NELL1;P3H2;PTPN2;NCK2;SMYD2;KLF10;SFRP4;CLMN;NOG;FRK;SKI;PTHLH;E2F3;SLURP1;TGFB1I1;IFI35;MYOG;IL10;GDF5;CELF1;P3H1;IRF1;MDM4;CDKN1B;KANK2;NIBAN2;TOB1;RARG;NF1;PIM2;BTG3;IGFBP6;EMD;PPP2R5C;MORC3;TBRG1;DUSP10;ITGB1BP1;CDKN3
prerank,generation of neurons (GO:0048699),0.3580408581431063,1.0779077573545315,0.3308108108108108,0.8764177106072423,1.0,28/190,9.30%,SIX1;MET;WNT9A;MARK1;CIT;WNT11;HES1;FGFR1;FGF13;FZD7;DOCK7;NRP1;ACSL3;NR4A2;ITM2C;PAFAH1B1;BHLHE40;WNT16;THOC2;ELP3;LHX2;MARK2;SIX4;FZD1;ATOH8;MAP1B;CTF1;DISC1
prerank,protein dephosphorylation (GO:0006470),0.3703604680129187,1.0778841000511332,0.34417040358744394,0.875713697072901,1.0,29/135,13.53%,EYA2;PTPN3;PPP3CA;PTPRU;UBASH3B;PPM1H;PPTC7;EYA4;PTPRF;PTPN2;PTPRA;EYA3;PPP2R2D;PTPN21;DUSP16;DUSP11;DUSP5;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PPP5C;PPP3CC;PTPN9;ILKAP;PPM1A;DAPP1;PPP4R2
prerank,cellular calcium ion homeostasis (GO:0006874),0.3736721429454182,1.0778730012954052,0.33914053426248547,0.8749790333241172,1.0,18/133,11.42%,SLC35G1;SLC24A3;ANK2;ATP1B1;ATP2C2;CAMK2D;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;TNNI3;DRD3;MCUB;MCU;CCL3;CCL1;SLC8B1
prerank,ubiquinone metabolic process (GO:0006743),0.511365211768558,1.0777909404948125,0.3883333333333333,0.8744177077654058,1.0,6/15,22.40%,COQ7;COQ10B;PDSS2;AIFM2;UBIAD1;COQ8A
prerank,establishment of spindle orientation (GO:0051294),0.45581762631543055,1.077569102521366,0.37577639751552794,0.8742248069007512,1.0,10/28,22.53%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;LLGL1;GPSM2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4337642830414222,1.076854642171569,0.38152011922503726,0.8753353271192159,1.0,10/35,23.72%,MPG;SMUG1;APEX1;POLB;RPA1;RFC1;TDG;POLD3;MBD4;RFC5
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.36356882965707915,1.0766248220891594,0.3288888888888889,0.8751909872088918,1.0,36/166,16.25%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;POLR1G;NR4A3;NR4A2;CREBBP;ESR1;MNAT1;TBL1X;E2F3;TEAD1;RXRA;RORA;POLR1A;RARG;MED27;RARA;NCOR1;TAF1D;TAF1C;GTF2E1;NR4A1;NR6A1;HNF4A;POLR1F;NCOR2;E2F2;HDAC10;ERCC3;WWTR1;KAT2B;TAF12
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.2748990174195684,-1.0766111069658395,0.27450980392156865,0.7352468674179812,1.0,30/152,12.59%,ADGRL4;ADGRL3;ADCY5;CACNA1D;ADCY1;LGR4;LPAR1;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;PRKACB;CHRM2;ADGRB3;ADRA2A;PDE2A;GRM8;ADGRG1;ADORA2A;S1PR1;PTH1R;ADM;RAMP2;TBXA2R;LPAR2;S1PR3;ADCY2;GPR37;ADGRB1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.38128132440624574,1.0764956624343247,0.3469387755102041,0.8747566238086754,1.0,25/107,19.08%,THBS1;MAP3K5;TMEM117;NIBAN1;GSK3B;ERP27;RNF185;VCP;DDIT3;AGR2;SEC16A;JUN;ATF6;DDRGK1;ERN2;UBA5;BCAP31;CREB3L1;CREB3L3;OS9;GORASP2;EIF2S1;MBTPS1;QRICH1;AIFM1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.45526252844364945,-1.0764669500385544,0.375,0.7342845655565746,1.0,3/12,8.24%,LYN;ELF2;CD300A
prerank,neural crest cell development (GO:0014032),-0.3329553875863206,-1.0761347136756019,0.3383458646616541,0.7337396142011421,1.0,12/44,12.22%,SEMA6A;CDH2;SEMA7A;RADIL;SEMA6D;TBX1;ERBB4;TAPT1;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.41973007855408573,1.075486584998979,0.37066666666666664,0.8766685759165388,1.0,10/52,9.91%,MBNL1;DDX5;RBFOX2;DDX17;SRSF6;CELF1;CELF3;MBNL2;RBM25;RBMX
prerank,prostanoid biosynthetic process (GO:0046457),-0.4343659963487918,-1.0752380274882996,0.36175710594315247,0.7347513405660598,1.0,8/15,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;MIF;CD74;PTGES3;PTGS2
prerank,cellular response to light stimulus (GO:0071482),0.4013215127640876,1.0751679169431352,0.35496688741721855,0.8767923907586358,1.0,15/66,18.46%,NEDD4;PRKCD;PDE6A;CREBBP;KDM1A;USP47;EP300;EIF2AK4;ZBTB1;YY1;USP28;EIF2S1;ATR;DHX36;INO80
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4646528238411817,-1.0751141928135632,0.36097560975609755,0.7336914754273647,1.0,4/12,12.01%,PIK3R1;DAB2IP;ERN1;BOK
prerank,positive regulation of macrophage migration (GO:1905523),0.4821781242672463,1.0751069625510443,0.38556067588325654,0.8761967237006378,1.0,4/19,10.91%,THBS1;CMKLR1;P2RX4;CCL3
prerank,blood circulation (GO:0008015),-0.3319522445501801,-1.0750651714341397,0.3235294117647059,0.732435064700213,1.0,15/49,11.62%,COL4A3;NOS3;SGCZ;GUCY1B1;CXCL12;NPR1;ACE;GUCY1A1;TBC1D8;ADORA2A;F5;BDKRB2;ACE2;ROCK2;STAT1
prerank,blood vessel endothelial cell migration (GO:0043534),0.47764317516047694,1.0750295176764004,0.38485804416403785,0.8756500054010844,1.0,4/22,3.98%,SLIT2;FGF2;ID1;NRP1
prerank,pyruvate metabolic process (GO:0006090),0.4171210164111434,1.0750215114524035,0.36883116883116884,0.8749118675207973,1.0,6/52,8.47%,ME1;SLC16A1;NR4A3;PFKFB2;PFKFB1;GPI
prerank,spindle assembly (GO:0051225),0.4067527527222851,1.0744842221454594,0.3670076726342711,0.8756161042326602,1.0,26/67,23.09%,MAPRE2;NEK7;MISP;CHEK2;TOGARAM1;ARHGEF10;CEP63;RHOA;SPICE1;NCOR1;SMC1A;TUBGCP6;PIBF1;TUBGCP5;STAG2;HAUS2;KIF3B;TUBGCP4;INO80;NEK6;STAG1;CSNK1D;OFD1;FLNA;AAAS;HAUS5
prerank,regulation of receptor binding (GO:1900120),-0.46672829473246263,-1.0742358490174528,0.4023809523809524,0.7332071836168358,1.0,4/10,15.94%,B2M;GREM2;ATP2A2;ATP2A3
prerank,regulation of monooxygenase activity (GO:0032768),0.4704041713245352,1.0739030340905693,0.3728813559322034,0.8764128801662737,1.0,1/23,0.24%,EGFR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3638096130515771,-1.073398155752453,0.3442622950819672,0.7340418623836071,1.0,14/32,21.45%,MAP2;NAV3;CLASP2;SNCA;STMN1;CAMSAP2;FKBP4;TPX2;TUBB4A;STMN2;APC2;CDH5;DYRK1A;CAMSAP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5454704747204019,1.07306233788362,0.40695652173913044,0.8779919690156326,1.0,4/10,10.59%,EZR;RHOA;SYNE4;MYO9A
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.35660945040784786,-1.0726817269595128,0.3343108504398827,0.7346138752907918,1.0,11/32,12.33%,IL1RAPL1;NEDD4L;TNIK;RAPGEF2;HECW2;RAP2A;OBSL1;ADGRB3;HECW1;CUX2;KNDC1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3268432572662898,-1.0724324814786113,0.31417624521072796,0.7339021138796872,1.0,7/46,6.18%,SEMA6A;LYN;TIMP3;FBLN1;SIRPA;DAB2IP;SPRED1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3906027468274533,1.0723031932284812,0.3652694610778443,0.8793145082631454,1.0,32/84,22.93%,MBNL1;DDX5;RBFOX2;SON;DDX17;SRSF6;CELF1;CELF3;MBNL2;RBM39;RBM25;PCBP4;RBMX;U2AF2;REST;THRAP3;ZBTB7A;JMJD6;SRPK1;KHDRBS1;SFSWAP;CIRBP;FXR2;DAZAP1;SNW1;FMR1;TRA2B;NUP98;RBM3;SRSF12;RBM5;RBM4
prerank,digestive tract morphogenesis (GO:0048546),0.5081366274942627,1.072194507205208,0.3935810810810811,0.8788524595208056,1.0,5/14,12.18%,STRA6;AGR2;EPHB3;ID2;NIPBL
prerank,secondary palate development (GO:0062009),-0.4316692449804729,-1.072127346135456,0.3564356435643564,0.7333933611111104,1.0,4/14,2.67%,LEF1;CHD7;TGFBR3;WNT5A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3700778065425185,1.0719567408099668,0.357630979498861,0.8787164544799666,1.0,31/138,16.25%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;NR4A3;NR4A2;CREBBP;ESR1;MNAT1;TBL1X;E2F3;TEAD1;RXRA;RORA;RARG;MED27;RARA;NCOR1;GTF2E1;NR4A1;NR6A1;HNF4A;NCOR2;E2F2;HDAC10;ERCC3;WWTR1;KAT2B;TAF12
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.37124318861822514,1.0717218232662356,0.35469107551487417,0.8785842758723145,1.0,25/118,13.30%,BMPER;FMNL2;NEDD4;EFNA5;PID1;SIPA1L1;PHLDB2;ARHGAP44;GSK3B;FGF2;GDNF;PDLIM5;EPHB3;MARK2;NF1;PROK2;BCL9L;ZDHHC15;ERBB2;ZMYM4;SH3D19;HTATIP2;TANC2;ZRANB1;PAK2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.521561876015126,1.0712811128546655,0.42105263157894735,0.8789608703864196,1.0,5/14,14.48%,PGF;NRP1;FOXC1;VEGFA;GAB1
prerank,regulation of protein modification process (GO:0031399),-0.31645651745219866,-1.0711751801098228,0.3483606557377049,0.7344574056624555,1.0,17/50,20.50%,LYN;PPP1R16B;GRM5;PTK2;CCDC88A;SPRED1;PPIB;CADM4;FNIP2;ABCA2;CCDC88C;NDUFS4;CDH5;PLXNB2;HSPB1;MT3;CCAR2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.43804888364704553,1.0705300349693938,0.39060205580029367,0.8802472789491658,1.0,2/33,0.27%,SLIT2;THBS1
prerank,response to interleukin-1 (GO:0070555),0.38919099117000006,1.0703318750977278,0.366751269035533,0.8800075729606396,1.0,13/73,12.53%,SOX9;HDAC4;TANK;ANXA1;PTGIS;NFKB1;RBMX;IRAK3;USP10;CCL3;CCL1;MYD88;ZC3H12A
prerank,neutrophil activation (GO:0042119),0.5200645365325992,1.0699023175758395,0.39209225700164746,0.880430270053229,1.0,1/12,2.06%,PRKCD
prerank,signal transduction by p53 class mediator (GO:0072331),0.4477481040652596,1.0698448994758263,0.37333333333333335,0.8798243585467871,1.0,6/30,12.88%,DDX5;NDRG1;FHIT;MDM4;USP10;ATRX
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.49250722875026764,1.0694425958776212,0.383147853736089,0.8801321759998227,1.0,6/18,12.36%,CTNNA1;GSK3B;MDFIC;POLR1A;OTUD7B;CHP1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.41789180716068075,-1.0691041470426255,0.3698630136986301,0.7384948574846519,1.0,10/18,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;CBR1;PTGES3;PTGS2
prerank,lymphocyte proliferation (GO:0046651),-0.38569688770695426,-1.068687557004276,0.3504273504273504,0.7382120637731926,1.0,7/22,19.01%,BCL2;MEF2C;CTPS1;PPP3CB;CD40;FLT3;PIK3CG
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3607426398667823,1.0685868806242602,0.3461962513781698,0.8817100531975446,1.0,29/186,10.41%,NXN;TRABD2B;TCF7L2;SOX9;MLLT3;LRP6;PTPRU;WNT11;GLI3;GRB10;PRICKLE1;GSK3B;MDFI;SFRP4;TSKU;TLE2;NOG;TLE6;INVS;LRP1;DDIT3;PSMB2;CSNK1A1;NLK;DACT1;DKK3;IGFBP6;PSMC6;EMD
prerank,cellular defense response (GO:0006968),0.4312053095088003,1.0681484982272818,0.383879781420765,0.882120915089491,1.0,6/40,7.11%,PTK2B;LBP;ITGB1;ZNF148;BECN1;KLRC2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.27648474265456197,-1.0679602565895032,0.26,0.7386952793281327,1.0,35/116,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;ADORA2A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;PLCG1;HCK;GPR176;ADCY4;FCGR1A;PLK2;GGT1;RHBDF2;SELENOS;VIPR2;LHCGR;TSHR;RXFP1;TREM2;SYK;CD163
prerank,positive regulation of translation (GO:0045727),0.38512065231809406,1.0677232099493659,0.34720570749108204,0.8825194908862649,1.0,22/94,20.06%,THBS1;SAMD4A;NIBAN1;YBX3;LARP4B;MRPS27;JMJD4;ERBB2;EIF3E;EIF6;MTOR;PRKDC;DHX9;RPUSD4;PLD1;AGO2;KHDRBS1;DHX36;CIRBP;FXR2;LARP4;FMR1
prerank,axon guidance (GO:0007411),0.35804308830242604,1.0676708920494211,0.35969664138678226,0.881916167166427,1.0,25/201,6.83%,SLIT3;SLIT2;NTN1;NFIB;EZR;SMO;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;PDLIM7;GRB10;SPTAN1;SHC1;NOTCH2;GAB2;ALCAM;KLF7;NRP1;TMEFF1;GDNF;PTPRA;EPHB3;NTN5
prerank,regulation of glycolytic process (GO:0006110),0.39733655408102087,1.067609090296855,0.36107554417413573,0.8813307740844134,1.0,15/68,17.01%,SLC4A4;HDAC4;NUP93;PFKFB2;PFKFB1;RANBP2;NCOR1;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;PRXL2C
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4669171165551189,1.066806849035263,0.392914653784219,0.8827640370488692,1.0,9/23,22.53%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;GPSM2
prerank,intracellular cholesterol transport (GO:0032367),0.4929844593171526,1.0665512902444825,0.3832236842105263,0.8826458407561292,1.0,3/15,8.53%,LRP6;LDLR;STARD4
prerank,neurotransmitter uptake (GO:0001504),-0.45496917745983123,-1.0664727473689342,0.38402061855670105,0.7412943288553041,1.0,5/12,9.99%,ATP1A2;SLC1A3;SLC29A1;SNAP25;SLC22A2
prerank,RNA splicing (GO:0008380),0.38385005034657915,1.0663692173901103,0.37383177570093457,0.882397469501787,1.0,40/95,27.42%,MBNL1;SNRNP48;SRSF11;CDK12;SYNCRIP;CELF3;FUS;TCERG1;SCAF11;SRRM1;PRPF3;SF3B1;SF3B2;PPIG;RNPC3;SRPK1;SCNM1;SNRNP35;WBP4;SNRNP40;SRSF2;TRA2B;PRPF18;NRDE2;DBR1;NOL3;ZCRB1;TXNL4A;TARDBP;LSM4;DHX8;RSRC1;SRPK2;SF3B3;RBM8A;DDX47;SMNDC1;PDCD7;PRPF6;SRSF7
prerank,cilium assembly (GO:0060271),0.3499177677326669,1.066112131379443,0.340625,0.882293967593475,1.0,78/296,20.58%,PKD1;BBS9;ABLIM3;EXOC4;RP1;GSN;PARVA;DNAAF3;PDE6D;PTPDC1;DZIP1;SFI1;PAFAH1B1;RAB11FIP3;ARL3;PCM1;EHD3;ARL13A;GBF1;ATAT1;CEP164;OCRL;TOGARAM1;EXOC5;CFAP70;CDC14A;CEP63;TMEM231;IFT46;DISC1;WDR35;AKAP9;EHD1;DYNC2I2;GALNT11;RPGRIP1;ARF4;CEP131;EHD2;CCDC40;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;CSNK1E;ATP6V0D1;NPHP1;CEP20;SSTR3;MKS1;SDCCAG8;NUDCD3;CEP43;IFT52;CEP89;HAUS2;TRIP11;KIF3B;CEP57;DYNC2I1;FAM161A;HYLS1;TEKT2;C2CD3;CEP97;LZTFL1;RILPL1;CEP70;RSPH9;IQCB1;GORAB;FUZ;POC1B;CSNK1D;IFT80;DYNC2H1;RAB1A
prerank,microtubule depolymerization (GO:0007019),-0.4250826635099919,-1.0660226630631524,0.3756345177664975,0.7410740090672645,1.0,7/17,25.88%,STMN4;STMN3;NCKAP5;STMN1;STMN2;KIF19;KIF18B
prerank,receptor catabolic process (GO:0032801),0.4618179434590451,1.0654277785096569,0.39939485627836613,0.8833266167922488,1.0,7/24,13.51%,NEDD4;AP2A2;BECN1;AP2A1;KIF16B;SMURF1;SH3GLB1
prerank,positive regulation of developmental growth (GO:0048639),-0.3247069789464687,-1.0653529387336742,0.35856573705179284,0.7414850855938682,1.0,16/49,16.31%,PLCB1;NEDD4L;SEMA7A;RIMS1;RIMS2;INSR;GHR;MAPT;SYT1;RNF157;TWF2;PPIB;LIMK1;MACF1;CPNE5;CDKL5
prerank,lamellipodium assembly (GO:0030032),0.45300100768655444,1.065335322818931,0.3951734539969834,0.8828129059149593,1.0,8/26,6.92%,ABLIM3;ITGB1;SRGAP2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,response to ethanol (GO:0045471),-0.44076720567902883,-1.0647566978605416,0.37468354430379747,0.7416938469275504,1.0,8/14,17.12%,GRIN2A;ADCY7;GRIN2B;GRIN1;GLRA1;SDF4;GRIN3A;GOT2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.43513145127665853,-1.0645978922480523,0.38443396226415094,0.7394458301200534,1.0,2/13,3.35%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.43513145127665853,-1.0645978922480523,0.38443396226415094,0.7394458301200534,1.0,2/13,3.35%,PLCB1;IL15RA
prerank,epidermis development (GO:0008544),0.4036030651146824,1.0645669411576735,0.3835978835978836,0.8840484134794391,1.0,9/56,8.58%,KRTDAP;DSP;GRHL1;EMP1;PTHLH;KRT14;CRABP2;SPRR1A;GRHL2
prerank,nucleic acid metabolic process (GO:0090304),0.39324641947707684,1.0644493696807837,0.37548387096774194,0.8836117963494341,1.0,18/69,23.03%,NT5E;RBFOX2;HNRNPH1;DXO;DUSP11;WRN;RBMX;ATXN2;HNRNPM;RECQL5;LSM8;TOPBP1;RAN;EXD2;DDX1;RAD50;DNASE2;DDX24
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5209488747591922,1.064161867571463,0.41118421052631576,0.883647118196169,1.0,6/14,21.94%,SRSF6;PCBP4;RBMX;U2AF2;SFSWAP;SRSF12
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3429318698716736,-1.0640932094738385,0.35785953177257523,0.7394842963442684,1.0,4/35,5.03%,PAM;ACSS3;FAR2;GGT5
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4292968608245913,1.063187078604934,0.40509915014164305,0.8855549768706388,1.0,5/39,7.16%,THBS1;ANO6;NFE2L2;PDCD4;IL10
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.40820058891239774,-1.0631430128217745,0.3888888888888889,0.7406919452120494,1.0,5/17,17.27%,APOE;FGF1;ABCG1;KPNB1;ABCA2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5024783208694875,1.0631337212073877,0.4022801302931596,0.8849517047705608,1.0,3/16,5.02%,SIX1;FTO;ZBTB7B
prerank,ubiquinone biosynthetic process (GO:0006744),0.5059467259189352,1.0630159126908312,0.4148397976391231,0.8845202047131971,1.0,3/15,10.30%,COQ7;COQ10B;PDSS2
prerank,negative regulation of secretion (GO:0051048),-0.47153502793263935,-1.0629230728320433,0.3991031390134529,0.7399036141278924,1.0,7/10,29.58%,NR1H3;CD74;PTGER3;ERBB3;NRG1;VAMP8;VAMP3
prerank,positive regulation of cell death (GO:0010942),0.40269920755696914,1.0623413277907061,0.38247011952191234,0.8856283727751912,1.0,12/59,12.53%,BMP4;MAP3K5;GSK3B;EIF4G1;LRP1;CLU;RIPK2;CELF1;CDKN1B;RARG;HTATIP2;ZC3H12A
prerank,endoplasmic reticulum organization (GO:0007029),0.39423604527725636,1.0620552308532714,0.37714987714987713,0.8856143875378082,1.0,15/72,12.07%,ATL3;ATL2;STX5;SPTSSB;SHTN1;TLE6;GAK;LMAN2L;DOP1B;SEC16A;EMD;TRAM2;SEC31A;SEC61A1;RTN3
prerank,quinone biosynthetic process (GO:1901663),0.5102335814189288,1.0618830960933336,0.4159592529711375,0.8853300324247003,1.0,3/14,10.30%,COQ7;COQ10B;PDSS2
prerank,histone acetylation (GO:0016573),0.39890499597331486,1.0615714772511577,0.3853904282115869,0.8854093022228368,1.0,37/69,28.31%,KAT6B;NAA40;CREBBP;TADA3;TRRAP;EP400;SGF29;CPA4;ZZZ3;BRCA2;PER1;KAT2A;BRD1;EP300;ATF2;EPC1;KAT2B;TRIM16;TAF12;BRD8;YEATS2;PHF20;PHF20L1;DMAP1;KAT5;MAP3K7;JADE2;NAA50;ING3;HAT1;KAT14;KAT6A;NAA60;TAF9;MORF4L2;TADA2A;TAF6L
prerank,protein heterooligomerization (GO:0051291),0.484760998343563,1.0612781994439227,0.3956043956043956,0.8854551340930138,1.0,2/17,2.20%,PKD1;TMEM120A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.39988184070184385,1.061242309013669,0.38010204081632654,0.8848029755518864,1.0,16/59,17.71%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;BCLAF1;MED27;JUN;CBFB;CCND1;MED14;TWIST1;MED24;CDKN1A
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5416984747896911,1.06079289778369,0.42413162705667273,0.8852692110714278,1.0,1/10,4.42%,PDE6A
prerank,regulation of cell differentiation (GO:0045595),0.36746847580603753,1.0605827778636006,0.35523385300668153,0.8851078604411359,1.0,16/148,7.45%,ZFHX3;SIX1;NGF;DDX5;PHLDB2;SMOC1;FGFR1;KLF4;TGFBR1;DDX17;CREBBP;ISL1;GDNF;PTHLH;LTBP4;ID2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5338204484041298,1.0599430787670567,0.4283154121863799,0.8860246314326724,1.0,4/10,25.61%,JUN;BAG3;NCK1;CITED2
prerank,regulation of peptidase activity (GO:0052547),-0.4003478743098641,-1.0593508392650546,0.3961218836565097,0.7478413108578105,1.0,2/19,3.26%,CTSH;CST3
prerank,regulation of presynapse organization (GO:0099174),0.4733426184719689,1.0593402181029123,0.40456769983686786,0.886080788728946,1.0,3/18,8.24%,GPC6;EIF4G1;GPC4
prerank,regulation of presynapse assembly (GO:1905606),0.4733426184719689,1.0593402181029123,0.40456769983686786,0.886080788728946,1.0,3/18,8.24%,GPC6;EIF4G1;GPC4
prerank,regulation of blood circulation (GO:1903522),0.43289342214826454,1.0591218646520173,0.36984352773826457,0.8858879331201175,1.0,3/34,4.28%,KCNMB2;CAMK2D;AGTR1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.42220667238608295,1.0590172023184492,0.3869625520110957,0.8854116108434031,1.0,7/41,9.36%,BMP4;BMPR1A;TGFBR2;ISL1;GATA4;JAG1;TNNI3
prerank,cell-cell junction organization (GO:0045216),0.38605605720689407,1.0587663106774108,0.37392373923739236,0.8853831620342841,1.0,9/79,3.27%,CDH1;CDH11;CTNND2;TGFB3;CXADR;NECTIN3;DSP;CTNNA1;DSG2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4574048550836198,1.058747861774686,0.4068554396423249,0.8846847131535118,1.0,11/25,28.35%,SCAF8;WDR43;SETD5;THOC5;CCNT1;HTATSF1;LDB1;EAF2;ALYREF;CCNT2;EAF1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.46699501831804147,-1.0585812073470349,0.3908872901678657,0.748550809177846,1.0,3/10,10.71%,PRKAA2;KLF15;MYOCD
prerank,striated muscle cell development (GO:0055002),-0.42933875939072547,-1.057944292992595,0.37659033078880405,0.7488818736605061,1.0,3/14,7.07%,PGM5;TMOD1;LMOD1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4668222608007415,-1.0579001965805948,0.40714285714285714,0.747649516348375,1.0,7/11,39.64%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL12B
prerank,regulation of mitochondrial fission (GO:0090140),-0.38554368141134465,-1.057267340718607,0.391304347826087,0.7479495233895768,1.0,5/24,8.12%,DCN;KDR;INF2;SPIRE1;MAPT
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4781679756457904,1.0567944150818989,0.40809968847352024,0.8891739991331457,1.0,1/21,0.25%,FOXP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4677100907960418,1.0563595422429715,0.4071207430340557,0.8895736716931826,1.0,10/23,23.16%,VCP;SEC16A;RANGRF;SEC13;NPLOC4;OS9;UFD1;FAF2;HERPUD1;SURF4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3767687097908423,1.0563334732621916,0.3773809523809524,0.8889003428660146,1.0,25/100,16.72%,FHIT;GIPC1;PRICKLE1;GSK3B;RNF144A;VCP;XPO1;ARIH1;CLU;RNF19A;CSNK1A1;COMMD1;RAD23B;WAC;ZYG11B;DESI1;USP7;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;TRIM39;TLK2;RNF14
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.4700777639264637,1.056181773144172,0.3984496124031008,0.8885503503118733,1.0,5/22,10.34%,RASSF2;PDGFC;RAP2C;PDGFA;VEGFA
prerank,protein autophosphorylation (GO:0046777),0.35723111140901154,1.0557979002165703,0.3777533039647577,0.8888249198257667,1.0,26/157,10.43%,STK39;EGFR;GRK5;PTK2B;CAMK2D;DDR2;ULK2;FGFR1;GSK3B;ABL1;CLK2;MKNK2;STK16;CDK12;MAP3K3;EPHB3;MARK2;CHEK2;RIPK3;AAK1;AURKA;MARK3;SIK2;PIM2;ATM;SRMS
prerank,protein phosphorylation (GO:0006468),0.3395841772046948,1.0556894784672528,0.3484848484848485,0.8883501914680524,1.0,90/478,13.69%,STK39;EGFR;BMP4;DCLK1;MAP3K5;GRK5;PKD1;MARK1;CCNA2;PTK2B;CIT;CAMK2D;ABI1;DDR2;WNK1;WNT11;PRKCD;ULK2;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ERC1;ABL1;BCR;TGFBR1;EFEMP1;CLK2;MKNK2;STK16;TGFBR2;SGK3;FRK;CDK12;CDC25B;BIRC6;MAP3K3;EPHB3;GDF6;VRK3;FAM20A;MARK2;IKBKE;CHEK2;TLR4;CSNK1A1;CSNK1G3;NLK;RIPK3;CHUK;AAK1;AURKA;SIK3;USP15;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;CAB39;SRMS;STRADA;MAPK12;CLSPN;SMAD2;ERBB2;MORC3;MAST2;HTATIP2;CDKL2;CSK;PDK3;MTOR;CSNK1G1;CHEK1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;ERN2;CDC42BPG;DYRK2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.44765937781498155,-1.0555846597160738,0.3825,0.7509382350025996,1.0,5/11,26.46%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,DNA methylation or demethylation (GO:0044728),0.48342958242172657,1.0545790031675617,0.41471048513302033,0.8898366652417518,1.0,8/19,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,DNA alkylation (GO:0006305),0.48342958242172657,1.0545790031675617,0.41471048513302033,0.8898366652417518,1.0,8/19,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,cellular response to organic cyclic compound (GO:0071407),0.36130761481687496,1.054578014124173,0.3743016759776536,0.8890974772164947,1.0,21/141,8.80%,EGFR;CDH1;CYP1B1;EZR;IGFBP5;CTNNA1;SLC26A6;DIAPH1;NR4A3;RAP1A;CASP6;ESR1;GOLPH3;DMTN;MYOG;LCOR;JUP;P2RX4;ATP1A3;ATP1A1;RORA
prerank,negative regulation of MAP kinase activity (GO:0043407),0.41672866482434,1.054269027838759,0.3950617283950617,0.8891670567889435,1.0,7/44,11.50%,BMP4;PRKCD;PDCD4;CBLC;NF1;IRAK3;DUSP10
prerank,regulation of developmental growth (GO:0048638),-0.3585358216734115,-1.0542056399095816,0.3855072463768116,0.7531979502781442,1.0,9/29,10.64%,PLCB1;IGF1;APOE;INSR;APP;GHR;SPAAR;OLFM1;MFSD2A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4698550158890067,1.0538193021540332,0.41185185185185186,0.8896231621067772,1.0,6/22,19.01%,CDK12;SCAF8;TCERG1;CDK13;THOC5;CCNT1
prerank,regulation of coagulation (GO:0050818),-0.4538282650197615,-1.053419019630012,0.4090909090909091,0.7538968746956942,1.0,8/11,40.76%,HS3ST5;HRG;F2R;FOXA2;GP1BA;F2RL1;CAV1;F2
prerank,cellular protein modification process (GO:0006464),0.3368854809841532,1.0529494411833449,0.301,0.8911170144331945,1.0,181/982,15.14%,STK39;FBXL7;ST3GAL4;THBS1;BMP4;DCLK1;MSLN;FSTL1;MAP3K5;GRK5;PTP4A2;MARK1;PTPN3;UST;EGLN3;CCN1;PPP3CA;PTK2B;CAMK2D;PLOD2;PTPRU;WNK1;FN1;ANXA1;WNT11;PRKCD;GPC3;FBXO10;DSP;ZBTB16;COL3A1;IGFBP5;B3GNT2;WWP2;FGFR1;LIMK2;HIPK1;DCAF6;BMPR1A;PPM1H;GSK3B;LARGE1;LOXL1;TLK1;PRKCE;NEK7;ABL1;BCR;PTPRF;TGFBR1;PHKA2;FBXO40;CHST5;CLK2;MKNK2;WIPI2;TGFBR2;SGK3;FBXW8;PHEX;GCNT2;KLHL22;CCDC8;DNAJC3;FRK;CDK12;ATG3;PTPRA;HIF3A;CDC25B;PSMB2;BIRC6;FBXL20;MPI;ASB9;TGM3;ASB16;P3H1;FAM20A;KTN1;SOCS2;MARK2;IKBKE;CHEK2;DCAF4;PTPN21;CSNK1A1;SPRR1A;CSNK1G3;DUSP16;NLK;DUSP11;UBE2F;KLHL13;DUSP5;UBE2D3;RIPK3;CHUK;AAK1;AURKA;FBXW11;SIK3;FEM1B;TNKS2;COMMD1;USP25;PPEF2;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;PPP1R12A;PSMC6;ARF4;STRADA;PPP2R5C;COPS7B;FBXO17;JMJD4;PRKCSH;ERBB2;MORC3;TIMP1;MAST2;ASB11;COPS5;DUSP10;SPSB2;PPP5C;CDKL2;CKAP4;LRRC41;PPP3CC;MACROD2;PTPN9;MAN2A1;COG3;CSK;COP1;ILKAP;PDK3;MTOR;FBXO4;YES1;CHEK1;PPM1A;PKN2;PAK2;PRKDC;DAPP1;CSNK1E;ERN2;PPP4R2;CDC42BPG;RCN1;DYRK2;TRIOBP;PSMD11;MGAT1;CUL3;BAP1;EIF2AK4;BMP15;ERCC8;DCAF5;UBE2S;PIGU;WDTC1;SBF1;PSMD1;TGM1;CCDC22;CDK11B;MAPKAPK2;PRKCA;ST3GAL2;ASB1;CDK16
prerank,regulation of neuron apoptotic process (GO:0043523),0.37464426682074414,1.0528274141098923,0.3877068557919622,0.8907248119941739,1.0,12/96,6.18%,SIX1;NGF;EGLN3;PTK2B;TGFB3;FOXO3;KCNB1;CLCF1;NFATC4;ISL1;GDNF;DDIT3
prerank,regulation of B cell activation (GO:0050864),-0.3761111329444281,-1.0524092836495615,0.364741641337386,0.7552366529406119,1.0,4/25,11.33%,AHR;SH3KBP1;TNIP2;SAMSN1
prerank,regulation of astrocyte differentiation (GO:0048710),0.5184121040515122,1.052190699945611,0.4297945205479452,0.8917187861191411,1.0,4/12,7.45%,HES1;CLCF1;NOG;ID2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5036959799826848,1.0514734707880498,0.41029900332225916,0.8928475770468715,1.0,4/12,14.51%,PLK3;WAC;PRKDC;CCND1
prerank,negative regulation of anoikis (GO:2000811),-0.4258930445301407,-1.0510325511341299,0.39086294416243655,0.7575554951976868,1.0,4/14,6.10%,TLE1;BCL2;NOTCH1;PTK2
prerank,signal transduction in response to DNA damage (GO:0042770),0.4057123272599758,1.050747909529195,0.3955321944809461,0.8940533939480391,1.0,15/49,17.95%,NDRG1;ABL1;CHEK2;MDM4;RAD17;CEP63;ATM;USP10;CLSPN;ATRX;CHEK1;HINFP;USP28;NBN;ATR
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3760766824924163,1.0503962955746673,0.39615846338535415,0.8942649916651478,1.0,24/94,19.08%,MAP3K5;DDX5;CYP1B1;TMEM117;PRKCD;FHIT;ABL1;DDIT3;IKBKE;CHEK2;ATM;DIABLO;ARL6IP5;TNFRSF1B;PRKDC;ERN2;CUL3;PML;CUL1;CASP2;CDKN1A;QRICH1;MOAP1;AIFM1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3343514346898288,-1.0503619706660245,0.40145985401459855,0.7581429435257337,1.0,9/40,10.81%,SHANK3;ANK3;TMSB4X;CALM1;AKAP6;ACTN2;CTSS;STAC;JPH2
prerank,regulation of type I interferon production (GO:0032479),0.3816081381386023,1.0495501216130572,0.39805825242718446,0.8958212278539837,1.0,34/84,23.90%,TAX1BP1;CREBBP;MAVS;POLR3D;IRF1;IKBKE;NFKB1;NFKB2;MYD88;IFIH1;PRKDC;XRCC5;EP300;NPLOC4;DHX9;RNF135;OTUD5;ACOD1;POLR3K;POLR3F;POLR3A;DHX36;POLR3E;UFD1;TRIM25;TRAF3;STAT6;GPATCH3;POLA1;IRF3;TRAF3IP1;POLR3B;CRCP;RNF26
prerank,regulation of DNA binding (GO:0051101),0.4210199707990701,1.0492434329648117,0.3991769547325103,0.8958847380896945,1.0,8/44,10.17%,NGF;SMO;HES1;MDFI;SKI;KDM1A;FOXC1;JUN
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4511789904377323,1.0489050291513684,0.4081041968162084,0.8960823349275552,1.0,9/29,21.88%,BMP5;SPRED2;IL17RD;LDLRAD4;NKX2-1;ADIPOR1;FUZ;FOXA1;GATA3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4141148567263624,-1.0487701175214708,0.4025974025974026,0.761058874033021,1.0,8/16,8.69%,IGF1;TGFBR3;NOTCH1;ERBB4;RBPJ;AKAP6;MEF2C;EDN1
prerank,regulation of ERAD pathway (GO:1904292),0.5240561518604429,1.0487340863021635,0.40468227424749165,0.8958056261507069,1.0,3/11,9.76%,USP13;RNF185;USP25
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4829660515164573,1.048557473272324,0.41025641025641024,0.8955182801519901,1.0,6/16,18.32%,ANK2;GBF1;SEC16A;DDRGK1;BCAP31;BCAP29
prerank,positive regulation of type I interferon production (GO:0032481),0.38711666369724584,1.0480948354234165,0.3849938499384994,0.8959638007697159,1.0,23/73,18.90%,CREBBP;MAVS;POLR3D;RIPK2;SETD2;IRF1;TLR4;CHUK;NFKB1;NFKB2;MYD88;IFIH1;PRKDC;XRCC5;EP300;DHX9;RNF135;TLR8;POLR3K;POLR3F;POLR3A;DHX36;POLR3E
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4069096736743185,1.0479302219641886,0.40214477211796246,0.8956836125876195,1.0,14/48,18.20%,ELOF1;POLR1G;POLR1A;TAF1D;TAF1C;KAT2A;CHEK1;EP300;POLR1F;SF3B1;KAT2B;DDX21;ZMIZ1;SMARCA5
prerank,vasoconstriction (GO:0042310),0.5125974959995669,1.0478808213233242,0.4214162348877375,0.8950923417368318,1.0,1/11,0.91%,EDNRA
prerank,Rap protein signal transduction (GO:0032486),-0.47098022988018207,-1.047846986385376,0.39770114942528734,0.7621314305781257,1.0,4/10,9.84%,RAPGEF3;RAPGEF2;RAP2A;RAPGEF1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3112388055870808,-1.0478034945546624,0.3617021276595745,0.7609055915012235,1.0,21/54,15.05%,APOE;PRKD1;NOS3;AKT3;ETS1;KDR;TMSB4X;MEF2C;HIF1A;ANGPT2;GATA2;ATP5F1B;RGCC;PRCP;NUS1;PLCG1;ATP5F1A;VASH1;ACVRL1;CD40;AKT1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.46938589280061793,1.0476754202704233,0.4203125,0.8948966792804237,1.0,7/20,9.36%,ANK2;ATP1B1;CACNA1C;CAMK2D;DMD;SLC9A1;TNNI3
prerank,negative regulation of transposition (GO:0010529),0.4735421236834011,1.0476397727834381,0.41818181818181815,0.8942475370869201,1.0,5/16,19.91%,MOV10;TDRD9;TUT7;TUT4;TEX15
prerank,neuropeptide signaling pathway (GO:0007218),-0.31121833461960097,-1.047614360026694,0.38190954773869346,0.7600194389172902,1.0,11/58,16.19%,SORT1;RAPGEF2;GLRA1;CYSLTR1;CYSLTR2;SORCS2;GLRA3;SORCS3;GPR37;PENK;SORCS1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4909844992128289,1.0474544977667337,0.42524916943521596,0.8940299616766635,1.0,3/17,3.98%,SLIT2;FGF2;NRP1
prerank,cellular response to interleukin-7 (GO:0098761),0.4777771962379859,1.0470948320613116,0.41042345276872966,0.8934924563480281,1.0,6/17,15.84%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4777771962379859,1.0470948320613116,0.41042345276872966,0.8934924563480281,1.0,6/17,15.84%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,cristae formation (GO:0042407),-0.36271319579726796,-1.0470683068781754,0.3785488958990536,0.7600935948309245,1.0,9/27,16.50%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;CHCHD6;ATP5F1D;MICOS13;ATP5MC2
prerank,cellular response to hydroxyurea (GO:0072711),0.5333748768773,1.046009050371506,0.4288224956063269,0.8956629758685346,1.0,5/10,20.06%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,negative regulation of immune response (GO:0050777),-0.25463635680876484,-1.0459753460059065,0.3162393162393162,0.7616615835343086,1.0,45/154,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;ENPP3;PRKACB;PRKAR1A;ADORA2A;CD300A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;NMI;ADCY2;SAMSN1;PLCG1;TYRO3;HAVCR2;TRIM21;HCK;GPR176;ADCY4;LYAR;FCGR1A;PLK2;GGT1;RHBDF2;VIPR2;LHCGR;TNFAIP3;TSHR;SPI1;RXFP1;TREM2;SYK;TRIM27;CD163
prerank,plasma membrane repair (GO:0001778),0.5152201143927302,1.0458828631184005,0.4209650582362729,0.8952612987208132,1.0,2/13,4.45%,AHNAK2;SYTL4
prerank,gluconeogenesis (GO:0006094),-0.3301426626918578,-1.045788220497992,0.33955223880597013,0.7607998208776595,1.0,13/39,21.63%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A11;SLC25A13
prerank,positive regulation of kinase activity (GO:0033674),0.37412533892326877,1.0457560878462293,0.3978622327790974,0.8948543578099223,1.0,10/107,4.30%,EGFR;RASSF2;MET;NTRK3;CCN1;PTK2B;LMO4;DDR2;FGFR1;RAP1A
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.48484368359245145,1.0456092311717209,0.4307178631051753,0.8944979335104567,1.0,6/16,17.86%,MCM7;WRN;MCM2;RPA1;RECQL5;RAD51
prerank,negative regulation of phosphatase activity (GO:0010923),0.44970287083265403,1.0456042573600426,0.4270833333333333,0.8937773640736429,1.0,9/25,20.92%,GSK3B;CRY2;STYXL1;BOD1L1;CHP1;URI1;PPP1R36;TGFB2;PTPA
prerank,membrane lipid biosynthetic process (GO:0046467),0.39598027674403957,1.0454528358686046,0.39378238341968913,0.8934637330083637,1.0,5/58,5.31%,ST3GAL4;ACER3;PLPP3;SGMS2;SPTSSB
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3448919908609045,1.0454474315551903,0.3870625662778367,0.8927510779763943,1.0,44/248,11.69%,EGFR;TCF7L2;SOX9;MLLT3;LRP6;CTNND2;PTPRU;WNK1;WNT11;GLI3;GPC3;PLEKHA4;PRICKLE1;GSK3B;FZD7;VCP;TRPM4;TMEM198;SFRP4;UBE2B;TLE2;NOG;TLE6;INVS;UBR5;DDIT3;BAMBI;TBL1X;PSMB2;JUP;CSNK1A1;CSNK1G3;USP34;NFKB1;DACT1;TNKS2;DKK3;IGFBP6;PSMC6;EMD;PRDM15;RNF146;USP47;RBMS3
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4260933875046058,-1.0454377111929156,0.4020356234096692,0.760443829661163,1.0,4/15,8.93%,APOE;APP;PFDN5;PFDN2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5108457632797396,1.04521686174848,0.4096774193548387,0.8926527136635883,1.0,4/12,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4616331258279705,1.0448432449031877,0.4130105900151286,0.8929071102409927,1.0,7/22,18.25%,ESR1;MED13;PSMC6;HNF1A;MED14;MED24;DHX36
prerank,cellular response to retinoic acid (GO:0071300),0.414617731563333,1.0447525985797097,0.40215924426450744,0.8924236710535375,1.0,5/42,3.31%,WNT9A;SOX9;PTK2B;WNT11;FZD7
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3530565171731569,1.0444663049627045,0.3951965065502183,0.8924501560278786,1.0,44/182,16.24%,FOXP1;BMP4;SLC24A3;ITGB8;SMO;WWP2;KLF4;BMPR1A;ZNF148;FGF2;NOTCH2;LRPAP1;ATP2B4;LDLR;ESR1;CELF1;MOV10;ID2;TNRC6C;REL;ATOH8;CD46;NFKB1;AURKA;VEGFA;ATXN2;SMCR8;CCL3;RB1;RBMS3;SNX12;ZC3H12A;DDRGK1;ANXA7;REST;CNOT7;CREB3L1;MAP2K2;ADAM10;HINFP;RIN3;AGO2;CPNE1;XDH
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.39455094696198756,1.044177601088212,0.4152202937249666,0.8925026220857895,1.0,23/64,28.59%,MLLT3;ELOF1;MNAT1;CDK12;SETD2;AFF4;ELOA;CTR9;NELFE;ELP4;ERCC3;CDK13;CCNT1;RTF1;PAF1;EAF2;ADRM1;ERCC2;GTF2F2;GTF2H3;CCNT2;EAF1;NCBP2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4445837913068566,-1.0440852706653145,0.41237113402061853,0.762734007920934,1.0,5/12,10.61%,PROM1;PODXL;BASP1;KLF15;PTPRO
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3343632186558614,-1.0438694703477474,0.35664335664335667,0.7619989268691654,1.0,16/38,23.62%,PHLPP1;PPARA;DAG1;THEM4;AKT1;ARRB2;PHLDA3;SH2B3;RACK1;HYAL2;GPER1;TRIB3;INPP5K;EPHA2;PTPRJ;PLEKHA1
prerank,RNA 3'-end processing (GO:0031123),0.3917797875307917,1.043721812315711,0.4015056461731493,0.8929383367966228,1.0,28/69,27.50%,SRSF11;THOC2;SRSF5;SRSF6;U2AF2;SRRM1;TUT7;CASC3;CHTOP;TUT4;U2AF1L4;ZC3H11A;THOC5;SRSF2;TENT2;FIP1L1;NUDT21;CDC40;CSTF1;CPSF7;UPF3B;RBM8A;CPSF3;ALYREF;SRSF3;CLP1;SRSF7;CPSF4
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3392658532339042,1.0432416958862138,0.39792746113989635,0.8934504540384802,1.0,48/308,11.56%,BMP4;SIX1;SOX9;FOXD1;ADRA1B;PDGFC;SMO;LBP;BMP1;TGFB3;ZBTB16;GRB10;ADRB2;BMPR1A;INHBA;FGF2;LRPAP1;CMKLR1;TGFBR1;NLRP5;TRPM4;TGFBR2;ZBTB7B;TSKU;GCNT2;NOG;GADD45G;TLE6;GDNF;KDM1A;LRP1;BAMBI;DECR1;TGFB1I1;IL10;SIX4;EHMT1;FOXC1;SCD;NIBAN2;IL33;HILPDA;ACVR1;VEGFA;BCL9L;SMAD2;INHBB;TIAM1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.42240105973161435,-1.0427607024167955,0.41911764705882354,0.7635676270626258,1.0,5/15,4.71%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,Notch signaling pathway (GO:0007219),-0.30701724935433444,-1.042685598951586,0.3807531380753138,0.7624114529731753,1.0,17/59,12.48%,SORBS2;MAML3;MAML2;NOTCH3;DTX4;NOTCH1;PLXND1;RBPJ;NOTCH4;BMP2;JAG2;DTX1;HEY2;MDK;STAT1;APH1B;YBX1
prerank,platelet degranulation (GO:0002576),0.36785553680988314,1.041457381124906,0.3957597173144876,0.897359270729301,1.0,18/118,11.37%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;PDGFA;SERPING1;GTPBP2;VEGFA;ITGB3;TIMP1;ABCC4
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3570884987906256,1.0404250866429277,0.41990846681922195,0.8993296666699986,1.0,22/132,12.53%,SLC4A4;EZR;ADAM9;PRKCD;FOXO3;GSK3B;IRS1;PFKFB2;TPCN1;MOV10;RDX;DXO;DAGLB;PFKFB1;ZC3H18;DACT1;PIM2;MTDH;ATF6;SH3D19;TNFRSF1B;ZC3H12A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3897070972192536,-1.0402911954268383,0.4022346368715084,0.7673216887147835,1.0,7/20,13.30%,BCL2;DCC;BCL2L1;FAS;BOK;CASP3;GSK3A
prerank,establishment of vesicle localization (GO:0051650),0.48156156756447516,1.0402099311513762,0.4263565891472868,0.8991857385483759,1.0,6/18,16.38%,LIMK2;SPG11;F8A1;TMEM230;SYNJ1;IKBKG
prerank,retinoic acid metabolic process (GO:0042573),-0.4213699110670559,-1.0399036868095446,0.38676844783715014,0.7669692945630567,1.0,2/14,1.99%,ALDH1A2;CYP26B1
prerank,protein localization to vacuole (GO:0072665),-0.43082979260155546,-1.0396467566319083,0.42216358839050133,0.7662444237976669,1.0,5/13,14.64%,CD81;RTN4;SH3BP4;GLMP;MFSD1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.45432998896147914,-1.0394170804544633,0.3986175115207373,0.7655427819344606,1.0,3/10,5.14%,RAPGEF2;KDR;CD34
prerank,positive regulation of protein transport (GO:0051222),0.39014970489567646,1.0393730082526524,0.42312579415501905,0.900616813303383,1.0,16/67,13.42%,EZR;TGFB3;ADAM9;BMP6;UNC13B;ACSL3;SYTL4;BCAS3;PCM1;GOLPH3;PLK3;CNST;CEP131;ARHGEF5;CHP1;EXPH5
prerank,regulation of stress fiber assembly (GO:0051492),0.3795122980972492,1.0390257761312582,0.425,0.9008402042412453,1.0,15/74,9.06%,TMEFF2;MET;SORBS3;ARAP1;TGFB3;WNT11;PHLDB2;ABL1;NRP1;TGFBR1;RHPN2;ARHGEF10;SLC9A1;S100A10;RHOA
prerank,regulation of ion transport (GO:0043269),0.3759509715926137,1.038490304432712,0.40914709517923364,0.9014969554159844,1.0,12/76,10.97%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;GDNF;SYT8;P2RX4;ATP1A1;DRD3;ITGB3;PER1
prerank,positive regulation of insulin secretion (GO:0032024),0.4230505508222255,1.0384685168194574,0.398876404494382,0.9008233675629929,1.0,7/36,11.28%,TCF7L2;TRPM4;ISL1;CLTRN;AACS;MCU;CAPN10
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5337351678399418,1.0384383461288365,0.4246100519930676,0.9001758447255367,1.0,2/10,1.93%,CYP1B1;WNK1
prerank,response to reactive oxygen species (GO:0000302),0.40093688057930926,1.038338728687891,0.4261437908496732,0.8997132488993314,1.0,6/54,10.17%,EGFR;ADAM9;COA8;PLK3;CHUK;JUN
prerank,regulation of actin filament-based process (GO:0032970),0.38704481660556284,1.0382415041325854,0.44061302681992337,0.8992256222260784,1.0,16/70,9.47%,EZR;EFNA5;PRKCD;ARHGAP44;RHOBTB1;ABL1;FAM107A;RHOQ;LRP1;DMTN;ARHGAP17;PDGFA;RHOA;IQGAP1;RND3;MLST8
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5254714689028281,1.0375753112446342,0.45068027210884354,0.9002681562041072,1.0,3/10,7.43%,PRKCD;CD9;RDX
prerank,regulation of synapse assembly (GO:0051963),-0.31895554945528093,-1.0375624605140183,0.38405797101449274,0.76905621889332,1.0,11/46,9.03%,IL1RAPL1;NRXN1;ROBO2;GRID2;EPHB1;APP;MEF2C;SNCA;SRPX2;LRFN5;LRRC4B
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3260842513734382,-1.0375186172093036,0.37209302325581395,0.7678532867352005,1.0,8/40,9.22%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;BMP2;ZC4H2;PROX1
prerank,positive regulation of developmental process (GO:0051094),0.35110344971970775,1.037402302197994,0.42684268426842686,0.900003324267803,1.0,28/164,12.07%,BMP4;SOX9;BMP5;FOXD1;COBL;BMP1;ZBTB16;PHLDB2;FGFR1;BMPR1A;LMNA;NLRP5;TRPM4;FOXO6;TLE6;ISL1;GDNF;AGR2;DDHD1;SHANK1;NIBAN2;AURKA;ACVR1;VEGFA;MCU;ZDHHC15;MIEF1;CORO1C
prerank,cardiac muscle cell development (GO:0055013),-0.38972550967912395,-1.0371671311742527,0.4136986301369863,0.7674633562399318,1.0,7/20,9.13%,SORBS2;PDGFRB;SLC8A1;MYH11;OBSL1;HEY2;PDGFRA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.450646367497579,-1.0371310402408849,0.39097744360902253,0.766234033766613,1.0,5/10,26.46%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,myeloid leukocyte differentiation (GO:0002573),0.38741023437559957,1.0370557322631304,0.43125,0.9002232873363064,1.0,4/65,4.97%,FOXP1;BMP4;GAB2;TGFBR2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4222317286318877,1.036928415917619,0.42035398230088494,0.8998536652032687,1.0,10/37,11.63%,TGFB3;IGFBP5;BMPR1A;FGF2;NR4A3;PDCD4;IL10;CDKN1B;JUN;HTR1B
prerank,regulation of cell division (GO:0051302),0.3823347490527005,1.0367226765329696,0.4076923076923077,0.8996610142452646,1.0,16/72,15.56%,MLLT3;KIF13A;NLRP5;RAB11FIP3;BECN1;TLE6;BIRC6;SETD2;PLK3;KLHL13;AURKA;PRDM15;ENTR1;SH3GLB1;HTR2B;AHCTF1
prerank,negative regulation of cell division (GO:0051782),-0.46089445112024885,-1.0366306072279423,0.42720763723150357,0.7662575825686722,1.0,7/11,33.65%,TXNIP;BLM;CHMP4C;E2F7;E2F8;MYC;AURKB
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.43791533458848464,-1.0366044202426512,0.4129353233830846,0.7650187452385089,1.0,5/11,30.16%,AKAP6;NOS1AP;TREM2;RNF207;LRRC55
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4928053046908535,1.036555126403116,0.4264705882352941,0.89865408866197,1.0,7/15,22.14%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4928053046908535,1.036555126403116,0.4264705882352941,0.89865408866197,1.0,7/15,22.14%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,regulation of proteolysis (GO:0030162),0.40703477129857385,1.036351666872749,0.4153645833333333,0.898461203001021,1.0,9/48,15.60%,CYFIP2;PERP;LTBP4;FBXW11;DNAJC1;TBC1D10A;SPOP;IST1;SERPINE2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4715953103137522,1.0362679614443426,0.4437194127243067,0.8979623875949646,1.0,6/18,20.81%,SMYD2;SETD2;EHMT1;KMT2D;EHMT2;ASH1L
prerank,N-terminal protein amino acid modification (GO:0031365),0.4917595526689132,1.0361518847198583,0.4161184210526316,0.897561690499723,1.0,7/14,27.52%,NAA40;NAA15;METAP1D;NAA35;METAP2;NAA50;NAA60
prerank,sphingolipid metabolic process (GO:0006665),-0.2768217231767938,-1.03555664454054,0.3643410852713178,0.7664446309151912,1.0,33/108,17.74%,ST6GALNAC3;ENPP2;PRKD1;CERS4;ACER2;SGMS1;ELOVL7;UGCG;CERT1;DEGS2;SMPD3;CERK;ELOVL6;CTSA;GAL3ST1;ESYT1;SPHK1;SPTSSA;SERINC1;SPNS2;HACD3;CERS1;ELOVL4;CERS2;HACD2;ORMDL3;HEXB;SMPD1;PSAP;PLPP2;ALDH3B1;ABCA2;CLN8
prerank,regulation of chemotaxis (GO:0050920),0.4343273071279263,1.0353160403379598,0.4287833827893175,0.8990109644664955,1.0,4/30,8.66%,THBS1;PTPN2;MYCBP2;P2RX4
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5245830506687167,1.035314340868591,0.4653130287648054,0.8983020936395572,1.0,2/10,7.65%,GALNT13;POGLUT3
prerank,actomyosin structure organization (GO:0031032),0.37900013621254075,1.035263247094425,0.3945409429280397,0.897720239516443,1.0,14/75,9.49%,EPB41L5;PHACTR1;CIT;CSRP3;EPB41L2;SORBS1;ITGB1;ITGB5;TMOD3;KRT19;SIX4;CSRP2;RHOA;FRMD6
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.39224858354169745,1.0352456157926602,0.4270967741935484,0.8970562706626883,1.0,15/60,18.25%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;MED27;CBFB;HNF1A;CCND1;MED14;MED24;CDKN1A;DHX36
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4426329177425053,1.0351424716928304,0.42836041358936483,0.896599553771392,1.0,5/27,4.75%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.37939759476203644,1.0350424751780913,0.42420382165605097,0.8961484858297839,1.0,7/76,6.42%,PLCE1;ADRA1B;GPR4;CMKLR1;AGTR1;ESR1;LPAR4
prerank,histone ubiquitination (GO:0016574),0.4592826691342515,1.0343388620128486,0.4093655589123867,0.897318044141161,1.0,10/21,29.00%,UBE2B;WAC;CTR9;USP22;UBE2N;RNF8;HUWE1;PAF1;RNF20;UBE2A
prerank,negative regulation of viral life cycle (GO:1903901),-0.4112620429001328,-1.0343363729690096,0.3974358974358974,0.7682477773219107,1.0,5/15,7.63%,LY6E;PPIA;IFITM1;BST2;IFITM3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.42181324340156356,1.0342644084828205,0.40634005763688763,0.8967925415565149,1.0,13/32,27.33%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;POLR1F;ERCC3;UBTF;ERCC2;RRN3;POLR1H;TAF1;GTF2H3
prerank,response to growth factor (GO:0070848),0.4168814510996266,1.0341193598562302,0.4295676429567643,0.8964685032022227,1.0,10/41,14.99%,SHC1;KLF4;BMPR1A;TGFBR1;TGFBR2;ACVR1;EMD;ERBB2;CPNE3;URI1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.49585396552111083,1.0340357664833233,0.44256756756756754,0.8959731411128358,1.0,3/12,5.27%,ATP1B1;WNK1;DMD
prerank,positive regulation of intracellular transport (GO:0032388),0.4221941515832791,1.0332123371250819,0.43333333333333335,0.8973460030906152,1.0,8/38,11.28%,NEDD4;BCAS3;PCM1;PLK3;EHD1;CEP131;EHD2;CAPN10
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5100565566523256,1.0329454422323685,0.4388984509466437,0.8973196735618612,1.0,6/12,19.73%,UPP2;TK1;TK2;CAD;DHODH;UMPS
prerank,regulation of protein localization to centrosome (GO:1904779),0.5218219930045149,1.0329312844421048,0.45233968804159447,0.8966411374289438,1.0,1/10,3.24%,GSK3B
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4469210938241356,1.0326925849251316,0.42989214175654855,0.8965860396170208,1.0,5/24,8.80%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4180718801324579,-1.0325311905733408,0.39800995024875624,0.7716397394942152,1.0,4/15,8.44%,TNK2;DGKD;HIP1R;SNAP91
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4364618640075526,1.0324543999257358,0.42857142857142855,0.8965334736430096,1.0,5/26,8.80%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,protein O-linked mannosylation (GO:0035269),0.47351521331343227,1.0322308298576086,0.44122383252818037,0.896404436228175,1.0,6/18,15.86%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.46106411068650394,1.0321692844126165,0.428341384863124,0.8958695325692609,1.0,4/20,10.18%,FMNL2;RHOQ;DLG1;NCKAP1
prerank,acylglycerol catabolic process (GO:0046464),0.4429004338332873,1.0319240511615866,0.42507645259938837,0.8957599207865655,1.0,6/30,19.51%,MGLL;PNPLA3;ABHD6;LYPLA2;FABP12;ABHD2
prerank,regulation of endocytosis (GO:0030100),-0.3012703974900819,-1.031698848304991,0.38493723849372385,0.7725080162899526,1.0,12/61,8.16%,APOE;PRKD1;NEDD4L;MCTP1;PICALM;CDH13;RIT2;OPHN1;SYT11;SNCA;HIP1R;SPHK1
prerank,natural killer cell activation (GO:0030101),0.4628719291878827,1.0312564281070562,0.4270676691729323,0.8967554659615143,1.0,3/23,6.37%,PBX1;CD2;NFIL3
prerank,regulation of cell size (GO:0008361),0.4560404415054926,1.030946191695221,0.43517138599105815,0.8968312458411525,1.0,7/23,12.91%,EZR;VAV2;RDX;RHOA;RARG;RAP1GAP2;MTOR
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.34999639642888314,-1.030736185919504,0.3670886075949367,0.7737175420070267,1.0,9/32,10.31%,MCTP1;RIMS1;RIMS2;MCTP2;MEF2C;SYT11;SLC30A1;CAMK2A;SYN1
prerank,smooth muscle cell differentiation (GO:0051145),0.49453661008090183,1.030701847939683,0.44424131627056673,0.8967779236151177,1.0,2/12,5.74%,BMP4;MRTFA
prerank,cytoplasmic translational initiation (GO:0002183),0.4756087816504561,1.030574577497369,0.4504065040650406,0.8964045050511523,1.0,8/17,23.47%,EIF4G1;EIF2D;EIF3A;EIF2S2;EIF4B;EIF2B3;RBM4;DHX29
prerank,negative regulation of interferon-gamma production (GO:0032689),0.44812178813000936,1.0304861040855688,0.4141566265060241,0.8959247572778052,1.0,5/23,12.53%,INHBA;DDIT3;TLR4;RARA;ZC3H12A
prerank,triglyceride metabolic process (GO:0006641),-0.3173956315975631,-1.0301534429483465,0.3906810035842294,0.7739468102479196,1.0,9/48,15.51%,APOE;LPGAT1;GK;LPIN3;GPAM;FABP5;DGAT1;LPL;LPIN1
prerank,histone H4 acetylation (GO:0043967),0.40670294575103394,1.029892353822273,0.43273231622746183,0.8967633242534019,1.0,27/47,28.08%,NAA40;TADA3;TRRAP;KANSL2;EP400;ZZZ3;BRCA2;PER1;KANSL3;KANSL1;EP300;HCFC1;MSL1;ATF2;EPC1;TRIM16;BRD8;PHF20;DMAP1;MCRS1;JADE2;OGT;ING3;HAT1;NAA60;MORF4L2;KMT2A
prerank,polarized epithelial cell differentiation (GO:0030859),0.49679053354241415,1.0297215491838463,0.45614035087719296,0.8964975378135432,1.0,7/13,21.78%,EZR;RHOA;SYNE4;MYO9A;SCRIB;CAMSAP3;CDC42
prerank,translesion synthesis (GO:0019985),0.40671457503153596,1.0296947246157029,0.40948275862068967,0.8958669262345852,1.0,17/42,28.48%,REV3L;VCP;USP10;NPLOC4;POLE2;ZBTB1;RPA1;UFD1;RFC1;REV1;TRIM25;POLD3;RFC5;POLK;RCHY1;POLI;PRIMPOL
prerank,regulation of cell development (GO:0060284),0.41714017527910313,1.0295709121813725,0.41889985895627646,0.8954771022542196,1.0,5/36,5.39%,HDAC9;HES1;NOTCH2;DOCK7;BHLHE40
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4900046290585482,1.0294315901519135,0.42326332794830374,0.895111282501367,1.0,5/14,14.68%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.451981574814052,1.028987937945543,0.42589703588143524,0.8955836387082067,1.0,2/21,4.22%,GUCY2C;ADCY9
prerank,regulation of calcium ion transport (GO:0051924),-0.30173167760809794,-1.0286116460153611,0.3684210526315789,0.7767230769965391,1.0,11/54,11.40%,MYLK;CACNA1D;EPB41;BCL2;ADRA2A;ATP2B1;CACNA2D1;TRPC6;CAMK2A;CD84;CAMK2B
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.46814904339007146,1.0284625703415986,0.45161290322580644,0.8961938130500956,1.0,5/18,18.57%,EZR;RDX;SNX12;MAP2K2;RAB21
prerank,response to hydroxyurea (GO:0072710),0.5141666021753615,1.0284529310197228,0.441025641025641,0.8955224220742011,1.0,5/11,20.06%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,neuron projection fasciculation (GO:0106030),-0.4570865434427871,-1.0282632477898705,0.42152466367713004,0.776317639149248,1.0,7/10,25.53%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.46099138456655064,1.0280747655925695,0.4364820846905538,0.8957762009978332,1.0,4/19,5.99%,EXT1;HS6ST2;GLCE;XYLT1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.43916231675906214,-1.0277634853861564,0.41854636591478694,0.7763409094621755,1.0,6/12,26.36%,CXCL12;APP;JAM2;DOCK8;PYCARD;CCL5
prerank,actin filament organization (GO:0007015),0.3503560213205172,1.0269309577805446,0.41648106904231624,0.8979720430948205,1.0,22/151,9.35%,DPYSL3;BAIAP2L1;VILL;COBL;ABI1;GSN;SHROOM3;RHOBTB1;TMOD3;FAT1;NLRP5;TLE6;NEBL;PLS1;DMTN;DLG1;GAS2L2;ARHGAP17;SHROOM4;RHOA;GAS2;RND3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.42716132081696345,-1.0267915532885639,0.4068627450980392,0.7775400347123439,1.0,2/12,6.87%,INSIG2;TAPT1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3367345051549618,-1.0267775345554204,0.4024767801857585,0.7762695100596688,1.0,9/31,20.70%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ATXN3;HSPA9
prerank,intracellular protein transport (GO:0006886),0.33760067872228916,1.0266798277629567,0.42012448132780084,0.8979055252226003,1.0,87/304,21.16%,PKD1;SGSM2;KIF13A;GIPC1;PRICKLE1;TLK1;STX11;NUP93;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;HPS4;XPO1;STAT3;IPO7;GRTP1;E2F3;ARF3;NSF;AP4E1;RAB3GAP2;TNPO2;SEC16A;AP2A1;EIF2D;EGR2;STX8;C2CD5;EHD1;CTTN;ARF4;STRADA;DESI1;KATNB1;TBC1D2B;TBC1D13;COPA;RANGRF;STX19;TBC1D25;SEC31A;ARCN1;CHP1;SEC13;NUP153;SMURF1;TBC1D10A;BAG3;RAB24;ARFIP1;TBC1D8B;GGA2;ARFIP2;TBC1D5;ARFGAP3;SAR1B;NUP214;SEC23IP;SGSM3;SNX31;NUP188;XPO4;SCFD2;NUP88;TBC1D17;RAB5B;AP3D1;SNX13;RAB21;SNF8;USO1;SNX8;AP4M1;NUTF2;RAN;TNPO3;HEATR3;RAB5A;AP4B1;RAB1A;STX2;TMED3;RAB18
prerank,sphingolipid catabolic process (GO:0030149),0.48422700163651133,1.026630446743378,0.4500818330605565,0.8973600660132077,1.0,2/15,3.98%,ACER3;PDXDC1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.37847081689340917,1.0266293197020593,0.4425,0.8966703256685565,1.0,21/72,18.37%,PLAGL1;NDRG1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;USP10;ATRX;EP300;CNOT7;PIDD1;PML;CASP2;NBN;CDKN1A;CARM1;TNKS1BP1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.46588881685698486,1.0266192912986971,0.4276422764227642,0.8959984769505283,1.0,8/18,20.50%,USP15;PUM2;NPLOC4;PUM1;ANKRD17;BIRC3;UFD1;GPATCH3
prerank,nuclear envelope organization (GO:0006998),0.46443553008104904,1.0263799160868314,0.42967542503863987,0.8959248837148144,1.0,8/20,22.26%,NUP93;TOR1AIP1;SUN3;EMD;TOR1B;LEMD2;TMEM170A;SUN2
prerank,regulation of organelle organization (GO:0033043),0.37612333409376586,1.0262357798275161,0.4187192118226601,0.8955978228741243,1.0,21/80,15.61%,CLIC4;EZR;CAPN2;DIAPH1;STX5;MAVS;CLEC16A;EHD3;GOLPH3;RDX;MARK2;CAPN6;ARMH3;AKAP9;ARHGEF5;TBC1D25;PAK2;EP300;PRMT6;SQSTM1;SAR1B
prerank,response to insulin (GO:0032868),-0.28497697175123105,-1.0258510971732453,0.41346153846153844,0.7774678300684245,1.0,22/80,18.23%,TBC1D4;PIK3R1;SORT1;FOXO1;CPEB2;ENPP1;INSR;INSIG2;LPIN3;MYO5A;SLC25A33;GSK3A;DENND4C;AKT1;RAB15;LPIN1;RAB31;RAB13;PDE3B;SELENOS;XBP1;SLC27A1
prerank,lamellipodium organization (GO:0097581),0.42704883455114817,1.0257014300862781,0.43134328358208956,0.8962800132067529,1.0,8/29,6.92%,ABLIM3;ITGB1;SNX2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,negative regulation of cell development (GO:0010721),-0.3697986343934452,-1.0255178242942202,0.4024024024024024,0.7770429266397689,1.0,3/25,4.40%,IGF1;B2M;NOTCH1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4593013289349661,-1.025505672137291,0.425531914893617,0.7757626440758612,1.0,2/10,2.52%,ZEB2;RAPGEF2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5191536546477895,1.0254147424070488,0.4388609715242881,0.896307010255275,1.0,3/10,10.34%,KDM1A;DISC1;VEGFA
prerank,regulation of cell cycle process (GO:0010564),0.36352680736809645,1.0252215068645532,0.43478260869565216,0.8960969323731863,1.0,29/104,22.64%,SOX9;KIF13A;TXLNG;RAB11FIP3;BECN1;CCDC8;BIRC6;SETD2;PLK3;KLHL13;AURKA;CEP85;ENTR1;CHEK1;SH3GLB1;AHCTF1;IHO1;KNSTRN;RMI2;CDK13;CSNK2A2;CSNK2A1;PDXP;YTHDF2;CUL7;CDC42;PRMT5;PLK4;ZFYVE26
prerank,transcription by RNA polymerase II (GO:0006366),0.3362235299992242,1.0251385519151668,0.44272445820433437,0.895620022927338,1.0,62/305,16.25%,NR3C2;RNMT;RARB;MLLT3;DDX5;HDAC9;ESR2;NOTCH2;ELOF1;PRRX1;NR2F1;NR4A3;NR4A2;ZBTB7B;CREBBP;ESR1;MNAT1;CDK12;MBD1;TBL1X;E2F3;SETD2;AFF4;SCAF8;NFIX;TEAD1;RXRA;NFYA;RORA;NFKB1;RARG;MED27;RARA;RBMX;RPAP1;SNAPC2;TTF2;NCOR1;NABP1;TAF1C;CBFB;ELOA;GTF2E1;NR4A1;NR6A1;CTR9;NELFE;HNF4A;LSM11;NCOR2;E2F2;HDAC10;ELP4;ZBTB1;INTS8;INTS5;ERCC3;WWTR1;KAT2B;TRIP11;DDX21;TAF12
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.42645238855054035,-1.0248234245182837,0.43908629441624364,0.7762512140409968,1.0,3/14,11.03%,TFRC;NECTIN2;RIF1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4623887147514255,1.0248040388047863,0.44992295839753466,0.895812416248253,1.0,9/20,27.27%,PAICS;AMPD3;PFAS;GMPS;AK4;AK3;GMPR2;AMPD2;ADSS2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.45431029454753685,-1.0245471634400272,0.45215311004784686,0.7756461508916284,1.0,5/10,13.77%,NEXMIF;NOTCH1;NOTCH4;RGCC;PPM1F
prerank,retrograde axonal transport (GO:0008090),0.4746030940572303,1.0242570407672036,0.4442675159235669,0.8965029673674447,1.0,4/16,9.48%,PAFAH1B1;DLG2;KIF1C;FBXW11
prerank,organophosphate catabolic process (GO:0046434),-0.4423304640549943,-1.0239210937036065,0.4292565947242206,0.7760244252141792,1.0,2/11,7.65%,ENPP2;ABHD12
prerank,negative regulation of axon extension (GO:0030517),-0.34436802679529616,-1.0235923119610673,0.4129032258064516,0.7756161542049396,1.0,11/30,13.00%,SEMA6A;SEMA7A;MAP2;SEMA6D;MAG;RTN4;SEMA5B;SEMA3G;SEMA6B;SEMA3B;TRIM46
prerank,protein import into nucleus (GO:0006606),0.3856404795846669,1.0235555052461336,0.4437340153452685,0.8976061906017194,1.0,19/66,20.35%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;KPNA1;RGPD1;TNPO2;RANBP2;KPNA4;SEC13;NUP153;NUP214;NUP188;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4544573286075061,-1.0234829944974069,0.4611764705882353,0.7745948799261159,1.0,2/10,11.06%,SACS;DNAJA4
prerank,apoptotic process (GO:0006915),0.34167520319487943,1.023318109018269,0.4507042253521127,0.8975271016520735,1.0,45/203,17.22%,PLAGL1;CYFIP2;EGLN3;PTK2B;CIT;EFNA5;PRKCD;PAWR;ZBTB16;NOTCH2;PRKCE;MAGI3;RFK;PDCD4;CASP6;TGFBR2;CD2;PLSCR1;ARHGEF6;GDF6;YARS1;IRF1;PLK3;BCLAF1;FEM1B;MCM2;NCKAP1;CDIP1;DIABLO;BCL2L13;MYD88;MTOR;CHEK1;EP300;PLSCR3;TRADD;CXCR4;CDK11B;PIDD1;TRPC5;ERCC3;IKBKG;CASP2;MRPS30;PAK4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4535888821609485,1.023257794036485,0.4371941272430669,0.8969976979627687,1.0,7/21,11.63%,IGFBP5;BMPR1A;FGF2;NR4A3;IL10;JUN;HTR1B
prerank,cellular glucose homeostasis (GO:0001678),-0.3223985892867053,-1.0225011745126955,0.4351145038167939,0.7758243682632875,1.0,9/41,7.99%,IGF1R;PIK3R1;FOXO1;ZBTB20;PRKAA2;HIF1A;PPARGC1A;ERN1;GAS6
prerank,positive regulation of cell aging (GO:0090343),-0.4462365698088036,-1.0224627178714731,0.4133949191685912,0.7746461846294227,1.0,3/11,10.01%,B2M;YPEL3;ABI3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.45791965068822055,1.0222743642196743,0.4344391785150079,0.8980671074898547,1.0,9/21,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.45791965068822055,1.0222743642196743,0.4344391785150079,0.8980671074898547,1.0,9/21,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,tRNA wobble uridine modification (GO:0002098),0.4890177717776341,1.0222556670270906,0.4470198675496689,0.8974307126876861,1.0,6/14,19.77%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4080487433265488,1.0218762122401877,0.42510699001426533,0.8977147918302353,1.0,4/37,3.51%,HMCN1;CXADR;NECTIN3;ALCAM
prerank,amino sugar biosynthetic process (GO:0046349),0.5162677005845558,1.021144436492569,0.4658493870402802,0.8988839971658582,1.0,4/12,19.89%,NANP;RENBP;UAP1;GFPT1
prerank,organic hydroxy compound transport (GO:0015850),-0.3280670480410819,-1.0209793818353101,0.4280701754385965,0.7772629720141961,1.0,5/36,6.19%,SLCO2B1;NCOA1;SLCO1C1;RBP4;SLC5A3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4159429728130069,-1.0206784691906756,0.43147208121827413,0.7768013664863836,1.0,6/13,28.41%,NOS3;ALDH4A1;GLUD1;NOS2;NOS1;DAO
prerank,lipid transport (GO:0006869),0.35807663238957005,1.020077640499409,0.4155363748458693,0.900849315749121,1.0,12/97,8.62%,SLCO3A1;TNFAIP8L3;ABCD3;SLCO2A1;LBP;PITPNC1;PITPNA;SLC27A3;LDLR;SLC10A2;RXRA;ATP8B1
prerank,actin cytoskeleton reorganization (GO:0031532),0.3873392747167338,1.0198491736890751,0.4366754617414248,0.9007532222539555,1.0,16/63,11.28%,EZR;PHACTR1;ANXA1;SIPA1L1;CXADR;GSN;PARVA;NRP1;ANTXR1;PIP5K1A;DMTN;RHOA;CTTN;MCU;MKLN1;CAPN10
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38648864319866716,1.0195803908975072,0.45359477124183006,0.9007212308828477,1.0,3/57,1.06%,MAP3K5;CYFIP2;PERP
prerank,neurotransmitter transport (GO:0006836),0.37306363873002,1.0194681878875884,0.4269938650306748,0.9003129474288666,1.0,2/73,0.29%,SLC38A2;SLC38A1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4349079060315406,-1.0189219746941127,0.4424552429667519,0.7800365522521774,1.0,3/11,8.24%,LYN;TNFRSF21;CD300A
prerank,acylglycerol metabolic process (GO:0006639),-0.32349114371443466,-1.0185313979636188,0.43986254295532645,0.7797595519591652,1.0,14/37,20.17%,APOE;DGKB;DGKI;GK;DGKD;ABHD12;DGKG;PGS1;DGAT1;LPL;PLAAT3;DGKE;DGKZ;APOC1
prerank,epithelium development (GO:0060429),0.3591833111414939,1.018336701339394,0.4490035169988277,0.9025045545340366,1.0,15/107,10.34%,SIX1;PKD1;SOX9;SMO;BDH2;MEOX2;ANXA4;EHF;CASP6;VCL;RIPK4;GRHL2;KANK2;DACT1;VEGFA
prerank,regulation of gluconeogenesis (GO:0006111),0.4341409669291734,1.0182005886768255,0.4452887537993921,0.9022018854599383,1.0,8/27,15.99%,CLK2;PTPN2;NNMT;C1QTNF12;USP7;ERFE;EP300;GNMT
prerank,glial cell development (GO:0021782),-0.3622029464827742,-1.0181670828000469,0.41348973607038125,0.7794607973057247,1.0,15/25,33.98%,CDK6;APP;NRROS;MDK;CSPG5;MYRF;MT3;DLL1;TPPP;SOX10;EIF2B1;SOX4;EIF2B5;S100A9;HES5
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.43580767201784676,-1.0179941335788383,0.45185185185185184,0.7786290915409187,1.0,3/12,7.06%,IGF1R;INSR;SETX
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3560749495706491,-1.017731493681616,0.4438040345821326,0.7780048893744592,1.0,4/25,3.44%,B2M;KIT;WNT5A;SLC7A5
prerank,transport along microtubule (GO:0010970),0.483124069475196,1.01705495649778,0.4563758389261745,0.9043005627937641,1.0,7/13,21.78%,ARHGAP21;DYNC1I1;SPG11;BAG3;COPG1;CAMSAP3;CDC42
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3651787554865986,-1.0163644559774279,0.47953216374269003,0.780299232353711,1.0,4/26,5.41%,LPGAT1;PRKAG2;NR1H3;PRKAA2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4435823843626389,-1.0161297463100392,0.46582278481012657,0.7795977979159895,1.0,2/11,3.38%,APOE;UGCG
prerank,carbohydrate homeostasis (GO:0033500),0.3815133876079448,1.0160896332053306,0.45942571785268416,0.9059901787328078,1.0,15/67,13.93%,TCF7L2;KCNB1;CRY2;IRS1;KLF7;PTPN2;STAT3;BACE2;MCU;SLC8B1;SELENOT;HNF4A;HNF1A;PAX6;ACSM2A
prerank,monocyte chemotaxis (GO:0002548),-0.34169750154609757,-1.0160283825660335,0.4537037037037037,0.7785824625051835,1.0,4/32,7.12%,FLT1;IL6R;RPS19;TNFRSF11A
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4405748579649636,1.0159334285269532,0.4456692913385827,0.9057083474153024,1.0,7/23,13.42%,HDAC4;CLK2;PFKFB1;C1QTNF12;NCOR1;ERFE;EP300
prerank,cytoskeleton organization (GO:0007010),0.35564667747023215,1.0159011250335301,0.4367015098722416,0.9050923692223108,1.0,19/114,11.67%,MICAL2;PLCE1;FMNL2;MARK1;ARHGAP10;STRIP2;PPP2R3C;RHOBTB1;DIAPH1;DMTN;FGD6;RHOA;RND3;PCLO;SPRYD3;CCL3;MAST2;ZMYM4;SH3D19
prerank,protein kinase A signaling (GO:0010737),0.4902074553263206,1.0157748350333204,0.47927927927927927,0.9047355204026145,1.0,2/12,7.43%,EZR;RDX
prerank,actin filament polymerization (GO:0030041),0.42763248708514906,1.0157548991867795,0.46107784431137727,0.9040992537362595,1.0,7/29,12.98%,COBL;GSN;FAM107A;DIAPH1;WASHC5;MSRB2;PSTPIP1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.42948218538136146,1.0154835964186841,0.46567164179104475,0.9041151239258811,1.0,6/30,10.76%,BMP4;MLLT3;INHBA;TNFRSF13B;HOXB4;PRRC2C
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3528066263282209,1.0153136542636383,0.44675925925925924,0.9038976328685874,1.0,27/129,13.71%,EGFR;WNK1;GPC3;PLEKHA4;VCP;TRPM4;TMEM198;SFRP4;UBE2B;UBR5;BAMBI;TBL1X;PSMB2;JUP;CSNK1G3;USP34;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;RNF146;USP47;CSNK1G1;PPM1A;CSNK1E;PSMD11
prerank,positive regulation of protein secretion (GO:0050714),0.38102157189335367,1.0151278267605055,0.4365284974093264,0.9036695164742533,1.0,11/69,8.03%,TCF7L2;EZR;TGFB3;ADAM9;BMP6;UNC13B;SYTL4;ISL1;GOLPH3;AACS;TLR4
prerank,glycoprotein catabolic process (GO:0006516),-0.39706393852372485,-1.0150699413229374,0.4385026737967914,0.7798010243435032,1.0,4/17,12.53%,ADAMTS9;ADAMTS12;STT3B;CTSL
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.48119705555091274,1.0147481511270429,0.4535073409461664,0.9039202237679437,1.0,2/13,6.08%,CD44;KDM1A
prerank,regulation of neuron migration (GO:2001222),-0.3514932429792855,-1.0147310887002774,0.4233128834355828,0.7793412876538162,1.0,9/26,11.40%,SEMA6A;CTNNA2;RAPGEF2;NEXMIF;DAB2IP;ADGRG1;CAMK2A;MDK;CAMK2B
prerank,organelle assembly (GO:0070925),0.33091045804557734,1.0143521440433871,0.4475025484199796,0.9042236772006118,1.0,115/384,24.02%,PKD1;BBS9;ABLIM3;EXOC4;MAPRE2;GSN;ULK2;PARVA;NEK7;RAB43;PDE6D;TMOD3;PTPDC1;DZIP1;WIPI2;ZFYVE1;HPS4;RAB11FIP3;BECN1;PDCD6IP;ARL3;ATG3;PCM1;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;CEP63;TMEM231;IFT46;DISC1;WDR35;RB1CC1;CDS1;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;PRRC2C;ATXN2;NCOR1;EHD2;ABCC4;BIN2;VPS37A;CCDC66;TUBGCP6;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;MKS1;TUBGCP5;IST1;NUDCD3;IFT52;CEP89;HAUS2;CENPT;AMBRA1;KIF3B;DYNC2I1;FAM161A;TUBGCP4;VPS37B;GORASP2;TSG101;SMIM22;HYLS1;RBM14;EIF2S1;TEKT2;LZTFL1;RILPL1;ATG2A;INO80;CIRBP;SNF8;NEK6;IQCB1;WDR45B;FUZ;POC1B;CSNK1D;IFT80;DYNC2H1;RAB1A;YTHDF2;FLII;OFD1;CLUAP1;TRAF3IP1;HGS;UBAP2L;TRAPPC14;FLNA;ULK1;PLK4;BBS2;HAUS5;TRAPPC6A;TMEM237;DHX29;VTA1;STX12;POGZ;LSM4;MAK
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4637054572874789,1.014018392207508,0.43829113924050633,0.9043767883499098,1.0,3/17,10.04%,ANK2;SNTA1;AKAP9
prerank,purine-containing compound biosynthetic process (GO:0072522),0.43557413007038864,1.0137614120615277,0.4331306990881459,0.9043603952734433,1.0,6/25,18.85%,PRPS2;PAICS;ADA;AMPD3;GMPS;DGUOK
prerank,embryonic axis specification (GO:0000578),0.48344913207189943,1.0136089462398645,0.4744645799011532,0.9040540618367566,1.0,2/15,2.16%,COBL;SMAD6
prerank,regulation of kinase activity (GO:0043549),0.3642135492468687,1.0132633957790675,0.4515738498789346,0.9042544674316256,1.0,7/89,2.89%,EGFR;PLCE1;MET;NTRK3;LMO4;DDR2;FGFR1
prerank,neuron fate commitment (GO:0048663),0.4808915888737178,1.0132332474470638,0.448,0.9036630360889282,1.0,4/14,13.40%,TGFBR1;ISL1;ID2;PAX6
prerank,brain morphogenesis (GO:0048854),-0.4348263614971799,-1.0130590124950651,0.4621409921671018,0.7822546694865828,1.0,2/12,2.16%,SHANK3;CTNNA2
prerank,protein K63-linked deubiquitination (GO:0070536),0.4259846596022123,1.0129852037303775,0.44709388971684055,0.9036052311941818,1.0,9/31,15.82%,USP13;OTUD1;USP25;USP7;OTUD7B;USP33;UIMC1;ZRANB1;OTUD5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.35022687736854313,1.0129412023738091,0.4491428571428571,0.9030431511967706,1.0,13/138,3.84%,GUCY2C;EGFR;MET;NTRK3;NGF;PTK2B;ABI1;PTPRU;DDR2;FGFR1;SHC1;POLR1G;PTPRF
prerank,negative regulation of cytokine production (GO:0001818),0.34419974919847696,1.0127242339033724,0.4402234636871508,0.902924549856609,1.0,34/163,17.00%,THBS1;EZR;FN1;ANXA1;HDAC9;ANXA4;KLF4;TAX1BP1;INHBA;CMKLR1;PDCD4;MAVS;DDIT3;IL10;IKBKE;TLR4;RARA;IRAK3;OTUD7B;INHBB;HOMER2;ZC3H12A;IFIH1;PIBF1;NPLOC4;NPTN;RNF135;TLR8;ASB1;OTUD5;ACOD1;C5AR2;NLRP12;ABCD1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.38697531187027484,-1.0126782629695574,0.43958868894601544,0.7819785593317895,1.0,4/18,8.09%,SHANK3;NRXN1;CACNG4;CACNG7
prerank,proteoglycan metabolic process (GO:0006029),0.4372985077222681,1.0126193616264076,0.43517138599105815,0.9025252241062113,1.0,12/26,20.12%,HS3ST4;SULF1;CHST13;FOXL1;XYLT1;B3GALT6;CHST11;CHST12;HPSE;GAL3ST4;SULF2;B4GALT7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4460091351597224,1.011956857776955,0.4428794992175274,0.9034958380798055,1.0,11/20,32.29%,ADAM9;SPPL2A;NFKB1;ADAM10;MBTPS1;SPPL2B;TRAF6;TGFB1;ADAM17;MBTPS2;PSEN1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.359728014866957,-1.011641222498999,0.46846846846846846,0.7835747293753412,1.0,6/26,10.34%,DNAJC6;SGIP1;PICALM;FNBP1L;SNAP91;INPP5F
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.39608189880492817,1.0115853352200797,0.4473324213406293,0.9037390014144028,1.0,5/42,8.81%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,regulation of macrophage activation (GO:0043030),0.4235358302945929,1.0114808452140807,0.4570596797671033,0.9033097672267759,1.0,5/30,9.65%,THBS1;LBP;TLR4;SHPK;IL33
prerank,ethanol metabolic process (GO:0006067),0.4887925485963379,1.011250837973049,0.4610169491525424,0.9031991461892364,1.0,2/12,4.55%,ADH7;SULT1A1
prerank,regulation of store-operated calcium entry (GO:2001256),0.5106647138489293,1.011122818472257,0.46539792387543255,0.9028165670817486,1.0,4/10,14.93%,SLC8B1;HOMER2;HOMER1;GRAMD2A
prerank,regulation of anoikis (GO:2000209),-0.38118760723642886,-1.0108707224669073,0.44266666666666665,0.7842931627620596,1.0,4/19,6.10%,TLE1;BCL2;NOTCH1;PTK2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.32584936392264807,1.0108036763265662,0.4686868686868687,0.9029335940216096,1.0,76/509,12.10%,F3;EGFR;THBS1;NR3C2;TCF7L2;MET;TNFAIP8L3;NTRK3;SOX9;NEDD4;ADRA1B;PDGFC;TCIM;TRAF3IP2;FN1;AKAP13;WNT11;NFAT5;ADRB2;FGFR1;SHC1;ALPK1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;STRN;TGFBR1;PDCD4;TAB3;CD80;GCNT2;BECN1;WNT16;IRAK4;ESR1;ITGAV;MAVS;DDIT3;RIPK2;GOLPH3;TRIM44;MAP3K3;RRAGB;IFI35;P2RX2;REL;IKBKE;STYXL1;PDGFA;TLR4;BCAR3;P2RX4;ROR1;RHOA;CHUK;IQGAP1;MLST8;BCLAF1;USP15;PLCG2;PIM2;LIMS1;MTDH;VEGFA;GOLT1B;SMCR8;CCL3;MIER1;ERBB2;ITGB1BP1;FGF22;PPP5C;MYD88;TRAF5
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4523257580755524,1.0106730359000233,0.4647239263803681,0.9025818880326675,1.0,6/19,14.40%,KLF4;ELF1;MAVS;CBFB;IFIH1;DHX9
prerank,protein processing (GO:0016485),0.3581762169072531,1.0106634394334395,0.44457831325301206,0.9019406780923301,1.0,19/102,15.41%,F3;PCSK5;DDI2;PRSS12;PHEX;MMP16;ASPRV1;XPNPEP3;MMP14;LONP2;ADAMTS3;YME1L1;TMPRSS2;OMA1;PITRM1;ECE1;PCSK7;PIDD1;ADAM10
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.424546556974954,1.0106093291934888,0.4552129221732746,0.9013983109336431,1.0,2/29,2.06%,SLIT2;PRKCD
prerank,positive regulation of interferon-beta production (GO:0032728),0.4192360765997789,1.0098975988387893,0.46638655462184875,0.9024949727124738,1.0,11/33,18.01%,MAVS;POLR3D;RIPK2;IRF1;TLR4;IFIH1;DHX9;RNF135;TLR8;POLR3F;POLR3A
prerank,negative regulation of binding (GO:0051100),0.3704535689115124,1.0096477392306307,0.45018450184501846,0.9024517205893626,1.0,19/81,13.47%,SMO;PRKCD;GSK3B;LRPAP1;BTAF1;MDFI;KDM1A;SLPI;DISC1;AURKA;DACT1;JUN;DDX11;ITGB1BP1;WAPL;USP33;CARD16;GTPBP4;CSNK1E
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4382257609340058,-1.0094131734401879,0.45990566037735847,0.7867013213182624,1.0,3/10,14.44%,PRKCH;ETV4;MED1
prerank,dopamine metabolic process (GO:0042417),-0.3936077679565568,-1.0092771314284097,0.4585635359116022,0.7858059603287043,1.0,5/18,7.59%,MOXD1;MAOB;MAOA;SNCA;COMT
prerank,positive regulation of viral genome replication (GO:0045070),-0.34600119993564976,-1.008845913086549,0.4618055555555556,0.7857612037049413,1.0,11/29,19.04%,PPARA;TOP2B;PPIA;HACD3;NR5A2;ADARB1;TARBP2;IFIT1;ADAR;DDX3X;PPIE
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4386806702011451,1.0087408523115917,0.44461538461538463,0.9039735692332318,1.0,5/20,10.91%,LBP;PRKCE;TLR4;MTDH;CCL3
prerank,primary miRNA processing (GO:0031053),0.5134693968697527,1.0083659590430507,0.4666666666666667,0.9042243842570487,1.0,6/10,26.01%,SMAD2;DGCR8;PUS10;DROSHA;SRRT;HNRNPA2B1
prerank,regulation of dendrite development (GO:0050773),0.4077658349860942,1.007949285124425,0.45479833101529904,0.904596926633821,1.0,5/37,3.24%,BMP5;COBL;MARK1;NEDD4;GSK3B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4830319526152835,1.007889581407631,0.4666666666666667,0.9040657453142203,1.0,2/13,7.11%,GAB2;KLRC2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3626400350663518,-1.0073859275685302,0.4323529411764706,0.7881790690649515,1.0,6/23,8.69%,SASH1;PAK1;DAB2IP;RPS3;TNFRSF11A;EDN1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5087493362675628,1.0070710364798527,0.4670138888888889,0.905487579151175,1.0,1/11,0.27%,THBS1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.41186350857992937,1.0070561484265526,0.46920821114369504,0.9048615141051147,1.0,12/40,18.53%,PTK2B;XPO1;CLU;COMMD1;RAD23B;DESI1;SMURF1;CCDC22;TRIM39;PML;CSNK2A2;CSNK2A1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3883469614129614,1.0070200598165109,0.4570673712021136,0.9042907356040106,1.0,17/52,21.77%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;PPP3CC;ARIH2;SH3GLB1;BAP1;CSNK2A2;RNF31;MAPK8;USP36;E2F1;HUWE1;NMT1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3873145339946243,-1.0068178051001722,0.4246575342465753,0.7884044970474519,1.0,6/16,19.74%,SLC30A10;PPARA;ABCB7;ASXL3;ABCD2;GPER1
prerank,negative regulation of transport (GO:0051051),-0.31203646742615143,-1.0068065305505431,0.424,0.7871799425628713,1.0,17/51,20.33%,PRKD1;MCTP1;DYSF;NR1H3;SIRPA;BST2;SYT11;CTTNBP2NL;SNCA;NDFIP2;PPM1F;RACK1;NR1H2;ERBB3;SNX3;PRTN3;NRG1
prerank,response to peptide (GO:1901652),0.40295028958746226,1.0067018979821656,0.4479768786127168,0.9044575758940422,1.0,9/33,20.87%,ANXA1;IRS1;STAT3;ERBIN;STAT5A;EIF2B2;STAT6;STAT4;EIF2B3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.337310964835284,1.0065136769100873,0.459546925566343,0.9042671394803138,1.0,42/198,14.97%,PLCE1;TNFAIP8L3;PLPPR2;PPP3CA;PLPP3;ALPL;LIMK2;PLCB3;IP6K2;INPP4A;PLCZ1;PLA2G4F;ACP3;STAT3;PLA2G15;PFKFB2;PFKP;NUDT4;OCRL;PLCD3;PFKFB1;DUSP16;GPI;DUSP5;SHPK;PLCG2;TOP1;NUDT5;DUSP10;NADK;LCAT;MTOR;PPIP5K2;PPM1A;PAK2;AGK;SYNJ1;PLPP1;PLA2G2C;HTR2B;PLCD1;ACP4
prerank,apical protein localization (GO:0045176),-0.44728342667878884,-1.0063605534708149,0.46859903381642515,0.7870672484189772,1.0,4/10,5.95%,SHROOM2;ACTB;MAL;JAM3
prerank,T cell mediated immunity (GO:0002456),0.4836987631344325,1.0059354725014926,0.46405228758169936,0.9050258164903959,1.0,4/13,8.83%,CD55;GNL1;JAG1;CD46
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4903397611473843,1.005456015087994,0.47796610169491527,0.9054963397991357,1.0,3/12,12.47%,MCM7;MCM2;CDC45
prerank,regulation of protein autophosphorylation (GO:0031952),-0.32821733996365454,-1.0051612858516268,0.451505016722408,0.7889167829260755,1.0,7/36,4.56%,ERRFI1;ENG;PDGFD;EPHA7;ENPP1;RAP2A;CALM1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.35289796122971534,-1.0051502653485074,0.4322033898305085,0.78768992427769,1.0,6/24,5.75%,VTN;EPN2;PRKCB;TMEM204;DAB2IP;HIF1A
prerank,DNA modification (GO:0006304),0.4401407811942224,1.0040681582576196,0.464,0.9081821919644538,1.0,9/22,29.29%,MPG;SMUG1;NEIL3;PARP3;TDG;MBD4;PARP2;EXOSC4;ACD
prerank,V(D)J recombination (GO:0033151),0.4929692585598765,1.003785095965757,0.4754653130287648,0.9081870030151616,1.0,3/11,13.31%,DCAF1;TCF3;PRKDC
prerank,development of primary male sexual characteristics (GO:0046546),0.41601085494981704,1.003747057472678,0.4581497797356828,0.9076106234647675,1.0,6/34,9.70%,SOX9;LHFPL2;INHBA;GATA4;SIX4;GATA1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3092527593356258,-1.0036146310824623,0.43673469387755104,0.7902979432980962,1.0,9/48,17.26%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18;TLR7;TLR3;CD276;FZD5
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3994403964441081,1.0031843394853301,0.45178335535006603,0.9083077316250111,1.0,10/51,10.29%,DCLK1;NGF;SRGAP2;SNX2;SHTN1;TRIO;ANKRD27;NBL1;NCKAP1;CTTN
prerank,insulin receptor signaling pathway (GO:0008286),0.3745869373011149,1.0027445117895655,0.4619289340101523,0.9086957772190374,1.0,17/69,14.48%,GRB10;SORBS1;SHC1;ATP6V0A4;GSK3B;IRS1;FOXC2;SLC39A14;PTPN2;RHOQ;IDE;BCAR3;C2CD5;PIK3R3;ATP6V0D1;TCIRG1;GAB1
prerank,nervous system development (GO:0007399),0.3245477414951919,1.002743065253537,0.46286876907426244,0.9080306092584277,1.0,55/429,10.34%,WWP1;CDH1;PCDHB16;CRIM1;DCLK1;MET;MBNL1;PKD1;ZIC4;HDAC4;NGF;PDGFC;RBFOX2;SMO;EFNA5;FN1;ZBTB16;HES1;GSN;INHBA;ZIC1;FGF13;FGF2;NOTCH2;ECRG4;GLRB;PMP22;NELL1;TGFBR1;NOG;GLIS2;STAT3;GDNF;JAG1;PCDHB13;NTN5;ELP3;DMBX1;SOX14;SNTG2;DAGLB;NBL1;TEAD1;NAGLU;GRHL2;PCDHB9;EGR2;PCDHB3;DACT1;NF1;BTBD3;ADGRG6;PCDHA1;NCKAP1;VEGFA
prerank,glycolipid metabolic process (GO:0006664),0.39331775506651234,1.0021469431996246,0.4520725388601036,0.9087767610851987,1.0,4/47,4.87%,ST3GAL4;ESYT3;HEXA;ESYT2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5090656067742736,1.0020485061189042,0.5025641025641026,0.9083250055195875,1.0,2/10,5.99%,DSE;XYLT1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4995656674431307,1.0017045260317259,0.4896551724137931,0.9084790848203148,1.0,2/11,7.26%,CAMK2D;CACNG6
prerank,histone lysine demethylation (GO:0070076),0.43552609906548767,1.0013555450243756,0.4549618320610687,0.9086867430578612,1.0,7/25,16.68%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;HR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5064834240757101,1.0009906500397026,0.47435897435897434,0.9082574279766155,1.0,2/10,8.98%,AP2A2;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5064834240757101,1.0009906500397026,0.47435897435897434,0.9082574279766155,1.0,2/10,8.98%,AP2A2;AP2A1
prerank,regulation of potassium ion transport (GO:0043266),0.4149788924610008,1.0009877603995045,0.4789156626506024,0.907598247092888,1.0,3/31,1.67%,FHL1;ANK2;PTK2B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4347207875379498,1.0005962385613691,0.4731182795698925,0.9078852796320002,1.0,6/26,11.06%,INHBA;PTPN2;TLR4;RARA;CCL3;TCTA
prerank,regulation of mRNA catabolic process (GO:0061013),0.34881517731166506,1.000503795294034,0.4631336405529954,0.9074606401895235,1.0,33/121,20.96%,SAMD4A;PRKCD;EIF4G1;XPO1;PSMB2;PKP1;MOV10;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;PABPC1;EXOSC7;ZC3H12A;PUM2;PSMD11;PSMD1;CNOT7;MAPKAPK2;DCP1A;PRKCA;PUM1;NUP214;PSMC1;PSMD7;EXOSC1;DHX36;FXR2;PSMD14;FMR1;PSMD3;YTHDF2
prerank,bile acid metabolic process (GO:0008206),-0.34261127163632676,-1.0004109251137803,0.45170454545454547,0.7972228388586953,1.0,7/27,20.37%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5066705913424007,1.0001596020097527,0.4795417348608838,0.9076439888456262,1.0,3/10,17.34%,KLF4;IRAK3;PALM3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.42815021863083214,0.9993867938186123,0.46074074074074073,0.9088252967126281,1.0,2/24,1.67%,PKD1;PTK2B
prerank,establishment of protein localization to membrane (GO:0090150),0.37431335819384925,0.9992452178579282,0.46786632390745503,0.908480006989363,1.0,20/66,20.75%,EGFR;NECTIN3;ATG3;ZDHHC11;RAB3GAP2;FRMPD1;PARD3;ZDHHC15;VPS37A;ZDHHC2;GOLGA7;ZDHHC20;SEC63;VPS37B;GORASP2;ZDHHC23;RABGEF1;ZDHHC12;NPC1;AFDN
prerank,manganese ion transport (GO:0006828),-0.4053896568777518,-0.9992024214005502,0.46578947368421053,0.7990825403329836,1.0,6/14,8.88%,SLC30A10;TRPC3;SLC39A8;ATP2C1;TRPC4;TRPC6
prerank,regulation of cellular component organization (GO:0051128),0.34109167047103706,0.9991505449838713,0.4714611872146119,0.9080433712763156,1.0,28/135,15.51%,PLCE1;SNCAIP;MLLT3;NEDD4;CAMK2D;STON1;ABL1;FAM107A;STON2;AGTR1;RAP1A;SGK3;LTBP4;SOCS2;ANGPTL7;RUFY1;AURKA;DCUN1D5;IRAK3;SNX12;MTOR;SETD5;HCFC1;BAP1;CDK11B;URI1;ARFGAP1;RAB4B
prerank,regulation of translation (GO:0006417),0.34440264241002577,0.999134248459322,0.4733405875952122,0.9074185412891025,1.0,43/173,23.16%,THBS1;SAMD4A;EIF4G3;FOXO3;IGFBP5;NIBAN1;PAIP2;EIF4G1;SYNCRIP;LARP4B;TOB1;ETF1;GSPT1;ATXN2;ERBB2;EIF3E;EIF6;MTOR;PRKDC;EIF2AK4;MTRF1;DHX9;CNOT7;EIF2B2;PLD1;MTIF2;PUM3;DHX36;TRAP1;CIRBP;EIF4B;FXR2;LARP4;CAPRIN1;FMR1;EIF4G2;EPRS1;DDX1;RBM3;NANOS2;EIF2AK3;RBM4;SAMD4B
prerank,proteasomal protein catabolic process (GO:0010498),0.3335893257485547,0.9991085969555321,0.48478260869565215,0.9068261920312376,1.0,36/201,17.12%,WWP1;NEDD4;UBE4B;WWP2;NFE2L2;DDI2;RNF185;VCP;UBE2B;KLHL22;DDIT3;TBL1X;PSMB2;RNF126;UBE2D3;FBXW11;FEM1B;RAD23B;PSMC6;PPP2R5C;SPSB2;MTA1;COP1;RNF122;SMURF1;PSMD11;CUL3;ERCC8;PSMD1;SPOP;PML;UBE2K;APPBP2;BFAR;PSMC1;PSMD7
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4102709563813281,0.9987682669015973,0.46628407460545196,0.9070061981655172,1.0,13/36,21.73%,CHEK2;RAD17;CEP63;ATM;CLSPN;CDC45;CHEK1;HINFP;USP28;NBN;ATR;E2F1;RAD9B
prerank,negative regulation of neuron differentiation (GO:0045665),0.45006598367363965,0.9983856137295963,0.4785932721712538,0.9072730210450102,1.0,3/22,3.24%,SOX9;HES1;GSK3B
prerank,regulation of vasculogenesis (GO:2001212),-0.4036056616244363,-0.9983107410572746,0.44221105527638194,0.8001049027716548,1.0,4/14,7.41%,RAPGEF2;KDR;CD34;HEY2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.34026269041028623,-0.9981303196202788,0.44171779141104295,0.7992953445047801,1.0,5/29,6.81%,RPS14;RPS21;RPS19;RPS8;RPS16
prerank,response to interleukin-6 (GO:0070741),0.511891393875342,0.9978993912227969,0.48576214405360135,0.9077990009623909,1.0,3/10,9.31%,PID1;PTGIS;NFKB1
prerank,positive regulation of DNA binding (GO:0043388),0.4182982977928523,0.9976273280840869,0.4668587896253602,0.9077740259050493,1.0,9/31,18.73%,NGF;HES1;SKI;FOXC1;NIBAN2;RB1;TWIST1;EGF;PPARG
prerank,endomembrane system organization (GO:0010256),0.3413065571704676,0.9976268993839329,0.4989059080962801,0.907119143635348,1.0,62/178,24.45%,ARHGAP21;ATL3;GOLGB1;NUP93;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;RAB30;GAK;LMAN2L;GOLPH3;DOP1B;GBF1;CSNK1A1;SEC16A;ATP8B1;SUN3;WASHC5;PLEKHM2;SEC31A;SEC61A1;COG3;A4GALT;TLCD1;NPLOC4;TLCD2;SQSTM1;SEC23IP;TRIP11;HOOK3;TOR1B;GORASP2;ANXA8;ANXA8L1;LEMD2;BNIP1;ARFGEF1;AP3D1;TMCC1;ZW10;CSNK1D;DYNC2H1;RAB1A;HUWE1;TMED3;VPS51;WASHC4;PLEKHF1;CUL7;CDC42;TMEM170A;SUN2;HOOK2;EIF2AK3;SURF4;RNF26;PHETA2;ARL1;TRAPPC11
prerank,regulation of wound healing (GO:0061041),0.395390652928814,0.9975343152967261,0.46311475409836067,0.9067039791014581,1.0,7/42,6.62%,CD109;ANXA1;ITGB1;FGF2;PRKCE;DMTN;SRSF6
prerank,glucose homeostasis (GO:0042593),0.3663962913809157,0.9975273267593514,0.46690734055354993,0.9060642783722006,1.0,18/83,13.93%,TCF7L2;LRRC8D;KCNB1;CRY2;IRS1;KLF7;FOXK1;PTPN2;STAT3;BACE2;MCU;SLC8B1;FOXK2;SELENOT;HNF4A;HNF1A;PAX6;ACSM2A
prerank,oligodendrocyte development (GO:0014003),-0.40294359815364456,-0.9975265196737689,0.4675,0.7994563103446113,1.0,10/15,33.98%,PLP1;CNTNAP1;MYRF;TPPP;SOX10;B4GALT5;B4GALT6;EIF2B1;EIF2B5;HES5
prerank,protein ubiquitination (GO:0016567),0.32393503878816055,0.9971445615090557,0.5025227043390514,0.906356038033766,1.0,139/471,23.18%,FBXL7;WWP1;NEDD4;FBXO10;UBE4B;WWP2;NPEPPS;NFE2L2;RNF144A;RNF115;FBXO40;HERC2;RNF138;RNF185;VCP;FBXW8;UBE2B;KLHL22;ARIH1;MKRN3;UBR5;ATG3;HIF3A;RNF19A;TRIM44;PSMB2;BIRC6;FBXL20;CDC16;RNF114;TRIP12;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;RNF141;TRIM47;KLHL13;RNF126;UBE2D3;LRSAM1;FBXW11;UBE4A;TNKS2;COMMD1;UVSSA;PSMC6;WAC;TRIM41;TRIM7;TRIM26;USP7;TRIM55;FBXO17;RNF146;ASB11;RNF111;SPSB2;CBFB;UBE2Z;CTR9;RNF122;FBXO4;HERC6;PEX13;RNF168;ARIH2;ANKIB1;PRKDC;SMURF1;HECTD2;PSMD11;CUL3;ERCC8;UBE2S;PSMD1;RNF135;FANCL;CCDC22;SPOP;ASB1;TRIM39;UBE2K;SH3RF3;CHFR;MKRN1;BFAR;CUL1;VCPIP1;UHRF2;RNF14;UBE3C;OS9;PSMC1;PSMD7;BCL10;BARD1;MKRN2;DTX3;FBXL19;USP22;USP9X;FBXO25;TRIM25;FBXL8;GAN;RTF1;PSMD14;TSPAN17;TRIM35;UBE2N;UBE2W;FBXL4;RNF31;CNOT4;PSMD3;TRPC4AP;KLHL18;MIB1;NFX1;RNF8;DET1;HUWE1;PPIL2;CUL7;RBCK1;CUL4A;RMND5A;ANAPC11;FBXL17;PEX2;PAF1;ANKRD9;FBXW9;FBXO11;FBXO27;UBE2Q2;RNF166
prerank,histone H2B ubiquitination (GO:0033523),0.5067293585514439,0.9971341478846218,0.46258503401360546,0.9057257262738814,1.0,6/10,31.54%,WAC;CTR9;RNF8;PAF1;RNF20;DTX3L
prerank,anterior/posterior axis specification (GO:0009948),-0.40379344374425474,-0.9968479582428736,0.4696969696969697,0.7998988983800864,1.0,2/15,2.55%,WLS;TBX3
prerank,cellular response to cytokine stimulus (GO:0071345),0.3222897385411159,0.9964295988119973,0.49846153846153846,0.9068061935173245,1.0,58/416,12.54%,STK39;F3;SLC12A2;DPYSL3;SOX9;LBP;PID1;WNK1;FN1;TANK;ANXA1;NFAT5;IL22RA1;FOXO3;PTGIS;GRB10;YBX3;SHC1;ITGB1;NFE2L2;GSK3B;FGF2;GAB2;SLC26A6;CLCF1;PTPN2;CD80;IRAK4;STAT3;SYNCRIP;IL10;IRF1;SOCS2;TLR4;CDKN1B;CXCL2;FOXC1;RORA;RHOA;CHUK;CTF1;NFKB1;SHPK;ERBIN;RBMX;IRAK3;IL18BP;VEGFA;USP10;IL20RB;CCL3;TIMP1;CCL1;PTPN9;IL5;TNFRSF1B;ZC3H12A;CSK
prerank,protein heterotetramerization (GO:0051290),0.4780629243837374,0.9962513245023327,0.47540983606557374,0.9065956077827677,1.0,1/13,1.11%,PKD1
prerank,protein sumoylation (GO:0016925),0.39107748105161283,0.9955214384750996,0.4858681022880215,0.9077372424201631,1.0,16/49,23.65%,NUP93;TRPM4;PIAS2;SAE1;PIAS3;EGR2;RANBP2;IFIH1;NUP153;NUP214;NUP188;NUP88;PIAS1;NUP98;AAAS;NUP54
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.47814076842053554,0.9953280214575129,0.4780405405405405,0.9075702293716968,1.0,3/13,5.59%,CD9;ITGB1;LDLR
prerank,regulation of hormone secretion (GO:0046883),0.4673215764764846,0.9952991480572825,0.4799357945425361,0.9069852170739152,1.0,1/15,1.98%,ANXA1
prerank,carboxylic acid catabolic process (GO:0046395),0.48901743272118436,0.9952547769421966,0.4690265486725664,0.9064508701716918,1.0,3/12,12.25%,PON3;ACOT8;RENBP
prerank,positive regulation of neurogenesis (GO:0050769),0.3658649885273726,0.995232125488084,0.4573248407643312,0.9058533807133431,1.0,10/68,11.56%,SLIT2;NGF;CUX1;TIAM2;FBXW8;KDM1A;RHOA;DISC1;VEGFA;TIAM1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.37236160508095134,0.995008017434434,0.4789808917197452,0.9057431492057344,1.0,13/67,10.86%,CYFIP2;PGF;PTK2B;ABI1;SULF1;VAV2;NRP1;NCK2;ITGAV;RHOA;NCKAP1;VEGFA;ITGB3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3273354256426217,-0.9947104366037909,0.4798657718120805,0.8041594646221958,1.0,11/33,15.05%,TGFA;DGKD;CCDC88A;ADRA2A;AFAP1L2;HIP1R;HBEGF;HIP1;CNOT9;AGT;AKT1
prerank,camera-type eye morphogenesis (GO:0048593),0.4956596466931399,0.994705320338945,0.4564459930313589,0.9058141396077172,1.0,4/10,10.34%,LRP6;SKI;NF1;VEGFA
prerank,calcium import into the mitochondrion (GO:0036444),0.5015731431001021,0.9944507702146572,0.48817567567567566,0.9058012349981714,1.0,5/10,26.67%,MCUB;MCU;MICU3;MICU1;MICU2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.38545915497468186,0.9942781337154933,0.4706666666666667,0.9055704937031788,1.0,8/50,15.40%,NXN;ABL1;HDAC8;U2AF2;USP4;CHP1;GTPBP4;SQSTM1
prerank,regulation of protein secretion (GO:0050708),0.3494515494499238,0.9939671818926485,0.4725787631271879,0.9056636695146799,1.0,15/119,7.51%,SLC12A2;CACNA1C;EZR;DISP1;TGFB3;ADAM9;KCNS3;KCNB1;BMP6;UNC13B;RAP1A;SYTL4;ITPR2;GOLPH3;P3H1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41271242308132117,0.9936099762404301,0.47503566333808844,0.9058899023762497,1.0,7/30,15.74%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.44167048863392705,0.9933164875529965,0.4712286158631415,0.9059280003177357,1.0,2/21,3.32%,FOXP1;ELF1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3719764492391096,0.9930626468233775,0.45430809399477806,0.9058574271154126,1.0,15/55,14.96%,GPC6;GPC3;CD44;FGF2;HEXA;SPAM1;ARSB;NAGLU;GPC4;SLC9A1;SGSH;GLB1;CHP1;IDUA;SDC4
prerank,cochlea morphogenesis (GO:0090103),0.4966552580578938,0.992445310340558,0.48128342245989303,0.906715815318313,1.0,1/10,1.12%,SOX9
prerank,positive regulation of actin nucleation (GO:0051127),0.48740790543058415,0.9922989339340473,0.48333333333333334,0.9064344979187079,1.0,6/11,25.42%,GSN;NCKAP1;FCHSD2;WHAMM;BRK1;CYFIP1
prerank,retinal metabolic process (GO:0042574),0.4842565827277431,0.9922279266556273,0.4825291181364393,0.905965566393858,1.0,1/12,1.54%,CYP1B1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.43872899139703586,0.9921948085785299,0.4688,0.9053956252149528,1.0,7/21,21.25%,SMO;KIF7;EVC;ARMC9;TTC23;TEDC2;DLG5
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5039886730738774,0.9919900039394209,0.47543859649122805,0.9052174503732392,1.0,2/10,3.62%,PRKCE;IRS1
prerank,error-prone translesion synthesis (GO:0042276),0.43970460785364723,0.9915385583064471,0.49122807017543857,0.9056376861265397,1.0,9/21,28.48%,REV3L;POLE2;RPA1;RFC1;REV1;RFC5;POLK;POLI;PRIMPOL
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.32737606253656787,-0.9912066346505419,0.4594594594594595,0.8118725221451102,1.0,5/32,9.44%,CDK14;CDK17;TFDP2;CDK15;BACH1
prerank,negative regulation of angiogenesis (GO:0016525),0.3587417844072882,0.9911779829919015,0.47630619684082626,0.9058330836080345,1.0,8/84,5.13%,THBS1;SLC12A2;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,mesenchyme morphogenesis (GO:0072132),0.4611464902776346,0.990994373576372,0.4769736842105263,0.9056417530528174,1.0,7/17,11.05%,SOX9;BMPR1A;NOG;ISL1;MDM4;ACVR1;SMAD2
prerank,regulation of trophoblast cell migration (GO:1901163),0.46810468557914864,0.9906015679925583,0.4793650793650794,0.9059499339149115,1.0,4/14,16.06%,ARHGDIB;VEGFA;TIMP1;AGO2
prerank,nuclear pore complex assembly (GO:0051292),0.4988150585708252,0.9900035322660024,0.49572649572649574,0.9067594995367841,1.0,5/10,22.22%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.49463056547683415,0.989784278190755,0.4982078853046595,0.9066426996029713,1.0,4/12,11.81%,HDAC8;DDX11;RB1;WAPL
prerank,diol metabolic process (GO:0034311),-0.37670649753749863,-0.9896301692537484,0.4787234042553192,0.8146063613030627,1.0,9/19,21.19%,NOS3;DEGS2;CALM1;SPHK1;AKT1;GCH1;PLPP2;SPHK2;SGPP1
prerank,hepaticobiliary system development (GO:0061008),0.4404011285288681,0.9893592869324884,0.4758942457231726,0.9070213154080322,1.0,2/20,1.25%,MET;COBL
prerank,plasma membrane organization (GO:0007009),0.3715929367413713,0.9892878252610213,0.48239895697522817,0.9065472300596945,1.0,15/61,15.12%,AHNAK2;ANK2;DMKN;ANO6;SYTL4;PLSCR1;NSF;EHD2;BIN2;A4GALT;CAVIN2;PLSCR3;TLCD1;CXCR4;TLCD2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4071477601350964,0.989265323319277,0.46075581395348836,0.9059552976570844,1.0,3/33,4.70%,EZR;UBASH3A;PTPN2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.23357003490692024,-0.9892427984050578,0.42857142857142855,0.8143180766176349,1.0,67/306,13.32%,APOE;RBMS1;RPS14;FUT9;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;EEF1B2;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;ALAS1;DTX1;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;GAL3ST2;RPL7;RPL36;BLM;RPS17;RPL32;RPL39;RPL14;RPS2;SET;ORC4;RPL8;POLR2G;RPL24
prerank,regulation of interferon-gamma production (GO:0032649),-0.2816046836322762,-0.9891736997165342,0.46798029556650245,0.8132339563513122,1.0,16/71,17.26%,IL1R1;PDE4B;SLC7A5;CD47;SIRPA;PDE4D;IL18;GAS6;AXL;TLR7;TLR3;HAVCR2;NR1H4;VSIR;CD276;FZD5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3696591579206731,-0.9885358116909998,0.4794871794871795,0.8135220278292316,1.0,5/19,9.16%,TJP1;NEXMIF;NOTCH1;NOTCH4;RGCC
prerank,cardiac muscle contraction (GO:0060048),0.4081079772934234,0.988456900584635,0.4704225352112676,0.9071962573084704,1.0,5/34,5.27%,ATP1B1;CAMK2D;CSRP3;GSN;DMD
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4937409222038031,0.9884085224446104,0.4834782608695652,0.9066806795439221,1.0,5/11,9.97%,TGFBR1;TGFBR2;GDF6;USP15;ACVR1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4025140140498179,-0.9882187078133096,0.485,0.813042135226398,1.0,4/13,6.24%,PPARA;NOS3;TMSB4X;PPARGC1A
prerank,regulation of protein kinase C signaling (GO:0090036),-0.40054266827972806,-0.9877469817153995,0.49385749385749383,0.8129495278429839,1.0,8/14,19.98%,ADGRV1;WNT5A;DGKD;DGKG;FLT4;CD40;MYADM;SPHK2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.32296577061787396,-0.9877226693947968,0.46875,0.8117558109273625,1.0,6/35,8.16%,SASH1;PHLPP1;MFHAS1;DAB2IP;BMP2;SPHK1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3588501554444041,0.9877055530678354,0.4829683698296837,0.9077105881670969,1.0,17/86,12.85%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;CLU;TOGARAM1;AKAP9;NCKAP1;CTTN;KATNB1;RB1;SLAIN2;FCHSD2;FCHSD1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4732103824626611,0.9875480503956865,0.48,0.9074536257035233,1.0,3/14,8.31%,IRS1;PTPN2;NNMT
prerank,Ras protein signal transduction (GO:0007265),0.33902463245302245,0.987377026250568,0.49772727272727274,0.9072145211483401,1.0,23/137,10.18%,PLCE1;NTN1;CDC42EP5;CCNA2;ARHGDIB;NRAS;KRAS;MRAS;SHC1;FGF2;AGTR1;RAP1A;SHOC2;SHTN1;RAPGEF6;RAP2C;G3BP2;RHOA;ARHGAP5;GNA13;NF1;JUN;NCKAP1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.29773380737867605,-0.9873200936839368,0.46473029045643155,0.8115372715226821,1.0,15/54,19.47%,NSA2;RPL23A;RPL26;RPL35A;RPL11;SNU13;RPL7;NOC2L;RPL14;NPM1;RPL24;RPL10A;RPL3;RPL5;LAS1L
prerank,regulation of organelle assembly (GO:1902115),0.366713533522958,0.986882637948348,0.48930817610062893,0.9077974980736178,1.0,23/72,20.38%,EZR;GSN;RABEP2;NPRL3;PDCD6IP;ATG3;RDX;KIF9;SPICE1;TBC1D2B;TBC1D13;ATXN2;TBC1D10A;STIL;TBC1D5;SDCCAG8;SGSM3;TSG101;TBC1D17;ODAD3;CEP295NL;NPRL2;RAB5A
prerank,regulation of lamellipodium organization (GO:1902743),0.46764187761847864,0.9868798013208434,0.4695222405271829,0.9071682876613721,1.0,2/14,6.54%,CD44;DMTN
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3834392608313132,-0.986379289529675,0.4744897959183674,0.81279573424975,1.0,3/17,12.01%,BCL2;BCL2L1;BOK
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.26904413906340696,-0.9861427817465832,0.4491017964071856,0.8121843214958767,1.0,12/90,7.60%,LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;PRDM16;GJA1;PPARGC1A;ELOVL6;IL18
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.33375945733619355,-0.9859319693251212,0.48026315789473684,0.811519488537714,1.0,5/29,4.82%,APOE;PPARA;LPGAT1;NR1H3;ZBTB20
prerank,negative regulation of developmental process (GO:0051093),0.36668791048147653,0.9857696248721477,0.48737373737373735,0.9091625059517041,1.0,5/69,3.88%,BMP4;NFIB;SOX9;WNT11;KLF7
prerank,dicarboxylic acid metabolic process (GO:0043648),0.38200203721317527,0.9856467629236358,0.4868073878627968,0.9088218253809895,1.0,10/52,19.44%,ME1;GCLC;ACOT8;FPGS;FOLR2;OGDH;NIT2;SLC19A1;SLC25A32;D2HGDH
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.47343946485069943,0.9853280827105315,0.4737678855325914,0.9089501854757498,1.0,4/13,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,keratan sulfate metabolic process (GO:0042339),0.41657038286410647,0.9848168372327624,0.47430249632892807,0.9094979618537749,1.0,5/31,6.43%,ST3GAL4;B3GNT2;HEXA;CHST5;B4GALT1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.352140104693739,0.9847593910928877,0.4951219512195122,0.9090068712742221,1.0,18/98,12.36%,EGFR;SORBS1;KCNB1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;AGR2;DLG1;C2CD5;ERBB2;RANGRF;MIEF1;ITGB1BP1;PPP3CC;PTPN9;CHP1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2812058298180569,-0.9847146506318899,0.4788135593220339,0.8133483933147619,1.0,14/63,15.05%,BCL2;VCAM1;TFRC;MEF2C;VAV3;CD81;CD38;IL18;IL6ST;MIF;CCL19;CD74;CD40;JAK3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.46002742066947433,0.9846981455855607,0.4781906300484653,0.9085208175889194,1.0,5/16,7.96%,PDGFC;ABL1;NRP1;NR4A3;PDGFA
prerank,"DNA-templated transcription, termination (GO:0006353)",0.36508688043606635,0.9843490958887527,0.48223350253807107,0.9086591710373642,1.0,33/68,32.70%,POLR1G;MNAT1;SCAF8;POLR1A;TTF2;TAF1D;TAF1C;TTF1;LSM11;POLR1F;ERCC3;POLR3K;MAZ;PRMT5;FIP1L1;UBTF;NUDT21;ERCC2;CSTF1;CPSF7;CPSF3;POLR1H;CLP1;GTF2H3;CPSF4;NCBP2;POLR1C;CDK7;SMN1;CSTF3;CSTF2T;SSU72;MTERF2
prerank,glycolytic process (GO:0006096),-0.3372479176873585,-0.9842427688786736,0.4618055555555556,0.8132958896085861,1.0,11/28,20.88%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;PFKM;ALDOA;ENO2;ENO1;PFKL
prerank,regulation of cholesterol transport (GO:0032374),-0.36923872405036473,-0.9842137605284306,0.48314606741573035,0.8121370024061738,1.0,7/20,20.17%,ABCA5;NR1H3;NUS1;ABCB4;ABCA2;NR1H2;APOC1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.43629388705610583,0.9841306687633578,0.4744408945686901,0.908513556141391,1.0,3/20,4.43%,BMP4;TGFBR1;PDCD4
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.26497044167976264,-0.9837236424362666,0.5172413793103449,0.8120963732423357,1.0,16/94,13.84%,PLCB1;IL1R1;RPS6KA5;PELI2;ST18;NOD1;BTRC;TNIP2;UBC;PSMB4;IRAK2;PSMB3;MAPK3;PSMB8;PSME2;PSMB10
prerank,cellular response to ionizing radiation (GO:0071479),0.37477872452409666,0.9828109652006184,0.47606382978723405,0.9110158260718197,1.0,14/47,18.46%,TANK;KDM1A;WRN;ATM;SPIDR;NIPBL;XRCC5;KDM4D;TLK2;CDKN1A;RAD51;ATR;TNKS1BP1;INO80
prerank,diacylglycerol metabolic process (GO:0046339),0.42979158158789293,0.9823043853874447,0.49016641452344933,0.9115562528921797,1.0,3/23,6.89%,PLCE1;PLA2G15;DGKA
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.45512523390446424,0.982190149491876,0.46869983948635635,0.9111683627191165,1.0,4/14,11.92%,PPP3CA;PPTC7;PPP2R2D;PPP5C
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.42400789025993724,0.9821317608006136,0.5021337126600285,0.9106756160694424,1.0,11/29,21.60%,TANK;IKBKE;TLR4;UBE2D3;CHUK;IKBKG;TLR6;BIRC3;TRAF3;IRF3;LY96
prerank,peptidyl-tyrosine modification (GO:0018212),0.3765387243353725,0.9820951755250971,0.4966532797858099,0.9101251226882404,1.0,7/56,4.26%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,positive regulation of biosynthetic process (GO:0009891),0.3929677361421473,0.9819105025574061,0.475177304964539,0.9099243077611059,1.0,3/40,2.90%,BMP4;TGFB3;SORBS1
prerank,mitotic DNA replication (GO:1902969),0.49525681436481434,0.9818481511552345,0.486013986013986,0.9094269706968429,1.0,4/10,20.73%,MCM2;CDC45;GINS3;POLA1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4375020765441988,0.9817950365710992,0.49147286821705427,0.9089180867079171,1.0,2/22,1.55%,ANK2;ATP1B1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4717220039933971,0.9816753875589526,0.4847457627118644,0.9085617010639712,1.0,6/13,17.78%,BMP5;NFKB1;DKK3;ERLIN1;REST;CYP27B1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3944184987904027,-0.9814113304137735,0.47642679900744417,0.8168132905053138,1.0,6/16,10.31%,MCTP1;RIMS1;MCTP2;MEF2C;CAMK2A;SYN1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.426068252484746,-0.9812761592885938,0.48426150121065376,0.8158973999718407,1.0,4/12,26.92%,ANK3;SCN4B;NOS1;PKP2
prerank,DNA damage checkpoint signaling (GO:0000077),0.4186279484530324,0.9812444073483234,0.4962292609351433,0.9089548955798784,1.0,11/28,20.85%,CHEK2;RAD17;CEP63;ATM;CLSPN;CHEK1;HINFP;USP28;NBN;ATR;E2F1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.34063057322531626,-0.9811291562896315,0.4584615384615385,0.8150291838041075,1.0,6/25,10.44%,EPHA4;OPHN1;HSP90AB1;RPS7;RPL23;RPL11
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.35315573073578055,-0.9807221961970269,0.5157593123209169,0.8147617012841166,1.0,6/24,14.44%,ERRFI1;PRKCH;ROCK2;CTSL;ETV4;MED1
prerank,regulation of cellular response to heat (GO:1900034),0.3641637966047214,0.9804869896019318,0.5006289308176101,0.9100932372221477,1.0,21/77,17.95%,CAMK2D;GSK3B;NUP93;CREBBP;HSPA1L;MLST8;RANBP2;ATM;HSPB8;CHORDC1;SEC13;NUP153;MTOR;EP300;BAG3;MAPKAPK2;NUP214;RPA1;NUP188;NUP88;ATR
prerank,embryonic hemopoiesis (GO:0035162),-0.4178566136811551,-0.9802956706215761,0.4732824427480916,0.814609712651988,1.0,5/12,17.01%,KIT;KDR;TAL1;SH2B3;FLT3LG
prerank,amyloid fibril formation (GO:1990000),-0.2968247496309242,-0.9802115085845166,0.47104247104247104,0.8135351229075094,1.0,11/51,13.12%,B2M;HSPG2;TSPAN5;CST3;ITM2B;APP;SNCA;MAPT;UBC;APH1B;MFGE8
prerank,protein secretion (GO:0009306),0.3703808049986519,0.9800542781654319,0.49107142857142855,0.9104920043710072,1.0,6/56,9.16%,PCSK5;ANXA1;TANGO6;LTBP2;GOLPH3;SNX19
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32069937156327044,-0.9798759400677011,0.48028673835125446,0.8132139410038058,1.0,8/36,6.50%,BCL2;SGMS1;TPD52L1;DAPK2;PPIA;DAB2IP;RPS3;FAS
prerank,peptidyl-lysine methylation (GO:0018022),0.4166604199946734,0.9796946461926553,0.5,0.9106864780328643,1.0,10/26,25.98%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;SETD6;METTL21C
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.39288837252210285,0.9795986838464957,0.49506346967559944,0.9102741833975571,1.0,8/39,12.62%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126;ERBB2;EPS15L1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.41814381044202265,-0.979183182691786,0.48346055979643765,0.8137457842704839,1.0,2/11,1.94%,SLC30A10;PPARA
prerank,detection of visible light (GO:0009584),0.4601643195745081,0.9791540535978855,0.5023771790808241,0.9106834605931954,1.0,2/16,7.26%,RP1;CACNA1F
prerank,regulation of T cell cytokine production (GO:0002724),0.460445324742355,0.9789419230494635,0.49411764705882355,0.910540204590893,1.0,2/15,4.96%,CD55;TRPM4
prerank,cellular response to lipid (GO:0071396),0.3260294739308833,0.9787956172712446,0.5172413793103449,0.9102540631059979,1.0,32/191,12.85%,EGFR;WNT9A;SOX9;PTK2B;LBP;PID1;ADAM9;WNT11;FZD7;IRS1;PDCD4;CD80;ESR1;MYOG;IL10;LCOR;TLR4;CXCL2;ATP1A3;ATP1A1;RORA;RHOA;NFKB1;SHPK;ATM;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;PDK3;CTR9
prerank,water transport (GO:0006833),-0.41705458121004757,-0.978776703862373,0.4878048780487805,0.8136101427489185,1.0,2/12,7.73%,AQP11;AQP4
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3622534668060122,-0.9785042017349317,0.4755043227665706,0.8130390578184324,1.0,9/23,32.18%,SLC24A2;SYT11;SLC30A1;PLK2;MTMR2;ACHE;SLC24A1;DRD2;SHANK2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3570830812202317,0.9784181035523657,0.4883435582822086,0.9104823462217869,1.0,6/75,4.42%,PLCE1;GRK5;MGLL;MRAP;SLC39A14;PDE6A
prerank,myoblast fusion (GO:0007520),0.48385481877934233,0.9784146214852206,0.5207612456747405,0.9098608572320379,1.0,3/12,6.39%,CD9;ADAM12;ADAMTS5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.49056897095956337,0.9780031470398953,0.5166112956810631,0.9101783388808329,1.0,1/11,1.08%,SCARA3
prerank,protein K48-linked deubiquitination (GO:0071108),0.4367001837706366,0.977911214883577,0.5137195121951219,0.9097576801613584,1.0,8/23,16.51%,USP34;USP25;OTUD7B;USP33;BAP1;OTUD3;OTUD5;VCPIP1
prerank,regulation of chemokine production (GO:0032642),0.4030121542375991,0.9778530740332426,0.49213161659513593,0.909262027244579,1.0,1/36,0.25%,FOXP1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.33415392563252755,-0.9778246221323708,0.4840764331210191,0.8135313465907132,1.0,3/28,2.98%,APOE;PPARA;PDK1
prerank,response to muscle stretch (GO:0035994),0.4704589626276288,0.9776045555050071,0.470873786407767,0.9092315829920617,1.0,4/15,8.86%,CSRP3;GSN;DMD;SLC9A1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4426610655263384,0.9772924963600791,0.5144157814871017,0.9093321839656887,1.0,7/23,19.22%,CCN3;IFI35;ZC3H12A;PPM1A;CPNE1;NLRP12;ADIPOR1
prerank,cellular response to amino acid starvation (GO:0034198),0.3548974389666301,0.9772229806619622,0.48427672955974843,0.9088819566732866,1.0,22/71,20.11%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;EIF2S1;SZT2;CDKN1A;RHEB;ATP6V1H;NPRL2;MAPK8
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3507962070319916,-0.9771324750837058,0.52,0.8140927381108227,1.0,4/22,3.76%,CACNA1D;GRM3;ADGRV1;CAP2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3157484043458947,0.9771163970486776,0.5517241379310345,0.9085347310500405,1.0,52/390,9.06%,EGFR;ARHGEF28;MET;CYFIP2;NTRK3;NGF;PGF;PDGFC;RBFOX2;PTK2B;EFNA5;ABI1;DDR2;SIPA1L1;SULF1;GRB10;ADRB2;VAV2;UBASH3B;FGFR1;SORBS1;SHC1;ATP6V0A4;GSK3B;FGF2;IRS1;FOXC2;AP2A2;POLR1G;NRP1;SPRED2;SLC39A14;NR4A3;SHOC2;PTPN2;NCK2;NFATC4;FRK;ITGAV;STAT3;RHOQ;IDE;FLRT2;EPHB3;HNRNPH1;SOCS2;PDGFA;BCAR3;FOXC1;ROR1;AP2A1;RHOA
prerank,ribosome assembly (GO:0042255),-0.2998780155248424,-0.9768608311062476,0.48846153846153845,0.8135663321474509,1.0,14/47,18.85%,RPS14;RPS19;RPS5;RPS15;RPS27;RPL23A;RPL11;NPM1;RPL24;MRPS11;RPL3;RPS28;DDX3X;RPL5
prerank,negative regulation of developmental growth (GO:0048640),-0.33059032219500883,-0.9767210420383597,0.49504950495049505,0.8126937997911893,1.0,7/30,9.85%,NKD1;MAP2;DCC;PTCH1;MAG;RTN4;SEMA3G
prerank,regulation of axonogenesis (GO:0050770),0.38005697883389217,0.9766647111473118,0.4795244385733157,0.9089269120409228,1.0,8/51,9.06%,SLIT2;NGF;SIPA1L1;GSK3B;TIAM2;EPHB3;MARK2;RHOA
prerank,dephosphorylation (GO:0016311),0.33631317041946024,0.9763416690309572,0.5122767857142857,0.909081407770931,1.0,30/147,15.49%,PLPPR2;PTPN3;PPP3CA;PTPRU;PLPP3;ALPL;PPM1H;PTPRF;ACP3;PTPRA;PTPN21;DUSP16;DUSP11;DUSP5;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PPP5C;PPP3CC;PTPN9;ILKAP;PPM1A;DAPP1;PPP4R2;PLPP1;SBF1;ACP4;PPP4R1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3557839319985655,-0.9761645295190261,0.49517684887459806,0.8116718750301897,1.0,4/23,15.15%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3557839319985655,-0.9761645295190261,0.49517684887459806,0.8116718750301897,1.0,4/23,15.15%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,ear morphogenesis (GO:0042471),0.43991733061048555,0.9758307577417943,0.48292682926829267,0.9096905048314529,1.0,3/20,5.48%,SIX1;ZIC1;NOG
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.39841524423111346,0.975816063437205,0.4908321579689704,0.909106144367171,1.0,8/36,8.48%,TCF7L2;PPP3CA;WNT11;PLCB3;PDE6A;MOV10;TNRC6C;NLK
prerank,COPII vesicle coating (GO:0048208),0.36676817525174943,0.9756356678645289,0.5026178010471204,0.9076960846523173,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.36676817525174943,0.9756356678645289,0.5026178010471204,0.9076960846523173,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,vesicle coating (GO:0006901),0.36676817525174943,0.9756356678645289,0.5026178010471204,0.9076960846523173,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,photoreceptor cell development (GO:0042461),0.4613193692698454,0.9755445630281072,0.5055118110236221,0.9072766104221656,1.0,3/14,10.34%,RP1;ARL3;VEGFA
prerank,mitotic nuclear division (GO:0140014),0.359424134512284,0.974927306624563,0.5114795918367347,0.9080752365055822,1.0,23/71,22.77%,SMC4;NDEL1;KLHL22;MISP;PPP2R2D;CHEK2;TOGARAM1;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;UBE2S;STAG2;KIF3B;KNSTRN;INO80;ZW10;RAN;STAG1;OFD1;FLNA;AAAS
prerank,cellular response to UV (GO:0034644),0.3572644437665172,0.974905685631102,0.4962311557788945,0.9075106086047313,1.0,20/76,18.46%,NEDD4;PRKCD;CREBBP;KDM1A;TIMP1;USP47;CARD16;CHEK1;EP300;EIF2AK4;ZBTB1;XPA;YY1;USP28;EIF2S1;CDKN1A;ERCC1;ATR;DHX36;INO80
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3460717474676559,-0.9748087384913019,0.4836795252225519,0.8139474863225474,1.0,8/24,18.16%,NR1H3;BCL2L1;AQP11;TMBIM6;RACK1;NR1H2;SELENOS;XBP1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.40734355757585755,-0.9745268857075663,0.5359801488833746,0.8134444089407886,1.0,2/13,5.81%,EPS8;EPS8L2
prerank,dendritic spine morphogenesis (GO:0060997),-0.3869285454771233,-0.9744165039789735,0.4911392405063291,0.8125456616309595,1.0,3/15,3.14%,DOCK10;SHANK3;EPHB1
prerank,response to amino acid starvation (GO:1990928),0.35413537163282416,0.9742955297662002,0.4962311557788945,0.9083051645626948,1.0,22/72,20.11%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;EIF2S1;SZT2;CDKN1A;RHEB;ATP6V1H;NPRL2;MAPK8
prerank,negative regulation of chemokine production (GO:0032682),-0.39605718209595653,-0.9740816395493098,0.4765625,0.8121459789625629,1.0,3/14,6.45%,APOD;SIRPA;C1QTNF3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5070826877572645,0.9740289040564803,0.5128205128205128,0.9077000905233742,1.0,2/10,4.65%,MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.5070826877572645,0.9740289040564803,0.5128205128205128,0.9077000905233742,1.0,2/10,4.65%,MPG;FTO
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3591259587539444,-0.9738322224682205,0.49584487534626037,0.8115836218072948,1.0,3/21,3.09%,IGF1;KDR;CTSH
prerank,positive regulation of signaling (GO:0023056),-0.3178052979040388,-0.9728062583152212,0.5136054421768708,0.8129631265413491,1.0,8/37,10.34%,WLS;RIMS1;GRIK2;RIMS2;SNCA;EDN1;SYT1;INPP5F
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4655367393265038,0.9723028311480063,0.48833333333333334,0.9110675649028248,1.0,2/13,5.02%,SIX1;ZBTB7B
prerank,regulation of transforming growth factor beta production (GO:0071634),0.44268591166307547,0.9719200764841074,0.5276461295418642,0.9113529548983945,1.0,4/18,8.83%,ITGB8;FN1;ITGAV;CD46
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.4349034000406741,-0.9719028237418317,0.5022026431718062,0.8140866942664107,1.0,4/10,16.29%,LYN;GHR;JAK3;STAT5B
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3449540654869716,0.9717418987998886,0.5054413542926239,0.9111491815670691,1.0,12/100,6.03%,EGFR;NTRK3;SOX9;NEDD4;PDGFC;FN1;FGFR1;FGF2;PIK3AP1;BECN1;WNT16;PIP5K1A
prerank,nuclear export (GO:0051168),0.35796510798089703,0.9715910797225761,0.5123456790123457,0.910902111283583,1.0,26/80,19.88%,PKD1;XPO1;SRSF11;THOC2;SRSF5;SRSF6;EGR2;U2AF2;STRADA;DESI1;CHP1;NUP153;SRRM1;SMURF1;CASC3;CHTOP;NUP214;NUP188;XPO4;U2AF1L4;ZC3H11A;THOC5;NXF1;SRSF2;NUTF2;RAN
prerank,positive regulation of dendritic spine development (GO:0060999),-0.36335622540056156,-0.9713997058615879,0.5094850948509485,0.8142023250180145,1.0,5/20,12.17%,SHANK3;APOE;LRP8;CAMK2B;CUX2
prerank,glycerolipid metabolic process (GO:0046486),0.4851739316001516,0.9705342280325058,0.5299145299145299,0.9127546134370823,1.0,4/11,6.89%,PNPLA3;PIP5K1A;PLA2G15;DGKA
prerank,regulation of interferon-beta production (GO:0032648),0.38355221220208674,0.9705062888339011,0.5040431266846361,0.912195170995821,1.0,15/46,19.32%,MAVS;POLR3D;RIPK2;IRF1;REL;TLR4;IFIH1;DHX9;RNF135;TLR8;YY1;POLR3F;POLR3A;PTPRS;TRAF3
prerank,prostaglandin metabolic process (GO:0006693),-0.34249713431370143,-0.970502260161337,0.4956521739130435,0.8152230299121881,1.0,9/26,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;PTGES3;PTGS2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3598760854929517,0.9704244770097555,0.5123152709359606,0.9117690450188031,1.0,9/69,7.87%,SIX1;NGF;PTK2B;TGFB3;CLCF1;NFATC4;ISL1;GDNF;SIX4
prerank,innate immune response in mucosa (GO:0002227),-0.4388606516200638,-0.9703917328431252,0.5023474178403756,0.8142997337146824,1.0,7/10,43.29%,DEFA6;RPL39;NOS2;CAMP;BPIFB1;DEFB1;LTF
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.43309102610500105,0.9702119456576908,0.5048387096774194,0.9116350681681823,1.0,3/20,6.40%,MET;MRAP;ADA
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4678332012152732,0.9701386574862164,0.4958813838550247,0.9111874836409641,1.0,3/12,16.62%,PAICS;PFAS;GMPS
prerank,regulation of inflammatory response (GO:0050727),0.3248451881295256,0.9701059577864836,0.5196078431372549,0.9106523104744559,1.0,28/190,12.34%,FOXP1;CCN3;MGLL;ANXA1;PRKCD;GPR4;PTGIS;KLF4;PIK3AP1;AGTR1;PDCD4;PTPN2;IL17RA;ISL1;IFI35;IL10;CELF1;DAGLB;TLR4;RORA;SHPK;NLRP6;IL33;CCL3;RB1;CCL1;MYD88;TNFRSF1B
prerank,cellular protein localization (GO:0034613),0.3193084725601631,0.9697360975964583,0.5667011375387797,0.910954432917205,1.0,59/285,16.58%,EGFR;ANK2;CSRP3;PTPRU;WNT11;SGSM2;KIF13A;CNTLN;TLK1;STX11;ID1;RAB43;TMED5;RAB6A;HERC2;WIPI2;AP3B1;STX5;VCL;DMD;RIC3;GRTP1;ARF3;RRAGB;NSF;RAB3GAP2;AP2A1;EIF2D;STX8;EHD1;CTTN;ARF4;TBC1D2B;TBC1D13;ZDHHC15;COPA;STX19;TBC1D25;SEC31A;USP4;NIPBL;ARCN1;COG3;SEC13;SMURF1;TBC1D10A;NPHP1;RAB24;ARFIP1;TBC1D8B;PIGU;GGA2;ARFIP2;TBC1D5;ARFGAP3;SAR1B;SEC23IP;SGSM3;SNX31
prerank,electron transport chain (GO:0022900),-0.38777195571768536,-0.9697319780129523,0.5062034739454094,0.8147502019928524,1.0,4/15,11.64%,SDHA;PPARGC1A;PDIA5;CYB561
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.40094588563482575,-0.9696884889846084,0.5,0.813669475579885,1.0,4/14,6.79%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,UV-damage excision repair (GO:0070914),0.4768703287934807,0.9696749200079563,0.499151103565365,0.910488641596546,1.0,6/12,25.71%,XPA;ERCC1;INO80;POLA1;POLD3;XPC
prerank,translational termination (GO:0006415),0.34513950625882234,0.9696329333392361,0.5131744040150564,0.9099829635748147,1.0,39/95,30.78%,MRPL33;MRPL48;MRRF;ETF1;MRPS27;GSPT1;MRPL14;MRPL32;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;ABCE1;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3937218726728199,-0.9690588679521764,0.4949748743718593,0.8140183353018267,1.0,2/13,8.12%,HIF1A;MAPT
prerank,neural crest cell migration (GO:0001755),0.391109186934955,0.9686024591912827,0.49135446685878964,0.9117117642652279,1.0,7/36,8.05%,FN1;SEMA3E;SEMA3D;SEMA3C;NRP1;GDNF;PITX2
prerank,glycoprotein metabolic process (GO:0009100),0.37633680678935233,0.9685896340956534,0.49586776859504134,0.9111354868930059,1.0,19/53,20.30%,ST3GAL4;FUT8;LARGE1;GOLPH3;FBXO17;PRKCSH;MAN2A1;GANC;TNIP1;ST3GAL2;OGA;ST8SIA2;HPSE;GAL3ST4;MAN2B1;GANAB;ENGASE;B4GALT7;B3GNT6
prerank,protein mannosylation (GO:0035268),0.4322068479609507,0.9684602185496005,0.5,0.9108318627521447,1.0,6/22,15.86%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.45056586778081426,0.9683413593715663,0.4992,0.9104868477848153,1.0,5/15,17.79%,IL17RA;STAT3;TLR4;MYD88;TLR6
prerank,chromatin remodeling (GO:0006338),0.3451686628101326,0.9681186430603201,0.5251461988304094,0.9103977964851946,1.0,27/100,19.09%,SOX9;HDAC4;ESR1;MYSM1;SRCAP;CHD1L;BAZ2B;TOP1;NUDT5;RB1;BPTF;KAT2A;SMARCA4;BAZ1A;ATRX;PBRM1;CHD3;HCFC1;KDM4D;ZBTB1;BAZ2A;KAT2B;ZBTB7A;EZH1;SMARCA5;INO80;SMARCC1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.4037115444298592,-0.9680791239451153,0.5356265356265356,0.8153633518282515,1.0,5/13,15.03%,IL18;GAS6;AXL;LAMP1;TYROBP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4129997634961038,-0.968070613791219,0.4975609756097561,0.8141882312131546,1.0,6/12,14.44%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.37996645439153226,0.9677707395190506,0.4993342210386152,0.9105753246251163,1.0,8/46,6.81%,TMEFF2;FN1;PARVA;SRGAP2;NRP1;ANTXR1;ITGAV;EPHB3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.32693712597827285,-0.9676667486169195,0.4781144781144781,0.8140470815127582,1.0,8/31,17.79%,BCL2;TFDP2;HIP1R;YWHAB;BOK;GSK3A;PPP3R1;CHCHD10
prerank,telomere maintenance (GO:0000723),0.3719519524673945,0.9674826694004398,0.5191256830601093,0.910590621073051,1.0,16/50,21.97%,STN1;WRN;ATM;APEX1;SMC5;PRKDC;XRCC5;RPA1;NBN;RAD51;ATR;PARP3;SMC6;POLD3;RAD50;TEN1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3835850821636449,0.9674604397675963,0.49577464788732395,0.9100313103517381,1.0,9/42,12.07%,VIT;FZD7;GCNT2;DMTN;AGR2;RHOA;NF1;LIMS1;CORO1C
prerank,membrane repolarization (GO:0086009),0.44872027480937393,0.9672377074299731,0.5250836120401338,0.9099421087968745,1.0,2/15,1.55%,KCNJ2;ATP1B1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.38601917067616265,-0.9671421292304981,0.49872773536895676,0.8141746738135786,1.0,4/14,18.15%,OSMR;IL6ST;PTGER3;PTGS2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2855005863726152,-0.9670552099901117,0.5222672064777328,0.8132073517295956,1.0,4/59,2.54%,ALDH1A2;CYP7B1;CYP27A1;GATM
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.347397099954844,-0.9668747690468239,0.5232558139534884,0.8124956719220551,1.0,6/24,15.92%,AGBL4;TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,regulation of protein dephosphorylation (GO:0035304),-0.312762085794617,-0.9668617063924378,0.5098684210526315,0.811346562729322,1.0,10/37,14.71%,MFHAS1;PPP1R16B;CALM1;PPIA;YWHAB;TIPRL;PPP2R5A;HSP90B1;CALM3;SMPD1
prerank,response to organonitrogen compound (GO:0010243),0.3853200691533543,0.966354255902084,0.494475138121547,0.9113233025548853,1.0,6/38,12.91%,GLRB;RNF185;VCP;DRD3;IRAK3;MTOR
prerank,protein alkylation (GO:0008213),0.4277702824740812,0.9663138751534837,0.5166402535657686,0.9108069212722444,1.0,11/22,28.13%,PRMT8;ETF1;GSPT1;PCMT1;METTL22;ETFBKMT;EEF1AKMT1;METTL21A;PRMT2;METTL21C;FAM98A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4773004525828095,0.9662749317946893,0.4847457627118644,0.9102829156960364,1.0,2/12,7.18%,TRPM4;CLTRN
prerank,positive regulation of JNK cascade (GO:0046330),0.36034699813012716,0.9658106966176252,0.5243589743589744,0.9107200557360323,1.0,6/70,5.60%,RASSF2;MAP3K5;PTK2B;FZD7;GADD45G;WNT16
prerank,axoneme assembly (GO:0035082),0.40822064226933136,0.9658065666758707,0.5058479532163743,0.9101234562991465,1.0,5/30,10.85%,RP1;DNAAF3;TOGARAM1;SPAG17;CCDC40
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.41403298846310177,0.9656388934134958,0.4962852897473997,0.9098844868363156,1.0,12/27,25.92%,TAB3;IRAK4;TLR4;IRAK3;MYD88;TNIP1;TLR1;TLR6;LY96;MAP3K7;TRAF6;CD36
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4153350529419077,0.9652344897972143,0.5112994350282486,0.9101710542407033,1.0,11/30,21.60%,TANK;IKBKE;TLR4;UBE2D3;CHUK;IKBKG;TLR6;BIRC3;TRAF3;IRF3;LY96
prerank,telomere maintenance via recombination (GO:0000722),0.4804732736125194,0.9651342005402445,0.5182608695652174,0.9097873423883027,1.0,5/11,21.85%,SMC5;RAD51;ERCC1;SMC6;RAD50
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.44642957263508604,0.9651328594716467,0.49333333333333335,0.9091853625071141,1.0,4/17,8.47%,TGFB3;PDCD4;IL10;CDKN1B
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4493373988463327,0.9651252095532799,0.5008156606851549,0.9085979781178307,1.0,7/16,19.22%,FOXK1;RORA;FOXK2;PDK3;GNB3;SCARB2;ADIPOR1
prerank,insulin secretion (GO:0030073),0.4385260127847873,0.9648654758775722,0.5064308681672026,0.9086378919244616,1.0,4/19,12.96%,ANXA1;CLTRN;SNX19;SELENOT
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3207422263761981,-0.9642145812741646,0.4896551724137931,0.8166568659590578,1.0,4/32,2.11%,AUTS2;PIK3R1;ENPP2;OCLN
prerank,cellular response to nitrogen compound (GO:1901699),0.4383986707001499,0.9635368364502691,0.5139318885448917,0.9109796517122313,1.0,5/20,12.88%,DDI2;ATP2B4;DDX11;SPIDR;ATRX
prerank,regulation of postsynapse organization (GO:0099175),-0.33594843474428443,-0.9635325110352911,0.5344827586206896,0.8171527256920005,1.0,11/28,17.42%,IL1RAPL1;SHANK3;PPFIA2;WNT5A;EPHA4;CFL1;ABI3;ARHGAP22;KIF1A;CDKL5;ABHD17C
prerank,regulation of secretion (GO:0051046),-0.3933064761907076,-0.963306411744628,0.5164556962025316,0.8165698085962924,1.0,4/13,8.64%,MYO6;SGK1;OAS2;KCNQ1
prerank,proton transmembrane transport (GO:1902600),-0.32102980762468625,-0.9630333231703745,0.5198675496688742,0.8160549762251174,1.0,1/36,0.02%,ATP1A2
prerank,nucleotide-excision repair (GO:0006289),0.3451171628318832,0.9627553853954078,0.5278450363196125,0.9120648665635906,1.0,30/101,25.71%,MNAT1;ERCC5;CHD1L;COMMD1;RAD23B;UVSSA;SLC30A9;BRCA2;COPS7B;USP7;RNF111;COPS5;SLX4;EP300;ERCC8;POLB;ERCC3;XPA;RPA1;ERCC1;RFC1;POLA1;POLD3;CUL4A;RFC5;BRIP1;ERCC2;COPS3;POLK;XPC
prerank,response to lipopolysaccharide (GO:0032496),0.32859770663634064,0.962376430566718,0.5377677564825254,0.9123438391368125,1.0,28/138,17.78%,FOXP1;LBP;ADAM9;SMAD6;PDCD4;CD80;SLPI;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;ERBIN;IRAK3;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9;MAPKAPK2;OTUD5;ACOD1;SBNO2;BCL10;PALM3;CYP27B1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4708924769384821,0.9623083090561344,0.5124792013311148,0.9119020381699335,1.0,1/13,2.06%,PRKCD
prerank,mRNA 3'-end processing (GO:0031124),0.356201980186824,0.9620976702548654,0.516728624535316,0.9117912470063072,1.0,32/78,28.97%,SRSF11;THOC2;SRSF5;SRSF6;SCAF8;U2AF2;PABPC1;SRRM1;LSM11;CASC3;CHTOP;U2AF1L4;ZC3H11A;THOC5;SRSF2;TENT2;PAF1;FIP1L1;NUDT21;CDC40;CSTF1;CPSF7;UPF3B;RBM8A;CPSF3;ALYREF;SRSF3;CLP1;SRSF7;CPSF4;NCBP2;CPSF4L
prerank,negative regulation of gene expression (GO:0010629),0.31721401616414246,0.9618650616984621,0.5635987590486039,0.9117320899323935,1.0,60/302,16.24%,FOXP1;BMP4;SLC24A3;SAMD4A;ITGB8;SMO;HDAC9;IGFBP5;WWP2;KLF4;BMPR1A;ZNF148;FGF2;NOTCH2;PAIP2;ATP2B4;ESR1;SYNCRIP;IL10;CELF1;MOV10;ID2;TNRC6C;DXO;REL;ATOH8;CD46;NFKB1;AURKA;TOB1;VEGFA;NCOR1;SMCR8;CCL3;EED;RB1;RBMS3;SNX12;ZC3H12A;DDRGK1;ANXA7;NCOR2;ZC3H12D;REST;NPTN;DNMT3A;SUZ12;CNOT7;CREB3L1;ASB1;MAP2K2;ADAM10;HINFP;EPC1;NUDT12;DIS3L2;KAT2B;AGO2;CPNE1;XDH
prerank,lymphocyte chemotaxis (GO:0048247),0.3898392665421106,0.96137211489581,0.4908579465541491,0.912238995880793,1.0,1/34,0.48%,SLC12A2
prerank,glycoprotein biosynthetic process (GO:0009101),0.357273946977216,0.9612362414018992,0.5363408521303258,0.9119526911576415,1.0,20/79,17.58%,ST3GAL4;B3GNT2;CHST13;LARGE1;FOXL1;GCNT2;XYLT1;GOLPH3;MPI;B3GALT6;CHST11;COG3;MGAT1;TNIP1;ST3GAL2;DDOST;CHST12;B3GNT9;ST8SIA2;GAL3ST4
prerank,cellular copper ion homeostasis (GO:0006878),-0.39527959013003866,-0.9610407505364973,0.5012106537530266,0.8198439362492901,1.0,7/14,25.95%,APP;ATOX1;SLC31A1;MT2A;ATP7A;COX19;ABCB6
prerank,protein complex oligomerization (GO:0051259),0.3533773143376893,0.9609780395209404,0.5345454545454545,0.9119456149101659,1.0,22/85,17.17%,LRRC8D;ATL3;TMEM120A;ATL2;MPP2;PDCD6IP;EHD3;FUS;G3BP2;SLC9A1;PRMT8;RBMX;EHD1;MCU;CUTC;ZC3H12A;YME1L1;RNF135;HOMER1;ZBTB1;JMJD6;BCL10
prerank,GTP metabolic process (GO:0046039),0.46141570742454635,0.960939444865027,0.5148514851485149,0.9114209286304862,1.0,5/15,19.88%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4415919548270793,0.960587747959237,0.4969040247678019,0.9116187975796858,1.0,5/17,9.77%,SPRED2;EIF4G1;DMTN;PARD3;PPEF2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33774999761121316,0.9602050229146432,0.5218934911242603,0.9119114504379323,1.0,6/108,3.05%,F3;MAP3K5;NGF;EGLN3;GSN;CRADD
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4170780364301167,0.9600223638096815,0.5345345345345346,0.9117438382630301,1.0,2/25,2.70%,EXT1;B3GNT2
prerank,glucose metabolic process (GO:0006006),-0.2769794400616956,-0.9598740969645898,0.5252100840336135,0.8214620348815792,1.0,17/58,21.63%,APOD;RBP4;PPARD;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;AKR1A1;ENO1;DCXR;SLC25A11;SLC25A13
prerank,ketone body metabolic process (GO:1902224),0.47991229131611524,0.9598229986249582,0.4851657940663176,0.9115477662590452,1.0,2/10,7.70%,BDH2;AACS
prerank,regulation of neuron differentiation (GO:0045664),0.3545715001497336,0.9597764825511149,0.5414572864321608,0.9110462255044801,1.0,6/76,2.89%,ZFHX3;SIX1;VWC2;NGF;HES1;FGFR1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32417143496113476,0.95969989479376,0.5348837209302325,0.9106060410823141,1.0,41/151,20.83%,ST3GAL4;ACER3;PCSK5;PLPP3;SGMS2;INHBA;LARGE1;DMD;SPTSSB;GOLPH3;NANP;NFS1;TYW5;SLC44A3;LPIN2;ELOVL5;TYW1;CDO1;LCAT;KDSR;CHKB;MOCOS;PLPP1;TNIP1;GSTM4;ST3GAL2;CEPT1;GSTA2;GAL3ST4;CSNK2A2;CSNK2A1;GSTT1;CERS6;CERS5;MOCS3;LPCAT1;ARG1;B3GNT6;PLA2G4A;HACD4;NMRAL1
prerank,regulation of insulin secretion (GO:0050796),0.34238234667805456,0.9596409354203604,0.5164319248826291,0.9101316778921815,1.0,16/101,11.42%,CCN3;TCF7L2;CACNA1C;EFNA5;KCNS3;KCNB1;IRS1;RAP1A;ISL1;ITPR2;AACS;MCU;LRP5;CAPN10;INHBB;SLC8B1
prerank,carnitine metabolic process (GO:0009437),0.4631084345096801,0.9595129343719582,0.5077720207253886,0.9098227599369252,1.0,3/12,8.44%,TMLHE;CPT1C;ACADM
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.47815466774603965,0.9593976511471752,0.5134649910233393,0.9094863419647808,1.0,2/11,12.53%,ANXA1;ZC3H12A
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4191555441817238,-0.958943874261142,0.5249406175771971,0.8225941300803455,1.0,4/11,23.30%,AGBL4;ICMT;LCMT1;ATG12
prerank,calcium ion homeostasis (GO:0055074),0.3427886045137635,0.9589406173477573,0.5235223160434258,0.909899250689151,1.0,15/95,11.42%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;FAM20A;TNNI3;DRD3;CCL3;CCL1;SLC8B1
prerank,myeloid cell differentiation (GO:0030099),-0.2980204918679884,-0.9583400126155478,0.5366795366795367,0.8229082098005868,1.0,7/47,8.33%,LYN;MFHAS1;KIT;SNRK;RPS14;RPS19;TAL1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3503249671526848,0.958294262622334,0.5392986698911729,0.9108098668113743,1.0,21/84,19.32%,SCARA3;LBP;PIK3AP1;TAB3;IRAK4;RIPK2;TLR4;UBE2D3;CHUK;PLCG2;IRAK3;MYD88;TNIP1;TLR1;MAPKAPK2;TLR8;IKBKG;BCL10;TLR6;BIRC3;TRAF3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4559484418466473,0.9578804468542407,0.4975609756097561,0.911138492254641,1.0,5/13,16.06%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,protein modification process (GO:0036211),0.35518955079139586,0.9578190178485699,0.5300613496932516,0.9106636087221796,1.0,31/76,25.10%,PLOD2;WWP2;ABL1;PHKA2;PHEX;ATG3;TGM3;CSNK1G3;UBE2D3;RIPK3;USP25;YES1;PRKDC;PPP4R2;BAP1;UBE2S;TGM1;GNMT;ST8SIA2;LOX;MAN2B1;TGM5;B4GALT7;PARP4;UBE2M;FBXO11;PIGH;GGCX;MCRS1;DUSP12;FBXW2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.37271559506825996,0.9577320281391726,0.5266666666666666,0.9102775397385621,1.0,17/48,20.85%,HIPK1;ABL1;IKBKE;CHEK2;ATM;CDIP1;TNFRSF1B;PRKDC;EP300;DYRK2;PML;CASP2;USP28;MOAP1;SNW1;MCL1;E2F1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.44149250793076705,0.9576572619354682,0.5279503105590062,0.9098567221413052,1.0,8/16,30.87%,PAICS;AMPD3;PFAS;GMPS;AMPD2;ADSS2;NUDT2;ATIC
prerank,positive regulation of autophagy (GO:0010508),-0.2659765587272466,-0.9576560304160272,0.5612244897959183,0.8234073230061884,1.0,9/81,5.91%,RNF152;PRKD1;DCN;FOXO1;KDR;TRIM14;PRKAA2;OPTN;PIK3C2A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4164367625036987,0.9574254711040121,0.5053272450532724,0.9098111218790735,1.0,4/26,6.43%,ST3GAL4;B3GNT2;CHST5;B4GALT1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3780509791392868,-0.9574178022112992,0.5075,0.822906894906946,1.0,5/15,10.42%,AEBP1;TIE1;NOTCH1;EFEMP2;FGFR4
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3594042537785935,-0.9569626655790368,0.5068870523415978,0.8228470696936261,1.0,2/18,5.66%,CORO2B;CEP120
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3230714769725503,0.9556050292338678,0.5798687089715536,0.9133215746762521,1.0,53/184,24.77%,FZR1;PKD1;ANAPC5;SFI1;PAFAH1B1;PCM1;PSMB2;CDC16;ID2;CEP164;ANAPC16;CDC14A;CEP63;AURKA;AKAP9;PSMC6;CEP131;CSNK1E;PSMD11;CUL3;UBE2S;PSMD1;SDCCAG8;ERCC3;CEP43;HAUS2;CUL1;MAD2L1;CEP57;PSMC1;PSMD7;INO80;CEP70;NEK6;PSMD14;ZW10;CSNK1D;PSMD3;KLHL18;E2F1;OFD1;ANAPC11;ANAPC10;PLK4;CDK2;CCNB1;HAUS5;RIOK2;CNTRL;CDC20;ERCC2;BUB3;PSMD12
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4077467000133066,0.9554380844281344,0.5358255451713395,0.9130552187460577,1.0,6/25,13.31%,FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3585832118502788,0.9551827785766593,0.529338327091136,0.9130116771293258,1.0,13/69,9.80%,PLCE1;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1;PLCD3;RHOA;NF1;PI4KB
prerank,regulation of mRNA stability (GO:0043488),0.32755322199631465,0.9547072792548997,0.5596846846846847,0.9134743284351472,1.0,38/145,20.96%,SAMD4A;PRKCD;FTO;EIF4G1;XPO1;GDNF;FASTKD1;PSMB2;CELF1;FUS;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;PABPC1;EXOSC7;PUM2;PSMD11;PSMD1;MAPKAPK2;DCP1A;PRKCA;PUM1;THRAP3;NUP214;PSMC1;PSMD7;EXOSC1;DHX36;CIRBP;FXR2;PSMD14;TENT5D;FMR1;PSMD3;E2F1;YTHDF2
prerank,apical junction assembly (GO:0043297),0.36727890819004844,0.9542875759992292,0.5230352303523035,0.9138141456811355,1.0,15/53,13.88%,MPP7;CTNNA1;STRN;VCL;PDCD6IP;CLDN11;DLG1;CLDN16;PATJ;GRHL2;RHOA;PARD3;PKN2;PAK2;WDR1
prerank,protein glycosylation (GO:0006486),0.33512215932656436,0.9540284756922592,0.5724137931034483,0.9137647957974868,1.0,30/125,20.54%,ST3GAL4;MGAT4C;FUT8;PLOD2;B3GNT2;LARGE1;GCNT2;MGAT3;B4GALT1;MPI;COG3;B4GAT1;DPM1;LARGE2;MGAT1;ST3GAL2;DDOST;POMGNT2;OGA;TMEM165;B3GNT9;ST8SIA2;ALG12;POFUT1;TUSC3;GFPT1;MGAT5;B4GALT7;B3GNT6;NPC1
prerank,female gonad development (GO:0008585),-0.36032259082046453,-0.9539901948033318,0.5230769230769231,0.8289586616782918,1.0,2/19,1.97%,NR2F2;KIT
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3922347744083089,-0.9538680842836312,0.5268542199488491,0.8280945322951361,1.0,2/13,2.14%,GRM3;ADGRV1
prerank,nuclear pore organization (GO:0006999),0.4474260992468485,0.953865044025224,0.5015625,0.9135219489532077,1.0,6/14,23.65%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A;NUP54
prerank,DNA recombination (GO:0006310),0.3876579481510681,0.9535127098020171,0.513235294117647,0.9137181859490314,1.0,11/37,21.85%,EXO1;WRN;IGHMBP2;RAD52;HDAC10;RPA1;RECQL5;RAD51;ERCC1;RAD51C;RAD50
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3430482437283784,-0.953453702945752,0.5365168539325843,0.8278848889125235,1.0,5/25,9.40%,ITPR1;CDH13;RIT2;MAPT;PLEK
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.40093173863702464,0.9534362429711124,0.5392441860465116,0.9132817021403743,1.0,3/36,5.13%,EGFR;NPR3;ATP2B4
prerank,positive regulation of transmembrane transport (GO:0034764),0.4493935629880114,0.9533987933481165,0.5464926590538336,0.9127730891794014,1.0,5/13,13.73%,ANO6;SLC26A6;NR4A3;C2CD5;AZIN1
prerank,phosphorylation (GO:0016310),0.3086845007858839,0.9531956983431435,0.6008146639511202,0.9126344367393145,1.0,76/384,15.49%,STK39;DCLK1;MAP3K5;GRK5;MARK1;PTK2B;CAMK2D;WNK1;WNT11;PRKCD;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ABL1;BCR;TGFBR1;CLK2;MKNK2;TGFBR2;SGK3;FRK;CDK12;STAT3;CDC25B;BIRC6;DGKA;FAM20A;MARK2;IKBKE;CHEK2;CSNK1A1;NLK;CHUK;AAK1;SHPK;AURKA;SIK3;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;STRADA;ERBB2;MORC3;MAST2;NADK;CDKL2;CSK;PDK3;MTOR;CHEK1;PKN2;PAK2;PRKDC;AGK;CSNK1E;ERN2;CDC42BPG;DYRK2;EIF2AK4;HTR2B;CDK11B;MAPKAPK2;PRKCA;CDK16;ADAM10;PPP4R1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4238051305258851,0.9531026209626902,0.5331179321486268,0.9122156397337279,1.0,9/22,23.25%,WDR43;ERBB2;DDX11;SMARCA4;MTOR;NOL11;WDR75;EIF2AK3;UBTF
prerank,Rho protein signal transduction (GO:0007266),0.37059134692501033,0.9527380980622173,0.5285913528591353,0.9124134311855494,1.0,9/53,9.40%,NTN1;CDC42EP5;RHOJ;ARHGDIB;AGTR1;SHTN1;RHOA;ARHGAP5;GNA13
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.32224047465687766,-0.9524897776381395,0.5579937304075235,0.8290447414794088,1.0,6/32,12.12%,DEFA6;PGLYRP1;RPS19;RPL30;GAPDH;RPL39
prerank,negative regulation of cellular component organization (GO:0051129),0.3463012337484842,0.9520213032879153,0.5401273885350318,0.9133890837522606,1.0,11/74,13.42%,TMEFF2;BMP6;GSK3B;ISL1;CLU;RDX;LRSAM1;IRAK3;VEGFA;XRCC5;EP300
prerank,muscle tissue morphogenesis (GO:0060415),0.4419645205624917,0.9520128933217976,0.5079365079365079,0.9128223351020308,1.0,1/16,0.28%,BMP4
prerank,histone H4-K16 acetylation (GO:0043984),0.43526606544073715,0.9518927988197137,0.5271317829457365,0.9124903248225095,1.0,10/19,28.08%,KANSL2;KANSL3;KANSL1;HCFC1;MSL1;PHF20;MCRS1;JADE2;OGT;KMT2A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37449579786672293,0.951227361134814,0.5211640211640212,0.9133286808891921,1.0,19/52,26.27%,SAMD4A;PAN3;EXOSC7;TUT7;CNOT7;DCP1A;TUT4;EXOSC1;TNKS1BP1;LSM2;PNLDC1;CNOT4;CNOT11;SAMD4B;CNOT3;LSM4;EDC3;RC3H2;PARN
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.41013731055737634,0.9512180580768481,0.5161764705882353,0.9127610614428745,1.0,4/27,9.48%,MAP3K5;CHUK;NFKB1;FBXW11
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4255174942232513,0.9509133528299525,0.5199386503067485,0.9128560153395106,1.0,5/20,13.42%,SMAD9;NFE2L2;VEGFA;CARF;EP300
prerank,positive regulation of immune effector process (GO:0002699),0.4004569528428214,0.9507764149933976,0.5327380952380952,0.9125502538993256,1.0,3/27,8.83%,LBP;IL10;CD46
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.33380060735086325,-0.9507585076948899,0.5149700598802395,0.8321727728093937,1.0,9/26,20.27%,APOE;HIF1A;NOS1AP;NUS1;SCARB1;AKT1;GCH1;ATP7A;CDH3
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.29984510104046824,-0.9503966779555308,0.5268817204301075,0.8318591718767921,1.0,16/42,24.26%,IL6R;DEFA6;OPTN;RPS19;RPL30;GSDMD;ADGRB1;CHGA;TREM2;SELP;MPEG1;PYCARD;ROMO1;MR1;NOS2;AQP1
prerank,organelle organization (GO:0006996),0.30930188737846087,0.9502472198259944,0.617737003058104,0.9131404595244514,1.0,56/388,13.10%,MICAL2;PLCE1;ABCD3;FMNL2;MARK1;ARHGAP21;ARHGAP10;STRIP2;ATL3;CXADR;VPS13C;PNPLA3;GOLGB1;DIAPH1;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;PDCD6IP;RAB30;TMEM135;GAK;LMAN2L;GOLPH3;DOP1B;DMTN;GBF1;GABPB1;CSNK1A1;KIF9;FGD6;SEC16A;ATP8B1;VPS13D;PCLO;PLEKHM2;HILPDA;NRF1;SPRYD3;CCL3;LONP2;MAST2;MTX2;ZMYM4;SH3D19;MTFR1;SEC31A;SEC61A1;WDR81;COG3;MTX3;ZRANB1;PPRC1;YME1L1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.37281245270516933,0.9501897219564801,0.5075445816186557,0.9126786187744416,1.0,10/47,12.53%,SIX1;ZBTB16;CMKLR1;TRPM4;ZBTB7B;ID2;CDS1;SYAP1;LRP5;ZC3H12A
prerank,limb development (GO:0060173),0.40477961024830966,0.9501758726387995,0.5139500734214391,0.9121185866650943,1.0,4/28,5.48%,PCSK5;GLI3;SMOC1;NOG
prerank,skeletal muscle contraction (GO:0003009),-0.3683607967802843,-0.950097463557371,0.5300261096605744,0.8313915271422027,1.0,8/19,32.40%,RCSD1;STAC;MYH14;STAC2;CCDC78;TCAP;TNNI2;STAC3
prerank,GPI anchor biosynthetic process (GO:0006506),0.40414330885396804,0.9499641687837218,0.5178041543026706,0.9120041959002626,1.0,14/30,26.58%,PGAP2;PIGB;DPM1;PIGU;GPAA1;PIGL;PIGN;PIGT;PIGH;PGAP3;PIGQ;MPPE1;PIGA;PIGK
prerank,response to UV-B (GO:0010224),-0.407541623471382,-0.949894765669034,0.5233415233415234,0.8306898841692881,1.0,6/12,29.85%,CRIP1;MFAP4;MME;HYAL2;RELA;IL12A
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3753109787072425,0.9498659898264931,0.5257301808066759,0.911631971419108,1.0,6/43,8.97%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126
prerank,negative regulation of receptor binding (GO:1900121),0.46445981328725516,0.9498294619423506,0.5223140495867769,0.9111296526948532,1.0,3/10,7.16%,PTPRF;NOG;IL10
prerank,protein export from nucleus (GO:0006611),0.4072523108833033,0.9497894887769841,0.5171385991058122,0.9106293111456351,1.0,12/27,19.88%,PKD1;XPO1;DUSP16;EGR2;STRADA;DESI1;CHP1;SMURF1;NUP214;XPO4;NUTF2;RAN
prerank,negative regulation of DNA binding (GO:0043392),0.39952233872627285,0.9494740074304827,0.5161290322580645,0.9107477066367881,1.0,5/28,10.17%,SMO;MDFI;KDM1A;GATA1;JUN
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3309845430213017,-0.9493990496066137,0.5326797385620915,0.8307055546842544,1.0,10/26,22.47%,LGR4;TLR3;TYRO3;LRRC14;IRF7;GPS2;BIRC2;TREM2;SMPDL3B;CACTIN
prerank,cyclooxygenase pathway (GO:0019371),-0.4238614292348914,-0.9492550359791455,0.503562945368171,0.8299044277793404,1.0,6/10,18.15%,PTGDS;PTGS1;HPGDS;CBR1;PTGES3;PTGS2
prerank,regulation of biomineral tissue development (GO:0070167),0.4068466175551632,0.9491755173379597,0.5307692307692308,0.9107961350203344,1.0,4/26,4.55%,SOX9;DDR2;SGMS2;TXLNG
prerank,positive regulation of inflammatory response (GO:0050729),-0.25524898616569897,-0.9490190455776311,0.5842105263157895,0.8293191596636197,1.0,23/86,15.34%,ETS1;WNT5A;OSMR;APP;CD47;RPS19;GPRC5B;CD81;PDE2A;SNCA;IL18;GRN;NAPEPLD;IL6ST;TLR7;NINJ1;NMI;MDK;TLR3;LPL;AGT;NUPR1;TNFRSF1A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4780836317289323,0.9490124006279093,0.5025817555938038,0.9105959859641367,1.0,4/10,7.23%,SOX9;ZBTB16;GDF6;GDF5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4412732146583867,0.9489566961910371,0.5220820189274448,0.9101284799503448,1.0,3/16,5.24%,MRAP;SLC39A14;ACP3
prerank,positive regulation of cellular process (GO:0048522),0.3069307046446434,0.9488522062601883,0.6549648946840522,0.9097830168603892,1.0,74/565,11.82%,EGFR;THBS1;BMP4;ACER3;ZFHX3;GRK5;NTRK3;SOX9;BMP5;HDAC4;LRP6;PGF;PPP3CA;PDGFC;PTK2B;LBP;TGFB3;FN1;PRKCD;HES1;KRAS;FGFR1;SHC1;BMP6;FGF2;FZD7;GAB2;IRS1;LMNA;GAREM1;TGFBR1;CLCF1;EIF4G1;TRPM4;TGFBR2;GCNT2;KLHL22;ISL1;ITGAV;GDNF;LRP1;BAMBI;PTHLH;RIPK2;CDC25B;CELF1;P2RX2;PDGFA;TLR4;CDKN1B;P2RX4;CHRD;CTF1;RAB25;EGR2;MMP14;PARD3;BCLAF1;RARA;HILPDA;ATM;PROK2;VEGFA;CEP131;MVD;LRP5;ERBB2;SMC5;TIMP1;CAPN10;USP47;TIAM1;ITGB1BP1;FGF22
prerank,mononuclear cell differentiation (GO:1903131),0.4063725831910081,0.9487345890823717,0.5333333333333333,0.9094638610309238,1.0,1/24,0.28%,BMP4
prerank,inositol phosphate metabolic process (GO:0043647),0.3764781415400832,0.9480328585885202,0.5367156208277704,0.9104660319803884,1.0,10/46,9.84%,PLCE1;PLCB3;FGF2;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.35495658649815,0.9478783068248546,0.5468164794007491,0.9102561361678335,1.0,8/72,6.97%,RBFOX2;FGFR1;FGF2;SPRED2;SHOC2;NOG;FLRT2;HNRNPH1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.33659400900003106,-0.9478731683908924,0.5366568914956011,0.8309733720871767,1.0,6/25,10.81%,TMTC2;ANK3;SLC8A1;SNCA;GRIN1;JPH2
prerank,regulation of phospholipase activity (GO:0010517),0.4793934712527748,0.9477003914920763,0.541095890410959,0.910049818252336,1.0,2/10,6.11%,FGFR1;LRP1
prerank,regulation of defense response (GO:0031347),0.34984399539466493,0.9476535963496022,0.5413625304136253,0.9095844522154245,1.0,12/76,11.94%,FOXP1;MGLL;ANXA1;PIK3AP1;AGTR1;CELF1;IRF1;DAGLB;SHPK;NLRP6;ERAP1;MYD88
prerank,response to unfolded protein (GO:0006986),-0.2913634830935795,-0.9475913259101574,0.5346153846153846,0.830538001407032,1.0,13/48,20.70%,HSPA8;DAB2IP;OPTN;ERN1;HSP90AB1;STT3B;TMBIM6;HSPA13;DNAJB5;PACRG;HSPB1;HSPE1;HSPA9
prerank,cell cycle G2/M phase transition (GO:0044839),0.3322546377688589,0.9475507228271595,0.5536130536130536,0.9092241318950445,1.0,18/129,10.58%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;CEP63;AURKA;FBXW11;AKAP9;PPP1R12A;CEP131;FBXL6
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.38730582624973364,0.9474989473389605,0.5243393602225312,0.9087664926776297,1.0,9/36,15.74%,FHIT;GIPC1;F8A1;USP25;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,negative regulation of glycolytic process (GO:0045820),0.4713537743482935,0.9473269465908465,0.5302245250431779,0.9079492974654674,1.0,3/10,10.78%,HDAC4;PFKFB1;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4713537743482935,0.9473269465908465,0.5302245250431779,0.9079492974654674,1.0,3/10,10.78%,HDAC4;PFKFB1;NCOR1
prerank,regulation of pH (GO:0006885),0.4793221492130877,0.9472813710124494,0.5177935943060499,0.9074709239098263,1.0,3/11,8.86%,ATP6V0A4;ATP1A4;SLC9A1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3387791691274194,0.9466451348283984,0.5496932515337424,0.908289381258203,1.0,23/88,15.63%,VPS13A;STXBP6;EXOC4;VPS13C;GOLGB1;CLINT1;ARL3;DOP1B;GBF1;EXOC5;AP4E1;RABEP1;AP2A1;COMMD1;SNAP23;KIF16B;SH3D19;GOPC;SCAMP2;GOLGA7;CCDC22;PUM1;MON2
prerank,RNA biosynthetic process (GO:0032774),0.39122751967290564,0.9464434079099596,0.5109170305676856,0.9081373896307534,1.0,13/31,25.80%,TTF2;TTF1;PRIM2;TAF12;TAF4;NCOA6;PRIM1;SMARCA5;HELB;POLA1;PRMT5;GTF2B;TAF13
prerank,mRNA destabilization (GO:0061157),0.38470419540711337,0.9462075440439802,0.5369318181818182,0.9080678595122007,1.0,16/38,26.48%,FTO;CELF1;MOV10;ZC3H12A;ZC3H12D;TUT7;PUM1;DIS3L2;TUT4;DHX36;YTHDF2;TARDBP;ROCK1;YTHDF3;RC3H2;MEX3D
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3861022782416227,0.946188046804814,0.532656023222061,0.9075274835950308,1.0,12/31,14.36%,EZR;DLG2;PDCD6IP;DLG1;MARK2;RHOA;PARD3;SYNE4;ERBIN;MYO9A;WDR1;SYNJ2BP
prerank,mitotic spindle assembly (GO:0090307),0.37641717839812,0.9460680617228772,0.5315934065934066,0.9072093075229307,1.0,14/42,22.77%,MISP;CHEK2;TOGARAM1;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;STAG2;KIF3B;STAG1;OFD1;FLNA;AAAS
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3259154980749959,-0.945983202842264,0.5481927710843374,0.8331991952123414,1.0,12/29,28.37%,NR1H3;DBI;PNPLA8;TMEM86B;NR1H2;PLAAT3;PLA2G4C;PLA2G5;PLA2G4E;PLBD1;PLB1;LPCAT3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4514668485043864,0.9459794738353784,0.5399673735725938,0.9068087661984154,1.0,9/15,35.69%,ZC3H12A;ZC3H12D;ZC3H12C;LACTB2;ZC3H12B;DICER1;NYNRIN;RNASEH1;POP1
prerank,modified amino acid transport (GO:0072337),-0.3819573814851616,-0.9459652495621239,0.5518987341772152,0.8320873405167875,1.0,2/15,0.29%,SLC6A13;SLC16A12
prerank,regulation of cellular respiration (GO:0043457),-0.37081177625564693,-0.9458530125394264,0.5227882037533512,0.8311868501517552,1.0,3/17,4.04%,CBFA2T3;IFNAR1;PRDM16
prerank,aerobic respiration (GO:0009060),-0.3513003963598028,-0.9458270286587025,0.5238095238095238,0.8300950089823637,1.0,10/20,30.52%,UQCRH;UQCR10;ME3;ATP5F1D;MTFR2;UQCRC1;UQCRB;SDHC;BLOC1S1;UQCRC2
prerank,cellular response to interleukin-12 (GO:0071349),-0.2830020293034866,-0.9457749988218083,0.5498154981549815,0.8290741482499988,1.0,12/48,14.81%,PLCB1;CNN2;CD47;SIRPA;PPIA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1
prerank,hexose biosynthetic process (GO:0019319),-0.29456031107422287,-0.9457191031746208,0.5177865612648221,0.8280561193088474,1.0,13/42,21.63%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A11;SLC25A13
prerank,negative regulation of protein binding (GO:0032091),0.3534979022964365,0.945692091731708,0.5387547649301143,0.9069037175018851,1.0,15/71,13.47%,PRKCD;ADRB2;GSK3B;LRPAP1;PTPRF;KDM1A;SLPI;DISC1;AURKA;DACT1;DDX11;ITGB1BP1;USP33;CARD16;CSNK1E
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32389980157234755,0.9453915658550198,0.5766666666666667,0.9069913318448727,1.0,30/149,16.38%,SLCO3A1;CARD14;EDA;ERC1;RAB7B;TAB3;STAT3;CLU;RIPK2;TLR4;RIPK4;ROR1;RIPK3;CHUK;NFKB1;IRAK3;MTDH;NFKB2;MYD88;TRAF5;DDRGK1;CARD16;EP300;TNFSF11;TRADD;DHX9;PIDD1;IL18RAP;ZBTB7A;IKBKG
prerank,membrane raft organization (GO:0031579),0.44304332963736304,0.944900250121222,0.5033333333333333,0.9074794360623566,1.0,6/15,22.25%,ANXA2;S100A10;ABCA7;CLN3;NPC1;EMP2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3529754284813077,0.9443739132101784,0.5515923566878981,0.9080815886011647,1.0,9/65,8.97%,EGFR;PTPN3;ARAP1;RNF115;PTPN2;AGR2;CBLC;BCAR3;RNF126
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2519697466728765,-0.9443200901791129,0.5886075949367089,0.8303918007628308,1.0,15/109,10.48%,PLCB1;INPP4B;PIK3R1;PDGFRB;PIP5K1B;LPGAT1;INPP5D;PLEKHA2;PIK3C2A;PIK3R6;BMX;PLEK;PTPN13;INPP5F;MTMR10
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3424735283637581,0.9441364460604345,0.5457967377666249,0.9080471507613984,1.0,17/85,13.47%,USP13;PRICKLE1;GSK3B;RNF144A;RNF185;VCP;ARIH1;CLU;RNF19A;CSNK1A1;PSMC6;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E
prerank,glycogen catabolic process (GO:0005980),0.4503919040312149,0.943985554577962,0.5165354330708661,0.9078236333243326,1.0,4/15,9.98%,PYGB;PHKA2;PHKB;RB1CC1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.38454325386078647,0.9437183647157964,0.5492957746478874,0.9077972497221951,1.0,18/36,26.54%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;E2F1;E2F6;MGA;YAF2;PCGF6;RBBP4
prerank,synapse organization (GO:0050808),0.3289431758111335,0.9437092569261284,0.5730858468677494,0.9072454215208106,1.0,9/125,3.84%,CDH1;PCDHB16;GPC6;CTNND2;NEDD4;SEMA3E;UNC13B;CAST;PTPRF
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4476783169594868,0.9436663724860522,0.531502423263328,0.9067654844372625,1.0,7/15,22.79%,PLCG2;DDRGK1;CUL3;DYRK3;KLHL18;PAF1;ATAD5
prerank,second-messenger-mediated signaling (GO:0019932),-0.25248451440362946,-0.9435857375280444,0.5612244897959183,0.8309987399835956,1.0,13/82,8.69%,APOE;CCR9;NOS3;MCTP1;GUCY1B1;RYR2;NDNF;MCTP2;DGKD;GUCY1A1;CHRM3;SPHK1;EDN1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3304937642146949,0.9434651712112738,0.5551684088269454,0.9066236269377604,1.0,18/128,10.58%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;CEP63;AURKA;FBXW11;AKAP9;PPP1R12A;CEP131;FBXL6
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.44525492591402316,0.9428773424261032,0.5325732899022801,0.9073319533019564,1.0,3/14,9.89%,ANXA1;CD80;RARA
prerank,receptor metabolic process (GO:0043112),0.35836690119878034,0.9427299203431382,0.5333333333333333,0.907084956450687,1.0,7/53,6.25%,RAMP1;NEDD4;CD9;ITGB1;BECN1;LRP1;EHD3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3143938189300009,-0.9424869009427004,0.5396825396825397,0.8324824404498399,1.0,7/29,11.18%,WNT5A;SAMHD1;IFNAR2;HSP90AB1;NLRC5;USP18;RNASEL
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4726218547690173,0.9421527952320798,0.5547576301615799,0.9077855864521276,1.0,3/12,14.22%,HES1;JAG1;REST
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.34297912880989045,-0.9417958609428594,0.5386819484240688,0.8330364405869614,1.0,2/23,7.99%,IGF1;GAS6
prerank,positive regulation of cell projection organization (GO:0031346),0.3304233059169772,0.9414571651685103,0.5611764705882353,0.9087262481430557,1.0,17/115,9.06%,SLIT2;DPYSL3;NTRK3;NGF;PTK2B;CUX1;RAP1A;KIDINS220;TIAM2;FBXW8;P3H1;MARK2;STYXL1;FZD1;ARSB;ROR1;RHOA
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4404173375348471,0.9414225973075578,0.5098039215686274,0.908219209355586,1.0,4/14,15.00%,YBX3;MYD88;ANGEL2;MAPKAPK2
prerank,post-translational protein modification (GO:0043687),0.3074545145820529,0.9412432758641396,0.6127703398558187,0.9080451090254709,1.0,60/332,17.12%,FBXL7;BMP4;MSLN;FSTL1;PTP4A2;CCN1;FN1;GPC3;FBXO10;ZBTB16;IGFBP5;DCAF6;FBXO40;FBXW8;KLHL22;CCDC8;DNAJC3;HIF3A;PSMB2;FBXL20;ASB9;ASB16;KTN1;SOCS2;DCAF4;UBE2F;KLHL13;FBXW11;FEM1B;COMMD1;PSMC6;COPS7B;FBXO17;PRKCSH;TIMP1;ASB11;COPS5;SPSB2;CKAP4;LRRC41;COP1;FBXO4;RCN1;PSMD11;CUL3;BMP15;ERCC8;DCAF5;WDTC1;PSMD1;CCDC22;ASB1;ADAM10;MXRA8;CALU;CUL1;ASB14;NUCB1;PSMC1;PSMD7
prerank,Golgi to plasma membrane transport (GO:0006893),0.36844280899790893,0.9405064084565022,0.5459459459459459,0.9091112158163592,1.0,13/47,14.85%,STXBP6;EXOC4;KIF13A;ARL3;GOLPH3;NSF;EXOC5;RABEP1;COMMD1;GOPC;GOLGA7;GGA2;CCDC22
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.33923427517669025,-0.9404360144798433,0.546242774566474,0.8351082780235439,1.0,5/24,12.10%,LPGAT1;CDS2;GPAM;PNPLA8;PGS1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3093488185524398,-0.9404051591774528,0.5418181818181819,0.8340332151063954,1.0,10/39,17.23%,MYO1B;PPFIA2;FNBP1L;MYO6;MYO5A;BICDL1;ACTN4;KIF1A;MYO5C;MYO1F
prerank,regulation of neuroblast proliferation (GO:1902692),0.44648147402685656,0.9402223689299379,0.5398089171974523,0.9091407118240205,1.0,4/15,10.34%,KDM1A;DISC1;NF1;VEGFA
prerank,response to tumor necrosis factor (GO:0034612),0.3375511663906895,0.9400563962427332,0.56,0.9089189789039179,1.0,16/91,15.93%,PID1;TANK;ADAM9;AFF3;YBX3;NFE2L2;CHUK;ERBIN;CCL3;CCL1;ZC3H12A;TRADD;DHX9;ADAM10;ZFAND6;ACOD1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2682801399355986,-0.9399325124134954,0.609375,0.8340109607376277,1.0,10/75,9.65%,PLCB1;GPCPD1;PDGFRB;PLA1A;SERINC5;ENPP6;ABHD12;SERINC1;PLEK;ABHD3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3680077017255752,0.9397787736879541,0.5411140583554377,0.9083894784295987,1.0,16/50,23.65%,NUP93;EIF4G1;RANBP2;SEC13;NUP153;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,regulation of gene silencing by RNA (GO:0060966),0.3680077017255752,0.9397787736879541,0.5411140583554377,0.9083894784295987,1.0,16/50,23.65%,NUP93;EIF4G1;RANBP2;SEC13;NUP153;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,cell chemotaxis (GO:0060326),0.3551572839994809,0.939766957060078,0.5461847389558233,0.9078408156561092,1.0,7/60,6.03%,CCN3;PRKCD;PARVA;NRP1;AGTR1;DEFB130A;PIP5K1A
prerank,negative regulation of axonogenesis (GO:0050771),-0.3246566386135439,-0.9386784749972895,0.541795665634675,0.8358665444384473,1.0,9/27,13.00%,MAP2;DCC;ARHGDIA;MAG;RTN4;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,regulation of adaptive immune response (GO:0002819),-0.361723247591176,-0.9386516229950446,0.5437665782493368,0.8347898029985424,1.0,7/18,23.30%,AHR;ADCY7;IL6ST;SAMSN1;IRF7;TRIM27;PYCARD
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.330885997077123,-0.9385599073603293,0.56973293768546,0.8338599595551062,1.0,7/24,24.71%,DACH1;RPS3;BLM;ACVRL1;TERF2IP;H1-0;DFFA
prerank,positive regulation of TOR signaling (GO:0032008),0.38170482864958755,0.9384778959068278,0.5445816186556928,0.9100794728023288,1.0,9/40,12.79%,TELO2;KLHL22;CLEC16A;GOLPH3;RRAGB;MLST8;SIK3;SMCR8;SEC13
prerank,mRNA splice site selection (GO:0006376),0.4084277873548746,0.9381611533401393,0.5603576751117735,0.9101651936887655,1.0,5/30,7.38%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3
prerank,mRNA stabilization (GO:0048255),0.3721998087973275,0.9379313456076476,0.528169014084507,0.9100826801558446,1.0,16/40,24.60%,YBX3;GDNF;SYNCRIP;FUS;PABPC1;MYD88;ANGEL2;DHX9;MAPKAPK2;THRAP3;CIRBP;TENT5D;E2F1;TARDBP;TAF15;TENT5C
prerank,sister chromatid segregation (GO:0000819),0.39310414317547593,0.9378677701318024,0.5585185185185185,0.9096558234077563,1.0,8/31,19.88%,SMC4;KLHL22;RB1;SMC1A;KNSTRN;INO80;ZW10;RAN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3424988475482693,-0.9378392435974652,0.5317919075144508,0.834326075234243,1.0,7/22,8.95%,PLA2R1;SPRED1;RPS15;RPL37;RPS7;RPL23;RPS20
prerank,megakaryocyte differentiation (GO:0030219),-0.4132888253125977,-0.9376184646401116,0.5314685314685315,0.8337066687560505,1.0,5/11,19.90%,KIT;TAL1;MED1;SH2B3;CDKN2B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2841483838356502,-0.9375801822912221,0.5903614457831325,0.832655086218428,1.0,22/49,28.71%,BCL2;SGMS1;BCL2L1;DAPK2;NOC2L;BOK;BMF;NUPR1;RACK1;DDX3X;P4HB;DNM1L;NDUFA13;PLAUR;PMAIP1;PYCARD;CYLD;PINK1;BCL2L2;SRC;BCL2L11;SIAH1
prerank,cardiac myofibril assembly (GO:0055003),0.4394789260855949,0.9375278703417053,0.5458937198067633,0.909818502759131,1.0,3/15,5.92%,CSRP3;MEF2A;NEBL
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4670089556606321,0.9375095668883008,0.5337726523887973,0.909291009193981,1.0,4/11,22.06%,YBX3;RIPK3;BIRC3;FZD9
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4698296748429297,0.9374646902128032,0.5526315789473685,0.9088177102949656,1.0,4/12,27.60%,FDX1;STARD3NL;AKR1B1;STAR
prerank,negative regulation of neuron death (GO:1901215),0.33914136378925386,0.9374114088244878,0.5800240673886883,0.9083707857182634,1.0,10/93,6.04%,SIX1;NGF;PTK2B;TGFB3;GSK3B;CLCF1;EIF4G1;NFATC4;ISL1;GDNF
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.390902208693195,0.9372851915009334,0.519650655021834,0.9075153015022974,1.0,17/32,31.61%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,tRNA export from nucleus (GO:0006409),0.390902208693195,0.9372851915009334,0.519650655021834,0.9075153015022974,1.0,17/32,31.61%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,intraciliary retrograde transport (GO:0035721),0.4695729709133062,0.9370736608968392,0.5371621621621622,0.9074296964245427,1.0,8/12,31.03%,WDR35;DYNC2I2;DYNC2I1;DYNC2H1;TTC21A;IFT43;TTC21B;IFT122
prerank,brain development (GO:0007420),0.32136401640468715,0.9368752946682123,0.5750577367205543,0.9072856817725123,1.0,16/136,9.78%,SLC23A1;PBX3;ZFHX3;NFIB;ADGRL2;PBX1;ZIC1;TGFBR2;PAFAH1B1;DMBX1;SHROOM4;GRHL2;PAFAH1B2;EGR2;FBXW11;NF1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.42162354952054787,0.936577876321698,0.521259842519685,0.906242396924671,1.0,8/20,25.14%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.42162354952054787,0.936577876321698,0.521259842519685,0.906242396924671,1.0,8/20,25.14%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.42162354952054787,0.936577876321698,0.521259842519685,0.906242396924671,1.0,8/20,25.14%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.45743793581756004,0.9360859353242302,0.5734265734265734,0.9067120480662456,1.0,4/11,16.00%,DDX11;SMARCA4;MTOR;NOL11
prerank,cell cycle checkpoint signaling (GO:0000075),0.45432957027862225,0.9358168111136683,0.5375626043405676,0.906737517071405,1.0,6/12,21.61%,NABP1;CHFR;PRCC;ZWILCH;ZW10;WEE1
prerank,negative regulation of response to wounding (GO:1903035),0.42104177934043774,0.935720630298486,0.5401929260450161,0.9063804893294747,1.0,2/19,3.29%,CD109;FGF2
prerank,negative regulation of DNA replication (GO:0008156),0.4533731599364412,0.9356383567679524,0.5481239804241436,0.9059848476968089,1.0,4/13,17.95%,RAD17;WAPL;GTPBP4;ATR
prerank,negative regulation of cyclase activity (GO:0031280),-0.3868245446285902,-0.9354699861400008,0.5461741424802111,0.8366298262846219,1.0,2/14,2.14%,GRM3;ADGRV1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4306187438636294,0.9353900282409984,0.5424528301886793,0.9059633694862539,1.0,2/19,3.93%,THBS1;CMKLR1
prerank,protein localization to kinetochore (GO:0034501),0.44053922157559267,0.935284458072048,0.5316455696202531,0.9056336985914992,1.0,7/14,28.26%,CENPT;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,leukotriene biosynthetic process (GO:0019370),-0.3889206182205838,-0.935102203047789,0.5440806045340051,0.8363384041094538,1.0,7/14,26.39%,GGT5;LTA4H;GGT1;GGT7;PLA2G5;ALOX5AP;MGST3
prerank,positive regulation of protein deacetylation (GO:0090312),0.45622238862366543,0.9346818278047008,0.5546623794212219,0.9063486657384564,1.0,6/14,23.60%,ZBTB7B;NNMT;NIPBL;SAP30BP;AKAP8L;BRMS1
prerank,protein homooligomerization (GO:0051260),0.33063555123730815,0.9346728686678383,0.5742690058479533,0.9058052092015619,1.0,15/114,10.05%,KCNJ2;DISP1;ATL3;TMEM120A;SCARA5;ATL2;TRPM4;MPP2;PDCD6IP;EHD3;FUS;G3BP2;PRMT8;RBMX;EHD1
prerank,mitochondrial translational termination (GO:0070126),0.3362725580629814,0.9346157709609484,0.5662042875157629,0.905366461497739,1.0,36/88,30.78%,MRPL33;MRPL48;MRRF;MRPS27;MRPL14;MRPL32;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,negative regulation of bone mineralization (GO:0030502),0.4514400895817467,0.9339847553369411,0.5673400673400674,0.9061281137399562,1.0,3/13,10.91%,PTK2B;TRPM4;CCL3
prerank,DNA-dependent DNA replication (GO:0006261),0.3227430178242834,0.9334024313591287,0.5665137614678899,0.9068422916950191,1.0,43/128,28.48%,REV3L;PSMB2;MCM7;WRN;MCMBP;MCM2;PSMC6;CDC45;BAZ1A;PSMD11;PRIM2;POLG2;POLB;PSMD1;POLE2;DDX21;RPA1;GINS3;RECQL5;PSMC1;PSMD7;PRIM1;RAD51;TOPBP1;RFC1;PSMD14;HELB;PSMD3;POLA1;POLD3;NOC3L;CDK2;RFC5;PSMD12;ORC3;SRPK2;CDK2AP1;PSMD4;PSME3;PSMD2;MCM6;RECQL;PRIMPOL
prerank,positive regulation of phospholipase activity (GO:0010518),0.4101700767890014,0.9330250704994323,0.5425531914893617,0.9070694844401759,1.0,7/22,10.39%,NTRK3;FGFR1;FGF2;AGTR1;ESR1;GNA13;ARF4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3417172296062905,0.9330044003085766,0.5531914893617021,0.9065508131717389,1.0,5/73,4.92%,F3;NGF;EGLN3;CRADD;VCP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4301845639681171,0.9329668767199395,0.5356576862123613,0.9060696854554329,1.0,5/15,16.06%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4175813794078189,-0.9328517181229758,0.5536159600997507,0.8404401403147457,1.0,4/10,18.51%,LPGAT1;NR1H3;NR1H2;ABCD2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.32030967333637683,-0.9321777726718187,0.5472312703583062,0.8409285714854904,1.0,5/31,14.78%,PLCB1;MDK;TLR3;CCL19;CD40
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.3870006437892122,-0.9321660170572258,0.5558139534883721,0.8398118779337943,1.0,5/12,15.05%,PPARA;FUT9;MDK;ASS1;AKT1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.42091779506378596,0.9321619208192866,0.5363489499192245,0.907214575298267,1.0,6/21,15.41%,ADAM9;SPPL2A;BACE2;RBMX;ERAP1;ADAM10
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3721801709127365,0.9314034184555914,0.5585714285714286,0.908234766411187,1.0,16/38,21.60%,BMP6;POLR3D;PLSCR1;IFI35;USP15;PUM2;DHX9;TLR8;PRKCA;PUM1;ACOD1;ANKRD17;POLR3F;ADAM8;AKIRIN2;LY96
prerank,NIK/NF-kappaB signaling (GO:0038061),0.34675746244902056,0.9313797076732863,0.5792141951837769,0.9077325313717217,1.0,16/72,20.49%,CARD14;PSMB2;REL;CHUK;FBXW11;PSMC6;NFKB2;PSMD11;PSMD1;CUL1;PSMC1;PSMD7;TLR6;BIRC3;PSMD14;PSMD3
prerank,response to steroid hormone (GO:0048545),0.3898712698878081,0.9312324865792263,0.547925608011445,0.90751020490446,1.0,2/31,1.84%,THBS1;TGFB3
prerank,positive regulation of bone resorption (GO:0045780),-0.39611010613269015,-0.9310021553314703,0.5406698564593302,0.8414661380546133,1.0,4/11,13.71%,TNFRSF11A;SPP1;ATP6AP1;PLEKHM1
prerank,membrane depolarization during action potential (GO:0086010),0.40448092217041737,0.9305075278317273,0.5402635431918009,0.9084902786810759,1.0,3/26,3.27%,KCNJ2;CACNA1C;CACNA1G
prerank,reticulophagy (GO:0061709),0.45532752415831057,0.9304963497013938,0.5442834138486312,0.9079628161821461,1.0,6/12,22.15%,ULK2;RB1CC1;DDRGK1;UBA5;ATG2A;ULK1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34562394579437233,0.930275667356025,0.6005121638924455,0.9078389636170006,1.0,11/75,11.32%,BMP4;LRP6;PRKCD;ABL1;IPO7;CBLC;CDKN1B;NF1;IRAK3;LRP5;RB1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3462839433428656,-0.9300841274395268,0.547683923705722,0.8424818737992953,1.0,4/22,5.71%,LYN;MFHAS1;NR1H3;DAB2IP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.39327531015124634,0.930061452613958,0.5359765051395007,0.9077253937415829,1.0,5/27,10.12%,MARK1;GSK3B;NDEL1;DISC1;MBOAT1
prerank,positive regulation of response to external stimulus (GO:0032103),0.32139317295133313,0.9300124462878097,0.5606060606060606,0.9072607484982876,1.0,29/128,18.16%,THBS1;GPR4;THBD;BMP6;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;LRSAM1;USP15;IL33;CCL3;CCL1;PUM2;TRADD;TNIP1;DHX9;TLR8;PRKCA;PUM1;ACOD1;ANKRD17;ABCC1;NLRP12;POLR3F;ADAM8
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.34527494626113553,0.9298817185771507,0.5559796437659033,0.9069826055663235,1.0,18/69,22.99%,UBE4B;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;EDEM2;UFD1;TRIM25;ECPAS;FAF2;HERPUD1;FBXO27
prerank,positive regulation of hormone secretion (GO:0046887),-0.3627838622613603,-0.9297942765207673,0.541871921182266,0.8420319071283225,1.0,3/17,8.69%,C1QTNF3;SPP1;EDN1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.40823896911314095,0.9297192972344919,0.5501519756838906,0.9067825437025139,1.0,6/22,16.13%,IRF1;CD46;DUSP10;CBFB;KAT2A;BCL6
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.28313410148291623,-0.9296018595642133,0.5578947368421052,0.8413321983495854,1.0,11/44,20.37%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;ALOX12;SCP2;CH25H;SC5D;OSBPL7;SLC27A2
prerank,histone H4-K8 acetylation (GO:0043982),0.43949772417971095,0.929560662674429,0.5301587301587302,0.9059980732742527,1.0,8/15,26.12%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;MCRS1;JADE2;OGT
prerank,histone H4-K5 acetylation (GO:0043981),0.43949772417971095,0.929560662674429,0.5301587301587302,0.9059980732742527,1.0,8/15,26.12%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;MCRS1;JADE2;OGT
prerank,regulation of phospholipase C activity (GO:1900274),0.4465773822928842,0.9295173764849199,0.56,0.9055365257594212,1.0,5/15,5.80%,NTRK3;FGFR1;FGF2;ABL1;ESR1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4294603298601174,0.9294320574540471,0.5446153846153846,0.905158136532784,1.0,2/17,3.69%,ADAM9;FOXC2
prerank,receptor-mediated endocytosis (GO:0006898),0.31952932055360633,0.9289868405279836,0.5883014623172104,0.9055603008429453,1.0,21/132,10.29%,RAMP1;LRP6;NEDD4;PDLIM7;CD9;ADRB2;COLEC11;ITGB1;AP2A2;IGF2R;LDLR;GAK;CLTB;LRP1;HPX;AP4E1;GPR107;AP2A1;FCHO2;PI4KB;CTTN
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.41361566245092196,0.9287498484467717,0.5179407176287052,0.9055047844502377,1.0,3/20,2.43%,SEMA3E;SEMA3D;SEMA3C
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3139408285841874,0.9282045463063161,0.624731182795699,0.9060786936266545,1.0,23/190,11.11%,SLIT2;THBS1;CCN3;CIT;TANK;PHLPP2;NPRL3;ATP2B4;UBE2B;PDE10A;ESR1;DDIT3;IFI35;RORA;DRD3;PPEF2;NF1;MARK3;USP10;PPP2R5C;PRDM15;PER1;OTUD7B
prerank,icosanoid secretion (GO:0032309),0.4542369209179694,0.9279896181142253,0.5574043261231281,0.905992739051925,1.0,3/12,11.37%,ANXA1;DRD3;ABCC4
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4276684537567702,0.927670861385157,0.5373608903020668,0.9055554084994394,1.0,2/14,6.32%,ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),0.4276684537567702,0.927670861385157,0.5373608903020668,0.9055554084994394,1.0,2/14,6.32%,ABCG2;HMOX2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4594643934129433,0.9274872891199977,0.5339130434782609,0.9048411762098798,1.0,1/10,2.06%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4594643934129433,0.9274872891199977,0.5339130434782609,0.9048411762098798,1.0,1/10,2.06%,PRKCD
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3936836386003956,0.927369099685224,0.5601173020527859,0.9045235870642419,1.0,10/29,17.73%,ISL1;ESR1;STRN3;KANK2;CBFB;DDRGK1;KMT2D;UBA5;DNAAF4;CARM1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.40560495920693795,0.9266372331314754,0.5705329153605015,0.9054954895841546,1.0,4/24,3.98%,SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3331450227371649,0.9266170222416317,0.5743405275779376,0.9049893683377092,1.0,12/87,12.33%,RBFOX2;CD44;FGFR1;FGF2;SPRED2;SHOC2;FLRT2;HNRNPH1;KIF16B;ITGB1BP1;FGF22;NR4A1
prerank,plasma membrane invagination (GO:0099024),0.3886214813820081,0.9263936657768322,0.5364041604754829,0.9049395398507805,1.0,5/29,11.89%,GULP1;GSN;SNX18;RHOA;BIN2
prerank,copper ion transport (GO:0006825),-0.4014340495994709,-0.9260503986839678,0.5573770491803278,0.8485349785277502,1.0,7/11,22.02%,ATOX1;SLC31A1;STEAP3;ATP7A;COX17;STEAP2;STEAP4
prerank,negative regulation of TOR signaling (GO:0032007),-0.2982095792893001,-0.9259162876885914,0.5970695970695971,0.8476871722907839,1.0,12/36,23.09%,RNF152;PRKAA2;SPAAR;TNFAIP8L1;SH3BP4;GSK3A;TMEM127;DEPTOR;MINAR1;DDIT4;CASTOR1;SESN1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.29825194221742996,-0.9257974417808592,0.5682656826568265,0.8468032812305887,1.0,14/40,20.15%,UNC13C;RIMS1;RIMS2;SYT7;SNCA;SNAP25;SYT1;BLOC1S6;PIP5K1C;SYT10;RAB3A;SYT2;CPLX1;DOC2B
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.32595376888305483,-0.9250391503988512,0.56,0.847467605802369,1.0,6/24,13.42%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,metanephric mesenchyme development (GO:0072075),0.47151382183086843,0.9246794491194784,0.5672413793103448,0.9080169341920445,1.0,2/10,7.87%,SIX1;SIX4
prerank,zinc ion transmembrane transport (GO:0071577),-0.3287785061017213,-0.9245290576575397,0.5781710914454278,0.8476019855189919,1.0,7/22,17.41%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4111644170343038,0.9245056666373043,0.55,0.907849680389564,1.0,8/21,25.14%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,cellular response to nutrient levels (GO:0031669),0.34920131816704136,0.9244546548839837,0.5741935483870968,0.9073970933477171,1.0,13/62,12.91%,KCNB1;FAM107A;WIPI2;EIF4G1;KLF10;ZFYVE1;VPS41;CLEC16A;RRAGB;WRN;INHBB;USP33;MTOR
prerank,cellular response to leucine starvation (GO:1990253),0.46934859513030824,0.9242587883137219,0.554806070826307,0.9072503964463681,1.0,3/10,14.02%,RRAGB;MTOR;EIF2AK4
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4497119489680754,0.9241934782829814,0.5714285714285714,0.906845519475049,1.0,3/13,15.84%,PTGIS;NNMT;NUDT12
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3342100387206154,-0.9240256655389488,0.5295774647887324,0.8476287883793823,1.0,5/23,11.62%,PARP14;NR1H3;HSP90AB1;NLRC5;STAT1
prerank,regulation of oxidoreductase activity (GO:0051341),0.44337487798121383,0.923973792509173,0.5628227194492255,0.9067554619948528,1.0,3/13,23.78%,ABL1;SZT2;ECSIT
prerank,regulation of steroid metabolic process (GO:0019218),-0.32494334216552634,-0.9237959484671079,0.5918367346938775,0.8470647607336816,1.0,5/23,20.99%,APOE;ABCG1;NR1H4;ABCA2;RORC
prerank,regulation of hydrolase activity (GO:0051336),0.3403682179271984,0.9237804971693936,0.5732323232323232,0.906623128533964,1.0,17/71,11.77%,EFNA5;SIPA1L1;VAV2;ARHGAP44;PAFAH1B1;ADAP1;EPHB3;RDX;RAPGEF6;OCRL;FGD6;RAB3GAP2;WRN;FBXW11;NF1;ARHGEF5;ITGB1BP1
prerank,DNA methylation (GO:0006306),0.4095856586322677,0.9235709899326976,0.5632716049382716,0.9065040356379913,1.0,8/23,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,neuron apoptotic process (GO:0051402),-0.3513549946518581,-0.9234017483806896,0.5641025641025641,0.8468181162158069,1.0,5/19,7.55%,BCL2;TNFRSF21;APP;FAS;GAPDH
prerank,response to thyroid hormone (GO:0097066),-0.3955565441213897,-0.9232338973820656,0.5703517587939698,0.8460750004070106,1.0,6/13,14.44%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,vesicle organization (GO:0016050),-0.2843564874543009,-0.9229469447133557,0.6,0.8456489004087367,1.0,9/46,17.52%,SORT1;FNBP1L;SRGN;CD34;DNM1;AKTIP;EPS15;DNAJC13;EXOC8
prerank,negative regulation of protein depolymerization (GO:1901880),-0.328542342531072,-0.9227554276987395,0.5756676557863502,0.8450292798574582,1.0,3/24,4.67%,PLEKHH2;NAV3;CLASP2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3928883851759062,-0.9222647887800148,0.5745192307692307,0.8450898422055028,1.0,3/12,8.93%,APOE;PFDN5;PFDN2
prerank,negative regulation of defense response (GO:0031348),0.34042452361155506,0.9220357192351506,0.5854858548585485,0.9091996351226055,1.0,11/77,11.32%,CCN3;PRKCD;PTGIS;KLF4;PTPN2;TRAFD1;ISL1;IL10;RORA;IRAK3;RB1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.45939839161914237,0.921646695894901,0.551433389544688,0.9094611540464258,1.0,1/10,2.86%,ANO6
prerank,cranial nerve development (GO:0021545),-0.3928685936279295,-0.9213350549740514,0.5248756218905473,0.8461917403966299,1.0,2/11,4.30%,CHD7;SALL1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3584013955246863,-0.9212668744578493,0.5882352941176471,0.8452336548602022,1.0,2/15,3.43%,IL34;CSF1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4439495916604593,0.9212586332663805,0.5546075085324232,0.9096800764319994,1.0,2/13,1.19%,SOAT1;RAMP1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.38890203488997166,0.9208725447503706,0.5625942684766214,0.909985114903556,1.0,11/26,28.10%,SETD2;CTR9;KMT2D;SETD5;ETFBKMT;KMT5B;WDR82;METTL21C;OGT;KMT2A;SETD1B
prerank,mammary gland development (GO:0030879),-0.336624835671093,-0.9199664649945857,0.5854341736694678,0.847038755905589,1.0,4/21,6.08%,WNT4;TBX3;ERBB4;NOTCH4
prerank,regulation of intracellular signal transduction (GO:1902531),0.29694214636722743,0.9197977414999274,0.6851282051282052,0.911662945149595,1.0,98/420,18.56%,EGFR;RASSF2;MOB3B;NTRK3;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;EZR;AKAP13;ARHGDIB;VAV2;USP2;HIPK1;ARHGAP44;ARHGAP31;BCR;SRGAP2;SRGAP3;CMKLR1;TIAM2;TELO2;SMYD2;ARAP2;TRIO;ITGAV;PIP5K1A;RHOQ;GATA4;EXO1;DLG1;ARHGEF6;RRAGB;OCRL;ARHGAP17;EHMT1;STYXL1;CHEK2;PLK3;MDM4;RAD17;RHOA;STARD13;ITFG2;ARHGAP5;WRN;GNA13;AURKA;MLST8;PLCG2;ATM;VEGFA;MYO9A;PPP2R5C;USP7;ARHGEF5;TIAM1;TRAF5;SOS2;ARHGAP40;CASTOR2;MTOR;CHEK1;PAK2;EP300;CHD3;TNFSF11;DYRK2;PIDD1;SQSTM1;PML;ZFAND6;CPNE1;TAF12;RBBP8;NEK8;IKBKG;TMBIM4;RPA1;RMI2;TOP3A;NLRP12;TAF4;VRK2;BARD1;PAK4;PRKAR2A;AKAP12;NBN;TRIP10;KMT5A;EHMT2;ATR;RBBP7;CSNK2A2;CSNK2A1;TOPBP1
prerank,mitotic recombination (GO:0006312),0.44630176692684576,0.9197806664958531,0.587248322147651,0.9111508497899906,1.0,6/15,21.85%,SMC5;RAD52;RAD51;ERCC1;SMC6;RAD50
prerank,ncRNA transcription (GO:0098781),0.44855913323818153,0.9197612713326834,0.5691489361702128,0.9106480521064789,1.0,2/13,10.27%,POLR1G;SNAPC2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.40465094750074226,-0.919633257149701,0.5475113122171946,0.8467108306931892,1.0,3/10,5.75%,VTN;PRKCB;HIF1A
prerank,snRNA metabolic process (GO:0016073),0.4205377270798586,0.9191734903923606,0.5407166123778502,0.9113324256296162,1.0,10/17,32.88%,ZCCHC8;INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;MEPCE;INTS7
prerank,regulation of mitochondrial fusion (GO:0010635),0.45937103848315103,0.9187283281680998,0.5692567567567568,0.9116882272303799,1.0,4/11,22.24%,PID1;OMA1;HUWE1;BNIP3
prerank,T cell receptor signaling pathway (GO:0050852),-0.23174008567384458,-0.9181254960537316,0.6929824561403509,0.848993844838526,1.0,23/138,14.58%,PIK3R1;PDE4B;PAK1;FYB1;RFTN1;INPP5D;TEC;TNFRSF21;PRKCQ;PDE4D;PAG1;MOG;PAK3;BTRC;THEMIS;PSMB4;PSMB3;PLCG1;PSMB8;PSME2;ICOSLG;PSMB10;MALT1
prerank,regulation of interleukin-17 production (GO:0032660),-0.30778995058649705,-0.9180503844945067,0.6037735849056604,0.8480674370450464,1.0,5/31,8.16%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.44259138590893976,0.9179906194063499,0.551056338028169,0.9127005758613203,1.0,4/13,8.83%,FSTL1;NOG;NBL1;CD46
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4569298194881847,0.9178924305234493,0.5471698113207547,0.9123589499595894,1.0,4/11,10.91%,P2RX2;P2RX4;PLCG2;CCL3
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3917201804954977,-0.9178831647914762,0.5800970873786407,0.8473409134464455,1.0,3/12,13.55%,ACSL1;FADS2;SCP2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2916844204356994,-0.9177111296437721,0.6006493506493507,0.8466453289184732,1.0,4/34,8.56%,RBP4;WNT5A;SLC7A5;LACC1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4083960939837206,-0.9175080056486581,0.5596330275229358,0.8460083504578484,1.0,4/10,23.01%,ENPP2;PNPLA8;PLA2G7;PLA2G5
prerank,DNA packaging (GO:0006323),0.4281467709905189,0.9173749019768084,0.5499207606973059,0.9128916184413189,1.0,6/16,27.45%,CHAF1B;AIFM1;CHAF1A;RBBP4;HAT1;KAT6A
prerank,peptide metabolic process (GO:0006518),0.3368775614383595,0.917364839572908,0.5900243309002433,0.912369185043886,1.0,10/75,9.28%,PCSK5;NPEPPS;CPQ;DMD;MGAT3;IDE;MMACHC;GSR;NLN;BACE2
prerank,cellular iron ion homeostasis (GO:0006879),-0.2714988493902263,-0.9171232321641803,0.6408163265306123,0.8457724270869996,1.0,9/55,13.01%,CP;FTH1;TFRC;SLC40A1;FTL;ABCB7;SLC22A17;BOLA2;ATP6AP1
prerank,negative regulation of lyase activity (GO:0051350),-0.36531119772863846,-0.9169954159697435,0.587012987012987,0.8449791859742138,1.0,2/16,2.14%,GRM3;ADGRV1
prerank,regulation of platelet aggregation (GO:0090330),-0.3573548703125339,-0.9167775406673199,0.5669291338582677,0.8443661267497312,1.0,4/17,5.72%,LYN;PRKG1;F11R;PRKCQ
prerank,microtubule nucleation (GO:0007020),0.41929786196616176,0.916741666726804,0.5660964230171073,0.9131680690056856,1.0,7/19,20.18%,NDEL1;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4;CSNK1D
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.31054963950713155,-0.9164699778634464,0.6080246913580247,0.8440202844479261,1.0,5/33,5.56%,PRKG1;APOD;OGN;IGFBP3;MEF2C
prerank,regulation of fatty acid oxidation (GO:0046320),0.4251434017440725,0.916455556442513,0.5737179487179487,0.9132122090430218,1.0,2/16,4.29%,SOX9;NR4A3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3016368299513243,-0.9163729133135073,0.5913621262458472,0.8431519936340169,1.0,10/31,13.72%,SHANK3;PPFIA2;EPHA4;LRP8;CFL1;ABI3;CAMK2B;CUX2;NGEF;KIF1A
prerank,regulation of mRNA processing (GO:0050684),0.3806548817855766,0.9162055542167741,0.5782792665726375,0.9131662162010501,1.0,8/32,18.05%,SLTM;SON;RBM39;DHX9;CDK11B;JMJD6;SRPK1;KHDRBS1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34787400819464953,-0.9161158038171102,0.5664893617021277,0.842649188613282,1.0,7/18,25.55%,DCP2;RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2
prerank,cell proliferation in forebrain (GO:0021846),0.47163584056247754,0.9158316235295958,0.5695364238410596,0.913345344815264,1.0,2/10,6.12%,DOCK7;PCM1
prerank,actin-myosin filament sliding (GO:0033275),-0.29676206880085065,-0.9157453403153292,0.5986159169550173,0.8413138930986263,1.0,6/38,8.73%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,muscle filament sliding (GO:0030049),-0.29676206880085065,-0.9157453403153292,0.5986159169550173,0.8413138930986263,1.0,6/38,8.73%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.37509471443616993,-0.915348519745555,0.5697399527186762,0.8411557438307303,1.0,6/13,24.31%,OAS2;IL6ST;STAT1;CRLF1;OASL;JAK1
prerank,cellular senescence (GO:0090398),0.3959128711214084,0.9153286451162702,0.5676077265973254,0.9138422475193244,1.0,7/27,20.64%,PRKCD;ECRG4;ID2;SMC5;PML;CDKN1A;SMC6
prerank,spliceosomal complex assembly (GO:0000245),0.36710839012983093,0.9153062916561694,0.5776315789473684,0.9133445162993936,1.0,19/46,28.18%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3;SCAF11;GCFC2;SF3B1;SRPK1;DDX1;NOL3;RBM5;TXNL4A;LUC7L;CELF4;SRPK2;SNRNP200;PRPF6;KHDC4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.38998660822189923,0.9149594116384662,0.556732223903177,0.9135084471424625,1.0,11/29,27.33%,MNAT1;ERCC5;CHD1L;RAD23B;ERCC3;XPA;RPA1;CUL4A;ERCC2;XPC;GTF2H3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.37435104971527505,-0.9149226652354058,0.5674300254452926,0.8410528621389923,1.0,5/14,23.56%,BCL2L1;TMBIM6;SELENOS;XBP1;CREB3
prerank,negative regulation of blood coagulation (GO:0030195),0.3726189172203152,0.9148787545822251,0.5757142857142857,0.9131290001520623,1.0,2/38,2.98%,F3;THBD
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3261434047457487,0.9148146129598778,0.6004842615012107,0.9127309450114584,1.0,9/98,5.19%,THBS1;PID1;ANXA2;KLF4;INHBA;AGTR1;EIF4G1;TGFBR2;SFRP4
prerank,negative regulation of hydrolase activity (GO:0051346),-0.27767246273552515,-0.9147063884734532,0.5958333333333333,0.8404583437707086,1.0,10/49,12.54%,CPEB2;MAP2;F11R;LRCH1;CST3;DAB2IP;GMIP;CAMK2A;SH3BP4;EGLN1
prerank,histone H3-K36 demethylation (GO:0070544),-0.40750957271369825,-0.914686891479891,0.5319148936170213,0.8394359439853679,1.0,2/10,7.27%,KDM7A;KDM2B
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.35988239413224055,-0.9146369783440454,0.5733695652173914,0.8384541912414177,1.0,6/16,17.49%,ACE;ADM;PRCP;KLK2;GSK3A;GPR37L1
prerank,presynapse organization (GO:0099172),-0.40190405773631066,-0.9144762344820007,0.558252427184466,0.83774903309069,1.0,2/10,7.72%,WNT5A;LRRTM3
prerank,regulation of mitotic nuclear division (GO:0007088),-0.27211857198155054,-0.9138707636069446,0.6294820717131474,0.8381144928176772,1.0,9/55,9.16%,IGF1;TGFA;PDGFRB;INSR;BMP7;OBSL1;CDK5RAP2;EDN1;RGCC
prerank,steroid biosynthetic process (GO:0006694),-0.2664055333813249,-0.9135373720256116,0.626984126984127,0.8377642349091363,1.0,11/56,20.37%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;SCP2;CH25H;SC5D;SRD5A1;OSBPL7;SLC27A2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3445153278163533,0.9134328358112163,0.5961783439490446,0.9150098048624775,1.0,11/65,12.91%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;MDM4;RORA;HILPDA;VEGFA;CARD16;MTOR
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.36488644334887355,0.9134219774822939,0.5574866310160428,0.9144889083100338,1.0,6/41,10.86%,CYP1B1;MGLL;ACOT8;DAGLB;SCD;ELOVL5
prerank,protein targeting to lysosome (GO:0006622),0.4069249936757741,0.9130191306431757,0.5584415584415584,0.9147467989215524,1.0,2/20,6.20%,NEDD4;CLU
prerank,microtubule bundle formation (GO:0001578),0.3643386328113264,0.9128341366605082,0.5855614973262032,0.9145940627882844,1.0,8/42,12.36%,RP1;CLIP1;GAS2L2;TOGARAM1;CAPN6;CCDC40;CCDC66;CHP1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.42025005534113086,0.9127962405200964,0.5659509202453987,0.9141295044267228,1.0,2/18,4.54%,MET;CCDC125
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3786945336089992,-0.911867115013655,0.573170731707317,0.8405078964875009,1.0,2/13,3.90%,IGF1;INSR
prerank,positive regulation of cell growth (GO:0030307),0.3258650228193988,0.9118289848599386,0.6132530120481928,0.9155474333315071,1.0,7/96,5.51%,EGFR;NTN1;NGF;TGFBR1;EIF4G1;KLHL22;SHTN1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.34337283684269937,0.9116237396465982,0.5917312661498708,0.9154391889158107,1.0,9/64,11.31%,CYP1B1;MGLL;PNPLA3;ACSL3;SLC27A3;ACOT8;DAGLB;ELOVL5;HACL1
prerank,intracellular sterol transport (GO:0032366),-0.38211971798244915,-0.9115116425061415,0.559610705596107,0.8401625560700984,1.0,3/13,9.41%,ABCA1;ABCG1;NPC2
prerank,protein autoubiquitination (GO:0051865),0.34329300194002516,0.911240215806783,0.6075129533678757,0.9156902496131244,1.0,17/61,20.94%,WWP2;RNF115;RNF185;UBE2B;RNF141;UBE2D3;LRSAM1;RNF146;RNF122;CUL3;ERCC8;SH3RF3;BFAR;UHRF2;CNOT4;NFX1;RNF8
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.38631657260031643,-0.9105411136638104,0.5590361445783133,0.8413412073209903,1.0,2/12,3.90%,IGF1;INSR
prerank,microtubule-based transport (GO:0099111),0.43855903233598464,0.9105022444702344,0.5446735395189003,0.9166399870439206,1.0,4/12,14.78%,DYNC1I1;SPAG17;CCDC40;DNAAF4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.24638053837069873,-0.9104306408113819,0.6588235294117647,0.8405094296361068,1.0,34/87,28.23%,IMMP2L;NDUFB9;NDUFAF4;SLC25A33;NDUFA8;NDUFC1;UQCC2;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;COA3;PET100;NDUFA1;NDUFA3;SCO1;CHCHD4;COX18;NDUFS4;COX17;NDUFA11;NDUFA13;NDUFB7;COX20;FOXRED1;SDHAF3;NDUFA2;NDUFA6;COX19;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,COPII-coated vesicle budding (GO:0090114),0.3379218230710816,0.9103297717787288,0.5940721649484536,0.916448171294768,1.0,30/68,26.91%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A;TRAPPC6A;TRAPPC9;MIA3;AREG;TBC1D20;PEF1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4511963695075542,0.9100745329831603,0.5822147651006712,0.916431882469433,1.0,6/12,28.92%,MAVS;IFIH1;DHX9;COLEC12;RALB;ZCCHC3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4478245921883421,0.9097149891887641,0.5521885521885522,0.9166317100143772,1.0,3/13,10.00%,DDX5;SPRED2;ATM
prerank,mitochondrial translation (GO:0032543),0.32105330197394955,0.9094347183652396,0.6007194244604317,0.9166714600563557,1.0,40/104,30.78%,MRPL33;EARS2;MRPL48;MRRF;MRPS27;MTIF3;MRPL14;MRPL32;MRPL40;GFM2;MRPS31;MTRF1;NOA1;MRPL21;MRPL42;MRPS30;MTIF2;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4340329280256092,0.9091306224939075,0.584873949579832,0.9167623802396241,1.0,4/15,22.02%,USP46;ZDHHC12;CLN3;STXBP1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.30979618317093727,-0.9091236110214846,0.5894428152492669,0.8423313667046834,1.0,9/27,19.60%,SIRPA;C1QTNF3;SYT11;GAS6;CD200;ARRB1;SELENOS;TNFAIP3;CX3CL1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3181282023024134,-0.9088468635909147,0.608433734939759,0.8418551078672747,1.0,16/25,25.92%,RBPJ;DGKD;CCDC88A;AFAP1L2;HIP1R;RTN4;HIP1;CNOT9;AGT;AKT1;NUP62;GPER1;PLAUR;PDE6G;HAP1;DOK1
prerank,regulation of microglial cell activation (GO:1903978),-0.36010751944262187,-0.9085486045673704,0.5973684210526315,0.8414551240245985,1.0,6/15,20.32%,SYT11;GRN;SPHK1;TTBK1;CX3CL1;TREM2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.34813079950321535,-0.9084908208565997,0.592,0.8405290266330053,1.0,6/19,20.68%,DDO;ALDH7A1;ASPA;GOT2;AASS;GCDH
prerank,receptor internalization (GO:0031623),0.3590262388324262,0.9084582664659296,0.5863945578231292,0.9175966208778955,1.0,5/44,6.11%,RAMP1;NEDD4;CD9;ITGB1;LRP1
prerank,regulation of actin filament-based movement (GO:1903115),0.4521617249758217,0.9083944742812196,0.5676625659050967,0.9171917663584686,1.0,1/10,1.49%,ANK2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.40366315652926077,0.9083521202634574,0.568659127625202,0.9167435647299648,1.0,10/22,27.38%,GSK3B;CRY2;STYXL1;BOD1L1;MGAT5;PTPA;LGALS3;ROCK1;IKBKB;FKBP1B
prerank,regulation of establishment of protein localization (GO:0070201),-0.37178397912730965,-0.9081624385160568,0.6214285714285714,0.8401633250407391,1.0,4/13,20.32%,CORO2B;CEP120;CTSD;TREM2
prerank,regulation of GTPase activity (GO:0043087),0.3058832110566219,0.908129344665393,0.6414253897550112,0.9166572156762872,1.0,33/177,11.77%,ARAP1;EFNA5;WNK1;WNT11;SGSM2;SIPA1L1;MAPRE2;VAV2;ARHGAP44;ITGB1;GSK3B;SRGAP2;NDEL1;RAP1A;SNX18;BCAS3;ADAP1;EPHB3;RDX;RAPGEF6;OCRL;RGP1;BCAR3;FGD6;RAB3GAP2;S100A10;NF1;LIMS1;CCL3;ERBB2;ARHGEF5;CCL1;ITGB1BP1
prerank,regulation of cell-cell adhesion (GO:0022407),0.3625765379260518,0.9080636773723016,0.5768688293370945,0.9162493696689389,1.0,5/39,6.81%,CDH1;EFNA5;ADA;JAG1;EPHB3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3677697543957952,0.9078531868408951,0.5898491083676269,0.9161385009856745,1.0,7/39,13.68%,TCF7L2;ISL1;AACS;MCU;CAPN10;SELENOT;TNFSF11
prerank,positive regulation of MAPK cascade (GO:0043410),0.2973515797012387,0.9071980969242867,0.6610348468848997,0.9169155231741014,1.0,17/245,4.30%,BMPER;EGFR;TNFAIP8L3;NTRK3;ADRA1B;PDGFC;PTK2B;CD44;ADRB2;FGFR1;SHC1;MID1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.33272089514027237,-0.906892835592797,0.5739644970414202,0.8419508003365421,1.0,13/21,32.97%,SLC30A10;PPARA;ABCB7;SIRT5;ABCD2;MT3;MMP3;SLC18A2;PINK1;PAX2;PLIN5;SIRT2;PARK7
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3430444165789871,-0.9068366635598568,0.5871313672922251,0.8410287556337604,1.0,5/20,21.43%,NR2F2;MYOCD;HHEX;INCA1;CEBPA
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.32075161180033884,0.9063765059216806,0.6295857988165681,0.9180776029327467,1.0,17/107,11.42%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;SLC39A14;ATP2B4;STIM2;SLC10A7;CASR;TNNI3;DRD3;SLC30A9;CCL3;SLC39A13;CCL1;SLC8B1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.39215109178537144,-0.9056539884890759,0.5880952380952381,0.8425600459631128,1.0,1/11,3.89%,AHR
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3385638503682018,0.9053204936276489,0.595360824742268,0.9196264899812273,1.0,17/68,17.79%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;TLR4;IL33;PLCG2;MYD88;IFIH1;TLR1;DHX9;TLR8;TWIST1;BCL10;TLR6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33611487570925463,0.9051284676013188,0.5968992248062015,0.9194684428868286,1.0,21/76,20.97%,PRICKLE1;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;CSNK1A1;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;SMURF1;CSNK1E;CCDC22;RNF14;PIAS1;DVL1;CSNK1D;DET1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.44731551701504996,0.9048459545089589,0.5776614310645725,0.9195268523814735,1.0,5/12,20.94%,TCERG1;NELFE;RNF168;RECQL5;RNF8
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.335795223126459,-0.9043038926934841,0.58311345646438,0.8445216505012425,1.0,12/21,36.92%,PAG1;SAMSN1;DUSP3;JAK3;TNFAIP3;LAPTM5;FOXJ1;LST1;FCGR2B;FGL1;TNFAIP8L2;IL4I1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.33629576266492733,0.904267556155188,0.6035578144853876,0.9201434176946997,1.0,7/67,4.26%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.42879409826901965,0.9041052387028716,0.5667752442996743,0.9199320972063865,1.0,4/16,5.27%,ANK2;CACNA1C;CAMK2D;DMD
prerank,anterograde axonal transport (GO:0008089),0.36387788036949814,0.903393775831372,0.5706134094151213,0.9208301207084998,1.0,9/37,18.89%,AP3B1;KIF1B;DLG2;KIF1C;KIF3B;RAB27B;AP3D1;RAB21;AP3S1
prerank,mitotic spindle organization (GO:0007052),0.31037591739128273,0.9033439876765936,0.654627539503386,0.9203811211189866,1.0,57/153,28.16%,NDEL1;CLIP1;VCP;TBCE;PAFAH1B1;XPO1;MISP;CHEK2;TOGARAM1;ARHGEF10;DYNC1I1;RHOA;SPICE1;AURKA;RANBP2;SMC1A;SEC13;PIBF1;DCTN6;STIL;RMDN1;AHCTF1;STAG2;CENPT;KIF3B;MAD2L1;NEK9;DYNC1LI2;SPDL1;ZWILCH;NEK6;CENPQ;ZW10;RAN;STAG1;NUP98;PTPA;OFD1;FLNA;SUN2;GPSM2;AAAS;KIF2C;CCNB1;CDC20;SKA2;BUB3;TTK;MECP2;CENPU;PCNT;SPC24;WDR62;KIF18A;CEP192;CENPK;CENPC
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.22418366143873508,-0.903193438828128,0.7731958762886598,0.8458970413080529,1.0,37/158,17.19%,TNFRSF19;PRKD1;WLS;LPAR1;TFRC;PELI2;NOD1;PRKCB;TRIM14;LGALS1;GJA1;ATP2C1;BST2;CXXC5;GPRC5B;TNFSF10;TRIM62;GAPDH;LITAF;ZDHHC17;CFLAR;TNIP2;TMED4;SLC44A2;CCL19;NDFIP2;EDAR;CD74;LURAP1;MALT1;TRIM21;CD40;TNFRSF1A;PLK2;CASP1;TIFA;TSPAN6
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.448348487035877,0.901948316155562,0.5844594594594594,0.9226689327514966,1.0,2/10,10.19%,ESR1;PSMC6
prerank,arachidonic acid secretion (GO:0050482),0.4518741489961621,0.901477294515822,0.581081081081081,0.9225353874531428,1.0,2/10,9.48%,ANXA1;DRD3
prerank,arachidonate transport (GO:1903963),0.4518741489961621,0.901477294515822,0.581081081081081,0.9225353874531428,1.0,2/10,9.48%,ANXA1;DRD3
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3637072749537206,-0.9013363870421923,0.6124031007751938,0.8490407846743937,1.0,3/14,15.03%,CSF1;ATP6AP1;TYROBP
prerank,regulated exocytosis (GO:0045055),0.3059905681070001,0.9013158854212074,0.6371584699453552,0.9223101470796046,1.0,23/173,11.37%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;DNAJC5;CLTRN;SYT8;ARHGAP17;PDGFA;SERPING1;GTPBP2;PCLO;VEGFA;ITGB3;TIMP1;ABCC4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.4501756373430335,0.9006987529523075,0.5834738617200674,0.923027684345853,1.0,5/11,20.06%,STAT3;PUM2;DHX9;PUM1;FMR1
prerank,regulation of response to external stimulus (GO:0032101),0.31542956658125837,0.9005009976481975,0.6316397228637414,0.9229102279735469,1.0,13/121,9.57%,FOXP1;CD55;MGLL;ANXA1;PIK3AP1;AGTR1;PDE6A;CELF1;IRF1;DAGLB;P2RX4;SHPK;NLRP6
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4208205941398132,0.9003205309299039,0.5758039816232772,0.9227309091939098,1.0,3/16,15.80%,RAET1E;PLEKHM2;LYST
prerank,positive regulation of stem cell proliferation (GO:2000648),0.420416528131789,0.9002249939111201,0.5796875,0.9223713242129727,1.0,2/17,6.08%,LTBP3;KDM1A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4375280073817341,0.90015789520783,0.568259385665529,0.9219814937728411,1.0,5/13,20.94%,TCERG1;NELFE;RNF168;RECQL5;RNF8
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41789369676318544,0.899887695434141,0.575,0.9219935058664381,1.0,4/15,8.86%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.318673087304118,0.8998775771174748,0.6298932384341637,0.9214800356142777,1.0,25/113,17.95%,TRABD2B;MPP7;GSK3B;UNC13B;EIF4G1;VCP;ESR1;CLU;CLTRN;TLR4;ERCC5;CHD1L;ATM;PSMC6;VEGFA;MYD88;SPIDR;IL5;SH3GLB1;ERCC3;XPA;RPA1;TLR6;ERCC1;ATR
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4424896802659448,0.8997499812908232,0.5886402753872634,0.9211976323069829,1.0,3/12,14.53%,ERLIN1;PIBF1;WDTC1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4085106669844961,-0.8991981590722793,0.6070588235294118,0.8526010517022622,1.0,5/10,23.96%,ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5MC3
prerank,heart contraction (GO:0060047),0.36528952410386395,0.8989866142011944,0.5994475138121547,0.9222004130443137,1.0,4/41,5.27%,SGCD;ATP1B1;CSRP3;DMD
prerank,glycogen metabolic process (GO:0005977),0.3841100458690115,0.8988765416454779,0.5908419497784343,0.9218741567376224,1.0,5/27,8.72%,PYGB;PPP1R3C;GSK3B;PHKA2;PHKB
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3550628236834429,0.8986813673894165,0.5865384615384616,0.9217525866139414,1.0,16/45,26.48%,FOXO3;GCNT2;ZC3H7A;ATXN2;PER1;PUM2;TDRD7;PUM1;PUM3;LARP4;MATR3;RBM3;NUDT21;CYFIP1;RBM4B;MEX3D
prerank,positive regulation of innate immune response (GO:0045089),0.3811839020592903,0.8986388738841278,0.5833333333333334,0.9212988232089203,1.0,11/30,20.33%,LBP;MAVS;POLR3D;PLSCR1;IFI35;DHX9;TLR8;UBE2K;POLR3F;ADAM8;AKIRIN2
prerank,organonitrogen compound catabolic process (GO:1901565),0.33777017811766147,0.8985006407644709,0.6005256241787122,0.9210346954701449,1.0,10/57,12.91%,NPEPPS;CPQ;PDXDC1;PLA2G15;IDE;LRSAM1;GADL1;ERAP1;RENBP;MTOR
prerank,tRNA modification (GO:0006400),0.33416258967710427,0.8982973182229508,0.5788113695090439,0.9209215960026653,1.0,24/62,30.94%,TYW5;ELP5;MTO1;TYW1;ALKBH8;TRMT13;PUS10;METTL6;CTU2;TRMT10A;TARBP1;TRDMT1;MOCS3;METTL1;SSB;PUSL1;QTRT1;THADA;GTPBP3;PUS7;THUMPD2;URM1;TRMT12;FTSJ1
prerank,protein homotrimerization (GO:0070207),0.4291153062026234,0.8980767690709026,0.5844370860927153,0.920271023954105,1.0,2/14,3.77%,DISP1;SCARA5
prerank,protein trimerization (GO:0070206),0.4291153062026234,0.8980767690709026,0.5844370860927153,0.920271023954105,1.0,2/14,3.77%,DISP1;SCARA5
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4504768682649275,0.8980203541619408,0.6233552631578947,0.9198552465934208,1.0,3/12,11.54%,STX11;SNAP23;STX19
prerank,adherens junction organization (GO:0034332),0.3496228672465274,0.8978394047893313,0.5913978494623656,0.9196971389121098,1.0,7/48,8.83%,CDH1;CDH11;NECTIN3;CTNNA1;VCL;JUP;PVR
prerank,negative regulation of macroautophagy (GO:0016242),0.3816164733388836,0.8976995317604667,0.5650887573964497,0.919455122772739,1.0,13/26,26.48%,CLEC16A;TMEM39A;SMCR8;MTOR;SMG1;SEC22B;NRBP2;USP36;RUBCN;LZTS1;CHMP4A;CHMP4B;PHF23
prerank,negative regulation of response to external stimulus (GO:0032102),0.3192331242198025,0.8976645900224928,0.6450471698113207,0.918995829286746,1.0,13/105,9.96%,CCN3;CD109;PRKCD;PTGIS;KLF4;FGF2;PTPN2;TRAFD1;ISL1;IL10;RORA;DRD3;IRAK3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4159439300444624,0.8969404872622295,0.5728314238952537,0.9198970486428689,1.0,2/17,3.79%,NFE2L2;VNN1
prerank,cellular protein catabolic process (GO:0044257),-0.25970863775259556,-0.8965129948484755,0.6512605042016807,0.8575780910527981,1.0,12/59,14.58%,CTSC;CTSH;ADAMTS12;DAB2IP;CTSB;CTSZ;CTSS;LGMN;CTSL;MYLIP;AFG1L;MALT1
prerank,myelin assembly (GO:0032288),0.4549524832616365,0.8964852263677127,0.5742397137745975,0.9202774843127569,1.0,2/10,3.78%,CD9;PMP22
prerank,regulation of gene silencing by miRNA (GO:0060964),0.33870342435053835,0.8958933194667543,0.6042983565107459,0.9209323805021196,1.0,19/62,23.65%,NUP93;EIF4G1;STAT3;RANBP2;SEC13;NUP153;PUM2;DHX9;PUM1;NUP214;AGO2;NUP188;NUP88;PPARG;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,embryonic heart tube development (GO:0035050),0.4284616780488962,0.8953939188700285,0.58125,0.9213278412753707,1.0,4/14,11.10%,HES1;PITX2;ACVR1;MEGF8
prerank,T cell homeostasis (GO:0043029),0.4537856697543411,0.895349118622672,0.5793103448275863,0.920886620911895,1.0,2/10,9.09%,PPP2R3C;RIPK3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4421300400665211,0.8949797519034549,0.580226904376013,0.921129592254998,1.0,3/11,14.22%,NR4A3;IL10;REST
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.39318028830784313,-0.8944176294731687,0.5969162995594713,0.8612147443231504,1.0,3/10,19.98%,RAPGEF3;PIH1D1;SPHK2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.42718013873817684,0.8941585300227657,0.5877483443708609,0.9222728558256207,1.0,4/14,25.95%,FUS;MRNIP;WDR48;RAD51AP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.3740808660987074,0.894023056449281,0.584070796460177,0.9219997597370706,1.0,7/28,12.36%,KCNB1;DMTN;C2CD5;ERBB2;MIEF1;ITGB1BP1;CHP1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3321143253233442,-0.8937751744222963,0.6380697050938338,0.861605227139653,1.0,7/18,24.31%,ST18;IL6R;IL6ST;STAT1;SPI1;CEBPA;JAK1
prerank,mitotic cell cycle phase transition (GO:0044772),0.29908203275117645,0.893715799995494,0.6659505907626209,0.9220969913116395,1.0,55/203,23.09%,FBXL7;CCNA2;INHBA;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;E2F3;CDC25B;CDC16;PPP2R2D;CEP164;CHEK2;PLK3;CDKN1B;CEP63;AURKA;FBXW11;ACVR1;PIM2;AKAP9;PPP1R12A;GSPT1;CEP131;FBXL6;RB1;CDKN3;CSNK1E;CUL3;UBE2S;CCND1;SDCCAG8;HINFP;CEP43;HAUS2;CUL1;CEP57;CDKN1A;KHDRBS1;CEP70;FBXL8;PPP6C;CSNK1D;ARPP19;E2F1;OFD1;CCNG1;WEE1;CUL4A;PLK4;FBXL17;CDK2;CCNB1;HAUS5
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4026110258985522,-0.8936069004601466,0.6057692307692307,0.8608674455185181,1.0,3/10,6.54%,APOE;ABCA1;PRKACB
prerank,response to light stimulus (GO:0009416),0.3440991801286707,0.8934316793513781,0.6067708333333334,0.9221342556482209,1.0,11/55,20.11%,UBE4B;CRY2;UBE2B;ERCC5;USP1;UVSSA;ERCC8;ERCC3;CIRBP;REV1;MAPK8
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3785637038182333,-0.8932125721992702,0.6009501187648456,0.8606408605510371,1.0,6/12,24.84%,MAOA;DDC;SMS;ATP7A;SLC22A3;SLC29A4
prerank,mitotic chromosome condensation (GO:0007076),0.3782235910626024,0.8931642770449171,0.610410094637224,0.9221341628056855,1.0,11/26,29.52%,SMC4;RB1;NCAPH2;KMT5A;CSNK2A2;CSNK2A1;CCNB1;AKAP8L;MCPH1;NCAPD3;SMC2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3044045379041272,-0.8928101109413735,0.634375,0.8604401615083105,1.0,12/29,36.92%,DDO;ALDH4A1;SARDH;CBS;GOT2;HSD17B10;ACADSB;DAO;THNSL2;AADAT;GSTZ1;IL4I1
prerank,regulation of cation channel activity (GO:2001257),0.3188882355022225,0.8922652137271042,0.616421568627451,0.9233996725519066,1.0,10/89,6.71%,ANK2;PTK2B;CAMK2D;AHNAK;SLMAP;ITGB1;FGF13;DLG2;DMD;DLG1
prerank,regulation of embryonic development (GO:0045995),-0.29446463737463374,-0.8922294049072415,0.6338983050847458,0.8605986111904733,1.0,10/34,16.18%,PLCB1;INSR;CLASP2;SOX17;CFL1;DAG1;NR2C2;WDPCP;RBM19;RPS6KA6
prerank,T cell activation involved in immune response (GO:0002286),-0.38237138423252437,-0.8921240791059231,0.6094527363184079,0.859753239725669,1.0,3/12,14.81%,MDK;CD74;LCP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3803388097003812,0.8920497901673404,0.5972644376899696,0.9232923658584647,1.0,4/27,9.06%,NFAT5;CD44;NR4A3;RHOA
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3298468795092964,0.8917932209603303,0.6116015132408575,0.9232620481275834,1.0,13/66,17.79%,FOXP1;ISL1;STAT3;RIPK2;TLR4;CCL3;MYD88;ZC3H12A;CARD16;TLR8;TRIM16;NLRP12;TLR6
prerank,mRNA processing (GO:0006397),0.29502796846310286,0.8914487148982746,0.7200832466181062,0.9234391860543253,1.0,97/287,27.50%,RNMT;DDX5;SON;SNRNP48;RBM6;SRSF11;MNAT1;THOC2;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;CELF1;FUS;USP49;RBMX;U2AF2;TCERG1;PABPC1;DDX42;ZCCHC8;SNRNP70;SCAF11;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;KIN;CHTOP;SF3B1;SF3B2;ERCC3;RNPC3;PRCC;U2AF1L4;RBM14;ESS2;ZC3H11A;LSM8;LSM2;SNRNP35;WBP4;THOC5;SNRNP40;SRSF2;SNW1;PNN;TRA2B;PRPF18;DBR1;ALKBH5;SRSF12;ZCRB1;RNGTT;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;AKAP8L;LSM4;NUDT21;CDC40;SUGP1;ERCC2;CSTF1;DHX8;PPIL1;RSRC1;CHERP;CPSF7;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;PRKACA;GTF2H3;SRSF7;CPSF4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.38692310524392093,0.891271088793001,0.6061493411420205,0.92325703336768,1.0,7/24,17.87%,PID1;MRAP;RHOQ;DMTN;ITGB1BP1;PPFIA1;LZTFL1
prerank,regulation of programmed cell death (GO:0043067),0.3047133641440778,0.8911666093593451,0.6699239956568946,0.9229340137863729,1.0,21/161,11.90%,ACER3;PERP;SOX9;NDRG1;FBXO10;CRADD;ABL1;CASP6;VCP;CREBBP;CLU;GAS1;KANK2;RIPK3;WRN;RBM25;RARG;ATM;APEX1;DDX42;HTATIP2
prerank,establishment of mitotic spindle localization (GO:0040001),0.37799547447464743,0.8910983154958322,0.5962732919254659,0.9225606278167509,1.0,5/28,9.48%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11
prerank,positive regulation of cilium assembly (GO:0045724),-0.33496263684126376,-0.8910410606464526,0.615606936416185,0.8609957423957894,1.0,3/18,6.87%,CEP120;CCDC88A;TAPT1
prerank,oligosaccharide metabolic process (GO:0009311),0.35469531872864174,0.8907272300705668,0.638700947225981,0.9227318657059653,1.0,2/46,1.56%,ST3GAL4;FUT8
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.33073907137664194,0.8904882634776516,0.6378446115288221,0.922693720602036,1.0,13/70,11.32%,TMEFF2;FN1;PARVA;SRGAP2;NRP1;ANTXR1;ITGAV;EPHB3;GRHL2;RHOA;RAB25;ITGB3;RB1
prerank,axonogenesis (GO:0007409),0.29525908493445496,0.8902907365976654,0.7025316455696202,0.9225637461811003,1.0,29/237,9.36%,SLIT3;SLIT2;EZR;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;ULK2;PDLIM7;GRB10;SPTAN1;SHC1;NOTCH2;DOCK7;GAB2;KLF7;NRP1;SHTN1;ISL1;GDNF;PTPRA;EPHB3;EMB;SPG11;MAP1B;GLI2;NIBAN2;PARD3
prerank,bone development (GO:0060348),0.36252820848908157,0.8901537609399301,0.6031073446327684,0.9222850054618582,1.0,7/39,7.51%,LRP6;AKAP13;SULF1;SFRP4;SKI;SLC10A7;P3H1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3915513228664395,0.890025770874145,0.578538102643857,0.9220165817103372,1.0,3/22,7.16%,CYP1B1;HES1;IL10
prerank,ribosomal small subunit assembly (GO:0000028),-0.35149092548371474,-0.8899233604272779,0.6197916666666666,0.8624161093719078,1.0,5/16,7.26%,RPS14;RPS19;RPS5;RPS15;RPS27
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3034391588974196,0.8898416317437652,0.6659142212189616,0.9218466460770451,1.0,22/161,10.41%,TCF7L2;SOX9;MLLT3;LRP6;PTPRU;WNT11;GLI3;PRICKLE1;GSK3B;SFRP4;TLE2;NOG;TLE6;INVS;DDIT3;PSMB2;CSNK1A1;DACT1;DKK3;IGFBP6;PSMC6;EMD
prerank,cardiac muscle cell differentiation (GO:0055007),0.38990780739766834,0.8897694417854245,0.6013179571663921,0.9214471550272787,1.0,4/21,10.34%,AKAP13;CXADR;ACVR1;VEGFA
prerank,pre-miRNA processing (GO:0031054),-0.35832096317260176,-0.8893293460177699,0.5847665847665847,0.8626513924152983,1.0,5/14,17.95%,LIN28B;AGO4;TARBP2;ADAR;AGO1
prerank,long-chain fatty acid transport (GO:0015909),-0.2993170561033347,-0.8892533324339172,0.6197604790419161,0.8617379788519991,1.0,7/30,10.64%,ACSL1;APOE;PRKAG2;ACACB;PRKAA2;FABP5;MFSD2A
prerank,establishment of protein localization to organelle (GO:0072594),0.33141856389741026,0.88915322338208,0.6370558375634517,0.9221762399056418,1.0,18/72,20.35%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;TNPO2;LRSAM1;ZDHHC15;SEC13;NUP153;NUP214;NUP188;NUP88;TSPAN17;NUTF2;RAN;TNPO3;HEATR3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3905621194531506,0.8888304943432827,0.5852895148669797,0.922291748435152,1.0,3/21,4.96%,SOX9;PTK2B;TRPM4
prerank,positive regulation of heart rate (GO:0010460),0.40839546851493586,0.8887043407252169,0.608346709470305,0.9220111757933683,1.0,2/17,4.96%,ADRA1B;TRPM4
prerank,negative regulation of translational initiation (GO:0045947),0.4404478109759589,0.8879150499139739,0.5924092409240924,0.923052939616802,1.0,7/13,26.51%,PAIP2;EIF3E;EIF2AK4;AGO2;FMR1;RBM4;EIF2AK1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3231128285388202,0.8877495511929568,0.6272838002436053,0.9228367060779828,1.0,11/85,12.18%,PIEZO2;ATP6V0A4;COL11A1;TBL1X;P2RX2;P2RX4;ROR1;CDC14A;SLC52A3;HOMER2;NIPBL
prerank,protein ADP-ribosylation (GO:0006471),-0.31124511380853415,-0.8875807381095844,0.6212121212121212,0.8643764436054504,1.0,9/28,22.12%,PARP14;ART3;PARP16;PARP8;TIPARP;PARP11;SIRT5;PARP10;HPF1
prerank,regulation of superoxide anion generation (GO:0032928),0.42542819697142364,0.8875384778407867,0.5894568690095847,0.9227606750109455,1.0,2/14,12.04%,PRKCD;AATF
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.45411727237084687,0.8874148228778889,0.5852459016393443,0.9224693514190859,1.0,6/10,27.54%,TLR4;MYD88;TLR6;MIA3;CD36;TICAM1
prerank,cellular glucan metabolic process (GO:0006073),0.43912800552406883,0.886701053101249,0.622673434856176,0.9233207388113216,1.0,3/11,8.72%,PPP1R3C;GSK3B;PHKB
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.313548694149092,0.8864949287263643,0.6424314660309892,0.922657231195479,1.0,22/104,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,cellular response to lectin (GO:1990858),0.313548694149092,0.8864949287263643,0.6424314660309892,0.922657231195479,1.0,22/104,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,regulation of viral genome replication (GO:0045069),-0.26434649267139754,-0.8857715874486917,0.7104072398190046,0.8672009828988115,1.0,19/56,21.26%,PPARA;PPIA;IFITM1;BST2;IFITM3;OAS2;PROX1;HACD3;RNASEL;NR5A2;ADARB1;TARBP2;IFIT1;ADAR;DDX3X;PPIE;OASL;PARP10;BANF1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.28204118082272334,-0.8856279048155322,0.6529850746268657,0.8664663083579148,1.0,7/37,8.16%,CEMIP;PRKAG2;BMP7;CALM1;APP;SPRED1;SPHK1
prerank,regulation of gastrulation (GO:0010470),-0.36151085243731546,-0.8848161971517223,0.5947242206235012,0.8671237187140697,1.0,6/14,18.30%,TENM4;CLASP2;OSR1;DAG1;RACK1;LHX1
prerank,lipoprotein catabolic process (GO:0042159),-0.3865867333475647,-0.884678053820755,0.6030150753768844,0.8663478022245303,1.0,4/11,17.42%,APOE;NOTUM;CTSD;ABHD17C
prerank,positive regulation by host of viral transcription (GO:0043923),-0.35419796598761377,-0.884055716379242,0.6134663341645885,0.8666397348270434,1.0,1/15,0.45%,LEF1
prerank,ceramide metabolic process (GO:0006672),0.3424579231881596,0.8839190713741597,0.6511936339522546,0.9271952874115421,1.0,5/49,6.16%,ACER3;PLPP3;SGMS2;SPTSSB;PLA2G15
prerank,ribosomal subunit export from nucleus (GO:0000054),0.42535339436923153,0.8839075203800011,0.5882352941176471,0.9266968522420785,1.0,6/13,19.88%,XPO1;LTV1;EIF6;NUP88;ABCE1;RAN
prerank,regulation of biosynthetic process (GO:0009889),-0.3908591733889544,-0.8838101594241957,0.6112469437652812,0.8661211490601818,1.0,6/11,35.33%,SNCA;SLC25A33;SPHK2;MID1IP1;GSTP1;CCN6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.31219458839556424,0.8833716912410967,0.6397146254458977,0.9272220694423468,1.0,22/105,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,regulation of mitochondrion organization (GO:0010821),0.346316682023101,0.8832837595316632,0.6286107290233838,0.9268722525315339,1.0,13/47,22.60%,PID1;GSK3B;GOLPH3;EP300;OMA1;PLSCR3;PRMT6;SQSTM1;SREBF1;CSNK2A2;USP36;PARL;RHOT1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.37956855590031646,0.8831423343088245,0.6047197640117994,0.9266323643289173,1.0,6/26,11.72%,MET;CLIP1;TOGARAM1;AKAP9;KATNB1;SLAIN2
prerank,tRNA methylation (GO:0030488),0.3581962779613129,0.8831180621732326,0.5800865800865801,0.9261691400779989,1.0,18/34,33.56%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;DALRD3;TRDMT1;METTL1;TRMT1L;THADA;GTPBP3;THUMPD2;TRMT12;FTSJ1;METTL2B;METTL2A;TRMT44
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4447788008529394,0.883110288864455,0.587521663778163,0.9256598779462841,1.0,3/11,9.28%,SOAT1;ITM2C;BACE2
prerank,purine ribonucleotide transport (GO:0015868),0.40765227778937513,0.8830698984868809,0.5996784565916399,0.9252140061892438,1.0,1/16,1.31%,LRRC8D
prerank,activation of adenylate cyclase activity (GO:0007190),0.3608409713781111,0.8825256850264803,0.6109510086455331,0.9257650281155135,1.0,3/35,4.22%,EDNRA;ADRB2;ADCY9
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3412424578472877,-0.8819216332511157,0.599476439790576,0.8690675754431806,1.0,5/16,24.07%,CLDN5;CLDN1;CLDN10;CLDN18;CLDN14
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.37340716512419375,0.8817431863863621,0.6101694915254238,0.9267738411586359,1.0,3/27,1.94%,PDGFC;DDR2;FN1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.30528603600586923,-0.8815271998706011,0.6486486486486487,0.8688014964731777,1.0,6/26,13.42%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,cytokine-mediated signaling pathway (GO:0019221),0.28204828677732313,0.8814273070774661,0.7823886639676113,0.9268779935960968,1.0,67/532,12.63%,F3;TNFRSF11B;CARD14;EDA;PTK2B;LBP;CAMK2D;TRAF3IP2;FN1;ANXA1;ANXA2;PRKCD;IL17RE;IL22RA1;FOXO3;CD44;GRB10;PITPNA;SHC1;MID1;ITGB1;FGF2;GAB2;IRS1;IP6K2;CLCF1;PDCD4;TAB3;CD80;IL17RA;IRAK4;STAT3;RIPK2;PSMB2;MAP3K3;IFI35;IL10;IRF1;SOCS2;CDKN1B;CXCL2;FOXC1;RORA;TNFRSF13B;CHUK;CTF1;NFKB1;FBXW11;IL33;IRAK3;LIMS1;IL18BP;PSMC6;CDIP1;VEGFA;IL20RB;TRIM26;CCL3;CAPZA1;TIMP1;CCL1;MYD88;TRAF5;IL5;TNFRSF1B;CSK;SMARCA4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.3614246541496223,-0.8807884956547867,0.6009732360097324,0.869318074498355,1.0,4/13,17.50%,NR1H3;AQP11;NUPR1;NR1H2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.43411363638288125,0.8807425380103021,0.6188118811881188,0.9276900554503629,1.0,4/13,12.68%,KPNA1;RGPD1;RANBP2;KPNA4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3289992919766393,0.8803748073927183,0.6525641025641026,0.9279055229535875,1.0,11/72,13.07%,SLIT2;PRKCD;FGF13;HDGFL3;LDLR;CLU;SHANK1;KANK4;KATNB1;LIMA1;SSH3
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.36634300208996506,-0.8800157613848829,0.6134663341645885,0.8699201745503486,1.0,2/13,7.48%,RNF152;SPAAR
prerank,regulation of autophagosome assembly (GO:2000785),0.3690918475969736,0.8796450164065613,0.620933521923621,0.9287995777145739,1.0,18/33,29.16%,NPRL3;RAB3GAP2;TMEM39A;LRSAM1;SMCR8;SH3GLB1;SEC22B;NPRL2;RAB5A;PIP4K2A;CHMP4A;CHMP4B;RAB3GAP1;PHF23;PIKFYVE;RALB;IFT88;FEZ2
prerank,positive regulation of GTPase activity (GO:0043547),0.29443492699281537,0.8795582388987748,0.696078431372549,0.9284446575150321,1.0,43/188,15.09%,NTRK3;ARAP1;WNT11;SGSM2;SIPA1L1;MAPRE2;ITGB1;GSK3B;DOCK7;BCR;SRGAP2;NDEL1;RAP1A;SNX18;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;RAPGEF6;RGP1;BCAR3;ARHGEF10;S100A10;NF1;LIMS1;TBC1D2B;TBC1D13;CCL3;ERBB2;ARHGEF5;CCL1;TIAM1;TBC1D25;CORO1C;RAP1GAP2;ASAP3;ARHGAP42;SIPA1L2;TBC1D10A;TBC1D8B;RSU1;TBC1D5
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2506000997084008,-0.8793148795960612,0.7872340425531915,0.8704071119684285,1.0,24/70,27.10%,ENPP2;SLC44A1;NR1H3;LPIN3;DBI;ABHD3;PNPLA8;MFSD2A;SLC44A2;CHKA;TMEM86B;LPIN1;NR1H2;SLC27A1;PLAAT3;PCYT1B;PLA2G4C;PLA2G7;PLA2G5;PEMT;ACHE;PLA2G4E;PLBD1;PLB1
prerank,neuromuscular process (GO:0050905),0.41871055411074265,0.8792938912913232,0.5888324873096447,0.9284254050182639,1.0,5/16,13.59%,STRA6;PAFAH1B1;MYCBP2;SHANK1;UBA5
prerank,C4-dicarboxylate transport (GO:0015740),0.4255190065751479,0.8792234098397126,0.6266666666666667,0.9280369454496215,1.0,1/14,1.31%,LRRC8D
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.41442928039512106,0.87919964739453,0.6227045075125208,0.9275615805083294,1.0,6/15,22.64%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1
prerank,regulation of tube diameter (GO:0035296),-0.36827992436576834,-0.8791891723550335,0.6235294117647059,0.8685667005814421,1.0,5/13,11.32%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,vascular process in circulatory system (GO:0003018),-0.36827992436576834,-0.8791891723550335,0.6235294117647059,0.8685667005814421,1.0,5/13,11.32%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,long-term memory (GO:0007616),-0.3346242217353611,-0.8786487693747684,0.6107954545454546,0.8687394649561484,1.0,3/19,5.67%,APOE;RASGRF1;SGK1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.42497017670194887,0.8786474104743667,0.5932773109243697,0.9280295983144403,1.0,7/13,29.22%,ALG13;ALG14;ALG12;ALG3;DPAGT1;ALG9;MPDU1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3438308527814562,-0.8775482352741351,0.620253164556962,0.870065636233826,1.0,6/15,25.55%,RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2
prerank,lipid modification (GO:0030258),0.35570176435868767,0.8775380077336025,0.6235955056179775,0.9296630134962044,1.0,5/37,10.31%,PLPPR2;PLPP3;DGKA;MBOAT1;MBOAT4
prerank,negative regulation of blood pressure (GO:0045776),-0.3612147707500912,-0.877364477758671,0.6491228070175439,0.8694428918760304,1.0,8/13,33.83%,NOS3;PRCP;GPR37L1;NOS2;NOS1;DRD2;BMPR2;APLN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.35443565086822065,0.8770603579523188,0.6146540027137042,0.9300727492693769,1.0,10/37,18.53%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;PML;TLK2;CSNK2A2;CSNK2A1
prerank,homotypic cell-cell adhesion (GO:0034109),0.3506783472235733,0.8767799314534073,0.616991643454039,0.9300613108534084,1.0,10/39,14.97%,FN1;PLPP3;UBASH3B;VCL;CLIC1;GATA1;ITGB3;DSC2;CEACAM5;GNAS
prerank,regulation of metal ion transport (GO:0010959),-0.3431144859402309,-0.8765576424015801,0.629080118694362,0.8700464433180745,1.0,5/16,11.40%,SLC30A10;EPB41;BCL2;CACNA2D1;CAMK2B
prerank,presynapse assembly (GO:0099054),-0.3375547597905203,-0.8765480149064088,0.6405405405405405,0.8690122504915652,1.0,3/16,7.72%,IL1RAPL1;WNT5A;LRRTM3
prerank,JNK cascade (GO:0007254),0.35231456929582794,0.8761151382881166,0.6388888888888888,0.9308522067366256,1.0,4/40,6.92%,MAP3K5;TAB3;RIPK2;ARHGEF6
prerank,global genome nucleotide-excision repair (GO:0070911),0.37544437722274965,0.8757726604977148,0.6163141993957704,0.930987924594217,1.0,10/26,27.33%,CHD1L;RAD23B;RNF111;ERCC3;XPA;ERCC1;CUL4A;ERCC2;XPC;GTF2H3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.44519397724441473,0.8757069086992774,0.6095406360424028,0.9306014966870515,1.0,2/10,11.50%,PDCD4;DUSP10
prerank,regulation of erythrocyte differentiation (GO:0045646),0.35796752178764885,0.8756374679508747,0.6358296622613803,0.930226439208702,1.0,7/35,13.31%,HOXA5;FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.35904252082661137,0.8755216025174924,0.6223776223776224,0.9299392764414435,1.0,19/38,29.26%,UBN1;CABIN1;HIRA;ATRX;CENPT;SMARCA5;RBBP7;CENPQ;HJURP;IPO4;CENPU;RBBP4;CENPX;NASP;HAT1;CENPK;CENPC;CENPW;CENPL
prerank,autophagosome organization (GO:1905037),0.3371918455759692,0.8754686459750127,0.6262755102040817,0.9295327923233264,1.0,15/50,26.19%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG5;ATG7
prerank,negative regulation of histone methylation (GO:0031061),-0.39420184669217,-0.8751933003886447,0.6409638554216868,0.8708132827303742,1.0,3/10,19.39%,JARID2;MTF2;AASS
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3637143669811758,0.8751626710125233,0.6196136701337296,0.9296010306346106,1.0,12/29,24.60%,GDNF;PKP1;FUS;PABPC1;THRAP3;CIRBP;TENT5D;FMR1;NBAS;E2F1;TAF15;TENT5C
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4329390008396834,0.8749869170738173,0.6061643835616438,0.9294399456321034,1.0,4/13,19.89%,RENBP;UAP1;SLC35A3;GFPT1
prerank,I-kappaB phosphorylation (GO:0007252),0.4518710954536419,0.8746888906613023,0.6252100840336134,0.9295242383928223,1.0,3/10,9.10%,ERC1;TLR4;CHUK
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.40385104884281536,0.8744940636101984,0.627906976744186,0.9293811659051742,1.0,2/17,3.11%,CD55;BMP6
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3656296619445083,-0.8739567799503276,0.6467391304347826,0.8723995253539176,1.0,3/14,9.51%,RPS3;CD81;NECTIN2
prerank,regulation of cell motility (GO:2000145),0.30490088304551227,0.8737692221667184,0.6738882554161916,0.9302621296912542,1.0,12/121,7.74%,EGFR;NTN1;LMO4;FGF2;ABL1;LMNA;DIAPH1;CCDC125;SGK3;MGAT3;CCDC25;MEMO1
prerank,response to interferon-beta (GO:0035456),-0.31693080514663696,-0.8736813179901657,0.6235955056179775,0.8719245206141666,1.0,6/22,11.62%,IFITM1;BST2;AIM2;IFNAR2;IFITM3;STAT1
prerank,DNA strand elongation (GO:0022616),0.39883815365508085,0.8735152031685116,0.6241830065359477,0.9302810464626858,1.0,6/18,21.85%,MCM7;GINS3;NBN;POLA1;POLD3;RAD50
prerank,intermediate filament organization (GO:0045109),0.39818684663716175,0.8734147408546291,0.5974025974025974,0.9299544435016499,1.0,3/17,7.24%,DSP;KRT14;PKP1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3010945194837867,0.8733298260931169,0.6705069124423964,0.9296001417880858,1.0,27/124,17.12%,TCF7L2;PPP3CA;WNT11;PLCB3;PRICKLE1;FZD7;AP2A2;PDE6A;SFRP4;PSMB2;MOV10;TNRC6C;FZD1;NLK;AP2A1;RHOA;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;NFATC1;PSMD1;CELSR3;AGO2;PSMC1;PSMD7
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3017278663044722,-0.8733124320593917,0.6876876876876877,0.8716083903264724,1.0,8/25,19.74%,CEMIP;AKAP6;SNCA;PLCG1;TRPC1;APLNR;CX3CL1;GPER1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.34424977013881447,0.8732718063842485,0.6369770580296896,0.929204451229928,1.0,8/47,10.78%,FOXO3;KLF4;INHBA;AGTR1;EIF4G1;CNDP1;NFKB1;ATXN2
prerank,negative regulation of proteolysis (GO:0045861),0.35894656014176224,0.8730630489111096,0.6301939058171745,0.9290992104632066,1.0,9/34,15.60%,PTPN3;TIMP2;GAS1;IL10;DNAJC1;TIMP1;SNX12;ACP4;SERPINE2
prerank,lipid droplet organization (GO:0034389),0.37966275252657034,0.8729748358650268,0.6308411214953271,0.928754542850078,1.0,9/22,26.41%,PNPLA3;ZFYVE1;HILPDA;CDS1;SMIM22;RAB18;FAF2;BSCL2;RAB3GAP1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.41139418527838667,0.8722223535332143,0.6168521462639109,0.9297404428795984,1.0,5/16,9.79%,SOX9;LTBP3;GATA4;FOXC1;HOXB4
prerank,adenine nucleotide transport (GO:0051503),0.401549845557523,0.8719813089951253,0.6184419713831478,0.9296790531804667,1.0,1/17,1.31%,LRRC8D
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27278963878356594,-0.871823507328694,0.686046511627907,0.8738014825779549,1.0,14/41,22.47%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;NR1H4;VSIR;SELENOS;TNFAIP3;CX3CL1;CHRNA7;TRIM27;CACTIN
prerank,autophagosome assembly (GO:0000045),0.3355266442933486,0.871694914599223,0.631917631917632,0.9297170427983562,1.0,16/52,26.19%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;SMURF1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG5;ATG7
prerank,regulation of cytokine production (GO:0001817),-0.2284434677532364,-0.8713944592109818,0.7777777777777778,0.8735780479475501,1.0,27/126,15.89%,CADM1;LYN;RPS6KA5;PLA2R1;LGR4;DTX4;SRGN;CD47;SIRPA;C1QTNF3;SYT11;ADRA2A;AFAP1L2;ATP2B1;GAPDH;MOG;RGCC;ACE2;MIF;BCL6B;ICOSLG;LURAP1;TRIM21;AGT;TRIM56;BTN3A3;NLRP4
prerank,regulation of microtubule nucleation (GO:0010968),-0.386307122512039,-0.8711118517373451,0.6305309734513275,0.8731614612745843,1.0,2/10,11.69%,PAK1;ARHGEF7
prerank,regulation of G0 to G1 transition (GO:0070316),0.35185419180518335,0.8710115350768399,0.6239554317548747,0.9304845864462136,1.0,18/38,26.54%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;E2F1;E2F6;MGA;YAF2;PCGF6;RBBP4
prerank,negative regulation of MAPK cascade (GO:0043409),0.3173620044198992,0.870888576171367,0.656516443361754,0.9302113708935317,1.0,14/87,11.77%,BMP4;EZR;PRKCD;SPRED2;PTPN2;DLG1;CBLC;TLR4;PPEF2;NF1;IRAK3;PRDM15;DUSP10;ITGB1BP1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34743710373112363,0.8706904111660294,0.616551724137931,0.9300484301800832,1.0,15/40,29.97%,WRN;BOD1L1;DDX11;ATRX;MCM9;SMARCAL1;RAD51;ATR;FANCM;EXD2;FAM111A;CENPX;ALYREF;PRIMPOL;RFWD3
prerank,mitochondrial protein processing (GO:0034982),0.43328406606151026,0.8706542186401495,0.5854092526690391,0.9295969312974495,1.0,7/11,27.58%,PMPCB;YME1L1;OMA1;IMMP1L;SPG7;MIPEP;STOML2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.43009393040286775,0.8699926960653167,0.5828970331588132,0.9303076427265552,1.0,1/11,1.20%,BMP5
prerank,negative regulation of platelet activation (GO:0010544),0.405800139790221,0.8699685817615709,0.609375,0.9298451198549808,1.0,4/16,7.96%,PRKCD;CD9;THBD;PDGFA
prerank,regulation of osteoclast differentiation (GO:0045670),0.36129809568713456,0.869762216006953,0.6361031518624641,0.9297174202746749,1.0,6/33,13.68%,UBASH3B;TLR4;CCL3;TCTA;MTOR;TNFSF11
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3796682626810491,0.8695905393479609,0.6138763197586727,0.9295290578252429,1.0,4/24,10.71%,MAP7D3;FGF13;HDGFL3;KATNB1
prerank,cellular response to gamma radiation (GO:0071480),0.3904778734872385,0.8691491696102832,0.6123417721518988,0.9298821492006765,1.0,6/17,17.95%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,response to retinoic acid (GO:0032526),0.32856988847009455,0.8690802582600193,0.6401028277634961,0.9294997736962894,1.0,9/59,10.00%,WNT9A;SOX9;PTK2B;WNT11;FZD7;RXRA;RARG;RARA;ATM
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3654619095411191,-0.8690583466890933,0.6616541353383458,0.8762612424011225,1.0,2/14,6.51%,ENPP1;ENPP3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.34051039512991255,-0.8690129350686941,0.6426592797783933,0.8752947893755847,1.0,4/18,7.22%,APOE;CTSC;VGLL4;CD81
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3694609828095135,-0.8689819447483097,0.5945273631840796,0.8743030751569424,1.0,2/12,10.36%,CYP26B1;CALR
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.40636616302703243,0.8689037059684632,0.6279461279461279,0.9293237535943167,1.0,4/14,16.59%,USP15;PUM2;PUM1;ANKRD17
prerank,regulation of translational initiation (GO:0006446),0.32838570250022303,0.8687895842670781,0.6219667943805874,0.929025452471075,1.0,21/63,24.57%,EIF4G3;PAIP2;EIF4G1;NCK2;DNAJC3;EIF3E;EIF2AK4;EIF2B2;AGO2;MTIF2;KHDRBS1;EIF4B;FMR1;EIF4G2;YTHDF2;DDX1;NCK1;EIF2AK3;RBM4;CDC123;YTHDF3
prerank,neuron development (GO:0048666),0.29831871969393714,0.8687598584195775,0.6840317100792752,0.9285693690494647,1.0,12/141,6.04%,VSX1;PBX3;NEDD4;PBX1;WNK1;RP1;GSK3B;DOCK7;HDGFL3;THOC2;ARL3;GDNF
prerank,mRNA metabolic process (GO:0016071),0.3171139068752297,0.8686863714488623,0.6765053128689492,0.9281936450449437,1.0,23/90,22.14%,DDX5;SON;SRSF11;SRSF5;CELF1;DXO;U2AF2;TCERG1;SCAF11;LSM11;ZC3H12D;PRPF3;KIN;SF3B2;NUDT12;DIS3L2;LSM2;SRSF2;PRPF18;YTHDF2;ALKBH5;SSB;NANOS2
prerank,nucleocytoplasmic transport (GO:0006913),-0.27777313285692773,-0.8686823806388909,0.6766666666666666,0.8738710892055452,1.0,11/40,23.40%,ATXN1;BACH2;ANP32A;NPM1;SNRPG;MALT1;DDX20;NUP205;RBM15B;NXT2;PHAX
prerank,tRNA transport (GO:0051031),0.35771015013850144,0.8686783963905198,0.630527817403709,0.9277028516761572,1.0,18/35,31.61%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;TOMM20;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,ERAD pathway (GO:0036503),0.3162101680977862,0.867913014829661,0.6679245283018868,0.9286015578520412,1.0,19/83,22.99%,UBE4B;USP13;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;UFD1;TRIM25;ECPAS;UGGT2;FAF2;HERPUD1;FBXO27
prerank,cellular response to starvation (GO:0009267),0.29500623619712496,0.8678778493726791,0.6858757062146893,0.9281506598520921,1.0,38/147,20.11%,MAP3K5;FOXO3;DAPL1;NPRL3;WIPI2;KLF10;ZFYVE1;BECN1;VPS41;CLEC16A;RRAGB;ITFG2;WRN;MLST8;SIK2;INHBB;USP33;ZC3H12A;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;SREBF1;EIF2S1;SZT2;CDKN1A;GAS2L1;EHMT2;RHEB;WDR45B;ATP6V1H;NPRL2;MAPK8
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.31957918543019737,0.8678172971205594,0.6590909090909091,0.9277641159963336,1.0,7/73,4.29%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1;NR4A3
prerank,positive regulation of stress fiber assembly (GO:0051496),0.34398891790782166,0.8674521003541732,0.6376404494382022,0.927976163212271,1.0,11/44,11.77%,SORBS3;TGFB3;WNT11;ABL1;NRP1;TGFBR1;ARHGEF10;S100A10;RHOA;ARHGEF5;ITGB1BP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.33968301110979693,-0.8673415162890049,0.6361111111111111,0.8755789060324384,1.0,1/16,0.56%,AUTS2
prerank,negative regulation of catalytic activity (GO:0043086),-0.3102070586325316,-0.8671095846133997,0.6527777777777778,0.8750409370884911,1.0,7/24,20.97%,NOTCH1;NES;CAMK2A;IFIT1;MT3;CCAR2;CAND1
prerank,membrane lipid metabolic process (GO:0006643),-0.3134114947387058,-0.8670401815637997,0.6543909348441926,0.8741541209185947,1.0,5/22,8.25%,ST3GAL6;CERK;GAL3ST1;SPHK1;SERINC1
prerank,polyol metabolic process (GO:0019751),0.3414481842647167,0.86652986342745,0.6376811594202898,0.9292391452385105,1.0,9/46,9.84%,PLCE1;PLCB3;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.35482411302336586,0.8665227932089826,0.627972027972028,0.9287448724973858,1.0,12/38,16.94%,TANK;ESR1;RORA;USP10;PER1;OTUD7B;ZC3H12A;PPM1A;TNIP1;CCDC22;TRIM39;NLRP12
prerank,triglyceride biosynthetic process (GO:0019432),-0.32610961214385314,-0.8664696382020253,0.6578947368421053,0.8743141583747369,1.0,6/18,15.51%,LPGAT1;GK;LPIN3;GPAM;DGAT1;LPIN1
prerank,ncRNA export from nucleus (GO:0097064),0.3534434115321945,0.866345375698045,0.6138613861386139,0.9285849793045718,1.0,19/36,31.61%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;NCBP2;XPOT;RAE1;NOL6;TSC1;SEH1L
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.39768582438247724,0.865138044645527,0.6292682926829268,0.9303843841054832,1.0,2/17,6.08%,CD44;KDM1A
prerank,selective autophagy (GO:0061912),0.33150634750154584,0.864390167568184,0.6687657430730478,0.9313227872332338,1.0,22/56,26.68%,ULK2;BECN1;DYNC1I1;ACBD5;RB1CC1;ATM;WDR81;DDRGK1;UBA5;SQSTM1;AMBRA1;DYNC1LI2;NBR1;ATG2A;UBE2N;ULK1;LGALS8;UBE2V1;RAB7A;ATG5;USP30;PCNT
prerank,microtubule anchoring at centrosome (GO:0034454),0.43550993821345074,0.863777630343612,0.625,0.9319690983870879,1.0,2/10,6.12%,NIN;PCM1
prerank,negative regulation of secretion by cell (GO:1903531),-0.282320287648224,-0.8637287500391863,0.703971119133574,0.8788602720346043,1.0,7/38,9.55%,IL1RAPL1;APOE;GRM7;NOTCH1;SYT11;SNCA;SLC30A1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3075453412554351,0.8636393444376598,0.6822541966426858,0.931735776158299,1.0,22/104,19.01%,LRP6;CCNA2;ADRB2;ABL1;TELO2;MNAT1;CDK12;CDKN1B;RHOA;PPEF2;SYAP1;CAB39;LRP5;RB1;CDKN3;GTPBP4;CCND1;MAP2K2;TSG101;CDKN1A;SNF8;CCNT1
prerank,negative regulation of hippo signaling (GO:0035331),0.42112605789135493,0.8635860702988841,0.5934819897084048,0.9313283661845153,1.0,2/12,9.89%,CIT;MARK3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3325760458760672,0.8633558064618715,0.6586345381526104,0.9312356040841608,1.0,7/54,13.05%,NXN;HDAC8;PIAS3;U2AF2;USP4;CHP1;GTPBP4
prerank,regulation of exosomal secretion (GO:1903541),0.3899690684948377,0.8630571435034226,0.6137071651090342,0.9312772081604361,1.0,8/19,25.05%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;ATP9A;RAB7A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.35629706525135,0.8628335493040404,0.6530324400564175,0.9312148940539788,1.0,11/33,23.07%,TELO2;STN1;ANKRD28;PPP6R3;RPA1;RAD51;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,hexose metabolic process (GO:0019318),-0.2809700755184378,-0.8626245723035146,0.6984732824427481,0.8800249091662541,1.0,12/39,23.44%,APOD;PPARD;PGM1;ALDOC;ALDOA;AKR1A1;PMM2;DCXR;KHK;CHST1;GALT;FUCA1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3809471101877579,0.8623321160666402,0.6363636363636364,0.9316391835568527,1.0,1/24,0.43%,PLCE1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3917474676429535,0.8619812850478987,0.6182707993474714,0.9318123055649019,1.0,2/17,5.73%,ANK2;SNTA1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.29606293610830026,-0.8617925519751658,0.6976744186046512,0.8806089208109418,1.0,8/30,20.70%,HSPA8;ERO1A;HSPA13;PTGES3;CHCHD4;DNAJB5;HSPE1;HSPA9
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.38241801286030425,0.8615947712775127,0.6452599388379205,0.9320149501373701,1.0,1/22,1.39%,CD55
prerank,histone H2A acetylation (GO:0043968),0.403308397259947,0.8614403458215745,0.6394557823129252,0.9317736484336305,1.0,8/16,27.77%,NAA40;TRRAP;EP400;EPC1;BRD8;DMAP1;ING3;MORF4L2
prerank,endosome organization (GO:0007032),0.34170992417870616,0.8614246343660186,0.6472222222222223,0.931302464602224,1.0,13/41,23.96%,EEA1;WASHC5;CORO1C;SQSTM1;HOOK3;ANXA8;ANXA8L1;TMCC1;WASHC4;PLEKHF1;HOOK2;RNF26;PHETA2
prerank,cellular response to virus (GO:0098586),0.35813424066862937,0.8614172731238235,0.6282420749279539,0.9308133212320175,1.0,9/30,23.94%,VWCE;GBF1;CHUK;ZC3H12A;IFIH1;RRP1B;FMR1;IRF3;LGALS8
prerank,cellular response to cAMP (GO:0071320),0.36628638219945664,0.8613378088784913,0.6310541310541311,0.9304555949109333,1.0,6/30,10.04%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN;AKAP9
prerank,macrophage activation involved in immune response (GO:0002281),0.41635127992340587,0.8613353195847795,0.6330578512396694,0.9299573735775644,1.0,3/13,9.84%,LBP;IFI35;PLCG2
prerank,mRNA catabolic process (GO:0006402),0.3342997412917047,0.8611862455675446,0.6441136671177267,0.9297401824580955,1.0,12/44,22.14%,DDX5;DXO;ZC3H12D;TUT7;THRAP3;NUDT12;DIS3L2;TUT4;LSM2;NBAS;YTHDF2;NANOS2
prerank,positive regulation of lipid storage (GO:0010884),0.3743360045062747,0.8611728065409362,0.6238244514106583,0.9292624296832221,1.0,5/21,12.53%,IKBKE;NFKB1;HILPDA;EHD1;ZC3H12A
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.28641165657231876,-0.8608164084940042,0.6666666666666666,0.8816018011410801,1.0,7/34,9.70%,RUNX1T1;FOXO1;ENPP1;WNT5A;GATA2;CCDC85B;LRP3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3031529884524802,-0.8607131276942888,0.6757575757575758,0.8807680110424065,1.0,9/24,20.74%,BCL2;CXCL12;BCL2L1;TPT1;MIF;CD74;TRIAP1;CCAR2;ING2
prerank,lymphocyte differentiation (GO:0030098),0.3236789594094415,0.8607013120795075,0.6611675126903553,0.9296346936122967,1.0,8/68,7.16%,HDAC4;PBX1;HDAC9;ITGB1;CLCF1;PTPN2;NFIL3;IL10
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3224728835744398,-0.8606770815080994,0.638121546961326,0.8798023000460607,1.0,4/20,17.27%,APOE;KPNB1;NR1H4;ABCA2
prerank,lipid homeostasis (GO:0055088),-0.25511643843617016,-0.8606664574585576,0.7405857740585774,0.8787921129596608,1.0,16/57,22.05%,APOE;NR1H3;ABCA1;ZBTB20;PRKAA2;ABCG1;PNPLA8;ABCB4;ORMDL3;ABCA2;CLN8;XBP1;DDX3X;TREM2;CEBPA;USF2
prerank,regulation of urine volume (GO:0035809),-0.3814990008210043,-0.8602984150685175,0.6312056737588653,0.8784890869966185,1.0,6/10,29.23%,NPR1;ADM;HYAL2;INPP5K;HAS2;TFAP2B
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2819782541443162,-0.8602888188898479,0.6855123674911661,0.8774741397449125,1.0,5/37,5.75%,APOD;PPARA;ADCY7;SIRPA;HIF1A
prerank,calcium ion import (GO:0070509),0.362008958325554,0.8602703092558914,0.6311239193083573,0.9299000076719203,1.0,6/28,10.39%,CACNA1C;CACNA1G;CASR;CACNA1F;MCUB;MCU
prerank,positive regulation of exosomal secretion (GO:1903543),0.4057152299442676,0.8599962946350358,0.6403940886699507,0.9299169274553615,1.0,7/15,25.05%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;RAB7A
prerank,regulation of rRNA processing (GO:2000232),0.401465673543975,0.8597120535569778,0.6258741258741258,0.9299176688527175,1.0,6/16,23.14%,WDR43;KAT2B;USP36;YTHDF2;WDR75;RIOK2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.392407640181594,0.8594513271290525,0.632398753894081,0.9299083843871881,1.0,8/19,25.52%,MTOR;PRDX5;ZNF76;POLR3F;DHX36;ICE2;TENM1;AR
prerank,proteoglycan biosynthetic process (GO:0030166),0.3601312058786732,0.8592317887762292,0.6215827338129496,0.9298250756065325,1.0,7/31,11.27%,EXT1;CHST13;GLCE;FOXL1;XYLT1;B3GALT6;CHST11
prerank,negative regulation of organelle assembly (GO:1902116),0.35200431493132034,0.8588784588163331,0.6534788540245566,0.9299477057601084,1.0,10/35,17.99%,LIMK2;STYXL1;TMEM39A;SMCR8;KAT2A;SEC22B;KAT2B;RBM14;CEP97;CDK10
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.29624007771175537,0.8587524067165828,0.725,0.9296770760412845,1.0,49/148,24.83%,USP2;HIPK1;SMYD2;EXO1;EHMT1;CHEK2;PLK3;MDM4;RAD17;WRN;AURKA;MLST8;ATM;PPP2R5C;USP7;MTOR;CHEK1;EP300;CHD3;DYRK2;PML;TAF12;RBBP8;RPA1;RMI2;TOP3A;TAF4;BARD1;NBN;KMT5A;EHMT2;ATR;RBBP7;CSNK2A2;CSNK2A1;TOPBP1;PAK1IP1;PHF20;CCNG1;RAD9B;RAD50;PRMT5;CDK2;TAF15;RFC5;BRIP1;POU4F1;PIP4K2A;KAT5
prerank,regulation of MAP kinase activity (GO:0043405),0.3090844843461374,0.8585633346998846,0.69079754601227,0.9295445634233341,1.0,14/92,11.11%,EGFR;BMP4;PDGFC;PRKCD;FGFR1;FGF2;CDK12;CBLC;PDGFA;PPEF2;NF1;IRAK3;VEGFA;ERBB2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.35118688953340604,0.8584444525508216,0.6351744186046512,0.9292655528071968,1.0,4/33,7.16%,TCF7L2;NFE2L2;CAST;IL10
prerank,granulocyte differentiation (GO:0030851),-0.32118060315175423,-0.8583440193213983,0.6581196581196581,0.8803921680284194,1.0,3/18,8.33%,LEF1;CBFA2T3;TAL1
prerank,mitotic cytokinesis (GO:0000281),0.3369703049099833,0.8583242156599928,0.6389261744966444,0.9289857309232806,1.0,7/47,12.33%,CIT;SNX18;SON;PDCD6IP;ARL3;TTC19;CNTROB
prerank,cellular response to lipopolysaccharide (GO:0071222),0.30384206524231994,0.857892959479117,0.7118437118437119,0.9293221032963008,1.0,19/101,12.85%,LBP;ADAM9;PRKCE;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;MTDH;TRIM41;CCL3;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9
prerank,regulation of amyloid-beta clearance (GO:1900221),0.38936961770788053,0.8574005973252038,0.6167763157894737,0.9297252176356955,1.0,3/16,6.20%,LRPAP1;LRP1;CLU
prerank,positive regulation of lyase activity (GO:0051349),-0.34196057707269656,-0.8573808561509086,0.6561679790026247,0.8812808445632615,1.0,2/14,1.98%,CACNA1D;NOS3
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.34428857944740787,-0.8570510644543123,0.6440217391304348,0.8809190377336242,1.0,2/16,3.90%,IGF1R;INSR
prerank,ribosomal large subunit assembly (GO:0000027),-0.304027136657165,-0.8569964789387079,0.6819571865443425,0.8800171958853683,1.0,10/24,29.29%,RPL23A;RPL11;FASTKD2;RPL24;RPL3;RPL5;RPLP0;RRS1;DDX28;RSL24D1
prerank,TOR signaling (GO:0031929),-0.29902452747770664,-0.8559643653649976,0.7178683385579937,0.8811188644061625,1.0,7/26,15.05%,PRR5L;CCDC88A;EIF4EBP2;TIPRL;EIF4EBP1;RICTOR;AKT1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.35567492867918404,-0.8558515405395064,0.66,0.8803126003442644,1.0,3/14,5.04%,PRKD1;LOXL3;CD63
prerank,cellular response to oxidative stress (GO:0034599),0.29983125199748206,0.8557966125096572,0.7048054919908466,0.932231894951377,1.0,13/118,10.19%,EGFR;PRKCD;FOXO3;NFE2L2;ABL1;WNT16;GPX8;MGAT3;VKORC1L1;GSR;CHUK;JUN;CCS
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.36271396768646413,0.8557405255633546,0.6320610687022901,0.931829211990195,1.0,5/26,10.84%,EFNA5;KLF7;TRPM4;CLTRN;LRP5
prerank,positive regulation of hydrolase activity (GO:0051345),0.2943538997598695,0.8556966191631752,0.7226697353279632,0.9314230837600359,1.0,24/137,11.36%,ARAP1;WNT11;SGSM2;MAPRE2;ITGB1;GSK3B;SRGAP2;NDEL1;RAP1A;SNX18;BCAS3;RAPGEF6;RGP1;BCAR3;S100A10;RHOA;RIPK3;WRN;NF1;LIMS1;MAPK12;CCL3;ERBB2;CCL1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.37389073650754845,-0.8553383121264622,0.6367816091954023,0.8803161630067228,1.0,3/11,11.99%,PAK1;RAC1;STMN1
prerank,alanine transport (GO:0032328),-0.3789892289668506,-0.8552984477152167,0.6613272311212814,0.8793611953712865,1.0,4/10,24.05%,SLC6A6;SLC6A17;SLC36A2;SLC7A10
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.38194231703479764,-0.8552590559077292,0.6428571428571429,0.8784116685710041,1.0,4/10,15.40%,PARP14;NF2;INPP5F;SH2B3
prerank,response to peptide hormone (GO:0043434),0.33839612648546524,0.8549054966783278,0.657608695652174,0.932440677420973,1.0,12/43,20.87%,ANXA1;IGFBP5;IRS1;ZBTB7B;STAT3;EIF6;STAT5A;EIF2B2;TRIM16;STAT6;STAT4;EIF2B3
prerank,glucan catabolic process (GO:0009251),0.40693641630529537,0.8548140993627826,0.6216640502354788,0.9321198310930803,1.0,3/15,8.72%,PYGB;PHKA2;PHKB
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2667658767135569,-0.8545986445078753,0.7125506072874493,0.8786543563460678,1.0,14/43,22.47%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;NR1H4;VSIR;SELENOS;TNFAIP3;CX3CL1;CHRNA7;TRIM27;CACTIN
prerank,positive regulation of macroautophagy (GO:0016239),0.3319787684095552,0.8543107018672211,0.638095238095238,0.9325107644759375,1.0,12/48,17.04%,ADRB2;RAB3GAP2;PAFAH1B2;LRSAM1;VPS13D;WAC;HSPB8;SMCR8;SH3GLB1;BAG3;IKBKG;SCOC
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3850166225429068,0.8539481982839459,0.6094224924012158,0.9326863612772646,1.0,2/18,3.79%,NFE2L2;VNN1
prerank,response to cytokine (GO:0034097),0.2914890701899307,0.853895967606529,0.70996640537514,0.9322836195658335,1.0,28/141,15.70%,DPYSL3;HDAC4;PID1;ADAM9;ANXA1;NFAT5;AFF3;COL3A1;PTPN2;TIMP2;STAT3;PLSCR1;SETD2;REL;IKBKE;RHOA;IRAK3;IL18BP;TIMP1;MYD88;PTPN9;IFNLR1;CXCR4;MAPKAPK2;PRKCA;ADAM10;PML;DDOST
prerank,telomere organization (GO:0032200),0.3366394433260498,0.8533650345838603,0.6544943820224719,0.9327036436668018,1.0,12/43,21.85%,STN1;WRN;ATM;APEX1;PRKDC;XRCC5;RPA1;NBN;ATR;PARP3;POLD3;RAD50
prerank,ncRNA metabolic process (GO:0034660),0.35119098536695104,0.853240325176938,0.621861152141802,0.9324337080416284,1.0,10/37,19.88%,DDX17;ZCCHC8;TDRD9;DGCR8;TUT7;AGO2;TDRD12;TUT4;DROSHA;RAN
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.321629295252615,-0.8529249830299485,0.6684073107049608,0.8810274455004156,1.0,1/18,0.71%,LYN
prerank,regulation of protein localization (GO:0032880),-0.24734481234141772,-0.8515433611140023,0.7522522522522522,0.8826869627523027,1.0,12/58,16.40%,PICALM;MAP2;RABGAP1L;TRIM14;HSP90AB1;TRIM46;MMD;PPM1F;WDPCP;TRIM21;CTSD;RACK1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3846713574375024,0.8512328142496116,0.6211180124223602,0.9356290831027773,1.0,8/21,18.25%,MED13;BCLAF1;JUN;HNF1A;MED14;TWIST1;MED24;DHX36
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3278779017617538,-0.8512213095396475,0.6744791666666666,0.8822988703942551,1.0,6/17,18.38%,CLDN5;F11R;S1PR3;ROCK2;TNFRSF1A;CDH5
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3024640066833113,-0.8509428050457123,0.7065217391304348,0.8818220370671818,1.0,12/25,27.87%,SHANK3;MEF2C;CACNG4;CACNG7;GSG1L;SHISA9;RELN;CNIH3;SHISA8;CACNG8;CACNG3;MAPK8IP2
prerank,endothelial cell differentiation (GO:0045446),0.41755912565548736,0.8505776320651276,0.6484751203852327,0.9363706590415689,1.0,2/12,6.70%,FSTL1;JAG1
prerank,determination of left/right symmetry (GO:0007368),0.34725549358899316,0.8504434564981447,0.6427566807313643,0.9361300453222566,1.0,11/36,21.70%,SMO;PITX2;GALNT11;CCDC40;MEGF8;STIL;DNAAF4;KIF3B;ODAD3;OFD1;ODAD2
prerank,GPI anchor metabolic process (GO:0006505),0.3702003573386884,0.8503557833703105,0.6569230769230769,0.935799415546081,1.0,11/26,26.24%,PGAP2;PIGB;DPM1;PIGU;PIGL;PIGN;PIGH;PGAP3;PIGQ;MPPE1;PIGA
prerank,cellular response to hexose stimulus (GO:0071331),0.3713204553809492,0.8501758214792312,0.6484018264840182,0.9356231776056309,1.0,4/23,4.23%,KCNB1;UNC13B;SLC26A6;SLC39A14
prerank,regulation of autophagy (GO:0010506),0.2814588511220889,0.8500915107174283,0.750788643533123,0.9352964669738253,1.0,36/216,13.55%,MET;NEDD4;EXOC4;EIF4G3;FOXO3;USP13;DAPL1;GSK3B;ABL1;FOXK1;TAB3;EIF4G1;KLHL22;STAT3;DDIT3;TPCN1;RRAGB;IL10;WDR41;MLST8;SNX32;PIM2;RB1CC1;ATM;MTDH;USP10;SMCR8;CISD2;ATF6;FOXK2;USP33;ZC3H12A;MTOR;EP300;SH3GLB1;ATP6V0D1
prerank,pore complex assembly (GO:0046931),0.38421896684146006,0.8498427485788618,0.6414523449319214,0.9352300455807478,1.0,8/19,22.22%,ANO6;NUP93;NUP153;ADAM10;AHCTF1;AFDN;NUP98;TMEM170A
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3294213771580965,0.8498334272232831,0.7,0.9347544883814993,1.0,16/59,21.83%,TANK;ERC1;TAB3;RIPK2;REL;TLR4;CHUK;IRAK1BP1;TRADD;TLR8;IKBKG;BCL10;BIRC3;RNF31;LY96;RBCK1
prerank,negative regulation of GTPase activity (GO:0034260),-0.31250329884147193,-0.8497591128766782,0.6925207756232687,0.8831668455793252,1.0,10/22,20.86%,CPEB2;F11R;LRCH1;DAB2IP;GMIP;SH3BP4;RASA4;PLXNB3;GPSM1;HRAS
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3129357936721277,0.8497463523895991,0.6931677018633541,0.934426561600941,1.0,7/75,5.13%,THBS1;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3866243672848457,0.8496180080818962,0.632183908045977,0.9341516562743788,1.0,3/18,5.51%,PTK2B;BCAS3;SHTN1
prerank,regulation of lipid metabolic process (GO:0019216),0.30979521711855157,0.849589610983985,0.69221260815822,0.9337048450960954,1.0,23/88,19.22%,TNFAIP8L3;CHD9;CREBBP;TBL1X;ID2;RXRA;NFYA;RORA;SCD;MVD;NCOR1;HNF4A;NCOR2;PLPP1;HMGCR;GNB3;SREBF1;CARM1;NCOA6;FDPS;PPARG;ABCA7;ADIPOR1
prerank,import into nucleus (GO:0051170),0.31859094010216576,0.8495174775171378,0.6821106821106822,0.9333314050510068,1.0,17/73,20.35%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;TNPO2;HTATIP2;SEC13;NUP153;NUP214;NUP188;GEMIN8;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,neutrophil degranulation (GO:0043312),0.27565784349644323,0.849329546848092,0.8253319713993871,0.933187347810709,1.0,72/425,16.12%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,positive regulation of neuron death (GO:1901216),0.33299580619934577,0.84930802144584,0.6581081081081082,0.9327351844445562,1.0,8/46,10.91%,MAP3K5;FOXO3;GSK3B;DDIT3;CLU;TLR4;NF1;CCL3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3327902838731142,0.8492686779446026,0.6711772665764547,0.9323092190335378,1.0,4/45,3.02%,CAMK2D;PRKCD;CD44;MID1
prerank,positive regulation of peptidase activity (GO:0010952),0.38039098374867397,0.8489022214917136,0.6622516556291391,0.9324940997183375,1.0,4/20,12.53%,TANK;VCP;MAPK12;DDRGK1
prerank,positive regulation of cytokine production (GO:0001819),0.27809787288151194,0.8484369505827264,0.7914046121593291,0.9328569969121778,1.0,41/292,14.40%,F3;FOXP1;CYP1B1;LBP;ANXA1;SULF1;RAB7B;ZBTB7B;CD80;IL17RA;CREBBP;ISL1;CD2;STAT3;MAVS;GATA4;DDIT3;POLR3D;RIPK2;IL10;IRF1;TLR4;RORA;CD46;NFKB1;IL33;PLCG2;RARA;HILPDA;NFKB2;CCL1;MYD88;KAT2A;IFIH1;PRKDC;PIBF1;XRCC5;EP300;HTR2B;TLR1;DHX9
prerank,neutrophil mediated immunity (GO:0002446),0.27544118515945526,0.8480112173666576,0.8382804503582395,0.9331118757965117,1.0,73/432,16.12%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;IRAK4;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,apoptotic nuclear changes (GO:0030262),-0.3108169005620981,-0.8478280603740058,0.6815476190476191,0.8859905598321073,1.0,10/24,24.71%,CECR2;BLCAP;CASP3;ACVR1C;KPNB1;FOXL2;GPER1;TOP2A;H1-0;DFFA
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2755297873551972,-0.8478204541718416,0.6798679867986799,0.8849857848954432,1.0,5/33,8.73%,NEDD4L;PICALM;GPM6B;HSP90AB1;ACTN2
prerank,cellular lipid catabolic process (GO:0044242),0.3565620256139323,0.8475324340118929,0.6578171091445427,0.9335013689852036,1.0,5/27,9.63%,CYP1B1;PLA2G15;ACOT8;ACBD5;LPIN2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.43290757443956573,0.8470172909933542,0.6209386281588448,0.9339171958213502,1.0,4/10,16.65%,TUT7;DIS3L2;CHFR;TUT4
prerank,neutrophil activation involved in immune response (GO:0002283),0.2746564892405083,0.8470102186677813,0.832482124616956,0.9334368573256748,1.0,72/428,16.12%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,oogenesis (GO:0048477),-0.3382625489517026,-0.8468882304039776,0.6754807692307693,0.8858358176820468,1.0,5/15,21.08%,FMN2;MDK;NANOS3;TRIP13;METTL3
prerank,RNA stabilization (GO:0043489),0.3458779531709308,0.8466686594817184,0.6425470332850941,0.9335496817097269,1.0,15/33,27.24%,GDNF;FUS;PABPC1;THRAP3;DHX36;TRDMT1;CIRBP;TENT5D;E2F1;TENT2;NAF1;TAF15;TENT5C;PARN;VIP
prerank,hemidesmosome assembly (GO:0031581),-0.36872814553793165,-0.8461789245135966,0.6568627450980392,0.8861629504568342,1.0,4/11,14.93%,ITGA6;DST;LAMC2;LAMC1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3461213311872127,0.8460580063243844,0.652050919377652,0.93415664440204,1.0,22/37,32.66%,PCM1;IFT46;WDR35;DYNC2I2;CEP131;IFT52;TRIP11;KIF3B;DYNC2I1;IFT80;DYNC2H1;CLUAP1;TRAF3IP1;IFT88;IFT43;TTC21B;IFT27;IFT122;IFT74;KIF17;IFT22;KIFAP3
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3711483283687712,-0.845997069615357,0.6593673965936739,0.8855344779331135,1.0,4/12,17.27%,CLCN2;KPNB1;H6PD;ABCA2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3296200459905451,-0.8456502850079082,0.6853333333333333,0.8851921984720067,1.0,6/18,15.05%,PPARA;PAG1;DUSP3;ASS1;AKT1;JAK3
prerank,regulation of establishment of planar polarity (GO:0090175),0.3019928517513515,0.8454531687016983,0.6931540342298288,0.934799460378282,1.0,26/88,23.10%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;AP2A1;RHOA;DACT1;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMC1;PSMD7;PSMD14;DVL1;FZD2;PSMD3;CDC42;FZD3;SPEF1;CELSR1
prerank,positive regulation of T cell activation (GO:0050870),-0.2469042010531099,-0.8442867506417444,0.7456140350877193,0.886771896528234,1.0,15/62,19.66%,VCAM1;TFRC;CD47;SIRPA;PRKCQ;RHOH;CD81;IL6ST;MDK;CCL19;JAK3;CD276;DOCK8;XBP1;CCL2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3658029830370077,-0.8440975704017781,0.684331797235023,0.8861248179550202,1.0,4/12,12.02%,PARP16;PARP8;TIPARP;PARP11
prerank,tRNA metabolic process (GO:0006399),-0.33288990436305155,-0.8439236429827691,0.6765498652291105,0.8854560100280104,1.0,6/17,25.73%,DARS2;POP5;POP7;SARS1;DTD1;RPP21
prerank,regulation of cholesterol esterification (GO:0010872),-0.38214381416458465,-0.8439059697834888,0.6633663366336634,0.8844757734510702,1.0,5/10,20.17%,APOE;ABCG1;AGT;ABCA2;APOC1
prerank,neuromuscular process controlling balance (GO:0050885),-0.3607677652210557,-0.8438270014350245,0.6641975308641975,0.8836188122295231,1.0,2/12,4.46%,NRXN1;PCDH15
prerank,mitochondrial translational elongation (GO:0070125),0.3033521939181673,0.8432691172367053,0.7047738693467337,0.9383109399877595,1.0,33/88,30.78%,MRPL33;MRPL48;MRPS27;MRPL14;MRPL32;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.28684882687382307,-0.8432472993544529,0.7053291536050157,0.883693172004687,1.0,6/26,12.65%,MFHAS1;NR1H3;RTN4;NINJ1;CYBA;TLR3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.33092891045599215,0.8429158381853051,0.6616022099447514,0.9384421864487589,1.0,8/42,10.34%,PTK2B;GSK3B;ABL1;NRP1;JUP;S100A10;LIMS1;VEGFA
prerank,cardiac ventricle development (GO:0003231),0.37090439067519493,0.8428041048149322,0.6345256609642301,0.9381447871487771,1.0,5/20,8.35%,HES1;STRA6;GATA4;TMEM65;MDM4
prerank,endocytic recycling (GO:0032456),0.33086229230197167,0.8427412377801189,0.6715425531914894,0.9377721525069773,1.0,22/50,25.05%,RAB11FIP3;EHD3;ANKRD27;EHD1;EHD2;ENTR1;SNX12;CCDC22;SNX31;SNF8;WASHC1;VPS52;VPS51;SNX4;RAB11B;RAB35;VPS53;CMTM6;VPS26C;SNX17;VPS29;RAB7A
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.35559806867923227,0.8426709965638951,0.6576980568011959,0.9373961061216568,1.0,3/28,6.18%,MAP3K5;TMEM117;DDIT3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.35428729428056394,0.8420784351545662,0.6632200886262924,0.9379977401922894,1.0,5/29,5.85%,NGF;SHC1;NOTCH2;SHOC2;ITGAV
prerank,hemopoiesis (GO:0030097),0.30777180924872216,0.8420644327838135,0.7232779097387173,0.9375286333936627,1.0,10/87,7.16%,BMP4;MFAP5;ZBTB16;HIPK1;INHBA;NOTCH2;MKNK2;TGFBR2;JAG1;IL10
prerank,regulation of execution phase of apoptosis (GO:1900117),0.41789867901105493,0.8416789745509098,0.6472602739726028,0.9377461137065014,1.0,2/11,12.53%,PTGIS;ZC3H12A
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3611391544165763,0.8416204719589689,0.6451127819548872,0.9373567738698662,1.0,9/26,14.84%,GSK3B;ATP2B4;SLC9A1;PLCG2;HOMER2;CHP1;RCAN1;DYRK2;LMCD1
prerank,iron ion transmembrane transport (GO:0034755),0.42493386386232546,0.8416141950189,0.6581196581196581,0.9368816949382983,1.0,2/10,4.23%,SCARA5;SLC39A14
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3983393700935063,0.8413378921745223,0.6528662420382165,0.936903684467355,1.0,6/13,21.09%,SEC16A;TMEM30B;BCAP31;SAR1B;EDEM2;TM9SF4
prerank,epithelial cell morphogenesis (GO:0003382),0.38112890715465714,0.8409515908430809,0.6431784107946027,0.9371161656770531,1.0,3/17,9.21%,MET;GRHL2;RAB25
prerank,regulation of vacuole organization (GO:0044088),0.37986212839022493,0.8406821498593879,0.6586466165413534,0.9371136669527277,1.0,2/20,4.76%,ANXA2;NPRL3
prerank,positive regulation of microtubule polymerization (GO:0031116),0.35894236718177963,0.8406585985714908,0.6616541353383458,0.9366651182012125,1.0,5/28,11.72%,MET;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,regulation of response to oxidative stress (GO:1902882),-0.3693806982724659,-0.8394450287853795,0.6748166259168704,0.8899295035127703,1.0,3/11,19.67%,MCTP1;STOX1;GGT7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3790787519346195,0.839035083530296,0.654320987654321,0.9391302681653894,1.0,5/20,15.02%,PID1;MRAP;RHOQ;CSK;PPFIA1
prerank,cell-substrate junction assembly (GO:0007044),0.3480106089460476,0.8383017411673593,0.6691394658753709,0.9399638876618015,1.0,8/33,12.78%,FN1;SORBS1;BCR;PIP5K1A;KRT14;CTTN;PLEC;TRIP6
prerank,cellular amino acid catabolic process (GO:0009063),-0.2298655609160565,-0.8380240240162019,0.8670212765957447,0.8915625799277408,1.0,29/87,28.90%,NOS3;DDO;ALDH7A1;ASPA;BCKDHB;ALDH4A1;QDPR;IVD;SARDH;MCCC2;CBS;ECHS1;GOT2;BCKDHA;AASS;GCDH;GLDC;GLUD1;NOS2;SHMT2;HAL;NOS1;HSD17B10;ACADSB;ALDH5A1;DAO;CRYM;BCKDK;ABAT
prerank,negative regulation of viral process (GO:0048525),-0.2454704036469366,-0.8376626675006341,0.8064516129032258,0.8912630554003358,1.0,22/57,27.94%,TRIM14;PPIA;IFITM1;BST2;TRIM62;IFITM3;OAS2;PROX1;RNASEL;STAT1;TRIM21;IFIT1;OASL;PARP10;TRIM27;BANF1;RSAD2;IFITM2;TRIM8;CCL5;TRIM32;TRIM6
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3439907894247621,0.8371715637784851,0.6861313868613139,0.9414843749234011,1.0,8/34,14.97%,UBASH3B;PTPRF;PTPN2;DUSP16;DUSP5;DUSP10;PTPN9;ACP4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4127084860460683,0.8369974186925545,0.6386138613861386,0.9413074932316547,1.0,2/11,6.08%,CD44;KDM1A
prerank,axonal fasciculation (GO:0007413),-0.3561253171683056,-0.8369507456470716,0.6878048780487804,0.8916277255610584,1.0,7/12,25.53%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,neurotrophin signaling pathway (GO:0038179),0.3799640996025009,0.8369038540063076,0.6909937888198758,0.9409922052076373,1.0,3/21,4.43%,NGF;RAP1A;KIDINS220
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3785960729526796,0.8368934157108389,0.6706948640483383,0.9405214794613739,1.0,3/20,6.03%,PID1;MRAP;RHOQ
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.29478290339621754,0.8367527949563393,0.7163289630512515,0.9402839624429411,1.0,16/101,11.55%,EGFR;PKD1;PDGFC;TCIM;ADRB2;FGFR1;FGF2;TELO2;ATP2B4;PDGFA;RHOA;SYAP1;VEGFA;CAB39;ERBB2;CCNYL1
prerank,N-glycan processing (GO:0006491),-0.3213858009783189,-0.836678990004824,0.6684931506849315,0.8911552743966764,1.0,5/18,8.43%,ST8SIA4;MAN1C1;ST8SIA6;MAN2A2;ST8SIA1
prerank,muscle cell development (GO:0055001),0.34779002402327996,0.8363809400637652,0.6891679748822606,0.9404838907876473,1.0,6/30,6.08%,ANK2;CXADR;HES1;DMD;NEBL;KDM1A
prerank,regulation of acute inflammatory response (GO:0002673),-0.319049513023298,-0.8358204229546479,0.6964285714285714,0.8917030182841257,1.0,2/18,10.57%,OSMR;IL6ST
prerank,glutathione derivative metabolic process (GO:1901685),-0.31570530314417095,-0.8357967772366229,0.699724517906336,0.8897411943019627,1.0,9/20,26.39%,HPGDS;GSTA4;MGST1;GSTK1;ESD;AKR1A1;GSTM1;GSTA3;MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.31570530314417095,-0.8357967772366229,0.699724517906336,0.8897411943019627,1.0,9/20,26.39%,HPGDS;GSTA4;MGST1;GSTK1;ESD;AKR1A1;GSTM1;GSTA3;MGST3
prerank,positive regulation of viral life cycle (GO:1903902),-0.300070497526702,-0.8350040118762129,0.676056338028169,0.8902106307197318,1.0,5/22,19.12%,LGALS1;AXL;TYRO3;CD74;P4HB
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3650236373825099,0.8345619095419451,0.6706766917293233,0.9431579885789886,1.0,11/25,27.02%,SCAF11;SRRM1;PRPF3;SF3B1;SNRNP40;TRA2B;DBR1;TXNL4A;SF3B3;SMNDC1;PRPF6
prerank,regulation of immunoglobulin production (GO:0002637),0.35609938178051304,0.8340588273440258,0.662557781201849,0.9435573777175514,1.0,3/23,8.47%,CLCF1;IL10;GPI
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3772067937676533,0.8340028818993989,0.6483870967741936,0.9431655669707477,1.0,11/18,37.33%,CDC25B;CCND1;RAD51C;CCNB1;MECP2;RAD51B;DTL;BRD4;RAB11A;FBXO5;CDK1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.39263590752751504,0.8339150551845774,0.6387096774193548,0.9428182216517039,1.0,2/15,6.08%,CD44;KDM1A
prerank,regulation of protein localization to cell periphery (GO:1904375),0.37459159291462496,0.8339013071387845,0.6581875993640699,0.9423498685514449,1.0,4/18,12.78%,MISP;STX8;MMP14;ZDHHC2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.30590489393727777,0.8336436141894636,0.724223602484472,0.9422990539123013,1.0,27/80,27.59%,PRICKLE1;FAM107A;KDM1A;RIPK2;BIRC7;MYCBP2;DCUN1D5;COMMD1;MTA1;FBXO4;CUL3;BCL10;FANCM;BIRC3;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;HUWE1;TSPYL5;SMAD7;TRAF6;ARRDC3;PHF23;CENPX;PEF1;RCHY1
prerank,DNA replication initiation (GO:0006270),0.343847385714409,0.8329925331180882,0.678082191780822,0.9429489216450864,1.0,12/37,25.31%,MCM7;MCM2;CDC45;PRIM2;POLE2;RPA1;PRIM1;TOPBP1;POLA1;NOC3L;CDK2;ORC3
prerank,receptor signaling pathway via STAT (GO:0097696),0.34937440733205627,0.8328673419946434,0.6738131699846861,0.9426844450191392,1.0,9/25,20.46%,PKD1;CLCF1;STAT3;SOCS2;CTR9;STAT5A;PIAS1;STAT6;STAT4
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.31799870957566756,-0.8321924957680454,0.6842105263157895,0.8945261367779587,1.0,3/18,8.02%,DCN;KDR;SPIRE1
prerank,MAPK cascade (GO:0000165),0.27151614735170065,0.8321168790840433,0.8090815273477813,0.943481353490015,1.0,37/295,11.11%,EGFR;MET;MAP3K5;SOX9;PTPN3;NRAS;KRAS;MRAS;SPTAN1;FGFR1;SHC1;FGF13;FGF2;IRS1;MEF2A;PDE6D;SHOC2;DLG2;ITGAV;GDNF;IL17RD;PTPRA;PSMB2;DLG1;MAP3K3;PDGFA;ABHD17B;DUSP5;CHUK;NFKB1;FBXW11;NF1;MARK3;PSMC6;MAPK12;CCL3;ERBB2
prerank,cholesterol transport (GO:0030301),0.3264563254058498,0.8318090176874309,0.6785225718194254,0.9435307588007005,1.0,7/45,12.80%,SOAT1;TSKU;LDLR;CLU;STARD4;LIMA1;LCAT
prerank,membrane fusion (GO:0061025),-0.2816487425949051,-0.831648345554548,0.7183544303797469,0.8945291616854539,1.0,3/33,3.39%,DNM3;RIMS1;DYSF
prerank,"transcription, DNA-templated (GO:0006351)",0.27783968824851235,0.831605085494233,0.7833511205976521,0.9433932720720756,1.0,52/207,23.80%,RNMT;MLLT3;DDX5;FOXO3;MEF2A;NR4A2;ZBTB7B;MNAT1;MBD1;AFF4;NFIX;NFYA;NFKB1;RBMX;RPAP1;SNAPC2;TTF2;TAF1C;CBFB;PPP5C;TTF1;ELOA;GTF2E1;CTR9;NELFE;HOXD3;BAZ2A;ERCC3;EPC1;CREBL2;TRIP11;DDX21;TAF12;POLR3K;TAF4;NCOA6;POLR3A;SMARCA5;CCNT1;RTF1;E2F1;NFX1;NFIC;RNGTT;THAP1;PRMT5;PAF1;UBTF;DRG1;TAF15;EAF2;CRCP
prerank,positive regulation of organelle assembly (GO:1902117),-0.25389350891604895,-0.8315582325268486,0.7490196078431373,0.8937055734956466,1.0,5/44,6.87%,ASAP1;CNOT6L;CEP120;CCDC88A;TAPT1
prerank,regulation of TORC1 signaling (GO:1903432),0.3433334581541301,0.8314155988348144,0.693502824858757,0.9432425502644775,1.0,9/33,12.58%,TELO2;KLHL22;CLEC16A;RRAGB;ITFG2;SIK3;ATM;SMCR8;CASTOR2
prerank,positive regulation of protein kinase activity (GO:0045860),0.2865513422704599,0.8313406548214176,0.7666290868094702,0.9429101492980033,1.0,20/148,10.86%,RASSF2;CCN1;PTK2B;DDR2;PRKCD;ADRB2;RAP1A;TELO2;TGFBR2;CLU;MARK2;RHOA;RIPK3;IQGAP1;SYAP1;VEGFA;CAB39;STRADA;CLSPN;ITGB3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3015994393401257,0.831004821842059,0.7270471464019851,0.9430276329686508,1.0,18/86,20.49%,EGLN3;NFE2L2;CREBBP;DDIT3;HIF3A;PSMB2;PSMC6;VEGFA;CHEK1;EP300;PSMD11;BAG3;PSMD1;PSMC1;PSMD7;INO80;PSMD14;PSMD3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3083570187336799,0.8306175447978353,0.7240506329113924,0.943237956099666,1.0,6/70,3.61%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,protein targeting to membrane (GO:0006612),0.2995361742120543,0.8305686215575628,0.7390761548064919,0.942838255915876,1.0,31/83,27.00%,ABCD3;PXMP2;ATG3;ZDHHC11;ACBD5;PARD3;ZDHHC15;SEC61A1;VPS37A;ZDHHC2;PEX13;GOLGA7;ZDHHC20;SEC63;VPS37B;ABCD1;ZDHHC23;RABGEF1;ZDHHC12;SRPRA;SLC25A17;PEX2;GET3;SIL1;PEX26;ZDHHC24;CHMP4A;CHMP4B;SRP19;PIKFYVE;CHM
prerank,intracellular lipid transport (GO:0032365),0.36246638030025835,0.8304948912360541,0.665625,0.9424848663026222,1.0,1/21,0.92%,ABCD3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4035039838132318,0.8304174115899079,0.6498371335504886,0.9421387752393833,1.0,2/12,6.12%,NIN;PCM1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3663937697727122,-0.8303553024924406,0.6828703703703703,0.8949071090817617,1.0,4/10,25.03%,PRKCZ;IL18;SPHK2;TSLP
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.30761476268079363,0.8302142679173832,0.7237008871989861,0.941997239433481,1.0,6/71,3.61%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2125394934465725,-0.8302074079432145,0.9196428571428571,0.8941677295331627,1.0,30/159,17.09%,TCF4;FMOD;SGIP1;PICALM;IMMP2L;RPL38;PIK3C2A;PDE4DIP;SNCA;HIP1R;MAPT;HSP90AB1;RTN4;HIP1;DNAI4;HOPX;COX7A2;NSG1;BIN1;POMP;CYBA;CASQ2;EIF4H;ANLN;EPS15;PTGES3L;GPX4;PTGES3;CHCHD4;HIGD1B
prerank,maturation of 5.8S rRNA (GO:0000460),0.3823652163896429,0.8297783292910591,0.6733128834355828,0.9422640371858975,1.0,9/17,22.70%,C1D;MPHOSPH6;EIF6;RPF1;PRKDC;RRP15;WDR12;URB1;FTSJ3
prerank,peptide hormone secretion (GO:0030072),0.3609991151949846,0.8297721420282115,0.6748466257668712,0.9417913000541761,1.0,3/26,9.16%,ANXA1;LTBP4;SNX19
prerank,genitalia development (GO:0048806),0.4047054524679624,0.8294678253811881,0.6566666666666666,0.9418316871570175,1.0,2/12,4.15%,PKD1;STRA6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.24515845851088983,-0.8293767723997983,0.7872340425531915,0.8946931420175247,1.0,20/55,24.09%,BCL2;TPD52L1;BCL2L1;DAB2IP;RPS3;TNFSF10;FAS;WWOX;BOK;BMF;AGT;NUPR1;RACK1;TNFSF12;HYAL2;GPER1;DNM1L;PMAIP1;PYCARD;G0S2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3808428552284491,0.8293063803229662,0.6682847896440129,0.9416443105143454,1.0,1/17,0.28%,BMP4
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.38615343220852283,0.8287190598360046,0.6616915422885572,0.9422133291000429,1.0,4/15,18.30%,ENTPD6;ENTPD2;ENTPD7;AK4
prerank,regulation of protein ubiquitination (GO:0031396),0.2931762149502647,0.8286098639561005,0.750291715285881,0.9419191143337636,1.0,23/108,21.01%,NXN;PRICKLE1;FAM107A;TGFBR1;HDAC8;RIPK2;BIRC7;MYCBP2;COMMD1;U2AF2;USP4;CHP1;FBXO4;GTPBP4;CUL3;SQSTM1;BCL10;PER2;BIRC3;UBE2N;WASHC1;DCUN1D1;HUWE1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2988119382733416,0.8282155357728364,0.7386634844868735,0.9421112884854004,1.0,8/93,7.11%,RASSF2;MAP3K5;PTK2B;MID1;FZD7;GADD45G;WNT16;GDF6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2907663552116026,-0.8281209879224847,0.7212121212121212,0.8959329062235295,1.0,7/25,20.70%,HSPA8;ERO1A;HSPA13;PTGES3;DNAJB5;HSPE1;HSPA9
prerank,response to axon injury (GO:0048678),0.38326892447440103,0.8268237151642706,0.6639209225700164,0.9440692735338486,1.0,1/18,0.87%,DPYSL3
prerank,nucleoside salvage (GO:0043174),0.4210249864978238,0.8261154330682277,0.66553480475382,0.9448317115443213,1.0,3/10,15.90%,UPP2;TK1;TK2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.35070976554468486,0.8256878122049781,0.6686217008797654,0.945062942012544,1.0,10/29,18.04%,ZC3H7A;SMAD2;DGCR8;PUM2;PUS10;TUT7;PUM1;AGO2;TUT4;DROSHA
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.402948982237773,0.8253944331180031,0.6415410385259631,0.9450739213577658,1.0,2/13,3.29%,FGFR1;FGF2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.36649551817796205,-0.8246392669735815,0.6715328467153284,0.9012468386462048,1.0,2/10,13.57%,CD81;CD74
prerank,regulation of axon extension (GO:0030516),0.3353894175446775,0.8245869463513912,0.6770098730606487,0.9459682062984437,1.0,4/37,5.51%,NTN1;GSK3B;ABL1;SHTN1
prerank,platelet aggregation (GO:0070527),0.34086662188119327,0.8243038119097914,0.6997126436781609,0.945996188839476,1.0,6/33,10.86%,FN1;UBASH3B;VCL;CLIC1;GATA1;ITGB3
prerank,response to histamine (GO:0034776),-0.3729851413879116,-0.8241372218111771,0.696969696969697,0.9011424095447966,1.0,4/10,15.04%,GABRB1;GABRB2;GABRB3;HRH1
prerank,cellular response to fluid shear stress (GO:0071498),0.4019642170995404,0.8241259477217265,0.6766666666666666,0.9458124057460272,1.0,2/12,3.18%,KLF4;NFE2L2
prerank,DNA conformation change (GO:0071103),0.3774730948679494,0.8240684038679853,0.6778309409888357,0.9454282919973811,1.0,7/17,27.45%,ABL1;TOP1;ERCC3;TOP3A;TOP1MT;HAT1;KAT6A
prerank,protein localization to condensed chromosome (GO:1903083),0.40131518109085623,0.8240082214285849,0.6704545454545454,0.9450472144124752,1.0,6/12,28.26%,SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.26912001463476554,-0.8237612846866118,0.75,0.900827257317224,1.0,12/37,22.75%,BCL2;BCL2L1;RPS3;RPS7;BOK;BMF;NUPR1;RACK1;NACC2;MSX1;DNM1L;PMAIP1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.32815282710308097,-0.8235110743207577,0.6889460154241646,0.900264053358646,1.0,6/15,19.73%,RYR2;SRP14;ZFAND2A;SPCS3;SEC61G;SPCS1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2865763493841498,0.8232543749442223,0.7552204176334106,0.9459159762155338,1.0,7/117,5.06%,ME1;SLC5A6;SLC16A1;ADH7;VNN1;ACSL3;CYP2S1
prerank,regulation of immune response (GO:0050776),0.2852709761961713,0.8231630896830909,0.749438202247191,0.945584167040711,1.0,11/135,9.52%,FOXP1;CXADR;COL3A1;ITGB1;RAET1E;SPPL2A;PLSCR1;IRF1;PVR;RIPK3;TREML1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3037715769727231,-0.8231232833546174,0.7254335260115607,0.8999659807478132,1.0,6/22,15.48%,INSR;CD63;ARRB1;NTF3;ARRB2;GREM1
prerank,regulation of primary metabolic process (GO:0080090),0.2875062820493436,0.8230672755244386,0.7538461538461538,0.9452579760375954,1.0,31/126,19.38%,TNFAIP8L3;CHD9;CREBBP;LDLR;TBL1X;PSMB2;ID2;RXRA;NFYA;SCD;PSMC6;MVD;NCOR1;HNF4A;PSMD11;AZIN1;NCOR2;PLPP1;PSMD1;HMGCR;NQO1;PSMC1;PSMD7;SREBF1;CARM1;NCOA6;FDPS;PPARG;ABCA7;ADIPOR1;PSMD14
prerank,protein tetramerization (GO:0051262),0.3069611906759083,0.823032403857768,0.7391857506361323,0.9448445150847311,1.0,2/67,1.11%,KCNJ2;PKD1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.37755469249037854,0.8230257619814328,0.6677265500794912,0.9443760922984844,1.0,3/18,10.57%,COX16;COA8;SCO2
prerank,toxin transport (GO:1901998),0.42179229916743033,0.8228943211243035,0.6626916524701874,0.9441195484692978,1.0,3/10,15.41%,ANTXR1;ANTXRL;ADAM10
prerank,dendritic cell migration (GO:0036336),-0.31992045017877435,-0.8227865370438485,0.6798941798941799,0.8995495982155454,1.0,4/16,19.01%,EPS8;CCL19;CCR5;PIK3CG
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.29229250490862607,0.8226024701998681,0.7387606318347509,0.9441599212180651,1.0,16/95,12.85%,LBP;ADAM9;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9
prerank,cellular polysaccharide catabolic process (GO:0044247),0.38647999638322633,0.8225860408063507,0.6635367762128326,0.9437041472260292,1.0,3/16,8.72%,PYGB;PHKA2;PHKB
prerank,response to muramyl dipeptide (GO:0032495),0.39580392770533257,0.8225241188386003,0.6604414261460102,0.9433356897573132,1.0,3/12,10.68%,RIPK2;ERBIN;TRIM41
prerank,cellular response to hypoxia (GO:0071456),0.2851164907779073,0.8223120965787942,0.7639046538024972,0.9432490788923674,1.0,24/126,18.30%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;CREBBP;HIF3A;PSMB2;PLK3;MDM4;RORA;HILPDA;PSMC6;VEGFA;CARD16;MTOR;EP300;PSMD11;PSMD1;TWIST1;PSMC1;PSMD7;ADAM8;AK4
prerank,RNA metabolic process (GO:0016070),-0.21196735442596232,-0.8220411695615959,0.8914728682170543,0.8999414341327384,1.0,31/127,20.24%,RBPMS;RBMS1;NOVA1;ATXN1;APOBEC1;HNRNPA0;ADARB2;ELAVL4;SETX;METTL14;AGO4;RNASEL;CELF2;FASTKD2;POLR2G;HNRNPH3;ADARB1;DDX20;TFIP11;ADAR;PABPN1;PCBP1;PCBP3;POLR2K;RNASE4;AGO1;DDX54;DDX3X;MTREX;NUFIP1;RNASEH2B
prerank,positive regulation of growth (GO:0045927),0.3135071771168421,0.8218668969565459,0.7180500658761528,0.9435574689084769,1.0,17/64,20.42%,EGFR;TGFBR1;EIF4G1;KLHL22;AGR2;MMP14;ERBB2;USP47;ADAM10;CEP43;DDX49;DNPH1;BRAT1;INO80;CSNK2A1;TGFB2;EIF4G2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.35819350599128924,0.8215030128723455,0.6762048192771084,0.9436731827377811,1.0,6/24,17.02%,NFE2L2;DDIT3;VEGFA;ATF6;CREB3L1;CREB3L3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.332502819604982,0.8214778348331253,0.6700581395348837,0.9432371972494624,1.0,13/37,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.349009961141076,0.821024339260605,0.6671664167916042,0.943537773673701,1.0,10/29,27.05%,ABL1;DCUN1D5;FEM1B;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;SMAD7;ARRDC3;FEM1A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.34961935001890293,0.8207804905262198,0.6631578947368421,0.9434712216039224,1.0,7/24,20.77%,FOXO3;DDIT3;NF1;CCL3;TFAP2A;TGFB2;MCL1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3736156867131017,0.8205339036893775,0.7080645161290322,0.9434262421750317,1.0,3/18,9.84%,LBP;IFI35;PLCG2
prerank,regulation of phosphate metabolic process (GO:0019220),0.3755362471874958,0.8204247144565132,0.6568627450980392,0.9431438217715451,1.0,5/16,17.18%,SMG6;MCM7;RAD17;GNB3;BARD1
prerank,regulation of cell adhesion (GO:0030155),0.282896907310799,0.8203894181493054,0.7691428571428571,0.9427259742897696,1.0,21/129,15.41%,ZFHX3;PPP3CA;PTK2B;EFNA5;ARHGDIB;GPR4;ABL1;ITGAV;EPHB3;CHRD;ATM;PPP1R12A;VEGFA;ERBB2;ITGB1BP1;ZDHHC2;CXCR4;RSU1;PRKCA;PLXNA2;ADAM10
prerank,positive regulation of interleukin-10 production (GO:0032733),0.33933095098565125,0.820082522295744,0.6954022988505747,0.9428144654083586,1.0,5/30,13.32%,STAT3;TLR4;CD46;PLCG2;PIBF1
prerank,synaptic vesicle transport (GO:0048489),0.4115373748853907,0.8197327699549172,0.6604414261460102,0.9429557363584868,1.0,3/11,13.79%,SPG11;TMEM230;SYNJ1
prerank,long-term synaptic potentiation (GO:0060291),0.3668850253745789,0.8196450260646271,0.6852713178294574,0.9426317454437159,1.0,3/21,5.30%,PTK2B;MPP2;NFATC4
prerank,vacuolar acidification (GO:0007035),0.35900811938552785,0.8196140397833909,0.6832298136645962,0.9422139543068909,1.0,6/21,20.33%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H;CLN3
prerank,melanosome organization (GO:0032438),0.3507187410475278,0.8195121625745359,0.6707132018209409,0.9419152298735625,1.0,6/26,18.18%,KIF13A;AP3B1;HPS4;PMEL;LYST;AP3D1
prerank,myelination (GO:0042552),0.3233606523319881,0.8194706051891533,0.6873315363881402,0.9415060574708037,1.0,8/46,9.90%,ACER3;MARVELD1;PMP22;SKI;ARHGEF10;PARD3;NF1;ADGRG6
prerank,presynaptic endocytosis (GO:0140238),0.35536305007337243,0.8194105529998404,0.6832844574780058,0.9411432457579428,1.0,5/24,13.79%,STON1;STON2;SYT8;FCHO2;SYNJ1
prerank,activation of GTPase activity (GO:0090630),0.29504028463880067,0.8184022958602688,0.7253948967193196,0.9424341021184707,1.0,25/89,16.46%,NTRK3;SGSM2;SIPA1L1;DOCK7;BCR;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;ARHGEF10;TBC1D2B;TBC1D13;ARHGEF5;TIAM1;TBC1D25;CORO1C;RAP1GAP2;ARHGAP42;SIPA1L2;TBC1D10A;TBC1D8B;TBC1D5;GPR65;SGSM3
prerank,regulation of secretion by cell (GO:1903530),0.3114532991463401,0.8180917617275346,0.7164179104477612,0.9424770034096303,1.0,5/54,7.94%,SNCAIP;DISP1;ANXA1;P3H1;NSF
prerank,regulation of actomyosin structure organization (GO:0110020),0.39449095954954794,0.8179530509256402,0.6903973509933775,0.9422471952045539,1.0,3/13,12.40%,AKAP13;SLC9A1;ASAP3
prerank,serine family amino acid metabolic process (GO:0009069),0.37877307131587534,0.8176696941049846,0.6785109983079526,0.9422541922633224,1.0,2/16,11.24%,GCLC;CDO1
prerank,cardiac cell development (GO:0055006),0.3941636249388521,0.8174281879678936,0.6536412078152753,0.9421893082608696,1.0,3/11,10.34%,CXADR;JAG1;VEGFA
prerank,dendrite morphogenesis (GO:0048813),0.3334259953878333,0.8165760911026932,0.7104136947218259,0.9431978935700447,1.0,8/35,11.72%,CTNND2;PHACTR1;MEF2A;KLF7;EPHB3;SHANK1;BTBD3;FARP1
prerank,histone mRNA catabolic process (GO:0071044),0.39301253459466057,0.8163765919861391,0.6920529801324503,0.9430748471182221,1.0,9/15,32.48%,ATM;TUT7;TUT4;TENT2;SSB;ERI1;EXOSC4;MTPAP;XRN1
prerank,postreplication repair (GO:0006301),0.3212201229861526,0.8161349802130459,0.7020979020979021,0.9430153693181523,1.0,17/45,29.00%,VCP;UBE2B;USP10;ZBTB1;NSMCE1;RPA1;RFC1;REV1;TRIM25;UBE2N;POLD3;RFC5;UBE2V1;POLK;POLI;PRIMPOL;UBE2A
prerank,histone H3 acetylation (GO:0043966),0.3325003921733351,0.8161155858556965,0.7219973009446694,0.9425827484752488,1.0,23/40,30.09%,KAT6B;TADA3;SGF29;BRCA2;PER1;KAT2A;BRD1;KAT2B;TRIM16;TAF12;YEATS2;PHF14;LDB1;MAP3K7;JADE2;KAT14;KAT6A;NAA60;TAF9;TADA2A;TAF6L;TADA1;TAF5
prerank,cellular response to UV-A (GO:0071492),-0.35612306848230224,-0.8160537729870554,0.6682692307692307,0.9096837663127236,1.0,9/11,41.63%,CERS1;MMP2;MME;MMP3;OPN3;OPN5;MMP9;MMP1;OPN1SW
prerank,amide biosynthetic process (GO:0043604),0.3171685298791772,0.815973739806277,0.6948924731182796,0.9423594087106758,1.0,5/47,6.97%,PCSK5;SGMS2;DMD;SPTSSB;NANP
prerank,regulation of cellular component size (GO:0032535),0.3463037086881515,0.8159019852068733,0.706997084548105,0.9420210171529915,1.0,7/30,15.69%,EZR;VAV2;RDX;RARG;RAP1GAP2;MTOR;RIN3
prerank,regulation of nervous system development (GO:0051960),0.33262651075497396,0.815191583170739,0.710334788937409,0.9427588510979342,1.0,9/37,22.52%,HES1;DOCK7;BHLHE40;TNFRSF1B;PER2;HEYL;YTHDF2;HES3;HES7
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.39353427655803624,0.8150495938125278,0.6968698517298187,0.9425393898415481,1.0,4/13,10.34%,SEMA3E;NRP1;TGFBR2;VEGFA
prerank,nucleoside phosphate catabolic process (GO:1901292),0.38475469493928405,0.8149090708453014,0.6804835924006909,0.9423165189046488,1.0,5/13,14.68%,ENTPD6;ENTPD2;SMPDL3A;ENTPD7;NUDT15
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.36421387489332013,0.8148037707002437,0.6756756756756757,0.9420218382537769,1.0,2/20,2.86%,NT5E;ANO6
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.36727442460744675,0.8147243808076859,0.6853035143769968,0.9416803177663993,1.0,3/18,6.18%,USP13;RNF185;DDIT3
prerank,regulation of protein kinase A signaling (GO:0010738),0.369107754465986,0.8146408737351308,0.6682316118935837,0.9413484572805941,1.0,2/20,2.69%,TCIM;ADRB2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.28514751866427385,0.8142856967105819,0.7517647058823529,0.9414676222939896,1.0,24/109,17.17%,PPP3CA;VAV2;SHC1;GAB2;NR4A3;TAB3;PSMB2;CHUK;NFKB1;FBXW11;PLCG2;JUN;PSMC6;MAP2K4;NFATC3;PAK2;PSMD11;NFATC1;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,regulation of catabolic process (GO:0009894),0.3695104633988928,0.8136198253404967,0.6671802773497689,0.9421333338679665,1.0,8/18,29.11%,ITGB1;CHEK2;ZDHHC2;SNF8;HGS;ODC1;FAF1;ZDHHC7
prerank,neutrophil migration (GO:1990266),-0.2368706607005494,-0.8136106524605013,0.8223140495867769,0.9129042496755958,1.0,13/58,20.93%,PECAM1;PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;PRTN3;SYK
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.396394246631691,0.8128249250836819,0.6743421052631579,0.9429865428042716,1.0,2/12,5.64%,CD80;ISL1
prerank,muscle contraction (GO:0006936),0.28160533400966864,0.8125412919718666,0.7752027809965237,0.9429719283123105,1.0,11/126,5.73%,EDNRA;SORBS3;CALD1;SORBS1;ITGB5;MYOM3;TMOD3;VCL;DMD;MYBPC2;SNTA1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3117463489444857,-0.8119111008960674,0.6932668329177057,0.9147830497674801,1.0,6/18,15.25%,VCAM1;SLC39A8;ITGA4;JAM2;ADD2;GCNT1
prerank,mitotic sister chromatid segregation (GO:0000070),0.28576160529347067,0.8118249440475507,0.7541766109785203,0.9437510543875337,1.0,34/98,30.36%,SMC4;BECN1;KLHL22;PDCD6IP;RB1;SMC1A;NIPBL;PIBF1;CUL3;NCAPH2;DIS3L2;KNSTRN;KMT5A;INO80;CSNK2A2;CSNK2A1;SPDL1;ZW10;RAN;KIF2C;CCNB1;TEX14;AKAP8L;POGZ;CHMP4A;CHMP4B;NAA50;KIF18A;MCPH1;CENPK;NCAPD3;SMC2;PINX1;RAD21L1
prerank,protein-containing complex subunit organization (GO:0043933),0.28927662939899695,0.8117947309743893,0.782051282051282,0.9433293432516531,1.0,27/109,21.80%,REPS2;SOX9;PTK2B;HES1;CREBBP;MNAT1;DMTN;TEAD1;MDM4;SHANK1;PARD3;MATN1;CAPZA1;SLC7A9;MAGI1;PML;IKBKG;TUBGCP4;GPAA1;ZW10;CAPZA2;NUP98;DET1;EPRS1;SPG7;LLGL1;DLG4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.33223149562353105,-0.8117657015101482,0.6982968369829684,0.9140119296373369,1.0,4/13,19.66%,KDR;EDN1;SELENOS;CCL2
prerank,fatty acid transmembrane transport (GO:1902001),0.3600478898172476,0.8117602362006155,0.6764705882352942,0.9429137270262636,1.0,1/19,0.92%,ABCD3
prerank,replicative senescence (GO:0090399),0.4001286925648276,0.8112384600895733,0.6786296900489397,0.9433323166035411,1.0,5/12,17.95%,WNT16;CHEK2;ATM;CHEK1;ATR
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.28498218992356156,-0.8112107863235766,0.7394957983193278,0.913958750030648,1.0,1/25,0.18%,IGF1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.35479656119283404,0.8107562450019113,0.6976744186046512,0.9437041050415081,1.0,2/22,6.60%,NFE2L2;PSMB2
prerank,ovarian follicle development (GO:0001541),0.3934176779351828,0.8106431874404614,0.6915077989601387,0.9434207953755956,1.0,4/13,15.26%,INHBA;VEGFA;INHBB;EIF2B2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.38854381839499696,0.81019927944674,0.6666666666666666,0.9437015527084183,1.0,4/15,18.25%,MKNK2;VCP;ZC3H12A;DHX36
prerank,serine family amino acid catabolic process (GO:0009071),-0.35344292616232986,-0.8099242742931694,0.6905940594059405,0.9151961411967932,1.0,5/10,33.17%,CBS;GLDC;SHMT2;DAO;THNSL2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.346635398306655,0.8097438659812245,0.7086383601756955,0.9439907795812567,1.0,2/30,3.24%,BMP5;GSK3B
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.31093862528578287,-0.80973885310494,0.7358490566037735,0.914525722811934,1.0,2/17,4.38%,CTNNA2;WASF3
prerank,Golgi ribbon formation (GO:0090161),0.3870462069028929,0.8092247710797877,0.6817447495961227,0.944378990949068,1.0,4/13,16.16%,TMED5;GOLPH3;VTI1A;TRIP11
prerank,peptide catabolic process (GO:0043171),0.3506475351737386,0.8090758142801389,0.6919504643962848,0.944186905503559,1.0,7/23,15.91%,NPEPPS;CPQ;XPNPEP1;IDE;ERAP1;ECE1;DPEP1
prerank,membrane protein proteolysis (GO:0033619),0.32468602005374064,0.8090688291344493,0.7048022598870056,0.9437303773953934,1.0,15/37,25.85%,ADAM9;SPPL2A;BACE2;NFKB1;RBMX;ERAP1;CLPP;ADAM10;RET;MBTPS1;PARL;SPPL2B;TRAF6;SPPL3;NAPSA
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.34579628369476234,-0.8090303563096147,0.687192118226601,0.9147402372055327,1.0,4/12,12.59%,SLC5A3;GRIN1;CYBA;ADGRB1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2989541626711237,-0.8083624100017265,0.7238372093023255,0.9149086342659333,1.0,5/21,10.26%,MFHAS1;PPP1R16B;PPP4R4;YWHAB;TIPRL
prerank,RNA destabilization (GO:0050779),0.3690713244437247,0.808124395244184,0.6940993788819876,0.9448191992157497,1.0,9/18,26.48%,FTO;CELF1;DXO;ZC3H18;PUM1;YTHDF2;ROCK1;YTHDF3;MEX3D
prerank,regulation of stem cell differentiation (GO:2000736),0.28854449415948047,0.8080787752228675,0.765142150803461,0.9444264646015383,1.0,16/89,17.12%,HES1;BMPR1A;ABL1;GDNF;PSMB2;JAG1;GATA1;HOXB4;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMC1;PSMD7
prerank,mitochondrial transport (GO:0006839),-0.24155294108337905,-0.8078320481619092,0.8209606986899564,0.9148466563118319,1.0,19/53,28.61%,BCL2;BCL2L1;TIMM17A;TOMM7;STARD3;TMEM14A;MFN2;COX18;TOMM40;ABCB10;TOMM22;SLC25A13;PMAIP1;MFF;SLC25A4;TMEM14C;BCS1L;SLC25A31;FBXO7
prerank,negative regulation of cell adhesion (GO:0007162),0.30166981472806464,0.8074997437725793,0.7569974554707379,0.9449581894275799,1.0,7/72,6.70%,CDH1;CYP1B1;ARHGDIB;FZD7;GCNT2;DMTN;JAG1
prerank,negative regulation of immune effector process (GO:0002698),0.3842789166108795,0.8073076563572587,0.6688524590163935,0.9448232172158045,1.0,1/13,1.39%,CD55
prerank,fluid transport (GO:0042044),0.3992524041569054,0.8070063588962869,0.6722972972972973,0.9448452279438343,1.0,2/12,9.82%,SLC26A6;AQP6
prerank,cellular response to insulin stimulus (GO:0032869),0.2814052570674674,0.8069925517854339,0.7844036697247706,0.9443969015045929,1.0,25/124,16.01%,HDAC9;GRB10;SORBS1;SHC1;ATP6V0A4;GSK3B;IRS1;FOXC2;SLC39A14;PTPN2;RHOQ;IDE;BCAR3;C2CD5;LPIN2;SYAP1;CAPN10;INHBB;PIK3R3;PRKDC;ATP6V0D1;TCIRG1;GAB1;ATP6V0E1;KAT2B
prerank,energy reserve metabolic process (GO:0006112),0.3664196608182728,0.8069618328987694,0.7072784810126582,0.9439782064493141,1.0,3/19,3.24%,PID1;PPP1R3C;GSK3B
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2816137381106176,-0.8069427810722756,0.7699115044247787,0.9153597031347348,1.0,7/27,14.71%,PPP1R16B;CALM1;PPIA;BMP2;PPP2R5A;CALM3;SMPD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.30091033870961587,-0.8064435769405361,0.7632311977715878,0.9152387277543277,1.0,3/22,12.94%,NR2F2;MYOCD;HHEX
prerank,RNA catabolic process (GO:0006401),0.31609564329617246,0.8063923642098418,0.717741935483871,0.9444653345067945,1.0,13/46,22.72%,SIDT2;DXO;PABPC4;EXOSC7;ZC3H12D;RNASEH2A;NUDT12;DIS3L2;RNASE6;LSM2;YTHDF2;NANOS2;RNASE3
prerank,purine-containing compound salvage (GO:0043101),0.39627409023403737,0.805807696725355,0.6919104991394148,0.944961701225762,1.0,5/12,24.85%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4151551576908816,0.8057776059720384,0.679646017699115,0.9445530623556115,1.0,5/11,33.14%,RENBP;UAP1;GFPT1;GNPDA1;AMDHD2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.35168360600075854,0.8057048007187672,0.69558599695586,0.9442020656682868,1.0,3/24,4.29%,PID1;COQ10B;NR4A3
prerank,snRNA processing (GO:0016180),0.3711097972802361,0.8055921330131016,0.6905158069883528,0.9439259934472629,1.0,8/16,32.88%,INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;INTS7
prerank,regulation of cardiac muscle contraction (GO:0055117),0.33034864050215473,0.8055404147567801,0.7060518731988472,0.9435485921858728,1.0,5/34,9.36%,ANK2;ATP1B1;P2RX4;SLC9A1;TNNI3
prerank,triglyceride catabolic process (GO:0019433),0.3724277984238907,0.8055363935118762,0.6962233169129721,0.943088382687794,1.0,1/19,3.45%,PNPLA3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.37413036297923324,0.8053243947719813,0.696078431372549,0.9429795448073144,1.0,6/17,22.64%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.31293436609515923,-0.8049319059811797,0.7206982543640897,0.9168318403892481,1.0,4/16,15.12%,CECR2;CASP3;KPNB1;FOXL2
prerank,neuron projection morphogenesis (GO:0048812),0.28052984452813384,0.8048848889432911,0.7886363636363637,0.9432470500295945,1.0,21/137,10.29%,DCLK1;NGF;CTNND2;DOCK7;ALCAM;SRGAP2;MEF2A;KLF7;SHTN1;ISL1;TRIO;ANKRD27;EPHB3;NBL1;SHANK1;MAP1B;IQGAP1;PARD3;BTBD3;NCKAP1;CTTN
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2833814451577255,0.8048725108557209,0.7714285714285715,0.9428034641408243,1.0,14/110,13.52%,TRABD2B;MPP7;GSN;GSK3B;VCP;ISL1;CLU;KIF9;VEGFA;RB1;SPIDR;EP300;SH3GLB1;HCFC1
prerank,positive regulation of viral process (GO:0048524),-0.23528340621422605,-0.8045965689505886,0.8605769230769231,0.9164129304550428,1.0,15/60,19.04%,PPARA;PPIA;HACD3;AXL;NELFCD;NR5A2;POLR2G;TYRO3;ADARB1;TARBP2;IFIT1;ADAR;POLR2K;DDX3X;PPIE
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.416874351513848,0.8038332020282279,0.687392055267703,0.9440150417101673,1.0,2/10,6.40%,WNK1;ADA
prerank,heme biosynthetic process (GO:0006783),0.3511681358193801,0.803800002547276,0.7340764331210191,0.9436096933836312,1.0,7/22,22.23%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.38401709557505226,0.8037985570270786,0.6996753246753247,0.9431472484688593,1.0,2/15,6.11%,DDR2;LRP1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3262989668648374,-0.8037396363520736,0.7349081364829396,0.9168716415674718,1.0,2/14,1.98%,CACNA1D;NOS3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.35895229731256717,0.8036647674542818,0.7245508982035929,0.9429232606313078,1.0,8/23,27.48%,RAD23B;COPS7B;COPS5;XPA;CUL4A;COPS3;XPC;COPS2
prerank,histone H2A monoubiquitination (GO:0035518),-0.30798268903232645,-0.8035900472591406,0.7377892030848329,0.9161113546245949,1.0,2/17,7.27%,PCGF5;KDM2B
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.28968008268288714,0.8035045302406992,0.7593052109181141,0.9427218579790613,1.0,23/85,22.07%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;AP2A1;RHOA;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMC1;PSMD7;PSMD14;DVL1;FZD2;PSMD3;CDC42;FZD3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2907817415560935,-0.8033235914683557,0.7335243553008596,0.915541760535178,1.0,5/23,15.10%,CADM1;PIK3R6;NECTIN2;LAMP1;ARRB2
prerank,stem cell differentiation (GO:0048863),0.3192989706959255,0.8030249994972434,0.719225449515906,0.9430556344353774,1.0,7/39,15.27%,MLLT3;LRP6;SETD2;HOXB4;PSMD11;HTR2B;PUM1
prerank,mitotic nuclear membrane organization (GO:0101024),0.3125538099669486,0.8030037693419251,0.7490196078431373,0.9421574084810821,1.0,15/51,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3125538099669486,0.8030037693419251,0.7490196078431373,0.9421574084810821,1.0,15/51,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,glycerolipid catabolic process (GO:0046503),0.36210280111842863,0.8027774033188497,0.7274167987321711,0.9420673685985366,1.0,7/19,20.47%,MGLL;PLA2G4F;ABHD6;LYPLA2;GDPD3;ABHD2;PLA2G4A
prerank,maturation of LSU-rRNA (GO:0000470),-0.2840863613100407,-0.802608446422833,0.7551020408163265,0.9157648881498724,1.0,10/26,25.89%,NSA2;SNU13;RPL7;RPL10A;NIFK;LAS1L;RPL7A;RPL35;NHP2;ZNHIT6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3545430484451134,0.8023163226981519,0.6848,0.9423643035937014,1.0,5/22,8.86%,CAMK2D;MEF2A;NR4A3;P2RX4;SLC9A1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.36431807710726927,-0.801941508758621,0.7292161520190024,0.9158611114823775,1.0,3/10,20.32%,IL18;ROCK2;HRG
prerank,multivesicular body assembly (GO:0036258),0.335293353643207,0.8012426652380422,0.7138686131386861,0.9436715309065141,1.0,10/30,25.39%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,positive regulation of transferase activity (GO:0051347),0.27582612973909243,0.8011453947780388,0.8224719101123595,0.9433858555557216,1.0,8/142,3.44%,EGFR;MET;NTRK3;LMO4;DDR2;FGFR1;KLF4;NEK7
prerank,cardiocyte differentiation (GO:0035051),0.4031985600815231,0.8009834997536929,0.7031539888682746,0.9431855206208491,1.0,1/10,2.03%,AKAP13
prerank,regulation of glucose metabolic process (GO:0010906),0.3336658224415699,0.8009115155704004,0.7114285714285714,0.9428452002795837,1.0,9/34,19.22%,IRS1;FOXK1;RORA;USP7;FOXK2;PDK3;GNMT;GNB3;ADIPOR1
prerank,RNA transport (GO:0050658),0.2995642638867633,0.8008755063332542,0.7660377358490567,0.9424419845325239,1.0,20/71,20.06%,TGFBR2;SIDT2;SRSF11;THOC2;SRSF5;SRSF6;U2AF2;ATXN2;NUP153;SRRM1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;ZC3H11A;THOC5;NXF1;SRSF2;FMR1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3556491028076866,-0.8007801023783163,0.7037037037037037,0.9168691622325491,1.0,4/10,41.93%,ARRB2;CX3CR1;FCGR2B;KLRC1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34506463015121935,0.8005793812168398,0.7015151515151515,0.9424628343227706,1.0,6/24,12.36%,KCNB1;C2CD5;ERBB2;MIEF1;ITGB1BP1;CHP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.29720737560973576,0.8003681956528248,0.7455919395465995,0.9423573316432224,1.0,21/72,27.48%,MNAT1;ERCC5;UVSSA;COPS7B;USP7;COPS5;EP300;ERCC8;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;COPS3;POLK;GTF2H3;COPS2
prerank,snRNA 3'-end processing (GO:0034472),0.3654946247006453,0.8002632985369662,0.707740916271722,0.9420842445749048,1.0,10/19,32.88%,EXOSC7;INTS8;INTS5;INTS6;INTS1;INTS2;EXOSC4;EXOSC2;EXOSC3;INTS7
prerank,RNA processing (GO:0006396),0.27363945775238685,0.7995040481752081,0.8091603053435115,0.9429028790863485,1.0,66/176,27.42%,MBNL1;SON;DDX17;SNRNP48;RBM6;SRSF11;CDK12;SRSF5;SYNCRIP;HNRNPH1;CELF1;CELF3;RBM39;FUS;PABPC4;DUSP11;U2AF2;TCERG1;ZCCHC8;SCAF11;SRRM1;TUT7;PRPF3;KIN;SF3B1;SF3B2;PPIG;RNPC3;TUT4;SRPK1;SCNM1;DROSHA;SNRNP35;WBP4;SNRNP40;SRSF2;TSEN54;PRPF18;NRDE2;ALKBH5;TENT2;NOL3;RBM3;ZCRB1;RNGTT;FASTKD5;RBM5;RBM4;TARDBP;AKAP8L;LSM4;NUDT21;DHX8;RSRC1;SRPK2;BICD1;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;DDX47;PDCD7;PRPF6;CLP1;PRKACA;SRSF7
prerank,protein localization to cell junction (GO:1902414),0.34982426635192587,0.7990513168307144,0.7082706766917293,0.943223694858773,1.0,5/22,9.65%,DSP;BSN;NPHS1;SHANK1;PCLO
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.31869366822488726,0.7987244879520825,0.731638418079096,0.9432980781691267,1.0,6/41,8.37%,PTPRU;PLPP3;CD44;GCNT2;IL10;DENND6A
prerank,phospholipid transport (GO:0015914),0.30531595264038436,0.7986077471488008,0.7342465753424657,0.9430331304570188,1.0,9/52,12.75%,TNFAIP8L3;PITPNC1;ATP10A;PITPNA;LDLR;ATP8B1;TMEM30B;ATP9B;ATP11A
prerank,chromosome condensation (GO:0030261),0.3208823896275911,0.7982048578113865,0.7178002894356006,0.9432319859905813,1.0,15/36,29.52%,SMC4;RB1;ERN2;NCAPH2;DFFB;KMT5A;CSNK2A2;CSNK2A1;AIFM1;CCNB1;AKAP8L;MCPH1;NCAPD3;ACIN1;SMC2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.343369515330241,0.7979435336370249,0.7217125382262997,0.9432151035808397,1.0,4/27,9.48%,GPR4;AGTR1;LPAR4;DRD3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24470176874977226,-0.7975161371538558,0.8262411347517731,0.9212899515139342,1.0,13/45,18.82%,WNT5A;APP;AIM2;GSDMD;P2RX7;CCL19;MALT1;LPL;TYROBP;CASP1;FZD5;GBP5;HSPB1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3946549172482621,0.7973174911417041,0.7046204620462047,0.9437207295822084,1.0,2/12,3.31%,PTK2B;NOTCH2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.40936392554596346,0.7967857901575505,0.6850533807829181,0.9441176937114977,1.0,2/10,11.32%,CLU;RB1
prerank,peptidyl-arginine modification (GO:0018195),-0.31921810193315003,-0.7965770676253543,0.7444444444444445,0.9218949101390039,1.0,10/15,36.08%,ART3;PRMT1;KRTCAP2;PADI2;PRMT7;PARK7;ART1;PADI1;PADI4;ART4
prerank,negative regulation of cell communication (GO:0010648),0.3549893486433107,0.7964038767618775,0.7226753670473083,0.9442593145789262,1.0,4/21,10.43%,UBASH3B;HHIP;ACVR1;SRMS
prerank,cholesterol efflux (GO:0033344),0.3509237987236898,0.7961050920661213,0.6967340590979783,0.9442615691006531,1.0,2/20,5.21%,SOAT1;TSKU
prerank,nitric oxide biosynthetic process (GO:0006809),0.38830778804456173,0.7960105581674519,0.6972789115646258,0.943945307628745,1.0,1/13,1.54%,CYP1B1
prerank,protein-DNA complex assembly (GO:0065004),0.2780511694774435,0.795301143230365,0.7846332945285215,0.9446602547724414,1.0,25/116,20.49%,SOX9;CHAF1B;KAT6B;MNAT1;PSMB2;ERCC5;CHD1L;MCM7;MCM2;RAD23B;PSMC6;ATRX;PSMD11;PSMD1;ERCC3;XPA;RPA1;PSMC1;PSMD7;NAP1L2;RAD51;SMARCA5;PSMD14;CHAF1A;PSMD3
prerank,primary alcohol metabolic process (GO:0034308),0.3381567038381198,0.7952773241506784,0.7213855421686747,0.9442442283150331,1.0,2/25,2.10%,CYP1B1;ADH7
prerank,stress-activated MAPK cascade (GO:0051403),0.302485815073515,0.7948679900513955,0.75,0.9444361124414993,1.0,7/61,9.48%,MAP3K5;TAB3;RIPK2;ARHGEF6;CHUK;NFKB1;FBXW11
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.34862311698182924,0.7946042718465886,0.7056145675265554,0.9443976613145113,1.0,9/23,21.61%,PLK3;NABP1;CHEK1;CHFR;PRCC;ZFYVE19;ZWILCH;ZW10;WEE1
prerank,nitric oxide metabolic process (GO:0046209),0.38344537417527585,0.7944979053690956,0.717607973421927,0.9441131717193778,1.0,1/14,1.54%,CYP1B1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.29137481198371273,0.7944274964342258,0.7575,0.9437933912219023,1.0,6/70,5.85%,NGF;HIPK1;CRADD;INHBA;GSK3B;ITGAV
prerank,positive regulation of nervous system process (GO:0031646),-0.297395886403148,-0.7942549011054864,0.7535410764872521,0.9247712473664437,1.0,3/18,4.47%,RIMS1;RIMS2;TENM4
prerank,response to cAMP (GO:0051591),0.3286911551034338,0.7940158494885987,0.7436974789915967,0.9439876257194935,1.0,5/37,6.54%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN
prerank,regulation of interleukin-6 production (GO:0032675),0.28372448752324264,0.7935847237373165,0.7738814993954051,0.944181672550903,1.0,23/96,17.79%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;IL10;TLR4;IL33;PLCG2;IRAK3;MYD88;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TLR8;TWIST1;C5AR2;NLRP12;BCL10;TLR6
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.28957545953288005,-0.7934964269983882,0.7492877492877493,0.9250059016299877,1.0,6/21,17.67%,CYP26B1;PPARD;LPIN3;AGXT;LPIN1;NUDT19
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3164941581151859,-0.7933554471318977,0.7361477572559367,0.9242611658309613,1.0,3/15,13.92%,ACACB;ACSS1;ACLY
prerank,neuron projection organization (GO:0106027),0.3713632820283963,0.7931375990452435,0.6990131578947368,0.9444415589778048,1.0,3/15,8.76%,GSK3B;PLS1;ATP1A3
prerank,telomere maintenance via telomerase (GO:0007004),0.3339763498287831,0.7923886860652006,0.7113997113997114,0.9452051573104845,1.0,9/28,23.07%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3352838017644534,0.7920847904037341,0.7059679767103348,0.9452439219328401,1.0,5/28,13.94%,NGF;CRADD;DIABLO;BAG3;TRADD
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3877196262995497,0.7919361766012672,0.688135593220339,0.9450374040358341,1.0,3/13,11.94%,PIK3AP1;IRAK4;MYD88
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.326466474558761,0.7913316468078901,0.7384843982169391,0.9455619728725346,1.0,4/29,7.68%,PKD1;CLCF1;STAT3;SOCS2
prerank,regulation of lipid kinase activity (GO:0043550),-0.34271819932260755,-0.7911433660194034,0.7437810945273632,0.927013122088686,1.0,3/11,14.00%,PIK3R1;PPP2R5A;RBL1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.32478250449886736,0.7910825842969129,0.7266187050359713,0.9455017076522506,1.0,5/30,11.05%,FSTL1;SFRP4;LTBP4;DKK3;SMAD2
prerank,nuclear membrane reassembly (GO:0031468),0.30446990982685274,0.7910811090583318,0.76,0.9450479792279413,1.0,15/54,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3759754822394914,0.7909491453997576,0.6986301369863014,0.9448100479109343,1.0,3/15,10.81%,ADAM9;EHD1;EHD2
prerank,positive regulation of reproductive process (GO:2000243),0.332174959563241,0.7909182206567761,0.7479224376731302,0.9444004389946035,1.0,4/31,11.38%,LHFPL2;INHBA;VEGFA;INHBB
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.24055561542013912,-0.7907660475935351,0.8345864661654135,0.9266328751187924,1.0,10/46,14.81%,PLCB1;CNN2;PPIA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3306215639576019,0.7907650319985161,0.7327707454289732,0.9441874517411123,1.0,3/35,4.54%,MET;ARHGAP44;CCDC125
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2622927162717597,0.7907040167305545,0.8575916230366493,0.9438362805636886,1.0,88/264,27.50%,DDX5;DDX17;SNRNP48;RBM6;SRSF11;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;FUS;USP49;RBMX;U2AF2;PABPC1;DDX42;ZCCHC8;SNRNP70;SCAF11;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;SF3B1;SF3B2;RNPC3;PRCC;CDK13;SRPK1;U2AF1L4;GEMIN8;RBM14;SCNM1;ESS2;LSM8;LSM2;SNRNP35;WBP4;SNRNP40;SRSF2;SNW1;PNN;TRA2B;DDX1;DBR1;SRSF12;ZCRB1;PRMT5;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;LSM4;NUDT21;CDC40;SUGP1;CSTF1;DHX8;PPIL1;CELF4;RSRC1;CHERP;CPSF7;SRPK2;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;SRSF7;CPSF4
prerank,male gonad development (GO:0008584),0.32768092119515385,0.7896767898807089,0.7219796215429404,0.9450214196863769,1.0,5/34,9.70%,SOX9;INHBA;GATA4;SIX4;GATA1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3084031616384519,0.7893671534261827,0.7369146005509641,0.9450431774407366,1.0,11/47,14.53%,PTGIS;CLK2;ATP2B4;NFKB1;C1QTNF12;ERFE;MPV17L;ZC3H12A;ERLIN1;EP300;WDTC1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.23392032003159846,-0.7893337369070829,0.8760330578512396,0.927871039108073,1.0,7/54,12.41%,RNF152;NEDD4L;UBE2E2;RFFL;KLHL3;ZNRF1;HACE1
prerank,regulation of T cell proliferation (GO:0042129),0.2939193207456775,0.7892719710948366,0.7805851063829787,0.9447527454424013,1.0,12/61,21.71%,ANXA1;NCK2;CD80;IL10;CD46;RIPK3;TNFRSF1B;SDC4;ARG1;DLG5;LGALS3;NCK1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3876196524824227,0.7890966079814143,0.7269736842105263,0.9445644454210755,1.0,7/13,29.16%,TMEM39A;SMCR8;SEC22B;CHMP4A;CHMP4B;PHF23;FEZ2
prerank,regulation of histone methylation (GO:0031060),0.3777236268002401,0.7889170397371297,0.7114093959731543,0.9444145647218978,1.0,7/13,24.19%,NNMT;CTCFL;CTR9;CHTOP;NSD1;PAF1;MTHFR
prerank,ruffle organization (GO:0031529),-0.3117922995813516,-0.7887874653517337,0.7581863979848866,0.927763635523551,1.0,8/16,23.62%,RAC1;PLEK;CSF1R;AIF1L;CORO1B;ARF6;INPP5K;PLEKHA1
prerank,regulation of interleukin-2 production (GO:0032663),0.30894681869291984,0.7887312494868564,0.7510489510489511,0.9442678058732817,1.0,5/43,11.70%,EZR;ANXA1;CD80;PLCG2;HOMER2
prerank,defense response to bacterium (GO:0042742),0.27903697245000864,0.7886959028249357,0.8037825059101655,0.9438706409774579,1.0,8/105,8.03%,LBP;ANXA3;PRKCD;SHC1;DEFB130A;MAVS;SLPI;TLR4
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2952394682167322,-0.788002467731619,0.7584415584415585,0.9279628276986512,1.0,3/19,12.81%,MAOB;CYBA;PRDX4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.36845863203120954,0.7879491116245303,0.6962457337883959,0.9446149093977808,1.0,3/15,12.34%,ADAM9;SH3D19;TNFRSF1B
prerank,interstrand cross-link repair (GO:0036297),0.30376075848399875,0.7879271664599554,0.7625994694960212,0.9442055670569414,1.0,16/53,20.94%,VCP;USP1;SLX4;RNF168;FANCL;MCM9;XPA;RPA1;RAD51;ERCC1;ATR;FANCM;NEIL3;WDR48;FAAP24;RNF8
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3121550083245645,0.7878170536544471,0.7323741007194244,0.9439234437925746,1.0,14/42,28.48%,VCP;WRN;USP10;ZBTB1;RPA1;RFC1;REV1;TRIM25;POLA1;POLD3;RFC5;POLK;POLI;PRIMPOL
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3956436272616337,0.7875692175034259,0.7117263843648208,0.9438743263933632,1.0,1/12,1.74%,CAMK2D
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3274992213850772,0.7872260733989584,0.7324749642346209,0.9439806691945116,1.0,15/35,31.65%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4;DHX36;NAF1;HNRNPA2B1;PARN;MAPK15;ACD;CCT6A;TCP1
prerank,B cell activation (GO:0042113),0.2938918250954557,0.786779332544842,0.7652284263959391,0.9442155351152567,1.0,9/68,13.05%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,mesoderm formation (GO:0001707),0.3632124294513789,0.7865506877104762,0.7260061919504643,0.944124318320955,1.0,3/17,11.05%,ITGB1;ITGB3;SMAD2
prerank,sphingoid metabolic process (GO:0046519),0.3795099108644412,0.7859058052390795,0.7257240204429302,0.9447048584004919,1.0,4/12,18.03%,PLPP3;KDSR;PLPP1;NAAA
prerank,regulation of fat cell differentiation (GO:0045598),0.2896220032174242,0.7857437799004167,0.7676767676767676,0.9444880185985551,1.0,11/74,10.84%,ZFPM2;ZBTB16;CMKLR1;FTO;TRPM4;TRIO;ID2;RORA;CDS1;SYAP1;LRP5
prerank,regulation of fibroblast proliferation (GO:0048145),0.3124522541518785,0.7857356902353388,0.7552155771905424,0.9440477089943994,1.0,8/45,11.15%,PDGFC;DDR2;FN1;SKI;PDGFA;NF1;EMD;MORC3
prerank,sulfur amino acid metabolic process (GO:0000096),0.336103251783081,0.7848494441936326,0.75,0.9450736086696954,1.0,5/24,18.41%,GCLC;GADL1;CDO1;DPEP1;ADO
prerank,negative regulation of cilium assembly (GO:1902018),0.38820460961882264,0.7847632488024793,0.7103109656301145,0.9447631766357956,1.0,3/12,17.99%,LIMK2;CEP97;CDK10
prerank,negative regulation of protein transport (GO:0051224),0.3326703566838637,0.7843694810610844,0.7242921013412816,0.9449337756498307,1.0,6/25,15.12%,WWP2;DRD3;SNX12;CSK;SERGEF;HMGCR
prerank,rRNA transcription (GO:0009303),0.35733634644020706,0.7838316388551714,0.729235880398671,0.9453644252755122,1.0,1/17,3.73%,POLR1G
prerank,regulation of receptor recycling (GO:0001919),0.365835663835332,0.7836433771251948,0.706081081081081,0.9452074942752252,1.0,4/16,14.14%,ANXA2;NSF;KIF16B;ECE1
prerank,positive regulation of cellular component movement (GO:0051272),0.337671575201445,0.7835192148320379,0.7412140575079872,0.9449660266912472,1.0,4/24,10.34%,NTN1;TGFBR1;CCDC25;VEGFA
prerank,histone H3-K4 methylation (GO:0051568),0.33204934826124277,0.7834664731560687,0.7435508345978755,0.9445914226127967,1.0,12/26,36.27%,KMT2C;CTR9;KMT2D;WDR82;OGT;KMT2A;SETD1B;ASH2L;PAXIP1;TET2;WDR5;DPY30
prerank,error-free translesion synthesis (GO:0070987),0.3446742691223879,0.7833992627829177,0.6984126984126984,0.9442511147957339,1.0,6/22,19.05%,VCP;NPLOC4;RPA1;UFD1;RFC1;REV1
prerank,phospholipid translocation (GO:0045332),0.32573326778345413,0.7831939860499098,0.722473604826546,0.9441156597420765,1.0,8/28,13.75%,ATP10A;ANO6;PLSCR1;ATP8B1;TMEM30B;ATP9B;ATP11A;PLSCR3
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3351345191605392,-0.7831122020870434,0.7428571428571429,0.9347587053364896,1.0,4/11,17.24%,NES;PLEK;TRPV4;STMN2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3586274139046425,0.7827805029010828,0.717948717948718,0.9443036907144322,1.0,8/20,22.65%,CELF1;MOV10;TNRC6C;EIF6;CNOT7;AGO2;NRDE2;TNRC6A
prerank,regulation of interleukin-10 production (GO:0032653),-0.24332418740704426,-0.7824955299094678,0.803088803088803,0.9347125297826651,1.0,26/44,40.80%,TNFRSF21;CD47;CD34;PRKCZ;TYROBP;JAK3;VSIR;DLL1;SYK;PYCARD;TSLP;HSPD1;CD28;HMGB1;TRIB2;FCGR2B;INAVA;IL23A;FOXP3;IRF4;LILRA5;F2RL1;IL12B;CD274;ISG15;XCL1
prerank,negative regulation of transferase activity (GO:0051348),0.32935472740049127,0.7823818408510993,0.7360482654600302,0.9444964552916216,1.0,3/28,8.47%,GSK3B;ABL1;CDKN1B
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3286553813868444,-0.781915727633105,0.7560386473429952,0.9346417459059584,1.0,9/11,49.28%,CCT8;WRAP53;TERF1;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5
prerank,negative regulation of receptor internalization (GO:0002091),0.37834538583686417,0.781642885240275,0.7071547420965059,0.945207980798535,1.0,5/12,21.80%,LRPAP1;ATXN2;RIN3;ANKRD13D;DLG4
prerank,histone H2A ubiquitination (GO:0033522),0.36368554936349323,0.7810207714201939,0.7100977198697068,0.9457559110246622,1.0,5/17,20.94%,UBE2B;RNF168;RNF2;PCGF1;RNF8
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3590541474773296,0.7810171423121939,0.7378335949764521,0.9453149768472621,1.0,9/17,30.90%,ZC3H14;CTR9;NELFE;CCNT1;NUDT21;CPSF7;RNF20;NCBP2;VIRMA
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3699732391700572,0.7809539118315251,0.7174603174603175,0.944963687694463,1.0,5/15,26.50%,TLR4;MYD88;TLR6;CD36;EIF2AK2
prerank,regulation of necroptotic process (GO:0060544),0.3418125589576593,0.7808729903782629,0.7064220183486238,0.9446485030782992,1.0,3/23,9.09%,YBX3;PDCD6IP;RIPK3
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.2882856888551697,-0.7806730816835,0.7900552486187845,0.9355879613710179,1.0,4/22,14.43%,ALDH1A2;LGMN;CUBN;CBR1
prerank,negative regulation of bone remodeling (GO:0046851),0.3838806437433745,0.7805538648537329,0.7152777777777778,0.9446813733186686,1.0,1/11,2.84%,UBASH3B
prerank,T cell activation (GO:0042110),0.2934827519169195,0.7798985061608597,0.789873417721519,0.9452586108276391,1.0,7/69,6.40%,PPP3CA;CXADR;CD44;PTPN2;NCK2;CD2;ADA
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.32130182472858954,0.7797097829820187,0.7539118065433855,0.9451150010058131,1.0,4/35,8.48%,CYP1B1;HES1;IL10;NLK
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2734529616815079,0.7797024137409705,0.8398058252427184,0.9446790422671577,1.0,24/119,15.05%,PLEKHA4;FGF2;TTC7A;PIK3C2B;IP6K2;INPP4A;MTMR12;PIP5K1A;ARF3;OCRL;SOCS2;RUFY1;PI4KB;PLCG2;CDS1;PGAP2;PIGB;PIK3R3;DPM1;SMG1;SYNJ1;PIGU;SBF1;PITPNM3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3214385128299997,0.7795889648244555,0.7255747126436781,0.9444146008132477,1.0,4/33,6.40%,CYP1B1;ADAM9;FOXC2;ADA
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3358327595073195,0.7789043426689478,0.7325038880248833,0.9450245914074987,1.0,10/24,28.34%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1;FXN;SUCLA2;RSAD1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3558261593656955,0.7785495496208997,0.7269736842105263,0.9451255691319738,1.0,3/18,8.09%,GSK3B;RAP1A;SLC4A8
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2245018379782935,-0.7784874893263283,0.8842592592592593,0.9380518526376991,1.0,20/62,23.83%,BCL2;CXCL12;BCL2L1;PPIA;TPT1;NOC2L;HYOU1;TMBIM6;AKT1;SELENOS;XBP1;HSPB1;DDX3X;ENO1;CCAR2;NME5;NDUFA13;PLAUR;CREB3;SNAI2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.38387459681262315,0.7783918193651257,0.7050847457627119,0.9449462348781068,1.0,4/13,19.95%,HES1;PIGU;EGF;MGAT5
prerank,tRNA aminoacylation (GO:0043039),0.3146563181684403,0.7783358038069105,0.7579710144927536,0.9445865270917531,1.0,2/37,7.55%,WARS2;YARS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.33726343853507934,0.7777684926114719,0.7459379615952733,0.9450358025927316,1.0,3/26,6.17%,NFE2L2;VNN1;GATA4
prerank,pentose-phosphate shunt (GO:0006098),0.3807647551740862,0.7777435526230878,0.7084048027444254,0.9446344667738198,1.0,3/11,13.89%,DERA;SHPK;RPIA
prerank,pinocytosis (GO:0006907),-0.3465044251668171,-0.7776535046985028,0.7420924574209246,0.9383018372706594,1.0,6/10,34.42%,DOCK2;AHSG;PYCARD;PPT1;SNX5;MAPKAPK3
prerank,regulation of viral release from host cell (GO:1902186),0.344001317226593,0.7776333808079647,0.7496159754224271,0.9443426556610852,1.0,7/21,21.13%,TRIM26;PML;VPS37B;TSG101;TRIM25;TRIM35;MID2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3103322079105752,0.777523696923718,0.7448559670781894,0.9440623207409539,1.0,16/44,24.57%,FTO;CELF1;MOV10;TNRC6C;TOB1;PABPC1;ZC3H12A;CNOT7;PUM1;AGO2;DHX36;YTHDF2;NANOS2;TNRC6A;ROCK1;YTHDF3
prerank,positive regulation of cellular component organization (GO:0051130),0.2747834981296894,0.7772917484745047,0.7961399276236429,0.9439862210638036,1.0,10/107,6.20%,TRABD2B;TGFB3;GPC3;MPP7;ATP10A;GSK3B;TGFBR1;VCP;LRP1;CLU
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.39608006182868516,0.7772235087597857,0.71900826446281,0.9432146273985523,1.0,1/10,7.26%,CACNA1F
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.39608006182868516,0.7772235087597857,0.71900826446281,0.9432146273985523,1.0,1/10,7.26%,CACNA1F
prerank,replication fork processing (GO:0031297),0.31574893523922126,0.7772198776040692,0.7626404494382022,0.9427778448805088,1.0,15/38,29.97%,WRN;BOD1L1;BRCA2;DDX11;ATRX;SMARCAL1;RAD51;ATR;FANCM;EXD2;FAM111A;CENPX;ALYREF;PRIMPOL;RFWD3
prerank,negative regulation of translation (GO:0017148),0.28864605629597484,0.7767012906901865,0.8047619047619048,0.9431208441566686,1.0,24/87,24.57%,SAMD4A;IGFBP5;FTO;PAIP2;SYNCRIP;CELF1;TOB1;EIF3E;EIF2AK4;CNOT7;PUM1;AGO2;DHX36;FXR2;CAPRIN1;FMR1;YTHDF2;EPRS1;NANOS2;EIF2AK3;RBM4;SAMD4B;ROCK1;YTHDF3
prerank,protein acylation (GO:0043543),-0.2496313436593327,-0.7764650109795062,0.8467432950191571,0.9391279559859471,1.0,6/38,10.54%,ZDHHC14;FOXO1;ZDHHC1;ZDHHC17;SPHK1;ZDHHC9
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3642380158426288,0.7761780469720381,0.7252032520325203,0.9434625504907468,1.0,5/16,23.32%,MOV10;ZC3H12A;ZC3H12D;DHX36;TARDBP
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.3256668196883468,-0.7754860145169682,0.7619047619047619,0.9396161203934106,1.0,4/13,18.72%,ADHFE1;IDH2;GOT2;PHYH
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2159091422896683,-0.7754039764131113,0.8888888888888888,0.9387461501060859,1.0,9/69,9.16%,TFRC;CARD10;PRKAA2;CCDC88A;SLC5A3;SYT11;MAPT;HSP90AB1;RTN4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.34132988563503713,0.7752430750437049,0.7391304347826086,0.9444922868365845,1.0,8/21,27.27%,CDC25B;CCND1;DYRK3;RAD51C;ATAD5;CCNB1;MECP2;RAD51B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3441686813315552,-0.7751515578546319,0.7506053268765133,0.9381369960155632,1.0,3/10,12.88%,APOD;SNCA;NDRG4
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.24085754347862293,-0.7751231181995398,0.8494623655913979,0.9371881318238107,1.0,4/42,8.83%,CECR2;ACTB;SMARCA2;MBD2
prerank,neuron projection extension (GO:1990138),0.323034948091245,0.7742798769540863,0.755072463768116,0.9455307627591847,1.0,6/32,9.15%,ULK2;ALCAM;NRP1;SPG11;MAP1B;IQGAP1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30890563360859635,-0.7740391008356661,0.7606635071090048,0.9378456246695719,1.0,6/15,18.90%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1;C3
prerank,regulation of protein neddylation (GO:2000434),-0.3538881481695688,-0.773765892480362,0.7464454976303317,0.9372892291574968,1.0,5/10,18.85%,HIF1A;RPL11;DCUN1D3;EPAS1;RPL5
prerank,regulation of macroautophagy (GO:0016241),0.271991885804284,0.7731069303512221,0.8249708284714119,0.9468645908721148,1.0,29/105,23.31%,NEDD4;EXOC4;CLEC16A;RRAGB;PAFAH1B2;MLST8;SNX32;RB1CC1;WAC;SMCR8;TBC1D25;MTOR;SMG1;SH3GLB1;ATP6V0D1;ATP6V0E1;IKBKG;SCOC;NRBP2;RHEB;CAPN1;ATP6V1H;MAPK8;CLN3;USP36;ULK1;BNIP3;LZTS1;SESN3
prerank,neural crest cell differentiation (GO:0014033),0.34992201792148503,0.7730488004950854,0.7321428571428571,0.9465107047348489,1.0,1/18,1.38%,LRP6
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3437808925382644,0.7729979441328291,0.7574334898278561,0.9461498817035066,1.0,3/21,10.04%,ANK2;SNTA1;AKAP9
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3820724274669601,0.7723193449707474,0.7291666666666666,0.9467541270061602,1.0,5/11,24.12%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A
prerank,cardiac atrium morphogenesis (GO:0003209),0.3597603012446716,0.7723011594292297,0.7185430463576159,0.946334470125474,1.0,4/16,6.17%,NOTCH2;NOG;ISL1;GATA4
prerank,neural tube development (GO:0021915),0.3679546462697936,0.7721469877951522,0.7418831168831169,0.9461198739336252,1.0,3/15,9.55%,PKD1;GRHL2;DACT1
prerank,cellular response to interleukin-6 (GO:0071354),0.3286849305754363,0.7715948235048168,0.7390029325513197,0.9465254845860355,1.0,5/26,12.85%,PID1;PTGIS;STAT3;NFKB1;CTR9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.27728384224645913,0.7715282007066306,0.8102372034956304,0.9461824154773227,1.0,20/88,21.91%,TRABD2B;MPP7;GSK3B;VCP;PDCD6IP;CLU;VEGFA;SPIDR;SLX4;SH3GLB1;SDC4;PRKCA;TSG101;EMILIN1;ERCC1;SNF8;CDC42EP2;SDC1;LGALS3;HGS
prerank,protein acetylation (GO:0006473),0.331161460022228,0.7711916301546536,0.7510729613733905,0.9462455319281118,1.0,16/30,27.52%,NAA40;CREBBP;EP300;KAT2B;NAA15;DSCC1;NAA35;GTF2B;KAT5;NAT10;ESCO1;NAA50;NAA80;HAT1;KAT6A;NAA60
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3745701788658389,0.7706186258242016,0.7211221122112211,0.9466949479268232,1.0,2/12,6.08%,CD44;KDM1A
prerank,positive regulation of exocytosis (GO:0045921),-0.24873533200151365,-0.7704681673811855,0.8392282958199357,0.9413395482968386,1.0,8/35,17.48%,CADPS;SMPD3;CLASP2;SNCA;SDCBP;ATP6AP1;RAB15;RAB3A
prerank,positive regulation of response to stimulus (GO:0048584),0.3127081624043,0.7701419617795996,0.7726027397260274,0.9469711302682525,1.0,12/40,21.88%,PRKCD;CD80;MAVS;BCLAF1;IFIH1;DHX9;HOMER1;NSMCE1;FXR2;FMR1;TGFB2;GATA3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.39605504684482096,0.7699464462015465,0.715008431703204,0.946817149515974,1.0,1/10,1.69%,SMOX
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3174361983911861,0.7698313781701756,0.7784090909090909,0.9465557651469654,1.0,18/36,30.06%,NECTIN3;KIF13A;GOLPH3;NSF;GOLGA7;GGA2;GORASP2;RILPL1;GOLGA4;AFDN;BBS2;SYS1;RAB7A;GGA1;GOLPH3L;VAMP2;VAMP4;RAB10
prerank,motile cilium assembly (GO:0044458),0.38094512417925935,0.7697109597558338,0.7169491525423729,0.9462845010088569,1.0,4/12,22.84%,DNAAF3;CCDC40;RSPH9;RSPH6A
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.29461080609420875,0.7694312567106447,0.7857142857142857,0.9462886112058676,1.0,7/56,9.70%,CIT;SNX18;SON;PDCD6IP;ARL3;RHOA;TTC19
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.336684875959265,-0.7694298134000397,0.7241379310344828,0.9419086045485897,1.0,4/10,24.27%,RIF1;TFIP11;DCLRE1B;TERF2IP
prerank,positive regulation of cell killing (GO:0031343),-0.31344807798911667,-0.7692640104680567,0.75,0.9411615600778355,1.0,3/13,12.36%,WNT5A;RAC1;CYBA
prerank,cellular response to inorganic substance (GO:0071241),-0.29174498231205337,-0.7687427917314792,0.7994428969359332,0.9408883327671288,1.0,5/21,14.13%,FOXO1;GUCY1B1;KCNC2;BLM;NSMCE3
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3211678233255165,-0.7685175545974509,0.7590361445783133,0.9402421771482484,1.0,2/13,6.68%,DDO;ASPA
prerank,regulation of phosphatase activity (GO:0010921),0.33044914019040933,0.7677703042793937,0.7397881996974282,0.9484098349702244,1.0,8/24,20.92%,RIPK3;PPP6R3;PPP6R2;CHP1;URI1;PPP1R36;PPP6R1;PTPA
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3653719366748098,0.767390069104424,0.7080536912751678,0.9485549599741927,1.0,2/13,9.33%,NEDD4;NIBAN2
prerank,negative regulation of viral release from host cell (GO:1902187),0.3725279033466575,0.7669321819614268,0.757328990228013,0.9488125400818426,1.0,4/13,21.13%,TRIM26;PML;TRIM35;MID2
prerank,coenzyme A metabolic process (GO:0015936),-0.31398562959507986,-0.7668655224489818,0.779291553133515,0.9416728116134305,1.0,3/14,13.92%,PANK1;ACOT7;ACLY
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3408122443214147,0.7668536280621954,0.7344461305007587,0.9484908411742541,1.0,9/24,15.61%,SEC24B;IDE;SEC23A;ERAP1;SEC31A;SEC13;SEC24D;BCAP31;SAR1B
prerank,defense response to protozoan (GO:0042832),-0.32319452298051615,-0.7666991915025541,0.7892030848329049,0.9409330397134091,1.0,3/12,14.78%,GBP7;GBP4;CD40
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.33857145108895775,0.7663413669052941,0.7507739938080495,0.9488299321616086,1.0,8/22,27.33%,CHD1L;RAD23B;ERCC3;XPA;CUL4A;ERCC2;XPC;GTF2H3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.31334938322399647,0.766242195880472,0.7774607703281027,0.948535911195863,1.0,7/36,11.50%,EZR;DLG1;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,pseudouridine synthesis (GO:0001522),0.36424127606690915,0.7661183868766342,0.7269736842105263,0.9482940310622745,1.0,7/13,30.74%,PUS10;PUS7L;PUSL1;TRUB2;PUS7;GAR1;RPUSD2
prerank,fatty acid metabolic process (GO:0006631),0.26715470069581754,0.7655080071579186,0.8370457209847597,0.9487556317536942,1.0,24/115,19.78%,ABCD3;PNPLA3;ACSL3;SLC27A3;PON3;PLA2G15;ACOT8;CPT1C;ACADM;ACBD5;LPIN2;ACOT12;GNPAT;HACL1;ACSM2A;ACSM2B;ANGPTL3;NAAA;ALKBH7;PER2;PPARG;ACOT11;ADIPOR1;NDUFAB1
prerank,positive regulation of T cell differentiation (GO:0045582),0.31589869663033465,0.7646337296454633,0.7874125874125875,0.9495987386368673,1.0,11/36,21.88%,GLI3;VNN1;CD46;GLI2;DUSP10;ZBTB1;BCL6;ZMIZ1;ADAM8;NKAP;GATA3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.37073617635922673,0.764627736769686,0.7210084033613445,0.9491720586343769,1.0,4/12,17.00%,IRS1;NR4A3;TWIST1;ABCD1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.31281504744342187,0.763710805155591,0.7719298245614035,0.9501143813256193,1.0,6/38,8.66%,PTGIS;KLF4;ATP2B4;CLU;TLR4;P2RX4
prerank,negative regulation of reproductive process (GO:2000242),0.35329077550261423,0.7631244963812016,0.7548076923076923,0.9505814732745693,1.0,2/17,2.53%,ARHGDIB;SULF1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3437957919349481,0.7628191132585461,0.730593607305936,0.950611829000456,1.0,8/22,25.76%,ERI3;EXOSC7;WDR12;KRI1;URB1;FTSJ3;ERI2;ERI1
prerank,cellular response to leucine (GO:0071233),0.3837462530521776,0.7627521495421153,0.726643598615917,0.949840368156225,1.0,2/10,12.91%,KLHL22;MTOR
prerank,response to leucine (GO:0043201),0.3837462530521776,0.7627521495421153,0.726643598615917,0.949840368156225,1.0,2/10,12.91%,KLHL22;MTOR
prerank,regulation of hemopoiesis (GO:1903706),0.3949357283722955,0.7623899787337078,0.7491349480968859,0.9499418073119971,1.0,3/10,11.74%,CREBBP;MYSM1;CBFB
prerank,cellular response to calcium ion (GO:0071277),0.2857873691518453,0.7622712598571969,0.795425667090216,0.9496889215218898,1.0,10/67,12.45%,CLIC4;CAMK2D;MEF2A;DMTN;SYT8;IQGAP1;PLCG2;CARF;ADD1;CPNE3
prerank,negative regulation of cell activation (GO:0050866),-0.31461013521160436,-0.7620373678490069,0.7894736842105263,0.9466950329414032,1.0,4/14,11.73%,APOE;NOS3;PDGFRA;CD200
prerank,axonemal dynein complex assembly (GO:0070286),0.3331105266138107,0.7618278545993866,0.7578008915304606,0.949887813146729,1.0,6/27,21.70%,DNAAF3;DNAH8;CCDC40;DNAAF4;ODAD3;ODAD2
prerank,protein import into peroxisome matrix (GO:0016558),-0.32829623513880185,-0.7618079209380424,0.8151658767772512,0.9460086901292264,1.0,2/12,10.19%,PEX5L;PEX6
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.26779236199868417,-0.7606743479414352,0.8116883116883117,0.9466164586005925,1.0,11/28,25.43%,NOD1;MAP2K6;LACC1;UBC;IRAK2;RPS27A;TNFAIP3;OTULIN;TAB1;RELA;CYLD
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3387502828339818,0.760638162133661,0.7035830618892508,0.9512576068121132,1.0,6/18,23.25%,WDR43;ERBB2;FLNA;WDR75;EIF2AK3;UBTF
prerank,multivesicular body organization (GO:0036257),0.31471408860829186,0.7603519179476396,0.7887931034482759,0.9512641612140994,1.0,10/31,25.39%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,focal adhesion assembly (GO:0048041),0.3358208138964199,0.7599384187074761,0.7463884430176565,0.951453463462274,1.0,5/21,12.78%,SORBS1;BCR;PIP5K1A;CTTN;TRIP6
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3507628303864385,-0.7596838723759604,0.7855361596009975,0.9470180443848116,1.0,2/10,11.03%,JARID2;RIF1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2756690858552169,-0.7594698924241227,0.8194444444444444,0.9463064822309527,1.0,6/22,19.98%,WNT5A;SLC7A5;LACC1;BTK;TRIL;SPHK2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.28255771239290817,0.7593738028691868,0.8182941903584673,0.951856262534985,1.0,17/72,20.02%,TAX1BP1;HIPK1;ELF1;PTPN2;SPPL2A;TRIM44;CHUK;IRAK3;CBFB;TRADD;IKBKG;VRK2;PALM3;ABCE1;BIRC3;PIAS1;RNF31
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2582936465388297,-0.7590583164682193,0.8256880733944955,0.9459436401185708,1.0,9/28,22.05%,CTSC;DAB2IP;PTK2;ECSCR;NUPR1;OSBPL7;TREM2;PSMC5;PSMC3
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2892912147333105,0.7590338617016664,0.8178294573643411,0.9519225997424355,1.0,13/56,19.32%,LBP;ALPK1;TAB3;IRAK4;TLR4;PLCG2;MYD88;TLR1;MAPKAPK2;TLR8;BCL10;TLR6;TRAF3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3545178160374271,0.7582611686824438,0.7483660130718954,0.9526240580583306,1.0,6/16,26.10%,RB1;SMC1A;NIPBL;DSCC1;POGZ;NAA50
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.30041501830619666,0.7581884297631768,0.7894021739130435,0.952297044774065,1.0,12/46,13.92%,DOCK7;ZNF423;FOXC2;ID1;NPR3;DDIT3;ADAMTS5;ABHD6;TLR4;RB1;TLE3;ACOT13
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.32116351381051456,-0.7579444355681091,0.7669902912621359,0.9465306317813448,1.0,4/13,22.54%,CDK5RAP2;ANAPC15;XRCC3;LCMT1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.31670026729399836,0.7578909903311271,0.7583212735166426,0.9522916777940337,1.0,7/32,18.09%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2967899832510133,-0.7576778772800408,0.8048128342245989,0.945904580935059,1.0,6/16,21.52%,PARP14;NF2;INPP5F;SH2B3;BCL3;LEPROT
prerank,steroid metabolic process (GO:0008202),-0.21363430657296884,-0.7576015447560558,0.9389671361502347,0.9450356078085111,1.0,4/72,4.75%,CYP7B1;CYP27A1;CYP26B1;LIPA
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3421494724347664,0.7574087532860448,0.7607655502392344,0.9525532670802636,1.0,2/18,6.20%,SLC2A13;CLU
prerank,protein transport (GO:0015031),0.24771800944279213,0.7572382618507136,0.9241025641025641,0.9523694259112544,1.0,78/332,21.16%,RAMP1;SGSM2;KIF13A;ATP6V0A4;TANGO6;TLK1;STX11;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;SLC10A7;LMAN2L;LRP1;CLU;GRTP1;GOLPH3;ARF3;NSF;RAB3GAP2;AP2A1;RUFY1;LRSAM1;EIF2D;STX8;EHD1;CTTN;ARF4;TBC1D2B;TBC1D13;COPA;ARL6IP5;STX19;TBC1D25;SEC31A;ARCN1;SCAMP2;SEC13;ATP6V0D1;TOM1;TBC1D10A;RAB24;TCIRG1;ARFIP1;GOLGA7;TBC1D8B;GGA2;ARFIP2;TBC1D5;ARFGAP3;COPG1;SAR1B;ATP6V0E1;SEC23IP;SGSM3;KIF3B;SNX31;SCFD2;TBC1D17;RAB5B;AP3D1;GOLGA4;SNX13;RAB21;PPARG;USO1;SNX8;ATP6V1H;AP4M1;RAB5A;RAB1A;TVP23A;STX2;TMED3;RAB18
prerank,protein homotetramerization (GO:0051289),0.29429495664406125,0.7571970003058789,0.7777777777777778,0.951999867262588,1.0,1/49,0.28%,KCNJ2
prerank,regulation of leukocyte migration (GO:0002685),0.3565820694902211,0.7571866748267733,0.7314662273476112,0.9515769507088739,1.0,2/16,10.34%,ANXA1;VEGFA
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.33902202671654774,-0.7570421627378107,0.7680180180180181,0.9448129529635996,1.0,5/10,18.22%,CORO2B;MAPT;NDFIP2;PPM1F;SNX3
prerank,leukotriene metabolic process (GO:0006691),-0.29004082262642206,-0.756602133796507,0.7717391304347826,0.9444142088131249,1.0,7/19,26.39%,GGT5;ALOX12;LTA4H;GGT1;PLA2G5;ALOX5AP;MGST3
prerank,maturation of SSU-rRNA (GO:0030490),-0.2525435493632598,-0.7554569702600213,0.856655290102389,0.9450677963254124,1.0,8/34,18.62%,RPS14;RPS19;RPS8;RPS16;SNU13;MRPS11;RPS28;TSR3
prerank,regulation of dephosphorylation (GO:0035303),-0.30490220935496204,-0.7552140001482796,0.781021897810219,0.9443727801198677,1.0,8/15,31.72%,PPP1R16B;SMG7;INPP5K;MTMR2;SRC;MTMR3;SMG5;CDK5RAP3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.34594134777124536,0.7551700310362939,0.7549019607843137,0.9540978505134838,1.0,1/18,1.66%,EZR
prerank,cellular response to ATP (GO:0071318),-0.31422276181847786,-0.7550476466033232,0.7903614457831325,0.9436275512087305,1.0,4/14,16.82%,P2RY1;P2RX7;HSP90B1;RYR3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3283881308879396,0.7548883389813698,0.7585669781931464,0.9540408738114377,1.0,6/24,10.34%,MAPRE2;ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.35141024530893783,0.7546201792568462,0.7536466774716369,0.9540147944881885,1.0,3/18,11.06%,TLR4;CCL3;TCTA
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.36944347289519675,0.7541664277357584,0.7308377896613191,0.9542211577707558,1.0,2/11,18.84%,IL10;CIITA
prerank,negative regulation by host of viral transcription (GO:0043922),0.369071561607499,0.7539114705072085,0.7430441898527005,0.9541514019792775,1.0,3/12,14.22%,JUN;CCL3;REST
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3534649948776263,0.7535774619298419,0.758957654723127,0.9542224553266004,1.0,2/15,10.44%,SMOX;SRM
prerank,regulation of multicellular organismal development (GO:2000026),0.3277709371043567,0.7534491315335776,0.7661764705882353,0.9539775036211074,1.0,9/25,21.88%,MYSM1;TRIP12;EHMT1;NIPBL;KAT2A;HPSE;DHX36;TDG;GATA3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2923790769451369,0.7533451062669388,0.8024032042723631,0.9536873239685519,1.0,11/51,22.04%,NEK7;SMG6;STN1;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4;TEN1;NAF1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3472147314183106,0.7533104097588698,0.7317880794701986,0.9532947162528577,1.0,4/16,8.86%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28825979566282095,0.7530167370960249,0.812,0.9532955503662498,1.0,14/53,20.60%,PKD1;XPO1;F8A1;COMMD1;RAD23B;PSMC6;DESI1;DDRGK1;NUDT15;DNAAF4;PSMD14;FMR1;TMF1;RHBDF1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.3835862567036394,0.7528803065289353,0.7333333333333333,0.9530708540571038,1.0,2/10,11.74%,ZBTB7B;CBFB
prerank,cellular response to oxygen levels (GO:0071453),-0.33885634770419615,-0.7528440121140241,0.7586206896551724,0.945675981368369,1.0,2/10,13.01%,CPEB4;ATP6AP1
prerank,regulation of centrosome cycle (GO:0046605),0.3344985760163953,0.7524383243044143,0.7619783616692427,0.9532920177888946,1.0,3/21,10.52%,PDCD6IP;AURKA;CEP131
prerank,regulation of JUN kinase activity (GO:0043506),0.30923550869392735,0.7518663401365512,0.7704225352112676,0.9536920108237408,1.0,5/33,11.50%,MAP3K5;PDCD4;PPEF2;ARHGEF5;DUSP10
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3585335298249821,0.7517001773862588,0.7437603993344426,0.9535028532053511,1.0,1/15,2.06%,PRKCD
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.225832182824466,-0.7512965817801117,0.9111969111969112,0.9468200233467952,1.0,14/51,19.86%,WNT5A;APP;AIM2;GSDMD;P2RX7;CCL19;MALT1;LPL;TYROBP;CASP1;FZD5;GBP5;HSPB1;TMED10
prerank,P-body assembly (GO:0033962),0.3714574143995936,0.7507285058114966,0.7554806070826307,0.9544743853767593,1.0,7/12,38.23%,ATXN2;LSM4;EDC3;DYNC1H1;LSM14A;EIF4ENIF1;LIMD1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2517177919582404,-0.7504503844503027,0.8523489932885906,0.9469852403925441,1.0,3/31,8.24%,LYN;TNFRSF21;CD300A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3610210781043731,0.7503940940556046,0.766497461928934,0.9545095881885994,1.0,4/14,16.43%,AGR2;COPS5;DDRGK1;BFAR
prerank,membrane organization (GO:0061024),0.2484195243048182,0.7502990033347826,0.9083245521601686,0.9541991367913357,1.0,31/227,13.79%,EGFR;REPS2;ANK2;ADRB2;STX11;NUP93;AP2A2;STON2;IGF2R;PDCD6IP;LDLR;GAK;CLTB;TOR1AIP1;OCRL;RABEP1;SUN3;AP2A1;AAK1;FCHO2;CTTN;EMD;SNAP23;GAPVD1;CORO1C;CHP1;A4GALT;EPS15L1;SH3GLB1;TLCD1;SYNJ1
prerank,negative regulation of T cell activation (GO:0050868),-0.24764918875850747,-0.7502944378730045,0.8651315789473685,0.9462299132198102,1.0,6/35,15.05%,RIPOR2;TNFRSF21;PAG1;DUSP3;HAVCR2;JAK3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.25093433810889765,0.7501533807642925,0.893687707641196,0.9539667328338824,1.0,42/172,20.47%,PLEKHA4;FGF2;PNPLA3;PIK3C2B;INPP4A;MTMR12;ETNK1;PIP5K1A;PLSCR1;DGKA;ARF3;OCRL;DDHD1;RUFY1;SLC44A3;LPIN2;PI4KB;PLCG2;CDS1;GNPAT;CPNE3;LCAT;PIK3R3;CHKB;AGK;SYNJ1;SBF1;PITPNM3;CEPT1;HDHD5;PLD1;CPNE1;LCLAT1;CSNK2A2;CSNK2A1;VAC14;LPCAT1;TAMM41;GPAT3;CLN3;RAB5A;PLA2G4A
prerank,iron ion homeostasis (GO:0055072),0.28652407093397003,0.749792704803419,0.8342105263157895,0.954021433101712,1.0,6/58,6.32%,BDH2;ABCG2;NEO1;BMP6;SCARA5;HMOX2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.32955182704257224,-0.7497547166562583,0.755056179775281,0.9459728834590916,1.0,2/10,9.40%,ACTN2;PLEK
prerank,negative regulation of kinase activity (GO:0033673),0.286093755157533,0.749266822592591,0.8307493540051679,0.9543962781641688,1.0,12/62,15.83%,LRP6;UBASH3B;CDKN1B;NF1;SMCR8;RB1;CEP85;ITGB1BP1;CHP1;PAK2;WWTR1;CEP43
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25103185656316435,0.7492208906197028,0.8972457627118644,0.9540276099035996,1.0,78/241,27.50%,DDX5;SNRNP48;RBM6;SRSF11;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;FUS;USP49;RBMX;U2AF2;PABPC1;DDX42;ZCCHC8;SNRNP70;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;SF3B1;SF3B2;RNPC3;PRCC;U2AF1L4;RBM14;ESS2;LSM8;LSM2;SNRNP35;WBP4;SNRNP40;SRSF2;SNW1;PNN;TRA2B;DBR1;SRSF12;ZCRB1;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;LSM4;NUDT21;CDC40;SUGP1;CSTF1;DHX8;PPIL1;RSRC1;CHERP;CPSF7;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;SRSF7;CPSF4
prerank,protein oxidation (GO:0018158),0.366364707003263,0.7489874631137153,0.7336601307189542,0.9539377808897538,1.0,4/11,22.49%,LOXL1;LOXL4;LOX;TMX3
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3251868436893122,-0.7481597744856903,0.7916666666666666,0.9451110452760082,1.0,2/11,11.80%,PANK1;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3251868436893122,-0.7481597744856903,0.7916666666666666,0.9451110452760082,1.0,2/11,11.80%,PANK1;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3251868436893122,-0.7481597744856903,0.7916666666666666,0.9451110452760082,1.0,2/11,11.80%,PANK1;ACOT7
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3303040028127356,0.7481334840214618,0.7529239766081871,0.9546986850517145,1.0,5/22,17.18%,MDFIC;DMTN;ITGB1BP1;CHP1;BARD1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.2870037265288988,-0.747519728269178,0.8087855297157622,0.9450315445395353,1.0,7/18,23.44%,ADAMTS9;SAMHD1;STT3B;AOAH;NEU2;FBXO44;FUCA1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3291350369667434,0.7469359401135103,0.7699680511182109,0.9559712202284344,1.0,1/20,1.20%,BMP5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2616286005118538,0.7468358758821936,0.8726415094339622,0.955698816838181,1.0,42/125,27.12%,NDEL1;CLIP1;TBCE;PAFAH1B1;XPO1;SETD2;DYNC1I1;AURKA;RANBP2;SEC13;DCTN6;STIL;RMDN1;AHCTF1;CENPT;KIF3B;MAD2L1;NEK9;DYNC1LI2;SPDL1;ZWILCH;NEK6;CENPQ;ZW10;RAN;NUP98;PTPA;SUN2;GPSM2;KIF2C;CCNB1;CDC20;SKA2;BUB3;TTK;MECP2;CENPU;TACC3;PCNT;SPC24;WDR62;KIF18A
prerank,outer dynein arm assembly (GO:0036158),0.36002985184747266,0.746719740005563,0.7431340872374798,0.95542666041383,1.0,7/14,33.37%,DNAH8;DNAAF4;ODAD3;ODAD2;DNAH5;ODAD1;DNAL1
prerank,negative regulation of B cell activation (GO:0050869),0.32477688157735224,0.7460348947750008,0.7805970149253731,0.9559972891787708,1.0,5/21,10.00%,INHBA;IL10;ID2;TNFRSF13B;ATM
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3292494421344013,0.7455387555173174,0.7609022556390977,0.9562488358409978,1.0,3/22,9.48%,AHNAK;DMD;DRD3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.31816341434984796,0.7447994836094323,0.7817109144542773,0.9568748504735359,1.0,3/25,9.84%,ANXA1;CD80;PLCG2
prerank,positive regulation of behavior (GO:0048520),0.38097280903254077,0.744583320079089,0.7567567567567568,0.9567324964875641,1.0,2/10,4.29%,STRA6;NR4A3
prerank,glutamate metabolic process (GO:0006536),0.3382111917672106,0.7443692801154931,0.7755102040816326,0.9566179146371679,1.0,2/19,12.51%,GCLC;FPGS
prerank,magnesium ion transport (GO:0015693),0.3624326698943557,0.7438530574853561,0.7504215851602024,0.9569314807074999,1.0,4/12,19.68%,CNNM4;NIPAL2;MRS2;TUSC3
prerank,organelle fission (GO:0048285),-0.2639823790538003,-0.7429801344871109,0.836676217765043,0.9499944866945563,1.0,3/24,8.37%,DNM3;SEC16B;DNM1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.29910087145349945,-0.7421779958026168,0.7924050632911392,0.9500775447232326,1.0,5/14,19.19%,RFFL;GAS6;CCDC3;TRAIP;GPS2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3100135824513198,0.7421393937467325,0.7774524158125915,0.958902334540349,1.0,2/32,2.23%,PRKCD;FOXO3
prerank,carbohydrate catabolic process (GO:0016052),-0.23959936161714268,-0.7419933813576485,0.8674242424242424,0.949360194592031,1.0,13/38,21.39%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;MAN2C1;PFKM;ALDOA;ENO2;ENO1;PFKL;NEU2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.355697451253127,0.7417525445190237,0.7838709677419354,0.9590044998957364,1.0,1/15,1.40%,NGF
prerank,myofibril assembly (GO:0030239),0.29489178520536213,0.741449320182018,0.8145604395604396,0.9589957315313467,1.0,5/42,7.90%,CSRP3;TMOD3;KRT19;SIX4;CSRP2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2983182266557351,0.7412488560693168,0.8061911170928667,0.9588327045013028,1.0,14/41,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;SCARB2;NUP188;NUP88;NUP98;AAAS;NUP54
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3671154090404058,0.7411048351724417,0.7560137457044673,0.9586198273334524,1.0,1/11,2.48%,GSN
prerank,histone monoubiquitination (GO:0010390),0.32273666732736683,0.7410675905205141,0.7946026986506747,0.9582319972616742,1.0,5/24,15.25%,WAC;CTR9;RNF168;RNF2;PCGF1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.256334505591791,-0.7401652144392368,0.8576271186440678,0.9507122323168407,1.0,4/30,14.46%,DACH1;DCP2;CERS1;ACVRL1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3483605547545491,0.7397649291202935,0.7754777070063694,0.9595863060213484,1.0,2/16,4.92%,PID1;VCP
prerank,inner mitochondrial membrane organization (GO:0007007),-0.22794264848885565,-0.7392793141512392,0.9446808510638298,0.9508744458758565,1.0,15/47,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;CHCHD6;ATP5F1D;MICOS13;ATP5MC2;MTX1;ATP5ME;HSPA9;NDUFA13;ROMO1;ATP5MC3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3235541647071177,-0.73920318247853,0.8073170731707318,0.9499898786349971,1.0,5/11,18.23%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3120331429288808,-0.7384586652381515,0.8024691358024691,0.9499276134484748,1.0,12/12,68.83%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5;GNL3;GNL3L;TCP1;CCT6A
prerank,positive regulation of glial cell differentiation (GO:0045687),0.342783313380688,0.7381078577462702,0.7471451876019576,0.9615852136291343,1.0,7/17,15.60%,HES1;CLCF1;ID2;EGR2;TNFRSF1B;CXCR4;SERPINE2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3698989285251234,0.7374361117303637,0.7531083481349912,0.962091169819706,1.0,3/11,8.66%,LMNA;ATP2B4;P2RX4
prerank,regulation of cellular catabolic process (GO:0031329),0.2793977300742355,0.7373249387369973,0.8238341968911918,0.9618064409666683,1.0,12/62,13.42%,USP13;ABL1;DDIT3;RRAGB;WDR41;ATM;USP10;SMCR8;CISD2;LONP2;USP33;EP300
prerank,negative regulation of RNA metabolic process (GO:0051253),0.34113452532293453,0.736646830414657,0.7880690737833596,0.9623500546396999,1.0,5/18,16.01%,ESR1;NCOR1;ZC3H12A;NCOR2;KAT2B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.20797654635404692,-0.7361451521634811,0.9640718562874252,0.9518920733319507,1.0,24/84,23.20%,IGF1;APOE;RTN1;RPS3;GAPDH;NTRK2;SPHK1;RTN4;CALR;RPL13A;BIN1;YBX1;CNOT9;ORMDL3;RACK1;NANOS3;DDX3X;CHRNA7;GGA3;CPEB3;BTG2;IGF2BP1;RTN2;PATL2
prerank,cellular macromolecule catabolic process (GO:0044265),0.2881458629560698,0.7361443754290461,0.8237704918032787,0.9626276774871372,1.0,10/49,18.00%,SIDT2;IDE;CHEK2;PABPC4;FBXO17;EXOSC7;RNASEH2A;DFFB;OGA;RNASE6
prerank,regulation of innate immune response (GO:0045088),0.2812060658442833,0.7357696303414683,0.8356687898089172,0.9627411653676078,1.0,16/57,20.33%,TRAFD1;POLR3D;PLSCR1;IFI35;IRF1;IRAK3;ERAP1;DHX9;RNF135;TLR8;ACOD1;POLR3F;ADAM8;ABCE1;BIRC3;AKIRIN2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.331053204665229,0.7356727241946749,0.7777777777777778,0.9624399026760798,1.0,6/20,20.28%,TGFBR1;DCUN1D5;ZMIZ1;DCUN1D2;WASHC1;DCUN1D1
prerank,oligodendrocyte differentiation (GO:0048709),0.33255390947689306,0.7355960480889211,0.7691082802547771,0.9621110006123664,1.0,1/19,1.12%,SOX9
prerank,negative regulation of metabolic process (GO:0009892),0.28503354868187386,0.7354100984604964,0.8273572377158035,0.9619474534096474,1.0,9/54,8.03%,DOCK7;ZNF423;FOXC2;ID1;NPR3;DDIT3;ADAMTS5;ABHD6;TLR4
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.31594318631706464,0.7350319830094243,0.7693474962063733,0.9620447766206096,1.0,4/25,8.66%,KLF4;CLU;TLR4;P2RX4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.31201355761988453,-0.7349491704508464,0.7971360381861575,0.951482635342616,1.0,11/11,68.83%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.31201355761988453,-0.7349491704508464,0.7971360381861575,0.951482635342616,1.0,11/11,68.83%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,prostanoid metabolic process (GO:0006692),-0.30798522285503416,-0.734097054144338,0.8199513381995134,0.9515812288919526,1.0,2/13,12.39%,PTGS1;HPGDS
prerank,sensory perception of taste (GO:0050909),0.3754456677754185,0.7340031196302143,0.7458471760797342,0.9630539039094945,1.0,3/10,25.92%,TAS1R3;PKD2L1;CD36
prerank,lipid droplet formation (GO:0140042),0.3667184122063629,0.7332576921100199,0.7684391080617495,0.9636943760526417,1.0,3/10,17.30%,ZFYVE1;CDS1;SMIM22
prerank,regulation of myoblast fusion (GO:1901739),0.37170704301114577,0.7330559715848857,0.7584369449378331,0.9635466568670643,1.0,3/11,10.81%,MYOG;EHD1;EHD2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.33142819156132525,0.7320881472413638,0.7734375,0.9644725706017343,1.0,5/19,16.44%,PPP2R3C;MMP14;PRKDC;ZBTB1;ZMIZ1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.23222566111724674,-0.7318514662275682,0.899641577060932,0.9533815746599494,1.0,7/40,14.09%,DEFA6;PGLYRP1;GBP7;GBP4;GSDMD;RPL39;CHGA
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3685374046412535,0.7316143426530501,0.7601410934744268,0.9646742710796004,1.0,3/10,14.31%,PARD3;PLPP1;HTR2B
prerank,establishment of spindle localization (GO:0051293),0.3468540674976264,0.7310788527995332,0.7581168831168831,0.9649800786609087,1.0,2/14,5.56%,NLRP5;TLE6
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2954406533458109,0.7310414057107041,0.8059071729957806,0.9645999388687496,1.0,4/36,7.16%,ADRB2;ITGB1;NRP1;IL10
prerank,regulation of microtubule polymerization (GO:0031113),0.2949387946851941,0.7309830477719721,0.8067226890756303,0.9642553334807425,1.0,6/40,11.72%,MET;ABL1;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,positive regulation of telomere capping (GO:1904355),0.3407305191186861,0.7307328697569767,0.7874794069192751,0.9641767286617113,1.0,2/17,9.59%,NEK7;TNKS2
prerank,Fc receptor signaling pathway (GO:0038093),0.25526704652730786,0.7299355109678344,0.8626760563380281,0.9648708569279001,1.0,23/110,17.17%,PPP3CA;VAV2;SHC1;GAB2;TAB3;PSMB2;CHUK;NFKB1;FBXW11;PLCG2;JUN;PSMC6;MAP2K4;NFATC3;PAK2;PSMD11;NFATC1;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,positive regulation of viral transcription (GO:0050434),0.31827704604582513,0.7299208848555068,0.7982062780269058,0.9644572222452527,1.0,4/25,19.01%,MDFIC;NELFE;DHX9;CCNT1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.30972616820481513,0.7297110899828285,0.7846385542168675,0.9643106804239705,1.0,4/26,8.66%,KLF4;CLU;TLR4;P2RX4
prerank,neutrophil chemotaxis (GO:0030593),-0.21655146322205515,-0.7287779693818203,0.9204545454545454,0.9561808268987907,1.0,21/53,31.61%,PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;SYK;JAML;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;PIK3CD
prerank,nucleic acid-templated transcription (GO:0097659),0.29683244482562654,0.7286905276620976,0.8398384925975774,0.9653018445024987,1.0,11/42,23.60%,MEF2A;NR4A2;PPP5C;HOXD3;BAZ2A;EPC1;CREBL2;POLR3A;E2F1;THAP1;DRG1
prerank,cellular response to interleukin-1 (GO:0071347),0.24769533390451845,0.7282110385525307,0.8864926220204313,0.9655642534799785,1.0,27/143,17.12%,SOX9;TANK;PTGIS;TAB3;IRAK4;RIPK2;PSMB2;MAP3K3;CHUK;NFKB1;FBXW11;RBMX;IRAK3;PSMC6;USP10;CCL3;CCL1;MYD88;ZC3H12A;PSMD11;PSMD1;SQSTM1;ACOD1;IKBKG;CUL1;PSMC1;PSMD7
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.32782998185601453,-0.7281562805445182,0.802439024390244,0.9559576475262053,1.0,1/10,2.18%,PCGF5
prerank,axonal transport (GO:0098930),0.29354342371879427,0.7280606869386752,0.8235294117647058,0.9653176996837262,1.0,8/36,18.89%,AP3B1;KIF1B;PAFAH1B1;FBXW11;KIF3B;AP3D1;RAB21;AP3S1
prerank,filopodium assembly (GO:0046847),0.3437398434488341,0.728051253426821,0.773524720893142,0.964898327095645,1.0,3/16,8.21%,EZR;SRGAP2;FGD6
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.2428744489837974,-0.7276953180155311,0.8902439024390244,0.9555081208723861,1.0,9/32,19.51%,SLC44A1;LPIN3;ABHD3;MFSD2A;SLC44A2;CHKA;LPIN1;SLC27A1;PCYT1B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3139819170956016,0.727267698426115,0.8138138138138138,0.9655364679989841,1.0,2/24,5.27%,CAMK2D;DMD
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3241754754395873,0.7270610305046938,0.7980769230769231,0.9653870710216939,1.0,5/19,10.34%,ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.35647182622632684,0.7265447034700521,0.765704584040747,0.9656534666375785,1.0,4/13,21.09%,RIC3;RANGRF;ABCA7;TM9SF4
prerank,lipid biosynthetic process (GO:0008610),0.2644490286251443,0.7263566688456231,0.8573216520650814,0.9654806591218987,1.0,15/77,20.37%,ABCD3;PIP5K1A;AGPS;SCD;MBOAT1;PDSS2;GNPAT;MVD;ACSM2A;ACSM2B;HMGCR;SREBF1;NDUFAB1;LPCAT1;CYP19A1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2571406039453971,-0.7255760985196227,0.8787061994609164,0.957129396688115,1.0,4/23,15.12%,CECR2;CASP3;KPNB1;FOXL2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.28984173858750467,0.7251874431433151,0.8184397163120567,0.9666284623089236,1.0,13/39,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,cholesterol homeostasis (GO:0042632),0.2671513807412139,0.7247729122825408,0.8357235984354628,0.9667756784908627,1.0,10/64,13.28%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A
prerank,regulation of macrophage cytokine production (GO:0010935),0.3511206129067245,0.7243056627733007,0.7739273927392739,0.9669756641065698,1.0,3/13,9.96%,TGFB3;PLCG2;IRAK3
prerank,regulation of exocytosis (GO:0017157),0.28310252722910045,0.7236299908812411,0.8326474622770919,0.9674945715624188,1.0,4/46,7.94%,STXBP6;ANXA1;SYTL4;NSF
prerank,telomere capping (GO:0016233),0.34297260905762916,0.7236098548498977,0.7904290429042904,0.967088776320445,1.0,5/16,21.97%,STN1;PRKDC;NBN;RAD50;TEN1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.29269724228552896,0.7230076667310789,0.8140161725067385,0.9674725722467395,1.0,8/40,19.43%,PID1;ABL1;VCP;ARL6IP5;RNF122;ABCD1;PYCR1;SLC25A36
prerank,granulocyte chemotaxis (GO:0071621),0.27163677862083735,0.7228772179930557,0.842456608811749,0.9672113308852416,1.0,6/55,11.36%,ANXA1;CXADR;GBF1;CXCL2;CCL3;CCL1
prerank,heterocycle biosynthetic process (GO:0018130),0.3487573969484838,0.7226137372120421,0.7926634768740032,0.9671513553436695,1.0,4/14,19.77%,NFS1;MOCOS;PYCR1;MOCS3
prerank,organelle fusion (GO:0048284),0.3149013933430048,0.7224628735654938,0.7966101694915254,0.9668996632154337,1.0,6/22,26.30%,EEA1;MIEF1;SPG7;MIGA1;MIEF2;USP30
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.34387997856836416,0.7222411786022149,0.7799671592775042,0.9667559593102812,1.0,2/14,5.64%,CD80;ISL1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3354937349946005,0.722082133072367,0.7866666666666666,0.9661385919303618,1.0,3/15,18.89%,AP3B1;AP3D1;AP3S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3354937349946005,0.722082133072367,0.7866666666666666,0.9661385919303618,1.0,3/15,18.89%,AP3B1;AP3D1;AP3S1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.31923752415987533,0.7219436556539744,0.7959814528593508,0.9658749695082331,1.0,6/21,12.07%,EFNA5;VCL;PTPRA;SLC9A1;RHOA;CORO1C
prerank,regulation of viral transcription (GO:0046782),-0.2331153545714077,-0.7218208814344713,0.926056338028169,0.9604882693084983,1.0,8/39,17.61%,TRIM14;TRIM62;IFITM3;NELFCD;POLR2G;TRIM21;TARBP2;POLR2K
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3235890017257964,0.7217271715017649,0.7836065573770492,0.9657324301778849,1.0,5/20,13.42%,CLK2;C1QTNF12;NCOR1;ERFE;EP300
prerank,cellular respiration (GO:0045333),-0.23085200764614433,-0.7215992415512918,0.9261992619926199,0.9597749935435581,1.0,19/41,30.52%,SDHA;PPARGC1A;UQCRH;UQCR10;ME3;CYCS;ATP5F1D;NDUFS4;MTFR2;COX4I2;COX10;SLC25A13;ETFRF1;UQCRC1;UQCRB;SDHC;BLOC1S1;MTLN;UQCRC2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.20904322690357968,-0.7212935504890237,0.9363636363636364,0.9591812095176938,1.0,15/61,22.05%,PPARA;PRKAG2;FGFR4;PSMB4;PSMB3;PSMB8;PSME2;PSMB10;NR1H4;SIRT5;PDK2;PDK4;PSMC5;PSMD9;PSMC3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.29469991453863537,-0.7211168525748728,0.8397932816537468,0.958401036405955,1.0,2/14,10.73%,ERN1;CPSF6
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3236352821753211,0.7207119466905316,0.7921259842519685,0.966675357062878,1.0,4/20,27.60%,FDX1;STARD3NL;AKR1B1;STAR
prerank,synaptic vesicle localization (GO:0097479),0.34760585487905554,0.7205748503516409,0.7794361525704809,0.9664415753147643,1.0,3/13,13.79%,SPG11;TMEM230;SYNJ1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.32651268033914793,0.7205118801221683,0.7765793528505393,0.9660987387820045,1.0,5/22,13.20%,DUSP16;DUSP5;DUSP10;PPP5C;PPM1A
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2937008759191143,-0.7199198081702526,0.8125,0.9588210192154856,1.0,4/12,20.32%,IL18;TTBK1;NUPR1;TREM2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.35003793134315386,0.7197770892301757,0.7773913043478261,0.9666340207442542,1.0,2/13,9.06%,NFAT5;RHOA
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3119939747693466,-0.7196756441027533,0.8067632850241546,0.9581391582314502,1.0,10/10,68.83%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5;TCP1;CCT6A
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.36436363732436117,0.7194315226312377,0.7846410684474123,0.9666449311167089,1.0,2/10,6.13%,TSKU;PLS1
prerank,nuclear membrane organization (GO:0071763),0.32298163720416695,0.7192325201300404,0.8003169572107766,0.9664791450601464,1.0,6/19,25.39%,TOR1AIP1;EMD;TOR1B;TARDBP;AKAP8L;CHMP4B
prerank,regulation of cellular localization (GO:0060341),0.2817177673056685,0.7179536609425917,0.8535620052770448,0.9677587780127955,1.0,4/46,6.08%,CAMK2D;EFNA5;GSN;KDM1A
prerank,sterol homeostasis (GO:0055092),0.2637172416164154,0.7179489783802272,0.8471502590673575,0.9673399387337338,1.0,13/65,17.40%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A;PLA2G12B;ABCD1;ANGPTL3
prerank,defense response to tumor cell (GO:0002357),0.36280392232961517,0.7175620733631943,0.7903780068728522,0.9674184560758919,1.0,2/10,11.69%,KLF4;RBMS3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.365165713859075,0.7170154575668451,0.7680672268907563,0.967698802302975,1.0,4/11,24.33%,ATL2;VCPIP1;BNIP1;STX18
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3338238845023109,0.7167131137395009,0.810207336523126,0.9676827936762544,1.0,6/16,26.24%,PIGB;PIGL;PIGN;PIGH;PIGQ;PIGA
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3109076831542384,-0.7166597550655627,0.8046511627906977,0.9606074418205096,1.0,6/10,25.89%,RUVBL1;PIH1D1;RUVBL2;NUFIP1;SHQ1;ZNHIT6
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.32507057328678024,-0.7158005426822099,0.823943661971831,0.9605772194089458,1.0,2/10,19.05%,SNCA;MT3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2778826986232815,0.7154777015001209,0.8381578947368421,0.9688575419064331,1.0,12/54,20.02%,TAX1BP1;HIPK1;PTPN2;SPPL2A;CHUK;CARD16;TRADD;UBE2K;CPNE1;IKBKG;BIRC3;RNF31
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.34167141334254914,0.7152362205793573,0.8023450586264657,0.9687422704889098,1.0,6/14,22.57%,ETNK1;LPIN2;CHKB;CEPT1;ETNPPL;ETNK2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.2788736152131147,-0.7151986578231342,0.8431372549019608,0.9602661660711754,1.0,1/17,0.71%,LYN
prerank,regulation of telomerase activity (GO:0051972),0.2827099207174871,0.7149244597339122,0.85,0.9687290093465425,1.0,6/45,13.35%,KLF4;NEK7;SMG6;GRHL2;ATM;XRCC5
prerank,synaptic vesicle membrane organization (GO:0048499),0.33277723491195504,0.7147630814816579,0.7975077881619937,0.968532949825676,1.0,8/17,29.86%,STX11;SNAP23;STX19;AP3D1;STX2;SYNGR2;SNAP47;STX1A
prerank,nuclear body organization (GO:0030575),-0.30013616298517326,-0.7146137702457467,0.8465473145780051,0.9599465042302089,1.0,1/12,2.38%,ETS1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.30043380193477226,-0.7142656043134836,0.8321995464852607,0.9593729707520992,1.0,3/12,17.86%,ABCC9;KCNJ8;ABCC8
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.23909578190049216,0.7142169239848237,0.9379679144385027,0.9688547968134273,1.0,54/208,20.02%,TRAF3IP2;TANK;AKAP13;ALPK1;TAB3;IRAK4;ESR1;MAVS;RIPK2;MAP3K3;REL;IKBKE;ROR1;RORA;RHOA;CHUK;PLCG2;PIM2;MTDH;GOLT1B;USP10;PER1;MIER1;OTUD7B;PPP5C;MYD88;TRAF5;ZC3H12A;CARD16;PPM1A;TRADD;TNIP1;HTR2B;S100B;CCDC22;TRIM39;PIDD1;SQSTM1;ZFAND6;CPNE1;DDX21;IKBKG;ANKRD17;NLRP12;BCL10;TLR6;DHX36;BIRC3;NEK6;TRIM25;TRAF3;UBE2N;SLC20A1;RNF31
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.26408269642288384,0.7141284234242481,0.8767772511848341,0.9685375420159636,1.0,21/88,23.16%,SAMD4A;IGFBP5;NELL1;PAIP2;SYNCRIP;RGP1;NFKB1;TOB1;DNAJC1;CNOT7;SERPINE2;DHX36;FXR2;CAPRIN1;FMR1;CLN3;EPRS1;NANOS2;EIF2AK3;RBM4;SAMD4B
prerank,chondroitin sulfate metabolic process (GO:0030204),0.29705544611947526,0.7136781965552292,0.8245363766048502,0.9686783518178954,1.0,9/30,19.19%,DSE;CHST13;HEXA;ARSB;CHST11;IDUA;CHST12;BGN;CHPF2
prerank,embryonic digit morphogenesis (GO:0042733),0.320076500056951,0.7134838113516965,0.8082408874801902,0.9684940070130507,1.0,3/18,5.59%,GLI3;NOG;CREBBP
prerank,sphingolipid biosynthetic process (GO:0030148),0.26341979011303096,0.7120135777463932,0.8881987577639752,0.9699937097891871,1.0,5/71,5.31%,ACER3;PLPP3;SGMS2;LARGE1;SPTSSB
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2939546863278331,-0.7118946951852654,0.8432835820895522,0.960966366862634,1.0,6/14,27.40%,ABCG1;APH1B;ADAM19;DYRK1A;NCSTN;PSENEN
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.33190003473406915,0.7109514441606016,0.8006379585326954,0.970992279880624,1.0,3/15,7.36%,FGFR1;MFRP;CELF1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3177265368890523,0.710652651590215,0.8077519379844961,0.9709613062270748,1.0,3/21,10.57%,COX16;COA8;SCO2
prerank,endoderm development (GO:0007492),0.3410882722709288,0.7102761006323896,0.7867768595041322,0.9710051310499977,1.0,3/13,11.14%,GATA4;DUSP5;KIF16B
prerank,Notch signaling involved in heart development (GO:0061314),0.3555386717785514,0.7097573619391493,0.7978910369068541,0.9712260255803392,1.0,3/11,10.24%,NOTCH2;JAG1;GALNT11
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.33816796301339896,0.7094438771642455,0.804635761589404,0.9712140064549054,1.0,4/13,17.18%,MDFIC;CHP1;NUP153;BARD1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.31819373490974895,0.7088875394255957,0.8087774294670846,0.9715260350495724,1.0,6/19,24.85%,ADA;AMPD3;DGUOK;POLD3;GMPR2;AMPD2
prerank,regulation of receptor internalization (GO:0002090),0.2865603317586565,0.7086369867143213,0.8307254623044097,0.97143608806156,1.0,11/35,21.80%,LRPAP1;SFRP4;VEGFA;ATXN2;MKLN1;TBC1D5;RIN3;EGF;FMR1;ANKRD13D;DLG4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.25856672402107056,0.708616064472912,0.8973105134474327,0.9710432651153635,1.0,23/83,21.90%,INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;PIM2;GSPT1;RB1;CDKN3;CDC45;CUL3;CCND1;CDK16;HINFP;CUL1;RRM2;CDKN1A;KHDRBS1;PPP6C;POLA1;E2F1;CUL4A
prerank,cellular response to dsRNA (GO:0071359),0.33572927931786334,0.7085973365656589,0.8065040650406504,0.9706458132371857,1.0,9/15,35.28%,MAVS;IFIH1;DHX9;COLEC12;RALB;ZCCHC3;MUL1;RIOK3;CGAS
prerank,phosphate ion homeostasis (GO:0055062),0.3524836795289509,0.7083664664168662,0.7924187725631769,0.970522936343888,1.0,2/10,7.18%,SFRP4;SLC34A2
prerank,protein N-linked glycosylation (GO:0006487),0.27078170474667607,0.7082945721276319,0.883419689119171,0.9701956010500355,1.0,15/66,20.12%,MGAT4C;FUT8;ALG13;MGAT3;B4GALT1;DPM1;MGAT1;ALG14;DDOST;TMEM165;ALG12;TUSC3;GFPT1;MGAT5;B4GALT7
prerank,innate immune response (GO:0045087),0.23757985589039138,0.7079640692503154,0.9574468085106383,0.9702048311783239,1.0,45/217,19.48%,PTK2B;LBP;COLEC11;ALPK1;VNN1;ANKHD1;FRK;IRAK4;MAVS;RIPK2;SETD2;SLPI;KLRC2;ZDHHC11;REL;TLR4;CLPB;CHUK;TREML1;PLCG2;SRMS;TRIM26;CAPZA1;MYD88;IFIH1;YES1;IFNLR1;S100B;RNF135;TLR8;TRIM39;PML;CLEC5A;IKBKG;ANKRD17;SRPK1;BCL10;CYP27B1;RNASE6;POLR3A;TTC4;PPARG;CIITA;TRIM25;TRIM35
prerank,regulation of cell projection organization (GO:0031344),-0.2943133901079539,-0.7079615020625963,0.8441247002398081,0.9641974807677104,1.0,5/13,20.81%,MFSD2A;CCL19;MACF1;TREM2;ERMN
prerank,mRNA methylation (GO:0080009),-0.28583246650758487,-0.7078796623265126,0.8526315789473684,0.9633263049061457,1.0,5/15,30.67%,METTL14;METTL3;ZC3H13;METTL16;METTL8
prerank,microtubule anchoring (GO:0034453),-0.29694755581585147,-0.7071712478043193,0.8284960422163589,0.9630997907786613,1.0,2/12,10.39%,CLASP2;DAG1
prerank,amyloid-beta metabolic process (GO:0050435),0.33067758695706684,0.7069770172691939,0.8253706754530478,0.971043784639207,1.0,3/16,9.28%,MGAT3;IDE;BACE2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3571151196200658,0.7067730585221984,0.8114186851211073,0.9708686336560127,1.0,2/10,15.68%,IYD;KYAT1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.31561326264168543,0.7050201804641092,0.7964743589743589,0.972654136025031,1.0,12/20,27.61%,FOXC1;NIBAN2;RB1;DDRGK1;PAX6;EP300;TWIST1;GATA3;POU4F1;GTF2B;TRAF6;TGFB1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3311898189019101,0.7049821166461134,0.7865168539325843,0.9722774705094749,1.0,5/15,25.48%,CHEK2;RAD17;ATF2;RAD9B;MDC1
prerank,macrophage chemotaxis (GO:0048246),-0.3147292340023816,-0.7048900259959154,0.8358862144420132,0.9645721224916636,1.0,5/10,27.20%,TAFA4;EDNRB;CCL2;CCL5;CXCL17
prerank,RNA interference (GO:0016246),0.3290919694403398,0.7048869440166862,0.788961038961039,0.9719695935574135,1.0,5/17,21.21%,CELF1;DHX9;AGO2;DROSHA;NRDE2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3104553256826523,0.7039351604464835,0.8006042296072508,0.9727685899664213,1.0,4/21,13.89%,DERA;GPI;SHPK;RPIA
prerank,spermatid development (GO:0007286),-0.23276249917678254,-0.7029264911106756,0.9235668789808917,0.9655777079058175,1.0,12/32,31.44%,NECTIN2;JAM2;CDYL;TDRD5;ING2;NME5;YTHDC2;DPY19L2;CCDC63;RSPH1;ZMYND15;SOX30
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.29486340465370264,0.7026597859598589,0.8377976190476191,0.9738881994741836,1.0,7/30,14.72%,KIF13A;GOLPH3;NSF;SEC16A;KRT18;GOLGA7;GGA2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.29083855921085255,-0.7025980490547421,0.8560794044665012,0.9649595312375029,1.0,5/13,14.47%,DCN;CSPG5;NCAN;IDS;HEXB
prerank,negative regulation of RNA splicing (GO:0033119),0.31982686494769325,0.7025256502146074,0.8138138138138138,0.9736389499100357,1.0,4/19,10.15%,SRSF6;PCBP4;RBMX;U2AF2
prerank,lipoprotein transport (GO:0042953),-0.30973699828164253,-0.7024330589084284,0.839622641509434,0.9641577847316519,1.0,3/10,16.68%,PRKCB;ZDHHC17;VMP1
prerank,lipid translocation (GO:0034204),0.31206648909323004,0.7022932265419712,0.8211920529801324,0.9734982750210356,1.0,8/21,19.16%,ATP10A;ATP8B1;TMEM30B;ATP9B;ATP11A;ABCC1;RFT1;ABCA7
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3238763048683953,0.7012761047715341,0.8019169329073482,0.9743549951403608,1.0,5/20,18.04%,ZC3H7A;PUM2;PUM1;AGO2;DROSHA
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.27530113729987105,-0.7009335112860623,0.8247422680412371,0.9647413034016483,1.0,1/17,2.28%,LPGAT1
prerank,rRNA 3'-end processing (GO:0031125),0.3629501523110329,0.7005062273546503,0.7947019867549668,0.9748852807651568,1.0,2/10,11.57%,ERI3;EXOSC7
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2736088675747255,-0.7003955955368993,0.8446115288220551,0.9643430866239948,1.0,6/17,26.66%,LPGAT1;PLAAT3;PLA2G4C;PLA2G5;PLA2G4E;PLBD1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.34710075616900854,0.6999924599306332,0.8190954773869347,0.97509135252711,1.0,1/11,4.28%,AGTR1
prerank,proteasome assembly (GO:0043248),0.34725124343859126,0.6996926398411967,0.7901861252115059,0.975034674131303,1.0,5/11,26.86%,PSMG2;PSMD11;PSMG1;ADRM1;PSMD4
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.26568515225488354,-0.6995651249043682,0.8622589531680441,0.9642493913308149,1.0,8/19,32.97%,GSK3A;FZD5;CAMKK2;DNM1L;PINK1;FBXO7;HTRA2;PARK7
prerank,protein targeting (GO:0006605),0.24543332414443714,0.6991778776623132,0.9108796296296297,0.975228389258285,1.0,32/118,22.42%,GIPC1;LTBP2;HPS4;ATG3;ZDHHC11;AP4E1;PARD3;KATNB1;ZDHHC15;LONP2;HACL1;SEC61A1;VPS37A;ZDHHC2;TIMM23;PITRM1;GOLGA7;BCAP31;TIMM17B;ZDHHC20;ZFAND6;SEC63;SRPRB;VPS37B;ZDHHC23;RABGEF1;AP4M1;ZDHHC12;AP4B1;DNAJC19;SRPRA;TOMM34
prerank,Golgi to lysosome transport (GO:0090160),0.34224273726360127,0.6985529611239626,0.788659793814433,0.9755623020523,1.0,5/11,20.33%,GAK;EHD3;RBSN;AP4M1;CLN3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3094215926362215,0.6984272371013588,0.8404726735598228,0.9752992949229687,1.0,2/22,4.79%,EDEM3;RNF185
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2949558572054242,0.698277097208406,0.8308605341246291,0.9750530936682293,1.0,3/30,6.54%,PRKCD;PTPN2;DMTN
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3489995295747133,0.6981280278548773,0.7937608318890814,0.974811136128836,1.0,2/10,9.65%,TLR4;IL33
prerank,glycosphingolipid metabolic process (GO:0006687),0.28039053880581605,0.6979806279337017,0.8575233022636485,0.9745617772136264,1.0,4/42,4.87%,ESYT3;LARGE1;HEXA;ESYT2
prerank,secondary alcohol metabolic process (GO:1902652),0.2787370190085803,0.6975971812047332,0.8494475138121547,0.9746070776291111,1.0,6/42,12.80%,SOAT1;FDX1;TSKU;RXRA;EBP;LCAT
prerank,placenta development (GO:0001890),-0.3043830659752685,-0.6974774925057126,0.8501228501228502,0.9654261149978705,1.0,5/12,29.83%,PTK2;E2F7;ADAM19;E2F8;SOD1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2950027480621651,0.6973439336762446,0.8320610687022901,0.9740676016585403,1.0,6/29,13.94%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2950027480621651,0.6973439336762446,0.8320610687022901,0.9740676016585403,1.0,6/29,13.94%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,regulation of neuron projection arborization (GO:0150011),-0.27994315040942597,-0.6966943810901871,0.8496042216358839,0.9652860206049404,1.0,4/15,17.37%,WNT5A;MFSD2A;MACF1;GRIP1
prerank,regulation of Golgi organization (GO:1903358),0.31793576572908033,0.6963448447242152,0.8107667210440457,0.9749067581260532,1.0,8/17,24.33%,STX5;EHD3;ARMH3;AKAP9;MAP2K2;RBSN;CAMSAP3;STX18
prerank,positive regulation of myelination (GO:0031643),0.34409139439729775,0.6961235231356924,0.7896494156928213,0.9747588523687483,1.0,3/11,12.34%,EGR2;PARD3;TNFRSF1B
prerank,cellular response to glucose stimulus (GO:0071333),0.28704937569255684,0.6951568959127952,0.8361823361823362,0.9755715359050015,1.0,6/30,12.96%,KCNB1;UNC13B;SLC39A14;CLTRN;PDK3;SELENOT
prerank,necroptotic process (GO:0070266),0.3213172768601373,0.6945450308540564,0.7914614121510674,0.9758854189493419,1.0,3/16,9.09%,TRPM7;TLR4;RIPK3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.33578827669554634,0.6943843881155611,0.811864406779661,0.9756462714486409,1.0,5/13,24.12%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.27780787475650665,0.6941369167480692,0.8681159420289855,0.9755317476839128,1.0,9/39,17.83%,TTC7A;PIK3C2B;IP6K2;SOCS2;PI4KB;PIK3R3;SMG1;IP6K1;IP6K3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.2609538641462301,-0.693874499970132,0.903485254691689,0.9671232806700598,1.0,2/19,4.62%,SLCO1C1;APP
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24972416515873427,0.6923566119673047,0.915527950310559,0.9773162183088326,1.0,33/94,29.62%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AKAP9;CEP131;CSNK1E;NPHP1;MKS1;SDCCAG8;CEP43;CEP89;HAUS2;CEP57;C2CD3;CEP97;CEP70;IQCB1;CSNK1D;OFD1;PLK4;HAUS5;CNTRL;PCNT;PRKACA;NPHP4;CEP192;CEP290;ODF2;RPGRIP1L;CEP83;YWHAE
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.2968741223319887,-0.6922658460681411,0.8916876574307305,0.9677549460440646,1.0,3/12,7.63%,LY6E;IFITM1;IFITM3
prerank,icosanoid biosynthetic process (GO:0046456),-0.3150245045763994,-0.6922359619312541,0.8369829683698297,0.9668333197574697,1.0,4/10,26.39%,LTA4H;PLA2G5;ALOX5AP;MGST3
prerank,renal filtration (GO:0097205),0.3529535192205941,0.6921809304821374,0.8241379310344827,0.9770994874701946,1.0,4/10,18.91%,SULF1;XPNPEP3;TBC1D8B;SULF2
prerank,copper ion homeostasis (GO:0055070),-0.2707922500798582,-0.692091740705628,0.8507462686567164,0.9660177791939585,1.0,4/17,11.45%,APP;ATOX1;SLC31A1;MT2A
prerank,striated muscle cell differentiation (GO:0051146),0.3196829591898581,0.6917628004427331,0.825,0.9771840110238937,1.0,2/16,5.66%,AKAP13;SKI
prerank,regulation of microtubule depolymerization (GO:0031114),0.3053904442429043,0.6911349469976563,0.8481203007518797,0.9774972821531173,1.0,4/25,10.71%,FGF13;HDGFL3;MAP1B;KATNB1
prerank,mitochondrial membrane organization (GO:0007006),-0.23058064707236858,-0.6908766946475333,0.9253731343283582,0.9662075209218358,1.0,11/32,25.84%,BCL2;BCL2L1;CHCHD6;MICOS13;MFN2;MTX1;HSPA9;MFN1;PMAIP1;RCC1L;SLC25A4
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2859554470447365,0.690576498972497,0.8600883652430045,0.9777528811741693,1.0,3/30,6.20%,CD44;KDM1A;CLU
prerank,response to gamma radiation (GO:0010332),0.29617333470865215,0.690529506202841,0.8627450980392157,0.9773895533070517,1.0,6/24,17.95%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.31514903891710855,0.690139124332933,0.8162939297124601,0.9774271240183813,1.0,3/16,8.83%,RAET1E;KLRC2;PVR
prerank,positive regulation of double-strand break repair (GO:2000781),0.2733509087623286,0.6898471319406797,0.8708333333333333,0.977328672542519,1.0,10/39,20.84%,FUS;DDX11;SPIDR;PRKDC;MRNIP;KDM4D;SHLD1;WDR48;PARP3;KMT5B
prerank,glutathione metabolic process (GO:0006749),0.2791503577659176,0.6897332687499972,0.8541953232462174,0.9770424000040119,1.0,7/38,18.75%,GCLC;MMACHC;GSR;GSTM4;DPEP1;GSTA2;GSTT1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3139687009254944,0.6896258098776606,0.8155038759689922,0.9767466042032199,1.0,9/18,35.46%,RNF185;OS9;EDEM2;UGGT2;MAN1B1;SEL1L;SYVN1;RNF5;RNF103
prerank,cellular amide metabolic process (GO:0043603),0.24844261448687285,0.689165157097662,0.9201430274135876,0.9768820308811892,1.0,15/102,14.01%,SLC5A6;PLPP3;VNN1;PLA2G15;ACOT8;NNMT;NLN;ACOT12;ACOT9;FPGS;FOLR2;ACOT13;ACSM2A;ACSM2B;PLPP1
prerank,histone exchange (GO:0043486),0.2801506055191345,0.6885670174292834,0.8681159420289855,0.9772169841976773,1.0,17/37,29.26%,SRCAP;VPS72;CENPT;SMARCA5;RBBP7;CENPQ;RNF8;HJURP;DMAP1;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,cellular response to interferon-gamma (GO:0071346),0.24702049838225928,0.6878056815437851,0.9190184049079755,0.977690010378469,1.0,11/88,11.36%,CAMK2D;PRKCD;CD44;MID1;SLC26A6;SYNCRIP;IRF1;TLR4;TRIM26;CCL3;CCL1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3312316481839486,0.6877319832145694,0.8414839797639123,0.9773700638643089,1.0,2/15,3.62%,PRKCE;IRS1
prerank,sterol biosynthetic process (GO:0016126),-0.22329094666163113,-0.6874751111567396,0.9425981873111783,0.9685018316425863,1.0,7/33,17.54%,PRKAG2;INSIG2;ACLY;HSD17B7;CH25H;SC5D;ACAT2
prerank,negative regulation of JNK cascade (GO:0046329),0.28888054431833304,0.6869085545527307,0.8651026392961877,0.977934337702478,1.0,6/31,11.50%,PDCD4;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25265481275483176,0.6865499891262473,0.8863049095607235,0.9779427429818679,1.0,23/70,28.08%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMC1;PSMD7;PSMD14;PSMD3;YTHDF2;GATA3;LDB1;PSMD12;EIF2AK2;PSMD4;PSME3;PSMD2;KMT2A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25235507794053863,0.6863097688073364,0.8984771573604061,0.9778068201174287,1.0,25/73,28.08%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;KITLG;PSMC1;PSMD7;DHX36;PSMD14;PSMD3;YTHDF2;GATA3;LDB1;PSMD12;EIF2AK2;PSMD4;PSME3;PSMD2;KMT2A
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3024014433981559,0.6862784397226224,0.8282674772036475,0.9774276311043487,1.0,4/23,9.36%,DSG2;ISL1;ID2;TNNI3
prerank,cobalamin metabolic process (GO:0009235),0.31559194483723013,0.685513351839116,0.8529886914378029,0.9778812201947881,1.0,7/17,26.37%,MMACHC;CD320;ABCC1;MMAB;MMADHC;CTRC;LMBRD1
prerank,inner dynein arm assembly (GO:0036159),0.34519539867084637,0.6851603849453844,0.8097643097643098,0.9778737169176464,1.0,2/10,14.78%,CCDC40;DNAAF4
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2965586083428921,-0.6843275944048833,0.8268292682926829,0.9705611088930399,1.0,1/12,4.99%,APOBEC1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2886618489631142,-0.684283556435114,0.8681592039800995,0.9696520840745764,1.0,2/13,7.41%,TMSB4X;HEY2
prerank,positive regulation of cell cycle process (GO:0090068),0.24622729480026292,0.6841388443111232,0.9221411192214112,0.9785834998061983,1.0,14/91,13.96%,CIT;GIPC1;PRKCE;CDC25B;PLSCR1;CDC14A;RHOA;AURKA;DRD3;LRP5;DDX11;ATRX;PKN2;CUL3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.309070749243952,0.6838451141517968,0.8183254344391785,0.9784864682515454,1.0,3/17,8.83%,RAET1E;KLRC2;PVR
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2710906701680662,-0.6830416594629125,0.8952618453865336,0.9698718190045269,1.0,8/16,34.82%,ACSS1;ACLY;GCDH;DIP2A;PPT1;HSD17B8;PPCS;SLC25A1
prerank,negative regulation of signaling (GO:0023057),0.2970359821047267,0.6828741797841801,0.84,0.9791688906437843,1.0,4/25,10.43%,UBASH3B;HHIP;ACVR1;SRMS
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3313659190068713,0.6816275194243766,0.8100840336134454,0.980157933350976,1.0,6/12,30.46%,SEC61A1;SEC63;GET3;CHMP4A;CHMP4B;SEC61B
prerank,transferrin transport (GO:0033572),-0.22346388827545582,-0.68106672240591,0.9355932203389831,0.9708348018295612,1.0,10/33,20.54%,TFRC;LMTK2;ATP6AP1;STEAP3;ATP6V1D;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,positive regulation of defense response (GO:0031349),0.24460394066364793,0.6808096650269518,0.91875,0.9806846447045515,1.0,20/89,18.16%,GPR4;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;LRSAM1;IL33;CCL3;CCL1;TRADD;TNIP1;DHX9;TLR8;ABCC1;NLRP12;POLR3F;ADAM8
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.25053624517878614,0.6798636118909223,0.9064102564102564,0.9813414454236761,1.0,21/72,25.16%,DXO;ERCC5;CHD1L;ZC3H12A;DCP1A;ERCC3;IHO1;XPA;RPA1;ERCC1;RNASE6;RFC1;EXD2;DDX1;POLD3;RAD50;CUL4A;RFC5;EDC3;ERCC2;POLK
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2895247391726164,0.679821834498782,0.8592375366568915,0.980971020897784,1.0,1/30,0.92%,ABCD3
prerank,lipoprotein localization (GO:0044872),-0.29263971103533676,-0.6797784903185692,0.8907363420427553,0.9710232360763976,1.0,3/11,16.68%,PRKCB;ZDHHC17;VMP1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2854847620040637,0.6792437356195142,0.863768115942029,0.9812089822568612,1.0,9/29,23.07%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,nuclear transport (GO:0051169),-0.2645234979451295,-0.6766394734831214,0.8825065274151436,0.9728963841248901,1.0,6/16,22.44%,ANP32A;NPM1;NUP205;RBM15B;BANF1;NXT2
prerank,negative regulation by host of viral process (GO:0044793),0.3397496515081095,0.6757249906676087,0.8101045296167247,0.9847408192918307,1.0,2/10,14.02%,ZC3H12A;EIF2AK4
prerank,regulation of synapse organization (GO:0050807),0.2916314104376421,0.6752693763980708,0.8727810650887574,0.9848338929145458,1.0,7/26,16.26%,NEDD4;ABL1;PDLIM5;ABHD17B;SETD5;GRIPAP1;SLITRK2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.24872052453266646,0.6748664127446428,0.9248407643312102,0.9848564763503941,1.0,12/74,17.12%,EGLN3;NFE2L2;CREBBP;HIF3A;PSMB2;PSMC6;VEGFA;EP300;PSMD11;PSMD1;PSMC1;PSMD7
prerank,protein catabolic process (GO:0030163),-0.19894984578564656,-0.6747397570070296,0.9956896551724138,0.9736765465720563,1.0,4/59,5.71%,APOE;ADAMTS9;HSPA8;DAB2IP
prerank,establishment of melanosome localization (GO:0032401),-0.2522973610389654,-0.6729776440058866,0.882051282051282,0.9742576489588388,1.0,7/19,26.31%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,erythrocyte development (GO:0048821),-0.3014784420931439,-0.6728822367950358,0.8668280871670703,0.9733906856730277,1.0,5/10,18.68%,ALAS1;MED1;SH2B3;LYAR;ABCB10
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.24953207509271624,-0.6728144464369697,0.8939393939393939,0.9725030014181798,1.0,4/21,11.35%,TOX;NES;PROX1;MDK
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.25027456833365963,-0.6726952230340619,0.9203296703296703,0.9716662810069835,1.0,1/19,1.24%,APOE
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.31320884313074965,0.6726557828481294,0.8640939597315436,0.9868747878303599,1.0,5/16,20.84%,PRKDC;KDM4D;SHLD1;PARP3;KMT5B
prerank,negative regulation of cellular metabolic process (GO:0031324),0.27209171957667927,0.6725497920468716,0.8781869688385269,0.9865697918145507,1.0,12/37,21.80%,LRPAP1;ITGAV;NFKB1;ATXN2;NCOR1;ITGB3;AATF;RIN3;TFAP2A;TRAP1;ANKRD13D;DLG4
prerank,protein autoprocessing (GO:0016540),-0.25898400436203284,-0.6720791937123587,0.8961748633879781,0.971242624059863,1.0,4/17,16.76%,CASP4;CTSL;MYRF;CASP1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.30189844867502136,0.6718863456653754,0.8478260869565217,0.9868737749993411,1.0,3/22,6.62%,NOTCH2;KLF9;SRSF6
prerank,regulation of defense response to virus (GO:0050688),0.3227437525841439,0.671757711677679,0.8327922077922078,0.9865975940935288,1.0,6/14,26.70%,IFNLR1;DHX9;TRAF3;TRAF3IP1;RNF26;PPM1B
prerank,translational elongation (GO:0006414),0.23657370416681378,0.6703678269816341,0.9356796116504854,0.9876974625913507,1.0,36/101,30.78%,MRPL33;MRPL48;GTPBP2;MRPS27;MRPL14;MRPL32;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;EEF2K;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;LTN1;MRPL9;MRPS34;MRPS16
prerank,mRNA modification (GO:0016556),-0.2451479178443565,-0.6703451463540234,0.9214501510574018,0.9717884205725681,1.0,22/22,75.53%,METTL14;METTL3;TRUB1;ZC3H13;METTL16;METTL8;TRMT10C;DKC1;CBLL1;PUS1;NSUN2;PUS3;TRMT61A;TRMT61B;CMTR1;TRMT6;VIRMA;RPUSD2;PCIF1;PUS7;TRUB2;WTAP
prerank,acyl-CoA metabolic process (GO:0006637),0.27403997869692626,0.6698888560396038,0.8796433878157504,0.9877916410369749,1.0,7/35,14.30%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B;OGDH
prerank,gene silencing by miRNA (GO:0035195),0.28765344290365646,0.6696929671925418,0.8751814223512336,0.9875948387088214,1.0,11/32,22.93%,ZC3H7A;MOV10;TNRC6C;EIF6;PUM2;CNOT7;PUM1;AGO2;RAN;TNRC6A;RBM4
prerank,aminoglycan metabolic process (GO:0006022),0.3406986936420251,0.669383990223674,0.8225255972696246,0.9875223208608274,1.0,3/10,20.12%,XYLT1;B3GALT6;B4GALT7
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2959789760405625,-0.6691767448718575,0.8713592233009708,0.9718519912969593,1.0,1/10,6.79%,PRKAR1A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3059942081743789,0.66916777308091,0.8454258675078864,0.9873328133697862,1.0,1/21,1.40%,NGF
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2930269248660339,0.6686050270225047,0.868421052631579,0.987493594311369,1.0,5/23,17.56%,MTMR12;OCRL;PIP4P2;SYNJ1;MTMR11
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2814370025568611,0.6685845322415914,0.8595988538681948,0.9870961984908921,1.0,4/31,7.51%,KCNB1;CACNA1G;CLTRN;SYT8
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2999827157040779,0.6684003048423923,0.8591331269349846,0.9868659546685609,1.0,10/21,29.51%,MCUB;MCU;SLC8B1;FATE1;BCAP31;MICU3;MICU1;MICU2;PDZD8;ANXA6
prerank,positive regulation of secretion (GO:0051047),0.3270129480721008,0.6675247352082919,0.8293103448275863,0.9873737874964524,1.0,1/11,4.38%,ACSL3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.34267744486654744,0.6674677108810869,0.8217993079584776,0.9870202550274206,1.0,1/10,3.18%,NFE2L2
prerank,positive regulation of histone modification (GO:0031058),-0.21894349795893073,-0.6671939255324474,0.9428571428571428,0.9725468664053855,1.0,9/33,20.74%,RPS6KA5;PPARGC1A;ARRB1;MAPK3;APLNR;CTBP1;RUVBL2;SART3;ING2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.33460090188613445,0.6670896845277426,0.8172043010752689,0.987002854376711,1.0,2/11,12.07%,CD44;CORO1C
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3057330078500358,0.666979042599782,0.8573743922204214,0.9867083479586888,1.0,1/18,1.90%,DDR2
prerank,indolalkylamine catabolic process (GO:0046218),0.33527898073181445,0.666567646674181,0.8242530755711776,0.9867461447198613,1.0,10/10,66.49%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT
prerank,regulation of T cell differentiation (GO:0045580),0.2726538880776478,0.6665074406968984,0.8746312684365781,0.9863956566816571,1.0,6/33,16.44%,ABL1;CD2;CBFB;KAT2A;ZBTB1;ZMIZ1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2480983095589527,0.6664154346121791,0.9278350515463918,0.9860729664326133,1.0,15/68,19.88%,SULT1A1;RHOQ;PTHLH;ACOT8;ACOT12;AMPD3;ACOT9;ENTPD7;ACOT13;ACSM2A;ACSM2B;AK4;AK3;ACOT11;RAN
prerank,cellular response to chemical stress (GO:0062197),0.23758210189036522,0.6661704602240734,0.9473684210526315,0.9859124383495043,1.0,12/96,12.53%,LRRC8D;FOXO3;NFE2L2;ABL1;GPX8;MGAT3;VKORC1L1;GSR;ATM;CCS;RAD52;ZC3H12A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24215980904037782,0.6651393088815544,0.9292803970223326,0.9861677365819499,1.0,21/78,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24215980904037782,0.6651393088815544,0.9292803970223326,0.9861677365819499,1.0,21/78,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.24708517374611216,-0.6642672659424508,0.9088319088319088,0.9740119935067492,1.0,7/21,23.56%,BCL2L1;BOK;TMBIM6;SELENOS;XBP1;PMAIP1;CREB3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.33579075141569026,0.6642493670233357,0.8411867364746946,0.9867125139101416,1.0,2/11,9.48%,ADRB2;DRD3
prerank,regulation of exit from mitosis (GO:0007096),0.2743988488407417,0.6642149065799574,0.8767908309455588,0.9863385291711867,1.0,11/38,24.59%,ANAPC5;CDC16;ANAPC16;CDC14A;UBE2S;MAD2L1;ZW10;ANAPC11;ANAPC10;CDC20;BUB3
prerank,folic acid metabolic process (GO:0046655),0.30767414408881405,0.6640143519995485,0.8439490445859873,0.9861359886890193,1.0,10/18,36.19%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1;MTRR;DHFR;PM20D2
prerank,receptor clustering (GO:0043113),0.27848062609572305,0.6639180707941236,0.8641791044776119,0.9858134861092308,1.0,10/27,23.28%,DLG2;DLG1;ITGB1BP1;SYNJ2BP;SCRIB;DVL1;DLG4;FLNA;LRP4;NRXN2
prerank,regulation of centriole replication (GO:0046599),0.3075656762709421,0.6638717877016521,0.8662519440124417,0.985447311432133,1.0,7/17,22.39%,SPICE1;KAT2A;STIL;KAT2B;RBM14;CEP295NL;PLK4
prerank,folic acid-containing compound metabolic process (GO:0006760),0.30240810540657187,0.663748447575906,0.8757861635220126,0.98517059798821,1.0,7/19,30.40%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1
prerank,sulfur amino acid catabolic process (GO:0000098),0.32988503867907376,0.6622873243267847,0.8341543513957307,0.9862838974311128,1.0,2/10,18.41%,GADL1;ADO
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2830657212859724,0.6620276495747776,0.875,0.9861435081505469,1.0,9/26,25.46%,ALPK1;TAB3;RIPK2;IFIH1;IKBKG;UBE2N;UBE2V1;MAP3K7;TRAF6
prerank,female gamete generation (GO:0007292),-0.22841257166511053,-0.6619489789772776,0.9323529411764706,0.9749687031588146,1.0,7/29,21.08%,DIAPH2;FMN2;SPO11;MDK;NANOS3;TRIP13;METTL3
prerank,protein localization to lysosome (GO:0061462),0.28185901980602857,0.659336445910131,0.8763040238450075,0.9885489587619795,1.0,1/28,1.48%,NEDD4
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23967540449270633,0.659228497151883,0.9478155339805825,0.988242320060315,1.0,22/82,23.67%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AURKA;AKAP9;CEP131;CSNK1E;SDCCAG8;CEP43;HAUS2;CEP57;CEP70;DYRK3;CSNK1D;OFD1;PLK4;ATAD5;CDK2;HAUS5;CNTRL
prerank,macroautophagy (GO:0016236),0.22923822964769122,0.6591296158169992,0.9585730724971231,0.9879276925575516,1.0,33/118,26.26%,WIPI2;VCP;ZFYVE1;BECN1;VPS41;ATG3;LIX1L;ACBD5;RB1CC1;VPS37A;TCIRG1;HDAC10;TBC1D5;SQSTM1;AMBRA1;VPS37B;TSG101;NBR1;CSNK2A2;CSNK2A1;SNF8;ATG4B;CLN3;HGS;ULK1;VTA1;TOMM20;PIP4K2A;CHMP4A;CHMP4B;ATG5;ATG7;LIX1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.2840379295932395,0.6588885096213067,0.8644578313253012,0.9877651598889188,1.0,4/28,9.01%,MAPRE2;ABL1;GAS2L2;MAP1B
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2563578849783298,0.6587666053409249,0.8987854251012146,0.9874856852917631,1.0,16/50,28.48%,CCNA2;MNAT1;CDKN1B;CDKN3;GTPBP4;CCND1;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNF;CDKN2C;CCNE2;CCNT2;GADD45A
prerank,maintenance of protein location in nucleus (GO:0051457),-0.24635495345606942,-0.6573264825811511,0.9408284023668639,0.9777723592203674,1.0,5/20,17.81%,ARL2BP;TAF3;SP100;CHCHD10;BCL3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2984125254945379,0.6569417031261902,0.8742138364779874,0.9889276378849851,1.0,4/18,21.21%,MCM7;GINS3;POLA1;POLD3
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3318102077145191,0.6569403233303823,0.8341880341880342,0.9885153334652764,1.0,3/10,20.76%,FEM1B;THOC5;WDR76
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.2784606656021963,-0.6567419980710663,0.9134615384615384,0.9772852675988369,1.0,2/12,8.24%,EPHB1;HSP90AB1
prerank,regulation of protein processing (GO:0070613),0.2969361512026209,0.6562318826861244,0.8713178294573644,0.9888040945795984,1.0,7/21,20.33%,GAS1;TNP2;SNX12;ACP4;SERPINE2;ADAM8;CLN3
prerank,regulation of cilium movement (GO:0003352),0.3335922381557319,0.6559632490168236,0.8446771378708552,0.9886467300441746,1.0,4/10,30.04%,CCDC40;ODAD2;CFAP43;DNAH11
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2866540620353396,-0.655957767999381,0.8847058823529412,0.9769375718400406,1.0,1/12,5.72%,PRKCQ
prerank,sensory perception of smell (GO:0007608),-0.28464725081596787,-0.6558350392757869,0.8894117647058823,0.9760913285843509,1.0,11/11,71.56%,SYT10;DRD2;OMP;ADCY3;GFY;OBP2B;SLC24A4;MKKS;UBR3;BEST2;BBS4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.32773427754976703,0.6555224780015315,0.8506711409395973,0.9886803249792109,1.0,3/11,19.50%,GATA4;REST;LANCL1
prerank,intestinal lipid absorption (GO:0098856),0.32691354905437214,0.6554801070008927,0.852991452991453,0.9883086057320919,1.0,2/11,12.29%,LDLR;LIMA1
prerank,myeloid dendritic cell activation (GO:0001773),0.3212722433322274,0.6548790998267762,0.8397976391231029,0.9885165529569453,1.0,1/12,4.97%,TGFBR2
prerank,negative regulation of protein kinase activity (GO:0006469),0.2375511932724671,0.6544503544046548,0.9487179487179487,0.9885376270793477,1.0,17/88,15.83%,LRP6;UBASH3B;ABL1;CDKN1B;NF1;LRP5;SMCR8;RB1;CEP85;DUSP10;ITGB1BP1;CORO1C;CHP1;PAK2;ACP4;WWTR1;CEP43
prerank,lytic vacuole organization (GO:0080171),0.2758058185720594,0.6543407273544376,0.8728571428571429,0.9882316635858543,1.0,14/32,29.29%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;MBTPS1;CLN3;HOOK2;TFEB;GAA;GNPTAB;ZKSCAN3;TPP1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.32716326225852693,0.6538374031286468,0.8392226148409894,0.9883007703237298,1.0,2/10,10.04%,DLGAP4;AKAP9
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.22204340976861595,-0.6535945422879704,0.9504373177842566,0.976853650700312,1.0,5/29,14.61%,CXCL12;GAS6;LGMN;CALR;JAM2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2792325906254745,0.6525621500373937,0.8808777429467085,0.9891597111063266,1.0,8/26,23.14%,ANAPC5;CDC16;RB1;CUL3;NEK6;ANAPC11;CCNB1;RIOK2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3094925107602554,0.6521343282180948,0.8466666666666667,0.989158046588893,1.0,3/13,17.36%,BCAP31;OS9;EDEM2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28278879810199165,0.6518915016380948,0.8985915492957747,0.9889929300897653,1.0,12/29,32.48%,EXOSC7;CNOT7;DCP1A;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;CNOT8;EXOSC2;DIS3;EXOSC3
prerank,ncRNA catabolic process (GO:0034661),0.28021161946554474,0.6512268185585114,0.867816091954023,0.9892474073291868,1.0,12/28,32.48%,EXOSC7;ZCCHC8;ERN2;DIS3L2;TUT4;PARN;NUDT16L1;EXOSC4;EXOSC2;DIS3;XRN1;EXOSC3
prerank,cellular response to glucose starvation (GO:0042149),0.2598495473650742,0.6511724789033287,0.916083916083916,0.9888789984015953,1.0,6/41,13.51%,FOXO3;BECN1;ITFG2;SIK2;ZC3H12A;SH3GLB1
prerank,glucan biosynthetic process (GO:0009250),-0.27562421587985586,-0.6508407578893163,0.8925,0.9769681024970659,1.0,3/12,11.63%,GBE1;PGM1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.27562421587985586,-0.6508407578893163,0.8925,0.9769681024970659,1.0,3/12,11.63%,GBE1;PGM1;PGM2L1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3251051854935999,0.6506615632203322,0.828099173553719,0.9885641853641893,1.0,5/11,22.93%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3251051854935999,0.6506615632203322,0.828099173553719,0.9885641853641893,1.0,5/11,22.93%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,positive regulation of isotype switching (GO:0045830),-0.2580125019582964,-0.6504045015644239,0.9172749391727494,0.9763591469006766,1.0,4/15,19.41%,TFRC;RIF1;CD40;SHLD3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3072747051161965,0.6498778884829732,0.8414239482200647,0.9889096582862095,1.0,5/13,25.28%,DDRGK1;BFAR;ABCA7;NCK1;PTPN1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2725987791276187,0.6498748681410622,0.8885630498533724,0.9885011325216679,1.0,6/30,19.70%,UBR5;TRIP12;TWIST1;SHLD1;RMI2;HELB
prerank,positive regulation of immune response (GO:0050778),0.24564097952894837,0.6498000735107308,0.926412614980289,0.9881595993627293,1.0,12/64,20.33%,POLR3D;PLSCR1;IFI35;IL10;CD46;EIF2AK4;DHX9;TLR8;POLR3F;ADAM8;TGFB2;AKIRIN2
prerank,cilium-dependent cell motility (GO:0060285),-0.23723331683974377,-0.649647440218101,0.9230769230769231,0.9759719725260736,1.0,7/22,30.46%,CFAP44;CFAP54;DNAH3;EFHC2;CCDC39;TEKT5;EFHC1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2608576779588326,0.6493459523376103,0.9144021739130435,0.9881828571396019,1.0,13/41,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;NUP88;NUP98;AAAS;NUP54
prerank,lysosome localization (GO:0032418),0.26481180750612987,0.6481217370225617,0.918918918918919,0.9889562915382574,1.0,3/37,4.45%,NDEL1;NR4A3;SYTL4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.31099870560056436,0.6478912413633381,0.8421926910299004,0.9887704688813114,1.0,5/15,22.22%,ATL2;ZFYVE27;RTN3;RAB18;TMEM170A
prerank,regulation of transposition (GO:0010528),0.30558694287507854,0.6468420929528025,0.8532883642495784,0.9893687191096974,1.0,13/13,69.47%,TDRD9;TEX15;PIWIL4;PIWIL2;SIRT7;AICDA;PIWIL1;BTBD18;UBR2;MYBL1;DDX4;SMYD5;SPOCD1
prerank,lysosome organization (GO:0007040),0.26760775582860286,0.6467994252050907,0.8783216783216783,0.9890009278004106,1.0,16/36,29.42%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;TMEM165;MBTPS1;CLN3;HOOK2;TFEB;GAA;GNPTAB;ZKSCAN3;TPP1;VPS33A
prerank,negative regulation of T cell proliferation (GO:0042130),0.2698062781632689,0.646299774262988,0.8919308357348703,0.989059392214699,1.0,6/28,21.25%,CD80;IL10;SDC4;SCRIB;ARG1;DLG5
prerank,mitochondrion distribution (GO:0048311),0.3204980942194569,0.6461782928457114,0.875,0.9887619239321151,1.0,1/12,3.86%,MEF2A
prerank,regulation of neurogenesis (GO:0050767),0.24583740026802042,0.6456750767293494,0.9365918097754293,0.988854298163493,1.0,13/55,22.52%,HES1;DOCK7;BHLHE40;PCM1;PAX6;REST;HOOK3;PER2;HEYL;SNW1;YTHDF2;HES3;HES7
prerank,rRNA modification (GO:0000154),-0.23077339332200025,-0.6455426644633045,0.945054945054945,0.978009123846326,1.0,10/21,36.16%,TSR3;BUD23;NOP10;TFB2M;NHP2;FBL;DIMT1;TRMT112;FBLL1;TFB1M
prerank,regulation of cellular amine metabolic process (GO:0033238),0.24802044393734457,0.6454650447744497,0.9228687415426252,0.9886389892731048,1.0,16/50,27.88%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;NQO1;PSMC1;PSMD7;PSMD14;PSMD3;ODC1;OAZ2;PSMD12;PSMD4;PSME3;PSMD2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23937604116560898,0.6448771248385565,0.9331651954602774,0.9887985723380807,1.0,26/69,31.75%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;ICE2;CCNT1;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;INTS2;TAF13;GTF2F2;GTF2A2;TAF9;CCNT2;SNAPC4;NCBP2;TAF5;INTS3;CDK7;TAF8
prerank,endodermal cell fate commitment (GO:0001711),-0.2892379154459264,-0.6448075259735554,0.863961813842482,0.9776167100317111,1.0,1/10,4.97%,SOX17
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.25914121047128713,-0.6444686777091254,0.9069767441860465,0.9769197039054442,1.0,1/15,2.62%,HECW2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2883159711224338,-0.6439220793640187,0.8832116788321168,0.9763594076880141,1.0,5/10,32.00%,CALM1;CALM3;GNB5;GPR35;DRD2
prerank,regulation of histone modification (GO:0031056),0.31568678357700397,0.6430740007529794,0.8780889621087314,0.9900465992780048,1.0,5/13,24.19%,NNMT;SETD5;UBE2N;AKAP8L;MTHFR
prerank,cellular response to amino acid stimulus (GO:0071230),0.2651563926358792,0.6425364583082688,0.8981612446958982,0.9901391460309178,1.0,5/33,12.91%,CAPN2;KLHL22;RRAGB;CASTOR2;MTOR
prerank,vasodilation (GO:0042311),0.30834554526628916,0.6415694249814198,0.8776167471819646,0.9905960287414264,1.0,1/13,2.69%,ADRB2
prerank,positive regulation of rRNA processing (GO:2000234),0.31708630690923234,0.6404029213321624,0.850091407678245,0.9912876799761923,1.0,3/10,23.14%,WDR43;WDR75;RIOK2
prerank,cellular response to radiation (GO:0071478),0.25598390355870165,0.6402543096043535,0.9319444444444445,0.9910218989023933,1.0,7/40,18.46%,TANK;SPIDR;KDM4D;CDKN1A;RAD51;TNKS1BP1;INO80
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.32238738153380175,0.6398856425229382,0.8491525423728814,0.9909519877271828,1.0,4/11,28.59%,BARD1;DHX36;PAF1;NCBP2
prerank,cellular response to pH (GO:0071467),0.2935217802498604,0.6398562726794446,0.872,0.9905725527754699,1.0,7/17,33.98%,SLC9A1;CHP1;RAB11B;PKD2L1;MCOLN1;GPR68;IMPACT
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.27100639184062847,-0.6397236965712713,0.9156327543424317,0.9783014885247517,1.0,1/13,2.07%,PRR5L
prerank,protein destabilization (GO:0031648),0.26787339192987686,0.6387688910784536,0.8986975397973951,0.9911405727122262,1.0,5/32,13.96%,GSN;CREBBP;FBXW11;EP300;CUL3
prerank,plasma membrane tubulation (GO:0097320),0.30519862128012976,0.6383396840349457,0.8690476190476191,0.9911257378077244,1.0,4/13,18.07%,EHD2;BIN2;CAVIN2;WHAMM
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24818694135766822,0.6376811440494157,0.9374149659863945,0.9912904638105674,1.0,10/46,21.66%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;LPCAT1;GPAT3;PLA2G4A;ABHD5
prerank,positive regulation of ATPase activity (GO:0032781),0.2565767591184483,0.6375694981159424,0.9315789473684211,0.9909746074328933,1.0,3/41,6.55%,ATP1B1;TOR1AIP1;PLSCR1
prerank,regulation of aerobic respiration (GO:1903715),-0.25434647868953214,-0.6373159282085151,0.9179487179487179,0.9789886557403908,1.0,5/15,18.52%,CBFA2T3;SLC25A33;COX7A2;UQCC2;ATP7A
prerank,tetrapyrrole metabolic process (GO:0033013),0.2900651348525817,0.636946092710158,0.8901453957996769,0.9911260500343768,1.0,7/18,26.37%,MMACHC;CD320;ABCC1;MMAB;MMADHC;CTRC;LMBRD1
prerank,eosinophil chemotaxis (GO:0048245),0.29706767935458295,0.6362568536775295,0.8834459459459459,0.9909261410197849,1.0,4/14,22.59%,CCL3;CCL1;LGALS3;CCL7
prerank,eosinophil migration (GO:0072677),0.29706767935458295,0.6362568536775295,0.8834459459459459,0.9909261410197849,1.0,4/14,22.59%,CCL3;CCL1;LGALS3;CCL7
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2591658097435276,-0.6354020299113744,0.9023136246786633,0.9793852394230753,1.0,5/15,18.85%,RPS7;RPL23;RPL11;LIMK1;RPL5
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2765835986384049,0.6353785927548499,0.8989598811292719,0.9913319288817848,1.0,8/30,23.38%,FUT8;DPM1;MGAT1;DDOST;TUSC3;MGAT5;UGGT2;ASGR2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2913931523331008,0.6350473897896132,0.8720379146919431,0.9911996391989913,1.0,7/17,28.26%,RB1;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.31067721537922577,0.6346158245644618,0.8841059602649006,0.9911890813253965,1.0,7/13,32.01%,FIP1L1;NUDT21;CPSF7;CPSF4;NCBP2;CPSF4L;CSTF2T
prerank,macrophage migration (GO:1905517),0.30787779165522333,0.634451608587597,0.8861209964412812,0.9909247585005144,1.0,2/13,10.91%,P2RX4;CCL3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.2622376897634329,-0.6344033174913456,0.9037974683544304,0.9791286223440742,1.0,3/13,11.03%,CD81;SEC16B;BRSK2
prerank,regulation of spindle assembly (GO:0090169),0.27437768215510744,0.6342013787959812,0.8847305389221557,0.9907388354136081,1.0,10/25,34.46%,PDCD6IP;CEP97;GPSM2;DRG1;CHMP4B;SENP6;RNF4;DYNC1H1;CHMP3;CHMP2B
prerank,programmed necrotic cell death (GO:0097300),0.2899559135848583,0.6337399342726026,0.8944805194805194,0.9907531139638498,1.0,3/18,9.09%,TRPM7;TLR4;RIPK3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2738745602277443,-0.6336994854805554,0.9129353233830846,0.9786800050915926,1.0,5/11,28.41%,ENPP3;SLC19A3;SLC25A19;DCK;THTPA
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.23055620215198386,0.6336957370516849,0.9516129032258065,0.9903835796618333,1.0,21/79,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,peptidyl-asparagine modification (GO:0018196),0.2741440037622427,0.6335387434157662,0.9026548672566371,0.9901123810363741,1.0,8/31,23.38%,FUT8;DPM1;MGAT1;DDOST;TUSC3;MGAT5;UGGT2;ASGR2
prerank,snRNA transcription (GO:0009301),0.23476566318768172,0.6316375863302105,0.95448798988622,0.9914008044478235,1.0,26/70,31.75%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;ICE2;CCNT1;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;INTS2;TAF13;GTF2F2;GTF2A2;TAF9;CCNT2;SNAPC4;NCBP2;TAF5;INTS3;CDK7;TAF8
prerank,zinc ion transport (GO:0006829),0.28454988736551734,0.631625588989179,0.8972809667673716,0.9910047444539611,1.0,4/21,11.19%,SLC39A11;SLC39A14;SLC30A9;SLC39A13
prerank,synaptic vesicle recycling (GO:0036465),0.2629670145307536,0.6314807359763117,0.8951841359773371,0.9907221802384145,1.0,4/31,9.53%,STON1;STON2;SYT8;FCHO2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.22633151344509564,0.6312494953418105,0.969770253929867,0.990523314202364,1.0,19/91,18.57%,STON1;ABL1;NRP1;STON2;ITGAV;GAS1;NSF;RUFY1;RAB25;USP7;SNX12;ARFGAP1;MAP2K2;RAB4B;PLD1;BET1L;RAB5B;MBTPS1;RAB21
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2864978817247644,0.6306798232249173,0.8885448916408669,0.9905965089142839,1.0,3/21,10.71%,FGF13;HDGFL3;KATNB1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.31077901195013613,0.630308362365027,0.8957264957264958,0.9905151231398404,1.0,1/13,4.05%,BMS1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.292333772838576,0.6294927531310931,0.8928,0.9908159275821065,1.0,16/16,70.80%,RIPK3;KLRD1;CYRIB;FADD;IL23R;AGER;LILRB1;CEACAM1;PTPRC;KLRC1;XCL1;IL12B;IL23A;IL12RB1;IL12A;STX7
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2700394200036412,0.6292412573814438,0.9144460028050491,0.9906321530273504,1.0,13/31,32.48%,EXOSC7;CNOT7;DCP1A;DIS3L2;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;CNOT8;EXOSC2;DIS3;EXOSC3
prerank,cholesterol metabolic process (GO:0008203),0.23431336820238804,0.6289804913039596,0.9518377693282636,0.9904599447919279,1.0,12/68,18.72%,SOAT1;FDX1;TSKU;RXRA;LBR;MVD;EBP;LCAT;HMGCR;ANGPTL3;FDPS;OSBPL5
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.24893928334014623,-0.6285942204946069,0.9260143198090692,0.9810827127573939,1.0,7/16,33.56%,TOP2B;EME2;TOP2A;MUS81;EME1;RMI1;CENPS
prerank,regulation of protein acetylation (GO:1901983),0.305955189770351,0.6283945804048813,0.8793388429752066,0.9905609111659509,1.0,1/12,3.24%,GSK3B
prerank,melanosome localization (GO:0032400),-0.23339822187413198,-0.6282874120730008,0.9456521739130435,0.9803484051191697,1.0,7/21,26.31%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3179963805428949,0.6280705082234509,0.8379310344827586,0.9904387252086294,1.0,2/10,18.04%,AGO2;DROSHA
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.28723552753126225,0.6276634931140904,0.875,0.9903892759842886,1.0,2/17,11.36%,ANO6;CCL1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3014907153738016,0.6273867717363928,0.8679245283018868,0.9902339107499625,1.0,4/13,14.40%,MAVS;TRIM44;IFIH1;DHX9
prerank,negative regulation of hormone secretion (GO:0046888),0.3125721517302815,0.6268331742374929,0.8573853989813243,0.9903145503796897,1.0,1/10,5.34%,RAB11FIP3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.24959404718732892,-0.6267282818107028,0.926829268292683,0.9804443210661061,1.0,3/15,10.26%,SAMHD1;NLRC5;USP18
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.27476301861852515,0.6261957721892466,0.9217791411042945,0.9904516445955637,1.0,10/24,35.43%,STN1;TNKS2;SLX4;TEN1;NAT10;ACD;PINX1;XRN1;ERCC4;TINF2
prerank,vitamin D metabolic process (GO:0042359),-0.25555826885327515,-0.6246209889230667,0.924812030075188,0.980879121708151,1.0,2/13,12.00%,LGMN;CUBN
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23292530183010296,0.6239134652873523,0.9514687100893997,0.9919011342220396,1.0,11/71,13.72%,CAPN2;DDI2;VCP;PDCD6IP;IDE;ZYG11B;OTUD7B;ZRANB1;YME1L1;CLPP;OMA1
prerank,canonical glycolysis (GO:0061621),0.2779690093051306,0.6234154861394562,0.9029850746268657,0.991527035449696,1.0,4/24,11.53%,FOXK1;PFKP;GPI;FOXK2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2779690093051306,0.6234154861394562,0.9029850746268657,0.991527035449696,1.0,4/24,11.53%,FOXK1;PFKP;GPI;FOXK2
prerank,renal absorption (GO:0070293),0.31652668535543876,0.6219504926480657,0.8865619546247818,0.9923338163634657,1.0,1/10,2.48%,GSN
prerank,nuclear membrane disassembly (GO:0051081),0.30077245181524614,0.6216005316677514,0.8789915966386554,0.9922033590622973,1.0,6/14,23.48%,CNEP1R1;PRKCA;NEK9;NEK6;CCNB1;AKAP8L
prerank,modulation by host of viral genome replication (GO:0044827),0.295499902224696,0.6214199106693129,0.8971631205673759,0.9919488820599405,1.0,5/13,28.43%,ZC3H12A;EIF2AK4;FMR1;TBC1D20;VAPA
prerank,sterol transport (GO:0015918),0.27930279874813446,0.6212753797059488,0.891271056661562,0.9916655906993533,1.0,6/19,27.67%,LDLR;LCAT;OSBPL5;NPC1;CD36;OSBPL2
prerank,protein insertion into ER membrane (GO:0045048),-0.19916625315987843,-0.6212716873665182,0.972027972027972,0.9819810149689553,1.0,11/37,24.02%,APP;MMGT1;CYB5A;UBE2J2;TRAM1;SEC61G;SERP1;EMC7;OTOF;SGTA;EMC6
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.28997412341289935,0.6212141530455905,0.8993506493506493,0.9913114777149824,1.0,5/16,21.66%,LDLR;DAGLB;CNEP1R1;SREBF1;ABHD5
prerank,negative regulation of viral genome replication (GO:0045071),-0.1987564752326913,-0.6176507852236967,0.9647058823529412,0.9832304696843059,1.0,21/40,34.55%,IFITM1;BST2;IFITM3;OAS2;PROX1;RNASEL;IFIT1;OASL;PARP10;BANF1;INPP5K;RSAD2;IFITM2;CCL5;TRIM6;SHFL;OAS3;ISG20;BTBD17;HMGA2;TNF
prerank,response to amino acid (GO:0043200),0.25871107941972216,0.6169140732532109,0.9161931818181818,0.9943079083416476,1.0,3/31,6.99%,CAPN2;GLRB;RRAGB
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2584057615371492,0.6165561960632737,0.9005602240896359,0.9941941384111772,1.0,6/33,17.68%,GCLC;FPGS;KYAT1;CAD;NIT2;PYCR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3025285052681683,0.6162359134210265,0.8777589134125636,0.9940355301062779,1.0,3/12,17.34%,WDR18;NBN;TICRR
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.28564181926155424,0.6161894617092861,0.9127625201938611,0.9936755741347224,1.0,2/19,5.07%,CUX1;FBXW8
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23624154811438403,0.6156957032935354,0.9398692810457516,0.9936339453766421,1.0,14/52,22.71%,SHC1;LMNA;DNAJC3;DDX11;SEC31A;ADD1;ERN2;ATP6V0D1;ARFGAP1;SRPRB;GFPT1;CUL7;SRPRA;DNAJB11
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.27343446770020796,0.615115305447895,0.9212121212121213,0.9936917486493765,1.0,9/23,25.01%,KIF1B;KIF1C;DYNC1I1;F8A1;HOOK3;MAP6;HOOK2;MYO10;CCDC186
prerank,establishment of protein localization to extracellular region (GO:0035592),0.24602484774831695,0.6149141912164742,0.9286694101508917,0.9934577193318541,1.0,3/39,6.41%,TANGO6;LTBP2;GOLPH3
prerank,phagosome maturation (GO:0090382),0.2501680977696982,0.6146317925892125,0.9348441926345609,0.9932750050305217,1.0,5/35,15.77%,ATP6V0A4;RAB43;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,positive regulation of telomerase activity (GO:0051973),0.2554882025111318,0.6141041631351681,0.9140401146131805,0.9932905750892145,1.0,3/33,8.58%,KLF4;NEK7;GRHL2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.30775815147294333,0.6140339079003233,0.8548672566371681,0.9929581728235797,1.0,5/10,32.30%,ACADM;ETFA;ETFDH;ACADS;ACADVL
prerank,phosphatidic acid metabolic process (GO:0046473),0.2377285023376359,0.6139349188189579,0.9607577807848444,0.9926352473743164,1.0,10/48,21.66%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;LPCAT1;GPAT3;PLA2G4A;ABHD5
prerank,histone lysine methylation (GO:0034968),0.25668768921833673,0.6138961430119882,0.9297218155197657,0.9922678154797061,1.0,11/33,33.61%,SMYD2;KMT2D;PRDM5;EHMT2;WDR82;SETD6;KMT2A;SETD1B;ASH2L;PAXIP1;SMYD3
prerank,steroid catabolic process (GO:0006706),-0.27376923855482893,-0.6138316005366157,0.894484412470024,0.9844966931682886,1.0,7/10,39.67%,SPP1;HSD11B1;HSD17B11;HSD17B14;CYP24A1;FGF23;YWHAH
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.29949090793527433,0.6136596173495726,0.8774834437086093,0.9920717310039384,1.0,1/11,5.97%,MAVS
prerank,epithelial cell development (GO:0002064),-0.23304515079498356,-0.6130065871728592,0.9455040871934605,0.9840359819697576,1.0,2/20,7.15%,WNT5B;ACTA2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2143101796453501,0.6124366915607826,0.9758620689655172,0.9926048808593715,1.0,45/132,28.49%,RPSA;LUC7L2;SRSF5;SRSF6;CELF1;CELF3;EIF2D;EIF6;EIF3A;SCAF11;BRIX1;PRKDC;XRCC5;GCFC2;DHX9;SF3B1;EIF2S2;NLE1;SRPK1;GEMIN8;EIF4B;PRPF18;DDX1;NOL3;NAF1;PRMT5;RBM5;TXNL4A;DHX29;LSM4;NUDT21;MDN1;LUC7L;MRPL20;CELF4;CPSF7;SRPK2;SNRNP200;PRPF6;MRPS7;CLP1;RAMAC;KHDC4;TGS1;PWP2
prerank,mitotic cytokinetic process (GO:1902410),0.2810021610599587,0.6121334015615211,0.9027777777777778,0.9924380701816479,1.0,3/20,12.33%,PDCD6IP;RHOA;CNTROB
prerank,regulation of mitotic spindle assembly (GO:1901673),0.2753022400316501,0.6116899573326358,0.904320987654321,0.9923724801076427,1.0,4/19,25.39%,PDCD6IP;CEP97;DRG1;CHMP4B
prerank,regulation of protein metabolic process (GO:0051246),0.24323221467018213,0.6106295941101539,0.9569313593539704,0.992820102893414,1.0,14/44,23.35%,KLF4;LDLR;LTBP4;CNDP1;CHEK2;ZDHHC2;SPOP;SNF8;ABCA7;TRAF3;MAPK8;HGS;PARL;ODC1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2690135475735731,0.6103858006297089,0.9256329113924051,0.992596644198066,1.0,1/20,1.74%,CAMK2D
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2292394450305691,0.6102011995854302,0.9615384615384616,0.9923387373636559,1.0,19/67,20.38%,RABEP2;ATG3;DMTN;RDX;ATP8B1;P2RX4;TBC1D2B;TBC1D13;TBC1D10A;TBC1D5;SDCCAG8;PLD1;SGSM3;ABITRAM;TBC1D17;FXR2;ODAD3;FMR1;RAB5A
prerank,stress granule assembly (GO:0034063),0.279877084952653,0.6099336624703656,0.910355486862442,0.9921465132168246,1.0,8/20,25.89%,PRRC2C;ATXN2;EIF2S1;CIRBP;YTHDF2;UBAP2L;YTHDF3;BICD1
prerank,positive regulation of cellular respiration (GO:1901857),0.3022548819104598,0.609359972515271,0.875,0.9921670477862228,1.0,2/11,14.01%,VCP;IFNLR1
prerank,protein lipidation (GO:0006497),0.22983206099791,0.6092704036668014,0.9515072083879423,0.9918400356018924,1.0,22/59,26.24%,WIPI2;PGAP2;ZDHHC15;HHAT;PIGB;ZDHHC2;DPM1;PIGU;ZDHHC20;ZDHHC23;PIGL;WDR45B;PIGN;ZDHHC12;PIGH;PGAP3;PIGQ;ZDHHC5;MPPE1;ATG5;ATG7;PIGA
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2535430015679238,0.6088081256668889,0.9335347432024169,0.9917865335945577,1.0,11/27,32.75%,CTPS2;GSR;RRM2;AK4;AK9;AK1;NUDT13;AK5;AK6;CMPK1;DTYMK
prerank,mitochondrial genome maintenance (GO:0000002),0.29850669726080287,0.6070309384775349,0.8760330578512396,0.992713204744263,1.0,4/11,21.49%,MEF2A;TOP3A;SLC25A36;MPV17
prerank,positive regulation of chromatin organization (GO:1905269),0.2932900365354738,0.6066973936198933,0.8861788617886179,0.9925832301948597,1.0,3/12,19.56%,MIER1;ATRX;UBE2N
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.28457487035509993,0.6064350356429876,0.9016129032258065,0.9923913710488517,1.0,4/14,17.00%,IRS1;LONP2;TWIST1;ABCD1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.24822786851577322,-0.6057354614617925,0.9402985074626866,0.9870211322397401,1.0,6/16,33.68%,AHR;TNFSF8;IL12A;CD22;LST1;TNFSF9
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28200143857411053,0.6054935033415011,0.9031746031746032,0.9927078548089344,1.0,4/18,11.15%,SKI;NF1;EMD;MORC3
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3009678596873253,0.6043299445496519,0.9156193895870736,0.9931529514515282,1.0,5/10,30.74%,RPUSD4;NAF1;RPUSD1;GAR1;RPUSD2
prerank,leukocyte tethering or rolling (GO:0050901),0.2759974419421334,0.6027235188094493,0.9168053244592346,0.9938802533710697,1.0,2/17,6.41%,ITGB1;GOLPH3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.26608720289667714,0.6013033672658825,0.9230769230769231,0.9944890080312793,1.0,6/25,19.33%,FOXK1;PFKP;GPI;FOXK2;ADPGK;GAPDHS
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2737026473717138,0.6007466306849485,0.9170731707317074,0.9944707382420316,1.0,2/18,11.89%,GSK3B;MPV17L
prerank,phospholipid homeostasis (GO:0055091),0.29552586688938476,0.5994287511292816,0.8844884488448845,0.9949999121929263,1.0,5/11,22.90%,HNF4A;TLCD1;TLCD2;ANGPTL3;FABP3
prerank,negative regulation of innate immune response (GO:0045824),0.24575154344922934,0.59941963990509,0.9415204678362573,0.9946051678592831,1.0,8/34,15.93%,PTPN2;TRAFD1;SERPING1;USP15;IRAK3;FAM3A;CNOT7;ACOD1
prerank,transcription preinitiation complex assembly (GO:0070897),0.29587910613121887,0.5980879981661594,0.8920741989881956,0.9951222526851855,1.0,5/12,27.17%,TAF12;GTF2B;GTF2A2;TAF7L;TAF1
prerank,regulation of centrosome duplication (GO:0010824),0.24991609733065753,0.5971848840452905,0.9288762446657184,0.9953495781111124,1.0,9/29,25.88%,PDCD6IP;SPICE1;CEP131;STIL;CEP295NL;NAT10;CHMP4B;FBXW5;CCNF
prerank,regulation of stem cell population maintenance (GO:2000036),0.2764003324766448,0.595333122138255,0.91875,0.9962421989035437,1.0,3/18,14.22%,WDR43;KAT2A;REST
prerank,termination of RNA polymerase II transcription (GO:0006369),0.24741100756311296,0.5928800158448352,0.9398280802292264,0.9974555279561566,1.0,15/33,32.50%,SCAF8;TTF2;LSM11;MAZ;FIP1L1;NUDT21;CSTF1;CPSF7;CPSF3;CLP1;CPSF4;NCBP2;CSTF3;CSTF2T;SSU72
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2182893121928506,-0.5923582054208146,0.9652173913043478,0.9930186093236466,1.0,6/24,19.18%,NOD1;MAP2K6;UBC;IRAK2;RPS27A;TNFAIP3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.18210732673316923,-0.5920693427435929,0.9918367346938776,0.9922282156384563,1.0,13/53,21.93%,CALCRL;CHRM2;HTR2C;CHRM3;HTR2A;AGT;HRH1;LHCGR;TSHR;CCL2;LPAR3;NPY;HTR1F
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.21106381003454067,-0.5919158209970913,0.9635854341736695,0.9913770163265492,1.0,2/23,7.16%,CALM1;NMT2
prerank,protein-DNA complex disassembly (GO:0032986),-0.23470282285538535,-0.5916997519162149,0.9457364341085271,0.9905645754613392,1.0,3/16,12.95%,RPL23;SMARCD1;SET
prerank,regulation of cell aging (GO:0090342),0.2951724557926003,0.5913495435027049,0.9238249594813615,0.9980377210554989,1.0,1/11,3.71%,LMNA
prerank,protein prenylation (GO:0018342),-0.27006841147304333,-0.5912762343859136,0.9166666666666666,0.9898391391980579,1.0,10/10,73.02%,PTAR1;CHML;FNTB;RCE1;AIPL1;RABGGTA;FNTA;PGGT1B;RABGGTB;CHM
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.2933597972908679,0.5889113235162698,0.898972602739726,0.9991889378410163,1.0,5/12,23.09%,CNEP1R1;PRKCA;NEK9;NEK6;CCNB1
prerank,cellular response to acid chemical (GO:0071229),0.2534065650821017,0.5881066297186068,0.9437037037037037,0.999312826941658,1.0,4/27,12.91%,CAPN2;RRAGB;VEGFA;MTOR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2547124021738113,0.5880393557360296,0.953662182361734,0.998958148691213,1.0,14/27,35.69%,ZC3H12A;ZC3H12D;ZC3H12C;RNASE6;LACTB2;PARN;CPSF3;CSTF3;XRN1;ZC3H12B;DICER1;NYNRIN;RNASEH1;POP1
prerank,mitochondrial fusion (GO:0008053),0.26121646791900555,0.5876846521056299,0.9191290824261276,0.9987810923554786,1.0,6/18,27.58%,MIEF1;SPG7;MIGA1;MIEF2;USP30;STOML2
prerank,histone mRNA metabolic process (GO:0008334),0.2540907965397401,0.5867850890784534,0.9357664233576642,0.9989839194528878,1.0,12/27,32.48%,ATM;LSM11;TUT7;TUT4;TENT2;SSB;ERI1;CPSF3;EXOSC4;NCBP2;MTPAP;XRN1
prerank,regulation of ATP metabolic process (GO:1903578),0.22610010377051878,0.5866311394683774,0.9719029374201787,0.9986772970794163,1.0,16/54,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;ABCD1;NUP88;AK4;NUP98;ATP5IF1;AAAS;NUP54
prerank,intracellular protein transmembrane transport (GO:0065002),0.23765165980865402,0.5853553001915949,0.9634831460674157,0.9990699300476579,1.0,12/42,24.32%,C2CD5;SEC61A1;TIMM23;TIMM17B;SEC63;AIFM1;DNAJC19;PEX2;GRPEL2;PEX7;PEX26;TOMM20
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.25733665604456196,-0.5851298929216974,0.9131455399061033,0.9918436961824255,1.0,4/10,21.09%,HK2;PFKM;PFKL;GFPT2
prerank,positive regulation of histone deacetylation (GO:0031065),0.2886483378542171,0.5850243527509433,0.9199346405228758,0.9988633956064649,1.0,3/12,12.18%,ZBTB7B;VEGFA;NIPBL
prerank,receptor recycling (GO:0001881),0.2887076815924493,0.5848975586810896,0.8880994671403197,0.9985398602922921,1.0,4/10,29.81%,EHD3;RAB11B;PHETA2;SORL1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.28193774706766644,0.5845883870297212,0.9114754098360656,0.9983464853915893,1.0,5/14,25.60%,DDX18;WDR12;URB1;FTSJ3;ZNHIT3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.22763305762703356,-0.5838913049187998,0.9512820512820512,0.9914355878323922,1.0,7/16,26.94%,SLC25A33;COX7A2;UQCC2;NUPR1;ATP7A;SHMT2;PINK1
prerank,fatty acid biosynthetic process (GO:0006633),0.2219250180722707,0.5838182908290005,0.9797211660329531,0.9984352268427896,1.0,12/63,21.57%,ABCD3;SCD;ELOVL5;ACSM2A;ACSM2B;GSTM4;ABCD1;ABHD2;NDUFAB1;TECR;HACD4;MCAT
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2943133316595532,0.5835678252024437,0.905,0.9981868311148855,1.0,11/11,70.59%,PARN;EXOSC4;EXOSC2;EXOSC3;EXOSC5;TENT4B;LARP7;DKC1;EXOSC10;FBLL1;FBL
prerank,RNA methylation (GO:0001510),0.21759333307551015,0.5823287737708228,0.9769820971867008,0.998560598888765,1.0,29/60,35.56%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;TRDMT1;METTL1;FTSJ3;WTAP;MRM2;THADA;GTPBP3;TGS1;NSUN4;PCIF1;METTL5;THUMPD2;TRMT12;VIRMA;FTSJ1;NOP2;MEPCE;METTL2B;METTL2A;TRMT44;NSUN3;TRMT6;CMTR1
prerank,regulation of nuclear division (GO:0051783),0.26315527105971875,0.5818425128895638,0.919093851132686,0.9984823970423826,1.0,5/20,22.25%,CCDC8;CDK13;PDXP;CUL7;PRMT5
prerank,protein targeting to mitochondrion (GO:0006626),0.2242531581065576,0.5815003221031487,0.9710144927536232,0.9982894291094007,1.0,16/52,27.37%,SAMM50;PMPCB;AGK;TIMM23;PITRM1;BCAP31;TIMM17B;IMMP1L;AIFM1;DNAJC19;TOMM34;GRPEL2;TOMM20;HSPA4;TIMM9;MIPEP
prerank,phasic smooth muscle contraction (GO:0014821),0.28569205299845274,0.5811784502295501,0.9039145907473309,0.9980941460037189,1.0,2/10,14.31%,GDNF;HTR2B
prerank,response to exogenous dsRNA (GO:0043330),0.2644703748808886,0.5792190758246637,0.9290123456790124,0.9989304177169444,1.0,4/18,14.40%,MAVS;IRAK3;IFIH1;DHX9
prerank,regulation of cytoplasmic translation (GO:2000765),0.27676625388797194,0.5771284417445635,0.9211822660098522,0.9997717808527607,1.0,4/14,20.06%,YBX3;DHX9;DHX36;FMR1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2876776981996414,0.575882676197701,0.9128205128205128,1.0,1.0,4/11,29.37%,PRDX5;PXDN;PRDX2;PRDX3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.24750893850226235,0.5750096680049103,0.9624624624624625,1.0,1.0,8/27,22.57%,ETNK1;PLA2G15;LPIN2;CHKB;CEPT1;NAAA;ETNPPL;ETNK2
prerank,regulation of myelination (GO:0031641),-0.1983999371321811,-0.5736821473381951,0.9739884393063584,0.9950166909649416,1.0,2/25,4.47%,TNFRSF21;TENM4
prerank,tryptophan catabolic process (GO:0006569),0.2843334170223448,0.5719327100531744,0.8958333333333334,1.0,1.0,11/11,71.59%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;AFMID
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.21153747102765869,0.5718833614291793,0.9769230769230769,1.0,1.0,12/67,17.12%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMC1;PSMD7
prerank,negative regulation of interferon-beta production (GO:0032688),0.2903344283913399,0.5713698649851334,0.9189655172413793,1.0,1.0,5/10,29.58%,REL;YY1;PTPRS;PPM1B;RELB
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.24506302721517553,-0.5698488234895461,0.9522546419098143,0.9956705301107723,1.0,1/12,4.28%,ACTB
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2475917120676575,0.5691955297938555,0.9498381877022654,1.0,1.0,6/25,15.69%,LRPAP1;ITGAV;ATXN2;ITGB3;NEU3;RIN3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.22418003044747387,0.568365482672832,0.9840637450199203,1.0,1.0,11/48,17.93%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NOA1;NUP214;ZBTB7A;NUP188;NUP88
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2161145965251032,0.5665342229459213,0.9718875502008032,1.0,1.0,16/53,27.88%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;NQO1;PSMC1;PSMD7;PSMD14;PSMD3;ODC1;OAZ2;PSMD12;PSMD4;PSME3;PSMD2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2442771760912323,0.5657973961195779,0.9567809239940388,1.0,1.0,2/23,10.12%,PLA2G4F;MBOAT1
prerank,regulation of isotype switching (GO:0045191),0.26369219576989666,0.5638935853535353,0.9372822299651568,1.0,1.0,4/14,20.84%,IL10;SHLD1;PARP3;KMT5B
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2589037027092631,0.5636861578970177,0.9371980676328503,1.0,1.0,4/19,19.89%,MPI;RENBP;UAP1;GFPT1
prerank,positive regulation of catalytic activity (GO:0043085),0.2282418832297185,0.562992567602249,0.9673295454545454,1.0,1.0,5/37,15.52%,ABL1;BCAS3;WRN;XRCC5;CHTOP
prerank,alpha-amino acid metabolic process (GO:1901605),-0.17381078092210234,-0.5620703155977989,0.9963369963369964,0.9977739216477317,1.0,15/45,27.23%,ASPA;ASPG;KYAT3;ASS1;NOX4;ASNS;DDAH2;CBS;GOT2;ATP7A;SLC25A13;PYCR2;GLUD1;NAT8L;GPT2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.27738571319227046,0.5617556305200533,0.9431034482758621,1.0,1.0,2/11,13.79%,OCRL;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.27738571319227046,0.5617556305200533,0.9431034482758621,1.0,1.0,2/11,13.79%,OCRL;SYNJ1
prerank,aggrephagy (GO:0035973),0.2398545467719403,0.561435129899742,0.9467625899280575,1.0,1.0,10/27,28.54%,DYNC1I1;ACBD5;WDR81;SQSTM1;DYNC1LI2;UBE2N;UBE2V1;ATG5;PCNT;IFT88
prerank,regulation of cilium assembly (GO:1902017),0.21366697679228375,0.5611758197568084,0.9858611825192802,1.0,1.0,25/62,28.76%,LIMK2;RABEP2;ATG3;TBC1D2B;TBC1D13;ENTR1;TBC1D10A;TBC1D5;SDCCAG8;SGSM3;CEP97;CDK10;TBC1D17;ODAD3;FUZ;ARHGAP35;KCTD17;CROCC;ATG5;TBC1D20;TBC1D19;BBS4;MAPK15;IFT88;TBC1D15
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.25103958513920754,0.560216040897206,0.9532258064516129,1.0,1.0,7/22,20.27%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.25103958513920754,0.560216040897206,0.9532258064516129,1.0,1.0,7/22,20.27%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,dendritic cell chemotaxis (GO:0002407),0.2675684450265331,0.5587919186292487,0.9371900826446281,1.0,1.0,2/14,14.55%,TRPM4;CXCR4
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2280546511773212,0.5583683807458376,0.9632352941176471,1.0,1.0,3/31,8.47%,CLCF1;IL10;GPI
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.29044569448492963,0.5575783875091432,0.9137323943661971,1.0,1.0,4/10,28.59%,DHX36;PAF1;NUDT21;NCBP2
prerank,DNA catabolic process (GO:0006308),0.27429073562641215,0.5575304184241305,0.9353680430879713,1.0,1.0,11/11,72.59%,DFFB;REXO4;DNASE1L1;DNASE1L3;DNASE1L2;DNASE1;SETMAR;FBH1;ISG20;XRN2;MUS81
prerank,inositol phosphate catabolic process (GO:0071545),0.2706247690502059,0.5575023382430406,0.9442567567567568,1.0,1.0,2/12,13.79%,OCRL;SYNJ1
prerank,mitochondrion organization (GO:0007005),0.19052949310292835,0.5573902375245987,0.9977653631284916,1.0,1.0,22/165,15.24%,PID1;CXADR;VPS13C;MEF2A;GABPB1;SAMM50;VPS13D;NRF1;MIEF1;MTX2;MTFR1;WDR81;MTX3;PPRC1;YME1L1;HCFC1;TIMM23;OMA1;PITRM1;POLG2;BCAP31;TIMM17B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.23126366469310825,0.5566604476963661,0.957325746799431,1.0,1.0,3/29,8.83%,RAET1E;KLRC2;PVR
prerank,negative regulation of cholesterol transport (GO:0032375),0.279679142376172,0.555409322777681,0.9283088235294118,1.0,1.0,1/10,9.31%,NFKB1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2488019664636604,0.5539275516687836,0.9462540716612378,1.0,1.0,3/20,13.93%,ACSL3;SCD;ACSM2A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.22887907606179467,-0.5527919877950749,0.973753280839895,1.0,1.0,8/13,40.80%,NECTIN2;MR1;STX7;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,defense response to fungus (GO:0050832),0.2537640693182468,0.5527621583305287,0.9349206349206349,1.0,1.0,3/17,17.17%,PLCG2;FAM3A;BCL10
prerank,cilium movement (GO:0003341),0.21502004809629877,0.5517088155975393,0.9786666666666667,1.0,1.0,11/47,22.91%,CFAP70;SPAG17;CCDC40;DNAAF4;TEKT2;RSPH9;ODAD3;ODAD2;CAMSAP3;RSPH6A;SPEF1
prerank,negative regulation of DNA recombination (GO:0045910),-0.1744274371061482,-0.5467018766909503,0.9855595667870036,1.0,1.0,12/43,29.98%,RIF1;BLM;POLR2G;POLR2K;SHLD3;TERF2IP;H1-0;UBQLN4;SMCHD1;POLR2L;TERF1;RADX
prerank,phagosome acidification (GO:0090383),0.23084729915764748,0.5459604551261081,0.9623493975903614,1.0,1.0,5/26,19.59%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H
prerank,regulation of response to interferon-gamma (GO:0060330),0.2545312669684956,0.5446474066096524,0.9463986599664992,1.0,1.0,1/14,4.70%,PTPN2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.26530332289512526,0.543679060427828,0.9360655737704918,1.0,1.0,6/12,31.61%,RMDN1;KIF2C;CENPC;CHAMP1;MAD1L1;SEH1L
prerank,regulation of TOR signaling (GO:0032006),0.20326542776099052,0.5428971124566141,0.9847908745247148,1.0,1.0,8/67,12.79%,TELO2;NPRL3;GOLPH3;RRAGB;ITFG2;MLST8;SMCR8;SEC13
prerank,autophagosome maturation (GO:0097352),0.22300052420941566,0.5426680713954722,0.9717912552891397,1.0,1.0,3/32,9.24%,WIPI2;VCP;LIX1L
prerank,protein localization to phagophore assembly site (GO:0034497),0.2694806954959466,0.5426475274074586,0.9220338983050848,1.0,1.0,1/11,4.80%,WIPI2
prerank,nucleus organization (GO:0006997),0.21402020807300987,0.5421987216761879,0.9831168831168832,1.0,1.0,12/47,25.39%,NUP93;PDCD6IP;SUN3;LEMD2;PITPNB;USP36;NUP98;TMEM170A;SUN2;NUP54;CHMP4A;CHMP4B
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.23783342533804297,-0.5418715309240298,0.9557109557109557,1.0,1.0,3/10,24.02%,MMGT1;EMC7;EMC6
prerank,positive regulation of DNA recombination (GO:0045911),0.22708706268284962,0.5399620805189059,0.9847560975609756,1.0,1.0,11/27,33.47%,FUS;MRNIP;SHLD1;WDR48;KMT5B;ERCC2;RAD51AP1;PAXIP1;ZCWPW1;ACTR2;KMT5C
prerank,gas transport (GO:0015669),-0.24169403523139987,-0.5387939800647299,0.954337899543379,1.0,1.0,6/10,34.15%,CA2;AQP1;MYC;MB;NGB;RHAG
prerank,cellular response to interferon-beta (GO:0035458),0.255963919159428,0.536868424626414,0.9379084967320261,1.0,1.0,3/14,15.93%,IRF1;UBE2K;ACOD1
prerank,mucosal immune response (GO:0002385),-0.21532657265142133,-0.5359003409284453,0.953551912568306,1.0,1.0,2/15,12.12%,DEFA6;RPL39
prerank,lysine catabolic process (GO:0006554),0.2645120521553883,0.5345213224307038,0.9244288224956063,1.0,1.0,6/12,28.58%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,lysine metabolic process (GO:0006553),0.2645120521553883,0.5345213224307038,0.9244288224956063,1.0,1.0,6/12,28.58%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2050527057733657,-0.5336767819684457,0.9782016348773842,1.0,1.0,5/17,26.54%,MMGT1;EMC7;SGTA;EMC6;GET4
prerank,tRNA 5'-end processing (GO:0099116),-0.21776280399911374,-0.5327095519201076,0.9763157894736842,1.0,1.0,10/15,41.96%,POP5;POP7;RPP21;HSD17B10;PRORP;RPP25L;RPP25;RPP40;TRMT10C;RPP14
prerank,glycine metabolic process (GO:0006544),0.25738927208438206,0.5321420574705944,0.9362416107382551,1.0,1.0,3/12,23.48%,GCAT;DLD;SDSL
prerank,myelin maintenance (GO:0043217),0.2694890685047405,0.5320726269146405,0.9474576271186441,1.0,1.0,3/10,17.00%,CLU;CXCR4;ABCD1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19646363682511248,0.5319029884083468,0.9897304236200257,1.0,1.0,12/70,17.12%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMC1;PSMD7
prerank,cardiolipin metabolic process (GO:0032048),0.2574280246045654,0.5287073173453308,0.9526315789473684,1.0,1.0,4/13,20.47%,PLSCR3;LCLAT1;TAMM41;PLA2G4A
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22195911649966152,0.5278682710253169,0.98125,1.0,1.0,6/28,20.84%,PRKDC;MRNIP;KDM4D;SHLD1;PARP3;KMT5B
prerank,isotype switching (GO:0045190),0.2648404826617872,0.5262859582610199,0.9499136442141624,1.0,1.0,4/10,33.07%,RNF168;RNF8;EXOSC3;LIG4
prerank,antibacterial humoral response (GO:0019731),-0.20743845645118908,-0.5262392428046503,0.9862637362637363,1.0,1.0,2/16,12.12%,DEFA6;RPL39
prerank,determination of bilateral symmetry (GO:0009855),0.22914747350943787,0.5249412865581694,0.9709480122324159,1.0,1.0,7/24,21.70%,PITX2;GALNT11;STIL;DNAAF4;KIF3B;ODAD3;ODAD2
prerank,mitochondrial gene expression (GO:0140053),0.2078637978901897,0.5236473478966491,0.9889042995839112,1.0,1.0,20/42,36.04%,FOXO3;GFM2;NOA1;MRPS28;MRPL57;FASTKD5;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPS34;MRPS16;PTCD3;GATC;QRSL1;MRPS24;NDUFA7;MRPS15
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2510503452311665,0.5234989765541322,0.9490131578947368,1.0,1.0,5/13,27.02%,USP4;PRPF3;LSM2;SRSF12;PRPF6
prerank,modulation by host of symbiont process (GO:0051851),0.21957398705096218,0.5208992099417581,0.983679525222552,1.0,1.0,11/31,23.32%,JUN;CCL3;SMARCA4;EP300;REST;RRP1B;CCNT1;SNW1;CHD1;SAP30BP;TARDBP
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.16080017524390663,-0.5205062655275841,0.9961685823754789,1.0,1.0,21/46,38.67%,HK2;TIMM17A;TOMM7;AKT1;MFN2;CHCHD4;TOMM40;TOMM22;RALA;ROMO1;MFF;PINK1;FBXO7;TOMM40L;HSPD1;GRPEL1;TOMM20L;TIMM13;HK1;TIMM44;TOMM5
prerank,DNA biosynthetic process (GO:0071897),0.2400068433077847,0.5203020437805693,0.9434276206322796,1.0,1.0,3/16,21.21%,WRN;POLA1;POLD3
prerank,RNA polyadenylation (GO:0043631),0.22548271937867728,0.517929913147954,0.9703125,1.0,1.0,10/26,32.50%,SCAF8;PABPC1;TENT2;PAF1;FIP1L1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,mRNA polyadenylation (GO:0006378),0.22548271937867728,0.517929913147954,0.9703125,1.0,1.0,10/26,32.50%,SCAF8;PABPC1;TENT2;PAF1;FIP1L1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,mitotic metaphase plate congression (GO:0007080),0.20281001355308284,0.5173189016733425,0.9906542056074766,1.0,1.0,16/51,30.11%,BECN1;PDCD6IP;PIBF1;CUL3;RMDN1;SPDL1;ZW10;KIF2C;CCNB1;CHMP4A;CHMP4B;KIF18A;CENPC;CHAMP1;MAD1L1;PINX1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2327058701690666,0.5160154682889021,0.9704049844236761,1.0,1.0,5/18,24.32%,TIMM23;TIMM17B;DNAJC19;GRPEL2;TOMM20
prerank,lipoxygenase pathway (GO:0019372),0.24937456525173485,0.5158819248045218,0.9458128078817734,1.0,1.0,1/14,5.77%,PON3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.24925513668339727,0.5144542056258855,0.9555921052631579,1.0,1.0,3/13,18.62%,NRP1;PLXNA2;PLXNB1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.17946075608085904,-0.5142537902225705,0.9937304075235109,1.0,1.0,1/25,1.89%,SORT1
prerank,peptidyl-methionine modification (GO:0018206),0.2521959135975058,0.5129353601952703,0.9629005059021922,1.0,1.0,4/12,27.52%,NAA15;METAP1D;METAP2;NAA60
prerank,methylguanosine-cap decapping (GO:0110156),-0.22818238837070048,-0.510356095827407,0.9647058823529412,1.0,1.0,5/10,35.39%,DCP2;PATL2;LSM1;EDC4;DCP1B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.25759762197065406,0.5077702524489552,0.9486754966887417,1.0,1.0,1/11,7.34%,TAS1R3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.24483170038970753,0.5074709242031027,0.9564489112227805,1.0,1.0,6/14,33.15%,TSEN54;DDX1;CLP1;CPSF4;RTCB;TRPT1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.25120742671471896,0.5073738182561274,0.958974358974359,1.0,1.0,3/10,20.50%,NPLOC4;UFD1;GPATCH3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.25015364569502113,0.5072959823417,0.9473684210526315,1.0,1.0,3/10,23.09%,KNSTRN;CDC42;CCNB1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.22439231994069161,0.5047900831621236,0.9792663476874003,1.0,1.0,2/20,8.78%,AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.22439231994069161,0.5047900831621236,0.9792663476874003,1.0,1.0,2/20,8.78%,AUH;HIBCH
prerank,melanosome transport (GO:0032402),0.22541153180719978,0.5043375831707083,0.977491961414791,1.0,1.0,1/18,3.59%,MLPH
prerank,pigment granule transport (GO:0051904),0.22541153180719978,0.5043375831707083,0.977491961414791,1.0,1.0,1/18,3.59%,MLPH
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.22972060466835587,0.5042820922438387,0.9657320872274143,1.0,1.0,4/20,19.51%,CLU;PSMG2;PSMG1;BBS12
prerank,regulation of lymphocyte migration (GO:2000401),-0.22177428643603198,-0.504213463534109,0.9861111111111112,1.0,1.0,6/10,39.40%,JAM2;AKT1;WASL;MSN;CCR6;SPN
prerank,negative regulation of defense response to virus (GO:0050687),-0.21897947655808697,-0.5041188620694056,0.9656019656019657,1.0,1.0,10/10,78.12%,TARBP2;TSPAN6;PCBP2;C1QBP;ITCH;MUL1;ILRUN;PPM1B;RNF26;TRAF3IP1
prerank,regulation of spindle organization (GO:0090224),-0.1949136577708006,-0.5034896642279856,0.9833729216152018,1.0,1.0,18/18,80.54%,MAP9;TPX2;NUP62;GNAI1;CLTC;FSD1;PSRC1;NUMA1;ANKRD53;DYNC1H1;RNF4;DCTN1;BORA;RAE1;SENP6;TACC3;GPSM2;PARP3
prerank,phosphate ion transport (GO:0006817),0.2316048421995621,0.5025557393478994,0.9663865546218487,1.0,1.0,5/16,29.42%,SLC34A2;SLC25A14;SLC20A1;SLC25A3;SLC37A1
prerank,CENP-A containing chromatin organization (GO:0061641),0.21364548930045493,0.5014674769487583,0.9895522388059701,1.0,1.0,13/29,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.21364548930045493,0.5014674769487583,0.9895522388059701,1.0,1.0,13/29,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.23542090621594283,0.4994096220476418,0.9675324675324676,1.0,1.0,5/16,28.59%,SFSWAP;WBP4;SRSF12;SNRNP200;NCBP2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.1904688230309881,-0.4983674513463233,0.9886039886039886,1.0,1.0,5/19,29.26%,POLR2G;POLR2K;TERF2IP;POLR2L;TERF1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.1904688230309881,-0.4983674513463233,0.9886039886039886,1.0,1.0,5/19,29.26%,POLR2G;POLR2K;TERF2IP;POLR2L;TERF1
prerank,regulation of lymphocyte activation (GO:0051249),-0.21203541837654769,-0.4963141464173104,0.9825436408977556,1.0,1.0,4/12,30.02%,PAG1;THEMIS2;CCL5;CRTAM
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.19588146659969866,-0.4957606224599666,0.9778325123152709,0.9998922896622261,1.0,15/15,80.44%,ERN1;TSEN15;FAM98B;TSEN34;RTRAF;CPSF1;ZBTB8OS;TSEN2;CSTF2;TRPT1;RTCB;CPSF4;CLP1;DDX1;TSEN54
prerank,steroid hormone biosynthetic process (GO:0120178),0.20840802874568842,0.49550007745698305,0.9815078236130867,1.0,1.0,7/29,27.60%,FDX1;STARD3NL;CYP19A1;DHCR7;HSD17B2;AKR1B1;STAR
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.2514736138322425,0.49426371072356773,0.9580536912751678,1.0,1.0,2/10,15.99%,USP7;GNMT
prerank,negative regulation of centrosome duplication (GO:0010826),0.2406481526591667,0.4941245515959048,0.9621993127147767,1.0,1.0,3/11,17.59%,KAT2A;KAT2B;RBM14
prerank,regulation of T cell activation (GO:0050863),0.19603436944055178,0.4934765696296753,0.9941690962099126,1.0,1.0,5/42,13.68%,ABL1;CD2;KAT2A;TNFRSF1B;TNFSF11
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.21645863176386393,0.49337789605740207,0.9794419970631424,1.0,1.0,6/24,18.84%,EED;DNMT3A;SUZ12;EPC1;RBBP7;TASOR
prerank,phagosome-lysosome fusion (GO:0090385),0.25320405104083876,0.4931406289737246,0.9700704225352113,1.0,1.0,1/10,4.75%,RAB7B
prerank,regulation of endocytic recycling (GO:2001135),0.241425031174166,0.493097168532887,0.956442831215971,1.0,1.0,4/11,23.44%,EHD1;EHD2;RAB11B;ATP9A
prerank,rRNA catabolic process (GO:0016075),0.2341997494472505,0.49274434232834097,0.9642301710730948,1.0,1.0,7/16,32.48%,EXOSC7;ERN2;EXOSC4;EXOSC2;DIS3;XRN1;EXOSC3
prerank,rRNA methylation (GO:0031167),0.21726022234784245,0.49222554247390576,0.9740061162079511,1.0,1.0,22/22,78.30%,METTL15;FTSJ3;MRM1;MRM2;NSUN4;METTL5;NOP2;NSUN3;MRM3;ZCCHC4;MTERF4;NSUN5;TFB1M;FBLL1;TRMT112;DIMT1;FBL;METTL16;TFB2M;FDXACB1;BUD23;EMG1
prerank,kinetochore organization (GO:0051383),-0.2049147905314622,-0.4920084975313671,0.9806295399515739,0.999713897064935,1.0,8/13,38.44%,CENPA;DLGAP5;NUF2;CENPF;NDC80;CDT1;CENPE;CENPH
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2166006259501681,-0.48813643975882115,0.964200477326969,0.9994860494282937,1.0,3/10,28.35%,MFSD2A;MTMR2;MTMR3
prerank,protein palmitoylation (GO:0018345),0.20312541800750908,0.48766802248218566,0.9912917271407837,1.0,1.0,8/30,20.27%,ZDHHC11;ZDHHC15;HHAT;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,piRNA metabolic process (GO:0034587),0.21859170443846299,0.48551740614065386,0.9755700325732899,1.0,1.0,18/19,68.90%,TDRD9;TDRD12;TEX15;MAEL;PIWIL4;EXD1;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MYBL1;DDX4;FKBP6
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.23352277263295573,0.4854441406750233,0.9770491803278688,1.0,1.0,1/11,5.94%,STAT3
prerank,intracellular pH reduction (GO:0051452),0.19710839309973333,0.47988395768772796,0.9897360703812317,1.0,1.0,5/33,19.59%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H
prerank,tRNA processing (GO:0008033),0.18146234797267366,0.4790562624943949,0.9987129987129987,1.0,1.0,23/61,35.69%,TYW5;ELP5;CTU2;TRMT10A;TRDMT1;TSEN54;METTL1;DDX1;SSB;QTRT1;PTCD1;FARS2;CLP1;CPSF4;URM1;FTSJ1;RTCB;KARS1;TRPT1;ELAC2;WDR4;TRMT6;POP1
prerank,regulation of cytoplasmic transport (GO:1903649),0.23271601025650174,0.4771384412232784,0.9701492537313433,1.0,1.0,3/11,23.44%,USP7;MAP2K2;ATP9A
prerank,tetrahydrofolate metabolic process (GO:0046653),0.24452394401556526,0.4764024680233716,0.9574105621805792,1.0,1.0,10/10,75.56%,MTHFR;MTHFD2L;DHFR;TYMS;MTHFD2;MTHFD1;SHMT1;MTHFD1L;MTHFS;SHMT2
prerank,homocysteine metabolic process (GO:0050667),-0.20867258128143557,-0.47590548879265226,0.9796954314720813,1.0,1.0,2/11,16.84%,NOX4;CBS
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.20013722674208104,-0.4744265421376079,0.9924812030075187,1.0,1.0,5/11,41.89%,BLM;FBH1;TIMELESS;GMNN;LIG3
prerank,heterochromatin assembly (GO:0031507),-0.17911076058190922,-0.47349623783034445,0.9917355371900827,0.9992366582577171,1.0,12/20,42.62%,MBD2;ZNFX1;SMCHD1;SUV39H1;SIRT2;HMGA2;H3-3A;CDKN2A;BEND3;POLE3;HELLS;CENPV
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.23728876732736282,0.4732026721182381,0.9695340501792115,1.0,1.0,3/10,25.09%,ZC3H12A;SMAD7;RC3H2
prerank,meiosis I (GO:0007127),0.20760050251256235,0.47312791855916086,0.9827856025039123,1.0,1.0,23/23,79.27%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZCWPW1;ZSCAN21;HSF2BP;BRDT;PTTG1;MEIOB;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;SGO1;MEIKIN;MOV10L1;MYBL1;DDX4;BCL2L11;SLC25A31;ING2
prerank,regulation of intracellular transport (GO:0032386),0.19141861189207132,0.4730309919825393,0.989041095890411,1.0,1.0,10/38,25.28%,NDEL1;GAS1;CAPN10;GRIPAP1;NUP214;RAB11B;AAAS;RBM4;ATP9A;PTPN1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.23654524162244844,0.4723810864244481,0.9741379310344828,1.0,1.0,7/11,37.64%,AGK;TIMM9;TIMM29;TIMM22;TIMM10;TIMM8B;TIMM10B
prerank,chromatin remodeling at centromere (GO:0031055),0.19877400180609583,0.47081572803160643,1.0,1.0,1.0,13/31,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,phagolysosome assembly (GO:0001845),0.23255726538333338,0.46927101847317493,0.9830508474576272,1.0,1.0,1/12,4.75%,RAB7B
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.1899560577526679,-0.46689062724919533,0.9875,0.9993278504047813,1.0,13/13,81.03%,BMF;PMAIP1;VDAC2;BCL2L11;BNIP3L;BAD;BLOC1S2;RTL10;RHOT2;BAX;RHOT1;BNIP3;MOAP1
prerank,RNA modification (GO:0009451),0.17581442771674846,0.4668253078503151,0.9945872801082544,1.0,1.0,19/54,32.85%,TYW5;ELP5;CTU2;JMJD6;TRDMT1;PUS7L;METTL1;SSB;FTSJ3;QTRT1;NAT10;PARN;MRM2;NSUN4;PUS7;URM1;FTSJ1;NOP2;MEPCE
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2004542655893371,0.465157981553244,0.9836552748885586,1.0,1.0,4/26,15.93%,TRAFD1;IRAK3;CARD16;ACOD1
prerank,regulation of mitotic spindle organization (GO:0060236),0.18957659074304467,0.4643349815610321,0.9926793557833089,1.0,1.0,13/35,34.46%,PDCD6IP;CEP97;PARP3;GPSM2;DRG1;CHMP4B;TACC3;RAE1;BORA;DCTN1;DYNC1H1;CHMP3;CHMP2B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.1944898138957797,0.46343021875126683,0.9942028985507246,1.0,1.0,9/31,24.32%,TIMM23;TIMM17B;AIFM1;DNAJC19;PEX2;GRPEL2;PEX7;PEX26;TOMM20
prerank,synaptonemal complex assembly (GO:0007130),0.21545976442082354,0.4598678652301688,0.9868421052631579,1.0,1.0,1/15,8.20%,P3H4
prerank,synaptonemal complex organization (GO:0070193),0.21545976442082354,0.4598678652301688,0.9868421052631579,1.0,1.0,1/15,8.20%,P3H4
prerank,secondary alcohol biosynthetic process (GO:1902653),0.1937449607095118,0.4596161959786943,0.9881305637982196,1.0,1.0,8/30,28.06%,LBR;MVD;EBP;HMGCR;FDPS;DHCR7;HMGCS1;FDFT1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.19023583125360993,-0.45947801008823597,0.98989898989899,0.9994104774980094,1.0,4/13,30.87%,BOLA2;YAE1;GLRX5;ISCA2
prerank,midbody abscission (GO:0061952),0.21371251149701742,0.4573385234354207,0.9843014128728415,1.0,1.0,1/17,5.43%,PDCD6IP
prerank,homologous chromosome segregation (GO:0045143),-0.16905955832791164,-0.4527269375002581,1.0,0.9993200902116501,1.0,1/20,6.12%,FMN2
prerank,pre-replicative complex assembly (GO:0036388),0.170064516658062,0.4521254967131462,1.0,1.0,1.0,16/64,28.33%,PSMB2;MCM7;MCM2;PSMC6;PSMD11;PSMD1;PSMC1;PSMD7;PSMD14;PSMD3;PSMD12;ORC3;PSMD4;PSME3;PSMD2;MCM6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.202743812352209,0.45098190359764173,0.9876923076923076,1.0,1.0,2/20,9.09%,PDCD6IP;RIPK3
prerank,male meiosis I (GO:0007141),0.20750926100332745,0.44749212462548893,0.9752066115702479,1.0,1.0,16/16,79.27%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZSCAN21;HSF2BP;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;SLC25A31;ING2
prerank,lymphocyte migration (GO:0072676),0.1816557373961506,0.4451304593520397,0.9914040114613181,1.0,1.0,7/32,22.59%,CCL3;CCL1;RET;ADAM8;GATA3;CCL15;CCL7
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.18757069247203703,0.4444760813116332,0.9955817378497791,1.0,1.0,29/29,81.28%,P3H4;IHO1;ANKRD31;RAD21L1;RNF212B;ZCWPW1;SIRT7;MEI4;REC8;PRDM9;MEIOB;RNF212;KASH5;SYCE1;SYCE3;SYCE2;SYCP1;TERB1;TERB2;HORMAD1;BAG6;RAD21;MAJIN;TEX11;SYCP2;STAG3;TEX12;TRIP13;FANCD2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1996629736939901,0.44265086531033315,0.9861111111111112,1.0,1.0,3/18,14.78%,SPAG17;CCDC40;DNAAF4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2076364379693661,0.43770490705939785,0.9853420195439739,1.0,1.0,5/14,29.33%,MRPS27;RPUSD4;MPV17L2;TRUB2;FASTKD3
prerank,transcription by RNA polymerase III (GO:0006383),0.1877437211167196,0.43624268063779903,0.9926362297496318,1.0,1.0,12/27,34.12%,SNAPC2;POLR3K;SNAPC5;ICE2;CRCP;SNAPC4;POLR3GL;GTF3C3;GTF3C2;GTF3C1;GTF3A;RO60
prerank,metallo-sulfur cluster assembly (GO:0031163),0.18841639465072446,0.43093019281174333,0.9892307692307692,1.0,1.0,3/22,17.46%,NFS1;NFU1;NUBP2
prerank,centromere complex assembly (GO:0034508),0.17753121743551936,0.42899291248930027,0.9985422740524781,1.0,1.0,14/36,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;POGZ;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,tRNA 5'-leader removal (GO:0001682),0.2067796610169491,0.4267040634003527,0.9847198641765704,1.0,1.0,13/13,79.34%,RPP38;SSB;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP25L;PRORP;RPP21;POP7;POP5
prerank,sensory perception of chemical stimulus (GO:0007606),0.19974699422668007,0.4238806122864472,0.9881154499151104,1.0,1.0,6/15,37.01%,GNAS;CD36;BBS4;BEST2;UBR3;MKKS
prerank,B cell mediated immunity (GO:0019724),-0.18367506367268455,-0.4225440223816028,1.0,1.0,1.0,4/10,36.15%,CD74;CARD9;FCGR2B;SLA2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.1842214757628659,0.4210623639400127,0.9967373572593801,1.0,1.0,6/24,25.16%,POLB;RPA1;RFC1;POLD3;RFC5;POLK
prerank,regulation of lipid catabolic process (GO:0050994),0.18585941812569728,0.42086748999337986,0.9934959349593496,1.0,1.0,6/19,28.56%,LONP2;ABCD1;ANGPTL3;TYSND1;BSCL2;PRKAA1
prerank,ESCRT complex disassembly (GO:1904896),0.20906295110776402,0.4154585585415023,0.9879310344827587,1.0,1.0,10/10,79.11%,IST1;VTA1;CHMP2B;CHMP5;CHMP2A;VPS4B;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),0.20906295110776402,0.4154585585415023,0.9879310344827587,1.0,1.0,10/10,79.11%,IST1;VTA1;CHMP2B;CHMP5;CHMP2A;VPS4B;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17466573030269303,0.41517357840970387,1.0,1.0,1.0,5/31,20.37%,NFS1;MOCOS;PYCR1;MOCS3;CYP19A1
prerank,cholesterol biosynthetic process (GO:0006695),0.17378082654263444,0.41156328073892573,0.9970059880239521,1.0,1.0,5/31,18.59%,LBR;MVD;EBP;HMGCR;FDPS
prerank,peptidyl-amino acid modification (GO:0018193),0.20522494611767267,0.40994459556194973,0.9898648648648649,1.0,1.0,3/10,25.10%,FKBP10;METAP1D;METAP2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.18867795381682548,0.4061193240045073,0.9899497487437185,1.0,1.0,4/16,25.16%,SHLD1;RMI2;HELB;POLQ
prerank,phosphate ion transmembrane transport (GO:0035435),-0.17035967610319502,-0.3961711736151479,1.0,1.0,1.0,12/12,82.98%,XPR1;SLC25A11;SLC37A3;SLC25A10;SLC20A2;SLC37A4;SLC25A30;SLC37A2;SLC37A1;SLC25A3;SLC20A1;SLC25A14
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.19178349327110733,0.3955859710413158,0.9930313588850174,1.0,1.0,1/11,11.74%,CBFB
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.16758278536453952,-0.3937892786865593,0.9974874371859297,1.0,1.0,4/12,29.32%,GRN;CLN6;PPT1;ATP6AP2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.18469672066469622,0.3922584930398404,0.9984251968503937,1.0,1.0,5/16,25.39%,TMEM50B;SNF8;VTA1;CHMP4A;CHMP4B
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.1568935208437971,-0.3916383184928224,1.0,0.9999869166441001,1.0,15/15,84.33%,QDPR;AADAT;GSTZ1;IL4I1;KYNU;IDO1;ACMSD;KMO;FAH;TAT;HAAO;HGD;IDO2;TDO2;KYAT1
prerank,covalent chromatin modification (GO:0016569),-0.15922223283705242,-0.38855921763015333,1.0,0.9991821930258357,1.0,3/14,21.85%,MBD2;MT3;HLCS
prerank,negative regulation of ATPase activity (GO:0032780),0.17997972858707875,0.38837505197795513,0.9952830188679245,1.0,1.0,5/16,34.06%,TNNI3;ATP5IF1;THADA;TSC1;PPIF
prerank,tryptophan metabolic process (GO:0006568),0.18522470499623386,0.3727254548635096,0.9982363315696648,1.0,1.0,11/11,81.49%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;ATP7A
prerank,positive regulation of translational initiation (GO:0045948),0.16969119229943702,0.371151705714681,1.0,1.0,1.0,5/18,24.57%,MTOR;KHDRBS1;YTHDF2;CDC123;YTHDF3
prerank,regulation of mitochondrial translation (GO:0070129),0.16460589397661402,0.36804360950215687,0.9984447900466563,1.0,1.0,7/21,31.21%,MRPS27;RPUSD4;MPV17L2;TRUB2;MALSU1;FASTKD3;MTG2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.18144731061319286,0.36186454870971596,0.9965156794425087,1.0,1.0,10/10,81.87%,OS9;YOD1;SVIP;DERL2;UBAC2;UBE2G2;DERL3;INSIG1;UBE2J1;ERLEC1
prerank,nucleosome disassembly (GO:0006337),0.16936578010116474,0.3594148834726585,0.9983792544570502,1.0,1.0,5/14,29.49%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,chromatin disassembly (GO:0031498),0.16936578010116474,0.3594148834726585,0.9983792544570502,1.0,1.0,5/14,29.49%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.1759155662932077,0.3515030669491702,1.0,1.0,1.0,2/10,18.46%,ATRX;INO80
prerank,B cell activation involved in immune response (GO:0002312),0.16854990583804136,0.34844150868041407,1.0,1.0,1.0,13/13,83.16%,RNF168;RNF8;EXOSC3;LIG4;CD40LG;MSH2;GAPT;CD19;MSH6;FCGR2B;GPR183;BATF;CD180
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.15756909460030222,0.346701387787205,0.9984202211690363,1.0,1.0,6/19,32.48%,STN1;TEN1;NAT10;ACD;PINX1;XRN1
prerank,iron-sulfur cluster assembly (GO:0016226),0.14350218294955225,0.3331110780428466,1.0,1.0,1.0,3/24,17.46%,NFS1;NFU1;NUBP2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.1426507537688443,0.3206629490915499,1.0,1.0,1.0,23/23,85.76%,SAMM50;AGK;MOAP1;HSPA4;TIMM9;BAX;TIMM29;TIMM22;TIMM10;TIMM8B;TIMM10B;MAIP1;TOMM70;BAD;HSP90AA1;TIMM13;BCL2L11;ROMO1;PMAIP1;NDUFA13;TOMM22;COX18;BMF
prerank,spliceosomal snRNP assembly (GO:0000387),0.12914177931468093,0.31579808169943635,1.0,0.9998404771488391,1.0,38/38,87.12%,USP4;PRPF3;GEMIN8;LSM2;SRSF12;PRMT5;LSM4;PRPF6;TGS1;SNUPN;SMN1;SNRPD2;SNRPD1;SNRPE;SNRPD3;CD2BP2;SART1;GEMIN5;PRPF8;COIL;GEMIN2;GEMIN6;GEMIN4;PRPF19;PRPF31;SNRPC;STRAP;SNRPB;SNRPF;GEMIN7;CLNS1A;PRMT7;SART3;WDR77;DDX20;SRSF10;SNRPG;AAR2
